Clustering O 0 0.007242425344884396
of O 0 0.0010483694495633245
missense O 0 0.004734106361865997
mutations O 0 0.0005667662480846047
in O 0 0.00020265995408408344
the O 0 0.0016067888354882598
ataxia B-Disease 1 0.9999955892562866
- I-Disease 1 0.998298704624176
telangiectasia I-Disease 1 0.9996803998947144
gene O 0 0.0002867102448362857
in O 0 0.00011047645239159465
a O 0 0.0006324529531411827
sporadic B-Disease 1 0.9210079908370972
T I-Disease 1 0.9999539852142334
- I-Disease 1 0.9948288798332214
cell I-Disease 1 0.873285174369812
leukaemia I-Disease 1 0.9998377561569214
. O 0 0.00187973293941468

Ataxia B-Disease 1 0.9999852180480957
- I-Disease 1 0.9994877576828003
telangiectasia I-Disease 1 0.9999873638153076
( O 1 0.5996677279472351
A B-Disease 1 0.9997573494911194
- I-Disease 1 0.9999281167984009
T I-Disease 1 0.999697208404541
) O 0 7.04177946317941e-05
is O 0 5.993340164422989e-05
a O 0 0.00019736334797926247
recessive B-Disease 1 0.9851560592651367
multi I-Disease 1 0.9998666048049927
- I-Disease 1 0.9999666213989258
system I-Disease 1 0.9964945912361145
disorder I-Disease 1 0.999998927116394
caused O 1 0.9897365570068359
by O 0 0.00012618581240531057
mutations O 0 7.902198558440432e-05
in O 0 2.104891427734401e-05
the O 0 5.871666144230403e-05
ATM O 0 0.00030676674214191735
gene O 0 0.00010213200584985316
at O 0 0.0001432698336429894
11q22 O 1 0.5777600407600403
- O 0 0.03460362181067467
q23 O 1 0.8797829151153564
( O 0 0.00046419352293014526
ref O 0 0.03807814046740532
. O 0 0.00014458788791671395
3 O 0 0.00030964543111622334
) O 0 0.0003623136435635388
. O 0 0.0007489730487577617

The O 0 0.0018976135179400444
risk O 0 0.02294144779443741
of O 0 0.014585386961698532
cancer B-Disease 1 0.99994957447052
, O 0 0.0022353746462613344
especially O 0 0.00834668055176735
lymphoid B-Disease 1 0.9997808337211609
neoplasias I-Disease 1 0.9990105628967285
, O 0 0.00013067942927591503
is O 0 6.752557237632573e-05
substantially O 0 0.0001550568558741361
elevated O 0 0.06487103551626205
in O 0 0.00016388796211685985
A B-Disease 1 0.9954333901405334
- I-Disease 1 0.9999610185623169
T I-Disease 1 0.999987006187439
patients O 0 0.34668076038360596
and O 0 6.878537533339113e-05
has O 0 5.826091728522442e-05
long O 0 0.00011186356277903542
been O 0 6.492468673968688e-05
associated O 0 0.0001539509103167802
with O 0 0.0003386118623893708
chromosomal O 1 0.9927796721458435
instability O 1 0.997308611869812
. O 0 0.0037098429165780544

By O 0 0.0019506624666973948
analysing O 0 0.009207190945744514
tumour B-Disease 1 0.9997242093086243
DNA O 0 0.0007121225353330374
from O 0 0.0002170451043639332
patients O 0 0.0018479571444913745
with O 0 0.0001320762385148555
sporadic B-Disease 0 0.2551368474960327
T I-Disease 1 0.9996685981750488
- I-Disease 1 0.9622827172279358
cell I-Disease 1 0.8223029971122742
prolymphocytic I-Disease 1 0.9999597072601318
leukaemia I-Disease 1 0.9999984502792358
( O 1 0.9064539670944214
T B-Disease 1 0.9999055862426758
- I-Disease 1 0.9211589694023132
PLL I-Disease 1 0.998641312122345
) O 0 6.691295857308432e-05
, O 0 4.612197881215252e-05
a O 0 8.655063720652834e-05
rare O 0 0.00042273063445463777
clonal B-Disease 0 0.3380318582057953
malignancy I-Disease 1 0.973899245262146
with O 0 4.463776349439286e-05
similarities O 0 8.488790626870468e-05
to O 0 2.6415114916744642e-05
a O 0 0.00012404436711221933
mature B-Disease 0 0.011719191446900368
T I-Disease 1 0.9855948686599731
- I-Disease 0 0.32127004861831665
cell I-Disease 0 0.039250388741493225
leukaemia I-Disease 1 0.9982435703277588
seen O 0 0.00017830784781835973
in O 0 0.00011384566460037604
A B-Disease 1 0.9452710151672363
- I-Disease 1 0.9936275482177734
T I-Disease 1 0.9776121377944946
, O 0 6.0466314607765526e-05
we O 0 3.0182778573362157e-05
demonstrate O 0 6.530781683977693e-05
a O 0 4.111276939511299e-05
high O 0 6.210081483004615e-05
frequency O 0 4.952927338308655e-05
of O 0 7.118063513189554e-05
ATM O 0 0.0006360335391946137
mutations O 0 0.00033298719790764153
in O 0 0.0003007513878401369
T B-Disease 1 0.9697782397270203
- I-Disease 0 0.3635377883911133
PLL I-Disease 1 0.9825032949447632
. O 0 0.0019068930996581912

In O 0 0.0008006864809431136
marked O 0 0.0011072682682424784
contrast O 0 0.0002164866600651294
to O 0 4.9922622565645725e-05
the O 0 7.209273462649435e-05
ATM O 0 0.000626737775746733
mutation O 0 0.00015303061809390783
pattern O 0 0.00021897449914831668
in O 0 8.612892997916788e-05
A B-Disease 1 0.9523131251335144
- I-Disease 1 0.9988982677459717
T I-Disease 1 0.9953508377075195
, O 0 6.263185059651732e-05
the O 0 4.526791235548444e-05
most O 0 2.896406476793345e-05
frequent O 0 6.284489791141823e-05
nucleotide O 0 8.10058627394028e-05
changes O 0 3.917530921171419e-05
in O 0 5.720187982660718e-05
this O 0 0.00012739264639094472
leukaemia B-Disease 1 0.9929889440536499
were O 0 0.0003670962469186634
missense O 0 0.016081953421235085
mutations O 0 0.0021648285910487175
. O 0 0.0012980470201000571

These O 0 0.00047456627362407744
clustered O 0 0.0007085472461767495
in O 0 0.00010029260738519952
the O 0 8.261248876806349e-05
region O 0 9.906332707032561e-05
corresponding O 0 6.41397200524807e-05
to O 0 2.888735252781771e-05
the O 0 5.312551002134569e-05
kinase O 0 0.00015444566088262945
domain O 0 6.418444536393508e-05
, O 0 3.946930155507289e-05
which O 0 1.9261888155597262e-05
is O 0 1.8189826732850634e-05
highly O 0 3.490714880172163e-05
conserved O 0 3.6148790968582034e-05
in O 0 3.53742616425734e-05
ATM O 0 0.00029852971783839166
- O 0 0.00027536650304682553
related O 0 7.779502630000934e-05
proteins O 0 6.537973240483552e-05
in O 0 6.329253665171564e-05
mouse O 0 0.0005199284059926867
, O 0 0.000178384012542665
yeast O 0 0.0008137262193486094
and O 0 0.0004055409226566553
Drosophila O 0 0.0024365310091525316
. O 0 0.001178278005681932

The O 0 0.0013274317607283592
resulting O 0 0.0011285750661045313
amino O 0 0.00043405930045992136
- O 0 0.002469398081302643
acid O 0 0.00029911543242633343
substitutions O 0 0.00014185825421009213
are O 0 1.7220829249708913e-05
predicted O 0 7.042229117359966e-05
to O 0 3.082082548644394e-05
interfere O 0 0.00010799475421663374
with O 0 5.379385765991174e-05
ATP O 0 0.0019879955798387527
binding O 0 0.00019967695698142052
or O 0 0.0002056892408290878
substrate O 0 0.000636534474324435
recognition O 0 0.0009037085110321641
. O 0 0.0009937358554452658

Two O 0 0.0005917230155318975
of O 0 0.0006213291781023145
seventeen O 0 0.005142776295542717
mutated O 1 0.8690106272697449
T B-Disease 1 0.9986283779144287
- I-Disease 0 0.17446576058864594
PLL I-Disease 1 0.7400090098381042
samples O 0 0.00014662327885162085
had O 0 0.00013617469812743366
a O 0 8.130915375659242e-05
previously O 0 0.00012031061487505212
reported O 0 0.0002918476820923388
A B-Disease 0 0.2894040644168854
- I-Disease 1 0.9931855201721191
T I-Disease 1 0.9985952973365784
allele O 0 0.003609749721363187
. O 0 0.0012756244977936149

In O 0 0.0010482994839549065
contrast O 0 0.0007956355111673474
, O 0 0.00019084574887529016
no O 0 0.00012695898476522416
mutations O 0 0.0001114458791562356
were O 0 3.9746544644003734e-05
detected O 0 9.990496619138867e-05
in O 0 3.69432418665383e-05
the O 0 7.655558147234842e-05
p53 O 0 0.0006316593498922884
gene O 0 0.00010492368892300874
, O 0 3.7912599509581923e-05
suggesting O 0 8.562202856410295e-05
that O 0 3.139484761049971e-05
this O 0 0.00010471487621543929
tumour B-Disease 1 0.9999955892562866
suppressor O 1 0.9737658500671387
is O 0 0.0001483722880948335
not O 0 5.494755896506831e-05
frequently O 0 0.00011789491691160947
altered O 0 0.00016041420167312026
in O 0 0.00010777933493955061
this O 0 0.0003454246907494962
leukaemia B-Disease 1 0.9969602227210999
. O 0 0.0012678286293521523

Occasional O 0 0.009039967320859432
missense O 0 0.013301094062626362
mutations O 0 0.0007531063165515661
in O 0 0.0001643905125092715
ATM O 0 0.0005110198981128633
were O 0 6.647297414019704e-05
also O 0 6.125235086074099e-05
found O 0 5.3748939535580575e-05
in O 0 5.846663407282904e-05
tumour B-Disease 1 0.9992409944534302
DNA O 0 0.00016272849461529404
from O 0 6.56835618428886e-05
patients O 0 0.0005608238861896098
with O 0 5.258939563645981e-05
B B-Disease 0 0.025287188589572906
- I-Disease 0 0.06655185669660568
cell I-Disease 0 0.04728630557656288
non I-Disease 0 0.20205458998680115
- I-Disease 1 0.9998052716255188
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999916553497314
( O 0 0.02330855280160904
B B-Disease 0 0.12342596799135208
- I-Disease 0 0.011803166009485722
NHL I-Disease 0 0.0003428097115829587
) O 0 4.533742685453035e-05
and O 0 4.863270078203641e-05
a O 0 0.00011265151260886341
B B-Disease 0 0.00200813845731318
- I-Disease 0 0.004906844347715378
NHL I-Disease 0 0.0021960209123790264
cell O 0 0.0013549569994211197
line O 0 0.0012155517470091581
. O 0 0.000923610816244036

The O 0 0.0007471516728401184
evidence O 0 0.000337290926836431
of O 0 0.00010616947110975161
a O 0 8.455722854705527e-05
significant O 0 5.044930367148481e-05
proportion O 0 4.784963675774634e-05
of O 0 0.00010771172674139962
loss O 1 0.7673181891441345
- O 0 0.3857108950614929
of O 0 0.010015780106186867
- O 1 0.9286893010139465
function O 0 0.00015560296014882624
mutations O 0 9.032162779476494e-05
and O 0 3.166545866406523e-05
a O 0 4.692624133895151e-05
complete O 0 0.00010089414718095213
absence O 0 0.00015685368271078914
of O 0 4.601601540343836e-05
the O 0 5.675551437889226e-05
normal O 0 9.52045083977282e-05
copy O 0 8.730346598895267e-05
of O 0 4.562515459838323e-05
ATM O 0 0.00014317204477265477
in O 0 2.8001462851534598e-05
the O 0 4.198258466203697e-05
majority O 0 4.7442346840398386e-05
of O 0 0.00013956525071989745
mutated O 1 0.6285810470581055
tumours B-Disease 1 0.9999251365661621
establishes O 0 0.37560781836509705
somatic O 0 0.15302957594394684
inactivation O 0 0.0312979593873024
of O 0 7.253490184666589e-05
this O 0 4.623832865036093e-05
gene O 0 5.676634100382216e-05
in O 0 2.6591025743982755e-05
the O 0 5.991711441311054e-05
pathogenesis O 0 0.08313776552677155
of O 0 0.00030848212190903723
sporadic B-Disease 1 0.9579096436500549
T I-Disease 1 0.9999649524688721
- I-Disease 1 0.9763941168785095
PLL I-Disease 1 0.9988340735435486
and O 0 7.893041038187221e-05
suggests O 0 0.00010766160994535312
that O 0 5.420447632786818e-05
ATM O 0 0.0003433333768043667
acts O 0 0.00015175218868535012
as O 0 0.00013059396587777883
a O 0 0.001409699209034443
tumour B-Disease 1 0.9999890327453613
suppressor O 1 0.9931897521018982
. O 0 0.0025076393503695726

As O 0 0.000927229062654078
constitutional O 0 0.001130433171056211
DNA O 0 0.00046011246740818024
was O 0 0.00029288011137396097
not O 0 6.285772542469203e-05
available O 0 3.5691358789335936e-05
, O 0 4.349741357145831e-05
a O 0 0.00012400263221934438
putative O 0 0.005687430500984192
hereditary O 1 0.9509954452514648
predisposition O 1 0.9978929162025452
to O 0 0.003566912142559886
T B-Disease 1 0.9999549388885498
- I-Disease 1 0.9870868921279907
PLL I-Disease 1 0.9986457228660583
will O 0 0.0001408997632097453
require O 0 0.00011181780428159982
further O 0 0.00011108556645922363
investigation O 0 0.0004326203197706491
. O 0 0.00034161697840318084
. O 0 0.0008790917345322669

Myotonic B-Disease 1 0.9999978542327881
dystrophy I-Disease 1 0.9999986886978149
protein O 0 0.010421514511108398
kinase O 0 0.006390176713466644
is O 0 0.00011570950300665572
involved O 0 8.597769192419946e-05
in O 0 4.238853580318391e-05
the O 0 6.213755114004016e-05
modulation O 0 0.0001790452079148963
of O 0 9.346365550300106e-05
the O 0 0.00038749349187128246
Ca2 O 1 0.9728065133094788
+ O 1 0.7297871112823486
homeostasis O 1 0.9702692031860352
in O 0 0.0019692988134920597
skeletal O 1 0.9999608993530273
muscle O 1 0.9998358488082886
cells O 0 0.1466495394706726
. O 0 0.0012886819895356894

Myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.9995408058166504
DM B-Disease 1 0.999998927116394
) O 0 0.0005269527900964022
, O 0 0.00015415038797073066
the O 0 0.00012715709453914315
most O 0 0.00023827279801480472
prevalent O 1 0.9996695518493652
muscular B-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999994039535522
in O 0 0.011204129084944725
adults O 0 0.00711502879858017
, O 0 8.718998287804425e-05
is O 0 4.663182335207239e-05
caused O 0 0.005039028823375702
by O 0 3.184030356351286e-05
( O 0 8.607515337644145e-05
CTG O 0 0.15918107330799103
) O 0 3.818277036771178e-05
n O 0 7.354778063017875e-05
- O 0 0.0001306784397456795
repeat O 0 0.00011032275506295264
expansion O 0 7.144681148929521e-05
in O 0 2.614759432617575e-05
a O 0 4.663217987399548e-05
gene O 0 5.699850225937553e-05
encoding O 0 4.575696220854297e-05
a O 0 7.031895074760541e-05
protein O 0 0.00013477218453772366
kinase O 0 0.000566483533475548
( O 0 0.0004179543466307223
DM B-Disease 1 0.9987589120864868
protein O 0 0.0003607478574849665
kinase O 0 0.0009930396918207407
; O 0 0.0001878412876976654
DMPK O 0 0.4480455219745636
) O 0 8.831243758322671e-05
and O 0 9.433587547391653e-05
involves O 0 0.00017674242553766817
changes O 0 0.00012669546413235366
in O 0 0.00012055672414135188
cytoarchitecture O 1 0.5196698307991028
and O 0 0.0005224617780186236
ion O 0 0.05809103325009346
homeostasis O 1 0.5595371723175049
. O 0 0.002269431948661804

To O 0 0.000620676320977509
obtain O 0 0.0004929237184114754
clues O 0 0.0004174796340521425
to O 0 0.00011038210504921153
the O 0 0.00013834520359523594
normal O 0 0.0001627588935662061
biological O 0 0.0001670382625889033
role O 0 0.00014151321374811232
of O 0 0.00018646527314558625
DMPK O 1 0.9978256821632385
in O 0 0.00021278587519191206
cellular O 0 0.013055716641247272
ion O 0 0.03824416548013687
homeostasis O 0 0.1136120930314064
, O 0 7.296933472389355e-05
we O 0 3.2276315323542804e-05
have O 0 2.4009081244003028e-05
compared O 0 4.4177435484016314e-05
the O 0 7.511149306083098e-05
resting O 0 0.033267147839069366
[ O 0 0.002241311827674508
Ca2 O 0 0.04446849599480629
+ O 0 0.001049576560035348
] O 0 0.0003204470267519355
i O 0 0.00012124682689318433
, O 0 5.506190791493282e-05
the O 0 5.272688940749504e-05
amplitude O 0 9.73139758571051e-05
and O 0 3.785912485909648e-05
shape O 0 0.00012801832053810358
of O 0 0.00022048984828870744
depolarization O 1 0.9997071623802185
- O 1 0.9979230761528015
induced O 1 0.9998503923416138
Ca2 O 1 0.9673171043395996
+ O 0 0.07377928495407104
transients O 0 0.023023508489131927
, O 0 5.780717037850991e-05
and O 0 2.731286804191768e-05
the O 0 3.965983705711551e-05
content O 0 3.2034738978836685e-05
of O 0 5.5815366067690775e-05
ATP O 0 0.03640255331993103
- O 0 0.0012833434157073498
driven O 0 0.0007847773958928883
ion O 0 0.0010967070702463388
pumps O 0 0.0013710518833249807
in O 0 0.00012452268856577575
cultured O 0 0.11526716500520706
skeletal O 1 0.9993634819984436
muscle O 1 0.9696362018585205
cells O 0 0.0002756830654107034
of O 0 0.00011687986989272758
wild O 0 0.0006933810072951019
- O 0 0.013921373523771763
type O 0 0.0005426644929684699
and O 0 0.00014915873180143535
DMPK O 1 0.9981606602668762
[ O 0 0.02657267451286316
- O 0 0.3665994703769684
/ O 1 0.5853528380393982
- O 0 0.16675730049610138
] O 0 0.0052228281274437904
knockout O 0 0.11205710470676422
mice O 0 0.002414279617369175
. O 0 0.001014961046166718

In O 0 0.0016911332495510578
vitro O 0 0.0051536886021494865
- O 0 0.005253665614873171
differentiated O 0 0.011684889905154705
DMPK O 1 0.9995946288108826
[ O 0 0.10428699105978012
- O 1 0.5618280172348022
/ O 1 0.635378360748291
- O 0 0.08114274591207504
] O 0 0.0010233846260234714
myotubes O 0 0.012391917407512665
exhibit O 0 0.00022560468642041087
a O 0 0.00011591977090574801
higher O 0 0.00010900403140112758
resting O 0 0.011425352655351162
[ O 0 0.0008494107751175761
Ca2 O 0 0.006102228537201881
+ O 0 0.00044001254718750715
] O 0 0.00016326094919349998
i O 0 6.709851004416123e-05
than O 0 1.5334278941736557e-05
do O 0 2.3627846530871466e-05
wild O 0 0.00010794986155815423
- O 0 0.0010126839624717832
type O 0 0.00031773195951245725
myotubes O 0 0.04922572523355484
because O 0 2.8703529096674174e-05
of O 0 2.3403457817039452e-05
an O 0 2.2879823518451303e-05
altered O 0 5.140249413670972e-05
open O 0 5.752314973506145e-05
probability O 0 3.6574885598383844e-05
of O 0 5.201209933147766e-05
voltage O 0 0.00035408526309765875
- O 0 0.0006682264502160251
dependent O 0 0.00029658983112312853
l O 0 0.013067463412880898
- O 0 0.0074146706610918045
type O 0 0.0013021407648921013
Ca2 O 0 0.013867625035345554
+ O 0 0.0010932162404060364
and O 0 0.0003081729228142649
Na O 0 0.11945178359746933
+ O 0 0.001720601343549788
channels O 0 0.000650242727715522
. O 0 0.000834828068036586

The O 0 0.003320555202662945
mutant O 0 0.28352677822113037
myotubes O 1 0.8710867166519165
exhibit O 0 0.0012892619706690311
smaller O 0 0.00026810806593857706
and O 0 0.0001481379003962502
slower O 0 0.0004347075882833451
Ca2 O 0 0.0009806755697354674
+ O 0 0.00033782399259507656
responses O 0 0.00011658758012345061
upon O 0 0.0001278302224818617
triggering O 0 0.0005074147484265268
by O 0 9.014704846777022e-05
acetylcholine O 0 0.0007049626437947154
or O 0 0.00010648358875187114
high O 0 0.0003257372591178864
external O 0 0.0005221947212703526
K O 0 0.0019461606862023473
+ O 0 0.0018593008862808347
. O 0 0.0011005360865965486

In O 0 0.0007768413051962852
addition O 0 0.0003442806482780725
, O 0 0.00016406182840000838
we O 0 8.857007924234495e-05
observed O 0 7.878737960709259e-05
that O 0 4.780001472681761e-05
these O 0 5.201075691729784e-05
Ca2 O 0 0.009678860194981098
+ O 0 0.006641162559390068
transients O 0 0.010767427273094654
partially O 0 0.0003740708052646369
result O 0 5.974332816549577e-05
from O 0 3.6013843782711774e-05
an O 0 3.795434895437211e-05
influx O 0 0.0001831057306844741
of O 0 9.25468048080802e-05
extracellular O 0 0.0004095573094673455
Ca2 O 0 0.0012059611035510898
+ O 0 0.0002613133692648262
through O 0 8.970576163847e-05
the O 0 0.00018617871683090925
l O 0 0.06171151623129845
- O 0 0.02110384590923786
type O 0 0.004055643919855356
Ca2 O 0 0.02663416601717472
+ O 0 0.00236863293685019
channel O 0 0.0017571108182892203
. O 0 0.0014586164616048336

Neither O 0 0.002102971775457263
the O 0 0.00042946916073560715
content O 0 0.00015231552242767066
nor O 0 0.0001209103938890621
the O 0 6.493595719803125e-05
activity O 0 0.0001001035125227645
of O 0 0.00013438580208458006
Na O 1 0.9469389319419861
+ O 0 0.01236962154507637
/ O 0 0.008056103251874447
K O 0 0.0011355275055393577
+ O 0 0.0008142957231029868
ATPase O 0 0.0020138495601713657
and O 0 0.0002634723496157676
sarcoplasmic O 1 0.986441969871521
reticulum O 1 0.9745157361030579
Ca2 O 1 0.8608046770095825
+ O 0 0.1681140810251236
- O 0 0.029921799898147583
ATPase O 0 0.005870173219591379
are O 0 6.035426849848591e-05
affected O 0 0.0002964383165817708
by O 0 0.0002577440463937819
DMPK O 1 0.9914764761924744
absence O 0 0.02839803509414196
. O 0 0.0016592472093179822

In O 0 0.000861207430716604
conclusion O 0 0.0007925413665361702
, O 0 0.0001630069309612736
our O 0 0.00011468376033008099
data O 0 4.129127410124056e-05
suggest O 0 7.303032180061564e-05
that O 0 6.18141348240897e-05
DMPK O 1 0.5291928648948669
is O 0 6.045351619832218e-05
involved O 0 6.155462324386463e-05
in O 0 3.809663758147508e-05
modulating O 0 0.00020429583673831075
the O 0 5.442377369035967e-05
initial O 0 0.00010987362475134432
events O 0 7.722618465777487e-05
of O 0 9.732446051202714e-05
excitation O 0 0.11005574464797974
- O 1 0.64618980884552
contraction O 1 0.9404861330986023
coupling O 0 0.043291185051202774
in O 0 0.0007006553350947797
skeletal O 1 0.9999098777770996
muscle O 1 0.9990097284317017
. O 0 0.0007581431418657303
. O 0 0.001255805604159832

Constitutional O 0 0.17753742635250092
RB1 O 1 0.9998733997344971
- O 1 0.8411410450935364
gene O 0 0.0015252205776050687
mutations O 0 0.000680252443999052
in O 0 0.00023991777561604977
patients O 0 0.06120540574193001
with O 0 0.0003316894581075758
isolated O 0 0.04666533321142197
unilateral B-Disease 0 0.21949079632759094
retinoblastoma I-Disease 1 0.9993211030960083
. O 0 0.003938209731131792

In O 0 0.000659125973470509
most O 0 0.000369485147530213
patients O 0 0.002564358990639448
with O 0 0.000147841710713692
isolated O 0 0.007227061782032251
unilateral B-Disease 1 0.7564597725868225
retinoblastoma I-Disease 1 0.99998939037323
, O 0 0.39418065547943115
tumor B-Disease 1 0.9999499320983887
development O 0 0.002048479625955224
is O 0 0.0001415396691299975
initiated O 0 0.0004888561088591814
by O 0 8.020723180379719e-05
somatic O 0 0.0010093095479533076
inactivation O 0 0.001840067794546485
of O 0 8.007020369404927e-05
both O 0 6.41690130578354e-05
alleles O 0 0.0001795365387806669
of O 0 0.00014523816935252398
the O 0 0.0007961861556395888
RB1 O 1 0.9995293617248535
gene O 0 0.0019784874748438597
. O 0 0.001291749649681151

However O 0 0.0006357036181725562
, O 0 0.00017711560940369964
some O 0 7.891753921285272e-05
of O 0 0.0001154976271209307
these O 0 8.006569260032848e-05
patients O 0 0.03125547617673874
can O 0 9.630414569983259e-05
transmit O 0 0.0013273716904222965
retinoblastoma B-Disease 1 0.993924081325531
predisposition O 1 0.6124159693717957
to O 0 0.00018365896539762616
their O 0 0.00028893628041259944
offspring O 0 0.0028041601181030273
. O 0 0.001242366386577487

To O 0 0.0004996364586986601
determine O 0 0.00023121591948438436
the O 0 0.00013010151451453567
frequency O 0 9.795899677556008e-05
and O 0 4.8235669964924455e-05
nature O 0 8.323814836330712e-05
of O 0 0.00010234961519017816
constitutional O 0 0.022708717733621597
RB1 O 1 0.9999923706054688
- O 1 0.9161356687545776
gene O 0 0.0004388750239741057
mutations O 0 0.00015468457422684878
in O 0 5.920577314100228e-05
patients O 0 0.0012105116620659828
with O 0 5.3818439482711256e-05
isolated O 0 0.0008769537089392543
unilateral B-Disease 0 0.00781620666384697
retinoblastoma I-Disease 1 0.9877283573150635
, O 0 8.469755266560242e-05
we O 0 4.966918277204968e-05
analyzed O 0 6.770733307348564e-05
DNA O 0 0.00011158709821756929
from O 0 0.00011547054600669071
peripheral O 1 0.5529636144638062
blood O 0 0.07579565793275833
and O 0 0.00035151850897818804
from O 0 0.018312940374016762
tumor B-Disease 1 0.9999901056289673
tissue O 1 0.9969570636749268
. O 0 0.0020900736562907696

The O 0 0.0008307495736517012
analysis O 0 0.0002394429175183177
of O 0 0.00029957262449897826
tumors B-Disease 0 0.3614221215248108
from O 0 6.921272142790258e-05
54 O 0 0.0001863207871792838
( O 0 8.128846093313769e-05
71 O 0 0.0001582901895744726
% O 0 4.6125060180202127e-05
) O 0 2.79917167063104e-05
of O 0 6.395123637048528e-05
76 O 0 0.00034010899253189564
informative O 0 0.0003531097318045795
patients O 0 0.0004641351697500795
showed O 0 0.00019859621534124017
loss O 0 0.00023714931739959866
of O 0 0.00012392306234687567
constitutional O 0 0.014376639388501644
heterozygosity O 1 0.999954104423523
( O 1 0.7785364985466003
LOH O 1 0.9999915361404419
) O 0 0.0003290764580015093
at O 0 0.0006474771653302014
intragenic O 1 0.6403722763061523
loci O 0 0.004497115965932608
. O 0 0.001168604358099401

Three O 0 0.001264102291315794
of O 0 0.0010060281492769718
13 O 0 0.003239256562665105
uninformative O 1 0.9557904601097107
patients O 0 0.16574591398239136
had O 0 0.0010519861243665218
constitutional O 0 0.002843780443072319
deletions O 0 0.02139645628631115
. O 0 0.002080450998619199

For O 0 0.0007544645923189819
39 O 0 0.0006414653616957366
randomly O 0 0.0003997012972831726
selected O 0 0.00052391376812011
tumors B-Disease 1 0.8895620107650757
, O 0 0.00021915955585427582
SSCP O 1 0.9944154024124146
, O 0 0.0004794786509592086
hetero O 1 0.9296756982803345
- O 0 0.012961427681148052
duplex O 0 0.03473652899265289
analysis O 0 7.449105760315433e-05
, O 0 4.724311293102801e-05
sequencing O 0 9.417058754479513e-05
, O 0 4.975233241566457e-05
and O 0 4.439095573616214e-05
Southern O 0 0.00012264757242519408
blot O 0 0.0007810679380781949
analysis O 0 7.842435297789052e-05
were O 0 4.204753349767998e-05
used O 0 6.079750164644793e-05
to O 0 7.32976695871912e-05
identify O 0 0.00027396291261538863
mutations O 0 0.0009978760499507189
. O 0 0.0012242619413882494

Mutations O 0 0.0013187803560867906
were O 0 0.0001996716164285317
detected O 0 0.0002037744561675936
in O 0 6.835243402747437e-05
21 O 0 0.00011418540816521272
( O 0 7.684631418669596e-05
91 O 0 0.00014843512326478958
% O 0 5.496034646057524e-05
) O 0 6.447097985073924e-05
of O 0 0.00011389799328753725
23 O 0 0.0007806653738953173
tumors B-Disease 1 0.9992045760154724
with O 0 0.007849762216210365
LOH O 1 0.9999860525131226
. O 0 0.0025498883333057165

In O 0 0.0006066469941288233
6 O 0 0.0004979652585461736
( O 0 0.00016089675773400813
38 O 0 0.00016897225577849895
% O 0 6.113406561780721e-05
) O 0 4.635608274838887e-05
of O 0 6.957104778848588e-05
16 O 0 0.0007246178574860096
tumors B-Disease 1 0.9994303584098816
without O 0 0.0014132916694507003
LOH O 1 0.9999905824661255
, O 0 9.840989514486864e-05
one O 0 7.209755131043494e-05
mutation O 0 0.00014101048873271793
was O 0 8.206358324969187e-05
detected O 0 8.962787251221016e-05
, O 0 2.48443175223656e-05
and O 0 1.6173386029549874e-05
in O 0 1.638236062717624e-05
9 O 0 3.799156911554746e-05
( O 0 2.8046521038049832e-05
56 O 0 4.532506500254385e-05
% O 0 2.3258391593117267e-05
) O 0 3.0784700356889516e-05
of O 0 5.887707811780274e-05
the O 0 0.000272521487204358
tumors B-Disease 1 0.9999284744262695
without O 0 0.004933107178658247
LOH O 1 0.999991774559021
, O 0 0.0001334011903963983
both O 0 6.72146852593869e-05
mutations O 0 0.00018735761113930494
were O 0 0.00013078190386295319
found O 0 0.00028292363276705146
. O 0 0.0006726706633344293

Thus O 0 0.0008641552412882447
, O 0 0.00020949880126863718
a O 0 0.00012398514081723988
total O 0 6.190015119500458e-05
of O 0 5.0425347581040114e-05
45 O 0 7.375489076366648e-05
mutations O 0 8.091144263744354e-05
were O 0 2.6113402782357298e-05
identified O 0 6.474767724284902e-05
in O 0 7.245374581543729e-05
tumors B-Disease 1 0.6978533267974854
of O 0 0.0002501295239198953
36 O 0 0.007517056539654732
patients O 1 0.8820070624351501
. O 0 0.0014719932805746794

Thirty O 0 0.0019276783568784595
- O 0 0.0007578690419904888
nine O 0 0.0001600119867362082
of O 0 8.084103319561109e-05
the O 0 8.538003748981282e-05
mutations O 0 0.00013695418601855636
- O 0 0.00021270514116622508
including O 0 3.371695856912993e-05
34 O 0 6.278870569076389e-05
small O 0 5.342536678654142e-05
mutations O 0 8.134747622534633e-05
, O 0 3.2416301110060886e-05
2 O 0 4.2081188439624384e-05
large O 0 7.287171320058405e-05
structural O 0 0.0009087884100154042
alterations O 0 0.0004518579808063805
, O 0 5.36524603376165e-05
and O 0 5.571092333411798e-05
hypermethylation O 0 0.04266104847192764
in O 0 6.415036477847025e-05
3 O 0 0.0009182268404401839
tumors O 1 0.9919813275337219
- O 0 0.0004501878865994513
were O 0 3.502790059428662e-05
not O 0 2.3273081751540303e-05
detected O 0 6.327063601929694e-05
in O 0 3.735575228347443e-05
the O 0 8.511940541211516e-05
corresponding O 0 0.00023563203285448253
peripheral O 1 0.5785606503486633
blood O 0 0.11379493772983551
DNA O 0 0.0015903261955827475
. O 0 0.0008636629790998995

In O 0 0.0005600762669928372
6 O 0 0.0004669335321523249
( O 0 0.00017538534302730113
17 O 0 0.0001599468378117308
% O 0 5.715493898605928e-05
) O 0 2.590537587821018e-05
of O 0 2.8299498808337376e-05
the O 0 4.4527387217385694e-05
36 O 0 0.00020332458370830864
patients O 0 0.008011152036488056
, O 0 3.8490852602990344e-05
a O 0 4.8429810703964904e-05
mutation O 0 0.00012869392230641097
was O 0 7.717804692219943e-05
detected O 0 4.1387225792277604e-05
in O 0 1.7802167349145748e-05
constitutional O 0 5.804198735859245e-05
DNA O 0 4.8601545131532475e-05
, O 0 2.059849794022739e-05
and O 0 1.6749798305681907e-05
1 O 0 3.0841703846817836e-05
of O 0 3.3463707950431854e-05
these O 0 1.8568420273368247e-05
mutations O 0 5.6583066907478496e-05
is O 0 2.256553307233844e-05
known O 0 3.418079359107651e-05
to O 0 2.4060787836788222e-05
be O 0 3.674072650028393e-05
associated O 0 9.836730168899521e-05
with O 0 0.00012136076111346483
reduced O 0 0.0006790574407204986
expressivity O 0 0.49062004685401917
. O 0 0.0013115279143676162

The O 0 0.0008328365511260927
presence O 0 0.0004561702080536634
of O 0 0.00017541660054121166
a O 0 0.0002092785871354863
constitutional O 0 0.0005595585680566728
mutation O 0 0.0005774322780780494
was O 0 0.00016237694944720715
not O 0 2.5931869458872825e-05
associated O 0 2.978714110213332e-05
with O 0 2.0759851395268925e-05
an O 0 3.7816840631421655e-05
early O 0 0.00017115144873969257
age O 0 0.00042476007365621626
at O 0 0.0007368680089712143
treatment O 1 0.7429502606391907
. O 0 0.0011130330385640264

In O 0 0.0012090931413695216
1 O 0 0.0014106392627581954
patient O 0 0.07244313508272171
, O 0 0.0005706609808839858
somatic O 0 0.34761178493499756
mosaicism O 1 0.9930819869041443
was O 0 0.000724110403098166
demonstrated O 0 0.00027069562929682434
by O 0 5.468076415127143e-05
molecular O 0 7.434146391460672e-05
analysis O 0 4.5739336201222613e-05
of O 0 5.033512206864543e-05
DNA O 0 0.00014495468349196017
and O 0 9.142919589066878e-05
RNA O 0 0.00035042990930378437
from O 0 0.00027324556140229106
peripheral O 1 0.9040408730506897
blood O 0 0.373760461807251
. O 0 0.0013209902681410313

In O 0 0.0006445781909860671
2 O 0 0.0007582317339256406
patients O 0 0.0035906294360756874
without O 0 7.771332457195967e-05
a O 0 0.0001493428717367351
detectable O 0 0.010505311191082
mutation O 0 0.00046352497884072363
in O 0 0.00011451546743046492
peripheral O 1 0.9958095550537109
blood O 1 0.8132054805755615
, O 0 0.00040991822606883943
mosaicism O 1 0.9897623658180237
was O 0 0.0003003230085596442
suggested O 0 9.047447383636609e-05
because O 0 3.3915093808900565e-05
1 O 0 5.218165460973978e-05
of O 0 4.9332094931742176e-05
the O 0 0.00043922135955654085
patients O 1 0.9986162185668945
showed O 1 0.9967536330223083
multifocal O 1 0.9999998807907104
tumors B-Disease 1 0.999988317489624
and O 0 0.0002199672017013654
the O 0 0.00010615711653372273
other O 0 6.452140951296315e-05
later O 0 0.0002624289190862328
developed O 0 0.000640169542748481
bilateral B-Disease 0 0.0020381370559334755
retinoblastoma I-Disease 1 0.9930825233459473
. O 0 0.0016569603467360139

In O 0 0.0010597779182717204
conclusion O 0 0.000973300717305392
, O 0 0.00025876174913719296
our O 0 0.00016949590644799173
results O 0 0.0001121762179536745
emphasize O 0 0.00019758286362048239
that O 0 4.2440107790753245e-05
the O 0 9.77609888650477e-05
manifestation O 0 0.4855060577392578
and O 0 0.00017942940758075565
transmissibility O 1 0.6486425995826721
of O 0 0.0003300233802292496
retinoblastoma B-Disease 1 0.9769790768623352
depend O 0 6.909296644153073e-05
on O 0 2.869942363759037e-05
the O 0 3.4772023354889825e-05
nature O 0 4.738374627777375e-05
of O 0 2.4370723622268997e-05
the O 0 3.2573225325904787e-05
first O 0 6.320152897387743e-05
mutation O 0 5.2450966904871166e-05
, O 0 1.541352685308084e-05
its O 0 1.0286099495715462e-05
time O 0 1.2461272490327246e-05
in O 0 1.266031995328376e-05
development O 0 3.7334808439482003e-05
, O 0 2.3139895347412676e-05
and O 0 1.4464940250036307e-05
the O 0 1.4758320503460709e-05
number O 0 1.2380794942146167e-05
and O 0 1.7547450624988414e-05
types O 0 2.2271675334195606e-05
of O 0 4.947781781083904e-05
cells O 0 0.00020073527412023395
that O 0 3.946057040593587e-05
are O 0 3.8982932892395183e-05
affected O 0 0.00020413479069247842
. O 0 0.00017769022088032216
. O 0 0.0006351954652927816

Hereditary B-Disease 1 0.9999215602874756
deficiency I-Disease 1 0.999983549118042
of I-Disease 0 0.0027586373034864664
the I-Disease 0 0.012124315835535526
fifth I-Disease 1 0.9876387119293213
component I-Disease 0 0.12416233122348785
of I-Disease 0 0.0008153876988217235
complement I-Disease 0 0.0023070494644343853
in O 0 0.00027439321274869144
man O 0 0.012042563408613205
. O 0 0.001069510355591774

I O 0 0.03614887595176697
. O 0 0.010609498247504234

Clinical O 0 0.3577409088611603
, O 0 0.0021786533761769533
immunochemical O 1 0.9889516234397888
, O 0 0.00048660035827197134
and O 0 0.00025717116659507155
family O 0 0.0007328681531362236
studies O 0 0.0005513441865332425
. O 0 0.0012585034128278494

The O 0 0.001670844852924347
first O 0 0.000655708194244653
recognized O 0 0.0006079994491301477
human O 0 0.0007487119291909039
kindred O 1 0.9805341362953186
with O 0 0.014898117631673813
hereditary B-Disease 1 0.9999879598617554
deficiency I-Disease 1 0.9999992847442627
of I-Disease 0 0.06017064303159714
the I-Disease 0 0.029749417677521706
fifth I-Disease 1 0.9855604767799377
component I-Disease 0 0.10590231418609619
of I-Disease 0 0.0011381529038771987
complement I-Disease 0 0.10023894160985947
( O 0 0.004894909914582968
C5 O 1 0.957444965839386
) O 0 0.00014607119373977184
is O 0 0.00019004747446160764
described O 0 0.0007235034718178213
. O 0 0.0006294219638220966

The O 0 0.0010937157785519958
proband O 0 0.036102037876844406
, O 0 0.0001660337147768587
a O 0 0.00013228596071712673
20 O 0 0.00015676187467761338
- O 0 0.0007042126380838454
year O 0 0.00011472183541627601
- O 0 0.003462261753156781
old O 0 0.02353515662252903
black O 1 0.6112022399902344
female O 1 0.9494714736938477
with O 1 0.9973284006118774
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.8479822874069214
age O 1 0.51486736536026
11 O 0 0.0195136871188879
, O 0 0.0012255061883479357
lacked O 1 0.9723868370056152
serum O 1 0.9999386072158813
hemolytic O 1 0.9999992847442627
complement O 0 0.022806217893958092
activity O 0 0.00027173562557436526
, O 0 8.160300785675645e-05
even O 0 0.00012198880722280592
during O 0 0.0007799033191986382
remission O 1 0.7746641039848328
. O 0 0.0012104033958166838

C5 O 1 0.9969490170478821
was O 0 0.00922481156885624
undetectable O 0 0.13784846663475037
in O 0 0.00025476072914898396
her O 0 0.0006257118657231331
serum O 0 0.13666342198848724
by O 0 0.00016139214858412743
both O 0 0.00027269459678791463
immunodiffusion O 1 0.9991077780723572
and O 0 0.017104048281908035
hemolytic O 1 0.9999914169311523
assays O 0 0.00683661550283432
. O 0 0.0015066972700878978

Other O 0 0.0006639256607741117
complement O 0 0.0009649629355408251
components O 0 0.0003719865344464779
were O 0 0.0001024748053168878
normal O 0 0.00013262976426631212
during O 0 0.00028697142261080444
remission O 1 0.9695817232131958
of O 0 0.26600217819213867
lupus O 1 0.9999997615814209
, O 0 0.007668167818337679
but O 0 0.00043106178054586053
C1 O 1 0.9999114274978638
, O 0 0.0005294111324474216
C4 O 1 0.9895274639129639
, O 0 0.00042294248123653233
C2 O 1 0.8402860760688782
, O 0 0.00018195009033661336
and O 0 0.00018623817595653236
C3 O 1 0.6235279440879822
levels O 0 0.0005457641091197729
fell O 0 0.0021300329826772213
during O 0 0.0024256594479084015
exacerbations O 1 0.9918012022972107
. O 0 0.0023531410843133926

A O 0 0.0031758162658661604
younger O 0 0.0031828193459659815
half O 0 0.0007513242308050394
- O 0 0.11852938681840897
sister O 0 0.020933862775564194
, O 0 0.0001344765623798594
who O 0 0.0001597758091520518
had O 0 0.00026967807207256556
no O 0 0.003437638282775879
underlying O 1 0.9983538389205933
disease O 1 0.999987006187439
, O 0 0.0007088727434165776
was O 0 0.0005378189962357283
also O 0 6.142854545032606e-05
found O 0 5.711870107916184e-05
to O 0 9.222092921845615e-05
lack O 0 0.0010722025763243437
immunochemically O 1 0.9959927201271057
detectable O 1 0.5671452283859253
C5 O 1 0.9602118134498596
. O 0 0.0016032386338338256

By O 0 0.004072751849889755
hemolytic O 1 0.9999827146530151
assay O 0 0.009382068179547787
, O 0 0.00025768240448087454
she O 0 0.00015684470417909324
exhibited O 0 0.00021355864009819925
1 O 0 7.408980309264734e-05
- O 0 0.00014909757010173053
2 O 0 3.606105747167021e-05
% O 0 1.878106195363216e-05
of O 0 2.7642614440992475e-05
the O 0 4.618866660166532e-05
normal O 0 0.0003135614388156682
serum O 1 0.8888322114944458
C5 O 1 0.892975926399231
level O 0 7.532882591476664e-05
and O 0 4.946441913489252e-05
normal O 0 9.040685836225748e-05
concentrations O 0 8.149973291438073e-05
of O 0 6.388041219906881e-05
other O 0 6.879947613924742e-05
complement O 0 0.0005515097873285413
components O 0 0.0007240028353407979
. O 0 0.000661982805468142

C5 O 1 0.8799636363983154
levels O 0 0.0007746709743514657
of O 0 0.00021078494319226593
other O 0 4.524400719674304e-05
family O 0 7.243881555041298e-05
members O 0 2.9501674362109043e-05
were O 0 2.2428059310186654e-05
either O 0 2.615113407955505e-05
normal O 0 3.9371036109514534e-05
or O 0 2.2281066776486114e-05
approximately O 0 3.7531361158471555e-05
half O 0 5.5988726671785116e-05
- O 0 0.0003906100173480809
normal O 0 7.775839185342193e-05
, O 0 4.203197386232205e-05
consistent O 0 0.00011769565753638744
with O 0 9.046687773661688e-05
autosomal O 0 0.10614243149757385
codominant O 1 0.8659358620643616
inheritance O 0 0.0014108306495472789
of O 0 0.00020911004685331136
the O 0 0.0016410944517701864
gene O 0 0.022960525006055832
determining O 0 0.423183411359787
C5 B-Disease 1 0.9999951124191284
deficiency I-Disease 1 0.9999967813491821
. O 0 0.0031171489972621202

Normal O 1 0.5504192113876343
hemolytic O 1 0.999984622001648
titers O 1 0.8348289728164673
were O 0 0.0002998383715748787
restored O 0 0.0005621357704512775
to O 0 0.00010122236562892795
both O 0 0.0001169936076621525
homozygous O 0 0.04576890915632248
C5 B-Disease 1 0.9999654293060303
- I-Disease 1 0.9975211024284363
deficient I-Disease 1 0.9998970031738281
( O 0 0.10017164051532745
C5D B-Disease 1 0.9999712705612183
) O 0 0.0003115717554464936
sera O 0 0.020256487652659416
by O 0 8.367306145373732e-05
addition O 0 0.00011284610809525475
of O 0 0.00016252782370429486
highly O 0 0.0004704771563410759
purified O 0 0.06499673426151276
human O 0 0.0021350819151848555
C5 O 1 0.9424661993980408
. O 0 0.0019880051258951426

In O 0 0.0014946159208193421
specific O 0 0.0010496705072000623
C5 O 1 0.9986597299575806
titrations O 1 0.7467454075813293
, O 0 0.00019606485147960484
however O 0 7.214232027763501e-05
, O 0 4.2640553147066385e-05
it O 0 2.736240094236564e-05
was O 0 6.922816828591749e-05
noted O 0 4.314225952839479e-05
that O 0 2.455171852489002e-05
when O 0 3.678426946862601e-05
limited O 0 4.7337049181805924e-05
amounts O 0 5.5463162425439805e-05
of O 0 7.472498691640794e-05
C5 O 0 0.01266359630972147
were O 0 5.359799615689553e-05
assayed O 0 0.0002475630899425596
in O 0 2.891628901124932e-05
the O 0 3.15420693368651e-05
presence O 0 3.613914304878563e-05
of O 0 4.118265860597603e-05
low O 0 7.782113971188664e-05
dilutions O 0 0.0016740805003792048
of O 0 0.00010748271597549319
either O 0 0.0005620324518531561
C5D B-Disease 1 0.999991774559021
serum O 1 0.8306730389595032
, O 0 0.00012080596934538335
curving O 0 0.00046567938989028335
rather O 0 6.011032746755518e-05
than O 0 3.879084033542313e-05
linear O 0 0.00010024355287896469
dose O 0 0.000930426933337003
- O 0 0.0002776463225018233
response O 0 7.205480505945161e-05
plots O 0 8.51453878567554e-05
were O 0 3.531022593961097e-05
consistently O 0 6.815079541411251e-05
obtained O 0 5.413102189777419e-05
, O 0 5.026254802942276e-05
suggesting O 0 0.00013234982907306403
some O 0 9.460828732699156e-05
inhibitory O 0 0.0006581092020496726
effect O 0 0.0008268802193924785
. O 0 0.0009226793772540987

Further O 0 0.001081069465726614
studies O 0 0.0004534795298241079
suggested O 0 0.00032699271105229855
that O 0 0.00010390056559117511
low O 0 0.0002473849162925035
dilutions O 0 0.004287955351173878
of O 0 0.0004679311241488904
C5D B-Disease 1 0.9999903440475464
serum O 1 0.8669419288635254
contain O 0 0.00011508866009535268
a O 0 0.00026382700889371336
factor O 0 0.0015363175189122558
( O 0 5.179283471079543e-05
or O 0 3.3939260902116075e-05
factors O 0 3.4195232728961855e-05
) O 0 2.5103650841629133e-05
interfering O 0 4.8350066208513454e-05
at O 0 3.466593989287503e-05
some O 0 1.719086867524311e-05
step O 0 7.158496737247333e-05
in O 0 4.3227588321315125e-05
the O 0 0.00014162604929879308
hemolytic O 1 0.9999788999557495
assay O 0 0.0012427594047039747
of O 0 0.0004604278947226703
C5 O 1 0.974815845489502
, O 0 8.473052002955228e-05
rather O 0 7.012829883024096e-05
than O 0 5.3700368880527094e-05
a O 0 0.00016499526100233197
true O 0 0.0008872291073203087
C5 O 1 0.9886849522590637
inhibitor O 1 0.7707279920578003
or O 0 0.0008526560268364847
inactivator O 1 0.5999816060066223
. O 0 0.0021909819915890694

Of O 0 0.0015985050704330206
clinical O 0 0.0036286385729908943
interest O 0 0.00018701654335018247
are O 0 4.0801751310937107e-05
( O 0 7.442304195137694e-05
a O 0 6.648425915045664e-05
) O 0 3.585377271519974e-05
the O 0 6.294325430644676e-05
documentation O 0 0.00019860983593389392
of O 0 0.0006224855897016823
membranous O 1 0.9999935626983643
glomerulonephritis B-Disease 1 0.9999998807907104
, O 1 0.9930058121681213
vasculitis B-Disease 1 0.9999998807907104
, O 1 0.7288041710853577
and O 1 0.9020527601242065
arthritis B-Disease 1 0.9999998807907104
in O 0 0.00035098628723062575
an O 0 0.0007476096507161856
individual O 0 0.0006975323776714504
lacking O 1 0.9804194569587708
C5 O 1 0.9996300935745239
( O 0 0.00011738585453713313
and O 0 2.8368051061988808e-05
its O 0 2.7073301680502482e-05
biologic O 0 0.009216221049427986
functions O 0 3.3949720091186464e-05
) O 0 2.3544598661828786e-05
, O 0 2.167836828448344e-05
and O 0 2.4116658096318133e-05
( O 0 5.165063339518383e-05
b O 0 0.00012013877130812034
) O 0 4.979904042556882e-05
a O 0 8.877783693606034e-05
remarkable O 0 0.0003553859132807702
propensity O 0 0.004968559369444847
to O 0 0.00015318917576223612
bacterial B-Disease 1 0.9990597367286682
infections I-Disease 1 0.9991121888160706
in O 0 0.00013075221795588732
the O 0 0.00042262469651177526
proband O 1 0.9832815527915955
, O 0 9.421181312063709e-05
even O 0 3.9301674405578524e-05
during O 0 6.538908201036975e-05
periods O 0 6.686817505396903e-05
of O 0 6.246972043300048e-05
low O 0 0.00017131897038780153
- O 0 0.0006403077277354896
dose O 0 0.0005081010749563575
or O 0 9.054507245309651e-05
alternate O 0 0.00027142028557136655
- O 0 0.01265609823167324
day O 0 0.0021387047600001097
corticosteroid O 1 0.997309684753418
therapy O 1 0.8329710960388184
. O 0 0.0013854679418727756

Other O 0 0.0006224648095667362
observations O 0 0.0007451777346432209
indicate O 0 0.000328480004100129
that O 0 8.614338003098965e-05
the O 0 0.00011691331746987998
C5D B-Disease 1 0.9922828078269958
state O 0 8.927838644012809e-05
is O 0 9.295994095737115e-05
compatible O 0 0.00011101313430117443
with O 0 4.6269477024907246e-05
normal O 0 0.00041664912714622915
coagulation O 1 0.5498033165931702
function O 0 5.44067588634789e-05
and O 0 2.9813916626153514e-05
the O 0 3.890156949637458e-05
capacity O 0 0.00010145950363948941
to O 0 5.701916597899981e-05
mount O 0 0.0017481052782386541
a O 0 0.0008080308325588703
neutrophilic O 1 0.9996703863143921
leukocytosis O 1 0.9997531771659851
during O 1 0.5317344069480896
pyogenic B-Disease 1 0.9999079704284668
infection I-Disease 1 0.9996029734611511
. O 0 0.0009678500355221331
. O 0 0.0012179416371509433

Susceptibility O 1 0.9679103493690491
to O 0 0.012789941392838955
ankylosing B-Disease 1 0.9999996423721313
spondylitis I-Disease 1 0.9999997615814209
in O 0 0.01934335008263588
twins O 1 0.9657873511314392
: O 0 0.0001347001234535128
the O 0 8.090287883533165e-05
role O 0 0.000116271163278725
of O 0 0.0001453673030482605
genes O 0 0.00042714926530607045
, O 0 0.0006831128848716617
HLA O 1 0.9996368885040283
, O 0 0.0001140577660407871
and O 0 0.0001335432316409424
the O 0 0.0002740146592259407
environment O 0 0.0012521835742518306
. O 0 0.0010469222906976938

OBJECTIVE O 0 0.002668950008228421
To O 0 0.0002534292871132493
determine O 0 0.00015476072439923882
the O 0 0.00014234687841963023
relative O 0 0.0002513732179068029
effects O 0 0.00041383234201930463
of O 0 0.00015522359171882272
genetic O 0 0.00034100518678314984
and O 0 7.471074059139937e-05
environmental O 0 0.00022493307187687606
factors O 0 8.256562432507053e-05
in O 0 9.79322794592008e-05
susceptibility O 1 0.9349718689918518
to O 0 0.014868425205349922
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9765627980232239
AS B-Disease 1 0.6204824447631836
) O 0 0.0008113280637189746
. O 0 0.0011621807934716344

METHODS O 0 0.003580530174076557
Twins O 0 0.05403786152601242
with O 0 0.00018334979540668428
AS B-Disease 0 0.00023248080105986446
were O 0 5.150907236384228e-05
identified O 0 6.460427539423108e-05
from O 0 5.2142459026072174e-05
the O 0 9.94965375866741e-05
Royal O 0 0.008678685873746872
National O 1 0.5611609816551208
Hospital O 1 0.999984860420227
for O 1 0.8744440078735352
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999980926513672
database O 0 0.19199107587337494
. O 0 0.003051512874662876

Clinical O 0 0.06853271275758743
and O 0 0.001096681458875537
radiographic O 0 0.3457415699958801
examinations O 0 0.0007868838729336858
were O 0 0.00010448058310430497
performed O 0 0.00011796913167927414
to O 0 5.6041077186819166e-05
establish O 0 0.0003625506942626089
diagnoses O 1 0.9835489988327026
, O 0 0.0010541139636188745
and O 0 0.008665586821734905
disease O 1 0.9999706745147705
severity O 1 0.9863060712814331
was O 0 0.007030055392533541
assessed O 0 0.00019931858696509153
using O 0 4.1494640754535794e-05
a O 0 7.56330118747428e-05
combination O 0 0.00017864546680357307
of O 0 0.00012834760127589107
validated O 0 0.0007765667396597564
scoring O 0 0.000544533715583384
systems O 0 0.00120064290240407
. O 0 0.0012605307856574655

HLA O 1 0.9728873372077942
typing O 0 0.004323375876992941
for O 0 0.00080528249964118
HLA O 1 0.9998553991317749
- O 1 0.6979632377624512
B27 O 1 0.9985080361366272
, O 0 0.006523985415697098
HLA O 1 0.9999374151229858
- O 1 0.5597344636917114
B60 O 1 0.9896401762962341
, O 0 0.00036625019856728613
and O 0 0.0006356008816510439
HLA O 1 0.9999847412109375
- O 1 0.9508280158042908
DR1 O 1 0.9970732927322388
was O 0 0.0006943842163309455
performed O 0 0.00016515863535460085
by O 0 6.312526966212317e-05
polymerase O 0 0.000288972893031314
chain O 0 0.0001318701106356457
reaction O 0 7.724843453615904e-05
with O 0 2.1604237190331332e-05
sequence O 0 4.60888295492623e-05
- O 0 0.00010897170432144776
specific O 0 3.8754380511818454e-05
primers O 0 0.0002088645560434088
, O 0 5.844427869305946e-05
and O 0 8.154170791385695e-05
zygosity O 0 0.022533386945724487
was O 0 0.0003353063075337559
assessed O 0 0.00044899023487232625
using O 0 0.0003628068370744586
microsatellite O 0 0.008927501738071442
markers O 0 0.002988258143886924
. O 0 0.0012768679298460484

Genetic O 0 0.0032662071753293276
and O 0 0.0005052441847510636
environmental O 0 0.0005057503003627062
variance O 0 0.00017923515406437218
components O 0 0.00015965549391694367
were O 0 3.853812086163089e-05
assessed O 0 6.647107511525974e-05
with O 0 2.7299691282678396e-05
the O 0 4.030327181681059e-05
program O 0 0.0001222343707922846
Mx O 0 0.014692191034555435
, O 0 3.797403769567609e-05
using O 0 2.1594472855213098e-05
data O 0 1.3431753359327558e-05
from O 0 1.2890065590909217e-05
this O 0 1.4487400221696589e-05
and O 0 1.821492514864076e-05
previous O 0 2.7545827833819203e-05
studies O 0 3.403893060749397e-05
of O 0 7.456012826878577e-05
twins O 0 0.09616953134536743
with O 0 0.00024323516117874533
AS B-Disease 0 0.003909427672624588
. O 0 0.0011063541751354933

RESULTS O 0 0.001291154301725328
Six O 0 0.00043451591045595706
of O 0 0.00031796982511878014
8 O 0 0.0011054901406168938
monozygotic O 1 0.9850203990936279
( O 0 0.0105016203597188
MZ O 1 0.999907374382019
) O 0 0.00014887879660818726
twin O 0 0.0028344241436570883
pairs O 0 0.00014198383723851293
were O 0 0.00010213210771325976
disease O 1 0.9522654414176941
concordant O 0 0.030754277482628822
, O 0 4.009732947451994e-05
compared O 0 2.8897655283799395e-05
with O 0 1.907645128085278e-05
4 O 0 3.454832040006295e-05
of O 0 5.126972610014491e-05
15 O 0 0.00011549158080015332
B27 O 0 0.12201138585805893
- O 0 0.0010963953100144863
positive O 0 0.00023769692052155733
dizygotic O 1 0.5238965153694153
( O 0 0.0002783518866635859
DZ O 1 0.5787038803100586
) O 0 6.95497656124644e-05
twin O 0 0.00034389254869893193
pairs O 0 7.399237074423581e-05
( O 0 5.1724418881349266e-05
27 O 0 7.932368316687644e-05
% O 0 3.346884477650747e-05
) O 0 2.642509207362309e-05
and O 0 1.9613205950008705e-05
4 O 0 4.739020732813515e-05
of O 0 6.762739212717861e-05
32 O 0 0.00019491180137265474
DZ O 1 0.8082742691040039
twin O 0 0.0009826275054365396
pairs O 0 0.00011250744137214497
overall O 0 0.0001359633170068264
( O 0 7.000062760198489e-05
12 O 0 9.513591066934168e-05
. O 0 4.3557811295613647e-05
5 O 0 0.00010400225437479094
% O 0 0.00012787044397555292
) O 0 0.00024074912653304636
. O 0 0.0005149568896740675

Nonsignificant O 1 0.9478840827941895
increases O 0 0.0009497430874034762
in O 0 0.00015501472807954997
similarity O 0 0.0002452305634506047
with O 0 7.012623245827854e-05
regard O 0 9.71244735410437e-05
to O 0 3.772513082367368e-05
age O 0 0.002361922524869442
at O 0 0.22338040173053741
disease O 1 0.9999948740005493
onset O 1 0.9999698400497437
and O 0 0.00012899618013761938
all O 0 3.036107045772951e-05
of O 0 0.0002257137675769627
the O 0 0.010555577464401722
disease O 1 0.9999173879623413
severity O 1 0.8452193140983582
scores O 0 0.00023993469949346036
assessed O 0 0.00011778659245464951
were O 0 4.731727676698938e-05
noted O 0 9.486485942034051e-05
in O 0 0.00014193427341524512
disease O 1 0.9997493624687195
- O 1 0.9553808569908142
concordant O 1 0.9983351826667786
MZ O 1 0.9999921321868896
twins O 1 0.7418102622032166
compared O 0 0.00038458165363408625
with O 0 0.0003698851796798408
concordant O 1 0.8836257457733154
DZ O 1 0.9997491240501404
twins O 1 0.8623812198638916
. O 0 0.002265737857669592

HLA O 1 0.9999450445175171
- O 1 0.9476789832115173
B27 O 1 0.9897963404655457
and O 0 0.00044172361958771944
B60 O 1 0.7071298956871033
were O 0 9.291138121625409e-05
associated O 0 6.0559395933523774e-05
with O 0 3.832255970337428e-05
the O 0 0.00035767510416917503
disease O 1 0.9997832179069519
in O 0 0.0007785551133565605
probands O 1 0.9995939135551453
, O 0 9.255695476895198e-05
and O 0 2.9914503102190793e-05
the O 0 4.792933032149449e-05
rate O 0 4.4865912059322e-05
of O 0 0.00014359944907482713
disease O 1 0.9989136457443237
concordance O 0 0.21921950578689575
was O 0 0.0017704800702631474
significantly O 0 9.470306395087391e-05
increased O 0 7.597174408147112e-05
among O 0 5.735313243349083e-05
DZ O 1 0.9095025658607483
twin O 0 0.0010924824746325612
pairs O 0 4.286462353775278e-05
in O 0 2.1388945242506452e-05
which O 0 2.3186457838164642e-05
the O 0 6.089759699534625e-05
co O 0 0.004442173521965742
- O 0 0.009908631443977356
twin O 0 0.03747978433966637
was O 0 0.00037355211679823697
positive O 0 0.00010354124242439866
for O 0 6.244214455364272e-05
both O 0 0.00011681269097607583
B27 O 1 0.6059573292732239
and O 0 0.0007321072625927627
DR1 O 1 0.9613069891929626
. O 0 0.001574659370817244

Additive O 0 0.01740097813308239
genetic O 0 0.0013014042051509023
effects O 0 0.0005421118112280965
were O 0 6.045697955414653e-05
estimated O 0 8.746795356273651e-05
to O 0 2.6480338419787586e-05
contribute O 0 7.951119187055156e-05
97 O 0 0.0001389913959428668
% O 0 4.902300133835524e-05
of O 0 5.6147306167986244e-05
the O 0 6.909256626386195e-05
population O 0 0.00012720595987048
variance O 0 0.00037885925848968327
. O 0 0.0005812849849462509

CONCLUSION O 0 0.023746328428387642
Susceptibility O 0 0.17730842530727386
to O 0 0.00024996360298246145
AS B-Disease 0 0.0005075889639556408
is O 0 0.00011050343164242804
largely O 0 8.769446139922366e-05
genetically O 0 9.118470188695937e-05
determined O 0 6.523953197756782e-05
, O 0 3.8142588891787454e-05
and O 0 2.441293872834649e-05
the O 0 3.9331182051682845e-05
environmental O 0 0.00029284582706168294
trigger O 0 0.0014792269794270396
for O 0 7.873840513639152e-05
the O 0 0.0011931355111300945
disease O 1 0.9997966885566711
is O 0 0.0014829870779067278
probably O 0 0.0045049749314785
ubiquitous O 0 0.0401473268866539
. O 0 0.0009529154631309211

HLA O 1 0.999881386756897
- O 1 0.5204585194587708
B27 O 0 0.22153329849243164
accounts O 0 0.0002341992367291823
for O 0 6.764930731151253e-05
a O 0 7.478815678041428e-05
minority O 0 9.030604269355536e-05
of O 0 7.54392531234771e-05
the O 0 0.00021650479175150394
overall O 0 0.07683604210615158
genetic O 0 0.07329851388931274
susceptibility O 0 0.26485541462898254
to O 0 0.0002211802639067173
AS B-Disease 0 0.001206788350827992
. O 0 0.001090642879717052

Cell O 0 0.010743744671344757
cycle O 0 0.007484310306608677
- O 0 0.005278684198856354
dependent O 0 0.0007774219266138971
colocalization O 1 0.6462258100509644
of O 0 0.0013878715690225363
BARD1 O 1 0.9999332427978516
and O 0 0.0005042811390012503
BRCA1 O 0 0.07572624087333679
proteins O 0 0.0001033101580105722
in O 0 8.202961907954887e-05
discrete O 0 0.00029032136080786586
nuclear O 0 0.0005476061487570405
domains O 0 0.0006764201680198312
. O 0 0.0009428117773495615

Germ O 1 0.9988848567008972
- O 0 0.396864116191864
line O 0 0.0012382511049509048
mutations O 0 0.00032233723322860897
of O 0 0.00016474940639454871
the O 0 0.0012093292316421866
BRCA1 O 1 0.998481810092926
gene O 0 0.0006220224313437939
predispose O 0 0.010715380311012268
women O 0 0.00012396917736623436
to O 0 3.9590231608599424e-05
early O 0 0.0007516744080930948
- O 1 0.999052107334137
onset O 1 0.9999996423721313
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9999438524246216
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
by O 0 0.002880720654502511
compromising O 0 0.1935551017522812
the O 0 0.0003373009094502777
genes O 0 0.0003883967874571681
presumptive O 1 0.9871388077735901
function O 0 0.00023988072643987834
as O 0 0.0001813817652873695
a O 0 0.002465447410941124
tumor B-Disease 1 0.999903678894043
suppressor O 1 0.9870330095291138
. O 0 0.002260420238599181

Although O 0 0.0010293753584846854
the O 0 0.0005574548267759383
biochemical O 0 0.0015971306711435318
properties O 0 0.00034450634848326445
of O 0 0.0002894962963182479
BRCA1 O 1 0.8826562762260437
polypeptides O 0 0.0005303624202497303
are O 0 3.48823559761513e-05
not O 0 3.361528069945052e-05
understood O 0 8.048351446632296e-05
, O 0 5.112949656904675e-05
their O 0 3.701010064105503e-05
expression O 0 0.00010163264232687652
pattern O 0 0.00018026829638984054
and O 0 7.296863623196259e-05
subcellular O 0 0.0005262362537905574
localization O 0 0.0003464877081569284
suggest O 0 7.42164411349222e-05
a O 0 7.424469367833808e-05
role O 0 0.00010997844219673425
in O 0 8.732102287467569e-05
cell O 0 0.002421649405732751
- O 0 0.01688051037490368
cycle O 0 0.0025453350972384214
regulation O 0 0.0008109960472211242
. O 0 0.0007599406526423991

When O 0 0.0041252728551626205
resting O 1 0.6049060821533203
cells O 0 0.001652455423027277
are O 0 8.18520929897204e-05
induced O 0 0.015461890026926994
to O 0 7.250537601066753e-05
proliferate O 0 0.00026450378936715424
, O 0 4.284672832000069e-05
the O 0 5.510877235792577e-05
steady O 0 0.00017889024456962943
- O 0 0.00011847879795823246
state O 0 3.4232758480357006e-05
levels O 0 4.7099027142394334e-05
of O 0 5.671157850883901e-05
BRCA1 O 0 0.006410554051399231
increase O 0 5.486666123033501e-05
in O 0 4.076437107869424e-05
late O 0 0.0002469438186381012
G1 O 0 0.12068915367126465
and O 0 5.203169712331146e-05
reach O 0 6.780956027796492e-05
a O 0 9.698417852632701e-05
maximum O 0 0.00015938992146402597
during O 0 0.0004361152241472155
S O 0 0.008620322681963444
phase O 0 0.004885285161435604
. O 0 0.001514509436674416

Moreover O 0 0.0018841676646843553
, O 0 0.00038246592157520354
in O 0 0.0002101143472827971
S O 1 0.5410301685333252
phase O 1 0.6810973286628723
cells O 0 0.04155872389674187
, O 0 0.00024604768259450793
BRCA1 O 0 0.3139496147632599
polypeptides O 0 0.00047498714411631227
are O 0 4.060084393131547e-05
hyperphosphorylated O 0 0.002892626915127039
and O 0 7.318969437619671e-05
accumulate O 0 0.00016993329336401075
into O 0 0.0001412097626598552
discrete O 0 0.0005051543121226132
subnuclear O 0 0.3792479634284973
foci O 0 0.035957857966423035
termed O 0 0.027563290670514107
" O 0 0.0019751761574298143
BRCA1 O 0 0.3163229823112488
nuclear O 0 0.0029588898178189993
dots O 0 0.005635181907564402
. O 0 0.00214936351403594

" O 0 0.012401013635098934
BRCA1 O 1 0.7269927263259888
associates O 0 0.0027735107578337193
in O 0 0.0002504972799215466
vivo O 0 0.0008864642004482448
with O 0 0.00010798342555062845
a O 0 0.0002932688221335411
structurally O 0 0.010070026852190495
related O 0 0.0004912280710414052
protein O 0 0.0008900494431145489
termed O 0 0.324567049741745
BARD1 O 1 0.9989294409751892
. O 0 0.0022623774129897356

Here O 0 0.0010265568271279335
we O 0 0.00026559949037618935
show O 0 0.0002091567002935335
that O 0 3.8737016438972205e-05
the O 0 5.171184602659196e-05
steady O 0 0.00019764846365433186
- O 0 0.00017705616482999176
state O 0 4.498278212849982e-05
levels O 0 4.933741001877934e-05
of O 0 6.443901656894013e-05
BARD1 O 1 0.9942737221717834
, O 0 7.04956692061387e-05
unlike O 0 5.7018733059521765e-05
those O 0 2.908737769757863e-05
of O 0 9.862447768682614e-05
BRCA1 O 1 0.6654078960418701
, O 0 8.603961032349616e-05
remain O 0 0.00012523261830210686
relatively O 0 0.0001448122493457049
constant O 0 0.00032151376944966614
during O 0 0.0006691795424558222
cell O 0 0.006422446109354496
cycle O 0 0.013958965428173542
progression O 0 0.37921467423439026
. O 0 0.0014377649640664458

However O 0 0.001506054657511413
, O 0 0.0008041610708460212
immunostaining O 1 0.7328422665596008
revealed O 0 0.0014403488021343946
that O 0 0.0001845415827119723
BARD1 O 1 0.9345111846923828
resides O 0 0.0010372145334258676
within O 0 0.00016495971067342907
BRCA1 O 0 0.07379183173179626
nuclear O 0 0.00033478601835668087
dots O 0 0.0003990216937381774
during O 0 0.00017016142373904586
S O 0 0.0009021178120747209
phase O 0 0.00022597520728595555
of O 0 5.544824671233073e-05
the O 0 0.00010032751015387475
cell O 0 0.0006672731833532453
cycle O 0 0.00029646570328623056
, O 0 3.218367783119902e-05
but O 0 2.6274623451172374e-05
not O 0 3.021370866918005e-05
during O 0 0.00019799514848273247
the O 0 0.0003305681166239083
G1 O 1 0.9143986105918884
phase O 0 0.005436515435576439
. O 0 0.0017906235298141837

Nevertheless O 0 0.011439554393291473
, O 0 0.001634635147638619
BARD1 O 1 0.912025511264801
polypeptides O 0 0.0007598544470965862
are O 0 4.886533133685589e-05
found O 0 4.5798264181939885e-05
exclusively O 0 4.879306288785301e-05
in O 0 2.219003545178566e-05
the O 0 2.9101476684445515e-05
nuclear O 0 6.518387817777693e-05
fractions O 0 7.908629049779847e-05
of O 0 4.7402369091287255e-05
both O 0 6.644117092946544e-05
G1 O 1 0.9094535708427429
- O 0 0.0010305233299732208
and O 0 0.00021650355483870953
S O 0 0.41659459471702576
- O 0 0.17141325771808624
phase O 0 0.14183270931243896
cells O 0 0.002639477839693427
. O 0 0.0012575045693665743

Therefore O 0 0.0020463995169848204
, O 0 0.0007311144145205617
progression O 0 0.003200908424332738
to O 0 0.00020277978910598904
S O 0 0.18145912885665894
phase O 0 0.0019460556795820594
is O 0 9.818858961807564e-05
accompanied O 0 0.0002583303430583328
by O 0 5.121059439261444e-05
the O 0 8.103629807010293e-05
aggregation O 0 0.00023033141042105854
of O 0 0.00017342949286103249
nuclear O 0 0.0009191320277750492
BARD1 O 1 0.6979740262031555
polypeptides O 0 0.0008943731663748622
into O 0 0.0003941977920476347
BRCA1 O 0 0.11336100846529007
nuclear O 0 0.001697964733466506
dots O 0 0.002890221308916807
. O 0 0.0012216955656185746

This O 0 0.0011249299859628081
cell O 0 0.0022379138972610235
cycle O 0 0.003436997765675187
- O 0 0.004306521732360125
dependent O 0 0.0004817383305635303
colocalization O 1 0.730892539024353
of O 0 0.0021591174881905317
BARD1 O 1 0.9999507665634155
and O 0 0.0007675790111534297
BRCA1 O 0 0.4793817400932312
indicates O 0 0.0002973327354993671
a O 0 0.00016548432176932693
role O 0 0.00025885869399644434
for O 0 0.0001445344096282497
BARD1 O 1 0.9972819089889526
in O 0 0.0012966679641976953
BRCA1 O 1 0.9999189376831055
- O 1 0.9982396364212036
mediated O 1 0.9993436932563782
tumor B-Disease 1 0.9999923706054688
suppression O 1 0.9997145533561707
. O 0 0.0095455851405859

Ethnic O 0 0.002039625309407711
differences O 0 0.0007178526138886809
in O 0 0.00035681240842677653
the O 0 0.00047529826406389475
HFE O 1 0.9010531902313232
codon O 0 0.002183716045692563
282 O 0 0.013136245310306549
( O 0 0.0016034357249736786
Cys O 1 0.9955463409423828
/ O 1 0.9017334580421448
Tyr O 1 0.9946566820144653
) O 0 0.0011234104167670012
polymorphism O 0 0.003510172013193369
. O 0 0.0014225566992536187

Recent O 0 0.0010797013528645039
studies O 0 0.0002992323716171086
have O 0 8.060010441113263e-05
shown O 0 0.00013131723972037435
that O 0 0.0002471939951647073
hereditary B-Disease 1 0.9999971389770508
hemochromatosis I-Disease 1 1.0
( O 1 0.9998766183853149
HH B-Disease 1 0.9999997615814209
) O 0 0.0009783846326172352
is O 0 6.921351450728253e-05
likely O 0 4.846030060434714e-05
to O 0 2.112644142471254e-05
be O 0 2.2580303266295232e-05
caused O 0 0.0001640733826206997
by O 0 3.898851355188526e-05
homozygosity O 0 0.004282600246369839
for O 0 4.266032192390412e-05
a O 0 0.0001507084525655955
Cys282Tyr O 1 0.6673616170883179
mutation O 0 0.00019965639512520283
in O 0 7.898393960203975e-05
the O 0 0.00020075480279047042
HFE O 1 0.9413025975227356
gene O 0 0.00028682671836577356
located O 0 0.0004264510644134134
4 O 0 0.0006489627412520349
. O 0 0.0008094329969026148

5 O 0 0.005981373600661755
Mb O 0 0.027294335886836052
telomeric O 0 0.2323039323091507
to O 0 0.002002424094825983
HLA O 1 0.9997527003288269
- O 0 0.13820381462574005
A O 0 0.006262099836021662
. O 0 0.0021064418833702803

Population O 0 0.0007874869625084102
studies O 0 0.0002612909593153745
of O 0 0.00017717709124553949
this O 0 7.76063825469464e-05
polymorphism O 0 0.00023937852529343218
are O 0 2.6088859158335254e-05
facilitated O 0 0.00011467589501990005
by O 0 3.012176057382021e-05
the O 0 4.51751948276069e-05
fact O 0 5.1505925512174144e-05
that O 0 3.4649547160370275e-05
the O 0 0.00011608924251049757
Cys282Tyr O 1 0.8699764013290405
mutation O 0 0.0009775535436347127
creates O 0 0.000764430791605264
a O 0 0.0005213020485825837
Rsal O 1 0.9152623414993286
restriction O 0 0.0015219207853078842
site O 0 0.0017211532685905695
. O 0 0.0011496635852381587

We O 0 0.0009039186988957226
have O 0 0.00021610554540529847
studied O 0 0.0002726397360675037
the O 0 0.0002290544071001932
codon O 0 0.0009768411982804537
282 O 0 0.0023869413416832685
( O 0 0.0010428944369778037
Cys O 1 0.995532751083374
/ O 1 0.6161983609199524
Tyr O 1 0.9059382081031799
) O 0 0.0003117351734545082
polymorphism O 0 0.000379411707399413
in O 0 8.851089660311118e-05
different O 0 6.0064940043957904e-05
ethnic O 0 0.00020547400345094502
groups O 0 0.00033795557101257145
. O 0 0.0007285952451638877

In O 0 0.0007578260847367346
agreement O 0 0.0005313559086062014
with O 0 0.00015163228090386838
previous O 0 0.00015957590949255973
observations O 0 0.00020697526633739471
the O 0 0.00020475333440117538
Tyr O 1 0.9830233454704285
allele O 0 0.0003100072790402919
appeared O 0 9.683660027803853e-05
to O 0 2.9107191949151456e-05
be O 0 2.973611481138505e-05
rare O 0 8.770432032179087e-05
or O 0 5.081873678136617e-05
absent O 0 0.00020398556080181152
in O 0 5.551861977437511e-05
Asiatic O 0 0.02203339897096157
( O 0 0.00013307695917319506
Indian O 0 0.00018249340064357966
, O 0 9.733846673043445e-05
Chinese O 0 0.0003876956179738045
) O 0 0.0002458038507029414
populations O 0 0.0004751512606162578
. O 0 0.0007444079965353012

The O 0 0.0011591004440560937
highest O 0 0.0008066114969551563
allele O 0 0.0004930989816784859
frequency O 0 0.00013046228559687734
( O 0 6.348470196826383e-05
7 O 0 9.034635149873793e-05
. O 0 3.690872836159542e-05
5 O 0 6.127700908109546e-05
% O 0 4.5982633309904486e-05
) O 0 5.933107968303375e-05
was O 0 0.000121163138828706
found O 0 7.813836418790743e-05
in O 0 0.00016074601444415748
Swedes O 0 0.001633216394111514
. O 0 0.0009711388847790658

Saamis O 0 0.37118273973464966
( O 0 0.0007912260480225086
2 O 0 0.000287993490928784
% O 0 0.00013537587074097246
) O 0 9.180154302157462e-05
and O 0 7.093094609444961e-05
Mordvinians O 0 0.015912087634205818
( O 0 7.408104283967987e-05
1 O 0 5.8384503063280135e-05
. O 0 2.4641087293275632e-05
8 O 0 5.0386504881316796e-05
% O 0 2.947540815512184e-05
) O 0 3.744795321836136e-05
had O 0 7.096578337950632e-05
significantly O 0 6.840264541096985e-05
lower O 0 7.994958286872134e-05
frequencies O 0 5.598370626103133e-05
of O 0 0.00010682215361157432
the O 0 0.0003308919258415699
Tyr O 1 0.8873335123062134
allele O 0 0.002017832361161709
. O 0 0.0008785671670921147

Comparisons O 0 0.0018484381726011634
with O 0 0.0003875633701682091
allele O 0 0.00042046053567901254
frequencies O 0 9.686513658380136e-05
based O 0 5.461187174660154e-05
on O 0 5.0240174459759146e-05
prevalence O 0 0.0004094292817171663
estimates O 0 6.760965334251523e-05
of O 0 0.00014489926979877055
HH B-Disease 1 0.9999428987503052
showed O 0 0.00030834338394925
some O 0 4.5262040657689795e-05
disagreements O 0 0.000153234155732207
with O 0 4.651155541068874e-05
the O 0 9.563179628457874e-05
RFLP O 0 0.0032399892807006836
data O 0 8.287104719784111e-05
, O 0 0.00010638532694429159
particularly O 0 0.00023072837211657315
in O 0 0.0002077546960208565
Finns O 0 0.002993921982124448
. O 0 0.0010998122161254287

The O 0 0.0025534527376294136
newly O 0 0.005785787012428045
described O 0 0.01906607858836651
HFE O 1 0.9992725253105164
marker O 0 0.022091906517744064
provides O 0 0.00026183758745901287
a O 0 8.041538967518136e-05
new O 0 4.992052708985284e-05
approach O 0 4.3800064304377884e-05
to O 0 1.4319139154395089e-05
the O 0 3.213436502846889e-05
screening O 0 8.581706788390875e-05
of O 0 0.00011435244960011914
HH B-Disease 1 0.9997968077659607
as O 0 5.8285819250158966e-05
well O 0 2.917299570981413e-05
as O 0 2.3340180632658303e-05
studies O 0 2.2616224669036455e-05
of O 0 2.790860708046239e-05
the O 0 4.771999374497682e-05
relationship O 0 0.00011817111953860149
between O 0 8.727058593649417e-05
the O 0 0.0012166786473244429
HFE O 1 0.9999834299087524
Tyr O 1 0.9999415874481201
allele O 0 0.008985981345176697
and O 0 0.00029469176661223173
different O 0 0.0003173066070303321
disorders O 1 0.9999010562896729
including O 0 0.1335485875606537
cancer B-Disease 1 0.9999512434005737

Autosomal B-Disease 1 0.9994040727615356
dominant I-Disease 1 0.9997978806495667
neurohypophyseal I-Disease 1 0.999998927116394
diabetes I-Disease 1 0.9999997615814209
insipidus I-Disease 1 0.9999785423278809
associated O 0 0.002204726915806532
with O 0 0.0001830594555940479
a O 0 0.00033423330751247704
missense O 0 0.004565456882119179
mutation O 0 0.0004927032277919352
encoding O 0 0.00023884688562247902
Gly23 O 1 0.9863109588623047
- O 1 0.6771632432937622
- O 1 0.5886406898498535
> O 0 0.12099321186542511
Val O 1 0.6676438450813293
in O 0 0.0004289769276510924
neurophysin O 1 0.9957881569862366
II O 1 0.9963164329528809
. O 0 0.001970769604668021

Autosomal B-Disease 1 0.9991464614868164
dominant I-Disease 1 0.9997381567955017
neurohypophyseal I-Disease 1 0.9999994039535522
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 1 0.9996629953384399
ADNDI B-Disease 1 0.9999983310699463
) O 0 0.005229754373431206
is O 0 0.0017157266847789288
an O 0 0.45637837052345276
inherited B-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
caused O 1 0.9999884366989136
by O 1 0.7545554041862488
progressive O 1 0.999997615814209
degeneration O 1 0.9999998807907104
of O 1 0.7745428681373596
the O 1 0.8888645172119141
magnocellular O 1 0.9999839067459106
neurons O 0 0.07293163985013962
of O 0 0.00014972213830333203
the O 0 0.00027801026590168476
hypothalamus O 0 0.47699105739593506
leading O 0 0.00033535013790242374
to O 0 4.429943874129094e-05
decreased O 0 0.00019536765466909856
ability O 0 4.335991252446547e-05
to O 0 3.224788815714419e-05
produce O 0 8.857016655383632e-05
the O 0 0.0001677830732660368
hormone O 0 0.029179058969020844
arginine O 0 0.005114294588565826
vasopressin O 0 0.2011108696460724
( O 0 0.001092585502192378
AVP O 1 0.7103121876716614
) O 0 0.0008775702444836497
. O 0 0.001191830262541771

Affected O 0 0.0025829642545431852
individuals O 0 0.00021853981888853014
are O 0 6.0717433370882645e-05
not O 0 9.446406329516321e-05
symptomatic O 1 0.9781345129013062
at O 0 0.0007114587933756411
birth O 0 0.0911339595913887
, O 0 0.00011652966350084171
but O 0 7.995621126610786e-05
usually O 0 0.0001513204479124397
develop O 0 0.01767410896718502
diabetes B-Disease 1 0.9999359846115112
insipidus I-Disease 1 0.9948121309280396
at O 0 0.0003271417517680675
1 O 0 0.00021971712703816593
- O 0 0.001280633732676506
6 O 0 0.0005312644643709064
yr O 0 0.09548785537481308
of O 0 0.00041894835885614157
age O 0 0.0013573241885751486
. O 0 0.0010605772258713841

The O 0 0.0015518789878115058
genetic O 0 0.0008644430199638009
locus O 0 0.0013202230911701918
of O 0 0.00019721302669495344
the O 0 0.0006918605067767203
disease O 1 0.9984807372093201
is O 0 0.00026598823023959994
the O 0 0.004978097043931484
AVP O 1 0.999991774559021
- O 1 0.9986281394958496
neurophysin O 1 0.9999698400497437
II O 1 0.9999760389328003
( O 0 0.09377997368574142
NPII O 1 0.9997912049293518
) O 0 0.00013462489005178213
gene O 0 0.00013016420416533947
, O 0 4.943263775203377e-05
and O 0 5.034750938648358e-05
mutations O 0 0.00012380826228763908
that O 0 5.901570330024697e-05
cause O 0 0.44528087973594666
ADNDI B-Disease 1 0.9982210993766785
have O 0 3.5855515307048336e-05
been O 0 2.5386289053130895e-05
found O 0 1.695328319328837e-05
in O 0 1.6974687241599895e-05
both O 0 1.6308598787873052e-05
the O 0 3.02031658065971e-05
signal O 0 8.708370296517387e-05
peptide O 0 8.591195364715531e-05
of O 0 4.459529372979887e-05
the O 0 0.00013541073712985963
prepro O 1 0.9931459426879883
- O 1 0.9723806381225586
AVP O 1 0.9999357461929321
- O 1 0.9468646049499512
NPII O 1 0.9994415640830994
precursor O 0 0.0043550520204007626
and O 0 0.000235664178035222
within O 0 0.0004938242491334677
NPII O 1 0.9840493202209473
itself O 0 0.00259031867608428
. O 0 0.0013342818710952997

An O 0 0.00182089873123914
affected O 0 0.0018452852964401245
girl O 0 0.00353879202157259
who O 0 0.00019582270761020482
presented O 0 0.00018134855781681836
at O 0 0.00010831157851498574
9 O 0 0.00013918250624556094
months O 0 9.13106050575152e-05
of O 0 7.057758921291679e-05
age O 0 0.00019741134019568563
and O 0 6.789923645555973e-05
her O 0 0.000357425567926839
similarly O 0 0.0004279974673409015
affected O 0 0.0005700363544747233
younger O 0 0.0027124558109790087
brother O 0 0.004357172176241875
and O 0 5.7389675930608064e-05
father O 0 0.00032633994123898447
were O 0 2.0937141016474925e-05
all O 0 1.7668891814537346e-05
found O 0 1.766073728504125e-05
to O 0 1.5443656593561172e-05
have O 0 1.6741783838369884e-05
a O 0 5.262166087049991e-05
novel O 0 0.0001956163177965209
missense O 0 0.0006796556408517063
mutation O 0 0.0003414256789255887
( O 0 0.00021798293164465576
G1758 O 1 0.935531497001648
- O 1 0.5857701301574707
- O 0 0.30826011300086975
> O 0 0.013963756151497364
T O 0 0.0012567118974402547
) O 0 5.035418507759459e-05
encoding O 0 4.935054312227294e-05
the O 0 5.0900653150165454e-05
amino O 0 8.210302621591836e-05
acid O 0 0.00032470442238263786
substitution O 0 0.0007090436993166804
Gly23 O 1 0.8942682147026062
- O 0 0.4644949436187744
- O 0 0.3501429259777069
> O 0 0.05127187445759773
Val O 0 0.47862690687179565
within O 0 0.00111807428766042
NPII O 1 0.980968713760376
. O 0 0.0020702797919511795

The O 0 0.0015722360694780946
mutation O 0 0.0014000568771734834
was O 0 0.0006017245468683541
confirmed O 0 0.0003780535771511495
by O 0 0.00017567386385053396
restriction O 0 0.0008007033029571176
endonuclease O 0 0.005393096245825291
analysis O 0 0.0008001723908819258
. O 0 0.0012111668474972248

A O 0 0.008764125406742096
T1 O 1 0.9487850666046143
- O 0 0.0019273527432233095
weighted O 0 0.0006982217309996486
magnetic O 0 0.0007364365737885237
resonance O 0 0.000470982602564618
imaging O 0 0.00040025453199632466
of O 0 0.00013396421854849905
the O 0 0.0003342119453009218
fathers O 1 0.8998608589172363
pituitary O 1 0.999963641166687
gland O 1 0.9995881915092468
demonstrates O 0 0.17120426893234253
an O 0 0.00679811742156744
attenuated O 1 0.9992724061012268
posterior O 1 0.999657154083252
pituitary O 1 0.9999264478683472
bright O 1 0.9534881711006165
spot O 0 0.042549096047878265
. O 0 0.002298056147992611

This O 0 0.0013208379969000816
mutation O 0 0.002500812755897641
may O 0 0.00019170111045241356
be O 0 5.679471360053867e-05
valuable O 0 0.00013491735444404185
for O 0 5.1366772822802886e-05
developing O 0 0.00014036093489266932
models O 0 0.00011671349784592167
of O 0 0.00029319641180336475
dominantly B-Disease 1 0.9997597336769104
inherited I-Disease 1 0.9999884366989136
neurodegeneration I-Disease 1 0.9999990463256836
, O 0 0.00028273192583583295
as O 0 5.8652585721574724e-05
the O 0 4.49692270194646e-05
early O 0 7.922479562694207e-05
age O 0 0.0001220988924615085
of O 0 0.0003910550440195948
onset O 1 0.9999585151672363
of O 1 0.5660708546638489
symptoms O 1 0.9999926090240479
suggests O 0 0.030501624569296837
that O 0 6.397569813998416e-05
this O 0 4.884893132839352e-05
mutation O 0 0.0005830689333379269
may O 0 6.056840356905013e-05
be O 0 3.407082476769574e-05
particularly O 0 9.583501378074288e-05
deleterious O 0 0.00026608206098899245
to O 0 6.581121851922944e-05
the O 0 0.0003080089809373021
magnocellular O 1 0.9959139227867126
neuron O 1 0.6507984399795532
. O 0 0.0007325958576984704
. O 0 0.001345145283266902

Frequent O 0 0.0058390418998897076
inactivation O 0 0.11409982293844223
of O 0 0.004015316721051931
PTEN O 1 0.9999394416809082
/ O 1 0.9984071850776672
MMAC1 O 1 0.9998452663421631
in O 0 0.02773186005651951
primary O 1 0.9996305704116821
prostate B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999985694885254
. O 0 0.20333388447761536

Sporadic B-Disease 1 0.9998502731323242
prostate I-Disease 1 0.9999997615814209
carcinoma I-Disease 1 0.9999998807907104
is O 0 0.00876417476683855
the O 0 0.0005837378557771444
most O 0 0.0001487353292759508
common O 0 0.001446483307518065
male B-Disease 0 0.4563608467578888
cancer I-Disease 1 0.9968967437744141
in O 0 4.987974898540415e-05
the O 0 6.307093281066045e-05
Western O 0 0.00020302239863667637
world O 0 0.00022977338812779635
, O 0 3.0833172786515206e-05
yet O 0 2.363307612540666e-05
many O 0 8.532353604095988e-06
of O 0 1.7140266209025867e-05
the O 0 3.406696123420261e-05
major O 0 0.00011779377382481471
genetic O 0 5.903742930968292e-05
events O 0 3.427842602832243e-05
involved O 0 3.842612204607576e-05
in O 0 2.3405043975799344e-05
the O 0 6.516373832710087e-05
progression O 0 0.14520703256130219
of O 0 0.00020012639288324863
this O 0 0.00011192063539056107
often O 0 0.00034008416696451604
fatal O 1 0.9999420642852783
cancer B-Disease 1 0.9995478987693787
remain O 0 0.00019839273591060191
to O 0 0.0001102588139474392
be O 0 0.0001903802913147956
elucidated O 0 0.004002556670457125
. O 0 0.0008657771977595985

Numerous O 0 0.0028112728614360094
cytogenetic O 0 0.469915509223938
and O 0 0.0008438820950686932
allelotype O 1 0.6825883388519287
studies O 0 0.00018682335212361068
have O 0 6.498087896034122e-05
reported O 0 0.0001231397473020479
frequent O 0 0.00013358077558223158
loss O 0 0.0005007943836972117
of O 0 0.0002059716498479247
heterozygosity O 1 0.9851810932159424
on O 0 0.0002973545342683792
chromosomal O 1 0.8350034952163696
arm O 1 0.9822720289230347
10q O 1 0.9993888139724731
in O 0 0.014598586596548557
sporadic B-Disease 1 0.9999078512191772
prostate I-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
. O 0 0.25695720314979553

Deletion O 0 0.005321265663951635
mapping O 0 0.0011879762168973684
studies O 0 0.00020379699708428234
have O 0 8.640285523142666e-05
unambiguously O 0 0.00023624638561159372
identified O 0 7.484308298444375e-05
a O 0 8.636504935566336e-05
region O 0 9.536334255244583e-05
of O 0 0.0002025660505751148
chromosome O 0 0.007720593828707933
10q23 O 0 0.3569835126399994
to O 0 4.141383760725148e-05
be O 0 3.245428524678573e-05
the O 0 5.880481330677867e-05
minimal O 0 0.00021655623277183622
area O 0 0.00021170906256884336
of O 0 0.00028866532375104725
loss O 0 0.01461978442966938
. O 0 0.0010035396553575993

A O 0 0.0034444406628608704
new O 0 0.001581914140842855
tumor B-Disease 1 0.99974125623703
suppressor O 1 0.9821615219116211
gene O 0 0.0027529567014425993
, O 0 0.001844938495196402
PTEN O 1 0.9999723434448242
/ O 1 0.9948537945747375
MMAC1 O 1 0.9998032450675964
, O 0 0.00022750493371859193
was O 0 0.0001626872253837064
isolated O 0 0.0001654085936024785
recently O 0 6.724123522872105e-05
at O 0 4.610738324117847e-05
this O 0 2.0807976397918537e-05
region O 0 5.827514542033896e-05
of O 0 7.749412179691717e-05
chromosome O 0 0.0011147742625325918
10q23 O 0 0.2171199768781662
and O 0 3.559163087629713e-05
found O 0 1.7988459148909897e-05
to O 0 1.3761203263129573e-05
be O 0 1.7612430383451283e-05
inactivated O 0 0.00018476606055628508
by O 0 2.8400316296028905e-05
mutation O 0 9.100991883315146e-05
in O 0 6.691219459753484e-05
three O 0 0.0165620818734169
prostate B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999984502792358
cell O 1 0.9381796717643738
lines O 0 0.0044409059919416904
. O 0 0.0009312215261161327

We O 0 0.0025629347655922174
screened O 0 0.005951650440692902
80 O 0 0.31444934010505676
prostate B-Disease 1 0.999995231628418
tumors I-Disease 1 0.9997968077659607
by O 0 0.0002653625560924411
microsatellite O 0 0.07628306746482849
analysis O 0 9.170477278530598e-05
and O 0 7.025260129012167e-05
found O 0 9.084743214771152e-05
chromosome O 0 0.0005605515907518566
10q23 O 0 0.018220750615000725
to O 0 5.01851063745562e-05
be O 0 5.7759392802836373e-05
deleted O 0 0.00015431715291924775
in O 0 8.214234549086541e-05
23 O 0 0.0003155448939651251
cases O 0 0.00040702271508052945
. O 0 0.0006637893384322524

We O 0 0.0007381270988844335
then O 0 0.00040935046854428947
proceeded O 0 0.0005031988839618862
with O 0 6.456646224251017e-05
sequence O 0 6.0960119299124926e-05
analysis O 0 3.854452006635256e-05
of O 0 6.000906432745978e-05
the O 0 0.00010851896513486281
entire O 0 0.011647151783108711
PTEN O 1 0.9998830556869507
/ O 1 0.8364614248275757
MMAC1 O 1 0.9945816397666931
coding O 0 0.0005618823925033212
region O 0 0.0001703900343272835
and O 0 8.63343448145315e-05
tested O 0 0.00016651616897433996
for O 0 7.723929593339562e-05
homozygous O 0 0.00025712387287057936
deletion O 0 0.0001854346046457067
with O 0 5.020017852075398e-05
new O 0 0.00010811922402353957
intragenic O 0 0.1573135405778885
markers O 0 0.0002787653938867152
in O 0 4.8051886551547796e-05
these O 0 2.5068820832530037e-05
23 O 0 8.173765672836453e-05
cases O 0 7.078856287989765e-05
with O 0 0.00011808618728537112
10q23 O 1 0.9132357239723206
loss O 0 0.067441426217556
of O 0 0.0024461799766868353
heterozygosity O 1 0.9987793564796448
. O 0 0.00290117459371686

The O 0 0.000835261307656765
identification O 0 0.0004791023675352335
of O 0 0.0001948200078913942
the O 0 0.00014126756286714226
second O 0 0.0003314052883069962
mutational O 0 0.018420102074742317
event O 0 0.00013143598334863782
in O 0 2.8065918741049245e-05
10 O 0 4.17527298850473e-05
( O 0 3.9329006540356204e-05
43 O 0 0.0001135425191023387
% O 0 0.00010144423140445724
) O 0 0.00026391734718345106
tumors B-Disease 1 0.9730878472328186
establishes O 0 0.2693628966808319
PTEN O 1 0.9998714923858643
/ O 1 0.7054049968719482
MMAC1 O 1 0.8764520287513733
as O 0 0.00012886770127806813
a O 0 0.0001243062870344147
main O 0 0.00022008175437804312
inactivation O 0 0.0009702667593955994
target O 0 0.00014485865540336818
of O 0 0.00015452862135134637
10q O 1 0.8845862150192261
loss O 0 0.12430847436189651
in O 0 0.001709405449219048
sporadic B-Disease 1 0.9999110698699951
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 0.009961425326764584
. O 0 0.002003381261602044

Risk O 0 0.006586320232599974
reversals O 0 0.005514111835509539
in O 0 0.0006675523472949862
predictive O 0 0.004400601610541344
testing O 0 0.006491208914667368
for O 0 0.005215183831751347
Huntington B-Disease 1 0.9999958276748657
disease I-Disease 1 0.999992847442627
. O 0 0.0223294235765934

The O 0 0.0012474569957703352
first O 0 0.0007469722768291831
predictive O 0 0.00173060258384794
testing O 0 0.0013337281998246908
for O 0 0.0016565053956583142
Huntington B-Disease 1 0.9999982118606567
disease I-Disease 1 0.9999991655349731
( O 0 0.35470762848854065
HD B-Disease 0 0.3687908947467804
) O 0 7.287462358362973e-05
was O 0 8.584866009186953e-05
based O 0 2.544533163018059e-05
on O 0 1.708499257802032e-05
analysis O 0 2.3560725821880624e-05
of O 0 4.1473551391391084e-05
linked O 0 0.00015916515258140862
polymorphic O 0 0.00046061401371844113
DNA O 0 9.587074600858614e-05
markers O 0 0.00011142397852381691
to O 0 2.6796022211783566e-05
estimate O 0 4.075018659932539e-05
the O 0 3.7261892430251464e-05
likelihood O 0 7.785677735228091e-05
of O 0 8.654948032926768e-05
inheriting O 0 0.02553602121770382
the O 0 0.0002659661404322833
mutation O 0 0.0008835617918521166
for O 0 0.0003562828351277858
HD B-Disease 0 0.004667095839977264
. O 0 0.001367039978504181

Limits O 0 0.0011645278427749872
to O 0 0.0002849481825251132
accuracy O 0 0.00029633005033247173
included O 0 0.00017883040709421039
recombination O 0 0.0002373825409449637
between O 0 7.414040010189638e-05
the O 0 6.329006282612681e-05
DNA O 0 0.00011497677041916177
markers O 0 0.00020109466277062893
and O 0 4.5167660573497415e-05
the O 0 4.8758734919829294e-05
mutation O 0 0.0001924987736856565
, O 0 5.8164219808531925e-05
pedigree O 0 0.00047306111082434654
structure O 0 0.00011529451148817316
, O 0 3.7858622818021104e-05
and O 0 2.77629242191324e-05
whether O 0 3.441953958827071e-05
DNA O 0 4.993323818780482e-05
samples O 0 4.538773646345362e-05
were O 0 2.9918413929408416e-05
available O 0 3.874828325933777e-05
from O 0 6.171118729980662e-05
family O 0 0.00021192395070102066
members O 0 0.0002842102258000523
. O 0 0.0007270914502441883

With O 0 0.0004822218616027385
direct O 0 0.0002651021641213447
tests O 0 0.00012782095291186124
for O 0 4.7069890570128337e-05
the O 0 0.0001668815966695547
HD B-Disease 0 0.20739881694316864
mutation O 0 0.0002231914986623451
, O 0 3.9385082345688716e-05
we O 0 2.1444620870170183e-05
have O 0 1.4461796126852278e-05
assessed O 0 3.570994522306137e-05
the O 0 2.2650739992968738e-05
accuracy O 0 4.12998597312253e-05
of O 0 2.595299702079501e-05
results O 0 3.290347376605496e-05
obtained O 0 3.141239358228631e-05
by O 0 2.828339347615838e-05
linkage O 0 0.0001838022581068799
approaches O 0 7.618140080012381e-05
when O 0 4.636443918570876e-05
requested O 0 6.461764860432595e-05
to O 0 1.586660619068425e-05
do O 0 1.430825977877248e-05
so O 0 1.5978881492628716e-05
by O 0 2.36125761148287e-05
the O 0 5.157921259524301e-05
test O 0 0.00020561805285979062
individuals O 0 0.0002055447403108701
. O 0 0.0006541128386743367

For O 0 0.000498914101626724
six O 0 0.0002408175205346197
such O 0 8.28612464829348e-05
individuals O 0 6.020687578711659e-05
, O 0 4.400345278554596e-05
there O 0 4.831660771742463e-05
was O 0 0.00015548312512692064
significant O 0 0.00015118690498638898
disparity O 0 0.0006121023325249553
between O 0 0.00011105123849119991
the O 0 0.00020178186241537333
tests O 0 0.0005839276709593832
. O 0 0.0006575016886927187

Three O 0 0.0004930355353280902
went O 0 0.0005377651541493833
from O 0 0.0001384320348734036
a O 0 0.00023338384926319122
decreased O 0 0.013289328664541245
risk O 0 0.0001243290607817471
to O 0 2.2045338482712395e-05
an O 0 3.062674659304321e-05
increased O 0 8.985970634967089e-05
risk O 0 0.00013079862401355058
, O 0 1.960039844561834e-05
while O 0 1.517444798082579e-05
in O 0 1.4349364391819108e-05
another O 0 3.6253328289603814e-05
three O 0 2.5992480004788376e-05
the O 0 0.00011163763701915741
risk O 0 0.0013085806276649237
was O 0 0.0018478014972060919
decreased O 0 0.00556325726211071
. O 0 0.000923753366805613

Knowledge O 0 0.0015097757568582892
of O 0 0.0003373523068148643
the O 0 0.0001774797565303743
potential O 0 0.00021447526523843408
reasons O 0 7.865930092521012e-05
for O 0 2.584291905805003e-05
these O 0 1.3027637578488793e-05
changes O 0 2.0893459804938175e-05
in O 0 1.757394420565106e-05
results O 0 2.972990296257194e-05
and O 0 2.4114313418976963e-05
impact O 0 5.6090149882948026e-05
of O 0 4.261884168954566e-05
these O 0 2.7706062610377558e-05
risk O 0 0.00012930984667036682
reversals O 0 0.0028966732788830996
on O 0 4.596881990437396e-05
both O 0 4.766363781527616e-05
patients O 0 0.006511165294796228
and O 0 4.038005499751307e-05
the O 0 9.329170279670507e-05
counseling O 1 0.5229679942131042
team O 0 0.00015341224207077175
can O 0 2.0967452655895613e-05
assist O 0 5.1869199523935094e-05
in O 0 1.439661173208151e-05
the O 0 2.796978151309304e-05
development O 0 4.178801827947609e-05
of O 0 2.9047960197203793e-05
strategies O 0 6.051973105059005e-05
for O 0 1.6102285371744074e-05
the O 0 5.481112384586595e-05
prevention O 1 0.6034424304962158
and O 0 4.620249819708988e-05
, O 0 2.9935910788481124e-05
where O 0 2.713875255722087e-05
necessary O 0 3.243306127842516e-05
, O 0 2.5734931114129722e-05
management O 0 4.6815748646622524e-05
of O 0 3.8633868825854734e-05
a O 0 0.00010204497812082991
risk O 0 0.0002353812160436064
reversal O 0 0.0005754126468673348
in O 0 5.080909249954857e-05
any O 0 6.923040928086266e-05
predictive O 0 0.0003344471915625036
testing O 0 0.00041447748662903905
program O 0 0.00040047249058261514
. O 0 0.0003116314474027604
. O 0 0.0007880713674239814

A O 0 0.002924667438492179
novel O 0 0.0017228859942406416
common O 0 0.0004963480751030147
missense O 0 0.0020468991715461016
mutation O 0 0.0004486347024794668
G301C O 0 0.0015928993234410882
in O 0 7.154177728807554e-05
the O 0 9.122140909312293e-05
N O 0 0.00035014169407077134
- O 0 0.001334253465756774
acetylgalactosamine O 1 0.7586584687232971
- O 0 0.03339823707938194
6 O 0 0.0024477499537169933
- O 0 0.3732982873916626
sulfate O 1 0.9833770990371704
sulfatase O 1 0.9944867491722107
gene O 0 0.0007564220577478409
in O 0 0.0006802388816140592
mucopolysaccharidosis B-Disease 1 0.998930037021637
IVA I-Disease 1 0.9998306035995483
. O 0 0.0036690107081085443

Mucopolysaccharidosis B-Disease 1 0.9995957016944885
IVA I-Disease 1 0.9999411106109619
( O 0 0.13949142396450043
MPS B-Disease 1 0.9806613922119141
IVA I-Disease 1 0.9999817609786987
) O 0 0.0004742234596051276
is O 0 0.0002720985794439912
an O 0 0.0010709825437515974
autosomal B-Disease 1 0.999834418296814
recessive I-Disease 1 0.9999949932098389
lysosomal I-Disease 1 0.9999995231628418
storage I-Disease 1 0.9999954700469971
disorder I-Disease 1 0.9999998807907104
caused O 1 0.9996412992477417
by O 0 0.00040196493500843644
a O 0 0.0056119333021342754
genetic B-Disease 0 0.4658207297325134
defect I-Disease 1 0.9983434677124023
in O 0 0.0001657028478803113
N O 0 0.004605002235621214
- O 0 0.04174545034766197
acetylgalactosamine O 1 0.9816845059394836
- O 0 0.22936120629310608
6 O 0 0.00546086672693491
- O 1 0.8082036375999451
sulfate O 1 0.9989675283432007
sulfatase O 1 0.9998140931129456
( O 0 0.0027905709575861692
GALNS O 1 0.9865651726722717
) O 0 0.0007368907681666315
. O 0 0.0010387108195573092

In O 0 0.0005792795564047992
previous O 0 0.00033076704130508006
studies O 0 0.00012416222307365388
, O 0 5.9307541960151866e-05
we O 0 2.790477628877852e-05
have O 0 1.532479109300766e-05
found O 0 1.8996355720446445e-05
two O 0 1.7901113096741028e-05
common O 0 3.672892489703372e-05
mutations O 0 9.711243910714984e-05
in O 0 5.5906832130858675e-05
Caucasians O 0 0.0034224633127450943
and O 0 0.00011286828521406278
Japanese O 0 0.0007628786261193454
, O 0 0.00022617758077103645
respectively O 0 0.0006009170319885015
. O 0 0.0007925134850665927

To O 0 0.0010647482704371214
characterize O 0 0.0016970508731901646
the O 0 0.000570915057323873
mutational O 0 0.03793743997812271
spectrum O 0 0.0004052833537571132
in O 0 5.866220817551948e-05
various O 0 4.055797035107389e-05
ethnic O 0 7.335026020882651e-05
groups O 0 2.9424798412946984e-05
, O 0 3.283088517491706e-05
mutations O 0 4.782938412972726e-05
in O 0 2.8770618882845156e-05
the O 0 6.901052256580442e-05
GALNS O 1 0.9840622544288635
gene O 0 0.00011700989853125066
in O 0 6.443827442126349e-05
Colombian O 0 0.007896024733781815
MPS B-Disease 1 0.9945176243782043
IVA I-Disease 1 0.9999988079071045
patients O 1 0.8222584128379822
were O 0 6.591484998352826e-05
investigated O 0 0.0009040766744874418
, O 0 8.063208224484697e-05
and O 0 5.202107786317356e-05
genetic O 0 8.652529504615813e-05
backgrounds O 0 5.980887726764195e-05
were O 0 2.7500997020979412e-05
extensively O 0 4.873818761552684e-05
analyzed O 0 3.530207686708309e-05
to O 0 1.588436498423107e-05
identify O 0 4.1356215660925955e-05
racial O 0 8.192987297661602e-05
origin O 0 4.431017077877186e-05
, O 0 4.018169056507759e-05
based O 0 3.323868804727681e-05
on O 0 4.0924503991845995e-05
mitochondrial O 0 0.00019027992675546557
DNA O 0 0.00021599719184450805
( O 0 0.00018468115013092756
mtDNA O 0 0.00035737582948058844
) O 0 0.0002577330160420388
lineages O 0 0.0009749365272000432
. O 0 0.0007342789322137833

Three O 0 0.0013523411471396685
novel O 0 0.0028812014497816563
missense O 0 0.049685072153806686
mutations O 0 0.000534880964551121
never O 0 0.00022094060841482133
identified O 0 7.198790990514681e-05
previously O 0 5.955640153842978e-05
in O 0 3.053721593460068e-05
other O 0 1.6379486623918638e-05
populations O 0 2.5869454475468956e-05
and O 0 1.754283221089281e-05
found O 0 1.8332086256123148e-05
in O 0 1.5946197891025804e-05
16 O 0 3.16791411023587e-05
out O 0 2.2538588382303715e-05
of O 0 4.5478635001927614e-05
19 O 0 0.0001737905404297635
Colombian O 0 0.001347069046460092
MPS B-Disease 0 0.11688321828842163
IVA I-Disease 1 0.9996565580368042
unrelated O 0 0.0016090819844976068
alleles O 0 0.0004787314683198929
account O 0 0.0001828985841711983
for O 0 0.00016115531616378576
84 O 0 0.0019432904664427042
. O 0 0.0011791156139224768

2 O 0 0.0009567140368744731
% O 0 0.00024741681409068406
of O 0 0.00017043195839505643
the O 0 0.00017495740030426532
alleles O 0 0.0003395545354578644
in O 0 0.00013756673433817923
this O 0 0.00019652600167319179
study O 0 0.0005559892160817981
. O 0 0.001070018857717514

The O 0 0.004430081229656935
G301C O 1 0.9263877868652344
and O 0 0.0015120106982067227
S162F O 1 0.6767483949661255
mutations O 0 0.0010037104366347194
account O 0 0.0005274638533592224
for O 0 0.0004029908450320363
68 O 0 0.002392298774793744
. O 0 0.001439116196706891

4 O 0 0.0024543514009565115
% O 0 0.0009710356243886054
and O 0 0.0006883245659992099
10 O 0 0.0011262488551437855
. O 0 0.001782474690116942

5 O 0 0.00094610481755808
% O 0 0.00022604932019021362
of O 0 0.00016038973990362138
mutations O 0 0.00026559949037618935
, O 0 6.366476736729965e-05
respectively O 0 8.985815657069907e-05
, O 0 4.717877527582459e-05
whereas O 0 4.805587377632037e-05
the O 0 4.718363197753206e-05
remaining O 0 8.789212006377056e-05
F69V O 1 0.5745225548744202
is O 0 7.157213985919952e-05
limited O 0 6.0021884564775974e-05
to O 0 4.271234502084553e-05
a O 0 0.0001596311485627666
single O 0 0.00043107205419801176
allele O 0 0.001501463819295168
. O 0 0.0008421213715337217

The O 0 0.0020092586055397987
skewed O 0 0.0024807679001241922
prevalence O 0 0.008908769115805626
of O 0 0.0006418789853341877
G301C O 1 0.941909670829773
in O 0 0.00020131490600761026
only O 0 0.00015906288172118366
Colombian O 0 0.0025064346846193075
patients O 0 0.00807211734354496
and O 0 9.089613013202325e-05
haplotype O 0 0.00038360999315045774
analysis O 0 7.367693615378812e-05
by O 0 4.791904575540684e-05
restriction O 0 0.00010964911780320108
fragment O 0 0.000178687900188379
length O 0 0.00011197722051292658
polymorphisms O 0 0.00015059614088386297
in O 0 3.523796476656571e-05
the O 0 9.290641901316121e-05
GALNS O 1 0.9514049887657166
gene O 0 0.00013017300807405263
suggest O 0 0.00010895611194428056
that O 0 5.180493099032901e-05
G301C O 0 0.0027611153200268745
originated O 0 0.0002035030338447541
from O 0 8.229256491176784e-05
a O 0 0.00023903712281025946
common O 0 0.000418362527852878
ancestor O 0 0.002494083484634757
. O 0 0.0011608597123995423

Investigation O 0 0.0033942353911697865
of O 0 0.0006593471625819802
the O 0 0.0002777056652121246
genetic O 0 0.00025570832076482475
background O 0 0.00020137112005613744
by O 0 5.4737840400775895e-05
means O 0 6.370400660671294e-05
of O 0 4.859449836658314e-05
mtDNA O 0 0.00010197688243351877
lineages O 0 6.549180397996679e-05
indicate O 0 5.0839531468227506e-05
that O 0 1.9810020603472367e-05
all O 0 2.299549669260159e-05
our O 0 8.4386054368224e-05
patients O 0 0.00035222177393734455
are O 0 3.1474948627874255e-05
probably O 0 0.00015655752213206142
of O 0 0.00016415321442764252
native O 0 0.000740513380151242
American O 0 0.0019313893280923367
descent O 0 0.015997275710105896

Low O 0 0.0022109432611614466
frequency O 0 0.0006381386774592102
of O 0 0.0004655290977098048
BRCA1 O 0 0.4950600564479828
germline O 0 0.015568285249173641
mutations O 0 0.0002855816564988345
in O 0 0.0001112702302634716
45 O 0 0.0006317472434602678
German O 1 0.9988640546798706
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 1 0.6514701247215271
. O 0 0.006082936190068722

In O 0 0.0007266689790412784
this O 0 0.00016507392865605652
study O 0 0.0001116641506087035
we O 0 5.555240932153538e-05
investigated O 0 0.00016527174739167094
45 O 0 0.00025634642224758863
German O 1 0.973484456539154
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
families O 0 0.045835770666599274
for O 0 0.003006208688020706
germline O 1 0.9909175038337708
mutations O 0 0.0003201038052793592
in O 0 9.140111797023565e-05
the O 0 0.0003705209819599986
BRCA1 O 1 0.9791710376739502
gene O 0 0.0013760278234258294
. O 0 0.0011879829689860344

We O 0 0.0008596717962063849
identified O 0 0.0004665704327635467
four O 0 0.00039040096453391016
germline O 0 0.01005982980132103
mutations O 0 0.00023916341888252646
in O 0 8.519826224073768e-05
three O 0 0.0003973417042288929
breast B-Disease 1 0.9999722242355347
cancer I-Disease 1 0.9995854496955872
families O 0 0.00026219780556857586
and O 0 0.0001254635426448658
in O 0 0.0003354316286277026
one O 1 0.9138726592063904
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.8664175271987915
. O 0 0.00012459275603760034
among O 0 3.67408683814574e-05
these O 0 1.2623319889826234e-05
were O 0 1.8190849004895426e-05
one O 0 5.144892929820344e-05
frameshift O 0 0.061843112111091614
mutation O 0 0.00020699245214927942
, O 0 3.79970770154614e-05
one O 0 4.8424732085550204e-05
nonsense O 0 0.004496385809034109
mutation O 0 0.00017151085194200277
, O 0 3.598424882511608e-05
one O 0 3.935383938369341e-05
novel O 0 0.0001865280355559662
splice O 0 0.0006589241093024611
site O 0 0.00025392728275619447
mutation O 0 0.0002596419944893569
, O 0 8.734985021874309e-05
and O 0 8.589139179093763e-05
one O 0 0.00024935041437856853
missense O 0 0.004130923189222813
mutation O 0 0.001787069602869451
. O 0 0.00125039869453758

The O 0 0.0021510871592909098
missense O 0 0.0548335500061512
mutation O 0 0.002065937267616391
was O 0 0.0004593948251567781
also O 0 0.00012927076022606343
found O 0 0.000115782801003661
in O 0 0.0001446554670110345
2 O 0 0.0005922700511291623
. O 0 0.0009439330315217376

8 O 0 0.0007315256516449153
% O 0 0.0001855293958215043
of O 0 9.517982107354328e-05
the O 0 6.523959746118635e-05
general O 0 0.00012772616173606366
population O 0 5.24501119798515e-05
, O 0 3.706660936586559e-05
suggesting O 0 7.636075315531343e-05
that O 0 2.38206976064248e-05
it O 0 3.11103394778911e-05
is O 0 0.00010270284838043153
not O 0 0.00014225243648979813
disease O 1 0.9643996953964233
associated O 0 0.0010557882487773895
. O 0 0.0012876493856310844

The O 0 0.0008862505783326924
average O 0 0.0006312825717031956
age O 0 0.0009573586285114288
of O 0 0.025236358866095543
disease O 1 0.9999957084655762
onset O 1 0.9999808073043823
in O 0 0.0007607797160744667
those O 0 0.00010523410310270265
families O 0 0.002267402596771717
harbouring O 1 0.9999252557754517
causative O 1 0.9974462985992432
mutations O 0 0.0009916427079588175
was O 0 0.0003621813957579434
between O 0 0.00022817659191787243
32 O 0 0.0007453002035617828
. O 0 0.0007079992210492492

3 O 0 0.004178397357463837
and O 0 0.0022330975625663996
37 O 0 0.005250591319054365
. O 0 0.0041655441746115685

4 O 0 0.0015324527630582452
years O 0 0.0003397099208086729
, O 0 0.00014857614587526768
whereas O 0 0.00014387343253474683
the O 0 7.310516230063513e-05
family O 0 0.00023123400751501322
harbouring O 1 0.7400974631309509
the O 0 0.0002775243192445487
missense O 0 0.026469416916370392
mutation O 0 0.0002636080316733569
had O 0 7.99515619291924e-05
an O 0 5.5770884500816464e-05
average O 0 7.453725265804678e-05
age O 0 0.0001239472912857309
of O 0 0.0001988660078495741
onset O 1 0.9881221652030945
of O 0 0.0012539863819256425
51 O 0 0.006588317919522524
. O 0 0.0014917118242010474

2 O 0 0.0074716960079967976
years O 0 0.006133320275694132
. O 0 0.004260311834514141

These O 0 0.0005461567197926342
findings O 0 0.0005794689059257507
show O 0 0.0003745411231648177
that O 0 0.00017207908967975527
BRCA1 O 0 0.07526472210884094
is O 0 0.00012005493772448972
implicated O 0 0.00040614083991385996
in O 0 4.2300907807657495e-05
a O 0 6.044821202522144e-05
small O 0 6.463385943789035e-05
fraction O 0 0.0003079678863286972
of O 0 0.2190481424331665
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999986886978149
families O 0 0.0029878101777285337
suggesting O 0 0.000560718821361661
the O 0 8.857007924234495e-05
involvement O 0 0.0003541212063282728
of O 0 0.00021204582299105823
another O 0 0.05492667108774185
susceptibility O 1 0.9300288558006287
gene O 0 0.001121769892051816
( O 0 0.0006486302590928972
s O 0 0.004899964202195406
) O 0 0.0017516468651592731

Paternal O 1 0.9946980476379395
transmission O 1 0.9991596937179565
of O 1 0.9996510744094849
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9989814162254333

We O 0 0.0011513726785779
report O 0 0.0004734118701890111
a O 0 0.0003967092779930681
rare O 0 0.0004755647969432175
case O 0 0.0005382184754125774
of O 0 0.00747652119025588
paternally O 1 0.9999837875366211
transmitted O 1 0.9999966621398926
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999942779541016
DM B-Disease 1 0.9999998807907104
) O 0 0.05014665797352791
. O 0 0.002441339660435915

The O 0 0.001563532743602991
proband O 0 0.09269627928733826
is O 0 0.0003198021149728447
a O 0 0.00020121972193010151
23 O 0 0.00025095121236518025
year O 0 0.00018565468781162053
old O 0 0.016827691346406937
, O 0 0.01152330357581377
mentally B-Disease 1 0.9999886751174927
retarded I-Disease 1 0.999992847442627
male O 1 0.9997022747993469
who O 1 0.9998595714569092
suffers O 1 0.9999998807907104
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 0.9999994039535522
. O 1 0.9634665250778198

He O 0 0.00413898890838027
presented O 0 0.00648267799988389
with O 0 0.02551984041929245
respiratory O 1 0.999997615814209
and O 0 0.062358658760786057
feeding O 1 0.8781221508979797
difficulties O 1 0.970596432685852
at O 0 0.043449029326438904
birth O 1 0.6113444566726685
. O 0 0.0014151142677292228

His O 0 0.00483987620100379
two O 0 0.002037039492279291
sibs O 1 0.9996895790100098
suffer O 1 0.9952660799026489
from O 0 0.014532295055687428
childhood O 1 0.9999675750732422
onset O 1 0.9999992847442627
DM B-Disease 1 0.9999994039535522
. O 0 0.31949561834335327

Their O 0 0.0005873408517800272
late O 0 0.0006555167492479086
father O 0 0.0006143653299659491
had O 0 0.00012758863158524036
the O 0 9.314344060840085e-05
adult O 0 0.00013425388897303492
type O 0 0.0005247509106993675
of O 0 0.003625566139817238
DM B-Disease 1 0.9999988079071045
, O 0 0.0002370482834521681
with O 0 0.00014314612781163305
onset O 1 0.9094556570053101
around O 0 0.0002622408210299909
30 O 0 0.00027168510132469237
years O 0 0.00048413118929602206
. O 0 0.0006465112091973424

Only O 0 0.0005159743595868349
six O 0 0.00026057669310830534
other O 0 6.405658496078104e-05
cases O 0 9.166795643977821e-05
of O 0 0.00012560455070342869
paternal O 1 0.9671911001205444
transmission O 1 0.9992984533309937
of O 1 0.9991886019706726
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.001004669931717217
been O 0 0.00031080807093530893
reported O 0 0.000657089170999825
recently O 0 0.0010865083895623684
. O 0 0.0007265227613970637

We O 0 0.0008331005228683352
review O 0 0.0003948038211092353
the O 0 0.000218693443457596
sex O 0 0.00039734397432766855
related O 0 0.0002503416035324335
effects O 0 0.001429445226676762
on O 0 0.0004612379416357726
transmission O 1 0.9579108357429504
of O 1 0.9474126100540161
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999996423721313
. O 0 0.27258580923080444

Decreased O 0 0.05936252698302269
fertility O 0 0.02608167938888073
of O 0 0.00041587158921174705
males O 0 0.0002865656861104071
with O 0 0.0002016076323343441
adult O 0 0.031089020892977715
onset O 1 0.9999967813491821
DM B-Disease 1 0.9999998807907104
and O 0 0.008116819895803928
contraction O 1 0.5854382514953613
of O 0 0.00013436184963211417
the O 0 0.00014039521920494735
repeat O 0 0.0009245661203749478
upon O 0 0.00013591187598649412
male O 0 0.0005381046212278306
transmission O 0 0.0008249960956163704
contribute O 0 5.075146327726543e-05
to O 0 1.5473642633878626e-05
the O 0 2.777839472400956e-05
almost O 0 5.31089972355403e-05
absent O 0 0.00015303703548852354
occurrence O 0 0.00016406962822657079
of O 0 0.00016075704479590058
paternal O 1 0.6168045401573181
transmission O 1 0.947117805480957
of O 1 0.9480268359184265
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999997615814209
. O 0 0.34320876002311707

Also O 0 0.0012732538161799312
the O 0 0.0005509523907676339
fathers O 0 0.0007688708719797432
of O 0 0.0001828490785555914
the O 0 0.00034839921863749623
reported O 0 0.0049927690997719765
congenitally O 1 0.9830145835876465
affected O 0 0.0020746844820678234
children O 0 0.00032542587723582983
showed O 0 0.00020346403471194208
, O 0 3.763016138691455e-05
on O 0 3.071868195547722e-05
average O 0 6.239381764316931e-05
, O 0 6.212830339791253e-05
shorter O 0 0.0001989179727388546
CTG O 0 0.21602559089660645
repeat O 0 0.0003345112781971693
lengths O 0 0.0001930958533193916
and O 0 6.673580355709419e-05
hence O 0 0.00017314282013103366
less O 0 0.0001538349752081558
severe O 1 0.9994014501571655
clinical O 1 0.97408127784729
symptoms O 1 0.9994959831237793
than O 0 0.00013993705215398222
the O 0 0.0004063258820679039
mothers O 0 0.10966286063194275
of O 0 0.007052977103739977
children O 1 0.9527136087417603
with O 1 0.9959765076637268
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999998807907104
. O 1 0.875433623790741

We O 0 0.0009495943086221814
conclude O 0 0.0010505514219403267
that O 0 0.0002611659001559019
paternal O 0 0.013090175576508045
transmission O 1 0.892240047454834
of O 1 0.992425799369812
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.06017272174358368
rare O 0 0.014826737344264984
and O 0 9.093323023989797e-05
preferentially O 0 0.0002436843205941841
occurs O 0 7.471963908756152e-05
with O 0 3.5888191632693633e-05
onset O 1 0.8916252851486206
of O 0 0.0013063446385785937
DM B-Disease 1 0.9999903440475464
past O 0 0.0001593531487742439
30 O 0 9.141262853518128e-05
years O 0 5.639667870127596e-05
in O 0 3.838502743747085e-05
the O 0 9.240121289622039e-05
father O 0 0.0014723774511367083
. O 0 0.0003478646103758365
. O 0 0.0007821524050086737

The O 0 0.004314546473324299
RB1 O 1 0.9981123208999634
gene O 0 0.0011932151392102242
mutation O 0 0.0005642254836857319
in O 0 0.00015457283006981015
a O 0 0.000472795421956107
child O 0 0.4044536352157593
with O 0 0.05058179050683975
ectopic B-Disease 1 0.9999819993972778
intracranial I-Disease 1 0.9999918937683105
retinoblastoma I-Disease 1 0.9999502897262573
. O 0 0.00931871123611927

The O 0 0.005712687503546476
RB1 O 1 0.9996455907821655
gene O 0 0.0017129553016275167
mutation O 0 0.0006640807841904461
was O 0 0.000275603961199522
investigated O 0 0.0002884958521462977
in O 0 9.493047400610521e-05
a O 0 0.00037517095915973186
child O 0 0.4639089107513428
with O 0 0.01016208529472351
ectopic B-Disease 1 0.999977707862854
intracranial I-Disease 1 0.9999772310256958
retinoblastoma I-Disease 1 0.9971010088920593
using O 0 0.00010217633098363876
DNA O 0 0.00013167885481379926
obtained O 0 6.485638004960492e-05
from O 0 3.527414446580224e-05
both O 0 5.2862978918710724e-05
the O 0 0.000176603120053187
pineal B-Disease 1 0.9943222999572754
and I-Disease 0 0.004848785698413849
retinal I-Disease 1 0.9999701976776123
tumours I-Disease 1 0.9998681545257568
of O 0 0.0022693227510899305
the O 0 0.06085924804210663
patient O 1 0.9987170696258545
. O 0 0.004334583878517151

A O 0 0.0043665384873747826
nonsense O 0 0.004774696659296751
mutation O 0 0.0006582574569620192
in O 0 0.00016618514200672507
exon O 0 0.0007594361086376011
17 O 0 0.00023558957036584616
( O 0 0.00012973013508599252
codon O 0 0.0003566442464943975
556 O 0 0.000477264984510839
) O 0 6.697551725665107e-05
of O 0 6.621934153372422e-05
the O 0 0.00011328082473482937
RB1 O 1 0.9966186285018921
gene O 0 0.00010284935706295073
was O 0 5.7113476941594854e-05
found O 0 1.6657773812767118e-05
to O 0 1.3124291399435606e-05
be O 0 1.2787730156560428e-05
present O 0 4.2523843148956075e-05
homozygously O 0 0.0012632074067369103
in O 0 3.5021752410102636e-05
both O 0 4.052205622429028e-05
the O 0 0.00016767815395724028
retinal B-Disease 1 0.997100293636322
and I-Disease 0 0.0003006335173267871
the I-Disease 0 0.00500155333429575
pineal I-Disease 1 0.9999052286148071
tumours I-Disease 1 0.9998579025268555
. O 0 0.0031776814721524715

The O 0 0.0011896311771124601
same O 0 0.0004818770394194871
mutation O 0 0.0005931267514824867
was O 0 0.00028056494193151593
present O 0 0.00014128735347185284
heterozygously O 0 0.06674137711524963
in O 0 4.313131648814306e-05
the O 0 3.956735963583924e-05
DNA O 0 4.089648791705258e-05
from O 0 1.6688110918039456e-05
the O 0 3.236687552998774e-05
constitutional O 0 8.223160693887621e-05
cells O 0 6.266596028581262e-05
of O 0 3.988406388089061e-05
the O 0 0.00011384088429622352
patient O 0 0.3205571174621582
, O 0 7.952407759148628e-05
proving O 0 0.00038923133979551494
it O 0 2.2622502001468092e-05
to O 0 2.4956638299045153e-05
be O 0 3.727425792021677e-05
of O 0 0.00016112705634441227
germline O 0 0.00597089808434248
origin O 0 0.000584155844990164
. O 0 0.0008033039630390704

The O 0 0.0011647786013782024
initial O 0 0.0013005714863538742
mutation O 0 0.0008212136453948915
was O 0 0.00021434650989249349
shown O 0 9.03485924936831e-05
to O 0 4.061571598867886e-05
have O 0 3.182367072440684e-05
occurred O 0 0.00011496536899358034
in O 0 5.830717054777779e-05
the O 0 0.00022268477187026292
paternally O 0 0.06215013563632965
derived O 0 0.0019575657788664103
RB1 O 1 0.9949297308921814
allele O 0 0.0036085972096771
. O 0 0.0017446735873818398

The O 0 0.0010853311978280544
mutation O 0 0.0007800281746312976
is O 0 9.69997126958333e-05
in O 0 4.686685497290455e-05
an O 0 3.8716927519999444e-05
area O 0 5.775025420007296e-05
of O 0 4.1374441934749484e-05
the O 0 4.2136325646424666e-05
gene O 0 4.285497561795637e-05
that O 0 1.9574305042624474e-05
encodes O 0 4.509083737502806e-05
the O 0 2.8334090529824607e-05
protein O 0 5.022838377044536e-05
- O 0 9.815106022870168e-05
binding O 0 3.275145354564302e-05
region O 0 4.4261269067646936e-05
known O 0 3.4304586733924225e-05
as O 0 1.9632314433692954e-05
the O 0 4.969846486346796e-05
pocket O 0 0.0022270604968070984
region O 0 6.226328696357086e-05
and O 0 2.661309736140538e-05
has O 0 2.970363129861653e-05
been O 0 2.9003449526499026e-05
detected O 0 4.9796570237958804e-05
in O 0 2.0319073883001693e-05
other O 0 1.9962250007665716e-05
cases O 0 5.534513184102252e-05
of O 0 0.00023532600607722998
retinoblastoma B-Disease 1 0.9952110648155212
. O 0 0.0005205398192629218
. O 0 0.0010824439814314246

Low O 0 0.0015520753804594278
levels O 0 0.00029949183226563036
of O 0 0.00018557009752839804
beta O 0 0.002740205265581608
hexosaminidase O 1 0.7678144574165344
A O 0 0.0004876706516370177
in O 0 0.00010785088670672849
healthy O 0 0.0015554279088974
individuals O 0 5.5973454436752945e-05
with O 0 0.0002350891736568883
apparent O 1 0.9988486766815186
deficiency O 1 0.9999980926513672
of O 0 0.06303239613771439
this O 0 0.0016056234017014503
enzyme O 0 0.061828065663576126
. O 0 0.0009765201830305159

Appreciable O 0 0.12257684022188187
beta O 0 0.019546354189515114
hexosaminidase O 1 0.8260311484336853
A O 0 0.002370163332670927
( O 0 0.0005648911464959383
hex O 0 0.00175826798658818
A O 0 0.000258606334682554
) O 0 6.145302904769778e-05
activity O 0 6.520924216601998e-05
has O 0 3.248425491619855e-05
been O 0 3.401284629944712e-05
detected O 0 0.00011578389967326075
in O 0 0.00010913579171756282
cultured O 1 0.8039697408676147
skin O 1 0.9999823570251465
fibroblasts O 1 0.9999465942382812
and O 1 0.9562917947769165
melanoma B-Disease 1 1.0
tissue O 1 0.9999017715454102
from O 0 0.005579317454248667
healthy O 0 0.21109639108181
individuals O 0 6.843885785201564e-05
previously O 0 0.00012808571045752615
reported O 0 0.00017765683878678828
as O 0 0.00010854731226572767
having O 0 0.0033499118871986866
deficiency B-Disease 1 0.9999260902404785
of I-Disease 0 0.0004490138089749962
hex I-Disease 0 0.07516840845346451
A I-Disease 0 0.00027942637098021805
activity O 0 8.119355334201828e-05
indistinguishable O 0 7.153017941163853e-05
from O 0 1.7966634914046153e-05
that O 0 1.9860015527228825e-05
of O 0 6.216533074621111e-05
patients O 1 0.7308045625686646
with O 0 0.34082192182540894
Tay B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
Sachs I-Disease 1 0.9999992847442627
disease I-Disease 1 0.9999996423721313
( O 1 0.9840713739395142
TSD B-Disease 1 0.999942421913147
) O 0 0.001221602549776435
. O 0 0.00131549674551934

Identification O 0 0.0028510356787592173
and O 0 0.0009103995398618281
quantitation O 0 0.006917818449437618
of O 0 0.0005092162173241377
hex O 0 0.006722231395542622
A O 0 0.0006845701136626303
, O 0 0.0001696671242825687
amounting O 0 0.0007089740829542279
to O 0 0.0001649913319852203
3 O 0 0.0004250598431099206
. O 0 0.0007427084492519498

5 O 0 0.0026451023295521736
% O 0 0.0014557557879015803
- O 0 0.004590134602040052
6 O 0 0.0029553300701081753
. O 0 0.002361776540055871

9 O 0 0.0008246003999374807
% O 0 0.00021343750995583832
of O 0 0.00016343928291462362
total O 0 0.0002171299565816298
beta O 0 0.0010615966748446226
hexosaminidase O 0 0.2536100149154663
activity O 0 0.00019040258484892547
, O 0 5.1825390983140096e-05
has O 0 3.616458343458362e-05
been O 0 4.2115676478715613e-05
obtained O 0 4.9370923079550266e-05
by O 0 5.639017399516888e-05
cellulose O 0 0.004603179171681404
acetate O 0 0.07977598905563354
gel O 0 0.04959457367658615
electrophoresis O 0 0.002002296270802617
, O 0 0.0001514188916189596
DEAE O 1 0.9600444436073303
- O 0 0.004932456649839878
cellulose O 0 0.011731988750398159
ion O 0 0.0007932445150800049
- O 0 0.0008723047794774175
exchange O 0 0.0002419964293949306
chromatography O 0 0.030247626826167107
, O 0 0.0002231328107882291
radial O 0 0.1347099095582962
immunodiffusion O 1 0.8650854229927063
, O 0 0.0005226356443017721
and O 0 0.0005238186568021774
radioimmunoassay O 0 0.4786646068096161
. O 0 0.0017584403976798058

Previous O 0 0.0023947067093104124
family O 0 0.0008313087746500969
studies O 0 0.00024287479755003005
suggested O 0 0.00014207714411895722
that O 0 4.22369412262924e-05
these O 0 2.326018875464797e-05
individuals O 0 3.2401028875028715e-05
may O 0 4.892968718195334e-05
be O 0 3.273977563367225e-05
compound O 0 0.0005087577155791223
heterozygotes O 0 0.0008248345111496747
for O 0 2.7852027415065095e-05
the O 0 8.107333269435912e-05
common O 0 0.0002554193779360503
mutant O 1 0.8000551462173462
TSD B-Disease 1 0.9998553991317749
gene O 0 0.0001621254050405696
and O 0 5.188304930925369e-05
a O 0 9.926104394253343e-05
rare O 0 0.0005096314125694335
( O 0 0.0002540083951316774
allelic O 0 0.020259272307157516
) O 0 0.00025554944295436144
mutant O 0 0.00209445646032691
gene O 0 0.0008537584217265248
. O 0 0.0010738708078861237

Thus O 0 0.0009517019498161972
, O 0 0.00022444012574851513
the O 0 0.00016902755305636674
postulated O 0 0.0009630672866478562
rate O 0 0.00021837485837750137
mutant O 0 0.0015299683436751366
gene O 0 0.00010840767208719626
appears O 0 6.923932232894003e-05
to O 0 2.072478127956856e-05
code O 0 3.0707960831932724e-05
for O 0 2.167047387047205e-05
the O 0 3.640590512077324e-05
expression O 0 5.2935316489310935e-05
of O 0 6.0369984566932544e-05
low O 0 0.00010540282528381795
amounts O 0 7.956534682307392e-05
of O 0 0.0001571270258864388
hex O 0 0.002246086485683918
A O 0 0.0012518239673227072
. O 0 0.0009162334026768804

Heterozygotes O 0 0.0392480343580246
for O 0 0.0004887118702754378
the O 0 0.0003637672052718699
rare O 0 0.0027325775008648634
mutant O 0 0.060931213200092316
may O 0 0.0001360625319648534
be O 0 4.17878181906417e-05
indistinguishable O 0 0.0002817021741066128
from O 0 9.378354297950864e-05
heterozygotes O 0 0.0011126428144052625
for O 0 0.00010762445162981749
the O 0 0.00029037834610790014
common O 0 0.0008919511456042528
TSD B-Disease 1 0.9993364214897156
mutant O 0 0.15995866060256958
. O 0 0.001700489316135645

However O 0 0.0007548226858489215
, O 0 0.00032422368531115353
direct O 0 0.00019636379147414118
visualization O 0 0.000590214622206986
and O 0 0.00012261950178071856
quantitation O 0 0.002981898607686162
of O 0 0.0001641272392589599
hex O 0 0.0010359649313613772
A O 0 0.00014653899415861815
by O 0 3.769183604163118e-05
the O 0 4.4211657950654626e-05
methods O 0 4.692060610977933e-05
described O 0 8.823852112982422e-05
may O 0 4.8347301344620064e-05
prevent O 0 0.0001328236685367301
false O 0 0.0004269744094926864
- O 0 0.02502540312707424
positive O 0 0.0006825932650826871
prenatal O 1 0.9775044322013855
diagnosis O 1 0.953464686870575
of O 0 0.0053287893533706665
TSD B-Disease 1 0.999956488609314
in O 0 0.0002687766100279987
fetuses O 0 0.15674537420272827
having O 0 0.0001253497030120343
the O 0 0.00013042298087384552
incomplete O 0 0.002934460761025548
hex B-Disease 1 0.5758324265480042
A I-Disease 0 0.38827115297317505
deficiency I-Disease 1 0.9999439716339111
of O 0 0.00026969402097165585
the O 0 0.000385711551643908
type O 0 0.0032104342244565487
described O 0 0.00017272697004955262
in O 0 6.270829180721194e-05
the O 0 0.00017158151604235172
four O 0 0.00040483931661583483
healthy O 0 0.003959821071475744
individuals O 0 0.001110127312131226

The O 0 0.006358419544994831
tumor B-Disease 1 0.9998922348022461
suppressor O 1 0.9990018010139465
gene O 0 0.12217128276824951
Smad4 O 1 0.9998762607574463
/ O 1 0.9974939823150635
Dpc4 O 1 0.9980074763298035
is O 0 0.0001869097468443215
required O 0 8.716563024790958e-05
for O 0 6.132050475571305e-05
gastrulation O 0 0.49538320302963257
and O 0 7.482324872398749e-05
later O 0 0.00010395041317678988
for O 0 7.180526881711558e-05
anterior O 0 0.04785729572176933
development O 0 0.0002596744161564857
of O 0 0.00025133482995443046
the O 0 0.0005438855150714517
mouse O 0 0.01089470461010933
embryo O 0 0.008101602084934711
. O 0 0.0013155763735994697

Mutations O 0 0.002071077236905694
in O 0 0.00046419218415394425
the O 0 0.0008004454430192709
SMAD4 O 1 0.9999746084213257
/ O 1 0.9998921155929565
DPC4 O 1 0.9999984502792358
tumor B-Disease 1 0.9999955892562866
suppressor O 1 0.996920108795166
gene O 0 0.00026032316964119673
, O 0 7.151674071792513e-05
a O 0 6.371238850988448e-05
key O 0 9.606851381249726e-05
signal O 0 0.00021626670786645263
transducer O 0 0.0005073713255114853
in O 0 6.340641266433522e-05
most O 0 7.122219540178776e-05
TGFbeta O 1 0.9915822148323059
- O 0 0.33141809701919556
related O 0 0.0003239598881918937
pathways O 0 0.0013721947325393558
, O 0 5.1537273975554854e-05
are O 0 1.8003218428930268e-05
involved O 0 4.6489913074765354e-05
in O 0 4.0640825318405405e-05
50 O 0 0.00011698258458636701
% O 0 0.00013561800005845726
of O 0 0.0010703136213123798
pancreatic B-Disease 1 0.9999823570251465
cancers I-Disease 1 0.999388575553894
. O 0 0.0030482651200145483

Homozygous O 0 0.11032939702272415
Smad4 O 1 0.9921532273292542
mutant O 1 0.7159284353256226
mice O 0 0.016527850180864334
die O 0 0.012269305065274239
before O 0 0.0005681910552084446
day O 0 0.0006861920119263232
7 O 0 0.001068043289706111
. O 0 0.001198723097331822

5 O 0 0.007409587036818266
of O 0 0.006098513025790453
embryogenesis O 0 0.3394137918949127
. O 0 0.0065467469394207

Mutant O 0 0.027612412348389626
embryos O 0 0.001758498139679432
have O 0 0.0002025673893513158
reduced O 0 0.00023347997921518981
size O 0 0.00011664004705380648
, O 0 7.082753290887922e-05
fail O 0 0.00016354017134290189
to O 0 5.300871271174401e-05
gastrulate O 0 0.022004490718245506
or O 0 7.295013347174972e-05
express O 0 0.00013858497550245374
a O 0 0.0001601730182301253
mesodermal O 1 0.8946251273155212
marker O 0 0.04537269100546837
, O 0 0.00017949510947801173
and O 0 0.0001312853128183633
show O 0 0.0006322881672531366
abnormal O 0 0.3293507397174835
visceral O 1 0.9654309153556824
endoderm O 1 0.9991194605827332
development O 0 0.010053735226392746
. O 0 0.0016957942862063646

Growth B-Disease 1 0.7987310886383057
retardation I-Disease 1 0.9992031455039978
of O 0 0.0006639675120823085
the O 0 0.032709140330553055
Smad4 O 1 0.999988317489624
- O 1 0.9994257688522339
deficient O 1 0.9673943519592285
embryos O 0 0.00043975148582831025
results O 0 7.0364294515457e-05
from O 0 5.786712426925078e-05
reduced O 0 0.00016568451246712357
cell O 0 0.00033120031002908945
proliferation O 0 0.0004875719314441085
rather O 0 0.0001050736682373099
than O 0 0.00012113219418097287
increased O 0 0.0005058796959929168
apoptosis O 0 0.005922398995608091
. O 0 0.0013223860878497362

Aggregation O 0 0.002964150160551071
of O 0 0.0009255714248865843
mutant O 1 0.8158115744590759
Smad4 O 1 0.9997195601463318
ES O 1 0.9957255125045776
cells O 0 0.0007872903952375054
with O 0 0.00017700147873256356
wild O 0 0.0005851087043993175
- O 0 0.011667837388813496
type O 0 0.0018994803540408611
tetraploid O 0 0.2061345875263214
morulae O 1 0.909408450126648
rescues O 0 0.2966821789741516
the O 0 0.00314892060123384
gastrulation B-Disease 1 0.9996441602706909
defect I-Disease 1 0.9982574582099915
. O 0 0.002319897757843137

These O 0 0.0005858832155354321
results O 0 0.0002610902301967144
indicate O 0 0.00026217210688628256
that O 0 0.00011402241216273978
Smad4 O 0 0.1810716837644577
is O 0 8.14051236375235e-05
initially O 0 8.511185296811163e-05
required O 0 3.3614065614528954e-05
for O 0 1.9093942682957277e-05
the O 0 3.201482832082547e-05
differentiation O 0 0.00013632290938403457
of O 0 6.535118154715747e-05
the O 0 0.00020119169494137168
visceral O 1 0.9550572633743286
endoderm O 1 0.9623197913169861
and O 0 7.647167512914166e-05
that O 0 3.6202814953867346e-05
the O 0 0.00010017494787462056
gastrulation B-Disease 1 0.9963066577911377
defect I-Disease 1 0.8012776970863342
in O 0 6.485044286819175e-05
the O 0 0.0001349106605630368
epiblast O 1 0.9939656853675842
is O 0 9.917580609908327e-05
secondary O 0 0.0004493737069424242
and O 0 0.00014760662452317774
non O 0 0.0008239829330705106
- O 0 0.006023090332746506
cell O 0 0.00101563916541636
autonomous O 0 0.0012628909898921847
. O 0 0.0010511865839362144

Rescued O 0 0.298488587141037
embryos O 0 0.051124054938554764
show O 0 0.03381882980465889
severe O 1 0.9998656511306763
anterior O 1 0.9999030828475952
truncations O 1 0.9996455907821655
, O 0 0.0007680326816625893
indicating O 0 0.00042936133104376495
a O 0 0.00013603581464849412
second O 0 0.00016339581634383649
important O 0 7.846931111998856e-05
role O 0 0.00016038362809922546
for O 0 0.00010799702431540936
Smad4 O 1 0.8894135355949402
in O 0 0.0005043080309405923
anterior O 1 0.9994317889213562
patterning O 1 0.996707022190094
during O 0 0.09858497232198715
embryogenesis O 1 0.9861262440681458
. O 0 0.002151191933080554

Prevalence O 0 0.027744561433792114
of O 0 0.0019161253003403544
p16 O 1 0.808125913143158
and O 0 0.0014673741534352303
CDK4 O 1 0.999811589717865
germline O 1 0.7484033703804016
mutations O 0 0.0003674532345030457
in O 0 0.00018353764608036727
48 O 0 0.2268345057964325
melanoma B-Disease 1 0.9999997615814209
- O 1 0.9987586736679077
prone O 1 0.9927022457122803
families O 0 0.0009181585628539324
in O 0 0.0004694900126196444
France O 0 0.006029031705111265
. O 0 0.0015048133209347725

The O 0 0.0052924626506865025
French O 1 0.7041980028152466
Familial B-Disease 1 0.9999582767486572
Melanoma I-Disease 1 0.9999991655349731
Study O 0 0.19409874081611633
Group O 0 0.031096139922738075
. O 0 0.0027486516628414392

Germline O 1 0.6915123462677002
mutations O 0 0.0011187903583049774
in O 0 0.00019586342386901379
the O 0 0.000283727771602571
p16 O 1 0.8226206302642822
and O 0 0.00038426974788308144
CDK4 O 1 0.995980978012085
genes O 0 8.62507222336717e-05
have O 0 2.104871418850962e-05
been O 0 2.433386725897435e-05
reported O 0 2.340301034564618e-05
in O 0 2.182664866268169e-05
a O 0 5.387897545006126e-05
subset O 0 0.00019214357598684728
of O 0 0.0008722561760805547
melanoma B-Disease 1 0.9999980926513672
pedigrees O 0 0.48407313227653503
, O 0 0.00012314996274653822
but O 0 4.460308264242485e-05
their O 0 4.2536903492873535e-05
prevalence O 0 0.006746484898030758
is O 0 6.356043013511226e-05
not O 0 4.8995516408467665e-05
well O 0 0.00010029519035015255
known O 0 0.0003927761281374842
. O 0 0.0007539578946307302

We O 0 0.0008181487792171538
searched O 0 0.0008376604528166354
for O 0 0.00014924108108971268
such O 0 7.993158214958385e-05
germline O 0 0.0010280022397637367
mutations O 0 9.276796481572092e-05
in O 0 5.757440521847457e-05
48 O 0 0.0003651610459201038
French O 1 0.9554052352905273
melanoma B-Disease 1 0.9999998807907104
- O 1 0.999075174331665
prone O 1 0.9852111339569092
families O 0 0.0001862817007349804
selected O 0 5.526570384972729e-05
according O 0 2.211752325820271e-05
to O 0 1.1549273040145636e-05
two O 0 1.1964162695221603e-05
major O 0 3.320760515634902e-05
criteria O 0 2.2686779630021192e-05
families O 0 2.655159551068209e-05
with O 0 1.7322423445875756e-05
at O 0 3.1247411243384704e-05
least O 0 2.1421481505967677e-05
three O 0 1.792208968254272e-05
affected O 0 3.771146293729544e-05
members O 0 1.9520335627021268e-05
( O 0 2.5000586902024224e-05
n O 0 6.721436511725187e-05
= O 0 9.193890582537279e-05
20 O 0 4.481955693336204e-05
) O 0 2.5940847990568727e-05
or O 0 1.98563611775171e-05
families O 0 1.9253880964242853e-05
with O 0 1.0700161510612816e-05
two O 0 1.461998817831045e-05
affected O 0 3.29464310198091e-05
members O 0 1.2496939234551974e-05
, O 0 1.1655937669274863e-05
one O 0 8.990816240839195e-06
of O 0 1.650628291827161e-05
them O 0 1.2782085832441226e-05
affected O 0 3.4761942515615374e-05
before O 0 1.970407902263105e-05
the O 0 1.545439772598911e-05
age O 0 2.611399941088166e-05
of O 0 2.1562369511229917e-05
50 O 0 3.58887373295147e-05
( O 0 3.421523069846444e-05
n O 0 6.943948392290622e-05
= O 0 7.375819404842332e-05
28 O 0 3.936097346013412e-05
) O 0 2.159900395781733e-05
, O 0 2.723660691117402e-05
and O 0 3.072023537242785e-05
one O 0 4.694553354056552e-05
additional O 0 0.00013197198859415948
minor O 0 0.0006925944471731782
criterion O 0 0.0013967062113806605
. O 0 0.0008673237171024084

Sixteen O 0 0.0040265037678182125
different O 0 0.0006696162163279951
p16 O 1 0.7048265933990479
germline O 0 0.3612627387046814
mutations O 0 0.00018795451615005732
were O 0 4.9760405090637505e-05
found O 0 2.5915580408764072e-05
in O 0 2.3233562387758866e-05
21 O 0 4.535528933047317e-05
families O 0 3.505058339214884e-05
, O 0 3.688396463985555e-05
while O 0 2.794648207782302e-05
one O 0 5.8908870414597914e-05
germline O 0 0.416853129863739
mutation O 0 0.0005652563413605094
, O 0 0.000110110457171686
Arg24His O 1 0.7929418683052063
, O 0 9.093305561691523e-05
was O 0 0.00014246662613004446
detected O 0 0.0001883355580503121
in O 0 9.01121529750526e-05
the O 0 0.00029120288672856987
CDK4 O 1 0.9965069890022278
gene O 0 0.0013037314638495445
. O 0 0.001189798815175891

The O 0 0.0011935470392927527
frequency O 0 0.0007722474983893335
of O 0 0.000370456138625741
p16 O 0 0.05795332416892052
gene O 0 0.0003470875963103026
mutation O 0 0.0001582615077495575
in O 0 3.673042738228105e-05
our O 0 5.428942313301377e-05
sample O 0 3.157249739160761e-05
( O 0 2.593778117443435e-05
44 O 0 4.400261241244152e-05
% O 0 2.8502006898634136e-05
) O 0 2.5401714083272964e-05
is O 0 2.029761344601866e-05
among O 0 2.1601559637929313e-05
the O 0 2.723735997278709e-05
highest O 0 5.354849054128863e-05
rates O 0 3.295830902061425e-05
yet O 0 3.591863060137257e-05
reported O 0 4.040825297124684e-05
and O 0 2.4587732696090825e-05
the O 0 7.245733286254108e-05
CDK4 O 1 0.9929613471031189
mutation O 0 0.00024316282360814512
is O 0 5.232916009845212e-05
the O 0 6.414870586013421e-05
second O 0 0.00016481192142236978
mutation O 0 0.00017259854939766228
detected O 0 0.00017459310765843838
in O 0 6.55557814752683e-05
this O 0 8.023308328120038e-05
gene O 0 0.000253554928349331
worldwide O 0 0.00045165690244175494
. O 0 0.0007604434504173696

In O 0 0.0008033621124923229
summary O 0 0.0008783884113654494
, O 0 0.00019669622997753322
our O 0 0.00015102479665074497
results O 0 8.046271250350401e-05
show O 0 8.755374437896535e-05
frequent O 0 7.622892735525966e-05
involvement O 0 0.00010694006050471216
of O 0 6.140364712337032e-05
the O 0 0.00025540083879604936
p16 O 1 0.9106706380844116
gene O 0 0.0005510683986358345
in O 0 0.00019574393809307367
familial B-Disease 1 0.9998979568481445
melanoma I-Disease 1 0.9999991655349731
and O 0 0.00032184680458158255
confirm O 0 0.00012369190517347306
the O 0 6.841973663540557e-05
role O 0 8.951845666160807e-05
of O 0 7.662686402909458e-05
the O 0 0.00019209703896194696
CDK4 O 1 0.9970059990882874
gene O 0 0.00016497072647325695
as O 0 9.75680086412467e-05
a O 0 0.0031291411723941565
melanoma B-Disease 1 0.999998927116394
- O 1 0.9950594902038574
predisposing O 1 0.9792466759681702
gene O 0 0.00126408482901752
. O 0 0.00041589836473576725
. O 0 0.0008568234625272453

Progression O 0 0.05057089403271675
of O 0 0.002446620026603341
somatic O 1 0.6848642230033875
CTG O 1 0.9799230694770813
repeat O 0 0.0013435583095997572
length O 0 0.00022616874775849283
heterogeneity O 0 0.0005017481162212789
in O 0 8.80934894667007e-05
the O 0 0.0005471186013892293
blood O 1 0.9920933842658997
cells O 1 0.9148513674736023
of O 1 0.9888960123062134
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999731779098511
. O 0 0.2886805832386017

The O 0 0.001040649600327015
genetic O 0 0.000626032124273479
basis O 0 0.00040276965592056513
of O 1 0.7875330448150635
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999874830245972
DM B-Disease 1 0.9999998807907104
) O 0 0.00029286090284585953
is O 0 4.355423880042508e-05
the O 0 5.872713154531084e-05
expansion O 0 0.00012862670700997114
of O 0 7.174584607128054e-05
an O 0 9.925905760610476e-05
unstable O 0 0.09234992414712906
CTG O 1 0.5513055920600891
repeat O 0 0.00024274515453726053
in O 0 4.578538209898397e-05
the O 0 7.101262599462643e-05
34 O 0 0.0001249077613465488
UTR O 0 0.0009086048230528831
of O 0 8.987127512227744e-05
the O 0 0.0002464432909619063
DM B-Disease 1 0.9998844861984253
protein O 0 0.00029622556758113205
kinase O 0 0.0005303879152052104
gene O 0 0.00016428192611783743
on O 0 0.00015450475621037185
chromosome O 0 0.000548507203347981
19 O 0 0.0008272052509710193
. O 0 0.0010848463280126452

One O 0 0.0005267360829748213
of O 0 0.00023991962370928377
the O 0 0.0001285212638322264
principal O 0 0.00024405984731856734
features O 0 8.674893615534529e-05
of O 0 9.533551201457158e-05
the O 0 0.014056692831218243
DM B-Disease 1 0.9999991655349731
mutation O 0 0.0024750095326453447
is O 0 5.399779183790088e-05
an O 0 4.173313936917111e-05
extraordinarily O 0 0.000313029158860445
high O 0 9.976673754863441e-05
level O 0 6.975033466005698e-05
of O 0 0.00011980071576545015
somatic O 1 0.6215947866439819
mosaicism O 1 0.9943980574607849
, O 0 6.925676279934123e-05
due O 0 3.359262700541876e-05
to O 0 1.6222555132117122e-05
an O 0 2.0867793864454143e-05
extremely O 0 6.02353029535152e-05
high O 0 4.7056557377800345e-05
degree O 0 6.095361095503904e-05
of O 0 8.556961984140798e-05
somatic O 0 0.053431253880262375
instability O 0 0.0024796000216156244
both O 0 3.963979543186724e-05
within O 0 4.732238085125573e-05
and O 0 5.06566466356162e-05
between O 0 8.350375719601288e-05
different O 0 0.0001473658630857244
tissues O 0 0.002787752542644739
. O 0 0.0006777129601687193

This O 0 0.001403089496307075
instability O 0 0.02259918488562107
appears O 0 0.0005070825573056936
to O 0 6.856591789983213e-05
be O 0 3.391322024981491e-05
biased O 0 9.631672583054751e-05
towards O 0 8.610149961896241e-05
further O 0 5.200505620450713e-05
expansion O 0 0.00010942779044853523
and O 0 2.9429316782625392e-05
continuous O 0 6.586156086996198e-05
throughout O 0 4.210579572827555e-05
the O 0 3.909410224878229e-05
life O 0 5.2614886953961104e-05
of O 0 3.6854635254712775e-05
an O 0 3.902065509464592e-05
individual O 0 4.120339872315526e-05
, O 0 3.323041528346948e-05
features O 0 3.0406738005694933e-05
that O 0 1.3052384019829333e-05
could O 0 1.5124762285267934e-05
be O 0 1.3097283954266459e-05
associated O 0 2.5771107175387442e-05
with O 0 2.448942541377619e-05
the O 0 6.671906885458156e-05
progressive O 0 0.03759625926613808
nature O 0 0.00038072929601185024
of O 0 0.0006770070176571608
the O 0 0.14999209344387054
disease O 1 0.9999774694442749
. O 0 0.003971238154917955

Although O 0 0.0018068350618705153
increasing O 0 0.000866785878315568
measured O 0 0.0004055382451042533
allele O 0 0.00042394554475322366
size O 0 0.0001791927934391424
between O 0 0.00013207044685259461
patients O 0 0.004738641902804375
clearly O 0 0.0001399987086188048
correlates O 0 0.0003940294263884425
with O 0 5.0093396566808224e-05
an O 0 7.797661965014413e-05
increased O 0 0.0002667872468009591
severity O 0 0.40113696455955505
of O 0 0.010703124105930328
symptoms O 1 0.9994590878486633
and O 0 8.79183498909697e-05
an O 0 6.002142254146747e-05
earlier O 0 0.0001026765166898258
age O 0 0.00028686010045930743
of O 0 0.001233208691701293
onset O 1 0.999946117401123
, O 0 0.00012918525317218155
this O 0 3.173468940076418e-05
correlation O 0 5.680998583557084e-05
is O 0 2.2621466996497475e-05
not O 0 1.1601520782278385e-05
precise O 0 3.0442251954809763e-05
and O 0 3.051311068702489e-05
measured O 0 6.006201874697581e-05
allele O 0 0.00010064996604342014
length O 0 4.7900313802529126e-05
cannot O 0 2.496518391126301e-05
be O 0 1.1050677130697295e-05
used O 0 1.1700298273353837e-05
as O 0 1.2100653293600772e-05
an O 0 1.698670348559972e-05
accurate O 0 5.596545452135615e-05
predictor O 0 0.0005041413241997361
of O 0 0.00011943047138629481
age O 0 0.0006269110599532723
of O 0 0.00270808394998312
onset O 1 0.9999288320541382
. O 0 0.003053477732464671

In O 0 0.0009438071865588427
order O 0 0.0003370657505001873
to O 0 0.00010325147013645619
further O 0 0.00013737007975578308
characterize O 0 0.000316624587867409
the O 0 0.00012685831461567432
dynamics O 0 0.0006316285580396652
of O 0 0.0012737923534587026
DM B-Disease 1 0.9999985694885254
CTG O 1 0.9998533725738525
repeat O 1 0.6389070749282837
somatic O 1 0.6630355715751648
instability O 0 0.13871853053569794
, O 0 7.580673991469666e-05
we O 0 4.262705260771327e-05
have O 0 2.4275917894556187e-05
studied O 0 6.383826257660985e-05
repeat O 0 0.00012774566130246967
length O 0 4.548692231765017e-05
changes O 0 3.4226166462758556e-05
over O 0 3.935406493837945e-05
time O 0 5.5426997278118506e-05
in O 0 0.00013418526214081794
111 O 1 0.9896708130836487
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9964444041252136
with O 0 0.00035999546525999904
varying O 0 0.00044968456495553255
clinical O 1 0.8504077792167664
severity O 1 0.9684534072875977
and O 0 0.0005607682396657765
CTG O 1 0.969661295413971
repeat O 0 0.0003546761872712523
size O 0 5.2743489504791796e-05
over O 0 3.359320544404909e-05
time O 0 2.2921407435205765e-05
intervals O 0 4.847490708925761e-05
of O 0 4.0468261431669816e-05
1 O 0 9.90206390270032e-05
- O 0 0.00038093223702162504
7 O 0 0.0003041982708964497
years O 0 0.0003872180241160095
. O 0 0.0005752306315116584

We O 0 0.0008629192598164082
have O 0 0.00012662626977544278
found O 0 9.34665949898772e-05
a O 0 0.00010091530566569418
direct O 0 0.00010170632594963536
progression O 0 0.000550909258890897
of O 0 7.324820762732998e-05
the O 0 6.133745046099648e-05
size O 0 5.9864458307856694e-05
heterogeneity O 0 0.0001474029413657263
over O 0 3.69373919966165e-05
time O 0 3.632648440543562e-05
related O 0 3.1244970159605145e-05
to O 0 2.1349533199099824e-05
initial O 0 0.00014990470663178712
CTG O 0 0.17889027297496796
repeat O 0 0.00022621924290433526
size O 0 6.549380486831069e-05
and O 0 3.727767398231663e-05
the O 0 4.195989095023833e-05
time O 0 5.390025398810394e-05
interval O 0 0.00014177900447975844
and O 0 5.521260391105898e-05
always O 0 9.113019768847153e-05
biased O 0 0.00024038740957621485
towards O 0 0.000353100651409477
further O 0 0.00039256573654711246
expansion O 0 0.0014481456018984318
. O 0 0.0013041265774518251

Attempts O 0 0.0018252806039527059
to O 0 0.000338483921950683
mathematically O 0 0.0006960678147152066
model O 0 0.0004315545374993235
the O 0 0.00017501329421065748
dynamics O 0 0.0005705875810235739
have O 0 4.983638064004481e-05
proved O 0 0.00026155487284995615
only O 0 4.48870487161912e-05
partially O 0 0.00019901947234757245
successful O 0 0.00011574405652936548
suggesting O 0 0.0001002050339593552
that O 0 1.7869080693344586e-05
individual O 0 2.1275225662975572e-05
specific O 0 2.1128615117049776e-05
genetic O 0 9.442956070415676e-05
and O 0 7.252924115164205e-05
/ O 0 0.09223264455795288
or O 0 8.471500768791884e-05
environmental O 0 0.00021170401305425912
factors O 0 5.261378100840375e-05
also O 0 2.717552888498176e-05
play O 0 3.574524453142658e-05
a O 0 5.050619802204892e-05
role O 0 9.265974222216755e-05
in O 0 0.00012705090921372175
somatic O 0 0.09380995482206345
mosaicism O 1 0.9879562258720398
. O 0 0.0005825672997161746
. O 0 0.0010280923452228308

Aspartylglucosaminuria B-Disease 1 0.990468442440033
among O 0 0.003746394068002701
Palestinian O 0 0.011957615613937378
Arabs O 0 0.025033781304955482
. O 0 0.00411519268527627

Aspartylglucosaminuria B-Disease 1 0.9999575614929199
( O 1 0.88254314661026
AGU B-Disease 1 0.9999438524246216
) O 0 0.0004101512022316456
is O 0 0.000169239443494007
a O 0 0.0004462228389456868
rare O 1 0.6304239630699158
disorder B-Disease 1 0.9999929666519165
of I-Disease 1 0.767768919467926
glycoprotein I-Disease 1 0.9999858140945435
metabolism I-Disease 1 0.993458092212677
caused O 1 0.8235013484954834
by O 0 0.00012544584751594812
the O 0 0.0016306574689224362
deficiency B-Disease 1 0.9999812841415405
of I-Disease 0 0.0022604507394135
the I-Disease 0 0.3471069037914276
lysosomal I-Disease 1 0.9999886751174927
enzyme I-Disease 1 0.99504154920578
aspartylglucosaminidase I-Disease 1 0.9998934268951416
( O 0 0.019605018198490143
AGA O 1 0.9972853660583496
) O 0 0.0009903587633743882
. O 0 0.001259643817320466

AGU B-Disease 1 0.9999644756317139
is O 0 0.011654362082481384
inherited O 1 0.995854914188385
as O 0 0.0017504682764410973
an O 0 0.09663142263889313
autosomal O 1 0.9999713897705078
recessive O 1 0.9999818801879883
trait O 1 0.995585560798645
and O 0 0.001541385892778635
occurs O 0 0.0002518304099794477
with O 0 4.123244798392989e-05
a O 0 6.699659570585936e-05
high O 0 8.019882079679519e-05
frequency O 0 2.431836946925614e-05
in O 0 2.763270640571136e-05
Finland O 0 9.058428258867934e-05
because O 0 4.399648605613038e-05
of O 0 5.907267768634483e-05
a O 0 0.00020931194012518972
founder O 0 0.016720179468393326
effect O 0 0.0010520202340558171
. O 0 0.0008894398342818022

While O 0 0.0013096529291942716
very O 0 0.0005013623158447444
few O 0 0.00030335719930008054
patients O 0 0.28134700655937195
with O 0 0.00044332235120236874
AGU B-Disease 1 0.9999699592590332
have O 0 4.6127701352816075e-05
been O 0 3.173311415594071e-05
reported O 0 4.2239964386681095e-05
from O 0 3.797273166128434e-05
non O 0 0.00023027430870570242
- O 0 0.0008062933338806033
Finnish O 0 0.0024957458954304457
origin O 0 5.9750964283011854e-05
, O 0 5.7574568927520886e-05
we O 0 6.355102959787473e-05
diagnosed O 1 0.9994309544563293
the O 0 0.0012859618291258812
disorder O 1 0.9999380111694336
in O 0 0.00011561950668692589
8 O 0 0.0009762726840563118
patients O 0 0.002453115303069353
originating O 0 6.071893949410878e-05
from O 0 3.0644689104519784e-05
3 O 0 5.887707811780274e-05
unrelated O 0 0.0001178663587779738
families O 0 3.7732756027253345e-05
, O 0 2.6628023988450877e-05
all O 0 1.9996163246105425e-05
Palestinian O 0 0.0001184867142001167
Arabs O 0 0.00012917759886477143
from O 0 4.769742736243643e-05
the O 0 7.39169045118615e-05
region O 0 0.00021015983656980097
of O 0 0.0003436847764533013
Jerusalem O 0 0.02068450301885605
. O 0 0.0017287813825532794

The O 0 0.003000945318490267
clinical O 1 0.9602532386779785
diagnosis O 1 0.9999556541442871
of O 1 0.9944484233856201
AGU B-Disease 1 0.9999998807907104
is O 0 0.011147702112793922
often O 0 8.943441207520664e-05
difficult O 0 8.363030065083876e-05
, O 0 3.2857471524039283e-05
in O 0 1.7965450751944445e-05
particular O 0 2.2466932932729833e-05
early O 0 2.0537028831313364e-05
in O 0 1.3685374142369255e-05
the O 0 2.0137507817707956e-05
course O 0 7.099177310010418e-05
of O 0 6.369780021486804e-05
the O 0 0.010129689238965511
disease O 1 0.9999191761016846
, O 0 6.534307613037527e-05
and O 0 1.9878300008713268e-05
most O 0 1.4675473721581511e-05
of O 0 4.6533470595022663e-05
the O 0 0.001056272187270224
patients O 1 0.8108736872673035
are O 0 3.319595998618752e-05
diagnosed O 1 0.9975855350494385
after O 0 0.00012480966688599437
the O 0 5.92377400607802e-05
age O 0 0.00010880784975597635
of O 0 0.00011629133223323151
5 O 0 0.00023271277314051986
years O 0 0.00040481978794559836
. O 0 0.0005018609808757901

However O 0 0.0008894669590517879
, O 0 0.000321672618156299
since O 0 0.0002069541806122288
these O 0 8.418336074100807e-05
patients O 0 0.0013502150541171432
excrete O 0 0.0013964734971523285
early O 0 6.557854794664308e-05
large O 0 3.829932029475458e-05
amounts O 0 3.8603371649514884e-05
of O 0 6.5566913690418e-05
aspartylglucosamine O 0 0.4424135386943817
in O 0 8.396064367843792e-05
urine O 0 0.00028638241929002106
, O 0 5.587777923210524e-05
biochemical O 0 0.0002583638415671885
screening O 0 0.00014017196372151375
is O 0 4.996386633138172e-05
easy O 0 0.00012442773731891066
by O 0 0.00011242401524214074
urine O 0 0.0016756464028730989
chromatography O 0 0.046250488609075546
. O 0 0.0004234881198499352
. O 0 0.0008536998648196459

Detection O 0 0.004622906446456909
of O 0 0.0008806057740002871
heterozygous O 0 0.0009222899680025876
carriers O 0 0.0003240537771489471
of O 0 0.00017484967247582972
the O 0 0.017242880538105965
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999709129333496
telangiectasia I-Disease 1 0.9999954700469971
( O 0 0.04942930117249489
ATM O 0 0.008287380449473858
) O 0 0.00012057901767548174
gene O 0 0.00012789241736754775
by O 0 0.00013379966549109668
G2 O 1 0.9458818435668945
phase O 0 0.039960891008377075
chromosomal O 0 0.4082639813423157
radiosensitivity O 1 0.9949783682823181
of O 0 0.16308607161045074
peripheral O 1 0.999935507774353
blood O 1 0.9997164607048035
lymphocytes O 1 0.9980558156967163
. O 0 0.002573111094534397

In O 0 0.004655689001083374
ataxia B-Disease 1 0.9999837875366211
- I-Disease 1 0.9997420907020569
telangiectasia I-Disease 1 0.999991774559021
( O 1 0.9383794069290161
A B-Disease 1 0.9999792575836182
- I-Disease 1 0.9999966621398926
T I-Disease 1 0.9999954700469971
) O 0 0.000596275320276618
patients O 0 0.011391442269086838
, O 0 3.234925679862499e-05
mutations O 0 3.41763261531014e-05
in O 0 1.2046491974615492e-05
a O 0 3.1005372875370085e-05
single O 0 5.290377157507464e-05
gene O 0 6.578222382813692e-05
, O 0 3.570504122762941e-05
ATM O 0 0.00020825785759370774
, O 0 3.1853483960730955e-05
result O 0 3.866169572575018e-05
in O 0 5.781251456937753e-05
an O 0 0.04359911009669304
autosomal B-Disease 1 0.9999991655349731
recessive I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
that O 0 0.02243069000542164
embraces O 1 0.9182117581367493
a O 0 0.0006851007929071784
variety O 0 0.00010267485049553216
of O 0 0.00022814572730567306
clinical O 0 0.379188597202301
features O 0 0.00040526228258386254
and O 0 0.00016396517457906157
manifests O 0 0.052927304059267044
extreme O 0 0.07440029084682465
radiosensitivity O 1 0.8913153409957886
and O 0 9.865230822470039e-05
a O 0 0.0001227594184456393
strong O 0 0.0001808243541745469
pre O 0 0.004949082620441914
- O 0 0.03470189869403839
disposition O 0 0.11938052624464035
to O 0 0.0005735280574299395
malignancy B-Disease 1 0.9991248250007629
. O 0 0.0019003194756805897

Heterozygotes O 0 0.028786977753043175
for O 0 0.0006343065178953111
the O 0 0.00036595683195628226
ATM O 0 0.0013933808077126741
gene O 0 0.00017189132631756365
have O 0 3.395690873730928e-05
no O 0 4.30092477472499e-05
clinical O 0 0.0001736697886371985
expression O 0 7.23610064596869e-05
of O 0 0.00024662946816533804
A B-Disease 1 0.9991010427474976
- I-Disease 1 0.9999676942825317
T I-Disease 1 0.9999716281890869
but O 0 0.00013113416207488626
may O 0 0.0001495643227826804
be O 0 9.512211545370519e-05
cancer B-Disease 1 0.9631239175796509
prone O 0 0.034038644284009933
with O 0 7.13746267138049e-05
a O 0 0.00017290459072683007
moderate O 0 0.0007925882237032056
increase O 0 8.791818254394457e-05
in O 0 9.738731023389846e-05
in O 0 0.00029769522370770574
vitro O 0 0.005496007390320301
radiosensitivity O 1 0.7197162508964539
. O 0 0.0013596739154309034

We O 0 0.0009471943485550582
performed O 0 0.0008550447528250515
a O 0 0.0004252190701663494
blind O 0 0.002297846134752035
chromosomal O 0 0.0007858920725993812
analysis O 0 0.0001277802512049675
on O 0 0.00010299363202648237
G2 O 1 0.9952133893966675
- O 0 0.006229216232895851
phase O 0 0.002779965056106448
lymphocytes O 0 0.0008015995845198631
from O 0 3.2406718673883006e-05
7 O 0 9.367709571961313e-05
unrelated O 0 0.00021816093067172915
A B-Disease 0 0.1724478155374527
- I-Disease 1 0.970304548740387
T I-Disease 1 0.9987081289291382
patients O 0 0.0026112948544323444
, O 0 5.3266641771188006e-05
13 O 0 0.00014688298688270152
obligate O 0 0.0018935194239020348
A B-Disease 1 0.9444330334663391
- I-Disease 1 0.9996343851089478
T I-Disease 1 0.9999336004257202
heterozygotes O 0 0.4825136363506317
( O 0 7.819203892722726e-05
parents O 0 4.7975107008824125e-05
of O 0 4.477264519664459e-05
the O 0 0.00010545067925704643
patients O 0 0.02577998675405979
) O 0 2.8727354219881818e-05
, O 0 2.2373966203304008e-05
and O 0 1.9534265447873622e-05
14 O 0 3.495488635962829e-05
normal O 0 4.66609162685927e-05
controls O 0 5.3668733016820624e-05
following O 0 4.81695678899996e-05
X O 0 0.0002577620034571737
- O 0 0.00025643149274401367
irradiation O 0 0.00020722427871078253
with O 0 4.026182068628259e-05
1 O 0 9.926757047651336e-05
Gy O 0 0.0022301292046904564
in O 0 3.915581328328699e-05
order O 0 3.397880573174916e-05
to O 0 2.5402028768439777e-05
evaluate O 0 8.448517473880202e-05
this O 0 4.079490099684335e-05
cytogenetic O 0 0.0004643803695216775
method O 0 6.697500793961808e-05
as O 0 6.71791858621873e-05
a O 0 9.891361696645617e-05
tool O 0 0.0002492688945494592
for O 0 0.00010197212395723909
detection O 0 0.00044742817408405244
of O 0 0.00026757438899949193
ATM O 0 0.007047676015645266
carriers O 0 0.001729578129015863
. O 0 0.0008184325997717679

Both O 0 0.001959432614967227
A B-Disease 1 0.8643336892127991
- I-Disease 1 0.9995573163032532
T I-Disease 1 0.9999047517776489
homozygotes O 1 0.9735308885574341
and O 0 0.0002914495125878602
heterozygotes O 0 0.196758434176445
showed O 0 0.00030353976762853563
significantly O 0 6.907650094944984e-05
increased O 0 5.19366076332517e-05
levels O 0 4.03310295951087e-05
of O 0 0.00011486149742268026
radiation O 1 0.9963319897651672
- O 1 0.9954185485839844
induced O 1 0.9998947381973267
chromatid O 1 0.9998601675033569
damage O 1 0.5666353702545166
relative O 0 0.00016272631182800978
to O 0 4.7082950914045796e-05
that O 0 3.9170077798189595e-05
of O 0 0.00013050732377450913
normal O 0 0.0003873928217217326
controls O 0 0.0005769900162704289
. O 0 0.0009227074915543199

These O 0 0.0004335161647759378
results O 0 0.00021042248408775777
show O 0 0.00014705449575558305
that O 0 5.5164186051115394e-05
the O 0 0.00011361628276063129
G2 O 1 0.9992831349372864
- O 0 0.22367632389068604
phase O 1 0.7010993957519531
chromosomal O 1 0.9291268587112427
radiosensitivity O 1 0.9960821270942688
assay O 0 0.00046493796980939806
can O 0 3.160759661113843e-05
be O 0 1.432598310202593e-05
used O 0 1.4865774573991075e-05
for O 0 1.690099816187285e-05
the O 0 3.709178781718947e-05
detection O 0 0.00018699816428124905
of O 0 0.00019588319992180914
A B-Disease 1 0.7197491526603699
- I-Disease 1 0.9964548349380493
T I-Disease 1 0.9985237717628479
heterozygotes O 0 0.3335443437099457
. O 0 0.0018154038116335869

In O 0 0.0009744030539877713
combination O 0 0.0010680914856493473
with O 0 0.00015764535055495799
molecular O 0 0.0003278617514297366
genetic O 0 0.0002462680859025568
analyses O 0 9.997053712140769e-05
, O 0 4.298730709706433e-05
this O 0 2.6838451958610676e-05
test O 0 5.4993062803987414e-05
may O 0 1.7529420802020468e-05
be O 0 9.609884727979079e-06
of O 0 1.778728619683534e-05
value O 0 1.8065924450638704e-05
in O 0 1.649013938731514e-05
studies O 0 2.8530344934551977e-05
of O 0 6.738109368598089e-05
familial B-Disease 1 0.8833628296852112
and I-Disease 0 0.0005342394579201937
sporadic I-Disease 0 0.41109758615493774
cancers I-Disease 1 0.959317147731781
aimed O 0 0.00041706321644596756
at O 0 0.00012949913798365742
determination O 0 0.0001985094859264791
of O 0 5.8846097090281546e-05
the O 0 5.673321720678359e-05
potential O 0 0.00010662603017408401
involvement O 0 0.0002914239594247192
of O 0 0.0002195825072703883
ATM O 0 0.07480239868164062
mutations O 0 0.0008290146943181753
in O 0 0.0002993662201333791
tumor B-Disease 1 0.9999688863754272
risk O 0 0.08515186607837677
or O 0 0.00021964362531434745
development O 0 0.0005895840004086494
. O 0 0.00037056670407764614
. O 0 0.0007474906742572784

Ataxia B-Disease 1 0.999994158744812
- I-Disease 1 0.9993301630020142
telangiectasia I-Disease 1 0.9997832179069519
: O 0 0.000706376216839999
identification O 0 0.00028126288088969886
and O 0 8.702858758624643e-05
detection O 0 0.00021346825815271586
of O 0 0.00011811783042503521
founder O 1 0.8100056648254395
- O 0 0.13983246684074402
effect O 0 0.00014438813377637416
mutations O 0 6.657079939031973e-05
in O 0 2.6541722036199644e-05
the O 0 6.828748155385256e-05
ATM O 0 0.00044251972576603293
gene O 0 0.00013549196592066437
in O 0 8.255838474724442e-05
ethnic O 0 0.0002962015860248357
populations O 0 0.0005101057467982173
. O 0 0.000835738203022629

To O 0 0.0006646860274486244
facilitate O 0 0.000602245912887156
the O 0 0.00025450633256696165
evaluation O 0 0.0003739852400030941
of O 0 0.00018873480439651757
ATM O 0 0.061612509191036224
heterozygotes O 0 0.10472843050956726
for O 0 9.701608360046521e-05
susceptibility O 0 0.0022091621067374945
to O 0 3.361819835845381e-05
other O 0 4.765000630868599e-05
diseases O 1 0.9926857948303223
, O 0 0.0001189026515930891
such O 0 9.404503362020478e-05
as O 0 0.13350896537303925
breast B-Disease 1 0.9999990463256836
cancer I-Disease 1 0.9999896287918091
, O 0 0.00019732081273104995
we O 0 3.240569640183821e-05
have O 0 2.0962974303984083e-05
attempted O 0 5.7095337979262695e-05
to O 0 2.3109989342628978e-05
define O 0 5.288511238177307e-05
the O 0 4.4248186895856634e-05
most O 0 2.8786756956833415e-05
common O 0 4.004894435638562e-05
mutations O 0 5.715003135264851e-05
and O 0 2.7421438062447123e-05
their O 0 2.085605592583306e-05
frequencies O 0 3.295032729511149e-05
in O 0 7.166973955463618e-05
ataxia B-Disease 1 0.9999493360519409
- I-Disease 1 0.9930567741394043
telangiectasia I-Disease 1 0.9999771118164062
( O 0 0.042884938418865204
A B-Disease 1 0.9940842986106873
- I-Disease 1 0.9995551705360413
T I-Disease 1 0.9993683695793152
) O 0 0.00014295052096713334
homozygotes O 0 0.0008643478504382074
from O 0 8.123097359202802e-05
10 O 0 0.00013858180318493396
ethnic O 0 0.00022978565539233387
populations O 0 0.0004695050010923296
. O 0 0.0007848375244066119

Both O 0 0.0011788656702265143
genomic O 0 0.001640775823034346
mutations O 0 0.0005499286926351488
and O 0 0.0001563769910717383
their O 0 0.00011187241034349427
effects O 0 0.00030880613485351205
on O 0 0.00017835001926869154
cDNA O 0 0.0014583395095542073
were O 0 0.0002762722142506391
characterized O 0 0.0015751339960843325
. O 0 0.0009303728002123535

Protein O 0 0.0032256748527288437
- O 0 0.003464579116553068
truncation O 0 0.0033510683570057154
testing O 0 0.0004990465822629631
of O 0 0.00020111442427150905
the O 0 0.00017468717123847455
entire O 0 0.00033797361538745463
ATM O 0 0.0004657816607505083
cDNA O 0 0.000642669212538749
detected O 0 0.00025961181381717324
92 O 0 0.0002835238992702216
( O 0 0.00013263456639833748
66 O 0 0.0002570302167441696
% O 0 0.00010962349915644154
) O 0 0.00012591479753609747
truncating O 0 0.000917963043320924
mutations O 0 0.00021481173462234437
in O 0 0.00011522812565090135
140 O 0 0.0006110327667556703
mutant O 0 0.0020721990149468184
alleles O 0 0.0014639379223808646
screened O 0 0.002189802238717675
. O 0 0.0014966249000281096

The O 0 0.0019774294923990965
haplotyping O 1 0.9742169380187988
of O 0 0.002442582743242383
patients O 1 0.8644967675209045
with O 0 0.000216148400795646
identical O 0 0.0010574753396213055
mutations O 0 0.000523720751516521
indicates O 0 0.00017619038408156484
that O 0 2.3185531972558238e-05
almost O 0 1.701189648883883e-05
all O 0 9.479566870140843e-06
of O 0 1.9516370230121538e-05
these O 0 9.30545138544403e-06
represent O 0 2.32793390750885e-05
common O 0 2.6487485229154117e-05
ancestry O 0 6.658108031842858e-05
and O 0 3.099904643022455e-05
that O 0 2.375228541495744e-05
very O 0 3.8156122172949836e-05
few O 0 0.00011325684317853302
spontaneously O 0 0.0017691734246909618
recurring O 0 0.03342834487557411
ATM O 0 0.007324432022869587
mutations O 0 0.0007520319195464253
exist O 0 0.00046764686703681946
. O 0 0.0006258570938371122

Assays O 0 0.003813008312135935
requiring O 0 0.0007948443526402116
minimal O 0 0.0005189633811824024
amounts O 0 0.0001782806357368827
of O 0 8.347351831616834e-05
genomic O 0 0.0001780346647137776
DNA O 0 0.00010234590445179492
were O 0 3.777567690121941e-05
designed O 0 7.781128078931943e-05
to O 0 2.8264734282856807e-05
allow O 0 4.459045158000663e-05
rapid O 0 0.00022356635599862784
screening O 0 0.00013213418424129486
for O 0 5.2310304454294965e-05
common O 0 0.00010358577856095508
ethnic O 0 0.0002611883101053536
mutations O 0 0.0009115886641666293
. O 0 0.001006634091027081

These O 0 0.0007831428083591163
rapid O 0 0.0015525823691859841
assays O 0 0.0005009080050513148
detected O 0 0.0002904354187194258
mutations O 0 0.00011179605644429103
in O 0 3.6950994399376214e-05
76 O 0 0.00010594839113764465
% O 0 3.228709101676941e-05
of O 0 4.5097847760189325e-05
Costa O 0 0.0003492019895929843
Rican O 0 0.017337895929813385
patients O 0 0.01251200307160616
( O 0 5.319927731761709e-05
3 O 0 3.9763941458659247e-05
) O 0 1.903036900330335e-05
, O 0 1.643857467570342e-05
50 O 0 1.8810098481480964e-05
% O 0 1.3511858924175613e-05
of O 0 2.924040200014133e-05
Norwegian O 0 0.00018602200725581497
patients O 0 0.00047250252100639045
( O 0 3.3915093808900565e-05
1 O 0 2.5430630557821132e-05
) O 0 1.562115539854858e-05
, O 0 1.224720381287625e-05
25 O 0 2.432987639622297e-05
% O 0 2.5681069018901326e-05
of O 0 4.716356852441095e-05
Polish O 0 0.09701677411794662
patients O 0 0.061946041882038116
( O 0 8.0725563748274e-05
4 O 0 6.12696458119899e-05
) O 0 2.5304205337306485e-05
, O 0 2.0705756469396874e-05
and O 0 1.427018560207216e-05
14 O 0 2.91950382234063e-05
% O 0 2.5023198759299703e-05
of O 0 3.667680357466452e-05
Italian O 0 0.0073979138396680355
patients O 0 0.09965719282627106
( O 0 7.22143886378035e-05
1 O 0 4.813283521798439e-05
) O 0 2.38887187151704e-05
, O 0 2.4045604732236825e-05
as O 0 1.8953034668811597e-05
well O 0 1.719747706374619e-05
as O 0 2.1577428924501874e-05
in O 0 3.40527985827066e-05
patients O 0 0.0001258237025467679
of O 0 0.00011236055433982983
Amish O 0 0.1869354546070099
/ O 0 0.06689494848251343
Mennonite O 0 0.02097960002720356
and O 0 0.00021652545547112823
Irish O 0 0.00092490972019732
English O 0 0.00043004145845770836
backgrounds O 0 0.001067425706423819
. O 0 0.0009039888973347843

Additional O 0 0.0013748351484537125
mutations O 0 0.00061827152967453
were O 0 0.0001045184544636868
observed O 0 9.06669010873884e-05
in O 0 7.0132315158844e-05
Japanese O 0 0.00023949315072968602
, O 0 9.347533341497183e-05
Utah O 0 0.00048236281145364046
Mormon O 0 0.0008055814541876316
, O 0 0.00012668580166064203
and O 0 0.00014054792700335383
African O 0 0.0006922371685504913
American O 0 0.0017738734604790807
patients O 0 0.09858746081590652
. O 0 0.0013224201975390315

These O 0 0.0005759333726018667
assays O 0 0.0006505367928184569
should O 0 0.00010164020204683766
facilitate O 0 0.00016987872368190438
screening O 0 0.00021087481582071632
for O 0 8.571237412979826e-05
A B-Disease 1 0.5391280651092529
- I-Disease 1 0.9974327683448792
T I-Disease 1 0.9988937973976135
heterozygotes O 0 0.00558328116312623
in O 0 7.533845928264782e-05
the O 0 0.00010599042434478179
populations O 0 0.00010388025839347392
studied O 0 0.00026454083854332566
. O 0 0.00023021106608211994
. O 0 0.0006618181942030787

The O 0 0.0034908342640846968
von B-Disease 1 0.8595557808876038
Hippel I-Disease 1 0.9998353719711304
- I-Disease 1 0.999762237071991
Lindau I-Disease 1 0.9999915361404419
tumor I-Disease 1 0.9999977350234985
suppressor O 1 0.9990032315254211
gene O 0 0.0004953640745952725
is O 0 9.006523760035634e-05
required O 0 7.660962000954896e-05
for O 0 8.612662350060418e-05
cell O 0 0.00040778241236694157
cycle O 0 0.0006025834591127932
exit O 0 0.0008320100605487823
upon O 0 0.0009037041454575956
serum O 0 0.12613646686077118
withdrawal O 0 0.00455864891409874
. O 0 0.0013521034270524979

The O 0 0.0015754451742395759
inactivation O 0 0.004759267903864384
of O 0 0.00035088922595605254
the O 0 0.00044535016058944166
von B-Disease 1 0.9462617039680481
Hippel I-Disease 1 0.9998533725738525
- I-Disease 1 0.9969115853309631
Lindau I-Disease 1 0.9999171495437622
( I-Disease 0 0.47077617049217224
VHL I-Disease 1 0.9999775886535645
) I-Disease 0 0.04291414096951485
tumor I-Disease 1 0.9999740123748779
suppressor O 1 0.9994035959243774
gene O 0 0.00410433579236269
predisposes O 1 0.907858669757843
affected O 0 0.00023285395582206547
individuals O 0 4.4854958105133846e-05
to O 0 4.334734330768697e-05
the O 0 0.0008443067199550569
human O 1 0.9986907839775085
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.2612362205982208
is O 0 0.004860495217144489
associated O 0 0.00044945316039957106
with O 0 0.002946889493614435
sporadic B-Disease 1 0.9998451471328735
renal I-Disease 1 1.0
cell I-Disease 1 0.999995231628418
carcinomas I-Disease 1 1.0
( O 1 0.999850869178772
RCC B-Disease 1 0.9999996423721313
) O 0 0.0020659095607697964
and O 0 0.0009847062174230814
brain B-Disease 1 0.9821897745132446
hemangioblastomas I-Disease 1 0.9912746548652649
. O 0 0.0017011904856190085

VHL O 1 0.9794667959213257
- O 0 0.009090691804885864
negative O 0 0.0012533534318208694
786 O 1 0.934559166431427
- O 1 0.7877920269966125
0 O 0 0.019977010786533356
RCC B-Disease 1 0.9999617338180542
cells O 0 0.0011297130258753896
are O 0 4.849580363952555e-05
tumorigenic O 0 0.06471998989582062
in O 0 0.0001385136420140043
nude O 0 0.10657711327075958
mice O 0 0.0005127984331920743
which O 0 5.3069765272084624e-05
is O 0 5.462802073452622e-05
suppressed O 0 0.00029955117497593164
by O 0 8.151077781803906e-05
the O 0 0.00018423513392917812
reintroduction O 0 0.003637840738520026
of O 0 0.0013523779343813658
VHL B-Disease 1 0.9987825751304626
. O 0 0.002772347768768668

Remarkably O 0 0.008252996020019054
, O 0 0.00041462920489721
this O 0 0.0001234799128724262
occurs O 0 0.00012946370407007635
without O 0 6.102008046582341e-05
affecting O 0 8.05188319645822e-05
the O 0 5.18872075190302e-05
growth O 0 0.0001802792976377532
rate O 0 5.277361924527213e-05
and O 0 4.4517204514704645e-05
cell O 0 0.00016803827020339668
cycle O 0 0.0002213882835349068
profile O 0 0.0001053499654517509
of O 0 7.285892934305593e-05
these O 0 4.5772019802825525e-05
cells O 0 0.00016420109022874385
in O 0 0.00012300597154535353
culture O 0 0.0008386123809032142
. O 0 0.0009098636219277978

The O 0 0.0015697880880907178
786 O 0 0.270740807056427
- O 0 0.007158855441957712
0 O 0 0.0005189876537770033
cell O 0 0.0006090041715651751
line O 0 0.00022587439161725342
, O 0 8.886965224519372e-05
like O 0 9.165387746179476e-05
many O 0 0.00010022930655395612
cancer B-Disease 1 0.9988172650337219
cells O 0 0.0009773086057975888
, O 0 8.7773943960201e-05
fails O 0 0.00016694779333192855
to O 0 3.625450699473731e-05
exit O 0 0.00014907197328284383
the O 0 0.00010996690980391577
cell O 0 0.0003636725596152246
cycle O 0 0.0007913520094007254
upon O 0 0.0005578391719609499
serum O 0 0.2996024191379547
withdrawal O 0 0.009085864759981632
. O 0 0.0014732623239979148

Here O 0 0.0013872154522687197
, O 0 0.0003424574388191104
it O 0 8.874347258824855e-05
is O 0 6.96611386956647e-05
shown O 0 5.527313260245137e-05
that O 0 2.7006100935977884e-05
reintroduction O 0 0.00015803395945113152
of O 0 4.562389221973717e-05
the O 0 8.612810051999986e-05
wild O 0 0.000501607486512512
- O 0 0.11782480031251907
type O 0 0.015294542536139488
VHL B-Disease 1 0.9867543578147888
gene O 0 0.00024690802092663944
restores O 0 0.0005912150954827666
the O 0 6.864952592877671e-05
ability O 0 9.203082299791276e-05
of O 0 0.00020591233624145389
VHL O 1 0.9999639987945557
- O 1 0.9978747367858887
negative O 1 0.8325256109237671
RCC B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999520778656006
cells O 0 0.0004715549002867192
to O 0 5.5580760090379044e-05
exit O 0 0.0001896340399980545
the O 0 9.264455002266914e-05
cell O 0 0.00025753650697879493
cycle O 0 0.00034005256020464003
and O 0 0.00012804994184989482
enter O 0 0.0006460098666138947
G0 O 1 0.9959750771522522
/ O 0 0.0068750036880373955
quiescence O 0 0.03185543790459633
in O 0 0.00044466997496783733
low O 0 0.0017539698164910078
serum O 0 0.04024359583854675
. O 0 0.0019090144196525216

Both O 0 0.002599891507998109
VHL O 1 0.9980328679084778
- O 0 0.027837850153446198
positive O 0 0.0006756361690349877
and O 0 0.0005520306876860559
VHL O 1 0.9999741315841675
- O 1 0.9884737133979797
negative O 0 0.07878599315881729
RCC B-Disease 1 0.9999895095825195
cells O 0 0.0014858579961583018
exit O 0 0.0002779127680696547
the O 0 0.00010144925909116864
cell O 0 0.00042023471905849874
cycle O 0 0.00044007692486047745
by O 0 0.00011334186274325475
contact O 0 0.00045989404316060245
inhibition O 0 0.002884172834455967
. O 0 0.0007722253794781864

The O 0 0.0023742171470075846
cyclin O 0 0.24756523966789246
- O 0 0.02357374131679535
dependent O 0 0.001009176834486425
kinase O 0 0.021288573741912842
inhibitor O 1 0.6814801692962646
, O 0 0.0002019829989876598
p27 O 0 0.2068575918674469
, O 0 0.0001153185949078761
accumulates O 0 0.001456323079764843
upon O 0 0.00022445619106292725
serum O 1 0.5611295700073242
withdrawal O 0 0.005102542694658041
, O 0 6.195683818077669e-05
only O 0 1.8849928892450407e-05
in O 0 1.8049600839731283e-05
the O 0 3.405026291147806e-05
presence O 0 9.214920282829553e-05
of O 0 0.00014172006922308356
VHL B-Disease 1 0.9994708895683289
, O 0 8.351053111255169e-05
as O 0 3.495308192213997e-05
a O 0 5.0852129788836464e-05
result O 0 3.659819412860088e-05
of O 0 3.833505616057664e-05
the O 0 7.72257408243604e-05
stabilization O 0 0.0006922843167558312
of O 0 0.000106413644971326
the O 0 0.00017636198026593775
protein O 0 0.00037504351348616183
. O 0 0.00045203889021649957

We O 0 0.0006214120658114552
propose O 0 0.0005359572824090719
that O 0 8.705838990863413e-05
the O 0 9.956886060535908e-05
loss O 0 0.00027794059133157134
of O 0 0.00017644137551542372
wild O 0 0.05617619678378105
- O 1 0.9599525928497314
type O 1 0.5020993947982788
VHL B-Disease 1 0.9995941519737244
gene O 0 0.00013583464897237718
results O 0 4.727654959424399e-05
in O 0 2.883593515434768e-05
a O 0 5.222915206104517e-05
specific O 0 3.710643431986682e-05
cellular O 0 0.0002825066039804369
defect O 0 0.08081483095884323
in O 0 0.00010671717609511688
serum O 1 0.8879688382148743
- O 0 0.04127509891986847
dependent O 0 0.00017851486336439848
growth O 0 0.00013890938134863973
control O 0 0.00010218208626611158
, O 0 6.550023681484163e-05
which O 0 6.416760879801586e-05
may O 0 0.00016095108003355563
initiate O 0 0.0033269687555730343
tumor B-Disease 1 0.9983996748924255
formation O 0 0.12440230697393417
. O 0 0.0014143397565931082

This O 0 0.000837696366943419
is O 0 0.0003107801894657314
corrected O 0 0.0005961887072771788
by O 0 7.805436325725168e-05
the O 0 6.347780436044559e-05
reintroduction O 0 0.00048153038369491696
of O 0 0.00016599065565969795
wild O 0 0.0018569069216027856
- O 1 0.7108830213546753
type O 0 0.48050186038017273
VHL B-Disease 1 0.9998788833618164
, O 0 0.00028200505767017603
implicating O 1 0.7983588576316833
VHL B-Disease 1 0.9803909063339233
as O 0 9.54537681536749e-05
the O 0 7.254811498569325e-05
first O 0 0.0004483961674850434
tumor B-Disease 1 0.998989999294281
suppressor O 0 0.0987551286816597
involved O 0 5.92528231209144e-05
in O 0 2.41624002228491e-05
the O 0 3.5029570426559076e-05
regulation O 0 5.690650505130179e-05
of O 0 6.863748421892524e-05
cell O 0 0.0009221555083058774
cycle O 0 0.0006036397535353899
exit O 0 0.000212797851418145
, O 0 2.9491660825442523e-05
which O 0 1.2797563613275997e-05
is O 0 1.350232651020633e-05
consistent O 0 3.7665671698050573e-05
with O 0 2.2800235456088558e-05
its O 0 3.252610258641653e-05
gatekeeper O 0 0.029142826795578003
function O 0 6.123915227362886e-05
in O 0 6.618064071517438e-05
the O 0 0.00042081880383193493
kidney O 1 0.9999535083770752
. O 0 0.0005195796256884933
. O 0 0.00069976452505216

Piebaldism B-Disease 1 0.9997410178184509
with O 0 0.04048820957541466
deafness B-Disease 1 0.9999916553497314
: O 0 0.0008588318014517426
molecular O 0 0.0005769971176050603
evidence O 0 0.00027390182367525995
for O 0 0.00016881655028555542
an O 0 0.0004874048172496259
expanded O 0 0.05111253634095192
syndrome O 1 0.9999899864196777
. O 0 0.002162346849218011

In O 0 0.0007195381331257522
a O 0 0.00045560221769846976
South O 0 0.0005745309754274786
African O 0 0.0006083034095354378
girl O 0 0.005205793306231499
of O 0 0.0005581587902270257
Xhosa O 1 0.9879671931266785
stock O 0 0.001724914531223476
with O 0 0.0011220938758924603
severe O 1 0.9999905824661255
piebaldism B-Disease 1 0.9999978542327881
and O 1 0.995374858379364
profound O 1 0.9999997615814209
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.0713285282254219
identified O 0 0.0009699704824015498
a O 0 0.0002548185584601015
novel O 0 0.0004642294079530984
missense O 0 0.0006799614056944847
substitution O 0 0.00015624167281202972
at O 0 4.634586730389856e-05
a O 0 4.3577914766501635e-05
highly O 0 4.9730322643881664e-05
conserved O 0 5.904744830331765e-05
residue O 0 0.0001442430802853778
in O 0 5.3766263590659946e-05
the O 0 6.88572326907888e-05
intracellular O 0 0.00020388871780596673
kinase O 0 0.00013464130461215973
domain O 0 8.446785068372265e-05
of O 0 0.00010069767449749634
the O 0 0.0003244686231482774
KIT O 1 0.9922796487808228
proto O 1 0.9950706958770752
- O 1 0.9373289942741394
oncogene O 1 0.9969616532325745
, O 0 0.0012209684355184436
R796G O 1 0.5481051802635193
. O 0 0.002680613426491618

Though O 0 0.004872436635196209
auditory B-Disease 1 0.6615522503852844
anomalies I-Disease 0 0.013400096446275711
have O 0 0.00013510146527551115
been O 0 8.03563671070151e-05
observed O 0 0.0001058606430888176
in O 0 4.932983574690297e-05
mice O 0 0.00012689556751865894
with O 0 3.68727050954476e-05
dominant O 0 0.00044747086940333247
white O 0 0.019007889553904533
spotting O 1 0.913568377494812
( O 0 0.003119222354143858
W O 0 0.3423706591129303
) O 0 7.15433488949202e-05
due O 0 6.997445598244667e-05
to O 0 5.312277426128276e-05
KIT O 1 0.9804952144622803
mutations O 0 0.003907125908881426
, O 0 0.00045887287706136703
deafness B-Disease 1 0.9999619722366333
is O 0 8.566350879846141e-05
not O 0 4.633217031368986e-05
typical O 0 0.00017606510664336383
in O 0 0.00011688355152728036
human O 0 0.0005697765154764056
piebaldism B-Disease 1 0.938535213470459
. O 0 0.00161618588026613

Thus O 0 0.0012775047216564417
, O 0 0.0003989532415289432
the O 0 0.0002633314288686961
occurrence O 0 0.002444484271109104
of O 0 0.12804311513900757
sensorineural B-Disease 1 0.9999996423721313
deafness I-Disease 1 0.9999997615814209
in O 0 0.0021311226300895214
this O 0 0.00026510367752052844
patient O 1 0.5177112817764282
extends O 0 0.0008574523963034153
considerably O 0 0.00017597027181182057
the O 0 6.548030796693638e-05
phenotypic O 0 0.00014914109488017857
range O 0 5.073123975307681e-05
of O 0 7.30485626263544e-05
piebaldism B-Disease 0 0.4468424916267395
due O 0 0.00012106774374842644
to O 0 5.432856778497808e-05
KIT O 1 0.5958784222602844
gene O 0 0.00014254325651563704
mutation O 0 0.00010958087659673765
in O 0 3.3766711567295715e-05
humans O 0 6.538683373946697e-05
and O 0 3.8304140616673976e-05
tightens O 0 0.0006751089822500944
the O 0 5.900872565689497e-05
clinical O 0 0.0003596058231778443
similarity O 0 0.00016365745977964252
between O 0 8.360670472029597e-05
piebaldism B-Disease 0 0.34325769543647766
and O 0 4.806765718967654e-05
the O 0 5.5937653087312356e-05
various O 0 3.771937554120086e-05
forms O 0 0.0003057252906728536
of O 1 0.8059395551681519
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.07599098235368729
. O 0 0.002296259393915534

Cycloheximide O 1 0.8110359311103821
facilitates O 0 0.003173473058268428
the O 0 0.0004755239642690867
identification O 0 0.0003565810329746455
of O 0 0.0002505331067368388
aberrant O 0 0.0036242741625756025
transcripts O 0 0.0002852847392205149
resulting O 0 0.0001411730336258188
from O 0 4.775700290338136e-05
a O 0 9.686347038950771e-05
novel O 0 0.0002289443655172363
splice O 0 0.0014340640045702457
- O 0 0.0005611890810541809
site O 0 0.0001702594745438546
mutation O 0 0.00012970069656148553
in O 0 6.583733193110675e-05
COL17A1 O 1 0.6494883298873901
in O 0 0.00013394826964940876
a O 0 0.0006332367775030434
patient O 1 0.7685697078704834
with O 0 0.01453081239014864
generalized O 1 0.9997877478599548
atrophic B-Disease 1 0.9999994039535522
benign I-Disease 1 0.9999964237213135
epidermolysis I-Disease 1 0.999997615814209
bullosa I-Disease 1 0.9999839067459106
. O 0 0.03981221094727516

Patients O 1 0.9857962727546692
with O 0 0.02946600131690502
generalized O 1 0.9998756647109985
atrophic B-Disease 1 0.9999996423721313
benign I-Disease 1 0.9999994039535522
epidermolysis I-Disease 1 0.9999995231628418
bullosa I-Disease 1 0.9999961853027344
often O 0 0.0009647103142924607
show O 0 0.000548271753359586
decreased O 0 0.0008112333016470075
expression O 0 0.0002624184126034379
of O 0 0.0005456571816466749
type O 1 0.9843724966049194
XVII O 1 0.9999985694885254
collagen O 1 0.999629020690918
, O 0 0.0002920330734923482
a O 0 0.00027646662783809006
transmembrane O 0 0.006572052836418152
hemidesmosomal O 0 0.22291924059391022
protein O 0 0.00024622862110845745
encoded O 0 0.00019018884631805122
by O 0 0.00028001549071632326
COL17A1 O 1 0.5693508982658386
. O 0 0.0016028921818360686

This O 0 0.0005344765377230942
report O 0 0.00025641926913522184
documents O 0 0.0001538339420221746
a O 0 0.00015035019896458834
novel O 0 0.00028374779503792524
splice O 0 0.0026518951635807753
- O 0 0.0012527555227279663
site O 0 0.00019038809114135802
mutation O 0 0.0001304481120314449
in O 0 5.21533984283451e-05
COL17A1 O 0 0.22327090799808502
in O 0 7.826961518730968e-05
a O 0 0.00021526483760681003
patient O 0 0.22903986275196075
with O 0 0.0020132516510784626
generalized O 1 0.9999006986618042
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.999998927116394
, O 0 0.0007769790245220065
and O 0 8.467189036309719e-05
applies O 0 7.724777242401615e-05
a O 0 6.157469033496454e-05
new O 0 5.0523056415840983e-05
methodology O 0 8.473327034153044e-05
to O 0 3.572881905711256e-05
define O 0 0.00010809016384882852
and O 0 8.654717385070398e-05
characterize O 0 0.0004251834179740399
the O 0 0.0002854158519767225
resulting O 0 0.0006999042816460133
mRNA O 0 0.0010749722132459283
splice O 0 0.00421803118661046
variants O 0 0.0014124499866738915
. O 0 0.0010463407961651683

Mutational O 0 0.018269354477524757
analysis O 0 0.0008454040507785976
of O 0 0.0004979455261491239
COL17A1 O 1 0.7913950681686401
identified O 0 0.00038872368168085814
a O 0 0.00036836921935901046
maternally O 0 0.06877069920301437
inherited O 1 0.9597356915473938
G O 1 0.5170420408248901
- O 0 0.02022331766784191
to O 0 0.00014431860472541302
- O 0 0.4209188222885132
T O 1 0.6196619272232056
transversion O 0 0.02728462405502796
at O 0 8.72771634021774e-05
the O 0 7.359618757618591e-05
- O 0 0.0001784194028005004
1 O 0 7.418135646730661e-05
position O 0 0.00011690618703141809
of O 0 0.00017323149950243533
exon O 0 0.001620447263121605
32 O 0 0.0008754655718803406
. O 0 0.0008392183226533234

This O 0 0.0012884715106338263
acceptor O 0 0.0038479084614664316
splice O 0 0.012322437018156052
- O 0 0.0035619810223579407
site O 0 0.00036877079401165247
mutation O 0 0.0002146665647160262
led O 0 0.00011416177585488185
to O 0 3.4223816328449175e-05
the O 0 6.416026735678315e-05
formation O 0 0.00019803893519565463
of O 0 0.00012813556531909853
aberrant O 0 0.0010147328721359372
transcripts O 0 0.00019613420590758324
present O 0 0.00010192827176069841
at O 0 0.00014471368922386318
extremely O 0 0.00030789096490480006
low O 0 0.00036158267175778747
levels O 0 0.00031826915801502764
. O 0 0.0005129043129272759

Based O 0 0.0005868126754648983
on O 0 0.000245195027673617
our O 0 0.0002240526955574751
recent O 0 0.00013624494022224098
finding O 0 0.00022530226851813495
that O 0 0.00010503620433155447
cycloheximide O 1 0.6801716685295105
stabilized O 0 0.3202090263366699
mutant O 0 0.024482687935233116
COL17A1 O 1 0.9575197100639343
transcripts O 0 0.00036899972474202514
in O 0 8.7592656200286e-05
keratinocytes O 0 0.013142446987330914
homozygous O 0 0.0002739780757110566
for O 0 5.215687269810587e-05
a O 0 0.00011508186435094103
frameshift O 0 0.1628085970878601
mutation O 0 0.00016194276395253837
, O 0 4.082938175997697e-05
the O 0 4.626294321496971e-05
effects O 0 0.00010844736971193925
of O 0 4.8390382289653644e-05
the O 0 0.00010232463682768866
splice O 0 0.005139207001775503
- O 0 0.0010957284830510616
site O 0 0.00020058259542565793
mutation O 0 0.00014759508485440165
on O 0 6.622660293942317e-05
splicing O 0 0.00019252687343396246
of O 0 0.00013231423508841544
COL17A1 O 0 0.11056508868932724
transcripts O 0 0.0002526124007999897
were O 0 6.883766764076427e-05
determined O 0 0.00015597684250678867
using O 0 7.125533738872036e-05
reverse O 0 0.00038798750028945506
transcriptase O 0 0.001368665718473494
polymerase O 0 0.0006335137295536697
chain O 0 0.00023209323990158737
reaction O 0 0.00011196184641448781
of O 0 6.161310739116743e-05
total O 0 7.107787678251043e-05
RNA O 0 0.00017412492888979614
from O 0 0.00013639495591633022
keratinocytes O 0 0.001509221619926393
incubated O 0 0.0009604594088159502
for O 0 0.00021987159561831504
2 O 0 0.0007074433378875256
. O 0 0.0009619274642318487

5 O 0 0.001862131292000413
h O 0 0.0014460303355008364
in O 0 0.00014787737745791674
the O 0 0.00011377771443221718
presence O 0 0.00012482130841817707
or O 0 5.740346387028694e-05
absence O 0 0.00021604042558465153
of O 0 0.00013767195923719555
10 O 0 0.0003354476357344538
microg O 1 0.8207285404205322
cycloheximide O 1 0.8103091716766357
per O 0 0.0010232875356450677
ml O 0 0.009630699642002583
. O 0 0.0010588201694190502

Using O 0 0.0006386223249137402
this O 0 0.00017883551481645554
approach O 0 0.00024334024055860937
, O 0 0.00013144576223567128
an O 0 0.00010060207569040358
abnormally O 0 0.001342956442385912
spliced O 0 0.0005187824135646224
transcript O 0 0.0002844577538780868
was O 0 8.9527755335439e-05
identified O 0 4.371793693280779e-05
that O 0 1.784758933354169e-05
contains O 0 2.3131862690206617e-05
an O 0 2.0942190531059168e-05
extra O 0 5.40475630259607e-05
264 O 0 0.00011371763685019687
bases O 0 7.729308708803728e-05
upstream O 0 9.821864659897983e-05
from O 0 3.674570325529203e-05
exon O 0 0.00015976758731994778
32 O 0 6.761029362678528e-05
, O 0 4.564112896332517e-05
resulting O 0 6.587883399333805e-05
in O 0 3.548081804183312e-05
a O 0 0.00012730035814456642
premature O 0 0.0017557775136083364
termination O 0 0.0016742637380957603
codon O 0 0.0005635060952045023
27 O 0 0.00040387737681157887
bp O 0 0.0006582583882845938
downstream O 0 0.000359110243152827
from O 0 0.00013932911679148674
the O 0 0.000209856269066222
cryptic O 0 0.00138897355645895
splice O 0 0.002938042627647519
site O 0 0.0015553331468254328
. O 0 0.0012034103274345398

Three O 0 0.0007950261933729053
other O 0 0.0002575915423221886
splice O 0 0.001287556253373623
variants O 0 0.00021286522678565234
, O 0 6.455716356867924e-05
including O 0 3.5141652915626764e-05
one O 0 3.3565727790119126e-05
derived O 0 3.435553298913874e-05
from O 0 2.548598604334984e-05
the O 0 5.370938015403226e-05
skipping O 0 0.0002877892693504691
of O 0 8.379522478207946e-05
exon O 0 0.0007083653472363949
32 O 0 0.00015759817324578762
, O 0 9.971613326342776e-05
were O 0 0.0001251583598786965
also O 0 0.0002138316776836291
identified O 0 0.0007103165262378752
. O 0 0.0008858698420226574

These O 0 0.00037166025140322745
results O 0 0.00029987154994159937
indicate O 0 0.00019886373775079846
the O 0 0.00012426362081896514
usefulness O 0 0.0005023903795517981
of O 0 0.00029185489984229207
cycloheximide O 1 0.9972398281097412
treatment O 0 0.1531669646501541
in O 0 6.054882760508917e-05
evaluating O 0 0.00019074477313552052
the O 0 7.743029709672555e-05
abnormal O 0 0.0004088290734216571
processing O 0 8.938163227867335e-05
of O 0 4.2819930968107656e-05
mRNA O 0 7.340918091358617e-05
due O 0 4.651514973375015e-05
to O 0 2.819038309098687e-05
splice O 0 0.0003357378300279379
- O 0 0.0002322727523278445
site O 0 0.0001295333495363593
mutations O 0 9.665992547525093e-05
, O 0 3.0704417440574616e-05
because O 0 4.027341492474079e-05
( O 0 5.569796485360712e-05
i O 0 7.80137415858917e-05
) O 0 4.912717122351751e-05
aberrant O 0 0.00023219284776132554
splicing O 0 0.00017377993208356202
often O 0 2.9480412194970995e-05
generates O 0 0.0001132557590608485
a O 0 8.775143214734271e-05
premature O 0 0.000748060701880604
termination O 0 0.0014811482978984714
codon O 0 0.0003236304910387844
, O 0 7.30123501853086e-05
( O 0 9.798478276934475e-05
ii O 0 0.0007355563575401902
) O 0 5.0490594730945304e-05
transcripts O 0 0.00013559770013671368
with O 0 6.221705552889034e-05
premature O 0 0.0024432449135929346
termination O 0 0.0026535186916589737
codons O 0 0.0002021569962380454
can O 0 2.2102514776634052e-05
occur O 0 2.7726307962439023e-05
at O 0 4.4586879084818065e-05
low O 0 8.685555803822353e-05
or O 0 4.519079811871052e-05
undetectable O 0 0.000814790022559464
levels O 0 4.195244764559902e-05
due O 0 2.589695213828236e-05
to O 0 2.2476726371678524e-05
nonsense O 0 0.00026571803027763963
- O 0 0.00017774903972167522
mediated O 0 0.00022538518533110619
mRNA O 0 0.0001185480723506771
decay O 0 0.00036616690340451896
, O 0 3.748421659111045e-05
and O 0 3.544314677128568e-05
( O 0 6.497232243418694e-05
iii O 0 0.0007133271428756416
) O 0 2.3961089027579874e-05
the O 0 2.6327596060582437e-05
levels O 0 2.803686584229581e-05
of O 0 2.200568087573629e-05
these O 0 1.3670372936758213e-05
transcripts O 0 5.760702697443776e-05
can O 0 2.3265136405825615e-05
be O 0 3.514966374495998e-05
increased O 0 0.00010500595817575231
by O 0 0.00018347290460951626
cycloheximide O 0 0.06312132626771927
. O 0 0.00114733655937016

A O 0 0.0034943395294249058
deletion O 0 0.008788185194134712
mutation O 0 0.0011642870958894491
in O 0 0.00016063585644587874
COL17A1 O 1 0.9380859732627869
in O 0 0.000113105088530574
five O 0 0.00017580055282451212
Austrian O 0 0.012845873832702637
families O 0 0.000573786674067378
with O 0 0.002937526209279895
generalized O 1 0.9997261166572571
atrophic B-Disease 1 0.9999997615814209
benign I-Disease 1 0.9999983310699463
epidermolysis I-Disease 1 0.9999995231628418
bullosa I-Disease 1 0.9999940395355225
represents O 0 0.18649519979953766
propagation O 0 0.008057571947574615
of O 0 0.00047188837197609246
an O 0 0.0006617752951569855
ancestral O 0 0.10464522242546082
allele O 0 0.005151006858795881
. O 0 0.0012783999554812908

Patients O 1 0.9752963781356812
with O 0 0.02710416167974472
generalized O 1 0.9999077320098877
atrophic B-Disease 1 0.9999997615814209
benign I-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999985694885254
, O 0 0.006406555417925119
a O 0 0.000510761805344373
usually O 0 0.00016395578859373927
nonlethal O 0 0.0012657050974667072
form O 0 0.00012568436795845628
of O 0 0.000716263719368726
junctional B-Disease 1 0.9999896287918091
epidermolysis I-Disease 1 0.9999973773956299
bullosa I-Disease 1 0.9999860525131226
, O 0 0.0002633176336530596
have O 0 0.00011031108442693949
generalized O 0 0.004185057245194912
blistering B-Disease 1 0.9923812747001648
, O 0 0.11764715611934662
nail B-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999998807907104
, O 1 0.9363591074943542
patchy B-Disease 1 0.9999955892562866
alopecia I-Disease 1 0.9999998807907104
, O 1 0.7628499269485474
and O 1 0.7266318202018738
dental B-Disease 1 0.9999960660934448
abnormalities I-Disease 1 0.9999357461929321
. O 0 0.007145068142563105

Skin B-Disease 1 0.9999409914016724
fragility I-Disease 1 0.9996084570884705
in O 0 0.00043738650856539607
most O 0 0.00014406013360712677
cases O 0 0.00017139430565293878
is O 0 5.815700569655746e-05
due O 0 7.01688404660672e-05
to O 0 2.90222124021966e-05
mutations O 0 4.7831752453930676e-05
in O 0 3.1564337405143306e-05
the O 0 6.383570871548727e-05
gene O 0 0.00016508370754308999
encoding O 0 0.0003070268430747092
type O 0 0.3063906729221344
XVII O 1 0.9999936819076538
collagen O 1 0.9999457597732544
( O 0 0.04897477477788925
COL17A1 O 1 0.9991990923881531
) O 0 0.0009222337976098061
. O 0 0.0012120883911848068

Recently O 0 0.0027217306196689606
, O 0 0.00035468730493448675
we O 0 0.0001440646592527628
reported O 0 0.00014010608720127493
five O 0 7.139612716855481e-05
Austrian O 0 0.000791081809438765
families O 0 0.0003741141699720174
with O 0 0.0007843661587685347
generalized O 1 0.9998065829277039
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999991655349731
epidermolysis I-Disease 1 0.9999995231628418
bullosa I-Disease 1 0.999984860420227
who O 0 0.0010819868184626102
share O 0 0.00019642185361590236
the O 0 0.00021504083997569978
same O 0 0.0005712587735615671
COL17A1 O 1 0.9993959665298462
mutation O 0 0.013294612057507038
. O 0 0.0011884826235473156

Affected O 0 0.002356210257858038
individuals O 0 0.0002077412063954398
in O 0 9.691493323771283e-05
three O 0 6.681858212687075e-05
families O 0 8.218238508561626e-05
are O 0 2.3719101591268554e-05
homozygous O 0 0.00023096341465134174
for O 0 6.06883731961716e-05
4003delTC O 0 0.2958357036113739
, O 0 7.57386878831312e-05
whereas O 0 6.121159094618633e-05
those O 0 1.7390351786161773e-05
in O 0 3.0830997275188565e-05
two O 0 3.2189815101446584e-05
others O 0 0.00012249233259353787
are O 0 0.00011033169721486047
compound O 0 0.002921029459685087
heterozygotes O 0 0.025705818086862564
. O 0 0.001331771956756711

To O 0 0.0005070980987511575
determine O 0 0.00031641911482438445
if O 0 0.00010536584886722267
the O 0 9.013295493787155e-05
occurrence O 0 0.00021790647588204592
of O 0 9.091060201171786e-05
4003delTC O 0 0.21634972095489502
in O 0 5.2949202654417604e-05
these O 0 2.1967354769003578e-05
unrelated O 0 0.00012933906691614538
families O 0 8.272616105386987e-05
signifies O 0 0.0016855777939781547
propagation O 0 0.00022136044572107494
of O 0 5.4962551075732335e-05
an O 0 5.070647603133693e-05
ancestral O 0 0.0010936748003587127
allele O 0 0.00015552077093161643
or O 0 4.52273125119973e-05
a O 0 8.425884880125523e-05
mutational O 0 0.10529446601867676
hot O 0 0.001212760922499001
spot O 0 0.00031583805684931576
, O 0 8.196565613616258e-05
haplotypes O 0 0.0002231645048595965
were O 0 4.8320431233150885e-05
determined O 0 8.437929500360042e-05
for O 0 4.207721212878823e-05
polymorphisms O 0 0.00017208713688887656
both O 0 5.789803617517464e-05
within O 0 0.00011953734792768955
and O 0 0.0002757984912022948
flanking O 1 0.5930778384208679
COL17A1 O 1 0.9980995059013367
. O 0 0.002446623519062996

Five O 0 0.0024392236955463886
intragenic O 1 0.7199275493621826
polymorphisms O 0 0.0015194923616945744
were O 0 0.00019858749874401838
chosen O 0 0.00020171512733213603
based O 0 0.00010453141294419765
on O 0 0.00013343973841983825
their O 0 0.0002775028988253325
informativeness O 0 0.06206197291612625
. O 0 0.0014413668541237712

One O 0 0.0005947372410446405
of O 0 0.00023194101231638342
these O 0 5.7972294598584995e-05
, O 0 5.378472633310594e-05
not O 0 2.7900465283892117e-05
previously O 0 4.864861330133863e-05
reported O 0 6.051846139598638e-05
, O 0 5.519407568499446e-05
was O 0 0.00015354716742876917
2988 O 0 0.14639897644519806
A O 0 0.0002806039701681584
or O 0 6.203736120369285e-05
C O 0 0.00012729356240015477
that O 0 2.716783455980476e-05
introduces O 0 0.00014423813263420016
a O 0 6.784565630368888e-05
new O 0 7.484394154744223e-05
restriction O 0 0.00019476782472338527
site O 0 0.00023651460651308298
for O 0 0.00021278952772263438
Eco0109 O 0 0.14059871435165405
I O 0 0.00340378494001925
. O 0 0.0016309275524690747

All O 0 0.0009398646070621908
the O 0 0.0006168436957523227
4003delTC O 0 0.3920634090900421
alleles O 0 0.0007862939964979887
showed O 0 0.0003242883540224284
the O 0 9.939791925717145e-05
same O 0 0.00010159834346268326
haplotype O 0 0.0003314337518531829
for O 0 6.266876880545169e-05
these O 0 4.741810334962793e-05
five O 0 0.00020971902995370328
polymorphic O 0 0.0022266218438744545
markers O 0 0.003176518715918064
. O 0 0.0014092990895733237

Fourteen O 0 0.006989840883761644
microsatellite O 0 0.03090798854827881
polymorphisms O 0 0.0009229572606272995
were O 0 0.00011229458323214203
selected O 0 8.524466102244332e-05
based O 0 3.468372960924171e-05
on O 0 2.26441534323385e-05
their O 0 2.3402675651595928e-05
high O 0 0.00010091289732372388
heterozygosity O 0 0.028021283447742462
and O 0 3.473835386103019e-05
their O 0 2.920506267400924e-05
location O 0 9.705671982374042e-05
within O 0 0.00013255668454803526
10q23 O 0 0.2655245065689087
- O 0 0.010653887875378132
q25 O 0 0.4864344000816345
near O 0 0.011157914064824581
COL17A1 O 1 0.9878822565078735
. O 0 0.0024990446399897337

Three O 0 0.0009933022083714604
families O 0 0.0008133279043249786
shared O 0 0.0006651480798609555
microsatellite O 0 0.1515503078699112
polymorphisms O 0 0.0011100501287728548
covering O 0 0.0005021669785492122
at O 0 0.00011253533739363775
most O 0 3.7617712223436683e-05
19 O 0 0.00011648089275695384
cM O 0 0.00021359977836254984
, O 0 4.4657979742623866e-05
whereas O 0 3.202331572538242e-05
the O 0 3.584293517633341e-05
others O 0 4.867752795689739e-05
shared O 0 5.6855620641727e-05
smaller O 0 3.694288898259401e-05
regions O 0 2.938769648608286e-05
consistent O 0 5.4370037105400115e-05
with O 0 3.0862505809636787e-05
cross O 0 0.0001440064370399341
- O 0 0.00040258426452055573
over O 0 3.610545172705315e-05
events O 0 4.372761395643465e-05
during O 0 6.484252662630752e-05
passage O 0 6.452694651670754e-05
of O 0 4.501461808104068e-05
this O 0 3.509972520987503e-05
mutation O 0 9.700377995613962e-05
through O 0 8.166061888914555e-05
several O 0 0.00019447313388809562
generations O 0 0.0009837651159614325
. O 0 0.0008561346912756562

These O 0 0.0008460850804112852
results O 0 0.00027250772109255195
indicate O 0 0.00028111436404287815
that O 0 0.00012563953350763768
4003delTC O 0 0.016493821516633034
occurs O 0 0.00018764118431136012
on O 0 9.971413965104148e-05
a O 0 0.00022487257956527174
single O 0 0.00030136556597426534
ancestral O 0 0.002356783952564001
allele O 0 0.0012555902358144522
. O 0 0.000410445558372885
. O 0 0.0007265477906912565

The O 0 0.004886358976364136
haptoglobin O 1 0.932070791721344
- O 0 0.036747392266988754
gene O 0 0.0013838313752785325
deletion O 0 0.0027056075632572174
responsible O 0 0.001270110602490604
for O 0 0.0007854975410737097
anhaptoglobinemia B-Disease 1 0.9593846201896667
. O 0 0.0027057244442403316

We O 0 0.0006454960675910115
have O 0 0.00012168486864538863
found O 0 7.12084656697698e-05
an O 0 6.880459113745019e-05
allelic O 0 0.000681862817145884
deletion O 0 0.0002619934093672782
of O 0 8.094501390587538e-05
the O 0 0.00021571684919763356
haptoglobin O 1 0.9721917510032654
( O 0 0.00033833467750810087
Hp O 0 0.0022683071438223124
) O 0 5.9776670241262764e-05
gene O 0 7.73923602537252e-05
from O 0 4.7208653995767236e-05
an O 0 8.51825752761215e-05
individual O 0 0.00015993831038940698
with O 0 0.00028272057534195483
anhaptoglobinemia B-Disease 1 0.8450060486793518
. O 0 0.0016746369656175375

The O 0 0.002581500681117177
Hp O 0 0.008530229330062866
gene O 0 0.0007868718239478767
cluster O 0 0.0006034418474882841
consists O 0 0.00021737150382250547
of O 0 8.671032264828682e-05
coding O 0 0.00015950821398291737
regions O 0 3.6984340113122016e-05
of O 0 4.239993359078653e-05
the O 0 7.705633470322937e-05
alpha O 0 0.0003864885657094419
chain O 0 0.00022459148021880537
and O 0 4.586981231113896e-05
beta O 0 8.782366785453632e-05
chain O 0 8.680323662701994e-05
of O 0 4.231026832712814e-05
the O 0 6.776172085665166e-05
haptoglobin O 0 0.18696390092372894
gene O 0 0.00014480092795565724
( O 0 8.331366552738473e-05
Hp O 0 0.0002832056488841772
) O 0 3.009196007042192e-05
and O 0 2.336581383133307e-05
of O 0 2.7806116122519597e-05
the O 0 4.5994693209649995e-05
alpha O 0 0.0001490246650064364
chain O 0 9.997091547120363e-05
and O 0 3.350822225911543e-05
beta O 0 9.498516010353342e-05
chain O 0 8.282443741336465e-05
of O 0 4.274334787623957e-05
the O 0 8.003028779057786e-05
haptoglobin O 1 0.5346637964248657
- O 0 0.0040079401805996895
related O 0 0.00012462935410439968
gene O 0 0.00018062102026306093
( O 0 0.00014699590974487364
Hpr O 0 0.11584525555372238
) O 0 5.047914237366058e-05
, O 0 3.3405489375581965e-05
in O 0 3.52732022292912e-05
tandem O 0 0.0001902625081129372
from O 0 4.409333996591158e-05
the O 0 9.756168583407998e-05
5 O 0 0.0002979649871122092
side O 0 0.0006874134414829314
. O 0 0.0010352683020755649

Southern O 0 0.004269677214324474
blot O 0 0.07713862508535385
and O 0 0.0004900642670691013
PCR O 0 0.0010151593014597893
analyses O 0 0.0001480660430388525
have O 0 3.5879256756743416e-05
indicated O 0 6.211645086295903e-05
that O 0 1.8976057617692277e-05
the O 0 2.9032449674559757e-05
individual O 0 4.17283627029974e-05
with O 0 5.960629277979024e-05
anhaptoglobinemia B-Disease 1 0.6292586922645569
was O 0 0.00035375982406549156
homozygous O 0 0.00019656537915579975
for O 0 2.3865879484219477e-05
the O 0 5.716735904570669e-05
gene O 0 8.29570708447136e-05
deletion O 0 0.00017173751257359982
and O 0 2.5367919079144485e-05
that O 0 1.5282323147403076e-05
the O 0 3.1075349397724494e-05
gene O 0 5.276894080452621e-05
deletion O 0 0.00013216478691902012
was O 0 6.094854688853957e-05
included O 0 3.060385643038899e-05
at O 0 2.5639003069954924e-05
least O 0 2.203129952249583e-05
from O 0 2.2838970835437067e-05
the O 0 5.00761998409871e-05
promoter O 0 0.0006082769832573831
region O 0 0.0001139813321060501
of O 0 0.00013176552602089942
Hp O 0 0.0008703359635546803
to O 0 6.947060319362208e-05
Hpr O 0 0.005772395525127649
alpha O 0 0.00015771936159580946
but O 0 3.4813867387128994e-05
not O 0 2.7370908355806023e-05
to O 0 6.495405250461772e-05
Hpr O 0 0.042644478380680084
beta O 0 0.001194415963254869
( O 0 0.0004282974696252495
Hpdel O 0 0.34173712134361267
) O 0 0.0005326581303961575
. O 0 0.0007244120934046805

In O 0 0.0005582734011113644
addition O 0 0.00028528014081530273
, O 0 0.00010884230869123712
we O 0 4.3602522055152804e-05
found O 0 3.518726225593127e-05
seven O 0 4.012712452095002e-05
individuals O 0 3.293675399618223e-05
with O 0 3.396733882254921e-05
hypohaptoglobinemia B-Disease 0 0.24954324960708618
in O 0 3.365624797879718e-05
three O 0 3.2852552976692095e-05
families O 0 4.131970854359679e-05
, O 0 2.198225411120802e-05
and O 0 2.08655656024348e-05
the O 0 3.308511804789305e-05
genotypes O 0 0.00013655904331244528
of O 0 2.7381585823604837e-05
six O 0 3.25728215102572e-05
of O 0 2.806246811815072e-05
the O 0 3.274520713603124e-05
seven O 0 3.5507353459252045e-05
individuals O 0 1.7707483493722975e-05
were O 0 2.2624659322900698e-05
found O 0 3.6380220990395173e-05
to O 0 5.382227755035274e-05
be O 0 0.00015083080506883562
Hp2 O 1 0.9011408090591431
/ O 0 0.2879732847213745
Hpdel O 1 0.8926624655723572
. O 0 0.002567500341683626

The O 0 0.0019620098173618317
phenotypes O 0 0.009047429077327251
and O 0 0.00022387866920325905
genotypes O 0 0.0007075236644595861
in O 0 4.6235465561039746e-05
one O 0 4.0470378735335544e-05
of O 0 3.2870229915715754e-05
these O 0 1.393797265336616e-05
three O 0 1.737188722472638e-05
families O 0 3.7471490941243246e-05
showed O 0 6.87143110553734e-05
the O 0 3.289612868684344e-05
father O 0 0.00012452197552192956
to O 0 2.565889008110389e-05
be O 0 4.0203962271334603e-05
hypohaptoglobinemic B-Disease 0 0.1644676774740219
( O 0 0.00014129880582913756
Hp2 O 0 0.16824612021446228
) O 0 6.874909740872681e-05
and O 0 9.969693928724155e-05
Hp2 O 1 0.9650216698646545
/ O 0 0.2398453801870346
Hpdel O 1 0.795268714427948
, O 0 7.162320980569348e-05
the O 0 4.915013414574787e-05
mother O 0 0.0001659275294514373
to O 0 2.832063546520658e-05
be O 0 3.0687006074003875e-05
Hp2 O 0 0.09649886935949326
- O 0 0.0005839616642333567
1 O 0 0.0001249792258022353
and O 0 0.0001259478012798354
Hp1 O 1 0.9983237385749817
/ O 1 0.7378883957862854
Hp2 O 1 0.7990648746490479
, O 0 4.099629586562514e-05
one O 0 2.154555477318354e-05
of O 0 2.168639184674248e-05
the O 0 2.756827416305896e-05
two O 0 1.769249684002716e-05
children O 0 3.939064117730595e-05
to O 0 1.975672239495907e-05
be O 0 3.3930653444258496e-05
hypohaptoglobinemic B-Disease 0 0.13160546123981476
( O 0 0.00015625476953573525
Hp2 O 0 0.20581333339214325
) O 0 7.813709817128256e-05
and O 0 0.00010063931404147297
Hp2 O 1 0.9552056193351746
/ O 0 0.28537023067474365
Hpdel O 1 0.7542789578437805
, O 0 7.732809899607673e-05
and O 0 3.395412568352185e-05
the O 0 4.276492109056562e-05
other O 0 1.906795660033822e-05
child O 0 0.00010261454008286819
to O 0 2.641733044583816e-05
be O 0 5.002665420761332e-05
Hp1 O 0 0.14229227602481842
and O 0 0.00018293627363163978
Hp1 O 1 0.996155321598053
/ O 1 0.7697134613990784
Hpdel O 1 0.9714658856391907
, O 0 0.0001449151459382847
showing O 0 0.0001801978360163048
an O 0 7.837552402634174e-05
anomalous O 0 0.0010619820095598698
inheritance O 0 0.0007485013920813799
of O 0 0.0002134800743078813
Hp O 0 0.08960682153701782
phenotypes O 0 0.0009835745440796018
in O 0 8.51710356073454e-05
the O 0 0.00017982091230805963
child O 0 0.007341668475419283
with O 0 0.0007457219180651009
Hp1 O 1 0.9976237416267395
. O 0 0.0018779552774503827

The O 0 0.004237056244164705
Hp2 O 1 0.9997710585594177
/ O 1 0.9903516173362732
Hpdel O 1 0.9969421029090881
individuals O 0 0.00019806178170256317
had O 0 0.0001237608230439946
an O 0 7.58562091505155e-05
extremely O 0 0.00012456972035579383
low O 0 9.026919724419713e-05
level O 0 5.778176273452118e-05
of O 0 5.112842336529866e-05
Hp O 0 0.0004671913047786802
( O 0 6.151694105938077e-05
mean O 0 8.596957195550203e-05
+ O 0 0.00031615857733413577
/ O 0 0.0003818753466475755
- O 0 0.000311795505695045
SD O 0 0.0006608764524571598
= O 0 0.00017196116095874459
0 O 0 0.00011473122867755592
. O 0 6.688922439934686e-05
049 O 0 0.001560654491186142
+ O 0 0.0003608696279115975
/ O 0 0.00031688823946751654
- O 0 0.0002298069157404825
0 O 0 0.00012542252079583704
. O 0 7.240954437293112e-05
043 O 0 0.0015617915196344256
mg O 0 0.0006805584998801351
/ O 0 0.00048531859647482634
ml O 0 0.0005021688994020224
; O 0 4.2150786612182856e-05
n O 0 8.750025153858587e-05
= O 0 7.466188253602013e-05
6 O 0 4.4463577069109306e-05
) O 0 2.340171704418026e-05
, O 0 1.933246494445484e-05
compared O 0 1.3460131413012277e-05
with O 0 1.1489479220472276e-05
the O 0 2.025169123953674e-05
level O 0 2.8768479751306586e-05
( O 0 2.635316559462808e-05
1 O 0 2.7639083782560192e-05
. O 0 2.3688582587055862e-05
64 O 0 9.179015614790842e-05
+ O 0 0.0002008991432376206
/ O 0 0.00027057898114435375
- O 0 0.00019245895964559168
1 O 0 7.208599708974361e-05
. O 0 6.098726953496225e-05
07 O 0 0.0009749694727361202
mg O 0 0.0019501687493175268
/ O 0 0.0009578494355082512
ml O 0 0.0007448681863024831
) O 0 5.33574384462554e-05
obtained O 0 6.300487439148128e-05
from O 0 4.976287164026871e-05
52 O 0 0.00019158398208674043
healthy O 0 0.0005828044377267361
volunteers O 0 0.0005133953527547419
having O 0 0.0004458752227947116
phenotype O 0 0.12487909197807312
Hp2 O 1 0.8428301811218262
, O 0 0.00010982953972415999
whereas O 0 0.00010331154044251889
the O 0 0.00010981989908032119
serum O 0 0.03242075815796852
Hp O 0 0.00036371054011397064
level O 0 5.336502363206819e-05
of O 0 3.359256515977904e-05
an O 0 4.543251634459011e-05
individual O 0 5.911234984523617e-05
with O 0 9.001819853438064e-05
Hp1 O 1 0.991594135761261
/ O 1 0.6122040152549744
Hpdel O 1 0.9879989624023438
was O 0 0.0015226780669763684
0 O 0 0.0008346340619027615
. O 0 0.0009455460822209716

50 O 0 0.0033048021141439676
mg O 0 0.18868021667003632
/ O 0 0.17604924738407135
ml O 0 0.0374760702252388
, O 0 0.00014500290853902698
which O 0 4.974616604158655e-05
was O 0 6.921443127794191e-05
approximately O 0 5.197495556785725e-05
half O 0 3.50245572917629e-05
the O 0 2.779286114673596e-05
level O 0 4.4551852624863386e-05
of O 0 5.2274441259214655e-05
Hp O 0 0.00023001273802947253
in O 0 3.816893513430841e-05
control O 0 0.00011766827083192766
sera O 0 0.0018568795640021563
from O 0 4.4143998820800334e-05
the O 0 8.32445002743043e-05
Hp1 O 1 0.9645267724990845
phenotype O 0 0.0011789420386776328
( O 0 5.8601373893907294e-05
1 O 0 3.912572719855234e-05
. O 0 2.4044869860517792e-05
26 O 0 8.725935185793787e-05
+ O 0 0.00017099615070037544
/ O 0 0.00023925077402964234
- O 0 0.00012748719018418342
0 O 0 5.8771005569724366e-05
. O 0 3.398101034690626e-05
33 O 0 0.00012092284305253997
mg O 0 0.00045118475100025535
/ O 0 0.0003132873971480876
ml O 0 0.00040441323653794825
; O 0 4.4300199078861624e-05
n O 0 9.120809409068897e-05
= O 0 0.00011757115134969354
9 O 0 7.353389082709327e-05
) O 0 4.20048127125483e-05
, O 0 4.344621629570611e-05
showing O 0 0.00010943551023956388
a O 0 0.00011267718218732625
gene O 0 0.0003471414092928171
- O 0 0.002001446671783924
dosage O 0 0.0025071646086871624
effect O 0 0.0007383208139799535
. O 0 0.0008176545379683375

The O 0 0.0009858881821855903
other O 0 0.0002304381487192586
allele O 0 0.0007075283792801201
( O 0 0.00023099713143892586
Hp2 O 0 0.2172623723745346
) O 0 6.498602306237444e-05
of O 0 7.125098636606708e-05
individuals O 0 4.732188244815916e-05
with O 0 9.515677811577916e-05
Hp2 O 1 0.9996663331985474
/ O 1 0.9639098644256592
Hpdel O 1 0.9854605793952942
was O 0 0.00018642100621946156
found O 0 2.259673783555627e-05
to O 0 1.2030706784571521e-05
have O 0 8.834627806209028e-06
, O 0 1.1584981621126644e-05
in O 0 1.0387664588051848e-05
all O 0 1.442862230760511e-05
exons O 0 0.00014094302605371922
, O 0 3.8920010410947725e-05
no O 0 4.841826739721e-05
mutation O 0 0.00010260916315019131
, O 0 4.740227814181708e-05
by O 0 7.280801219167188e-05
DNA O 0 0.0004243055882398039
sequencing O 0 0.0013650793116539717
. O 0 0.000997424591332674

On O 0 0.00047762072063051164
the O 0 0.0001839616452343762
basis O 0 9.039806172950193e-05
of O 0 6.589938857359812e-05
the O 0 6.581661727977917e-05
present O 0 6.59523211652413e-05
study O 0 4.1517043428029865e-05
, O 0 2.5922527129296213e-05
the O 0 3.789655238506384e-05
mechanism O 0 8.836213237373158e-05
of O 0 7.438939792336896e-05
anhaptoglobinemia B-Disease 0 0.28427085280418396
and O 0 4.007351162726991e-05
the O 0 4.8053861974040046e-05
mechanism O 0 9.567083179717883e-05
of O 0 7.57261150283739e-05
anomalous O 0 0.01591811515390873
inheritance O 0 0.0061417026445269585
of O 0 0.0008713170536793768
Hp O 1 0.6613340377807617
phenotypes O 0 0.0028155858162790537
were O 0 0.00017699912132229656
well O 0 0.0003274163173045963
explained O 0 0.0011562324361875653
. O 0 0.0012177291791886091

However O 0 0.0014308445388451219
, O 0 0.0007991566671989858
the O 0 0.0005022878176532686
mechanism O 0 0.0015592299168929458
of O 0 0.0010366278002038598
hypohaptoglobinemia B-Disease 1 0.9876872897148132
remains O 0 0.055710677057504654
unknown O 0 0.015403957106173038

ATM O 0 0.01681441068649292
mutations O 0 0.0018584897043183446
and O 0 0.0004738529387395829
phenotypes O 0 0.02900419943034649
in O 0 0.0033439621329307556
ataxia B-Disease 1 0.9999990463256836
- I-Disease 1 0.9998753070831299
telangiectasia I-Disease 1 0.9999481439590454
families O 0 0.000325007044011727
in O 0 6.952482362976298e-05
the O 0 9.765812137629837e-05
British O 0 0.0006501268362626433
Isles O 0 0.001563431229442358
: O 0 9.342809789814055e-05
expression O 0 7.351116801146418e-05
of O 0 5.371931547415443e-05
mutant O 0 0.0011375226313248277
ATM O 0 0.00027479842538014054
and O 0 3.454456600593403e-05
the O 0 6.831138307461515e-05
risk O 0 0.0018151738913729787
of O 0 0.15453797578811646
leukemia B-Disease 1 1.0
, O 1 0.9999061822891235
lymphoma B-Disease 1 1.0
, O 1 0.9951657056808472
and O 1 0.9983617663383484
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999979734420776
. O 0 0.20520690083503723

We O 0 0.0010144863044843078
report O 0 0.00046472795656882226
the O 0 0.00017737031157594174
spectrum O 0 0.0002245173673145473
of O 0 9.108649828704074e-05
59 O 0 0.0002804611867759377
ATM O 0 0.00041291164234280586
mutations O 0 0.00010932536679320037
observed O 0 7.530412403866649e-05
in O 0 0.0001226137683261186
ataxia B-Disease 1 0.9999879598617554
- I-Disease 1 0.9991282820701599
telangiectasia I-Disease 1 0.9999942779541016
( O 1 0.5098468065261841
A B-Disease 1 0.9996625185012817
- I-Disease 1 0.9999685287475586
T I-Disease 1 0.999962568283081
) O 0 0.0001344765623798594
patients O 0 0.00024749580188654363
in O 0 5.25808718521148e-05
the O 0 0.00010647200542734936
British O 0 0.0004779543087352067
Isles O 0 0.003028254024684429
. O 0 0.0014586684992536902

Of O 0 0.001388821634463966
51 O 0 0.0016433937707915902
ATM O 0 0.003458918770775199
mutations O 0 0.0002796099870465696
identified O 0 0.00012505076301749796
in O 0 3.5978278901893646e-05
families O 0 4.238319888827391e-05
native O 0 4.396938675199635e-05
to O 0 1.9069793779635802e-05
the O 0 3.078185181948356e-05
British O 0 7.885321974754333e-05
Isles O 0 0.00019823333423119038
, O 0 3.938087320420891e-05
11 O 0 6.034304169588722e-05
were O 0 3.633341475506313e-05
founder O 0 0.001784855150617659
mutations O 0 8.761429489823058e-05
, O 0 2.5407069188077003e-05
and O 0 1.7534001017338596e-05
2 O 0 2.23110691877082e-05
of O 0 2.029672214121092e-05
these O 0 1.564884587423876e-05
11 O 0 8.134802192216739e-05
conferred O 0 0.00025944082881323993
a O 0 0.00017300189938396215
milder O 0 0.0060854945331811905
clinical O 0 0.03792848438024521
phenotype O 0 0.010926671326160431
with O 0 9.466325718676671e-05
respect O 0 0.00016219064127653837
to O 0 0.0001058762936736457
both O 0 0.000721986114513129
cerebellar B-Disease 1 0.9999967813491821
degeneration I-Disease 1 0.9999991655349731
and O 0 0.06755056977272034
cellular O 0 0.4884282052516937
features O 0 0.0015418932307511568
. O 0 0.0011153521481901407

We O 0 0.0004970123409293592
report O 0 0.0001623103889869526
, O 0 6.173802830744535e-05
in O 0 3.108862802037038e-05
two O 0 3.9223792555276304e-05
A B-Disease 0 0.027822397649288177
- I-Disease 1 0.806592583656311
T I-Disease 1 0.8891181349754333
families O 0 5.789726128568873e-05
, O 0 3.139628461212851e-05
an O 0 4.4111762690590695e-05
ATM O 0 0.00030586315551772714
mutation O 0 0.00016711870557628572
( O 0 0.0001619704271433875
7271T O 1 0.8790522813796997
- O 0 0.3181411325931549
- O 0 0.308350145816803
> O 0 0.06205017864704132
G O 0 0.006596908438950777
) O 0 3.40994301950559e-05
that O 0 1.8742701286100782e-05
may O 0 1.9035198420169763e-05
be O 0 1.1493796591821592e-05
associated O 0 1.662043905525934e-05
with O 0 1.2437883015081752e-05
an O 0 3.7307047023205087e-05
increased O 0 0.00017344240040984005
risk O 0 0.005094561260193586
of O 0 0.11543241888284683
breast B-Disease 1 0.9999982118606567
cancer I-Disease 1 0.9999257326126099
in O 0 0.00023122341372072697
both O 0 0.00014965818263590336
homozygotes O 1 0.9866264462471008
and O 0 0.00024450026103295386
heterozygotes O 0 0.2832137644290924
( O 0 7.99283807282336e-05
relative O 0 7.853953138692304e-05
risk O 0 5.739049447583966e-05
12 O 0 4.0769857150735334e-05
. O 0 2.0070290702278726e-05
7 O 0 5.099286499898881e-05
; O 0 4.2300020140828565e-05
P O 0 0.0003123727219644934
= O 0 0.00017443037359043956
. O 0 4.20060932810884e-05
0025 O 0 0.008174460381269455
) O 0 4.3084495700895786e-05
, O 0 2.5300923880422488e-05
although O 0 1.8009126506512985e-05
there O 0 1.2470176443457603e-05
is O 0 1.5224920389300678e-05
a O 0 3.628362901508808e-05
less O 0 7.271149661391973e-05
severe O 1 0.9992067217826843
A B-Disease 1 0.9993649125099182
- I-Disease 1 0.9999706745147705
T I-Disease 1 0.9999146461486816
phenotype O 0 0.0005275789881125093
in O 0 2.411863715678919e-05
terms O 0 2.5131292204605415e-05
of O 0 3.305298741906881e-05
the O 0 7.445270603056997e-05
degree O 0 0.005683346651494503
of O 1 0.8081375360488892
cerebellar B-Disease 1 0.9999996423721313
degeneration I-Disease 1 0.9999998807907104
. O 1 0.5042177438735962

This O 0 0.0009569756803102791
mutation O 0 0.0012293881736695766
( O 0 0.0006172044668346643
7271T O 1 0.9828238487243652
- O 1 0.9245861172676086
- O 1 0.906761646270752
> O 0 0.3282408118247986
G O 0 0.0038030340801924467
) O 0 4.936517871101387e-05
also O 0 3.15968063659966e-05
allows O 0 2.612246862554457e-05
expression O 0 2.4522350940969773e-05
of O 0 2.522998875065241e-05
full O 0 5.443321788334288e-05
- O 0 0.00018616557645145804
length O 0 4.7767844080226496e-05
ATM O 0 9.881378355203196e-05
protein O 0 2.755071545834653e-05
at O 0 3.329265382490121e-05
a O 0 2.6021027224487625e-05
level O 0 3.0228289688238874e-05
comparable O 0 5.3914132877252996e-05
with O 0 2.5570072466507554e-05
that O 0 2.721944110817276e-05
in O 0 7.87307508289814e-05
unaffected O 0 0.001218430115841329
individuals O 0 0.0003242335806135088
. O 0 0.0008090031915344298

In O 0 0.0005233098636381328
addition O 0 0.00025497289607301354
, O 0 6.790921179344878e-05
we O 0 3.3972133678616956e-05
have O 0 2.0626570403692313e-05
studied O 0 6.917987047927454e-05
18 O 0 0.00013535753532778472
A B-Disease 1 0.8784125447273254
- I-Disease 1 0.9998096823692322
T I-Disease 1 0.9999425411224365
patients O 0 0.011008881963789463
, O 0 3.10773029923439e-05
in O 0 2.1855854356545024e-05
15 O 0 3.000146898557432e-05
families O 0 3.492176620056853e-05
, O 0 2.9866159820812754e-05
who O 0 0.00014132763317320496
developed O 0 0.16451296210289001
leukemia B-Disease 1 0.9999991655349731
, O 1 0.7114125490188599
lymphoma B-Disease 1 1.0
, O 1 0.61285001039505
preleukemic O 1 0.9999955892562866
T O 1 0.9999499320983887
- O 1 0.7902109622955322
cell O 0 0.20011824369430542
proliferation O 1 0.8102898001670837
, O 0 0.020448343828320503
or O 1 0.9658530950546265
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.03430895507335663
mostly O 0 0.0005252327537164092
in O 0 0.0005939656402915716
childhood O 1 0.9721355438232422
. O 0 0.0022871820256114006

A O 0 0.0020500801037997007
wide O 0 0.0005972562357783318
variety O 0 0.00023202817828860134
of O 0 0.00016887900710571557
ATM O 0 0.002736148191615939
mutation O 0 0.0002284600486746058
types O 0 6.0242429753998294e-05
, O 0 4.4166565203340724e-05
including O 0 3.869016290991567e-05
missense O 0 0.0006715856143273413
mutations O 0 8.083139982772991e-05
and O 0 3.251863017794676e-05
in O 0 5.238298399490304e-05
- O 0 0.005060456693172455
frame O 0 0.0010995498159900308
deletions O 0 0.00031894867424853146
, O 0 5.637974027195014e-05
were O 0 4.135195558774285e-05
seen O 0 0.00010809613741002977
in O 0 6.795792432967573e-05
these O 0 9.668112761573866e-05
patients O 0 0.004723473452031612
. O 0 0.0007335955742746592

We O 0 0.0006807978497818112
also O 0 0.00015901285223662853
show O 0 0.00010230707994196564
that O 0 2.3233627871377394e-05
25 O 0 3.0279357815743424e-05
% O 0 2.2669497411698103e-05
of O 0 2.6940817406284623e-05
all O 0 3.663227107608691e-05
A B-Disease 1 0.5492348074913025
- I-Disease 1 0.99710613489151
T I-Disease 1 0.9992635846138
patients O 0 0.0024528075009584427
carried O 0 6.133838905952871e-05
in O 0 5.8245252148481086e-05
- O 0 0.0015769536839798093
frame O 0 0.001428327290341258
deletions O 0 0.000700680015143007
or O 0 6.279350054683164e-05
missense O 0 0.0010921717621386051
mutations O 0 7.84122385084629e-05
, O 0 1.807554144761525e-05
many O 0 1.0167272193939425e-05
of O 0 2.4905946702347137e-05
which O 0 2.0698964362964034e-05
were O 0 1.941321897902526e-05
also O 0 2.8880105674033985e-05
associated O 0 3.922162431990728e-05
with O 0 3.965673386119306e-05
expression O 0 0.00016936342581175268
of O 0 0.00022245179570745677
mutant O 0 0.041441239416599274
ATM O 0 0.0034211333841085434
protein O 0 0.000766615616157651
. O 0 0.0008442308171652257

The O 0 0.003088250057771802
DMPK O 1 0.9970710277557373
gene O 0 0.0017467312281951308
of O 0 0.017026280984282494
severely O 1 0.9999768733978271
affected O 1 0.9999836683273315
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999973773956299
is O 1 0.9643740057945251
hypermethylated O 1 0.9999889135360718
proximal O 1 0.9994378685951233
to O 0 0.00021247081167530268
the O 0 0.0002788363490253687
largely O 0 0.0006004201713949442
expanded O 0 0.0014054498169571161
CTG O 1 0.7194324135780334
repeat O 0 0.004786207340657711
. O 0 0.0014318001922219992

Using O 0 0.0013408028753474355
methylation O 0 0.0016734463861212134
- O 0 0.0015851695789024234
sensitive O 0 0.0006097429431974888
restriction O 0 0.0003572808054741472
enzymes O 0 0.00017403728270437568
, O 0 6.910238153068349e-05
we O 0 4.292042285669595e-05
characterized O 0 0.00010949604620691389
the O 0 4.82203540741466e-05
methylation O 0 0.00011016076314263046
pattern O 0 0.0001149631934822537
on O 0 4.133113907300867e-05
the O 0 4.309193536755629e-05
5 O 0 4.7970166633604094e-05
side O 0 5.6205270084319636e-05
of O 0 4.424177313921973e-05
the O 0 8.277138840639964e-05
CTG O 0 0.27735379338264465
repeat O 0 0.00031084008514881134
in O 0 5.082779534859583e-05
the O 0 9.79536707745865e-05
DMPK O 1 0.9186403751373291
gene O 0 7.984406693140045e-05
of O 0 4.791868195752613e-05
normal O 0 5.946339661022648e-05
individuals O 0 3.20944600389339e-05
and O 0 4.878659819951281e-05
of O 0 0.00036719394847750664
patients O 1 0.9834790229797363
affected O 1 0.7198340892791748
with O 1 0.9751449227333069
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.07264595478773117
showing O 0 0.009457739070057869
expansions O 0 0.002144048921763897
of O 0 0.0003137339372187853
the O 0 0.00046426348853856325
repetitive O 0 0.06255349516868591
sequence O 0 0.0005798639613203704
. O 0 0.0009600821067579091

The O 0 0.0016328932251781225
gene O 0 0.0008829448488540947
segment O 0 0.0006137320888228714
analyzed O 0 0.00024589174427092075
corresponds O 0 0.00017502930131740868
to O 0 5.126063115312718e-05
the O 0 0.00013355366536416113
genomic O 0 0.0004482752119656652
SacI O 0 0.28543421626091003
- O 0 0.0013140980154275894
HindIII O 0 0.013576062396168709
fragment O 0 0.0005725176306441426
carrying O 0 0.0003252906317356974
exons O 0 0.0006627403199672699
11 O 0 0.0004926850670017302
- O 0 0.0009742535767145455
15 O 0 0.000797294604126364
. O 0 0.0012081859167665243

There O 0 0.001209259033203125
is O 0 0.0004806780780199915
constitutive O 0 0.0012451433576643467
methylation O 0 0.00031198462238535285
in O 0 8.735700976103544e-05
intron O 0 0.0009870025096461177
12 O 0 9.586691157892346e-05
at O 0 5.978287663310766e-05
restriction O 0 5.6334753026021644e-05
sites O 0 4.3048807128798217e-05
of O 0 5.9362206229707226e-05
SacII O 0 0.1827259659767151
and O 0 9.474253602093086e-05
HhaI O 0 0.156805157661438
, O 0 7.6011594501324e-05
localized O 0 0.00016000391042325646
1 O 0 4.1563191189197823e-05
, O 0 4.501230068854056e-05
159 O 0 0.00013938611664343625
- O 0 0.0001321787858614698
1 O 0 6.155661685625091e-05
, O 0 4.436844028532505e-05
232 O 0 0.00016291168867610395
bp O 0 0.00018106210336554796
upstream O 0 0.0001144707202911377
of O 0 6.106782529968768e-05
the O 0 9.824254811974242e-05
CTG O 1 0.9299959540367126
repeat O 0 0.0007866596570238471
, O 0 4.5819229853805155e-05
whereas O 0 3.446079426794313e-05
most O 0 1.3983506505610421e-05
, O 0 1.975340819626581e-05
if O 0 1.133413752540946e-05
not O 0 7.226919478853233e-06
all O 0 6.200825737323612e-06
, O 0 1.0758946700661909e-05
of O 0 1.2602161405084189e-05
the O 0 1.6287614926113747e-05
other O 0 9.7994970928994e-06
sites O 0 2.20008132600924e-05
of O 0 3.947630466427654e-05
SacII O 1 0.8967375755310059
, O 0 0.00013244526053313166
HhaI O 1 0.9318909049034119
, O 0 8.53239544085227e-05
and O 0 6.0489732277346775e-05
HpaII O 0 0.04082847386598587
in O 0 4.549130244413391e-05
this O 0 2.8313237635302357e-05
region O 0 5.2964751375839114e-05
are O 0 2.2536245523951948e-05
unmethylated O 0 0.001649018144235015
, O 0 5.3490817663259804e-05
in O 0 3.328090679133311e-05
normal O 0 4.938636993756518e-05
individuals O 0 2.56077491940232e-05
and O 0 3.259522418375127e-05
most O 0 4.400899342726916e-05
of O 0 0.00011257656296947971
the O 0 0.0005025627906434238
patients O 0 0.3391978442668915
. O 0 0.0012256299378350377

In O 0 0.0003408749180380255
a O 0 0.00025028648087754846
number O 0 6.593106809305027e-05
of O 0 0.00010430907423142344
young O 0 0.03902970626950264
and O 0 0.001518882461823523
severely O 1 0.9976270794868469
affected O 0 0.443021297454834
patients O 1 0.9268667101860046
, O 0 0.00011569604248506948
however O 0 4.53855718660634e-05
, O 0 3.2802279747556895e-05
complete O 0 7.228618778754026e-05
methylation O 0 4.4030904973624274e-05
of O 0 2.9207374609541148e-05
these O 0 1.5841733329580165e-05
restriction O 0 4.337732752901502e-05
sites O 0 2.9758350137853995e-05
was O 0 5.3416501032188535e-05
found O 0 3.5983219277113676e-05
in O 0 4.5430999307427555e-05
the O 0 0.00014623746392317116
mutated O 0 0.0015315571799874306
allele O 0 0.0015045315958559513
. O 0 0.001168687827885151

In O 0 0.0004071210860274732
most O 0 0.00012477692507673055
of O 0 0.00011716689186869189
these O 0 5.146006878931075e-05
patients O 0 0.001723747351206839
, O 0 6.357212987495586e-05
the O 0 0.00011600626021390781
onset O 1 0.9996986389160156
of O 0 0.27671483159065247
the O 1 0.998963475227356
disease O 1 0.9999998807907104
was O 1 0.9999725818634033
congenital O 1 0.9999998807907104
. O 0 0.47114261984825134

Preliminary O 0 0.0032439196947962046
in O 0 0.0008691147668287158
vivo O 0 0.0045151556842029095
footprinting O 0 0.06148361414670944
data O 0 0.00016653348575346172
gave O 0 0.00014162632578518242
evidence O 0 6.906346243340522e-05
for O 0 4.022839493700303e-05
protein O 0 6.908427167218179e-05
- O 0 0.00017706191283650696
DNA O 0 6.347042653942481e-05
contact O 0 3.43804458680097e-05
in O 0 2.264953036501538e-05
normal O 0 3.8421800127252936e-05
genes O 0 3.2597556128166616e-05
at O 0 5.2768333262065426e-05
an O 0 5.6096356274792925e-05
Sp1 O 0 0.0068111298605799675
consensus O 0 8.507152961101383e-05
binding O 0 5.342342774383724e-05
site O 0 6.276595377130434e-05
upstream O 0 0.0001004306977847591
of O 0 4.737855488201603e-05
the O 0 7.261317659867927e-05
CTG O 1 0.6272104978561401
repeat O 0 0.00021115568233653903
and O 0 2.926054185081739e-05
for O 0 2.0486870198510587e-05
a O 0 3.3146039640996605e-05
significant O 0 4.076604818692431e-05
reduction O 0 6.592176214326173e-05
of O 0 2.5952724172384478e-05
this O 0 2.0616342226276174e-05
interaction O 0 4.955473923473619e-05
in O 0 2.7315993065712973e-05
cells O 0 9.367038728669286e-05
with O 0 8.412782335653901e-05
a O 0 0.0003426983021199703
hypermethylated O 1 0.9982969164848328
DMPK O 1 0.999646782875061
gene O 0 0.000941009318921715
. O 0 0.00042288220720365644
. O 0 0.0007119952933862805

The O 0 0.009506340138614178
hemochromatosis B-Disease 1 0.9999914169311523
gene O 0 0.0014789086999371648
product O 0 0.00042814924381673336
complexes O 0 0.00038329378003254533
with O 0 7.513169111916795e-05
the O 0 0.00015364617865998298
transferrin O 1 0.8300528526306152
receptor O 0 0.0005009087035432458
and O 0 0.00010530619329074398
lowers O 0 0.0006309566088020802
its O 0 7.455431477865204e-05
affinity O 0 0.0003055306151509285
for O 0 0.00016183378465939313
ligand O 0 0.0009717746288515627
binding O 0 0.0006830302299931645
. O 0 0.0010309037752449512

We O 0 0.0013791988603770733
recently O 0 0.0009125341894105077
reported O 0 0.0002645930799189955
the O 0 0.00013502906949725002
positional O 0 0.0006817795801907778
cloning O 0 0.0002363903768127784
of O 0 7.8601275163237e-05
a O 0 0.00013301832950673997
candidate O 0 0.0003438115818426013
gene O 0 0.0005626381025649607
for O 0 0.000595014716964215
hereditary B-Disease 1 0.9999855756759644
hemochromatosis I-Disease 1 0.9999998807907104
called O 1 0.9982900023460388
HFE O 1 0.9999512434005737
. O 0 0.00458694389089942

The O 0 0.0010001775808632374
gene O 0 0.000571262848097831
product O 0 0.00027111402596347034
, O 0 8.726667874725536e-05
a O 0 8.093598444247618e-05
member O 0 6.337086961138994e-05
of O 0 5.340294956113212e-05
the O 0 8.691811672179028e-05
major O 0 0.0056375605054199696
histocompatibility O 1 0.9999270439147949
complex O 0 0.014681784436106682
class O 0 0.08058689534664154
I O 0 0.07087607681751251
- O 0 0.008823065087199211
like O 0 6.244833639357239e-05
family O 0 7.924179953988642e-05
, O 0 3.074579217354767e-05
was O 0 4.899733903585002e-05
found O 0 1.8193799405707978e-05
to O 0 1.1123145668534562e-05
have O 0 1.2652341865759809e-05
a O 0 3.5333265259396285e-05
mutation O 0 7.612998160766438e-05
, O 0 8.077207166934386e-05
Cys O 0 0.01735898293554783
- O 0 0.0009935455163940787
282 O 0 0.011646022088825703
- O 0 0.36798757314682007
- O 1 0.5619351863861084
> O 1 0.5952893495559692
Tyr O 1 0.9971780776977539
( O 0 0.0002837489009834826
C282Y O 0 0.021873915567994118
) O 0 6.85358390910551e-05
, O 0 3.3922824513865635e-05
in O 0 3.395205203560181e-05
85 O 0 0.00013582169776782393
% O 0 9.209904237650335e-05
of O 0 0.0002890123287215829
patient O 0 0.07156030833721161
chromosomes O 0 0.0021707024425268173
. O 0 0.001485704444348812

This O 0 0.0014787671389058232
mutation O 0 0.0014439909718930721
eliminates O 0 0.0011462158290669322
the O 0 0.00024142077018041164
ability O 0 0.00013800844317302108
of O 0 0.00011613066453719512
HFE O 0 0.4015335440635681
to O 0 6.683949322905391e-05
associate O 0 0.00023744729696772993
with O 0 0.0001383499475196004
beta2 O 1 0.9879587888717651
- O 1 0.6046476364135742
microglobulin O 1 0.9965806603431702
( O 0 0.0014721109764650464
beta2m O 1 0.6949240565299988
) O 0 0.00014065140567254275
and O 0 0.00016001518815755844
prevents O 0 0.0021670227870345116
cell O 0 0.002250977559015155
- O 0 0.00481634633615613
surface O 0 0.0010733818635344505
expression O 0 0.0011911403853446245
. O 0 0.0010905057424679399

A O 0 0.0029498417861759663
second O 0 0.0013518916675820947
mutation O 0 0.00043341348646208644
that O 0 6.7210836277809e-05
has O 0 4.307775816414505e-05
no O 0 5.0217899115523323e-05
effect O 0 9.962147305486724e-05
on O 0 8.154015813488513e-05
beta2m O 1 0.9360124468803406
association O 0 0.0017476793145760894
, O 0 0.00017290787945967168
H63D O 1 0.9857565760612488
, O 0 7.697282126173377e-05
was O 0 8.854854240780696e-05
found O 0 2.8740014386130497e-05
in O 0 1.8526856365497224e-05
eight O 0 3.143900539726019e-05
out O 0 3.089928941335529e-05
of O 0 5.139332643011585e-05
nine O 0 0.00016310536011587828
patients O 0 0.002013004384934902
heterozygous O 0 0.00027290082653053105
for O 0 9.016372496262193e-05
the O 0 0.00031786435283720493
C282Y O 1 0.9196784496307373
mutant O 0 0.037148039788007736
. O 0 0.0019040892366319895

In O 0 0.0007480243220925331
this O 0 0.00017141277203336358
report O 0 0.00015230332792270929
, O 0 6.974129792070016e-05
we O 0 5.2494648116407916e-05
demonstrate O 0 0.00010202045814367011
in O 0 6.650379509665072e-05
cultured O 0 0.0005728467949666083
293 O 0 0.0032172775827348232
cells O 0 0.000780892267357558
overexpressing O 0 0.14715729653835297
wild O 0 0.0005071295308880508
- O 0 0.013485552743077278
type O 0 0.0008220764575526118
or O 0 0.00015696229820605367
mutant O 0 0.0065852561965584755
HFE O 1 0.538385272026062
proteins O 0 3.998697138740681e-05
that O 0 1.9362003513379022e-05
both O 0 2.0551917259581387e-05
the O 0 3.892475797329098e-05
wild O 0 0.00016788531502243131
- O 0 0.008980882354080677
type O 0 0.0037651776801794767
and O 0 0.0004213764041196555
H63D O 1 0.9999339580535889
HFE O 1 0.9993857145309448
proteins O 0 0.00013530696742236614
form O 0 9.832566865952685e-05
stable O 0 0.0003130862023681402
complexes O 0 0.000275884463917464
with O 0 5.6564131227787584e-05
the O 0 0.0002675307623576373
transferrin O 1 0.9945317506790161
receptor O 0 0.0034249327145516872
( O 0 0.0006887918571010232
TfR O 1 0.9437010884284973
) O 0 0.0005648874212056398
. O 0 0.0008714690338820219

The O 0 0.0032660006545484066
C282Y O 1 0.9782125353813171
mutation O 0 0.005424694158136845
nearly O 0 0.000731819192878902
completely O 0 0.0007765408372506499
prevents O 0 0.0005394192412495613
the O 0 0.00014782986545469612
association O 0 0.00019121295190416276
of O 0 0.00013957310875412077
the O 0 0.0002977514232043177
mutant O 0 0.37177345156669617
HFE O 1 0.9967309236526489
protein O 0 0.000248332362389192
with O 0 0.00014183632447384298
the O 0 0.0005694582359865308
TfR O 1 0.9954131245613098
. O 0 0.0017880864907056093

Studies O 0 0.000870801683049649
on O 0 0.00039486761670559645
cell O 0 0.0010559341171756387
- O 0 0.0012835952220484614
associated O 0 0.00017549072799738497
transferrin O 0 0.0018308251164853573
at O 0 9.077572758542374e-05
37 O 0 0.0001125997441704385
degrees O 0 6.882572051836178e-05
C O 0 0.00011458233348093927
suggest O 0 4.723004894913174e-05
that O 0 2.456816037010867e-05
the O 0 4.117072239750996e-05
overexpressed O 0 0.0008830037550069392
wild O 0 0.0002809026918839663
- O 0 0.004124234896153212
type O 0 0.0011590420035645366
HFE O 1 0.8701048493385315
protein O 0 0.00011772976722568274
decreases O 0 0.00012398547551129013
the O 0 6.564561044797301e-05
affinity O 0 0.0001444363297196105
of O 0 0.00014634084072895348
the O 0 0.0003609621780924499
TfR O 1 0.9732353091239929
for O 0 0.0008503193384967744
transferrin O 1 0.6609570384025574
. O 0 0.0018127112416550517

The O 0 0.002559051616117358
overexpressed O 1 0.5035598278045654
H63D O 1 0.99679034948349
protein O 0 0.0002732606662902981
does O 0 7.283766899490729e-05
not O 0 2.430879249004647e-05
have O 0 1.2398862054396886e-05
this O 0 1.5086572602740489e-05
effect O 0 2.948884866782464e-05
, O 0 1.9919916667276993e-05
providing O 0 2.607515489216894e-05
the O 0 2.1782483599963598e-05
first O 0 3.1998224585549906e-05
direct O 0 3.228789137210697e-05
evidence O 0 4.147319486946799e-05
for O 0 3.189968992955983e-05
a O 0 7.775305130053312e-05
functional O 0 0.00016878466703929007
consequence O 0 0.0003589233965612948
of O 0 0.00019371695816516876
the O 0 0.0007328094798140228
H63D O 1 0.9996389150619507
mutation O 0 0.019237399101257324
. O 0 0.0018429268384352326

Addition O 0 0.001190708251670003
of O 0 0.0006954541313461959
soluble O 0 0.004310866817831993
wild O 0 0.0016980076907202601
- O 1 0.5058295726776123
type O 1 0.8294757008552551
HFE O 1 0.9999877214431763
/ O 1 0.9967708587646484
beta2m O 1 0.9984229803085327
heterodimers O 1 0.7210935354232788
to O 0 0.00014078493404667825
cultured O 0 0.0064529371447861195
cells O 0 0.0002921801060438156
also O 0 4.947574052494019e-05
decreased O 0 0.00011391688894946128
the O 0 5.4969681514194235e-05
apparent O 0 0.00020690976816695184
affinity O 0 9.929446969181299e-05
of O 0 4.6252927859313786e-05
the O 0 7.021830242592841e-05
TfR O 0 0.38894572854042053
for O 0 3.200154969817959e-05
its O 0 3.1200899684336036e-05
ligand O 0 0.00015945771883707494
under O 0 7.832480332581326e-05
steady O 0 0.00044248643098399043
- O 0 0.00025257898960262537
state O 0 5.140200300957076e-05
conditions O 0 6.197527545737103e-05
, O 0 2.808337376336567e-05
both O 0 2.5029739845194854e-05
in O 0 4.309575160732493e-05
293 O 0 0.001761964289471507
cells O 0 0.00030722623341716826
and O 0 0.00012075437552994117
in O 0 0.00024913629749789834
HeLa O 1 0.9993395209312439
cells O 0 0.00360585143789649
. O 0 0.0011177239939570427

Furthermore O 0 0.0017293014097958803
, O 0 0.0003196104080416262
at O 0 0.0001536023773951456
4 O 0 0.0001456610334571451
degrees O 0 0.0001558114163344726
C O 0 0.00022258286480791867
, O 0 6.907044735271484e-05
the O 0 7.012984133325517e-05
added O 0 0.00013854852295480669
soluble O 0 0.00027191443950869143
complex O 0 0.00021687711705453694
of O 0 0.0003946352517232299
HFE O 1 0.9997639060020447
/ O 1 0.5529850721359253
beta2m O 1 0.6905548572540283
inhibited O 0 0.0012179994955658913
binding O 0 0.00017904913693200797
of O 0 0.00017070959438569844
transferrin O 0 0.02352353371679783
to O 0 0.0001656156382523477
HeLa O 1 0.9843621253967285
cell O 0 0.0010213222121819854
TfR O 0 0.25922584533691406
in O 0 8.863455150276423e-05
a O 0 0.0002190601226175204
concentration O 0 0.05793304741382599
- O 0 0.030926959589123726
dependent O 0 0.0008664794731885195
manner O 0 0.0011229823576286435
. O 0 0.0007517195190303028

Scatchard O 0 0.01277104951441288
plots O 0 0.001410021330229938
of O 0 0.00032905576517805457
these O 0 7.10953027009964e-05
data O 0 6.127046071924269e-05
indicate O 0 5.946878081886098e-05
that O 0 3.479205770418048e-05
the O 0 5.9929458075203e-05
added O 0 0.00016469063120894134
heterodimer O 0 0.0040967026725411415
substantially O 0 0.00017395152826793492
reduced O 0 8.577991684433073e-05
the O 0 8.891144534572959e-05
affinity O 0 0.00020856504852417856
of O 0 0.00035762463812716305
TfR O 1 0.98752361536026
for O 0 0.000817978463601321
transferrin O 1 0.871282160282135
. O 0 0.0019963595550507307

These O 0 0.00045129109639674425
results O 0 0.00029316454310901463
establish O 0 0.00027923728339374065
a O 0 0.00018635985907167196
molecular O 0 0.0002098706754622981
link O 0 0.0002288568502990529
between O 0 0.0001076327680493705
HFE O 1 0.9796924591064453
and O 0 6.182055949466303e-05
a O 0 6.408297485904768e-05
key O 0 7.348089275183156e-05
protein O 0 4.5393710024654865e-05
involved O 0 4.985891791875474e-05
in O 0 4.45106670667883e-05
iron O 1 0.9767951965332031
transport O 0 0.0005834291223436594
, O 0 6.667346315225586e-05
the O 0 9.747427247930318e-05
TfR O 1 0.9865484833717346
, O 0 4.169988460489549e-05
and O 0 2.5419429221074097e-05
raise O 0 3.565839506336488e-05
the O 0 2.8109845516155474e-05
possibility O 0 5.332132786861621e-05
that O 0 2.2834223273093812e-05
alterations O 0 0.00010486986866453663
in O 0 2.255985418742057e-05
this O 0 2.065617445623502e-05
regulatory O 0 5.845849227625877e-05
mechanism O 0 7.448153337463737e-05
may O 0 2.5538294721627608e-05
play O 0 2.2168924260768108e-05
a O 0 4.941194492857903e-05
role O 0 7.745348557364196e-05
in O 0 5.24262577528134e-05
the O 0 0.00015875922690611333
pathogenesis O 1 0.9858150482177734
of O 0 0.1883181482553482
hereditary B-Disease 1 0.9999991655349731
hemochromatosis I-Disease 1 1.0
. O 0 0.3401939868927002
. O 0 0.0033197985030710697

Genomic O 0 0.0039896657690405846
organization O 0 0.001109285862185061
of O 0 0.00040400386205874383
the O 0 0.0007397910812869668
UBE3A O 1 0.9998248219490051
/ O 1 0.9879521727561951
E6 O 1 0.9995020627975464
- O 0 0.4819888472557068
AP O 0 0.0033479754347354174
gene O 0 0.0004086735425516963
and O 0 0.0002026193542405963
related O 0 0.0005945184384472668
pseudogenes O 0 0.0070473491214215755
. O 0 0.0013106350088492036

The O 0 0.00478581665083766
UBE3A O 1 0.5702382922172546
gene O 0 0.0013738202396780252
encodes O 0 0.0008744109072722495
the O 0 0.0004062773077748716
E6 O 1 0.8520830869674683
- O 0 0.044310443103313446
AP O 0 0.0040667373687028885
ubiquitin O 0 0.06596948206424713
- O 0 0.002524541923776269
protein O 0 0.00016613189654890448
ligase O 0 0.000953062204644084
and O 0 4.2814866901608184e-05
has O 0 3.84777486033272e-05
recently O 0 5.9273006627336144e-05
been O 0 2.629964001243934e-05
shown O 0 3.4256729122716933e-05
to O 0 2.1009005649830215e-05
be O 0 4.9267073336523026e-05
mutated O 0 0.008594377897679806
in O 0 0.25973695516586304
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999910593032837
who O 1 0.7524318099021912
lack O 1 0.9919147491455078
15q11 O 1 0.9999862909317017
- O 1 0.9973735809326172
q13 O 1 0.9990422129631042
deletions O 0 0.006557038985192776
or O 0 0.00026934919878840446
chromosome O 0 0.0009629434207454324
15 O 0 0.0006579140317626297
paternal O 0 0.31945955753326416
uniparental B-Disease 1 0.999869704246521
disomy I-Disease 1 0.9989736080169678
. O 0 0.0032381771598011255

Previous O 0 0.004184459336102009
UBE3A O 1 0.8414308428764343
cDNA O 0 0.00315574137493968
analysis O 0 0.00025851515238173306
has O 0 0.00010844096686923876
shown O 0 0.00011836351040983573
a O 0 0.00011599032586673275
coding O 0 0.0001896960602607578
region O 0 0.00013054242299403995
of O 0 0.00011824009561678395
approximately O 0 0.00039622775511816144
2 O 0 0.0005491283955052495
. O 0 0.0008731837733648717

6 O 0 0.002711620181798935
kb O 0 0.0029025492258369923
and O 0 0.0002602775057312101
a O 0 0.00022935401648283005
3 O 0 0.00016125339607242495
- O 0 0.0004175262583885342
untranslated O 0 0.001153898541815579
region O 0 0.0002324599918210879
( O 0 0.00013518212654162198
UTR O 0 0.0016667679883539677
) O 0 5.567130574490875e-05
of O 0 8.4085957496427e-05
< O 0 0.00038201158167794347
50 O 0 0.00010235790250590071
bp O 0 0.00029083553818054497
, O 0 4.739197174785659e-05
whereas O 0 4.391307447804138e-05
Northern O 0 4.272094156476669e-05
analysis O 0 2.644888991198968e-05
has O 0 2.5202265533152968e-05
indicated O 0 4.9140107876155525e-05
mRNA O 0 5.183300163480453e-05
sizes O 0 3.4028063964797184e-05
of O 0 4.011660348623991e-05
5 O 0 0.00013264620793052018
- O 0 0.00048093448276631534
8 O 0 0.0005734455189667642
kb O 0 0.003871532855555415
. O 0 0.0012383318971842527

We O 0 0.0008528136531822383
have O 0 0.00015889493806753308
analyzed O 0 0.0002126281033270061
additional O 0 0.00013633916387334466
cDNA O 0 0.0009390361956320703
clones O 0 0.0006007567280903459
and O 0 5.440987297333777e-05
provide O 0 5.63703833904583e-05
evidence O 0 7.075981557136402e-05
for O 0 4.0056816942524165e-05
an O 0 7.327656931011006e-05
additional O 0 0.00018629875557962805
0 O 0 0.0004670951166190207
. O 0 0.0007906812243163586

5 O 0 0.0011990712955594063
kb O 0 0.0018935393309220672
of O 0 0.0002466473379172385
5 O 0 0.00031475318246521056
- O 0 0.0011502956040203571
UTR O 0 0.006373434793204069
and O 0 0.00013212524936534464
> O 0 0.0004255095846019685
2 O 0 0.00013893043796997517
kb O 0 0.0004625349538400769
of O 0 0.0001300940930377692
3 O 0 0.0004185833386145532
- O 0 0.005036361515522003
UTR O 0 0.12174554914236069
. O 0 0.001276158494874835

We O 0 0.0006656363839283586
have O 0 0.0001547522988403216
established O 0 0.00019124755635857582
the O 0 0.00013880689220968634
genomic O 0 0.0002687873784452677
organization O 0 0.00016766582848504186
of O 0 0.00015609186084475368
UBE3A O 1 0.8813357353210449
and O 0 8.566400356357917e-05
the O 0 8.226133650168777e-05
sequence O 0 0.00011055844515794888
of O 0 0.0002290561533300206
intron O 1 0.8905137181282043
- O 0 0.10584863275289536
exon O 0 0.005425393581390381
borders O 0 0.0011994666419923306
. O 0 0.0012969421222805977

We O 0 0.0010856587905436754
have O 0 0.00020957173546776175
also O 0 0.00014968360483180732
mapped O 0 0.00021005846792832017
two O 0 8.826856355881318e-05
highly O 0 0.00018908732454292476
homologous O 0 0.0004388896923046559
processed O 0 0.00020509604655671865
pseudogenes O 0 0.0010131543967872858
, O 0 0.00016446906374767423
UBE3AP1 O 1 0.888783872127533
and O 0 0.0001370155659969896
UBE3AP2 O 1 0.8051080107688904
, O 0 4.4795666326535866e-05
to O 0 2.3848609998822212e-05
chromosomes O 0 5.752446304541081e-05
2 O 0 3.812280192505568e-05
and O 0 2.5973697120207362e-05
21 O 0 5.1201517635490745e-05
, O 0 3.336454392410815e-05
respectively O 0 4.427334715728648e-05
, O 0 4.362024264992215e-05
and O 0 5.054002031101845e-05
determined O 0 0.00012488024367485195
their O 0 0.00010245468001812696
genomic O 0 0.0006279539666138589
organization O 0 0.0006017062696628273
. O 0 0.001036477624438703

These O 0 0.0005148238269612193
results O 0 0.0003169371630065143
will O 0 8.600041473982856e-05
form O 0 4.794999404111877e-05
the O 0 4.749830623040907e-05
basis O 0 3.603562436182983e-05
for O 0 3.736872167792171e-05
studies O 0 7.776120764901862e-05
of O 0 0.0001117103747674264
mutation O 0 0.00043975026346743107
and O 0 0.00015870502102188766
imprinting O 0 0.012378081679344177
of O 0 0.0019295662641525269
UBE3A O 1 0.9992461204528809
. O 0 0.002313340315595269

Mutation O 0 0.006484562996774912
spectrum O 0 0.002348985057324171
and O 0 0.0006022352026775479
genotype O 0 0.020209239795804024
- O 0 0.02210402674973011
phenotype O 0 0.003787761554121971
analyses O 0 0.00029232611996121705
in O 0 0.0004424075596034527
Cowden B-Disease 1 0.9999958276748657
disease I-Disease 1 0.9999971389770508
and O 1 0.9078554511070251
Bannayan B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999992847442627
Zonana I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
, O 0 0.05648296698927879
two O 0 0.016926264390349388
hamartoma B-Disease 1 0.9999972581863403
syndromes I-Disease 1 0.9999960660934448
with O 1 0.7523625493049622
germline O 1 0.9999722242355347
PTEN O 1 0.9999691247940063
mutation O 0 0.4095771610736847
. O 0 0.0023900149390101433

The O 0 0.06088979169726372
tumour B-Disease 1 0.9999947547912598
suppressor O 1 0.9998098015785217
gene O 0 0.3183744549751282
PTEN O 1 0.9978207349777222
, O 0 0.000516089960001409
which O 0 0.00017463022959418595
maps O 0 0.0006248065619729459
to O 0 0.00041992063052020967
10q23 O 0 0.026727337390184402
. O 0 0.002017807215452194

3 O 0 0.0012570698745548725
and O 0 0.00044695587712340057
encodes O 0 0.0005238123703747988
a O 0 0.00017821401706896722
403 O 0 0.0006620799540542066
amino O 0 0.00013590202433988452
acid O 0 0.00022893147252034396
dual O 0 0.0002543384616728872
specificity O 0 0.0002639991289470345
phosphatase O 0 0.010205778293311596
( O 0 0.00013012411363888532
protein O 0 0.00012168673129053786
tyrosine O 0 0.00051410763990134
phosphatase O 0 0.0737839788198471
; O 0 0.00012503527977969497
PTPase O 1 0.7308441996574402
) O 0 7.570864545414224e-05
, O 0 7.000916957622394e-05
was O 0 7.16036738594994e-05
shown O 0 5.2657491323770955e-05
recently O 0 4.890733544016257e-05
to O 0 2.147818850062322e-05
play O 0 3.395904423086904e-05
a O 0 7.259912672452629e-05
broad O 0 0.00019873410928994417
role O 0 0.0002963066508527845
in O 0 0.00029476062627509236
human O 0 0.0055032819509506226
malignancy B-Disease 1 0.999717652797699
. O 0 0.002990403678268194

Somatic O 1 0.918521523475647
PTEN O 1 0.9918904304504395
deletions O 0 0.0031925360672175884
and O 0 0.0002486247103661299
mutations O 0 0.00019258340762462467
were O 0 6.405145541066304e-05
observed O 0 8.478725794702768e-05
in O 0 6.366610614350066e-05
sporadic B-Disease 0 0.24904929101467133
breast I-Disease 1 0.9999897480010986
, I-Disease 1 0.7765320539474487
brain I-Disease 1 0.9999903440475464
, I-Disease 1 0.9880207180976868
prostate I-Disease 1 1.0
and I-Disease 1 0.9999244213104248
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 1 0.9858245849609375
lines O 0 0.000653170223813504
and O 0 4.705898027168587e-05
in O 0 3.6402609111974016e-05
several O 0 3.820272468146868e-05
primary O 0 0.00043634872417896986
tumours B-Disease 1 0.9883087873458862
such O 0 0.0001050105711328797
as O 0 0.017569128423929214
endometrial B-Disease 1 0.9999986886978149
carcinomas I-Disease 1 0.9999997615814209
, O 1 0.9999629259109497
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999938011169434
thyroid B-Disease 1 1.0
tumours I-Disease 1 0.9999996423721313
. O 1 0.8711234927177429

In O 0 0.0015953978290781379
addition O 0 0.00109185092151165
, O 0 0.0007311914232559502
PTEN O 1 0.9836158156394958
was O 0 0.0005877670482732356
identified O 0 0.00011824619286926463
as O 0 7.607947190990672e-05
the O 0 9.117391891777515e-05
susceptibility O 0 0.0007872104761190712
gene O 0 0.00012384877481963485
for O 0 7.329019717872143e-05
two O 0 0.00032651665969751775
hamartoma B-Disease 1 0.9999992847442627
syndromes I-Disease 1 1.0
Cowden B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999996423721313
( O 1 0.7586708068847656
CD B-Disease 0 0.41714486479759216
; O 0 0.00027391695766709745
MIM O 1 0.9589184522628784
158350 O 0 0.08242276310920715
) O 0 0.00010568180005066097
and O 0 0.00014209515939000994
Bannayan B-Disease 1 0.8040755391120911
- I-Disease 0 0.05602431297302246
Zonana I-Disease 1 0.9710170030593872
( I-Disease 0 0.0005128878983668983
BZS I-Disease 0 0.08632172644138336
) I-Disease 0 0.00020014929759781808
or I-Disease 0 0.0001959627988981083
Ruvalcaba I-Disease 1 0.8854319453239441
- I-Disease 0 0.2333369106054306
Riley I-Disease 1 0.9921274185180664
- I-Disease 1 0.9980644583702087
Smith I-Disease 1 0.9991718530654907
syndrome I-Disease 1 0.9999997615814209
( O 1 0.9606274366378784
MIM O 1 0.9999904632568359
153480 O 1 0.9997703433036804
) O 0 0.0018239226192235947
. O 0 0.0015516062267124653

Constitutive O 0 0.01073218509554863
DNA O 0 0.0008440755191259086
from O 0 0.00021245094831101596
37 O 0 0.0004270670178811997
CD B-Disease 0 0.0004305365728214383
families O 0 0.00013000280887354165
and O 0 7.77290333644487e-05
seven O 0 0.00017184560419991612
BZS B-Disease 0 0.36686137318611145
families O 0 0.00020904347184114158
was O 0 0.00043816943070851266
screened O 0 0.0007593260379508138
for O 0 0.00035352501436136663
germline O 1 0.975663423538208
PTEN O 1 0.9984185695648193
mutations O 0 0.003872505621984601
. O 0 0.00195150391664356

PTEN O 1 0.9967982172966003
mutations O 0 0.0009036698029376566
were O 0 0.00013216353545431048
identified O 0 0.00010445429506944492
in O 0 3.65692721970845e-05
30 O 0 4.48196406068746e-05
of O 0 5.28096170455683e-05
37 O 0 0.00010669174662325531
( O 0 5.8338759117759764e-05
81 O 0 0.00012840196723118424
% O 0 3.49286274285987e-05
) O 0 4.0835613617673516e-05
CD B-Disease 0 0.00010318926069885492
families O 0 4.5643304474651814e-05
, O 0 3.1667150324210525e-05
including O 0 2.8866752472822554e-05
missense O 0 0.00021206989185884595
and O 0 5.417140346253291e-05
nonsense O 0 0.0005235276184976101
point O 0 9.814076474867761e-05
mutations O 0 9.371059422846884e-05
, O 0 6.37575431028381e-05
deletions O 0 0.00023418493219651282
, O 0 6.873363599879667e-05
insertions O 0 0.0003603350487537682
, O 0 6.651057628914714e-05
a O 0 0.0001578062801854685
deletion O 0 0.0010739333229139447
/ O 0 0.002309634583070874
insertion O 0 0.0010676388628780842
and O 0 0.0002246231451863423
splice O 0 0.0023531457409262657
site O 0 0.0010390498209744692
mutations O 0 0.0012400776613503695
. O 0 0.0008966957102529705

These O 0 0.0007429094985127449
mutations O 0 0.00038994630449451506
were O 0 9.61628247750923e-05
scattered O 0 0.00012086104834452271
over O 0 4.829532190342434e-05
the O 0 4.4335873099043965e-05
entire O 0 0.00012119110760977492
length O 0 6.986770313233137e-05
of O 0 0.00011918621748918667
PTEN O 1 0.9913397431373596
, O 0 4.1219591366825625e-05
with O 0 1.9636694560176693e-05
the O 0 2.4090844817692414e-05
exception O 0 3.4768145269481465e-05
of O 0 2.5038285457412712e-05
the O 0 2.59767439274583e-05
first O 0 4.828210876439698e-05
, O 0 5.5002506996970624e-05
fourth O 0 0.00023220523144118488
and O 0 9.43804916460067e-05
last O 0 0.0003848398046102375
exons O 0 0.0017369043780490756
. O 0 0.0008059116080403328

A O 0 0.004234901629388332
hot O 0 0.0038510255981236696
spot O 0 0.0017986559541895986
for O 0 0.0003471039526630193
PTEN O 1 0.9657562375068665
mutation O 0 0.0003954858402721584
in O 0 7.278384873643517e-05
CD B-Disease 0 0.00025852376711554825
was O 0 9.221504296874627e-05
identified O 0 4.537389031611383e-05
in O 0 2.1056503101135604e-05
exon O 0 0.00014342115900944918
5 O 0 3.696903513628058e-05
that O 0 1.6253294234047644e-05
contains O 0 2.646105167514179e-05
the O 0 4.701645957538858e-05
PTPase O 0 0.03678661212325096
core O 0 0.00027956522535532713
motif O 0 0.00016703475557733327
, O 0 3.118055246886797e-05
with O 0 1.33331268443726e-05
13 O 0 3.150608608848415e-05
of O 0 2.448690247547347e-05
30 O 0 3.292971814516932e-05
( O 0 3.501767787383869e-05
43 O 0 6.895488331792876e-05
% O 0 4.061184517922811e-05
) O 0 4.635250297724269e-05
CD B-Disease 0 0.00022425936185754836
mutations O 0 9.056198905454949e-05
identified O 0 6.055656194803305e-05
in O 0 4.838858512812294e-05
this O 0 0.0001266819454031065
exon O 0 0.001994532300159335
. O 0 0.0008633765392005444

Seven O 0 0.0007891660206951201
of O 0 0.0002716667077038437
30 O 0 0.00017933736671693623
( O 0 0.00011450870078988373
23 O 0 0.00010460209887241945
% O 0 4.4401796913007274e-05
) O 0 2.321995998499915e-05
were O 0 1.531879934191238e-05
within O 0 2.0014555047964677e-05
the O 0 3.332721098558977e-05
core O 0 0.00014350994024425745
motif O 0 0.00013447937089949846
, O 0 2.5544140953570604e-05
the O 0 2.6090552637469955e-05
majority O 0 2.0129022232140414e-05
( O 0 1.6870915715117007e-05
five O 0 1.4903760529705323e-05
of O 0 2.338630292797461e-05
seven O 0 3.067021316383034e-05
) O 0 2.1630088667734526e-05
of O 0 2.2162392269819975e-05
which O 0 1.9568313291529194e-05
were O 0 3.614141314756125e-05
missense O 0 0.000759665563236922
mutations O 0 0.00010770041990326717
, O 0 4.619540413841605e-05
possibly O 0 7.65330987633206e-05
pointing O 0 8.519069524481893e-05
to O 0 1.919730129884556e-05
the O 0 4.8515972594032064e-05
functional O 0 0.00010721779108280316
significance O 0 0.00011856061610160396
of O 0 8.95082121132873e-05
this O 0 0.00011816503683803603
region O 0 0.0005724412039853632
. O 0 0.0008096618112176657

Germline O 1 0.9990777969360352
PTEN O 1 0.9985495209693909
mutations O 0 0.000844727735966444
were O 0 0.00010960866347886622
identified O 0 9.090296953218058e-05
in O 0 3.818808909272775e-05
four O 0 3.6022600397700444e-05
of O 0 5.109644916956313e-05
seven O 0 8.457706280751154e-05
( O 0 7.978887879289687e-05
57 O 0 0.0002592235105112195
% O 0 0.00013243919238448143
) O 0 0.0002030885952990502
BZS B-Disease 0 0.011930514127016068
families O 0 0.0004924684180878103
studied O 0 0.0009723414550535381
. O 0 0.001266979961656034

Interestingly O 0 0.006286022253334522
, O 0 0.0005726082599721849
none O 0 0.00035751520772464573
of O 0 0.00016793032409623265
these O 0 6.67053900542669e-05
mutations O 0 0.00014074909267947078
was O 0 0.0001372574915876612
observed O 0 0.00011876735516125336
in O 0 7.629030733369291e-05
the O 0 0.00021548743825405836
PTPase O 1 0.6938415169715881
core O 0 0.006171597167849541
motif O 0 0.00522144278511405
. O 0 0.0016605824930593371

It O 0 0.0005069649196229875
is O 0 0.00016284397861454636
also O 0 9.524427878204733e-05
worthy O 0 0.0002580386644694954
of O 0 4.794318010681309e-05
note O 0 4.379313031677157e-05
that O 0 1.679059823800344e-05
a O 0 3.7117551983101293e-05
single O 0 5.5199023336172104e-05
nonsense O 0 0.0007975334883667529
point O 0 9.245532419299707e-05
mutation O 0 0.00018464031745679677
, O 0 5.083274299977347e-05
R233X O 0 0.10968232154846191
, O 0 5.546274041989818e-05
was O 0 7.695858221268281e-05
observed O 0 4.373512274469249e-05
in O 0 2.737852992140688e-05
the O 0 6.019958891556598e-05
germline O 0 0.001048685167916119
DNA O 0 8.792254084255546e-05
from O 0 3.713379192049615e-05
two O 0 4.1265448089689016e-05
unrelated O 0 0.0003237866621930152
CD B-Disease 0 0.0003655028704088181
families O 0 0.00014478241791948676
and O 0 0.00014959057443775237
one O 0 0.0003571707638911903
BZS B-Disease 1 0.6715421676635742
family O 0 0.0015305709093809128
. O 0 0.0014445632696151733

Genotype O 1 0.9632925987243652
- O 1 0.6689108610153198
phenotype O 0 0.015770653262734413
studies O 0 0.00015733932377770543
were O 0 4.998864824301563e-05
not O 0 3.443470995989628e-05
performed O 0 6.629876588704064e-05
on O 0 3.399096385692246e-05
this O 0 2.735843554546591e-05
small O 0 6.213790038600564e-05
group O 0 0.00010151272726943716
of O 0 0.0003015297115780413
BZS B-Disease 1 0.697367787361145
families O 0 0.0011600040597841144
. O 0 0.0014462920371443033

However O 0 0.0019370191730558872
, O 0 0.000860159401781857
genotype O 0 0.0055795712396502495
- O 0 0.00562177924439311
phenotype O 0 0.0012656358303502202
analysis O 0 0.000125705570098944
inthe O 0 0.004188643302768469
group O 0 0.0001164771310868673
of O 0 0.00011706571240210906
CD B-Disease 0 0.0009023997699841857
families O 0 9.463111928198487e-05
revealed O 0 0.0001065943215508014
two O 0 2.0491013856371865e-05
possible O 0 3.843535523628816e-05
associations O 0 4.334531695349142e-05
worthy O 0 0.00015827616152819246
of O 0 6.645201210631058e-05
follow O 0 9.680687071522698e-05
- O 0 0.00022603379329666495
up O 0 9.409653284819797e-05
in O 0 7.385391654679552e-05
independent O 0 0.00015952311514411122
analyses O 0 0.0005253694835118949
. O 0 0.0006413188530132174

The O 0 0.0007511703297495842
first O 0 0.00044718431308865547
was O 0 0.00042598810978233814
an O 0 8.653925033286214e-05
association O 0 0.0001349450321868062
noted O 0 4.5610540837515146e-05
in O 0 2.4199413019232452e-05
the O 0 3.335035580676049e-05
group O 0 4.416981028043665e-05
of O 0 0.00012170390255050734
CD B-Disease 0 0.015353111550211906
families O 0 0.000534683174919337
with O 0 0.0400262288749218
breast B-Disease 1 0.9999955892562866
disease I-Disease 1 0.9999791383743286
. O 0 0.008704757317900658

A O 0 0.002127676969394088
correlation O 0 0.0008523555006831884
was O 0 0.00038904265966266394
observed O 0 0.0001501828373875469
between O 0 8.186302147805691e-05
the O 0 0.00011299600009806454
presence O 0 0.0002894695498980582
/ O 0 0.006270951125770807
absence O 0 0.00041941931704059243
of O 0 0.00016066036187112331
a O 0 0.005117898806929588
PTEN O 1 0.9996411800384521
mutation O 0 0.00031903685885481536
and O 0 5.533209696295671e-05
the O 0 7.002065103733912e-05
type O 0 0.0004715782997664064
of O 0 0.0004410777473822236
breast O 1 0.9999347925186157
involvement O 1 0.7888778448104858
( O 0 0.22957664728164673
unaffected O 1 0.9789184927940369
versus O 1 0.9910667538642883
benign O 1 0.9999091625213623
versus O 1 0.9982160925865173
malignant O 1 0.9999892711639404
) O 0 0.0012276084162294865
. O 0 0.0015719336224719882

Specifically O 0 0.0009478660067543387
and O 0 0.0002089346817228943
more O 0 5.379637150326744e-05
directly O 0 5.881384277017787e-05
, O 0 5.54147336515598e-05
an O 0 5.762362343375571e-05
association O 0 0.00015877437544986606
was O 0 7.802459731465206e-05
also O 0 2.633831900311634e-05
observed O 0 3.711351382662542e-05
between O 0 2.104823215631768e-05
the O 0 2.4615019356133416e-05
presence O 0 4.849053220823407e-05
of O 0 8.133421215461567e-05
a O 0 0.007521842606365681
PTEN O 1 0.9999709129333496
mutation O 1 0.9392433762550354
and O 1 0.9465668797492981
malignant B-Disease 1 1.0
breast I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999990463256836
. O 1 0.7171832919120789

Secondly O 0 0.042632825672626495
, O 0 0.0005236923461779952
there O 0 0.00015577871818095446
appeared O 0 0.0001575628702994436
to O 0 3.209614078514278e-05
be O 0 2.7087688067695126e-05
an O 0 4.459508272702806e-05
interdependent O 0 0.001423718873411417
association O 0 0.00018040859140455723
between O 0 5.1766812248388305e-05
mutations O 0 0.00011161316797370091
upstream O 0 0.00014636553532909602
and O 0 4.5707249228144065e-05
within O 0 4.0127393731381744e-05
the O 0 9.00711675058119e-05
PTPase O 1 0.7843730449676514
core O 0 0.0012632765574380755
motif O 0 0.00032346852822229266
, O 0 5.0560320232762024e-05
the O 0 3.918356742360629e-05
core O 0 0.00013136131747160107
motif O 0 0.00013825157657265663
containing O 0 3.753372220671736e-05
the O 0 2.5852335966192186e-05
majority O 0 2.927589048340451e-05
of O 0 4.67982936243061e-05
missense O 0 0.004569229669868946
mutations O 0 0.00010650652257027104
, O 0 3.1894640414975584e-05
and O 0 2.0683672119048424e-05
the O 0 2.7478503398015164e-05
involvement O 0 9.812756616156548e-05
of O 0 3.744891728274524e-05
all O 0 2.9753045964753255e-05
major O 0 0.0005203079781495035
organ O 1 0.8775724768638611
systems O 0 0.0067594218999147415
( O 0 0.0001659770350670442
central O 0 0.00025005752104334533
nervous O 1 0.509861171245575
system O 0 0.003148821648210287
, O 0 0.015058568678796291
thyroid O 1 0.9999983310699463
, O 1 0.6534900069236755
breast O 1 0.9999988079071045
, O 1 0.9762555956840515
skin O 1 0.9999990463256836
and O 1 0.9945451021194458
gastrointestinal O 1 0.9999997615814209
tract O 1 0.9999974966049194
) O 0 0.03567984700202942
. O 0 0.0020233269315212965

However O 0 0.0010644008871167898
, O 0 0.0003210246213711798
these O 0 6.144962389953434e-05
observations O 0 0.00010564936383161694
would O 0 4.863789945375174e-05
need O 0 4.0957529563456774e-05
to O 0 1.774849988578353e-05
be O 0 1.873153269116301e-05
confirmed O 0 3.973892307840288e-05
by O 0 1.872667417046614e-05
studying O 0 5.276038427837193e-05
a O 0 4.914273085887544e-05
larger O 0 5.08786179125309e-05
number O 0 4.038841507281177e-05
of O 0 0.00013431547267828137
CD B-Disease 0 0.0006706782733090222
families O 0 0.00041655561653897166
. O 0 0.0006489565712399781

Molecular O 0 0.04978111386299133
defects O 1 0.9704911112785339
leading O 0 0.001140724285505712
to O 0 0.00016467996465507895
human O 0 0.0005378164350986481
complement B-Disease 1 0.5919445157051086
component I-Disease 1 0.9999632835388184
C6 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999994039535522
in O 0 0.0003099990135524422
an O 0 0.00034068123204633594
African O 0 0.022194024175405502
- O 0 0.26681920886039734
American O 0 0.0011129067279398441
family O 0 0.0013771840604022145
. O 0 0.0008081887499429286

Complement B-Disease 1 0.720270037651062
component I-Disease 1 0.9998315572738647
C6 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
( O 1 0.9759576916694641
C6D B-Disease 1 0.999990701675415
) O 0 0.0009756218641996384
was O 0 0.004618472419679165
diagnosed O 1 0.9374913573265076
in O 0 4.271141006029211e-05
a O 0 7.325826300075278e-05
16 O 0 9.597273310646415e-05
- O 0 0.0007053430890664458
year O 0 8.850802259985358e-05
- O 0 0.0009276740020141006
old O 0 0.0011277883313596249
African O 0 0.0013115005567669868
- O 0 0.027815228328108788
American O 0 0.0009703845717012882
male O 0 0.037423957139253616
with O 0 0.09617184847593307
meningococcal B-Disease 1 0.9999984502792358
meningitis I-Disease 1 0.999997615814209
. O 0 0.06137575954198837

The O 0 0.0030136611312627792
patients O 0 0.2188887596130371
father O 0 0.0021662330254912376
and O 0 0.0001107798598241061
two O 0 5.536244498216547e-05
brothers O 0 0.0012259363429620862
also O 0 7.38191301934421e-05
had O 0 0.0004447695682756603
C6D B-Disease 1 0.9992226362228394
, O 0 6.281529931584373e-05
but O 0 2.5311881472589448e-05
gave O 0 5.407096614362672e-05
no O 0 2.752235195657704e-05
history O 0 0.00010190825560130179
of O 0 0.0010603235568851233
meningitis B-Disease 1 0.999995231628418
or O 0 0.003359147347509861
other O 0 0.0006982936174608767
neisserial B-Disease 1 0.9999668598175049
infection I-Disease 1 0.9999228715896606
. O 0 0.003404335118830204

By O 0 0.0008724593790248036
using O 0 0.0004048535483889282
exon O 0 0.0017439605435356498
- O 0 0.0005647048237733543
specific O 0 0.0001553764013806358
polymerase O 0 0.0005606889026239514
chain O 0 0.00023589663032907993
reaction O 0 0.00017027667490765452
( O 0 7.213655044324696e-05
PCR O 0 0.00021911402291152626
) O 0 5.514645454240963e-05
/ O 0 0.00029545530560426414
single O 0 0.00010663334978744388
- O 0 0.00026849075220525265
strand O 0 0.00023777986643835902
conformation O 0 0.00023954635253176093
polymorphism O 0 0.00020349817350506783
as O 0 5.358409180189483e-05
a O 0 7.568381261080503e-05
screening O 0 9.95815935311839e-05
step O 0 0.0001140397071139887
and O 0 4.573872502078302e-05
nucleotide O 0 8.178016287274659e-05
sequencing O 0 7.820889732101932e-05
of O 0 4.083693420398049e-05
target O 0 5.966691242065281e-05
exons O 0 0.0001287124614464119
, O 0 2.956371827167459e-05
we O 0 3.569605541997589e-05
determined O 0 4.240414273226634e-05
that O 0 1.6657042579026893e-05
the O 0 4.8523052100790665e-05
proband O 0 0.014073196798563004
was O 0 0.00013772172678727657
a O 0 0.0001080503934645094
compound O 0 0.001228552428074181
heterozygote O 0 0.005531016271561384
for O 0 0.00012273436004761606
two O 0 0.0002444419951643795
C6 O 1 0.999259889125824
gene O 0 0.0009423838346265256
mutations O 0 0.001379393390379846
. O 0 0.0009500142186880112

The O 0 0.0010932569857686758
first O 0 0.0006088561494834721
, O 0 0.00023650782532058656
1195delC O 0 0.00222189468331635
located O 0 0.00021222380746621639
in O 0 7.767708302708343e-05
exon O 0 0.0006164414226077497
7 O 0 0.0001287675986532122
, O 0 5.028297164244577e-05
is O 0 3.7355359381763265e-05
a O 0 5.914325447520241e-05
novel O 0 0.0001498406782047823
mutation O 0 8.261997572844848e-05
, O 0 2.5890138203976676e-05
while O 0 1.7874534023576416e-05
the O 0 2.842703543137759e-05
second O 0 6.844453309895471e-05
, O 0 5.3067487897351384e-05
1936delG O 0 0.0014403803506866097
in O 0 5.4730848205508664e-05
exon O 0 0.0003853084344882518
12 O 0 5.612257882603444e-05
, O 0 3.161043059662916e-05
has O 0 2.0713576304842718e-05
been O 0 2.359047175559681e-05
described O 0 6.121987826190889e-05
before O 0 5.479445098899305e-05
to O 0 3.484931221464649e-05
cause O 0 0.0017275704303756356
C6D B-Disease 1 0.8509246706962585
in O 0 5.7426786952419207e-05
an O 0 7.114643085515127e-05
unrelated O 0 0.00040274581988342106
African O 0 0.0012178219622001052
- O 0 0.05979732424020767
American O 0 0.0006417502299882472
individual O 0 0.0003980221808888018
. O 0 0.0008680500322952867

Both O 0 0.0015550634125247598
mutations O 0 0.0011751429410651326
result O 0 0.00028858662699349225
in O 0 0.0002454612113069743
premature O 0 0.3408747613430023
termination O 1 0.5835220813751221
codons O 0 0.004505726974457502
and O 0 0.0010149029549211264
C6 O 1 0.9975020289421082
null O 0 0.0059260111302137375
alleles O 0 0.004453636705875397
. O 0 0.0019464902579784393

Allele O 0 0.008184944279491901
- O 0 0.0021074190735816956
specific O 0 0.00022572583111468703
PCR O 0 0.0008892475161701441
indicated O 0 0.0002092368813464418
that O 0 4.694969902629964e-05
the O 0 0.00010865511285373941
probands O 0 0.034689221531152725
two O 0 6.474057590821758e-05
brothers O 0 0.0006009457283653319
also O 0 8.633681136416271e-05
inherited O 0 0.19854262471199036
the O 0 0.00027725304244086146
1195delC O 1 0.9880434274673462
mutation O 0 0.00024086254416033626
from O 0 4.264941890141927e-05
their O 0 3.611695137806237e-05
heterozygous O 0 0.0001800769241526723
mother O 0 0.0002916290832217783
and O 0 5.253636118141003e-05
the O 0 0.00010990632290486246
1936delG O 0 0.3976794481277466
mutation O 0 0.00023376756871584803
from O 0 8.783672819845378e-05
their O 0 9.559313912177458e-05
homozygous O 0 0.0008024995331652462
father O 0 0.0012556249275803566
. O 0 0.0005226430366747081
. O 0 0.0009262523963116109

PAX6 O 1 0.9928515553474426
mutations O 0 0.017886795103549957
reviewed O 0 0.009241517633199692
. O 0 0.005754404701292515

Mutations O 0 0.003925257828086615
in O 0 0.0008305505616590381
PAX6 O 1 0.9840609431266785
are O 0 7.965211989358068e-05
responsible O 0 0.00020700250752270222
for O 0 9.948059596354142e-05
human O 0 0.001957009546458721
aniridia B-Disease 1 0.9998132586479187
and O 0 8.268003148259595e-05
have O 0 2.1160372853046283e-05
also O 0 1.4961719898565207e-05
been O 0 1.3696433597942814e-05
found O 0 1.9413329937378876e-05
in O 0 2.275392398587428e-05
patients O 0 0.0008788480190560222
with O 0 9.99926560325548e-05
Peters B-Disease 1 0.9996651411056519
anomaly I-Disease 1 0.9999781847000122
, O 0 0.4924451410770416
with O 1 0.9960957169532776
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9924218058586121
with O 1 0.9097438454627991
autosomal B-Disease 1 0.9999885559082031
dominant I-Disease 1 0.9999333620071411
keratitis I-Disease 1 0.9999994039535522
, O 0 0.012676708400249481
and O 0 0.00042444109567441046
with O 0 0.0017841154476627707
isolated B-Disease 1 0.9951509237289429
foveal I-Disease 1 0.9999946355819702
hypoplasia I-Disease 1 0.9999959468841553
. O 0 0.042186230421066284

No O 0 0.0018915380351245403
locus O 0 0.002038914943113923
other O 0 0.00014208271750248969
than O 0 0.00013601560203824192
chromosome O 0 0.0008025610586628318
11p13 O 0 0.19912131130695343
has O 0 0.00011404655379010364
been O 0 7.748429197818041e-05
implicated O 0 0.0016208868473768234
in O 0 0.0001846008817665279
aniridia B-Disease 1 0.9999508857727051
, O 0 0.00048004731070250273
and O 0 0.00033058642293326557
PAX6 O 1 0.9991341233253479
is O 0 8.980299753602594e-05
clearly O 0 9.49374443734996e-05
the O 0 5.0056241889251396e-05
major O 0 0.00013125751866027713
, O 0 4.540557347354479e-05
if O 0 2.7130266971653327e-05
not O 0 2.178963040933013e-05
only O 0 4.1605981095926836e-05
, O 0 0.00011163487215526402
gene O 0 0.00036692971480078995
responsible O 0 0.0007397537119686604
. O 0 0.0008698065648786724

Twenty O 0 0.0033380617387592793
- O 0 0.00156569411046803
eight O 0 0.0003005418402608484
percent O 0 0.00014918290253262967
of O 0 0.0001500960934208706
identified O 0 0.0003651224251370877
PAX6 O 1 0.9994086027145386
mutations O 0 0.00033254275331273675
are O 0 4.623837594408542e-05
C O 0 0.0018986704526469111
- O 0 0.02382829412817955
T O 0 0.005069753620773554
changes O 0 8.515577792422846e-05
at O 0 8.513678039889783e-05
CpG O 0 0.0007634973735548556
dinucleotides O 0 0.0031796512193977833
, O 0 6.512274558190256e-05
20 O 0 6.0166810726514086e-05
% O 0 3.242112143198028e-05
are O 0 1.2047802556480747e-05
splicing O 0 9.455184044782072e-05
errors O 0 7.173414633143693e-05
, O 0 2.1641744751832448e-05
and O 0 1.6465970475110225e-05
more O 0 1.467289803258609e-05
than O 0 1.7300004401477054e-05
30 O 0 4.223746509524062e-05
% O 0 4.156164504820481e-05
are O 0 3.7119250919204205e-05
deletion O 0 0.00044463988160714507
or O 0 0.00019898208847735077
insertion O 0 0.001424565794877708
events O 0 0.0009200263884849846
. O 0 0.0011989002814516425

There O 0 0.0006771932239644229
is O 0 0.00032577727688476443
a O 0 0.00034636302734725177
noticeably O 0 0.0095168836414814
elevated O 0 0.029052965342998505
level O 0 0.00011073191126342863
of O 0 6.804092117818072e-05
mutation O 0 0.00010819554154295474
in O 0 2.8437390938051976e-05
the O 0 3.601631397032179e-05
paired O 0 6.73755057505332e-05
domain O 0 4.9908387154573575e-05
compared O 0 3.32715135300532e-05
with O 0 1.636896195122972e-05
the O 0 3.894994006259367e-05
rest O 0 0.000116271163278725
of O 0 0.0001155959180323407
the O 0 0.0002170989173464477
gene O 0 0.0007071009604260325
. O 0 0.0007485692040063441

Increased O 0 0.0020035889465361834
mutation O 0 0.0007205834845080972
in O 0 0.00015209898992907256
the O 0 0.00023209191567730159
homeodomain O 0 0.07521645724773407
is O 0 0.0001495132892159745
accounted O 0 0.00019890963449142873
for O 0 5.205909110372886e-05
by O 0 7.358327275142074e-05
the O 0 0.00017469568410888314
hypermutable O 0 0.12722420692443848
CpG O 0 0.0041918386705219746
dinucleotide O 0 0.005046637263149023
in O 0 0.00041548008448444307
codon O 0 0.0018547711661085486
240 O 0 0.002124850172549486
. O 0 0.001545436098240316

Very O 0 0.00072099594399333
nearly O 0 0.00040592285222373903
all O 0 8.255303691839799e-05
mutations O 0 0.00014213420217856765
appear O 0 6.472662789747119e-05
to O 0 3.947540244553238e-05
cause O 0 0.0011751519050449133
loss O 0 0.000374951574485749
of O 0 3.990670666098595e-05
function O 0 3.551396002876572e-05
of O 0 4.114866169402376e-05
the O 0 8.7370426626876e-05
mutant O 0 0.010972046293318272
allele O 0 0.00010042609937954694
, O 0 1.6862359188962728e-05
and O 0 1.0292831575497985e-05
more O 0 7.096303761500167e-06
than O 0 1.1444729352660943e-05
80 O 0 2.868360752472654e-05
% O 0 2.3412565496983007e-05
of O 0 7.265465683303773e-05
exonic O 0 0.08592456579208374
substitutions O 0 0.00029736533178947866
result O 0 0.00013246432354208082
in O 0 0.0001404229406034574
nonsense O 0 0.0023593464866280556
codons O 0 0.0017894965130835772
. O 0 0.0009349751635454595

In O 0 0.000810705590993166
a O 0 0.0005411430611275136
gene O 0 0.00032300601014867425
with O 0 0.00012873002560809255
such O 0 6.706728891003877e-05
extraordinarily O 0 0.0006075258716009557
high O 0 0.00014449238369707018
sequence O 0 6.859430141048506e-05
conservation O 0 8.321456698467955e-05
throughout O 0 3.2696279959054664e-05
evolution O 0 5.9857378801098093e-05
, O 0 3.697446663863957e-05
there O 0 2.5458219170104712e-05
are O 0 1.5128815903153736e-05
presumed O 0 0.00023756278096698225
undiscovered O 0 0.014717256650328636
missense O 0 0.003375999629497528
mutations O 0 0.0001748004724504426
, O 0 5.384584437706508e-05
these O 0 2.165855221392121e-05
are O 0 1.6613639672868885e-05
hypothesized O 0 9.465558105148375e-05
to O 0 2.0012836102978326e-05
exist O 0 3.391664722585119e-05
in O 0 3.523991472320631e-05
as O 0 5.2619903726736084e-05
- O 0 0.00030688371043652296
yet O 0 0.00014578957052435726
unidentified O 0 0.0013622416881844401
phenotypes O 0 0.0043222373351454735
. O 0 0.0002666776126716286
. O 0 0.0006564207142218947

Genetic O 0 0.005991803947836161
heterogeneity O 0 0.006325294263660908
and O 0 0.0004619829123839736
penetrance O 0 0.004919872153550386
analysis O 0 0.00017062350525520742
of O 0 0.00016062786744441837
the O 0 0.0007072293665260077
BRCA1 O 1 0.9962537288665771
and O 0 0.0010212463093921542
BRCA2 O 1 0.9974058270454407
genes O 0 0.0016968650743365288
in O 0 0.03623555973172188
breast B-Disease 1 0.9999985694885254
cancer I-Disease 1 0.9999884366989136
families O 0 0.08856526017189026
. O 0 0.0029655483085662127

The O 1 0.8165542483329773
Breast B-Disease 1 0.9999945163726807
Cancer I-Disease 1 0.9999887943267822
Linkage O 1 0.9988113641738892
Consortium O 1 0.5903931260108948
. O 0 0.003841598518192768

The O 0 0.0016592906322330236
contribution O 0 0.0015558202285319567
of O 0 0.001009270898066461
BRCA1 O 1 0.9969883561134338
and O 0 0.006697746925055981
BRCA2 O 1 0.9998763799667358
to O 0 0.04216707870364189
inherited B-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
was O 1 0.9887785315513611
assessed O 0 0.01421134453266859
by O 0 6.743547419318929e-05
linkage O 0 0.0015833397628739476
and O 0 4.575940693030134e-05
mutation O 0 4.074334356118925e-05
analysis O 0 1.5556945072603412e-05
in O 0 2.0380202840897255e-05
237 O 0 0.00017176517576444894
families O 0 3.961678521591239e-05
, O 0 1.9118579075438902e-05
each O 0 9.189666343445424e-06
with O 0 8.701975275471341e-06
at O 0 1.8504711988498457e-05
least O 0 1.6764564861659892e-05
four O 0 2.3795086235622875e-05
cases O 0 4.42223645222839e-05
of O 0 0.0066214618273079395
breast B-Disease 1 0.999997615814209
cancer I-Disease 1 0.9999040365219116
, O 0 0.00012435323151294142
collected O 0 0.00010289586498402059
by O 0 0.00013694177323486656
the O 0 0.04925950616598129
Breast B-Disease 1 0.9999995231628418
Cancer I-Disease 1 0.9999979734420776
Linkage O 1 0.999220609664917
Consortium O 0 0.17317652702331543
. O 0 0.0016355226980522275

Families O 0 0.001475656172260642
were O 0 0.000265729206148535
included O 0 0.00015194504521787167
without O 0 6.470829248428345e-05
regard O 0 0.00010459601617185399
to O 0 3.163509609294124e-05
the O 0 5.4044216085458174e-05
occurrence O 0 0.000477619149023667
of O 0 0.022724682465195656
ovarian B-Disease 1 0.9999984502792358
or I-Disease 0 0.012754803523421288
other I-Disease 0 0.00047453996376134455
cancers I-Disease 1 0.9947348833084106
. O 0 0.001504832529462874

Overall O 1 0.9253839254379272
, O 0 0.20012088119983673
disease O 1 0.9998918771743774
was O 0 0.058182064443826675
linked O 0 0.008948402479290962
to O 0 8.850861195242032e-05
BRCA1 O 0 0.03039158321917057
in O 0 3.123856367892586e-05
an O 0 2.131445762643125e-05
estimated O 0 3.207570262020454e-05
52 O 0 4.906387403025292e-05
% O 0 2.27343371079769e-05
of O 0 2.5687291781650856e-05
families O 0 3.7267331208568066e-05
, O 0 2.285223854414653e-05
to O 0 1.7510321413283236e-05
BRCA2 O 0 0.00039281771751120687
in O 0 2.0992703866795637e-05
32 O 0 4.643815555027686e-05
% O 0 2.3329786927206442e-05
of O 0 2.6784140572999604e-05
families O 0 4.083382009412162e-05
, O 0 1.705943031993229e-05
and O 0 1.3650948858412448e-05
to O 0 1.4708231901749969e-05
neither O 0 3.4087792300852016e-05
gene O 0 2.0490035240072757e-05
in O 0 1.6631962353130803e-05
16 O 0 4.129111403017305e-05
% O 0 2.9907429052400403e-05
( O 0 3.1544775993097574e-05
95 O 0 6.106671935413033e-05
% O 0 4.017724859295413e-05
confidence O 0 0.000106080922705587
interval O 0 0.00014177820412442088
[ O 0 0.0001632621861062944
CI O 0 0.0016287426697090268
] O 0 0.0001534114999230951
6 O 0 7.166611612774432e-05
% O 0 3.576740709831938e-05
- O 0 8.416730270255357e-05
28 O 0 6.679030775558203e-05
% O 0 4.279662243789062e-05
) O 0 3.9267099054995924e-05
, O 0 6.589775148313493e-05
suggesting O 0 0.00025413144612684846
other O 0 0.00010132280294783413
predisposition O 0 0.02843833528459072
genes O 0 0.0008311328128911555
. O 0 0.0011349780252203345

The O 0 0.0010562652023509145
majority O 0 0.00034768751356750727
( O 0 0.0001314041728619486
81 O 0 0.0002538665139582008
% O 0 4.62781245005317e-05
) O 0 5.279214747133665e-05
of O 0 9.849722118815407e-05
the O 0 0.04013007879257202
breast B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
families O 0 0.0175558403134346
were O 0 0.00020896096248179674
due O 0 0.0004927729023620486
to O 0 7.100991933839396e-05
BRCA1 O 1 0.691217839717865
, O 0 4.1429004340898246e-05
with O 0 2.4022065190365538e-05
most O 0 1.5701809388701804e-05
others O 0 2.8856456992798485e-05
( O 0 3.775496588787064e-05
14 O 0 5.42744091944769e-05
% O 0 4.641991836251691e-05
) O 0 8.043701382121071e-05
due O 0 0.0002188208745792508
to O 0 0.00029512197943404317
BRCA2 O 0 0.031177716329693794
. O 0 0.001088396762497723

Conversely O 0 0.005086693447083235
, O 0 0.00036725413519889116
the O 0 0.00015858492406550795
majority O 0 0.00012842804426327348
of O 0 8.740642078919336e-05
families O 0 9.96642338577658e-05
with O 0 7.478558836737648e-05
male B-Disease 0 0.006122195161879063
and I-Disease 0 0.008054978214204311
female I-Disease 1 0.9996742010116577
breast I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.999990701675415
were O 0 0.0002484619035385549
due O 0 0.0003618945484049618
to O 0 0.00010714349627960473
BRCA2 O 1 0.6549908518791199
( O 0 0.000230007033678703
76 O 0 0.00087623210856691
% O 0 0.0002764719247352332
) O 0 0.00034173604217357934
. O 0 0.0007008457323536277

The O 0 0.0008195930276997387
largest O 0 0.0007091761799529195
proportion O 0 0.00028199778171256185
( O 0 0.0001184973370982334
67 O 0 0.00015397541574202478
% O 0 5.6994264014065266e-05
) O 0 3.798171746893786e-05
of O 0 5.019783930038102e-05
families O 0 4.4034557504346594e-05
due O 0 3.1974184821592644e-05
to O 0 1.5068111679283902e-05
other O 0 1.2484360013331752e-05
genes O 0 1.977557440113742e-05
was O 0 3.019962241523899e-05
found O 0 1.513629194960231e-05
in O 0 1.188743863167474e-05
families O 0 1.6589036022196524e-05
with O 0 1.0443297469464596e-05
four O 0 1.733128010528162e-05
or O 0 2.0512168703135103e-05
five O 0 3.202765219612047e-05
cases O 0 5.795061952085234e-05
of O 0 0.0009536407887935638
female O 1 0.9997071623802185
breast B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999829530715942
only O 0 0.0012153838761150837
. O 0 0.0013357377611100674

These O 0 0.0004422488564159721
estimates O 0 0.0003281894896645099
were O 0 0.00010191816545557231
not O 0 6.808844045735896e-05
substantially O 0 0.00015967711806297302
affected O 0 9.22014078241773e-05
either O 0 3.765891960938461e-05
by O 0 3.127829768345691e-05
changing O 0 6.862622103653848e-05
the O 0 7.738822750980034e-05
assumed O 0 0.0002785616379696876
penetrance O 0 0.050651635974645615
model O 0 0.00024067408230621368
for O 0 7.490220741601661e-05
BRCA1 O 0 0.0564255528151989
or O 0 6.334247882477939e-05
by O 0 4.0473041735822335e-05
including O 0 7.358608127105981e-05
or O 0 0.00013399386079981923
excluding O 0 0.0005864791455678642
BRCA1 O 1 0.51957768201828
mutation O 0 0.0007676339591853321
data O 0 0.00031456357100978494
. O 0 0.000872866774443537

Among O 0 0.0009518524748273194
those O 0 0.00022907470702193677
families O 0 0.0004742912424262613
with O 0 0.0074069746769964695
disease O 1 0.9999871253967285
due O 0 0.12710803747177124
to O 0 0.00018958051805384457
BRCA1 O 1 0.8888944387435913
that O 0 2.5162087695207447e-05
were O 0 2.410962406429462e-05
tested O 0 5.473069177241996e-05
by O 0 1.525238712929422e-05
one O 0 1.7388727428624406e-05
of O 0 2.5951290808734484e-05
the O 0 4.530591832008213e-05
standard O 0 6.434156966861337e-05
screening O 0 9.41951948334463e-05
methods O 0 3.754009594558738e-05
, O 0 2.699518699955661e-05
mutations O 0 4.1129787859972566e-05
were O 0 2.0546938685583882e-05
detected O 0 5.429935845313594e-05
in O 0 1.7344043953926302e-05
the O 0 2.7367826987756416e-05
coding O 0 7.975229527801275e-05
sequence O 0 3.0441320632235147e-05
or O 0 2.3052936739986762e-05
splice O 0 9.571125701768324e-05
sites O 0 1.879342380561866e-05
in O 0 1.110970424633706e-05
an O 0 1.730142321321182e-05
estimated O 0 2.8292053684708662e-05
63 O 0 5.117194086778909e-05
% O 0 2.6682726456783712e-05
( O 0 3.848659616778605e-05
95 O 0 8.34235324873589e-05
% O 0 4.656045348383486e-05
CI O 0 0.0011824595276266336
51 O 0 0.0001791319518815726
% O 0 8.773945592110977e-05
- O 0 0.0003394970262888819
77 O 0 0.00043543981155380607
% O 0 0.00021626341913361102
) O 0 0.00038119140663184226
. O 0 0.0007499536732211709

The O 0 0.002002625958994031
estimated O 0 0.0011605456238612533
sensitivity O 0 0.0012853953521698713
was O 0 0.00042339187348261476
identical O 0 0.00016630228492431343
for O 0 5.992162550683133e-05
direct O 0 9.062195749720559e-05
sequencing O 0 0.00024420113186351955
and O 0 0.00010843144991667941
other O 0 0.00010736829426605254
techniques O 0 0.0007349866791628301
. O 0 0.0008494689827784896

The O 0 0.002161388285458088
penetrance O 0 0.35571232438087463
of O 0 0.0015637156320735812
BRCA2 O 1 0.9113601446151733
was O 0 0.0005851649329997599
estimated O 0 0.0001389446115354076
by O 0 5.030421743867919e-05
maximizing O 0 0.0002557195257395506
the O 0 8.540747512597591e-05
LOD O 0 0.09547881036996841
score O 0 0.00012160286860307679
in O 0 0.0001310305524384603
BRCA2 O 1 0.9742936491966248
- O 0 0.02608463540673256
mutation O 0 0.0002887622104026377
families O 0 8.261950279120356e-05
, O 0 6.468879291787744e-05
over O 0 6.39648933429271e-05
all O 0 0.00010385520727140829
possible O 0 0.00032551895128563046
penetrance O 0 0.01818217523396015
functions O 0 0.0007912623113952577
. O 0 0.0013916329480707645

The O 0 0.0009760551038198173
estimated O 0 0.000718441791832447
cumulative O 0 0.002039905870333314
risk O 0 0.012442661449313164
of O 0 0.06613386422395706
breast B-Disease 1 0.999995231628418
cancer I-Disease 1 0.9998670816421509
reached O 0 0.000963133352342993
28 O 0 0.0002537155232857913
% O 0 6.092321200412698e-05
( O 0 4.76859204354696e-05
95 O 0 8.44947571749799e-05
% O 0 4.63566102553159e-05
CI O 0 0.0009306267602369189
9 O 0 8.73415992828086e-05
% O 0 3.066597128054127e-05
- O 0 8.758204785408452e-05
44 O 0 4.840007750317454e-05
% O 0 2.5440383979002945e-05
) O 0 1.9299179257359356e-05
by O 0 1.5306493878597394e-05
age O 0 3.128119351458736e-05
50 O 0 3.376831955392845e-05
years O 0 2.9313829145394266e-05
and O 0 2.0056131688761525e-05
84 O 0 5.516628880286589e-05
% O 0 2.356074946874287e-05
( O 0 3.382117211003788e-05
95 O 0 5.7209570513805375e-05
% O 0 3.259540972067043e-05
CI O 0 0.000809197430498898
43 O 0 8.697043085703626e-05
% O 0 3.63639228453394e-05
- O 0 0.00011921008990611881
95 O 0 7.951467705424875e-05
% O 0 3.327316153445281e-05
) O 0 3.756222577067092e-05
by O 0 5.0023219955619425e-05
age O 0 0.00016383483307436109
70 O 0 0.00043095124419778585
years O 0 0.0006314017227850854
. O 0 0.00107112608384341

The O 0 0.011458535678684711
corresponding O 1 0.9951409101486206
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999997615814209
risks O 1 0.9599114656448364
were O 0 0.0011161483125761151
0 O 0 0.0016178555088117719
. O 0 0.0014143908629193902

4 O 0 0.0010033423313871026
% O 0 0.00023729725216981024
( O 0 0.00012205803068354726
95 O 0 0.0002067555469693616
% O 0 7.186732545960695e-05
CI O 0 0.002013476798310876
0 O 0 6.0482638218672946e-05
% O 0 3.160247433697805e-05
- O 0 8.110418275464326e-05
1 O 0 2.9269105652929284e-05
% O 0 1.7477839719504118e-05
) O 0 1.5929326764307916e-05
by O 0 1.2683256500167772e-05
age O 0 2.831820529536344e-05
50 O 0 2.5298055334133096e-05
years O 0 1.9326991605339572e-05
and O 0 1.3715189197682776e-05
27 O 0 3.635442044469528e-05
% O 0 2.193718682974577e-05
( O 0 2.6271765818819404e-05
95 O 0 5.321901699062437e-05
% O 0 4.62472416984383e-05
CI O 0 0.0007425043149851263
0 O 0 4.832222839468159e-05
% O 0 3.0847586458548903e-05
- O 0 6.509703962365165e-05
47 O 0 6.413164373952895e-05
% O 0 3.510528404149227e-05
) O 0 2.7029833290725946e-05
by O 0 4.0820628782967106e-05
age O 0 0.00014896200445946306
70 O 0 0.0003004959726240486
years O 0 0.00048205157509073615
. O 0 0.000913904223125428

The O 0 0.001719312509521842
lifetime O 1 0.5405551791191101
risk O 1 0.6726552248001099
of O 1 0.9388396143913269
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999960660934448
appears O 0 0.050873443484306335
similar O 0 6.484147161245346e-05
to O 0 3.353299689479172e-05
the O 0 7.792718679411337e-05
risk O 0 0.0016735234530642629
in O 0 0.00011984952288912609
BRCA1 O 1 0.9987602233886719
carriers O 0 0.0006821734714321792
, O 0 2.9915130653535016e-05
but O 0 1.6125150068546645e-05
there O 0 1.3869675058231223e-05
was O 0 3.382026989129372e-05
some O 0 1.574290763528552e-05
suggestion O 0 5.9416859585326165e-05
of O 0 4.2597635911079124e-05
a O 0 7.039798219921067e-05
lower O 0 0.0001127822179114446
risk O 0 0.00012856393004767597
in O 0 8.022596739465371e-05
BRCA2 O 1 0.5400152206420898
carriers O 0 0.0003169909759890288
< O 0 0.0004317144048400223
50 O 0 0.00014131685020402074
years O 0 0.0001640590198803693
of O 0 0.0002740825875662267
age O 0 0.0011694824788719416
. O 0 0.0010152491740882397

Eye B-Disease 1 0.9974647760391235
movement I-Disease 0 0.4226035475730896
abnormalities I-Disease 1 0.9805224537849426
correlate O 0 0.0015101128956303
with O 0 0.00040421285666525364
genotype O 0 0.2780025601387024
in O 0 0.005212806630879641
autosomal O 1 0.9999591112136841
dominant O 1 0.9999853372573853
cerebellar B-Disease 1 0.9999998807907104
ataxia I-Disease 1 0.9999998807907104
type I-Disease 1 0.9999363422393799
I I-Disease 1 0.9984869956970215
. O 0 0.004136395175009966

We O 0 0.0011215636041015387
compared O 0 0.0009499697480350733
horizontal O 0 0.003460215637460351
eye O 0 0.16786812245845795
movements O 0 0.00043785618618130684
( O 0 0.0002669338136911392
visually O 0 0.0009091114043258131
guided O 0 0.0033355196937918663
saccades O 1 0.9959133267402649
, O 0 0.00032408523838967085
antisaccades O 1 0.7433245182037354
, O 0 0.00010912444849964231
and O 0 6.958744052099064e-05
smooth O 0 0.0003550731635186821
pursuit O 0 0.0004980846424587071
) O 0 3.7810961657669395e-05
in O 0 2.604535620776005e-05
control O 0 5.150814104126766e-05
subjects O 0 6.581762136192992e-05
( O 0 5.668108497047797e-05
n O 0 0.00010458825272507966
= O 0 0.00011838202772196382
14 O 0 7.740461296634749e-05
) O 0 4.256579632055946e-05
and O 0 3.947931691072881e-05
patients O 0 0.00010449811816215515
with O 0 2.594106990727596e-05
three O 0 4.413053102325648e-05
forms O 0 9.28242297959514e-05
of O 0 0.0007213131757453084
autosomal O 1 0.9989363551139832
dominant O 1 0.9990229606628418
cerebellar B-Disease 1 0.9999996423721313
ataxias I-Disease 1 0.9999978542327881
type I-Disease 1 0.9994394183158875
I I-Disease 1 0.993858277797699
spinocerebellar B-Disease 1 0.9999836683273315
ataxias I-Disease 1 0.987703800201416
1 I-Disease 0 0.0002164433099096641
and I-Disease 0 5.978937406325713e-05
2 I-Disease 0 9.15053315111436e-05
( O 0 8.811963198240846e-05
SCA1 B-Disease 0 0.012717570178210735
, O 0 6.96521092322655e-05
n O 0 0.00010797333379741758
= O 0 0.00010836178989848122
11 O 0 8.941419218899682e-05
; O 0 7.970233127707615e-05
SCA2 B-Disease 0 0.0014014056650921702
, O 0 9.051235974766314e-05
n O 0 0.00012505434278864413
= O 0 0.00017023869440890849
10 O 0 5.863049955223687e-05
) O 0 5.1813083700835705e-05
and O 0 9.454192331759259e-05
SCA3 B-Disease 1 0.9839844107627869
/ O 0 0.059138890355825424
Machado B-Disease 1 0.787825345993042
- I-Disease 1 0.5707564353942871
Joseph I-Disease 1 0.7536946535110474
disease I-Disease 1 0.9999371767044067
( O 0 0.016388045623898506
MJD B-Disease 1 0.9998971223831177
) O 0 0.00014036255015525967
( O 0 0.00010210493201157078
n O 0 0.00024171281256712973
= O 0 0.0003218005003873259
16 O 0 0.0002499564434401691
) O 0 0.00028196146013215184
. O 0 0.0007744687027297914

In O 0 0.002465158933773637
SCA1 B-Disease 1 0.9733933806419373
, O 0 0.0009274499025195837
saccade O 0 0.025228332728147507
amplitude O 0 0.000906684435904026
was O 0 0.0004134664195589721
significantly O 0 0.00021995004499331117
increased O 0 0.00013920852506998926
, O 0 0.00012443200103007257
resulting O 0 0.00027887889882549644
in O 0 0.0003266340645495802
hypermetria B-Disease 1 0.6671723127365112
. O 0 0.0016302583971992135

The O 0 0.002220532391220331
smooth O 0 0.004373399540781975
pursuit O 0 0.033244818449020386
gain O 0 0.0022545186802744865
was O 0 0.0037978782784193754
decreased O 0 0.012116915546357632
. O 0 0.0012773131020367146

In O 0 0.003490011440590024
SCA2 B-Disease 1 0.9685361981391907
, O 0 0.0017547647003084421
saccade O 0 0.10594584792852402
velocity O 0 0.002808608580380678
was O 0 0.002338613383471966
markedly O 0 0.006147486157715321
decreased O 0 0.005167726427316666
. O 0 0.0018403934082016349

The O 0 0.000702243356499821
percentage O 0 0.00047343355254270136
of O 0 0.0002293435245519504
errors O 0 0.0004966420237906277
in O 0 0.00020261493045836687
antisaccades O 1 0.9975584745407104
was O 0 0.0050692083314061165
greatly O 0 0.0003321688564028591
increased O 0 0.00010355724225519225
and O 0 5.054590292274952e-05
was O 0 9.266274719266221e-05
significantly O 0 8.721775520825759e-05
correlated O 0 0.0001230472553288564
with O 0 6.920070882188156e-05
age O 0 0.004948049318045378
at O 0 0.20526038110256195
disease O 1 0.999987006187439
onset O 1 0.9999828338623047
. O 0 0.018003221601247787

In O 0 0.0008143592276610434
addition O 0 0.00037024321500211954
, O 0 0.0001390315592288971
a O 0 0.00012557617446873337
correlation O 0 0.00015555460413452238
between O 0 8.895359496818855e-05
smooth O 0 0.0004286723560653627
pursuit O 0 0.001130207092501223
gain O 0 0.00012030304787913337
and O 0 4.422312485985458e-05
the O 0 4.197517773718573e-05
number O 0 3.63293984264601e-05
of O 0 0.00011539460683707148
trinucleotide O 1 0.7328508496284485
repeats O 0 0.0007663154392503202
was O 0 0.0005690320977009833
found O 0 0.0003903561446350068
. O 0 0.0008660375024192035

In O 0 0.002594313584268093
SCA3 B-Disease 1 0.9997797608375549
, O 0 0.0029904579278081656
gaze B-Disease 1 0.986404538154602
- I-Disease 1 0.9967365860939026
evoked I-Disease 1 0.999462902545929
nystagmus I-Disease 1 0.9996551275253296
was O 0 0.0006224900134839118
often O 0 6.656496407231316e-05
present O 0 7.957884372444823e-05
as O 0 6.10403367318213e-05
was O 0 0.00031140452483668923
saccade O 0 0.3821258842945099
hypometria O 1 0.5994183421134949
and O 0 0.00015128091035876423
smooth O 0 0.0006025676848366857
pursuit O 0 0.004867303650826216
gain O 0 0.0009052067762240767
was O 0 0.002022526692599058
markedly O 0 0.008450696244835854
decreased O 0 0.004101048689335585
. O 0 0.001202738261781633

Three O 0 0.0013558896025642753
major O 0 0.0011416890192776918
criteria O 0 0.00041149783646687865
, O 0 0.00036866957088932395
saccade O 0 0.009754519909620285
amplitude O 0 0.000584268884267658
, O 0 0.00015630931011401117
saccade O 0 0.002486701123416424
velocity O 0 0.0002092807844746858
, O 0 7.398622256005183e-05
and O 0 3.9615460991626605e-05
presence O 0 7.249244663398713e-05
of O 0 0.00011189076030859724
gaze B-Disease 0 0.21377381682395935
- I-Disease 1 0.7727653980255127
evoked I-Disease 1 0.9857686161994934
nystagmus I-Disease 1 0.9951276779174805
, O 0 9.106269862968475e-05
permitted O 0 5.893438355997205e-05
the O 0 4.232419451000169e-05
correct O 0 6.57299387967214e-05
assignment O 0 6.230949657037854e-05
of O 0 2.9087101211189292e-05
90 O 0 2.627374487929046e-05
% O 0 2.3791864805389196e-05
of O 0 3.1537558243144304e-05
the O 0 5.4654181440128013e-05
SCA1 B-Disease 1 0.696655809879303
, O 0 3.206517794751562e-05
90 O 0 3.892505628755316e-05
% O 0 1.9604100089054555e-05
of O 0 2.3681490347371437e-05
the O 0 6.685669359285384e-05
SCA2 B-Disease 1 0.8713290691375732
, O 0 3.7686873838538304e-05
and O 0 1.8107599316863343e-05
93 O 0 6.882782327011228e-05
% O 0 2.6451465600985102e-05
of O 0 2.919865983130876e-05
the O 0 8.173695823643357e-05
patients O 0 0.030553102493286133
with O 0 9.718247747514397e-05
SCA3 B-Disease 1 0.9999051094055176
to O 0 4.28543244197499e-05
their O 0 3.80431956727989e-05
genetically O 0 0.00012212706496939063
confirmed O 0 7.62699346523732e-05
patient O 0 0.0011850392911583185
group O 0 4.801386967301369e-05
and O 0 3.081580143771134e-05
, O 0 2.7230216801399365e-05
therefore O 0 3.425797331146896e-05
, O 0 3.356393426656723e-05
may O 0 4.4492073357105255e-05
help O 0 8.519647235516459e-05
orient O 0 0.0007694670930504799
diagnoses O 0 0.0591241680085659
of O 0 0.0006142532220110297
SCA1 B-Disease 1 0.9999544620513916
, O 0 0.003142341272905469
SCA2 B-Disease 1 0.9997132420539856
, O 0 0.0001361611793981865
and O 0 9.331679757451639e-05
SCA3 B-Disease 1 0.9969833493232727
at O 0 0.00018825581355486065
early O 0 0.00019837119907606393
clinical O 0 0.0011482167756184936
stages O 0 0.0007956719491630793
of O 0 0.000368613371392712
the O 0 0.02286962978541851
diseases O 1 0.9998297691345215
. O 0 0.0006684869877062738
. O 0 0.0009522679029032588

Genetic O 0 0.0032733557745814323
basis O 0 0.001007687533274293
and O 0 0.000704408623278141
molecular O 0 0.001447500311769545
mechanism O 0 0.18679040670394897
for O 1 0.598272979259491
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999998807907104
fibrillation I-Disease 1 0.9999996423721313
. O 1 0.8315106630325317

Ventricular B-Disease 1 0.9999988079071045
fibrillation I-Disease 1 0.999991774559021
causes O 0 0.4368938207626343
more O 0 8.256862201960757e-05
than O 0 4.444593650987372e-05
300 O 0 0.0001357502187602222
, O 0 7.767938222968951e-05
000 O 0 0.0003190064453519881
sudden O 0 0.00303704384714365
deaths O 0 0.00019110905122943223
each O 0 3.762000778806396e-05
year O 0 7.157050276873633e-05
in O 0 7.04609919921495e-05
the O 0 0.00023582734866067767
USA O 0 0.001893452601507306
alone O 0 0.0008015228086151183
. O 0 0.0007472335710190237

In O 0 0.0003641823714133352
approximately O 0 0.0002782420488074422
5 O 0 0.0001973386824829504
- O 0 0.00024212429707404226
12 O 0 6.832370127085596e-05
% O 0 3.0709747079527006e-05
of O 0 2.8750211640726775e-05
these O 0 1.5181946764641907e-05
cases O 0 2.435578244330827e-05
, O 0 2.1442492652568035e-05
there O 0 1.5358033124357462e-05
are O 0 9.44099883781746e-06
no O 0 4.9673919420456514e-05
demonstrable O 1 0.9943325519561768
cardiac O 1 0.9999871253967285
or O 0 0.06155576556921005
non O 1 0.9939754605293274
- O 1 0.9999778270721436
cardiac O 1 0.9999982118606567
causes O 1 0.6706334352493286
to O 0 3.7373134546214715e-05
account O 0 3.3863871067296714e-05
for O 0 1.5913203242234886e-05
the O 0 3.6745634133694693e-05
episode O 0 0.00039205377106554806
, O 0 3.793538417085074e-05
which O 0 2.883280103560537e-05
is O 0 4.983909093425609e-05
therefore O 0 8.950770279625431e-05
classified O 0 0.0005819624057039618
as O 0 0.07578510791063309
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.99951171875
IVF B-Disease 1 0.9999738931655884
) O 0 0.0016138878418132663
. O 0 0.0012493772665038705

A O 0 0.001519870711490512
distinct O 0 0.00038521437090821564
group O 0 0.0003128603275399655
of O 0 0.031631819903850555
IVF B-Disease 1 0.9999969005584717
patients O 1 0.9174957871437073
has O 0 9.631507418816909e-05
been O 0 4.10078682762105e-05
found O 0 3.052498504985124e-05
to O 0 2.3620008505531587e-05
present O 0 5.9775356930913404e-05
with O 0 4.9770551413530484e-05
a O 0 0.00026939617237076163
characteristic O 0 0.006270208396017551
electrocardiographic O 1 0.9860829710960388
pattern O 0 0.04429515823721886
. O 0 0.0014132335782051086

Because O 0 0.0005736836465075612
of O 0 0.00024017640680540353
the O 0 0.00017185299657285213
small O 0 7.958886999404058e-05
size O 0 5.453038102132268e-05
of O 0 3.621020368882455e-05
most O 0 3.043000106117688e-05
pedigrees O 0 0.00016368650540243834
and O 0 2.7798110750154592e-05
the O 0 5.946090095676482e-05
high O 0 0.0005026360158808529
incidence O 0 0.20585225522518158
of O 0 0.001370087149553001
sudden B-Disease 1 0.999581515789032
death I-Disease 1 0.8759110569953918
, O 0 0.0001074071042239666
however O 0 3.9251222915481776e-05
, O 0 3.185646346537396e-05
molecular O 0 5.169626456336118e-05
genetic O 0 5.419599619926885e-05
studies O 0 5.3362939070211723e-05
of O 0 0.00012543579214252532
IVF B-Disease 1 0.9749928116798401
have O 0 6.286714051384479e-05
not O 0 4.6624307287856936e-05
yet O 0 0.00010691682109609246
been O 0 0.00013897776079829782
done O 0 0.0006296841311268508
. O 0 0.0010751289082691073

Because O 1 0.5959620475769043
IVF B-Disease 1 0.9999872446060181
causes O 1 0.9999324083328247
cardiac O 1 0.9999978542327881
rhythm O 1 0.9999338388442993
disturbance O 1 0.9998108744621277
, O 0 0.00031925534131005406
we O 0 8.035345672396943e-05
investigated O 0 0.00017903154366649687
whether O 0 9.561338083585724e-05
malfunction O 0 0.22818492352962494
of O 0 0.0001141093234764412
ion O 0 0.0007639806135557592
channels O 0 8.015539060579613e-05
could O 0 7.040429045446217e-05
cause O 0 0.008247170597314835
the O 0 0.0003932044783141464
disorder O 1 0.9995793700218201
by O 0 6.803754513384774e-05
studying O 0 0.00012428389163687825
mutations O 0 0.00012543555931188166
in O 0 6.1003091104794294e-05
the O 0 0.00024969966034404933
cardiac O 1 0.9991872906684875
sodium O 0 0.004202126059681177
channel O 0 0.0006638137274421751
gene O 0 0.0016677678795531392
SCN5A O 1 0.8909392356872559
. O 0 0.002040621591731906

We O 0 0.0008502791752107441
have O 0 0.00019367225468158722
now O 0 0.00014932791236788034
identified O 0 0.0001547511201351881
a O 0 0.00016009759565349668
missense O 0 0.0012261884985491633
mutation O 0 0.00021800083050038666
, O 0 5.419413355411962e-05
a O 0 0.00012154663272667676
splice O 0 0.04796331003308296
- O 0 0.247576504945755
donor O 0 0.007559938356280327
mutation O 0 0.00047041100333444774
, O 0 5.352704829419963e-05
and O 0 5.197198333917186e-05
a O 0 0.00010418232704978436
frameshift O 0 0.09837092459201813
mutation O 0 0.00013756750558968633
in O 0 4.49319340987131e-05
the O 0 5.784141831099987e-05
coding O 0 0.00015463710587937385
region O 0 0.00010937061597360298
of O 0 0.0001846741361077875
SCN5A O 1 0.936057448387146
in O 0 0.00015114480629563332
three O 0 0.00030948134372010827
IVF B-Disease 1 0.9893223643302917
families O 0 0.0011100162519142032
. O 0 0.001204733271151781

We O 0 0.000967213069088757
show O 0 0.00047875134623609483
that O 0 0.00011786478717112914
sodium O 0 0.00021824371651746333
channels O 0 5.9595950006041676e-05
with O 0 5.1476316002663225e-05
the O 0 6.642558582825586e-05
missense O 0 0.0012513400288298726
mutation O 0 0.00033189094392582774
recover O 0 0.0009358483948744833
from O 0 8.748013351578265e-05
inactivation O 0 0.006475948728621006
more O 0 2.606831731100101e-05
rapidly O 0 8.398041245527565e-05
than O 0 2.3606900867889635e-05
normal O 0 2.997767660417594e-05
and O 0 1.8530812667449936e-05
that O 0 2.228478479082696e-05
the O 0 6.116794975241646e-05
frameshift O 0 0.1589300036430359
mutation O 0 0.000448958802735433
causes O 0 0.0003954405547119677
the O 0 5.770313509856351e-05
sodium O 0 9.401849820278585e-05
channel O 0 6.559718895005062e-05
to O 0 2.527319338696543e-05
be O 0 4.875194645137526e-05
non O 0 0.0003430989454500377
- O 0 0.0008564104791730642
functional O 0 0.0008798886556178331
. O 0 0.0008195493137463927

Our O 0 0.0013156903441995382
results O 0 0.0004000821791123599
indicate O 0 0.00018451570940669626
that O 0 7.033639121800661e-05
mutations O 0 0.00013079513155389577
in O 0 8.910326141631231e-05
cardiac O 1 0.9999274015426636
ion O 1 0.5392953157424927
- O 0 0.06387841701507568
channel O 0 0.00011432824976509437
genes O 0 4.3399086280260235e-05
contribute O 0 5.3686031606048346e-05
to O 0 1.935100408445578e-05
the O 0 4.3284515413688496e-05
risk O 0 0.00014722203195560724
of O 0 0.0001927447010530159
developing O 0 0.05032108351588249
IVF B-Disease 1 0.9993834495544434
. O 0 0.0004988719592802227
. O 0 0.0009394648368470371

Molecular O 0 0.0032529737800359726
heterogeneity O 0 0.005501770414412022
in O 0 0.0006554719875566661
mucopolysaccharidosis B-Disease 1 0.998596727848053
IVA I-Disease 1 0.9996065497398376
in O 0 0.00023142147983890027
Australia O 0 0.0001752203534124419
and O 0 6.459060386987403e-05
Northern O 0 0.00011360230564605445
Ireland O 0 0.00017850617587100714
: O 0 7.519448263337836e-05
nine O 0 0.00011030834866687655
novel O 0 0.00024045501777436584
mutations O 0 0.0001237576361745596
including O 0 7.137291686376557e-05
T312S O 0 0.3726103603839874
, O 0 0.00010553680476732552
a O 0 0.00012859089474659413
common O 0 0.000134033864014782
allele O 0 0.00028275587828829885
that O 0 9.98635368887335e-05
confers O 0 0.01724850758910179
a O 0 0.0026530541945248842
mild O 1 0.9879876375198364
phenotype O 1 0.6938332319259644
. O 0 0.0024123461917042732

Mucopolysaccharidosis B-Disease 1 0.999789297580719
IVA I-Disease 1 0.9999774694442749
( O 0 0.31187504529953003
MPS B-Disease 1 0.9950573444366455
IVA I-Disease 1 0.9999889135360718
) O 0 0.0006587844109162688
is O 0 0.0003841120924334973
an O 0 0.0009553313138894737
autosomal B-Disease 1 0.999812662601471
recessive I-Disease 1 0.9999935626983643
lysosomal I-Disease 1 0.9999997615814209
storage I-Disease 1 0.9999960660934448
disorder I-Disease 1 0.9999998807907104
caused O 1 0.9987661838531494
by O 0 0.00022343509772326797
a O 0 0.0019408597145229578
genetic B-Disease 0 0.38676947355270386
defect I-Disease 1 0.9935970306396484
in O 0 0.00011112158244941384
N O 0 0.003561686724424362
- O 0 0.07156669348478317
acetylgalactosamine O 1 0.9781484603881836
- O 0 0.19044961035251617
6 O 0 0.015802357345819473
- O 1 0.9381902813911438
sulfate O 1 0.99969482421875
sulfatase O 1 0.9999027252197266
( O 0 0.006074936129152775
GALNS O 1 0.9971700310707092
) O 0 0.001167533453553915
. O 0 0.0014438508078455925

Previous O 0 0.001218225690536201
studies O 0 0.0004432885907590389
of O 0 0.00028317541000433266
patients O 0 0.0030827822629362345
from O 0 9.058894647751004e-05
a O 0 0.00019833807891700417
British O 0 0.0011379205388948321
- O 0 0.02700972557067871
Irish O 0 0.0007311938679777086
population O 0 5.2878051064908504e-05
showed O 0 9.885798499453813e-05
that O 0 2.562861300248187e-05
the O 0 8.17578547867015e-05
I113F O 1 0.9263218641281128
mutation O 0 0.00018151324184145778
is O 0 2.632182076922618e-05
the O 0 2.529045559640508e-05
most O 0 1.787659857654944e-05
common O 0 2.4331777240149677e-05
single O 0 6.625906826229766e-05
mutation O 0 0.0002838257059920579
among O 0 0.000312715390464291
MPS B-Disease 1 0.9978184700012207
IVA I-Disease 1 0.9999996423721313
patients O 1 0.9891721606254578
and O 0 0.0016902430215850472
produces O 0 0.05745990201830864
a O 0 0.1159101203083992
severe O 1 0.9999483823776245
clinical O 1 0.9993780851364136
phenotype O 1 0.9962323307991028
. O 0 0.0026497431099414825

We O 0 0.0007415948784910142
studied O 0 0.0005213611293584108
mutations O 0 0.00030665824306197464
in O 0 8.737409370951355e-05
the O 0 0.00012779976532328874
GALNS O 1 0.7593392729759216
gene O 0 0.00014551762433256954
from O 0 7.336355338338763e-05
23 O 0 0.00013009979738853872
additional O 0 0.000146019970998168
MPS B-Disease 0 0.3679980933666229
IVA I-Disease 1 0.9999861717224121
patients O 0 0.11550716310739517
( O 0 9.596559539204463e-05
15 O 0 7.185821596067399e-05
from O 0 3.198522608727217e-05
Australia O 0 4.984137194696814e-05
, O 0 2.727668652369175e-05
8 O 0 3.3537220588186756e-05
from O 0 2.174189103243407e-05
Northern O 0 4.2619900341378525e-05
Ireland O 0 6.251662853173912e-05
) O 0 3.056597415707074e-05
, O 0 2.1650972485076636e-05
with O 0 2.5150402507279068e-05
various O 0 4.0433198591927066e-05
clinical O 0 0.0942252054810524
phenotypes O 1 0.8374723792076111
( O 0 0.0028617680072784424
severe O 1 0.9609582424163818
, O 0 4.330904266680591e-05
16 O 0 7.23107295925729e-05
cases O 0 3.4784956369549036e-05
; O 0 2.0308572857175022e-05
intermediate O 0 7.819823076715693e-05
, O 0 2.7711346774594858e-05
4 O 0 4.145595448790118e-05
cases O 0 4.699377313954756e-05
; O 0 3.741032924153842e-05
mild O 0 0.001092245220206678
, O 0 5.1586244808277115e-05
3 O 0 0.00012411881471052766
cases O 0 0.0001522417733212933
) O 0 0.0003105364739894867
. O 0 0.0007751428056508303

We O 0 0.0005828027497045696
found O 0 0.00019565247930586338
two O 0 8.078246901277453e-05
common O 0 9.181274799630046e-05
mutations O 0 7.817340519977733e-05
that O 0 2.193394539062865e-05
together O 0 3.118989116046578e-05
accounted O 0 6.675045005977154e-05
for O 0 2.0045001292601228e-05
32 O 0 4.589992022374645e-05
% O 0 2.0230534573784098e-05
of O 0 3.627829937613569e-05
the O 0 5.342088115867227e-05
44 O 0 0.00019816038548015058
unrelated O 0 0.0003001281002070755
alleles O 0 0.00017008002032525837
in O 0 8.139052806654945e-05
these O 0 0.00011161263682879508
patients O 0 0.007112162187695503
. O 0 0.0008487869636155665

One O 0 0.0006963006453588605
is O 0 0.00025194327463395894
the O 0 0.0002655283606145531
T312S O 1 0.9843160510063171
mutation O 0 0.0013470555422827601
, O 0 9.153692371910438e-05
a O 0 0.00010905360977631062
novel O 0 0.00035027641570195556
mutation O 0 0.0001717884442768991
found O 0 7.302781159523875e-05
exclusively O 0 0.00012060454173479229
in O 0 0.00015071104280650616
milder O 0 0.04035664349794388
patients O 0 0.08067779988050461
. O 0 0.001347537967376411

The O 0 0.0008019387605600059
other O 0 0.00017676939023658633
is O 0 0.0001492434967076406
the O 0 0.00013827109069097787
previously O 0 0.0002203761541750282
described O 0 0.0004298029525671154
I113F O 1 0.6981847286224365
that O 0 0.00022369428188540041
produces O 0 0.0009499046136625111
a O 0 0.0016753001837059855
severe O 1 0.9996552467346191
phenotype O 1 0.9598010182380676
. O 0 0.002024896675720811

The O 0 0.002706406405195594
I113F O 1 0.8923543095588684
and O 0 0.0005228312220424414
T312S O 0 0.2794719934463501
mutations O 0 0.00028208407456986606
accounted O 0 0.00020542170386761427
for O 0 3.3974174584727734e-05
8 O 0 5.3800013120053336e-05
( O 0 3.1825249607209116e-05
18 O 0 2.7279289497528225e-05
% O 0 1.5388322935905308e-05
) O 0 1.236934622284025e-05
and O 0 1.3484645023709163e-05
6 O 0 2.9502572942874394e-05
( O 0 2.1810690668644384e-05
14 O 0 3.172545984853059e-05
% O 0 1.821574187488295e-05
) O 0 1.7482974726590328e-05
of O 0 3.824026862275787e-05
44 O 0 0.00011122186697321013
unrelated O 0 0.00030550381052307785
alleles O 0 0.00036833059857599437
, O 0 0.00018204782099928707
respectively O 0 0.0006187788676470518
. O 0 0.0007819459424354136

The O 0 0.001372616970911622
relatively O 0 0.0007049841806292534
high O 0 0.0009870176436379552
residual O 0 0.06817401200532913
GALNS O 1 0.9835493564605713
activity O 0 0.00030671965214423835
seen O 0 0.00017779767222236842
when O 0 8.857388456817716e-05
the O 0 0.00013811349344905466
T312S O 0 0.11555562913417816
mutant O 0 0.0011758663458749652
cDNA O 0 0.0005994109669700265
is O 0 0.0001648515317356214
overexpressed O 0 0.0008971418137662113
in O 0 0.00010100194776896387
mutant O 0 0.0018854395020753145
cells O 0 0.00014298321912065148
provides O 0 6.277529610088095e-05
an O 0 3.426058538025245e-05
explanation O 0 0.00010907962132478133
for O 0 4.880725828115828e-05
the O 0 0.00015198982146102935
mild O 1 0.8874631524085999
phenotype O 0 0.4451667368412018
in O 0 0.00014610729704145342
patients O 0 0.116031713783741
with O 0 0.000176786765223369
this O 0 0.00026896115741692483
mutation O 0 0.0027671351563185453
. O 0 0.0008185011683963239

The O 0 0.0008245937060564756
distribution O 0 0.00037968886317685246
and O 0 9.854061499936506e-05
relative O 0 9.479469008510932e-05
frequencies O 0 6.235623004613444e-05
of O 0 5.71587479498703e-05
the O 0 8.506584708811715e-05
I113F O 1 0.5544596910476685
and O 0 0.00010761829616967589
T312S O 1 0.725725531578064
mutations O 0 0.00015461941075045615
in O 0 4.0449511288898066e-05
Australia O 0 8.008020813576877e-05
corresponded O 0 8.147300104610622e-05
to O 0 1.7117185052484274e-05
those O 0 1.4185328836902045e-05
observed O 0 2.3757836970617063e-05
in O 0 2.1799462047056295e-05
Northern O 0 5.571018482442014e-05
Ireland O 0 5.4010928579373285e-05
and O 0 1.9282841094536707e-05
are O 0 9.18027672014432e-06
unique O 0 1.3024530744587537e-05
to O 0 6.730787845299346e-06
these O 0 5.830919235449983e-06
two O 0 1.1082339369750116e-05
populations O 0 1.9982286175945774e-05
, O 0 2.2289481421466917e-05
suggesting O 0 4.877329047303647e-05
that O 0 1.5559588064206764e-05
both O 0 2.2758242266718298e-05
mutations O 0 5.485891961143352e-05
were O 0 2.8215017664479092e-05
probably O 0 6.528826634166762e-05
introduced O 0 4.1903382225427777e-05
to O 0 1.913895357574802e-05
Australia O 0 4.1966130083892494e-05
by O 0 2.874977326428052e-05
Irish O 0 0.00010681573621695861
migrants O 0 0.00011267750960541889
during O 0 0.00014538476534653455
the O 0 0.00019385828636586666
19th O 0 0.000921350612770766
century O 0 0.0012027423363178968
. O 0 0.000798298860900104

Haplotype O 0 0.0076065026223659515
analysis O 0 0.000739494280423969
using O 0 0.0003159133193548769
6 O 0 0.0008109871414490044
RFLPs O 0 0.006286379881203175
provides O 0 0.00022627248836215585
additional O 0 7.217995880637318e-05
data O 0 4.401843762025237e-05
that O 0 3.1150302675087005e-05
the O 0 8.936969970818609e-05
I113F O 0 0.056878428906202316
mutation O 0 0.0002137026604032144
originated O 0 0.00017011504678521305
from O 0 8.55751713970676e-05
a O 0 0.00021297138300724328
common O 0 0.00040965687367133796
ancestor O 0 0.003103335155174136
. O 0 0.001360201626084745

The O 0 0.0009904083563014865
other O 0 0.00018527201609686017
9 O 0 0.00037067991797812283
novel O 0 0.00033711217110976577
mutations O 0 0.00014440712402574718
identified O 0 5.922666605329141e-05
in O 0 3.013112655025907e-05
these O 0 2.0102892449358478e-05
23 O 0 0.00011989842460025102
patients O 0 0.00016688843606971204
were O 0 2.232852239103522e-05
each O 0 2.1454521629493684e-05
limited O 0 2.6293620976503007e-05
to O 0 2.591419433883857e-05
a O 0 9.929769294103608e-05
single O 0 0.00024236751778516918
family O 0 0.000669571163598448
. O 0 0.0008620030130259693

These O 0 0.0007099236827343702
data O 0 0.00021203106734901667
provide O 0 0.0001900050847325474
further O 0 0.00013512953591998667
evidence O 0 0.00010860654583666474
for O 0 6.522914918605238e-05
extensive O 0 0.00023057925864122808
allelic O 0 0.002734687179327011
heterogeneity O 0 0.0012185233645141125
in O 0 0.0001538436335977167
MPS B-Disease 0 0.1812254637479782
IVA I-Disease 1 0.9998729228973389
in O 0 0.000200605922145769
British O 0 0.01328597217798233
- O 1 0.772830605506897
Irish O 0 0.1902478039264679
patients O 0 0.10835245996713638
and O 0 4.256701504345983e-05
provide O 0 4.004199581686407e-05
evidence O 0 4.404048013384454e-05
for O 0 2.0587855033227243e-05
their O 0 1.835216608014889e-05
transmission O 0 6.465075421147048e-05
to O 0 1.959905421244912e-05
Australia O 0 4.5036002120468765e-05
by O 0 4.361184255685657e-05
British O 0 0.0001685792813077569
- O 0 0.0008848811266943812
Irish O 0 0.0006286287680268288
migrants O 0 0.00036519355489872396
. O 0 0.0003142482601106167
. O 0 0.0005894332425668836

Identification O 0 0.002272526267915964
of O 0 0.000899729726370424
constitutional O 0 0.01544854138046503
WT1 O 1 0.9998301267623901
mutations O 0 0.002048891270533204
, O 0 0.0001457361940992996
in O 0 0.0001325501361861825
patients O 0 0.044291071593761444
with O 0 0.00030766031704843044
isolated O 1 0.9963712692260742
diffuse B-Disease 1 0.9999986886978149
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.002748392755165696
and O 0 0.00010937103070318699
analysis O 0 5.404916373663582e-05
of O 0 0.0002318994520464912
genotype O 1 0.821065366268158
/ O 1 0.7094002366065979
phenotype O 0 0.005405702628195286
correlations O 0 0.00015728530706837773
by O 0 4.068937778356485e-05
use O 0 3.788802132476121e-05
of O 0 8.87978239916265e-05
a O 0 0.00027438797405920923
computerized O 0 0.0033066817559301853
mutation O 0 0.0011609159409999847
database O 0 0.0010667771566659212
. O 0 0.0011686405632644892

Constitutional O 0 0.0031509927939623594
mutations O 0 0.0010168057633563876
of O 0 0.000385059422114864
the O 0 0.0003930798848159611
WT1 O 1 0.9922047257423401
gene O 0 0.00021743163233622909
, O 0 7.140886737033725e-05
encoding O 0 7.887968968134373e-05
a O 0 0.00014416154590435326
zinc O 1 0.6433477997779846
- O 0 0.009653549641370773
finger O 0 0.01070978119969368
transcription O 0 0.0006177996983751655
factor O 0 0.000513044185936451
involved O 0 0.00024631552514620125
in O 0 0.0004386671644169837
renal O 1 0.9999985694885254
and O 0 0.012522589415311813
gonadal O 1 0.9999743700027466
development O 0 0.021518342196941376
, O 0 5.280261757434346e-05
are O 0 8.685070497449487e-06
found O 0 1.4905068383086473e-05
in O 0 1.8257727788295597e-05
most O 0 2.519508052500896e-05
patients O 0 0.0004810690588783473
with O 0 0.00018210992857348174
Denys B-Disease 1 0.9999951124191284
- I-Disease 1 0.9999969005584717
Drash I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 1 0.994860053062439
DDS B-Disease 1 0.999998927116394
) O 0 0.0006457397248595953
, O 0 0.0004682921280618757
or O 0 0.006868619006127119
diffuse B-Disease 1 0.9999501705169678
mesangial I-Disease 1 0.9999998807907104
sclerosis I-Disease 1 1.0
( O 1 0.9880036115646362
DMS B-Disease 1 0.9999595880508423
) O 0 0.00012193390284664929
associated O 0 8.857329521561041e-05
with O 0 7.265702151926234e-05
pseudohermaphroditism B-Disease 1 0.9852801561355591
and O 0 0.00025980742066167295
/ O 1 0.8883147239685059
or O 0 0.09500548243522644
Wilms B-Disease 1 0.9999991655349731
tumor I-Disease 1 0.9999912977218628
( O 0 0.08382716029882431
WT B-Disease 1 0.9987345337867737
) O 0 0.0010262922151014209
. O 0 0.0014964466681703925

Most O 0 0.0013967646518722177
mutations O 0 0.001439408166334033
in O 0 0.0005911696935072541
DDS B-Disease 1 0.9999439716339111
patients O 0 0.03144186735153198
lie O 0 0.0005687811062671244
in O 0 0.00012997207522857934
exon O 0 0.0008196122362278402
8 O 0 0.00018781836843118072
or O 0 7.686903700232506e-05
exon O 0 0.0002979672863148153
9 O 0 0.00012964257621206343
, O 0 6.067060894565657e-05
encoding O 0 9.534714627079666e-05
zinc O 0 0.000885701912920922
finger O 0 0.0004174701462034136
2 O 0 0.00010274418309563771
or O 0 7.14870766387321e-05
zinc O 0 0.04342291131615639
finger O 0 0.0010445649968460202
3 O 0 7.767864008201286e-05
, O 0 3.2875683245947585e-05
respectively O 0 3.667645432869904e-05
, O 0 3.1489420507568866e-05
with O 0 2.2126638214103878e-05
a O 0 5.3085914260009304e-05
hot O 0 0.00029507523868232965
spot O 0 0.00029223470482975245
( O 0 0.00012640500790439546
R394W O 0 0.0025270285550504923
) O 0 8.190096559701487e-05
in O 0 9.061885066330433e-05
exon O 0 0.001037951442413032
9 O 0 0.0007067580590955913
. O 0 0.0007533302414231002

We O 0 0.0005644573247991502
analyzed O 0 0.0003450123476795852
a O 0 0.00011274758435320109
series O 0 9.59635799517855e-05
of O 0 6.173567089717835e-05
24 O 0 0.00016296529793180525
patients O 0 0.0004840167239308357
, O 0 4.392781193018891e-05
10 O 0 6.047173519618809e-05
with O 0 4.1567116568330675e-05
isolated B-Disease 0 0.022000456228852272
DMS I-Disease 1 0.9999630451202393
( O 0 0.003451639786362648
IDMS B-Disease 1 0.9948358535766602
) O 0 4.161836113780737e-05
, O 0 3.270628803875297e-05
10 O 0 4.704982347902842e-05
with O 0 4.704722232418135e-05
DDS B-Disease 1 0.9653549194335938
, O 0 7.6031603384763e-05
and O 0 7.428633398376405e-05
4 O 0 0.00015183757932391018
with O 0 0.00031689880415797234
urogenital B-Disease 1 0.999984622001648
abnormalities I-Disease 1 0.9998507499694824
and O 0 0.006759924814105034
/ O 1 0.9478455185890198
or O 0 0.0030669867992401123
WT B-Disease 1 0.9949368238449097
. O 0 0.002771607134491205

We O 0 0.002244104165583849
report O 0 0.000919150363188237
WT1 O 1 0.8952654004096985
heterozygous O 0 0.0007755343685857952
mutations O 0 0.00023519861861132085
in O 0 7.189975440269336e-05
16 O 0 0.00027178434538654983
patients O 0 0.001969036413356662
, O 0 6.119245517766103e-05
4 O 0 0.0001014570880215615
of O 0 0.00011544522567419335
whom O 0 0.0004298996354918927
presented O 0 0.0007155024213716388
with O 0 0.0006521271425299346
IDMS B-Disease 1 0.9989350438117981
. O 0 0.001469266600906849

One O 0 0.001174764707684517
male O 0 0.0009372757631354034
and O 0 0.00026438175700604916
two O 0 0.00024339687661267817
female O 1 0.9198525547981262
IDMS B-Disease 1 0.999997615814209
patients O 1 0.9997302889823914
with O 1 0.7196359634399414
WT1 O 1 0.9999992847442627
mutations O 1 0.9951135516166687
underwent O 1 0.9999632835388184
normal O 1 0.5892235040664673
puberty O 1 0.9953237175941467
. O 0 0.0022734033409506083

Two O 0 0.0009664259268902242
mutations O 0 0.0014180700527504086
associated O 0 0.00043315719813108444
with O 0 0.00027913268422707915
IDMS B-Disease 1 0.9901665449142456
are O 0 2.551210309320595e-05
different O 0 2.3199598217615858e-05
from O 0 3.347494202898815e-05
those O 0 4.767446080222726e-05
described O 0 0.0002361778897466138
in O 0 0.0004700412100646645
DDS B-Disease 1 0.9999706745147705
patients O 1 0.8968494534492493
. O 0 0.0015034038806334138

No O 0 0.006839931011199951
WT1 O 1 0.9974958300590515
mutations O 0 0.0007739750435575843
were O 0 0.0001429248950444162
detected O 0 0.0001958649227162823
in O 0 5.799440259579569e-05
the O 0 6.841386493761092e-05
six O 0 0.00011564796295715496
other O 0 0.0001160564788733609
IDMS B-Disease 1 0.999984860420227
patients O 1 0.605623722076416
, O 0 0.00021312781609594822
suggesting O 0 0.0006319422973319888
genetic O 0 0.0004908732953481376
heterogeneity O 0 0.02335876226425171
of O 0 0.0037188101559877396
this O 0 0.003710034769028425
disease O 1 0.999813973903656
. O 0 0.0028617214411497116

We O 0 0.0019549590069800615
analyzed O 0 0.002014411147683859
genotype O 0 0.011562366038560867
/ O 0 0.028841722756624222
phenotype O 0 0.0015136011643335223
correlations O 0 0.0002761492214631289
, O 0 6.05686946073547e-05
on O 0 2.7857977329404093e-05
the O 0 3.4572116419440135e-05
basis O 0 2.84545876638731e-05
of O 0 4.501513467403129e-05
the O 0 4.664285006583668e-05
constitution O 0 6.504912744276226e-05
of O 0 7.256077515194193e-05
a O 0 0.00033601545146666467
WT1 O 1 0.9134023785591125
mutation O 0 0.00018272254965268075
database O 0 5.981920548947528e-05
of O 0 6.893528188811615e-05
84 O 0 0.004109933506697416
germ O 1 0.9997115731239319
- O 0 0.22187332808971405
line O 0 0.00027815558132715523
mutations O 0 8.142811566358432e-05
, O 0 2.878626219171565e-05
to O 0 1.7831800505518913e-05
compare O 0 3.900800220435485e-05
the O 0 2.875333848351147e-05
distribution O 0 3.528188244672492e-05
and O 0 3.623970769695006e-05
type O 0 7.638872921233997e-05
of O 0 6.593622674699873e-05
mutations O 0 0.00011144460586365312
, O 0 3.9255639421753585e-05
according O 0 2.8794165700674057e-05
to O 0 2.65593462245306e-05
the O 0 8.141320722643286e-05
different O 0 0.00015024484309833497
symptoms O 1 0.7545227408409119
. O 0 0.0011741291964426637

This O 0 0.0006180106429383159
demonstrated O 0 0.0008053819183260202
( O 0 0.0002140068681910634
1 O 0 0.0001313162356382236
) O 0 4.8829784645931795e-05
the O 0 4.483905286178924e-05
association O 0 6.959168240427971e-05
between O 0 2.3711772882961668e-05
mutations O 0 3.632904918049462e-05
in O 0 1.850511944212485e-05
exons O 0 9.352811321150512e-05
8 O 0 5.501792111317627e-05
and O 0 2.4832475901348516e-05
9 O 0 8.72824020916596e-05
and O 0 7.346611528191715e-05
DMS B-Disease 1 0.5453305244445801
; O 0 4.836546941078268e-05
( O 0 5.1134960813215e-05
2 O 0 6.175793532747775e-05
) O 0 4.5159602450439706e-05
among O 0 5.526791210286319e-05
patients O 0 0.00047726003685966134
with O 0 8.066668669926003e-05
DMS B-Disease 1 0.9822143912315369
, O 0 3.817206379608251e-05
a O 0 4.404215724207461e-05
higher O 0 3.258261131122708e-05
frequency O 0 2.5966886823880486e-05
of O 0 2.8461699912440963e-05
exon O 0 0.00016851643158588558
8 O 0 7.305316103156656e-05
mutations O 0 5.315409362083301e-05
among O 0 4.255333624314517e-05
46 O 0 0.00012877103290520608
, O 0 0.00017580743588041514
XY O 1 0.9955748319625854
patients O 0 0.025046948343515396
with O 0 7.92297869338654e-05
female O 0 0.004671962931752205
phenotype O 0 0.0017142905853688717
than O 0 2.8425680284271948e-05
among O 0 3.823618681053631e-05
46 O 0 0.00017892847245093435
, O 0 0.0003083098563365638
XY O 1 0.9989834427833557
patients O 0 0.02061905711889267
with O 0 5.673159466823563e-05
sexual O 0 0.00034364956081844866
ambiguity O 0 0.00184051098767668
or O 0 0.000260111759416759
male O 0 0.026583829894661903
phenotype O 0 0.07727820426225662
; O 0 3.486240530037321e-05
and O 0 2.4801352992653847e-05
( O 0 4.2110295908059925e-05
3 O 0 3.851901419693604e-05
) O 0 2.8503258363343775e-05
statistically O 0 2.39807504840428e-05
significant O 0 1.7527279851492494e-05
evidence O 0 2.1745125195593573e-05
that O 0 1.4596863366023172e-05
mutations O 0 2.6562132916296832e-05
in O 0 1.8719942090683617e-05
exons O 0 8.48943818709813e-05
8 O 0 6.731597386533394e-05
and O 0 2.983274134749081e-05
9 O 0 6.36715631117113e-05
preferentially O 0 7.968425779836252e-05
affect O 0 5.756567406933755e-05
amino O 0 3.6173209082335234e-05
acids O 0 4.254948362358846e-05
with O 0 3.006066799571272e-05
different O 0 3.160045525874011e-05
functions O 0 0.00010969545837724581
. O 0 0.00015319339581765234
. O 0 0.0005168667994439602

The O 0 0.0034364783205091953
185delAG O 1 0.9974910020828247
BRCA1 O 1 0.9677746891975403
mutation O 0 0.0010174874914810061
originated O 0 0.0003629020066000521
before O 0 0.00014383462257683277
the O 0 9.319408127339557e-05
dispersion O 0 0.00025243571144528687
of O 0 6.798696267651394e-05
Jews O 0 0.00011380288196960464
in O 0 3.518914309097454e-05
the O 0 7.227239984786138e-05
diaspora O 0 0.00024012693029362708
and O 0 5.4831671150168404e-05
is O 0 4.640982660930604e-05
not O 0 3.989288961747661e-05
limited O 0 0.00012638236512430012
to O 0 0.00016170697927009314
Ashkenazim O 0 0.005189845338463783
. O 0 0.0011527372989803553

The O 0 0.0019140489166602492
185delAG O 1 0.9783841371536255
mutation O 0 0.009062351658940315
in O 0 0.00026518505183048546
BRCA1 O 1 0.9751274585723877
is O 0 0.00012705889821518213
detected O 0 0.00020983145805075765
in O 0 6.138187018223107e-05
Ashkenazi O 0 0.0003917925641871989
Jews O 0 0.00012850019265897572
both O 0 5.526559834834188e-05
in O 0 0.00019064602383878082
familial B-Disease 1 0.99998939037323
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.9999725818634033
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
and O 0 0.0013593335170298815
in O 0 0.00015642144717276096
the O 0 0.0003258841170463711
general O 0 0.0008128095651045442
population O 0 0.0002870368189178407
. O 0 0.000625789980404079

All O 0 0.0014275998109951615
tested O 0 0.002384172286838293
Ashkenazi O 0 0.005077353212982416
mutation O 0 0.0007645320147275925
carriers O 0 0.00022305536549538374
share O 0 6.175669113872573e-05
the O 0 6.857697007944807e-05
same O 0 8.590089419158176e-05
allelic O 0 0.0018719389336183667
pattern O 0 0.0005867704749107361
at O 0 0.00029678671853616834
the O 0 0.0006358782993629575
BRCA1 O 1 0.968781590461731
locus O 0 0.016985371708869934
. O 0 0.0013756484258919954

Our O 0 0.0015683621168136597
previous O 0 0.0004921462968923151
study O 0 0.00027957241400144994
showed O 0 0.00023845415853429586
that O 0 5.294172660796903e-05
this O 0 5.0761289458023384e-05
Ashkenazi O 0 0.0012896156404167414
mutation O 0 0.00019758155394811183
also O 0 5.333516310201958e-05
occurs O 0 4.916874604532495e-05
in O 0 2.5121278667938896e-05
Iraqi O 0 0.00013361811579670757
Jews O 0 0.00016211938054766506
with O 0 6.539519381476566e-05
a O 0 0.00022132074809633195
similar O 0 0.00034698998206295073
allelic O 0 0.060444239526987076
pattern O 0 0.0040790969505906105
. O 0 0.0013131777523085475

We O 0 0.0007417825399897993
extended O 0 0.0004508417041506618
our O 0 0.0001243660517502576
analysis O 0 5.7522269344190136e-05
to O 0 2.9913077014498413e-05
other O 0 3.072937761317007e-05
non O 0 0.00012888909259345382
- O 0 0.00022376702690962702
Ashkenazi O 0 0.000320105638820678
subsets O 0 0.00024118402507156134
354 O 0 0.00028728871257044375
of O 0 9.514007979305461e-05
Moroccan O 0 0.00034806891926564276
origin O 0 8.441173122264445e-05
, O 0 8.334767335327342e-05
200 O 0 0.00026878839707933366
Yemenites O 0 0.002240316942334175
and O 0 0.00015599216567352414
150 O 0 0.0003807938483078033
Iranian O 0 0.000628716021310538
Jews O 0 0.0013024992076680064
. O 0 0.0008793548331595957

Heteroduplex O 0 0.0894249901175499
analysis O 0 0.0009545061038807034
complemented O 0 0.001008809544146061
by O 0 0.0001599065726622939
direct O 0 0.0001538437936687842
DNA O 0 0.000191310333320871
sequencing O 0 0.000286414404399693
of O 0 0.00015769964375067502
abnormally O 0 0.0022665872238576412
migrating O 0 0.00040141501813195646
bands O 0 0.00043100223410874605
were O 0 0.0002318265032954514
employed O 0 0.0011663723271340132
. O 0 0.0010004396317526698

Four O 0 0.0006052851094864309
of O 0 0.0002682090562302619
Moroccan O 0 0.0007707212935201824
origin O 0 0.00012525722559075803
( O 0 7.233962969621643e-05
1 O 0 4.7107383579714224e-05
. O 0 2.217645123891998e-05
1 O 0 2.9362654458964244e-05
% O 0 2.5510786144877784e-05
) O 0 1.7549056792631745e-05
and O 0 1.608107595529873e-05
none O 0 3.803764411713928e-05
of O 0 4.568907752400264e-05
the O 0 9.129031968768686e-05
Yemenites O 0 0.09911248832941055
or O 0 7.395957072731107e-05
Iranians O 0 0.00015279921353794634
was O 0 0.00012451056682039052
a O 0 0.0001211168200825341
carrier O 0 0.000311777665046975
of O 0 0.00016031635459512472
the O 0 0.00038686822517775
185delAG O 1 0.9928597807884216
mutation O 0 0.0131119629368186
. O 0 0.0010553267784416676

BRCA1 O 1 0.9865947961807251
allelic O 0 0.05676046758890152
patterns O 0 0.000655304582323879
were O 0 0.00012009317288175225
determined O 0 0.00011787310359068215
for O 0 3.368662146385759e-05
four O 0 3.606841710279696e-05
of O 0 3.3123036700999364e-05
these O 0 1.5030079339339864e-05
individuals O 0 1.9443530618445948e-05
and O 0 1.650124613661319e-05
for O 0 1.9497823814162984e-05
12 O 0 4.989410808775574e-05
additional O 0 7.618778909090906e-05
non O 0 0.00020580242562573403
- O 0 0.0010415054857730865
Ashkenazi O 0 0.0022546774707734585
185delAG O 1 0.5651577711105347
mutation O 0 0.00208635744638741
carriers O 0 0.0005870380555279553
who O 0 0.0008908614399842918
had O 1 0.9321884512901306
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
. O 0 0.23887528479099274

Six O 0 0.0024324788246303797
non O 0 0.012303979136049747
- O 0 0.05921213701367378
Ashkenazi O 0 0.002728336723521352
individuals O 0 0.00014136215031612664
shared O 0 0.00012272688036318868
the O 0 0.00010349870717618614
common O 0 0.00018969822849612683
Ashkenazi O 0 0.07550273835659027
haplotype O 0 0.00241609918884933
, O 0 3.7691977922804654e-05
four O 0 3.0730374419363216e-05
had O 0 4.62844836874865e-05
a O 0 3.727753210114315e-05
closely O 0 3.765590372495353e-05
related O 0 6.098261656006798e-05
pattern O 0 0.00017222372116521
, O 0 3.672934326459654e-05
and O 0 3.3637155866017565e-05
the O 0 3.734898200491443e-05
rest O 0 8.901401452021673e-05
( O 0 4.954415271640755e-05
n O 0 0.0001036442699842155
= O 0 0.00012324970157351345
6 O 0 0.00010133758041774854
) O 0 7.048169209156185e-05
displayed O 0 0.00016674194193910807
a O 0 0.0001644841249799356
distinct O 0 0.00036994199035689235
BRCA1 O 0 0.34454163908958435
allelic O 0 0.0735127404332161
pattern O 0 0.005340164992958307
. O 0 0.0017968099564313889

We O 0 0.0011153393425047398
conclude O 0 0.0008775225142017007
that O 0 0.00017464673146605492
the O 0 0.0003269213193561882
185delAG O 1 0.9789013266563416
BRCA1 O 1 0.950575053691864
mutation O 0 0.0004501202784013003
occurs O 0 8.638901636004448e-05
in O 0 3.17634257953614e-05
some O 0 3.322667544125579e-05
non O 0 0.0002119920391123742
- O 0 0.0018501352751627564
Ashkenazi O 0 0.0006044693291187286
populations O 0 5.6989047152455896e-05
at O 0 5.326872269506566e-05
rates O 0 4.993147376808338e-05
comparable O 0 7.814552373019978e-05
with O 0 4.362723120721057e-05
that O 0 7.232099596876651e-05
of O 0 0.00034032127587124705
Ashkenazim O 0 0.15909966826438904
. O 0 0.0011753326980397105

The O 0 0.0007847429369576275
majority O 0 0.00040254087070934474
of O 0 0.0002792743325699121
Jewish O 0 0.011642328463494778
185delAG O 1 0.9995356798171997
mutation O 0 0.05349823832511902
carriers O 0 0.00043869554065167904
have O 0 3.7206853448878974e-05
a O 0 0.00010278406989527866
common O 0 0.000144010700751096
allelic O 0 0.0671641081571579
pattern O 0 0.0022520101629197598
, O 0 0.00010161249520024285
supporting O 0 0.00013722215953748673
the O 0 7.018416363280267e-05
founder O 0 0.009144731797277927
effect O 0 0.00010473415750311688
notion O 0 0.00012349628377705812
, O 0 3.330484832986258e-05
but O 0 2.172448148485273e-05
dating O 0 4.671433998737484e-05
the O 0 2.866586328309495e-05
mutations O 0 3.8716778362868354e-05
origin O 0 2.064837644866202e-05
to O 0 1.687519579718355e-05
an O 0 2.3945489374455065e-05
earlier O 0 5.1713373977690935e-05
date O 0 8.661288302391768e-05
than O 0 5.473586134030484e-05
currently O 0 0.00014603667659685016
estimated O 0 0.00041539553785696626
. O 0 0.0007196313817985356

However O 0 0.0009075345005840063
, O 0 0.00023624727327842265
the O 0 0.0001564772246638313
different O 0 6.542943447129801e-05
allelic O 0 0.000986147322691977
pattern O 0 0.00036939853453077376
at O 0 0.00013114817556925118
the O 0 0.00018497969722375274
BRCA1 O 1 0.763242244720459
locus O 0 0.0006410839268937707
even O 0 5.397452332545072e-05
in O 0 3.152370118186809e-05
some O 0 2.613522701722104e-05
Jewish O 0 0.00021257821936160326
mutation O 0 0.0012254202738404274
carriers O 0 0.00021909960196353495
, O 0 4.760359297506511e-05
might O 0 5.951445200480521e-05
suggest O 0 4.8292098654201254e-05
that O 0 2.68321546172956e-05
the O 0 6.194868183229119e-05
mutation O 0 0.00017543767171446234
arose O 0 0.0003135981969535351
independently O 0 0.00012126116052968428
. O 0 0.00020188905182294548
. O 0 0.00047225624439306557

Crystal O 0 0.013438125140964985
structure O 0 0.0018661362119019032
of O 0 0.0008007700089365244
the O 0 0.005985064897686243
hemochromatosis B-Disease 1 0.9999988079071045
protein O 0 0.01902478188276291
HFE O 1 0.9996155500411987
and O 0 0.00017684356134850532
characterization O 0 0.0004513538733590394
of O 0 0.00013843020133208483
its O 0 0.00011363699013600126
interaction O 0 0.0003173810546286404
with O 0 0.0002714228758122772
transferrin O 1 0.7143911719322205
receptor O 0 0.0018041245639324188
. O 0 0.0011274564312770963

HFE O 1 0.9958046078681946
is O 0 0.0006766620208509266
an O 0 0.0006157150492072105
MHC O 1 0.979541003704071
- O 0 0.010607822798192501
related O 0 0.00014663611364085227
protein O 0 9.398890688316897e-05
that O 0 3.72052236343734e-05
is O 0 3.658510831883177e-05
mutated O 0 0.00015682152297813445
in O 0 6.354042852763087e-05
the O 0 0.0006431901128962636
iron B-Disease 1 0.9999934434890747
- I-Disease 1 0.9999961853027344
overload I-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999998807907104
hereditary B-Disease 1 0.9999997615814209
hemochromatosis I-Disease 1 1.0
. O 1 0.9946711659431458

HFE O 1 0.9614150524139404
binds O 0 0.003909000661224127
to O 0 0.0009065812337212265
transferrin O 1 0.8480739593505859
receptor O 0 0.0036238606553524733
( O 0 0.0009935820708051324
TfR O 1 0.7222424745559692
) O 0 0.00014014056068845093
and O 0 6.800175469834358e-05
reduces O 0 0.00010516829934203997
its O 0 3.703904803842306e-05
affinity O 0 9.919812873704359e-05
for O 0 6.891805969644338e-05
iron O 1 0.7829071283340454
- O 0 0.02478640154004097
loaded O 0 0.002690546680241823
transferrin O 0 0.3881417214870453
, O 0 0.0004094191244803369
implicating O 1 0.6553512811660767
HFE O 1 0.9994646906852722
in O 0 0.0011010330636054277
iron O 1 0.9994342923164368
metabolism O 0 0.3438839614391327
. O 0 0.0014593270607292652

The O 0 0.005863208789378405
2 O 0 0.005676629953086376
. O 0 0.004371958319097757

6 O 0 0.004298122599720955
A O 0 0.002898360835388303
crystal O 0 0.009562166407704353
structure O 0 0.0006455304683186114
of O 0 0.0004559433145914227
HFE O 1 0.9978255033493042
reveals O 0 0.0012066207127645612
the O 0 7.576186908409e-05
locations O 0 8.620394510217011e-05
of O 0 0.001919076661579311
hemochromatosis B-Disease 1 0.9999996423721313
mutations O 0 0.0031819043215364218
and O 0 0.00010897222091443837
a O 0 0.0006070008967071772
patch O 1 0.9828886985778809
of O 0 0.0004801474860869348
histidines O 1 0.9840906262397766
that O 0 4.892529977951199e-05
could O 0 3.242124876123853e-05
be O 0 1.7695972928777337e-05
involved O 0 4.994161645299755e-05
in O 0 5.678751040250063e-05
pH O 0 0.011253937147557735
- O 0 0.002895400859415531
dependent O 0 0.0005345715908333659
interactions O 0 0.0005191653035581112
. O 0 0.0007317466661334038

We O 0 0.001176082412712276
also O 0 0.00045674628927372396
demonstrate O 0 0.0007416790467686951
that O 0 0.00027637547464109957
soluble O 0 0.09899476170539856
TfR O 1 0.9980643391609192
and O 0 0.0006335294456221163
HFE O 1 0.9923602938652039
bind O 0 0.0003209123096894473
tightly O 0 0.00018417788669466972
at O 0 9.668868005974218e-05
the O 0 6.65875559207052e-05
basic O 0 0.00010517722694203258
pH O 0 0.0002094055525958538
of O 0 4.1243260056944564e-05
the O 0 7.063589873723686e-05
cell O 0 0.0003462921886239201
surface O 0 8.289049583254382e-05
, O 0 4.038436964037828e-05
but O 0 2.6904102924163453e-05
not O 0 2.2875721697346307e-05
at O 0 6.136992305982858e-05
the O 0 9.474561375100166e-05
acidic O 0 0.0010550754377618432
pH O 0 0.0011626689229160547
of O 0 0.0004789175000041723
intracellular O 0 0.0048215147107839584
vesicles O 0 0.015198302455246449
. O 0 0.001700688386335969

TfR O 1 0.9959967136383057
HFE O 1 0.9881206750869751
stoichiometry O 0 0.010204525664448738
( O 0 0.00037160926149226725
2 O 0 0.00022563977108802646
1 O 0 0.00015498546417802572
) O 0 9.194443555315956e-05
differs O 0 0.00010430399561300874
from O 0 0.00010114342876477167
TfR O 0 0.42966923117637634
transferrin O 0 0.031035440042614937
stoichiometry O 0 0.0011313532013446093
( O 0 0.00012823138968087733
2 O 0 8.047261508181691e-05
2 O 0 7.921874930616468e-05
) O 0 4.69361366413068e-05
, O 0 4.678219556808472e-05
implying O 0 0.00012162108032498509
a O 0 4.264095696271397e-05
different O 0 2.419267184450291e-05
mode O 0 7.394666317850351e-05
of O 0 5.993706145090982e-05
binding O 0 7.733960956102237e-05
for O 0 7.733127858955413e-05
HFE O 1 0.9662337899208069
and O 0 0.0001632111525395885
transferrin O 0 0.13452211022377014
to O 0 0.00010330406075809151
TfR O 1 0.8210752606391907
, O 0 9.729718294693157e-05
consistent O 0 0.00010721922444645315
with O 0 4.101287777302787e-05
our O 0 8.206084021367133e-05
demonstration O 0 0.0005819882499054074
that O 0 0.00012524194607976824
HFE O 1 0.9929486513137817
, O 0 0.0004494047025218606
transferrin O 1 0.7576596140861511
, O 0 0.000247563817538321
and O 0 0.00027248618425801396
TfR O 1 0.9433972239494324
form O 0 0.0005298934993334115
a O 0 0.0007726273615844548
ternary O 0 0.013328972272574902
complex O 0 0.0032013372983783484
. O 0 0.0018645338714122772

Identification O 0 0.0016353715909644961
of O 0 0.0003714286140166223
three O 0 0.00017596154066268355
novel O 0 0.0004276222316548228
mutations O 0 0.00012444434105418622
and O 0 4.0943243220681325e-05
a O 0 4.8444406274938956e-05
high O 0 5.414232873590663e-05
frequency O 0 2.943125400634017e-05
of O 0 4.152203109697439e-05
the O 0 7.357232243521139e-05
Arg778Leu O 1 0.8165956139564514
mutation O 0 0.00023534215870313346
in O 0 8.085151785053313e-05
Korean O 1 0.7386456727981567
patients O 1 0.8741073608398438
with O 0 0.0038986466825008392
Wilson B-Disease 1 0.9995259046554565
disease I-Disease 1 0.9999477863311768
. O 0 0.0026146897580474615

Four O 0 0.0013255146332085133
mutations O 0 0.001912164269015193
- O 0 0.05869045853614807
- O 0 0.20006008446216583
R778L O 1 0.9781618118286133
, O 0 0.0004226383753120899
A874V O 1 0.8670975565910339
, O 0 0.0002018711675191298
L1083F O 0 0.2679758071899414
, O 0 8.354031888302416e-05
and O 0 6.742267578374594e-05
2304delC O 0 0.12194277346134186
- O 0 0.001101913396269083
- O 0 0.00022197231010068208
in O 0 4.492276275414042e-05
the O 0 0.00010053859296021983
copper O 0 0.08309875428676605
- O 0 0.0010007575619965792
transporting O 0 0.0008989883936010301
enzyme O 0 0.00023110727488528937
, O 0 6.969409150769934e-05
P O 0 0.0015926067717373371
- O 0 0.0014992578653618693
type O 0 0.0006841311696916819
ATPase O 0 0.09440955519676208
( O 0 0.00021744925470557064
ATP7B O 1 0.5014577507972717
) O 0 4.795301356352866e-05
, O 0 3.0145094569888897e-05
were O 0 2.81078064290341e-05
identified O 0 8.471727051073685e-05
in O 0 6.996971933403984e-05
Korean O 0 0.09105046838521957
Patients O 1 0.6431321501731873
with O 0 0.0039071147330105305
Wilson B-Disease 1 0.9997522234916687
disease I-Disease 1 0.9999727010726929
. O 0 0.0051459153182804585

Arg778Leu O 1 0.976791262626648
, O 0 0.0006186187383718789
the O 0 0.00018966641800943762
most O 0 7.843848288757727e-05
frequently O 0 7.408965757349506e-05
reported O 0 0.00010894718434428796
mutation O 0 8.644621266284958e-05
of O 0 4.858152533415705e-05
this O 0 3.8768575905123726e-05
enzyme O 0 0.000128722662338987
, O 0 3.0567432986572385e-05
was O 0 4.5858483645133674e-05
found O 0 1.52365255416953e-05
in O 0 1.5119123418116942e-05
six O 0 3.0046079700696282e-05
of O 0 5.0771697715390474e-05
eight O 0 0.00012686992704402655
unrelated O 0 0.0008153461385518312
patients O 0 0.0032344304490834475
studied O 0 0.000137483308208175
, O 0 7.382829062407836e-05
an O 0 6.993775605224073e-05
allele O 0 0.0002659752790350467
frequency O 0 0.00010819140879902989
of O 0 0.00018191314302384853
37 O 0 0.0010132037568837404
. O 0 0.0008518032846041024

5 O 0 0.001082681235857308
% O 0 0.00035313295666128397
, O 0 0.00014153197116684169
which O 0 6.138936441857368e-05
is O 0 5.2336996304802597e-05
considerably O 0 7.687394827371463e-05
higher O 0 3.379016197868623e-05
than O 0 2.076211058010813e-05
those O 0 1.558801523060538e-05
in O 0 2.8129181373515166e-05
other O 0 5.748893090640195e-05
Asian O 0 0.0004469015693757683
populations O 0 0.0004164630954619497
. O 0 0.000677717849612236

The O 0 0.0011916067451238632
novel O 0 0.0012048851931467652
single O 0 0.0003711048047989607
nucleotide O 0 0.00036034605000168085
deletion O 0 0.0006722118123434484
, O 0 0.00017337145982310176
2304delC O 0 0.12074101716279984
, O 0 6.675795157207176e-05
was O 0 0.00012279888323973864
found O 0 6.827927427366376e-05
in O 0 9.42856859182939e-05
one O 0 0.00027845200384035707
patient O 0 0.039222922176122665
. O 0 0.0012174684088677168

Since O 0 0.0016214610077440739
a O 0 0.0007222600397653878
mutation O 0 0.0005008853040635586
at O 0 0.00034234661143273115
cDNA O 0 0.0011536782840266824
nucleotide O 0 0.0007484775269404054
2302 O 1 0.9428489208221436
( O 0 0.0003559984907042235
2302insC O 0 0.048982881009578705
) O 0 5.75668818783015e-05
had O 0 5.2575858717318624e-05
been O 0 3.5098120861221105e-05
previously O 0 4.809058009414002e-05
described O 0 7.88915713201277e-05
, O 0 3.1932504498399794e-05
this O 0 1.6226082152570598e-05
region O 0 4.4498865463538095e-05
of O 0 3.8378508179448545e-05
the O 0 0.00026485807029530406
ATP7B O 1 0.9999306201934814
gene O 0 0.0003684306575451046
may O 0 5.442668043542653e-05
be O 0 3.262097015976906e-05
susceptible O 0 0.00022342913143802434
to O 0 7.98361434135586e-05
gene O 0 0.0006036892300471663
rearrangements O 1 0.6824362277984619
causing O 1 0.9974910020828247
Wilson B-Disease 1 0.9991222023963928
disease I-Disease 1 0.9999560117721558
. O 0 0.003024766221642494

Disruption O 0 0.013715705834329128
of O 0 0.0010983564425259829
splicing O 0 0.0012439157580956817
regulated O 0 0.00038091078749857843
by O 0 0.00013543476234190166
a O 0 0.0003529685200192034
CUG O 1 0.9981698989868164
- O 0 0.026415320113301277
binding O 0 0.0004563567927107215
protein O 0 0.0009648848790675402
in O 0 0.0036742661613970995
myotonic B-Disease 1 0.9999960660934448
dystrophy I-Disease 1 0.9999982118606567
. O 0 0.02589879184961319

Myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 1.0
( O 1 0.9998086094856262
DM B-Disease 1 0.9999997615814209
) O 0 0.001317124697379768
is O 0 0.0002521004353184253
caused O 0 0.0016508843982592225
by O 0 6.48023997200653e-05
a O 0 0.00013978460629004985
CTG O 0 0.13340622186660767
expansion O 0 0.00018023926531895995
in O 0 3.471272066235542e-05
the O 0 4.345209526945837e-05
3 O 0 7.293754606507719e-05
untranslated O 0 0.0004841422778554261
region O 0 0.00017838095664046705
of O 0 0.00017650295922067016
the O 0 0.0010582412360236049
DM B-Disease 1 0.9999896287918091
gene O 0 0.002484367461875081
. O 0 0.0015353310154750943

One O 0 0.0016821024473756552
model O 0 0.0018052153754979372
of O 0 0.0062627908773720264
DM B-Disease 1 0.9999990463256836
pathogenesis O 1 0.9995970129966736
suggests O 0 0.000952056550886482
that O 0 9.143878560280427e-05
RNAs O 0 0.00019708707986865193
from O 0 3.750896212295629e-05
the O 0 4.734590038424358e-05
expanded O 0 0.00012302567483857274
allele O 0 0.00010325520997866988
create O 0 5.393275205278769e-05
a O 0 6.74504044582136e-05
gain O 0 0.00010399671737104654
- O 0 0.00037806815817020833
of O 0 0.00014411963638849556
- O 0 0.01602081023156643
function O 0 6.902935274410993e-05
mutation O 0 7.13170666131191e-05
by O 0 2.4554599804105237e-05
the O 0 4.1379567846888676e-05
inappropriate O 0 0.0001112977261072956
binding O 0 3.896710040862672e-05
of O 0 4.309381984057836e-05
proteins O 0 4.197125235805288e-05
to O 0 4.68944817839656e-05
the O 0 0.00023187624174170196
CUG O 1 0.9023653864860535
repeats O 0 0.0024944995529949665
. O 0 0.001340848975814879

Data O 0 0.0009228938724845648
presented O 0 0.0007181433611549437
here O 0 0.0003027949423994869
indicate O 0 0.00021633313735947013
that O 0 6.009794378769584e-05
the O 0 8.808224811218679e-05
conserved O 0 0.00017965778533834964
heterogeneous O 0 0.000448274367954582
nuclear O 0 0.0004990029847249389
ribonucleoprotein O 0 0.2867460250854492
, O 0 0.0001628399477340281
CUG O 1 0.5642725825309753
- O 0 0.0003804049629252404
binding O 0 9.645092359278351e-05
protein O 0 0.00011955661466345191
( O 0 0.0001863893703557551
CUG O 1 0.9933019876480103
- O 0 0.017997533082962036
BP O 0 0.004386104177683592
) O 0 5.815240365336649e-05
, O 0 5.218723163125105e-05
may O 0 4.306662958697416e-05
mediate O 0 0.00019177678041160107
the O 0 0.00010362056491430849
trans O 0 0.0009195558959618211
- O 0 0.0016516698524355888
dominant O 0 0.00035763555206358433
effect O 0 0.00017758402100298554
of O 0 0.00017268939700443298
the O 0 0.0002643996267579496
RNA O 0 0.0009934300323948264
. O 0 0.0007126825512386858

CUG O 1 0.9997394680976868
- O 1 0.7667459845542908
BP O 0 0.07377926260232925
was O 0 0.0005378845380619168
found O 0 0.00011448250734247267
to O 0 4.82044524687808e-05
bind O 0 7.363801705650985e-05
to O 0 2.9883993192925118e-05
the O 0 8.694845746504143e-05
human O 0 0.008146467618644238
cardiac O 1 0.9999964237213135
troponin O 1 0.9999980926513672
T O 1 0.9997945427894592
( O 0 0.000655858835671097
cTNT O 0 0.3691946864128113
) O 0 0.0001520351943327114
pre O 0 0.001191399060189724
- O 0 0.0012571795377880335
messenger O 0 0.0008230683160945773
RNA O 0 0.00019347495981492102
and O 0 9.272771421819925e-05
regulate O 0 0.00017088401364162564
its O 0 0.00012023215822409838
alternative O 0 0.0007765985210426152
splicing O 0 0.0024048828054219484
. O 0 0.0012811266351491213

Splicing O 0 0.004424366634339094
of O 0 0.0012586148222908378
cTNT O 1 0.9739862084388733
was O 0 0.013243582099676132
disrupted O 1 0.7191333770751953
in O 0 0.030812937766313553
DM B-Disease 1 0.9999998807907104
striated O 1 0.9999932050704956
muscle O 1 0.9992828965187073
and O 0 0.0001953903993126005
in O 0 0.00010331469093216583
normal O 0 0.00043622084194794297
cells O 0 0.0003294311463832855
expressing O 0 0.00023248368233907968
transcripts O 0 0.00023708127264399081
that O 0 0.00012267868441995233
contain O 0 0.00035335388383828104
CUG O 1 0.7657990455627441
repeats O 0 0.0030724091921001673
. O 0 0.0014948529424145818

Altered O 0 0.00315675837919116
expression O 0 0.0007827519439160824
of O 0 0.000259355001617223
genes O 0 0.00021563337941188365
regulated O 0 0.000245732837356627
posttranscriptionally O 0 0.22905923426151276
by O 0 0.0002840964589267969
CUG O 1 0.9997732043266296
- O 0 0.34573057293891907
BP O 0 0.04141385480761528
therefore O 0 0.00017672270769253373
may O 0 0.00014441731036640704
contribute O 0 0.0002663607883732766
to O 0 0.0002601936284918338
DM B-Disease 1 0.999980092048645
pathogenesis O 1 0.9983111619949341
. O 0 0.0008628321811556816
. O 0 0.0010383561020717025

Identification O 0 0.0019119459902867675
of O 0 0.0005593328387476504
a O 0 0.0005414469633251429
novel O 0 0.0012695228215306997
nonsense O 0 0.05608782544732094
mutation O 0 0.00022220842947717756
and O 0 4.928803537040949e-05
a O 0 7.833525887690485e-05
missense O 0 0.0002547374169807881
substitution O 0 0.00010697067045839503
in O 0 3.44574436894618e-05
the O 0 7.631329935975373e-05
vasopressin O 0 0.3137016296386719
- O 0 0.14882326126098633
neurophysin O 1 0.9823085069656372
II O 1 0.7224014401435852
gene O 0 0.00011491124314488843
in O 0 4.751216329168528e-05
two O 0 4.389067544252612e-05
Spanish O 0 0.0002608782087918371
kindreds O 0 0.17034630477428436
with O 0 0.0018088589422404766
familial B-Disease 1 0.9999877214431763
neurohypophyseal I-Disease 1 0.9999996423721313
diabetes I-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.9999982118606567
. O 0 0.4658378064632416

Familial B-Disease 1 0.9999791383743286
neurohypophyseal I-Disease 1 0.9999992847442627
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 1 0.9998968839645386
FNDI B-Disease 1 0.9999995231628418
) O 0 0.0025623301044106483
is O 0 0.0003889950457960367
an O 0 0.0020105012226849794
autosomal B-Disease 1 0.9998266100883484
dominant I-Disease 1 0.999934196472168
disease I-Disease 1 0.9999997615814209
caused O 1 0.9999927282333374
by O 1 0.8744804263114929
deficiency O 1 0.9999995231628418
in O 0 0.008823619224131107
the O 1 0.631472647190094
antidiuretic O 1 0.9999852180480957
hormone O 1 0.99552321434021
arginine O 0 0.11351898312568665
vasopressin O 0 0.3752407729625702
( O 0 0.0003319447278045118
AVP O 0 0.02610662393271923
) O 0 6.181130447657779e-05
encoded O 0 3.6509372876025736e-05
by O 0 3.098556771874428e-05
the O 0 7.476462633349001e-05
AVP O 1 0.7758853435516357
- O 0 0.06505575776100159
neurophysin O 1 0.9955863952636719
II O 1 0.9994321465492249
( O 0 0.017273899167776108
AVP O 1 0.999809205532074
- O 1 0.5997594594955444
NPII O 1 0.9899840354919434
) O 0 0.0002136861439794302
gene O 0 0.0002504937001504004
on O 0 0.00020019338990096003
chromosome O 0 0.0016567704733461142
20p13 O 0 0.1688552349805832
. O 0 0.001406000112183392

In O 0 0.000599644728936255
this O 0 0.0002054068463621661
study O 0 0.00010469921107869595
, O 0 6.215917528606951e-05
we O 0 3.8848145777592435e-05
analyzed O 0 5.15911633556243e-05
two O 0 3.361903509357944e-05
families O 0 6.159465556265786e-05
with O 0 5.39549691893626e-05
FNDI B-Disease 1 0.7046862840652466
using O 0 4.896889367955737e-05
direct O 0 5.1974460802739486e-05
automated O 0 0.0001915443135658279
fluorescent O 0 0.00047785911010578275
, O 0 6.375620432663709e-05
solid O 0 0.00019452747073955834
phase O 0 0.00033379675005562603
, O 0 5.2832892833976075e-05
single O 0 9.640144708100706e-05
- O 0 0.00021515056141652167
stranded O 0 0.0002458743692841381
DNA O 0 0.00011790930147981271
sequencing O 0 0.00014561561692971736
of O 0 0.00014851015293970704
PCR O 0 0.0013351452071219683
- O 0 0.002526334021240473
amplified O 0 0.005610733292996883
AVP O 1 0.9972836971282959
- O 0 0.29087594151496887
NPII O 1 0.9899060130119324
DNA O 0 0.002581107895821333
. O 0 0.0017327935202047229

In O 0 0.00040811958024278283
one O 0 0.00012715187040157616
of O 0 0.0001229850749950856
the O 0 0.00010420279431855306
families O 0 0.0001747284986777231
, O 0 7.645475852768868e-05
affected O 0 0.00011839850776595995
individuals O 0 2.9576096494565718e-05
presented O 0 9.411339851794764e-05
a O 0 8.420351514359936e-05
novel O 0 0.00027713648159988225
nonsense O 0 0.001936890184879303
mutation O 0 9.230574505636469e-05
in O 0 2.9918555810581893e-05
exon O 0 0.00019859886378981173
3 O 0 5.013817280996591e-05
of O 0 4.0715614886721596e-05
the O 0 4.1524286643834785e-05
gene O 0 5.3350315283751115e-05
, O 0 2.3944849090185016e-05
consisting O 0 4.325901318225078e-05
in O 0 2.6142455681110732e-05
a O 0 8.600540604675189e-05
G O 0 0.0002846579591277987
to O 0 5.2356463129399344e-05
T O 0 0.0007574030896648765
transition O 0 0.00019864883506670594
at O 0 0.00010940733045572415
nucleotide O 0 0.00015781050024088472
2101 O 0 0.004821928683668375
, O 0 5.9473775763763115e-05
which O 0 3.121429108432494e-05
produces O 0 6.124031642684713e-05
a O 0 5.062172931502573e-05
stop O 0 0.00010198426753049716
signal O 0 0.00011402263044146821
in O 0 4.588945739669725e-05
codon O 0 0.00033563768374733627
82 O 0 0.0004991188761778176
( O 0 0.0003298865631222725
Glu O 0 0.47898176312446594
) O 0 0.00031006813514977694
of O 0 0.0006946728099137545
NPII O 1 0.867161750793457
. O 0 0.0028877640143036842

The O 0 0.003978143446147442
premature O 0 0.43725478649139404
termination O 0 0.11258520931005478
eliminates O 0 0.001884548575617373
part O 0 0.0002595054102130234
of O 0 0.00015989257371984422
the O 0 0.0002287512761540711
C O 0 0.004142835270613432
- O 0 0.0016004294157028198
terminal O 0 0.00044439034536480904
domain O 0 7.333808753173798e-05
of O 0 0.00010215343354502693
NPII O 1 0.9258671402931213
, O 0 4.5453365601133555e-05
including O 0 2.6412593797431327e-05
a O 0 3.9240218029590324e-05
cysteine O 0 6.752897752448916e-05
residue O 0 7.487807306461036e-05
in O 0 1.82606527232565e-05
position O 0 4.4316595449345186e-05
85 O 0 6.585302617168054e-05
, O 0 2.5522760552121326e-05
which O 0 1.6075922758318484e-05
could O 0 1.9922312276321463e-05
be O 0 1.3628798114950769e-05
involved O 0 3.221020961063914e-05
in O 0 3.270691377110779e-05
the O 0 7.894983718870208e-05
correct O 0 0.0002572955272626132
folding O 0 0.0012956364080309868
of O 0 0.00030626350780948997
the O 0 0.0008998239645734429
prohormone O 1 0.9944861531257629
. O 0 0.001813560607843101

In O 0 0.0006727390573360026
the O 0 0.00037615399924106896
second O 0 0.000332885974785313
family O 0 0.0002413968468317762
, O 0 9.774755744729191e-05
a O 0 0.00014786439714953303
G279A O 0 0.008311524987220764
substitution O 0 0.00021691394795197994
at O 0 6.931206735316664e-05
position O 0 7.426607771776617e-05
- O 0 0.00012483775208238512
1 O 0 4.9510013923281804e-05
of O 0 4.559449735097587e-05
the O 0 5.8203171647619456e-05
signal O 0 0.0002540601999498904
peptide O 0 0.00019733040244318545
was O 0 0.00010938271589111537
observed O 0 8.271346450783312e-05
in O 0 5.592815432464704e-05
all O 0 8.096377132460475e-05
affected O 0 0.000362911174306646
individuals O 0 0.00031916098669171333
. O 0 0.0008657796424813569

This O 0 0.0010452676797285676
missense O 0 0.004612798802554607
mutation O 0 0.0009839428821578622
, O 0 0.00019818118016701192
which O 0 0.0001369889359921217
replaces O 0 0.23464511334896088
Ala O 1 0.9880087375640869
with O 0 0.0002443013072479516
Thr O 1 0.9979568719863892
, O 0 0.00021955737611278892
is O 0 0.00010740126890596002
frequent O 0 0.0004225684970151633
among O 0 0.00782764982432127
FNDI B-Disease 1 0.9999984502792358
patients O 1 0.9676804542541504
and O 0 0.00011600559810176492
is O 0 5.8793710195459425e-05
thought O 0 8.551839709980413e-05
to O 0 2.3171207431005314e-05
reduce O 0 4.807485674973577e-05
the O 0 5.37340747541748e-05
efficiency O 0 0.00016765735927037895
of O 0 9.926842903951183e-05
cleavage O 0 0.0035308138467371464
by O 0 0.0001797393342712894
signal O 0 0.0007488577393814921
peptidases O 0 0.006950476206839085
. O 0 0.00038456093170680106
. O 0 0.0008585904142819345

Genetic O 0 0.002755281049758196
heterogeneity O 0 0.006172138266265392
of O 0 0.023122940212488174
Saethre B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999979734420776
Chotzen I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
, O 0 0.015246539376676083
due O 0 0.0006662437226623297
to O 0 0.0001450370909878984
TWIST O 1 0.5780748724937439
and O 0 0.0009482823661528528
FGFR O 1 0.9996659755706787
mutations O 0 0.004808157216757536
. O 0 0.0015153809217736125

Thirty O 0 0.006213084794580936
- O 0 0.0033197286538779736
two O 0 0.00026294434792362154
unrelated O 0 0.0007448543328791857
patients O 0 0.0008000023663043976
with O 0 8.224329212680459e-05
features O 0 0.00015656647155992687
of O 0 0.01274330448359251
Saethre B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999991655349731
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0441615954041481
a O 0 0.04452309384942055
common O 0 0.06155239790678024
autosomal B-Disease 1 0.99411940574646
dominant I-Disease 1 0.8055654764175415
condition I-Disease 1 0.9905127882957458
of O 1 0.9906512498855591
craniosynostosis B-Disease 1 1.0
and O 1 0.9991394281387329
limb B-Disease 1 0.9999998807907104
anomalies I-Disease 1 0.9996821880340576
, O 0 0.00022291972709354013
were O 0 4.605781577993184e-05
screened O 0 0.00010861876944545656
for O 0 3.3000258554238826e-05
mutations O 0 5.421119567472488e-05
in O 0 3.4847016650019214e-05
TWIST O 0 0.023373007774353027
, O 0 0.00014087448653299361
FGFR2 O 1 0.9968492388725281
, O 0 0.00023296495783142745
and O 0 0.00028181634843349457
FGFR3 O 1 0.9531785249710083
. O 0 0.0012606437085196376

Nine O 0 0.0025002716574817896
novel O 0 0.001294711953960359
and O 0 0.0003336364170536399
three O 0 0.00024230075359810144
recurrent O 1 0.9891701340675354
TWIST O 1 0.7990360260009766
mutations O 0 0.0003726891882251948
were O 0 6.4749714510981e-05
found O 0 8.434744086116552e-05
in O 0 8.416175842285156e-05
12 O 0 0.0003389587509445846
families O 0 0.0006650253781117499
. O 0 0.0009070590022020042

Seven O 0 0.0011075816582888365
families O 0 0.00035446236142888665
were O 0 0.00010420339094707742
found O 0 4.750147490995005e-05
to O 0 3.577218376449309e-05
have O 0 2.990526263602078e-05
the O 0 0.00011412914318498224
FGFR3 O 1 0.9999105930328369
P250R O 1 0.9992493987083435
mutation O 0 0.0016005327925086021
, O 0 5.04432427987922e-05
and O 0 2.8454749553930014e-05
one O 0 3.00860501738498e-05
individual O 0 2.9520244424929842e-05
was O 0 5.637694266624749e-05
found O 0 2.6376148525741883e-05
to O 0 1.769388109096326e-05
have O 0 3.318462768220343e-05
an O 0 0.00011299168545519933
FGFR2 O 1 0.9777525067329407
VV269 O 1 0.9104500412940979
- O 0 0.009772324934601784
270 O 0 0.00241340440697968
deletion O 0 0.006498925853520632
. O 0 0.0015536973951384425

To O 0 0.00045218071318231523
date O 0 0.00029374478617683053
, O 0 0.00014965562149882317
our O 0 0.00012063951726304367
detection O 0 0.0001685923052718863
rate O 0 6.41273582004942e-05
for O 0 3.157722676405683e-05
TWIST O 0 0.0022761791478842497
or O 0 9.33978080865927e-05
FGFR O 1 0.794654130935669
mutations O 0 5.4546340834349394e-05
is O 0 2.9616912797791883e-05
68 O 0 0.00010434817522764206
% O 0 3.265994382672943e-05
in O 0 5.4886448197066784e-05
our O 0 0.00026598721160553396
Saethre B-Disease 1 0.9999818801879883
- I-Disease 1 0.9999912977218628
Chotzen I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
patients O 1 0.9993752837181091
, O 0 0.00036269324482418597
including O 0 0.00010028888209490106
our O 0 8.842147508403286e-05
five O 0 0.0001365593052469194
patients O 0 0.05845368653535843
elsewhere O 0 0.0001623275747988373
reported O 0 0.00016722692816983908
with O 0 0.0001669653138378635
TWIST O 0 0.3204220235347748
mutations O 0 0.0016614198684692383
. O 0 0.0009683282696641982

More O 0 0.0004210423503536731
than O 0 0.00014322256902232766
35 O 0 0.0001404040667694062
different O 0 5.0291651859879494e-05
TWIST O 0 0.004245371092110872
mutations O 0 0.00013208102609496564
are O 0 3.2636624382575974e-05
now O 0 5.6973938626470044e-05
known O 0 7.279322016984224e-05
in O 0 6.85575432726182e-05
the O 0 0.00019826246716547757
literature O 0 0.0005767307593487203
. O 0 0.0009464771719649434

The O 0 0.00110137602314353
most O 0 0.00029908979195170105
common O 0 0.0002651066752150655
phenotypic O 0 0.0005261186743155122
features O 0 0.0001399592001689598
, O 0 3.995708539150655e-05
present O 0 2.9503024052246474e-05
in O 0 1.588030681887176e-05
more O 0 1.0546466000960208e-05
than O 0 1.1911428373423405e-05
a O 0 2.7658436010824516e-05
third O 0 5.902042903471738e-05
of O 0 4.37849921581801e-05
our O 0 0.00011011318565579131
patients O 0 0.013834928162395954
with O 0 7.744905451545492e-05
TWIST O 0 0.2800544202327728
mutations O 0 0.00019346573390066624
, O 0 6.128448876552284e-05
are O 0 3.675509651657194e-05
coronal B-Disease 0 0.07240645587444305
synostosis I-Disease 0 0.4917910099029541
, O 0 0.00022138364147394896
brachycephaly B-Disease 1 0.5768451690673828
, O 0 0.0003021017473656684
low B-Disease 0 0.008374487049877644
frontal I-Disease 1 0.9999022483825684
hairline I-Disease 1 0.9999985694885254
, O 0 0.18459925055503845
facial B-Disease 1 0.9999749660491943
asymmetry I-Disease 1 0.9998548030853271
, O 1 0.5737400650978088
ptosis B-Disease 1 0.9999980926513672
, O 0 0.025380756705999374
hypertelorism B-Disease 1 0.9995132684707642
, O 0 0.00034045870415866375
broad B-Disease 0 0.0013355432311072946
great I-Disease 0 0.031084634363651276
toes I-Disease 1 0.9039193987846375
, O 0 0.0004151756293140352
and O 0 0.0006242022500373423
clinodactyly B-Disease 1 0.9760802984237671
. O 0 0.001597135909833014

Significant O 0 0.0035458612255752087
intra O 0 0.47244149446487427
- O 0 0.23385415971279144
and O 0 0.0006351621123030782
interfamilial O 1 0.9371140003204346
phenotypic O 0 0.0013511941069737077
variability O 0 0.0004132394678890705
is O 0 7.773333345539868e-05
present O 0 8.528027683496475e-05
for O 0 5.178853825782426e-05
either O 0 0.00014420898514799774
TWIST O 0 0.13956236839294434
mutations O 0 0.001040268107317388
or O 0 0.000657853321172297
FGFR O 1 0.9987407326698303
mutations O 0 0.002841997193172574
. O 0 0.0016824882477521896

The O 0 0.0009358421666547656
overlap O 0 0.0005162901943549514
in O 0 0.00014262156037148088
clinical O 0 0.0010399429593235254
features O 0 0.00010242948337690905
and O 0 3.7379551940830424e-05
the O 0 3.481844760244712e-05
presence O 0 6.278649379964918e-05
, O 0 2.521875467209611e-05
in O 0 1.1438619367254432e-05
the O 0 1.8456650650477968e-05
same O 0 1.471766154281795e-05
genes O 0 2.0733577912324108e-05
, O 0 1.8170236216974445e-05
of O 0 2.3786124074831605e-05
mutations O 0 3.3319389331154525e-05
for O 0 1.0596399079076946e-05
more O 0 1.2350829820206854e-05
than O 0 1.7901080354931764e-05
one O 0 5.6484033848391846e-05
craniosynostotic B-Disease 1 0.8866756558418274
condition I-Disease 0 0.02617065981030464
- O 0 0.0008984310552477837
such O 0 4.179064490017481e-05
as O 0 8.314389560837299e-05
Saethre B-Disease 1 0.9657807350158691
- I-Disease 0 0.15364143252372742
Chotzen I-Disease 1 0.9943511486053467
, I-Disease 0 0.00025928279501385987
Crouzon I-Disease 1 0.9627833366394043
, I-Disease 0 0.00022939121117815375
and I-Disease 0 0.0004694261879194528
Pfeiffer I-Disease 1 0.9999790191650391
syndromes I-Disease 1 0.9999884366989136
- O 0 0.1813199520111084
support O 0 0.00011525065201567486
the O 0 0.00010147180000785738
hypothesis O 0 0.00027426949236541986
that O 0 3.296478098491207e-05
TWIST O 0 0.039007604122161865
and O 0 0.00012433166557457298
FGFRs O 0 0.1763031780719757
are O 0 3.310042302473448e-05
components O 0 7.518802885897458e-05
of O 0 3.6244444345356897e-05
the O 0 3.705628841998987e-05
same O 0 3.481237217783928e-05
molecular O 0 9.501441672910005e-05
pathway O 0 0.00015653348236810416
involved O 0 3.9742371882312e-05
in O 0 3.4859811421483755e-05
the O 0 7.521498628193513e-05
modulation O 0 0.0010941947111859918
of O 0 0.003994254395365715
craniofacial O 1 0.9999990463256836
and O 0 0.2915841042995453
limb O 1 0.999983549118042
development O 0 0.005394068080931902
in O 0 0.00021542377362493426
humans O 0 0.00042572140228003263
. O 0 0.00026045675622299314
. O 0 0.0007507627597078681

Mutation O 0 0.004183674231171608
analysis O 0 0.0013639571843668818
of O 0 0.001566832885146141
UBE3A O 1 0.9999856948852539
in O 1 0.999319314956665
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.999994158744812
. O 1 0.8809683322906494

Angelman B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 1 0.9128806591033936
AS B-Disease 1 0.5849127173423767
) O 0 0.00024094569380395114
is O 0 0.0001671964710112661
caused O 0 0.011909633874893188
by O 0 0.00015071807138156146
chromosome O 0 0.010872067883610725
15q11 O 1 0.9954190254211426
- O 0 0.32842782139778137
q13 O 1 0.6981795430183411
deletions O 0 0.0006555594736710191
of O 0 0.00014987184840720147
maternal O 0 0.0021812692284584045
origin O 0 8.916693332139403e-05
, O 0 5.720553599530831e-05
by O 0 6.96591378073208e-05
paternal O 0 0.4523515999317169
uniparental B-Disease 1 0.9999890327453613
disomy I-Disease 1 0.9999221563339233
( O 0 0.035829611122608185
UPD B-Disease 1 0.9996984004974365
) O 0 8.220809104386717e-05
15 O 0 8.588100172346458e-05
, O 0 6.063619366614148e-05
by O 0 8.309499389724806e-05
imprinting O 1 0.6432159543037415
defects O 1 0.9949313998222351
, O 0 0.00010011439735535532
and O 0 7.067525439197198e-05
by O 0 6.960104656172916e-05
mutations O 0 0.00015341443940997124
in O 0 0.0001224627048941329
the O 0 0.00043841093429364264
UBE3A O 1 0.9993151426315308
gene O 0 0.0020042485557496548
. O 0 0.0015446636825799942

UBE3A O 0 0.2470438927412033
encodes O 0 0.002609889255836606
a O 0 0.0009084801422432065
ubiquitin O 0 0.040700528770685196
- O 0 0.005332207772880793
protein O 0 0.0003454026591498405
ligase O 0 0.0030138129368424416
and O 0 0.00015710994193796068
shows O 0 0.0003779485123232007
brain O 0 0.1978594809770584
- O 0 0.0016964952228590846
specific O 0 0.00030562354368157685
imprinting O 0 0.02037118934094906
. O 0 0.0014116967795416713

Here O 0 0.0017820962239056826
we O 0 0.0006479747826233506
describe O 0 0.000965273822657764
UBE3A O 1 0.9217760562896729
coding O 0 0.0018420096021145582
- O 0 0.0031843429896980524
region O 0 0.00026493764016777277
mutations O 0 0.00019934441661462188
detected O 0 0.00022055943554732949
by O 0 6.605032103834674e-05
SSCP O 0 0.08484815806150436
analysis O 0 5.079649781691842e-05
in O 0 3.618607661337592e-05
13 O 0 7.300546712940559e-05
AS B-Disease 0 0.0001287052291445434
individuals O 0 8.583326416555792e-05
or O 0 0.0001473346637794748
families O 0 0.0003926042700186372
. O 0 0.0005895079229958355

Two O 0 0.0008371211006306112
identical O 0 0.0007899197516962886
de O 0 0.001383723458275199
novo O 0 0.002154231769964099
5 O 0 0.000486444536363706
- O 0 0.0010799216106534004
bp O 0 0.0009173331200145185
duplications O 0 0.0007982630631886423
in O 0 0.00012970082752872258
exon O 0 0.0008524078293703496
16 O 0 0.00021757467766292393
were O 0 0.0002405536506557837
found O 0 0.00043226536945439875
. O 0 0.0010307658230885863

Among O 0 0.0008403450483456254
the O 0 0.00021869449119549245
other O 0 5.18872075190302e-05
11 O 0 9.244280954590067e-05
unique O 0 7.247896428452805e-05
mutations O 0 6.433064845623448e-05
, O 0 3.230415313737467e-05
8 O 0 4.688867193181068e-05
were O 0 2.07234170375159e-05
small O 0 3.155747617711313e-05
deletions O 0 0.00012295950728002936
or O 0 3.115167055511847e-05
insertions O 0 0.00019258268002886325
predicted O 0 7.00170494383201e-05
to O 0 3.146927338093519e-05
cause O 0 0.002116128336638212
frameshifts O 0 0.4348280727863312
, O 0 3.727340663317591e-05
1 O 0 3.530709363985807e-05
was O 0 5.138759297551587e-05
a O 0 3.3443928259657696e-05
mutation O 0 4.786898352904245e-05
to O 0 1.3083040357741993e-05
a O 0 2.7638001483865082e-05
stop O 0 5.2119692554697394e-05
codon O 0 8.212855755118653e-05
, O 0 2.3027536371955648e-05
1 O 0 2.9011307560722344e-05
was O 0 5.6316013797186315e-05
a O 0 5.585332473856397e-05
missense O 0 0.0006104823551140726
mutation O 0 0.00010752371599664912
, O 0 3.549394750734791e-05
and O 0 2.6772853743750602e-05
1 O 0 3.53095201717224e-05
was O 0 0.00010054204176412895
predicted O 0 7.922162330942228e-05
to O 0 3.7112735299160704e-05
cause O 0 0.00014882640971336514
insertion O 0 0.0001682973961578682
of O 0 4.4549815356731415e-05
an O 0 5.69918702240102e-05
isoleucine O 0 0.0019913266878575087
in O 0 5.0117574573960155e-05
the O 0 7.445767550962046e-05
hect O 0 0.002594500780105591
domain O 0 9.106226934818551e-05
of O 0 5.771766518591903e-05
the O 0 0.00010129941074410453
UBE3A O 1 0.8856827616691589
protein O 0 7.555299816885963e-05
, O 0 3.185907189617865e-05
which O 0 2.198632137151435e-05
functions O 0 3.461051528574899e-05
in O 0 4.370601527625695e-05
E2 O 0 0.0017366234678775072
binding O 0 0.00015473712119273841
and O 0 0.00018442037981003523
ubiquitin O 0 0.001574560534209013
transfer O 0 0.000742623582482338
. O 0 0.0013688456965610385

Eight O 0 0.0008205088670365512
of O 0 0.000312106596538797
the O 0 0.00016916057211346924
cases O 0 0.0001610677718417719
were O 0 0.00011509941396070644
familial O 0 0.4423862397670746
, O 0 0.0001341882161796093
and O 0 7.916257163742557e-05
five O 0 0.00013460074842441827
were O 0 0.00017430767184123397
sporadic O 0 0.001689890748821199
. O 0 0.000867798225954175

In O 0 0.0008074513170868158
two O 0 0.00028916806331835687
familial O 0 0.046135254204273224
cases O 0 0.0003147282695863396
and O 0 0.00011369724234100431
one O 0 8.246176003012806e-05
sporadic O 0 0.0008509483886882663
case O 0 0.0007151989848352969
, O 0 0.00026268477085977793
mosaicism O 1 0.9875738024711609
for O 0 0.00025835202541202307
UBE3A O 1 0.9997269511222839
mutations O 0 0.0002630275848787278
was O 0 0.00016297523688990623
detected O 0 6.306894647423178e-05
in O 0 1.9507904653437436e-05
the O 0 2.6438348868396133e-05
mother O 0 0.00010356168786529452
of O 0 3.629428465501405e-05
three O 0 3.4336433600401506e-05
AS B-Disease 0 0.00040386756882071495
sons O 0 0.0051124729216098785
, O 0 5.597975541604683e-05
in O 0 2.7375293939257972e-05
the O 0 5.165595575817861e-05
maternal O 0 0.009939637035131454
grandfather O 0 0.010533777065575123
of O 0 9.773748752195388e-05
two O 0 4.267301119398326e-05
AS B-Disease 0 0.00024937422131188214
first O 0 7.674664084333926e-05
cousins O 0 0.00024495203979313374
, O 0 2.837600368366111e-05
and O 0 1.8788816305459477e-05
in O 0 2.0241437596268952e-05
the O 0 4.388510933495127e-05
mother O 0 0.0006430383655242622
of O 0 0.00019216042710468173
an O 0 0.0003296224749647081
AS B-Disease 0 0.01279457751661539
daughter O 1 0.5188769698143005
. O 0 0.0015735406195744872

The O 0 0.0006940501043573022
frequencies O 0 0.0002325107343494892
with O 0 0.0001030488419928588
which O 0 4.495323446462862e-05
we O 0 4.312317105359398e-05
detected O 0 9.730878082336858e-05
mutations O 0 4.89588055643253e-05
were O 0 2.3250850063050166e-05
5 O 0 3.8685480831190944e-05
( O 0 2.716490598686505e-05
14 O 0 4.1404200601391494e-05
% O 0 1.8331562387174927e-05
) O 0 1.610747494851239e-05
of O 0 1.8786182408803143e-05
35 O 0 4.349479786469601e-05
in O 0 2.1441061107907444e-05
sporadic O 0 0.00011023357365047559
cases O 0 2.9613578590215184e-05
and O 0 2.285766640852671e-05
8 O 0 3.690464291139506e-05
( O 0 3.231943628634326e-05
80 O 0 3.3020125556504354e-05
% O 0 1.775398413883522e-05
) O 0 1.590833198861219e-05
of O 0 2.205699092883151e-05
10 O 0 4.1924326069420204e-05
in O 0 6.096389552112669e-05
familial O 0 0.01827070862054825
cases O 0 0.00030307855922728777
. O 0 0.00033313073799945414
. O 0 0.0008678697049617767

The O 0 0.003767552087083459
hemochromatosis B-Disease 1 0.9999845027923584
845 O 1 0.9982213377952576
G O 1 0.9551152586936951
- O 1 0.5369296073913574
- O 0 0.017370235174894333
> O 0 0.0006397597026079893
A O 0 0.0001645590818952769
and O 0 6.35686083114706e-05
187 O 0 0.00019716416136361659
C O 0 0.00035278318682685494
- O 0 0.0023152451030910015
- O 0 0.0048407213762402534
> O 0 0.002716883784160018
G O 0 0.0015094573609530926
mutations O 0 0.0001712175435386598
: O 0 0.00011438025103416294
prevalence O 0 0.0004312504315748811
in O 0 0.00011219205043744296
non O 0 0.0007008109823800623
- O 0 0.012349528260529041
Caucasian O 0 0.07272724062204361
populations O 0 0.0007000367040745914
. O 0 0.0009330430766567588

Hemochromatosis B-Disease 1 0.9999632835388184
, O 0 0.005120594520121813
the O 0 0.15496940910816193
inherited B-Disease 1 0.9999986886978149
disorder I-Disease 1 0.9999998807907104
of I-Disease 1 0.9995741248130798
iron I-Disease 1 0.9999998807907104
metabolism I-Disease 1 0.9999617338180542
, O 0 0.053724031895399094
leads O 1 0.5565182566642761
, O 0 0.0003441129229031503
if O 0 0.00014414793986361474
untreated O 1 0.9843324422836304
, O 0 0.00015529849042650312
to O 0 0.0001497514167567715
progressive O 1 0.9977473616600037
iron B-Disease 1 0.9999854564666748
overload I-Disease 1 0.9999794960021973
and O 0 0.0156946312636137
premature B-Disease 1 0.9774174690246582
death I-Disease 1 0.5783270001411438
. O 0 0.0015949817607179284

The O 0 0.028312381356954575
hemochromatosis B-Disease 1 0.9999969005584717
gene O 0 0.10597187280654907
, O 0 0.005218855105340481
HFE O 1 0.9998565912246704
, O 0 0.00022716159583069384
recently O 0 0.00016057566972449422
has O 0 4.316481499699876e-05
been O 0 2.859574306057766e-05
identified O 0 4.240397538524121e-05
, O 0 2.361068436584901e-05
and O 0 2.703978680074215e-05
characterization O 0 0.00014321178605314344
of O 0 5.03480841871351e-05
this O 0 3.5068074794253334e-05
gene O 0 5.420881643658504e-05
has O 0 2.1293186364346184e-05
shown O 0 2.397153730271384e-05
that O 0 1.0679842489480507e-05
it O 0 1.1601190635701641e-05
contains O 0 1.8208915207651444e-05
two O 0 1.449733736080816e-05
mutations O 0 3.5936413041781634e-05
that O 0 2.1061283405288123e-05
result O 0 3.593230212572962e-05
in O 0 2.9948358132969588e-05
amino O 0 6.667868001386523e-05
acid O 0 0.0001626434677746147
substitutions O 0 0.00019737293769139796
- O 0 0.00021349046437535435
cDNA O 0 0.0005219737649895251
nucleotides O 0 0.00021277654741425067
845 O 0 0.0015073028625920415
G O 0 0.0008018249063752592
- O 0 0.0006790567422285676
- O 0 0.0007163671543821692
> O 0 0.00041902370867319405
A O 0 0.000164776123710908
( O 0 0.00011885730782523751
C282Y O 0 0.000544442271348089
) O 0 4.9001497245626524e-05
and O 0 4.781086681759916e-05
187 O 0 0.0002299811749253422
C O 0 0.0004709525965154171
- O 0 0.0018444660818204284
- O 0 0.01523867342621088
> O 0 0.026861488819122314
G O 0 0.04720628634095192
( O 0 0.0007134692277759314
H63D O 1 0.8524459004402161
) O 0 0.0007963204989209771
. O 0 0.0009555079159326851

Although O 0 0.007810107432305813
hemochromatosis B-Disease 1 0.9999417066574097
is O 0 0.0004904739325866103
common O 0 0.00023399745987262577
in O 0 0.00012257404159754515
Caucasians O 0 0.012658052146434784
, O 0 0.00012667939881794155
affecting O 0 0.0007903196383267641
> O 0 0.003217757912352681
= O 0 0.00030376241193152964
1 O 0 7.93126382632181e-05
/ O 0 0.00023772500571794808
300 O 0 8.621982124168426e-05
individuals O 0 2.371991467953194e-05
of O 0 2.828528158715926e-05
northern O 0 5.4931315389694646e-05
European O 0 3.705720882862806e-05
origin O 0 3.967133307014592e-05
, O 0 2.9075785278109834e-05
it O 0 1.5576692021568306e-05
has O 0 2.0007952116429806e-05
not O 0 1.4461465070780832e-05
been O 0 2.324473280168604e-05
recognized O 0 4.134083428652957e-05
in O 0 3.733153425855562e-05
other O 0 5.6755896366667e-05
populations O 0 0.00028326938627287745
. O 0 0.0005137045518495142

The O 0 0.00099731155205518
present O 0 0.0004140501841902733
study O 0 0.0001799871533876285
used O 0 0.0001325845078099519
PCR O 0 0.00045682291965931654
and O 0 0.00012013188825221732
restriction O 0 0.00036031511262990534
- O 0 0.002143288031220436
enzyme O 0 0.0003233612806070596
digestion O 0 0.00025302727590315044
to O 0 2.072009738185443e-05
analyze O 0 4.8053952923510224e-05
the O 0 2.8063457648386247e-05
frequency O 0 2.054149445029907e-05
of O 0 1.7567677787155844e-05
the O 0 4.10916400142014e-05
845 O 0 0.006353198084980249
G O 0 0.002772078849375248
- O 0 0.0006646598340012133
- O 0 0.0003714709309861064
> O 0 0.0001619832473807037
A O 0 8.211069507524371e-05
and O 0 5.338186747394502e-05
187 O 0 0.00020782103820238262
C O 0 0.00033243687357753515
- O 0 0.0007155092316679657
- O 0 0.0007806389476172626
> O 0 0.001006620586849749
G O 0 0.000627948553301394
mutations O 0 0.00011863662803079933
in O 0 9.038841380970553e-05
HLA O 1 0.9191546440124512
- O 0 0.00030568387592211366
typed O 0 0.00017836940241977572
samples O 0 5.5683096434222534e-05
from O 0 4.769487713929266e-05
non O 0 0.0002000933891395107
- O 0 0.0006851184298284352
Caucasian O 0 0.0016896630404517055
populations O 0 9.129955287789926e-05
, O 0 6.032319288351573e-05
comprising O 0 0.00013225038128439337
Australian O 0 0.000334937940351665
Aboriginal O 0 0.0005017031216993928
, O 0 8.585798786953092e-05
Chinese O 0 0.0001586635917192325
, O 0 8.966805035015568e-05
and O 0 0.00013423647033050656
Pacific O 0 0.0007117618806660175
Islanders O 0 0.0017021658131852746
. O 0 0.001005975529551506

Results O 0 0.0007672160281799734
showed O 0 0.000419928808696568
that O 0 9.649874118622392e-05
the O 0 0.00012418780534062535
845 O 0 0.34056493639945984
G O 0 0.43682190775871277
- O 1 0.5391921997070312
- O 0 0.33022168278694153
> O 0 0.022827649489045143
A O 0 0.00045218071318231523
mutation O 0 0.00023329860414378345
was O 0 8.403513493249193e-05
present O 0 4.181082113063894e-05
in O 0 1.8609300241223536e-05
these O 0 1.3488889635482337e-05
populations O 0 2.5873845515889116e-05
( O 0 2.6820132916327566e-05
allele O 0 4.144338527112268e-05
frequency O 0 1.822881131374743e-05
0 O 0 2.4129038138198666e-05
. O 0 1.412337223882787e-05
32 O 0 2.9706692657782696e-05
% O 0 2.055342702078633e-05
) O 0 2.6564412110019475e-05
, O 0 2.6013931346824393e-05
and O 0 2.3287242584046908e-05
, O 0 3.19224527629558e-05
furthermore O 0 4.406988591654226e-05
, O 0 2.0836532712564804e-05
it O 0 1.900831557577476e-05
was O 0 6.514212145702913e-05
always O 0 5.255094583844766e-05
seen O 0 5.6976114137796685e-05
in O 0 3.458675564615987e-05
conjunction O 0 0.000127523293485865
with O 0 7.65368968131952e-05
HLA O 1 0.9980131387710571
haplotypes O 0 0.000557327875867486
common O 0 6.071372627047822e-05
in O 0 6.108354864409193e-05
Caucasians O 0 0.0005015518981963396
, O 0 4.6058601583354175e-05
suggesting O 0 6.0288974054856226e-05
that O 0 3.1134026357904077e-05
845 O 0 0.10384625196456909
G O 0 0.44835978746414185
- O 1 0.6655137538909912
- O 1 0.5236408710479736
> O 0 0.02812919020652771
A O 0 0.00031859890441410244
may O 0 4.912932854495011e-05
have O 0 2.062871317320969e-05
been O 0 3.059953814954497e-05
introduced O 0 3.764577559195459e-05
into O 0 4.295768303563818e-05
these O 0 3.1638504879083484e-05
populations O 0 0.00011873451148858294
by O 0 0.0001799272431526333
Caucasian O 0 0.005366163328289986
admixture O 0 0.03865472599864006
. O 0 0.0019353062380105257

187 O 0 0.006276406347751617
C O 0 0.011573259718716145
- O 0 0.10830099135637283
- O 0 0.08143835514783859
> O 0 0.006992856971919537
G O 0 0.0011287546949461102
was O 0 0.00017768530233297497
present O 0 8.587895717937499e-05
at O 0 9.02099855011329e-05
an O 0 0.00011181033914908767
allele O 0 0.0002672488335520029
frequency O 0 0.00012970676471013576
of O 0 0.0002428139268886298
2 O 0 0.0007390124374069273
. O 0 0.001054404187016189

68 O 0 0.001890702755190432
% O 0 0.00031871249666437507
in O 0 0.00010977226338582113
the O 0 8.681118197273463e-05
two O 0 5.686266740667634e-05
populations O 0 0.00010285956523148343
analyzed O 0 0.00017772462160792202
( O 0 0.00016899498587008566
Australian O 0 0.00045408992446027696
Aboriginal O 0 0.0007922582444734871
and O 0 0.00019314537348691374
Chinese O 0 0.0006804515141993761
) O 0 0.0005214218399487436
. O 0 0.0009880892466753721

In O 0 0.0007259953999891877
the O 0 0.00033446948509663343
Australian O 0 0.0004385409120004624
Aboriginal O 0 0.00035105651477351785
samples O 0 0.00010190067405346781
, O 0 5.022513141739182e-05
187 O 0 0.0001860065822256729
C O 0 0.0005930001498199999
- O 0 0.04892110079526901
- O 0 0.061559733003377914
> O 0 0.004494251683354378
G O 0 0.000557463092263788
was O 0 8.020095992833376e-05
found O 0 2.5294026272604242e-05
to O 0 1.675246676313691e-05
be O 0 2.0049610611749813e-05
associated O 0 5.70209049328696e-05
with O 0 8.012482430785894e-05
HLA O 1 0.9992458820343018
haplotypes O 0 0.0012444212334230542
common O 0 8.607786003267393e-05
in O 0 6.745007704012096e-05
Caucasians O 0 0.05402039736509323
, O 0 4.992352478438988e-05
suggesting O 0 6.116013537393883e-05
that O 0 1.525149946246529e-05
it O 0 1.7356189346173778e-05
was O 0 7.26146245142445e-05
introduced O 0 9.878786659101024e-05
by O 0 6.789262988604605e-05
recent O 0 0.00029294355772435665
admixture O 0 0.003307976759970188
. O 0 0.0012139076134189963

In O 0 0.0005733960424549878
the O 0 0.00023385605891235173
Chinese O 0 0.00019830385281238705
samples O 0 6.560331530636176e-05
analyzed O 0 6.375041994033381e-05
, O 0 4.9825739552034065e-05
187 O 0 0.00012453693489078432
C O 0 0.00026748969685286283
- O 0 0.0015243288362398744
- O 0 0.004385302308946848
> O 0 0.0015208234544843435
G O 0 0.0003517974400892854
was O 0 7.44033168302849e-05
present O 0 4.20623691752553e-05
in O 0 3.082617695326917e-05
association O 0 7.647064921911806e-05
with O 0 1.7038164514815435e-05
a O 0 6.41838923911564e-05
wide O 0 8.466372673865408e-05
variety O 0 7.928253762656823e-05
of O 0 0.0004922911757603288
HLA O 1 0.9999772310256958
haplotypes O 0 0.01079608965665102
, O 0 7.662438292754814e-05
showing O 0 0.00013316860713530332
this O 0 2.9237669878057204e-05
mutation O 0 6.513323751278222e-05
to O 0 1.9251387129770592e-05
be O 0 1.8021873984253034e-05
widespread O 0 5.5424297897843644e-05
and O 0 1.9266444724053144e-05
likely O 0 2.7579551897360943e-05
to O 0 1.7052307157428004e-05
predate O 0 0.00010588759323582053
the O 0 2.914663309638854e-05
more O 0 1.9337057892698795e-05
genetically O 0 5.9711659559980035e-05
restricted O 0 6.956865399843082e-05
845 O 0 0.0317792147397995
G O 0 0.10967880487442017
- O 0 0.17143301665782928
- O 0 0.09611666947603226
> O 0 0.0036107338964939117
A O 0 0.0017722091870382428
mutation O 0 0.002274863887578249
. O 0 0.00111305748578161

Genotype O 0 0.1954212486743927
- O 0 0.1306103616952896
phenotype O 0 0.01667643152177334
correlations O 0 0.002904590917751193
in O 0 0.002918969141319394
attenuated B-Disease 1 0.9999169111251831
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.9999799728393555
. O 0 0.14174918830394745

Germ O 1 0.997117280960083
- O 0 0.06290421634912491
line O 0 0.001453683478757739
mutations O 0 0.0004461633216124028
of O 0 0.0002770397695712745
the O 0 0.005761267617344856
tumor B-Disease 1 0.9999932050704956
suppressor O 1 0.9998018145561218
APC O 1 0.9689699411392212
are O 0 7.684784941375256e-05
implicated O 0 0.006349653005599976
in O 0 0.0017920108512043953
attenuated B-Disease 1 0.9999827146530151
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
( O 1 0.9996004700660706
AAPC B-Disease 1 0.9999978542327881
) O 0 0.00031334091909229755
, O 0 0.0001438512117601931
a O 0 0.0002628029906190932
variant O 0 0.0014629728393629193
of O 0 0.003458545310422778
familial B-Disease 1 0.9999971389770508
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
( O 1 0.999890923500061
FAP B-Disease 1 0.9999958276748657
) O 0 0.0027807913720607758
. O 0 0.0016849874518811703

AAPC B-Disease 1 0.9986972212791443
is O 0 0.0007820428581908345
recognized O 0 0.0003634850727394223
by O 0 0.0001003506695269607
the O 0 9.292182949138805e-05
occurrence O 0 0.0002219420566689223
of O 0 0.00023124151630327106
< O 0 0.08784990757703781
100 O 0 0.0007015366572886705
colonic B-Disease 1 0.9994844198226929
adenomas I-Disease 1 0.6692928075790405
and O 0 8.4207124018576e-05
a O 0 0.00010293697414454073
later O 0 0.000269827782176435
onset O 1 0.9999518394470215
of O 1 0.9981924891471863
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
( O 0 0.27578800916671753
age O 0 0.04557237774133682
> O 0 0.003655637614428997
40 O 0 0.00019430556858424097
years O 0 0.0001814862625906244
) O 0 0.00027572011458687484
. O 0 0.0006557987653650343

The O 0 0.0008091010968200862
aim O 0 0.000848587485961616
of O 0 0.0001384483912261203
this O 0 5.043073542765342e-05
study O 0 7.62298732297495e-05
was O 0 9.859363490249962e-05
to O 0 6.085852510295808e-05
assess O 0 0.0003011464432347566
genotype O 0 0.004585502669215202
- O 0 0.008946622721850872
phenotype O 0 0.0030352252069860697
correlations O 0 0.0007728725904598832
in O 0 0.0006141194025985897
AAPC B-Disease 1 0.9989798665046692
families O 0 0.001763939973898232
. O 0 0.0018339683301746845

By O 0 0.0009977419394999743
protein O 0 0.0007907798863016069
- O 0 0.001437835511751473
truncation O 0 0.003605080768465996
test O 0 0.0004036856407765299
( O 0 0.00018166250083595514
PTT O 0 0.0007336276466958225
) O 0 8.950035407906398e-05
assay O 0 0.0001904917589854449
, O 0 4.3590425775619224e-05
the O 0 4.099356010556221e-05
entire O 0 9.944854537025094e-05
coding O 0 9.514616249362007e-05
region O 0 5.6767152273096144e-05
of O 0 5.237309596850537e-05
the O 0 0.00014571590872947127
APC B-Disease 1 0.9798282980918884
gene O 0 0.00015443343727383763
was O 0 0.00012198578042443842
screened O 0 0.00010450409899931401
in O 0 3.854448004858568e-05
affected O 0 6.359753024298698e-05
individuals O 0 2.6579109544400126e-05
from O 0 5.1871676987502724e-05
11 O 0 0.001028119819238782
AAPC B-Disease 1 0.9999154806137085
kindreds O 1 0.5010229349136353
, O 0 9.615787712391466e-05
and O 0 5.884575512027368e-05
their O 0 5.3555588237941265e-05
phenotypic O 0 0.00036077486583963037
differences O 0 0.0002013373450608924
were O 0 0.00024221112835220993
examined O 0 0.0018038772977888584
. O 0 0.0012279197108000517

Five O 0 0.002515137894079089
novel O 0 0.005252895876765251
germ O 1 0.9991042017936707
- O 1 0.8060580492019653
line O 0 0.02364194206893444
APC B-Disease 1 0.9145730137825012
mutations O 0 0.00025894385180436075
were O 0 8.931381307775155e-05
identified O 0 0.0001411751873092726
in O 0 0.00016451235569547862
seven O 0 0.0006126859807409346
kindreds O 0 0.08102966099977493
. O 0 0.0015413067303597927

Mutations O 0 0.0014267693040892482
were O 0 0.0002310951385879889
located O 0 0.0001471172145102173
in O 0 4.70861850772053e-05
three O 0 2.7465746825328097e-05
different O 0 1.2575462278618943e-05
regions O 0 3.140814078506082e-05
of O 0 4.473637090995908e-05
the O 0 7.960655784700066e-05
APC B-Disease 1 0.7202045321464539
gene O 0 0.000126116065075621
( O 0 4.237593020661734e-05
1 O 0 3.4715369110926986e-05
) O 0 1.72942309291102e-05
at O 0 2.231715370726306e-05
the O 0 1.9022005290025845e-05
5 O 0 2.506611963326577e-05
end O 0 4.076542245456949e-05
spanning O 0 7.130843005143106e-05
exons O 0 9.038599091582e-05
4 O 0 3.87229083571583e-05
and O 0 1.895852983579971e-05
5 O 0 3.143867797916755e-05
, O 0 2.5905943402904086e-05
( O 0 2.7522431992110796e-05
2 O 0 2.8775009923265316e-05
) O 0 2.3478343791794032e-05
within O 0 2.965610838145949e-05
exon O 0 0.00017550576012581587
9 O 0 8.307304960908368e-05
, O 0 3.312512126285583e-05
and O 0 2.7540207156562246e-05
( O 0 3.401154754101299e-05
3 O 0 3.8617366953985766e-05
) O 0 2.39742348639993e-05
at O 0 3.270825618528761e-05
the O 0 3.68519285984803e-05
3 O 0 9.866002801572904e-05
distal O 0 0.00048449818859808147
end O 0 0.00012457424600142986
of O 0 0.00014086159353610128
the O 0 0.0002617587451823056
gene O 0 0.0006255741463974118
. O 0 0.0006431128713302314

Variability O 0 0.0022660635877400637
in O 0 0.0002168364153476432
the O 0 0.0001418403844581917
number O 0 0.00011499432002892718
of O 0 0.1437426656484604
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999986886978149
was O 0 0.40774133801460266
most O 0 0.00010716239921748638
apparent O 0 0.009787258692085743
in O 0 3.740044485311955e-05
individuals O 0 2.3656393750570714e-05
with O 0 2.336744000785984e-05
mutations O 0 4.3059728341177106e-05
in O 0 2.0657987988670357e-05
region O 0 7.493177690776065e-05
1 O 0 7.977306086104363e-05
, O 0 7.075265602907166e-05
and O 0 0.00011411422747187316
upper O 1 0.9157357215881348
- O 1 0.9994749426841736
gastrointestinal O 1 0.9999779462814331
manifestations O 1 0.9027621746063232
were O 0 0.00011988482583547011
more O 0 7.737996202195063e-05
severe O 1 0.8401128053665161
in O 0 0.00023748487001284957
them O 0 0.00031176727497950196
. O 0 0.0009363210992887616

In O 0 0.0007685389718972147
individuals O 0 0.00023578913533128798
with O 0 0.00010830650717252865
mutations O 0 9.697881614556536e-05
in O 0 3.708322765305638e-05
either O 0 3.5641223803395405e-05
region O 0 5.6348890211666e-05
2 O 0 4.2283969378331676e-05
or O 0 2.5756120521691628e-05
region O 0 3.389925404917449e-05
3 O 0 2.8437199944164604e-05
, O 0 1.85136086656712e-05
the O 0 2.1738533177995123e-05
average O 0 2.9487666324712336e-05
number O 0 1.4802707482886035e-05
of O 0 4.9196274630958214e-05
adenomas B-Disease 1 0.5986067056655884
tended O 0 5.850020534126088e-05
to O 0 1.1868000001413748e-05
be O 0 1.2877679182565771e-05
lower O 0 1.8396358427708037e-05
than O 0 1.0613056474539917e-05
those O 0 8.99380938790273e-06
in O 0 1.4202735655999277e-05
individuals O 0 1.4128786460787524e-05
with O 0 1.8703331079450436e-05
mutations O 0 4.121864913031459e-05
in O 0 1.796000469767023e-05
region O 0 4.663319850806147e-05
1 O 0 5.928046448389068e-05
, O 0 5.332702130544931e-05
although O 0 4.974388866685331e-05
age O 0 0.00014128601469565183
at O 0 0.00025406989152543247
diagnosis O 0 0.41401150822639465
was O 0 0.0008245976059697568
similar O 0 0.0004978705546818674
. O 0 0.0010793085675686598

In O 0 0.0014506301376968622
all O 0 0.0009255206678062677
AAPC B-Disease 1 0.9978699684143066
kindreds O 0 0.01870967634022236
, O 0 0.00022658360830973834
a O 0 0.00021582507179118693
predominance O 0 0.003912188112735748
of O 0 0.0006912927492521703
right O 1 0.6816240549087524
- O 1 0.9998830556869507
sided O 1 0.9999945163726807
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999996423721313
and O 1 0.9951555728912354
rectal B-Disease 1 0.9999994039535522
polyp I-Disease 1 0.9999988079071045
sparing O 1 0.9993045330047607
was O 0 0.1606004536151886
observed O 0 0.002272142330184579
. O 0 0.0015546312788501382

No O 0 0.030878577381372452
desmoid B-Disease 1 0.999308705329895
tumors I-Disease 1 0.9976688027381897
were O 0 0.0003216327168047428
found O 0 0.00026447552954778075
in O 0 0.00021305585687514395
these O 0 0.00034894057898782194
kindreds O 0 0.01520533487200737
. O 0 0.0016998854698613286

Our O 0 0.0013271505013108253
data O 0 0.0001961755333468318
suggest O 0 0.00018394058861304075
that O 0 7.020559132797644e-05
, O 0 8.740467455936596e-05
in O 0 8.686052751727402e-05
AAPC B-Disease 1 0.9932928085327148
families O 0 0.00010249552724417299
, O 0 3.633352025644854e-05
the O 0 3.5839693737216294e-05
location O 0 4.655370503314771e-05
of O 0 5.206852074479684e-05
the O 0 0.00016715806850697845
APC B-Disease 1 0.9853670597076416
mutation O 0 0.0017961353296414018
may O 0 0.0001491046859882772
partially O 0 0.0005318352486938238
predict O 0 0.0003853557864204049
specific O 0 0.00023664765467401594
phenotypic O 0 0.001233404385857284
expression O 0 0.0010454102884978056
. O 0 0.0008308628457598388

This O 0 0.0006405855529010296
should O 0 0.00029365491354838014
help O 0 0.0001526042615296319
in O 0 6.904686597408727e-05
the O 0 9.663742821430787e-05
design O 0 0.0002093003422487527
of O 0 0.0001920959330163896
tailored O 0 0.003603104967623949
clinical O 0 0.2100665271282196
- O 0 0.03562610596418381
management O 0 0.0004232035716995597
protocols O 0 0.00015299413644243032
in O 0 3.676435153465718e-05
this O 0 3.346479206811637e-05
subset O 0 0.0002546582545619458
of O 0 0.001090353005565703
FAP B-Disease 1 0.999990701675415
patients O 1 0.8828564286231995
. O 0 0.00040183981764130294
. O 0 0.0009845871245488524

Wilms B-Disease 1 0.9999731779098511
' I-Disease 1 0.8339925408363342
tumor I-Disease 1 0.9889843463897705
1 O 0 0.000577883212827146
and O 0 0.0003182227665092796
Dax O 1 0.8330330848693848
- O 0 0.0008168415515683591
1 O 0 0.00017116303206421435
modulate O 0 0.00036207554512657225
the O 0 0.00015317107317969203
orphan O 0 0.01323640439659357
nuclear O 0 0.0005043820710852742
receptor O 0 0.0005705046351067722
SF O 1 0.8127573728561401
- O 0 0.0002834638871718198
1 O 0 0.00011070760956499726
in O 0 8.29866694402881e-05
sex O 0 0.00022040243493393064
- O 0 0.0004481216019485146
specific O 0 0.00013135267363395542
gene O 0 0.0003947236982639879
expression O 0 0.000679082702845335
. O 0 0.0010270527563989162

Products O 0 0.001562618650496006
of O 0 0.0007810709648765624
steroidogenic O 1 0.9575345516204834
factor O 0 0.0009639264899305999
1 O 0 0.00025699834804981947
( O 0 0.00038002870860509574
SF O 1 0.9803447127342224
- O 0 0.0005999653949402273
1 O 0 9.302041871706024e-05
) O 0 7.713359809713438e-05
and O 0 0.00017392731388099492
Wilms B-Disease 1 0.9999662637710571
tumor I-Disease 1 0.9997226595878601
1 O 0 0.0007114153704605997
( O 0 0.0006137519958429039
WT1 O 1 0.93873530626297
) O 0 9.506063361186534e-05
genes O 0 7.181745604611933e-05
are O 0 2.342685911571607e-05
essential O 0 9.122593473875895e-05
for O 0 7.895796443335712e-05
mammalian O 0 0.0004249757621437311
gonadogenesis O 0 0.007201788481324911
prior O 0 0.00034298564423806965
to O 0 0.00017366828978992999
sexual O 0 0.0011880039237439632
differentiation O 0 0.003397450316697359
. O 0 0.0013282581930980086

In O 0 0.0006605490925721824
males O 0 0.0006266231066547334
, O 0 0.00045896630035713315
SF O 1 0.9992783665657043
- O 0 0.006429269444197416
1 O 0 0.0001611829939065501
participates O 0 0.00015120390162337571
in O 0 5.057840098743327e-05
sexual O 0 0.00010064162052003667
development O 0 7.082138472469524e-05
by O 0 2.4526865672669373e-05
regulating O 0 6.72782989568077e-05
expression O 0 5.8234756579622626e-05
of O 0 5.776016405434348e-05
the O 0 0.00019620172679424286
polypeptide O 1 0.5900859832763672
hormone O 1 0.9356205463409424
Mullerian O 1 0.9994699358940125
inhibiting O 1 0.8195880055427551
substance O 1 0.8263996839523315
( O 0 0.0027868924662470818
MIS O 1 0.902374804019928
) O 0 0.0007576144998893142
. O 0 0.001145326648838818

Here O 0 0.0016120708314701915
, O 0 0.0004892103606835008
we O 0 0.00019617742509581149
show O 0 0.0003754670324269682
that O 0 0.00022938265465199947
WT1 O 1 0.9784168004989624
- O 0 0.014012320898473263
KTS O 1 0.8243653178215027
isoforms O 0 0.00041788461385294795
associate O 0 0.0003683467220980674
and O 0 0.0001775349082890898
synergize O 0 0.07515350729227066
with O 0 0.0003648115089163184
SF O 1 0.9995043277740479
- O 0 0.003608034923672676
1 O 0 0.00020410542492754757
to O 0 0.00011728291428880766
promote O 0 0.0006736918003298342
MIS O 1 0.696079671382904
expression O 0 0.0014522700803354383
. O 0 0.0011396604822948575

In O 0 0.001437955186702311
contrast O 0 0.001867828075774014
, O 0 0.0011168671771883965
WT1 O 1 0.998977541923523
missense O 0 0.03658805787563324
mutations O 0 0.000478135421872139
, O 0 0.00010031335114035755
associated O 0 8.759791671764106e-05
with O 0 6.547094380948693e-05
male B-Disease 0 0.0021055631805211306
pseudohermaphroditism I-Disease 1 0.9998646974563599
in O 0 0.015229393728077412
Denys B-Disease 1 0.9999979734420776
- I-Disease 1 0.9999966621398926
Drash I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
, O 0 0.006012622732669115
fail O 0 0.0013171395985409617
to O 0 0.00012464409519452602
synergize O 1 0.8466712832450867
with O 0 0.0009996964363381267
SF O 1 0.9999511241912842
- O 0 0.12521910667419434
1 O 0 0.0009679215727373958
. O 0 0.0010073124431073666

Additionally O 0 0.0010352249955758452
, O 0 0.0002619679435156286
the O 0 0.0001644765870878473
X O 0 0.004237462300807238
- O 0 0.0008794381283223629
linked O 0 0.00018048982019536197
, O 0 5.342944132280536e-05
candidate O 0 0.00012315901403781027
dosage O 0 0.0005350543069653213
- O 0 0.00033468767651356757
sensitive O 0 0.00015722143871244043
sex O 0 0.00013156639761291444
- O 0 0.0003628950798884034
reversal O 0 0.0012052824022248387
gene O 0 8.691156835993752e-05
, O 0 7.116231427062303e-05
Dax O 0 0.4516505002975464
- O 0 0.0004517877532634884
1 O 0 0.00010033842409029603
, O 0 6.841830327175558e-05
antagonizes O 0 0.0011930458713322878
synergy O 0 0.0013428475940600038
between O 0 0.0001934365718625486
SF O 1 0.9997072815895081
- O 0 0.022298987954854965
1 O 0 0.00019904700457118452
and O 0 0.00016053172294050455
WT1 O 1 0.9363397359848022
, O 0 6.458345160353929e-05
most O 0 3.588658000808209e-05
likely O 0 4.3739208194892853e-05
through O 0 3.786295201280154e-05
a O 0 5.354905442800373e-05
direct O 0 8.782450458966196e-05
interaction O 0 0.0001409000251442194
with O 0 0.0001994927297346294
SF O 1 0.9992164373397827
- O 0 0.008064229972660542
1 O 0 0.0008229307713918388
. O 0 0.0010301219299435616

We O 0 0.0010297637199983
propose O 0 0.0012470107758417726
that O 0 0.0003091832040809095
WT1 O 1 0.8303474187850952
and O 0 0.00040065046050585806
Dax O 1 0.9972668886184692
- O 0 0.03072422929108143
1 O 0 0.00020581264107022434
functionally O 0 0.0003664092510007322
oppose O 0 8.786924445303157e-05
each O 0 1.9722201614058577e-05
other O 0 1.947968667082023e-05
in O 0 4.291681761969812e-05
testis O 0 0.0034756462555378675
development O 0 0.00016379078442696482
by O 0 0.00012016099935863167
modulating O 1 0.6844784617424011
SF O 1 0.999855637550354
- O 0 0.04955470561981201
1 O 0 0.0004874722508247942
- O 0 0.01042908988893032
mediated O 0 0.004312099423259497
transactivation O 0 0.12623342871665955
. O 0 0.0006408905610442162
. O 0 0.0012707071145996451

A O 0 0.0036360330414026976
mouse O 0 0.0038143559359014034
model O 0 0.001632411265745759
for O 0 0.0016687717288732529
Prader B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999980926513672
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999967813491821
- O 1 0.9999395608901978
centre O 1 0.9982227683067322
mutations O 0 0.17546068131923676
. O 0 0.0020841702353209257

Imprinting O 0 0.009875144809484482
in O 0 0.0007916144677437842
the O 0 0.0009418919216841459
15q11 O 1 0.995798647403717
- O 0 0.4539669454097748
q13 O 1 0.899704098701477
region O 0 0.0003396547108422965
involves O 0 0.0004469955456443131
an O 0 0.00016978738131001592
imprinting O 1 0.6415054798126221
centre O 0 0.1551230400800705
( O 0 0.0013111006701365113
IC O 1 0.5313383340835571
) O 0 4.880423512076959e-05
, O 0 2.2654283384326845e-05
mapping O 0 4.408501990837976e-05
in O 0 1.620933471713215e-05
part O 0 3.124228533124551e-05
to O 0 1.7677133655524813e-05
the O 0 3.7812402297277004e-05
promoter O 0 0.0005126413307152689
and O 0 6.911833770573139e-05
first O 0 0.00015185699157882482
exon O 0 0.0013784313341602683
of O 0 0.0007289390196092427
SNRPN O 1 0.9886659383773804
. O 0 0.001974375220015645

Deletion O 0 0.005554627161473036
of O 0 0.0007657220121473074
this O 0 0.0005560024874284863
IC O 1 0.8610022664070129
abolishes O 0 0.0731949582695961
local O 0 0.00030465773306787014
paternally O 0 0.00526339840143919
derived O 0 0.00018306102720089257
gene O 0 0.00010341482993680984
expression O 0 8.311655255965889e-05
and O 0 4.570594319375232e-05
results O 0 8.90761730261147e-05
in O 0 0.0005898051895201206
Prader B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999996423721313
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999535083770752
PWS B-Disease 1 0.9999996423721313
) O 0 0.010761374607682228
. O 0 0.0016404609195888042

We O 0 0.0007928666309453547
have O 0 0.0001777639554347843
created O 0 0.0002926660527009517
two O 0 9.536679135635495e-05
deletion O 0 0.0005851940368302166
mutations O 0 0.00017804688832256943
in O 0 7.929599814815447e-05
mice O 0 0.00039489322807639837
to O 0 5.66314956813585e-05
understand O 0 0.0003630536957643926
PWS B-Disease 1 0.9998772144317627
and O 0 0.00013071692956145853
the O 0 0.0001358503068331629
mechanism O 0 0.00024714917526580393
of O 0 0.00019903903012163937
this O 0 0.0003166357637383044
IC O 1 0.9375720620155334
. O 0 0.0013727195328101516

Mice O 0 0.02762087620794773
harbouring O 1 0.5886464715003967
an O 0 0.0007131578167900443
intragenic O 1 0.9905224442481995
deletion O 0 0.054792482405900955
in O 0 0.00039182062027975917
Snrpn O 1 0.9923965334892273
are O 0 7.2176379035227e-05
phenotypically O 0 0.0389854796230793
normal O 0 0.0001312366221100092
, O 0 4.810594327864237e-05
suggesting O 0 7.128075958462432e-05
that O 0 2.2889689716976136e-05
mutations O 0 6.914675759617239e-05
of O 0 7.326636841753498e-05
SNRPN O 1 0.9632527828216553
are O 0 3.999871842097491e-05
not O 0 4.7022556827869266e-05
sufficient O 0 0.00022373568208422512
to O 0 0.00020931672770529985
induce O 0 0.00888675544410944
PWS B-Disease 1 0.9995059967041016
. O 0 0.0027800945099443197

Mice O 0 0.004385937470942736
with O 0 0.00036980866570957005
a O 0 0.0002943789877463132
larger O 0 0.0002737180329859257
deletion O 0 0.0005632679676637053
involving O 0 0.00023923914704937488
both O 0 0.00012096561840735376
Snrpn O 0 0.1889658272266388
and O 0 0.00014566327445209026
the O 0 0.0003118662571068853
putative O 1 0.9976492524147034
PWS O 1 0.9999996423721313
- O 1 0.9993404746055603
IC O 1 0.9964197874069214
lack O 0 0.0005688314558938146
expression O 0 9.122323535848409e-05
of O 0 5.860623423359357e-05
the O 0 8.74212637427263e-05
imprinted O 0 0.02143171802163124
genes O 0 0.0001728004135657102
Zfp127 O 1 0.665825605392456
( O 0 0.0001798524899641052
mouse O 0 0.0003000530996359885
homologue O 0 0.0007063984521664679
of O 0 0.00016016341396607459
ZNF127 O 1 0.9963135123252869
) O 0 0.00013707987091038376
, O 0 0.0001285397884203121
Ndn O 0 0.4936394691467285
and O 0 0.00018290974549017847
Ipw O 0 0.022971708327531815
, O 0 0.00012567429803311825
and O 0 0.00010493729496374726
manifest O 0 0.0004575913189910352
several O 0 0.00014502974227070808
phenotypes O 0 0.0020831411238759756
common O 0 0.0003963675117120147
to O 0 0.0005506719462573528
PWS B-Disease 1 0.9999890327453613
infants O 1 0.9950897693634033
. O 0 0.0030208074022084475

These O 0 0.0003269129083491862
data O 0 0.0001489219575887546
demonstrate O 0 0.00014625406765844673
that O 0 3.489094160613604e-05
both O 0 1.8616028683027253e-05
the O 0 2.776745350274723e-05
position O 0 5.999361746944487e-05
of O 0 5.191690070205368e-05
the O 0 9.423696610610932e-05
IC O 1 0.7106872200965881
and O 0 3.7630270526278764e-05
its O 0 2.265527655254118e-05
role O 0 5.9032419812865555e-05
in O 0 2.4274413590319455e-05
the O 0 4.334159893915057e-05
coordinate O 0 8.82646199897863e-05
expression O 0 7.525215187342837e-05
of O 0 4.106872438569553e-05
genes O 0 3.6201778129907325e-05
is O 0 2.7912334189750254e-05
conserved O 0 4.1014558519236743e-05
between O 0 3.8099358789622784e-05
mouse O 0 0.00019194728520233184
and O 0 3.44674990628846e-05
human O 0 5.603508907370269e-05
, O 0 2.618881808302831e-05
and O 0 2.1108557120896876e-05
indicate O 0 2.8842810934293084e-05
that O 0 1.171919302578317e-05
the O 0 2.8520062187453732e-05
mouse O 0 0.00011787490075221285
is O 0 2.2490166884381324e-05
a O 0 3.38428835675586e-05
suitable O 0 7.188768358901143e-05
model O 0 6.294601917034015e-05
system O 0 2.8793067031074315e-05
in O 0 1.7019974620779976e-05
which O 0 1.2815613445127383e-05
to O 0 1.2048239113937598e-05
investigate O 0 4.239346526446752e-05
the O 0 3.213056334061548e-05
molecular O 0 5.408396100392565e-05
mechanisms O 0 5.140072971698828e-05
of O 0 4.9583526561036706e-05
imprinting O 0 0.000944475585129112
in O 0 4.6352324716281146e-05
this O 0 2.825212141033262e-05
region O 0 6.026621122146025e-05
of O 0 9.078542643692344e-05
the O 0 0.0001458624319639057
genome O 0 0.000579094048589468
. O 0 0.0002704118669498712
. O 0 0.0005747154937125742

Mutations O 0 0.002758823800832033
of O 0 0.0007311136578209698
the O 0 0.00042039682739414275
ATM O 0 0.0013290465576574206
gene O 0 0.00020778579346369952
detected O 0 0.0002217199798906222
in O 0 0.00012968808005098253
Japanese O 1 0.7588027119636536
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999918937683105
telangiectasia I-Disease 1 0.9999986886978149
patients O 1 0.9942328333854675
: O 0 0.0002554909442551434
possible O 0 0.00013931423018220812
preponderance O 0 0.0014625659678131342
of O 0 8.964419976109639e-05
the O 0 8.064407302299514e-05
two O 0 8.760218042880297e-05
founder O 0 0.07785618305206299
mutations O 0 0.0029140301048755646
4612del165 O 1 0.9656664133071899
and O 0 0.0008373229065909982
7883del5 O 1 0.8893839716911316
. O 0 0.0016224130522459745

The O 0 0.0012713561300188303
ATM O 0 0.0048967450857162476
( O 0 0.001269343658350408
A O 0 0.42184433341026306
- O 1 0.9936453104019165
T O 1 0.9971051812171936
, O 0 0.00016566556587349623
mutated O 0 0.00039517474942840636
) O 0 7.854882278479636e-05
gene O 0 9.932136163115501e-05
on O 0 0.00010292118531651795
human O 0 0.00035024870885536075
chromosome O 0 0.002843522233888507
11q22 O 1 0.5366960167884827
. O 0 0.0015751535538583994

3 O 0 0.0013500916538760066
has O 0 0.0003710378659889102
recently O 0 0.0002989626373164356
been O 0 6.899499567225575e-05
identified O 0 6.884869071654975e-05
as O 0 5.199399311095476e-05
the O 0 6.24402382527478e-05
gene O 0 7.904316589701921e-05
responsible O 0 7.28402374079451e-05
for O 0 3.383104194654152e-05
the O 0 0.00020090931502636522
human O 1 0.7947717905044556
recessive B-Disease 1 0.9999990463256836
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
telangiectasia I-Disease 1 0.9999998807907104
( O 1 0.9994840621948242
A B-Disease 1 0.9999784231185913
- I-Disease 1 0.9999816417694092
T I-Disease 1 0.9999114274978638
) O 0 0.0007774222176522017
. O 0 0.0008381154621019959

In O 0 0.0005257779848761857
order O 0 0.0002679082681424916
to O 0 6.53935712762177e-05
define O 0 0.00010182082769460976
the O 0 5.287109161145054e-05
types O 0 6.815456436015666e-05
of O 0 0.0028561565559357405
disease O 1 0.9999971389770508
- O 1 0.999219536781311
causing O 1 0.9721071124076843
ATM O 0 0.02553829923272133
mutations O 0 8.693444397067651e-05
in O 0 3.105005089309998e-05
Japanese O 0 0.05087398365139961
A B-Disease 1 0.999402642250061
- I-Disease 1 0.9999876022338867
T I-Disease 1 0.9999873638153076
patients O 0 0.026052074506878853
as O 0 2.770136052276939e-05
well O 0 2.0177167243673466e-05
as O 0 1.6841899196151644e-05
to O 0 1.333519958279794e-05
look O 0 4.036400423501618e-05
for O 0 3.074984124395996e-05
possible O 0 7.919518975540996e-05
mutational O 0 0.05648243427276611
hotspots O 0 0.003105109091848135
, O 0 8.293856080854312e-05
reverse O 0 0.00020873855100944638
- O 0 0.00024073029635474086
transcribed O 0 0.00011338380863890052
RNA O 0 0.00010574309999356046
derived O 0 6.267934804782271e-05
from O 0 2.6660040020942688e-05
ten O 0 6.264241528697312e-05
patients O 0 0.0001068654382834211
belonging O 0 7.034833106445149e-05
to O 0 2.4304803446284495e-05
eight O 0 5.4834232287248597e-05
unrelated O 0 0.00014507208834402263
Japanese O 0 0.0030562891624867916
A B-Disease 1 0.8548821210861206
- I-Disease 1 0.9926676154136658
T I-Disease 1 0.9893981218338013
families O 0 8.44722890178673e-05
was O 0 0.00012537074508145452
analyzed O 0 6.641633808612823e-05
for O 0 4.660879130824469e-05
mutations O 0 8.836331107886508e-05
by O 0 5.636436617351137e-05
the O 0 0.00013974503963254392
restriction O 0 0.0004791941901203245
endonuclease O 0 0.003578962292522192
fingerprinting O 0 0.0017607109621167183
method O 0 0.0010933111188933253
. O 0 0.000996907358057797

As O 0 0.0007938811904750764
has O 0 0.00019198386871721596
been O 0 0.00010723333980422467
reported O 0 0.00010764118633233011
by O 0 3.552537600626238e-05
others O 0 5.687612065230496e-05
, O 0 4.416210867930204e-05
mutations O 0 7.807416841387749e-05
that O 0 2.867236798920203e-05
lead O 0 9.79615215328522e-05
to O 0 4.6845318138366565e-05
exon O 0 0.000762323965318501
skipping O 0 0.0013307806802913547
or O 0 0.00018139801977667958
premature O 0 0.002340160310268402
protein O 0 0.00016774117830209434
truncation O 0 0.0005133092636242509
were O 0 6.410454807337373e-05
also O 0 8.466203871648759e-05
predominant O 0 0.0002842801623046398
in O 0 0.0002160004951292649
our O 0 0.0006692413589917123
mutants O 0 0.005191017407923937
. O 0 0.0016070259734988213

Six O 0 0.0010041737696155906
different O 0 0.00013261382991913706
mutations O 0 0.00018382383859716356
were O 0 5.071648774901405e-05
identified O 0 4.522174640442245e-05
on O 0 3.019619543920271e-05
12 O 0 5.2787061576964334e-05
of O 0 6.49689172860235e-05
the O 0 0.0001098225184250623
16 O 0 0.00038170412881299853
alleles O 0 0.0009010478388518095
examined O 0 0.0015151196857914329
. O 0 0.0008132479852065444

Four O 0 0.0010750162182375789
were O 0 0.0002790337020996958
deletions O 0 0.0007124404655769467
involving O 0 0.0003441480512265116
a O 0 0.0001570661988807842
loss O 0 0.0004344449262134731
of O 0 9.659063653089106e-05
a O 0 0.00014712898700963706
single O 0 0.00014693592675030231
exon O 0 0.0007214503712020814
exon O 0 0.0005269648390822113
7 O 0 0.00013369751104619354
, O 0 8.656318095745519e-05
exon O 0 0.00036658099270425737
16 O 0 0.0001556645438540727
, O 0 0.00013388441584538668
exon O 0 0.0008095491793937981
33 O 0 0.0004507330013439059
or O 0 0.00024193186254706234
exon O 0 0.0021477369591593742
35 O 0 0.0011550179915502667
. O 0 0.0011052427580580115

The O 0 0.001050385762937367
others O 0 0.00039994349936023355
were O 0 0.00016807032807264477
minute O 0 0.0002624809858389199
deletions O 0 0.000633533694781363
, O 0 0.00014291235129348934
4649delA O 0 0.0014854181790724397
in O 0 0.00015167088713496923
exon O 0 0.0007992727914825082
33 O 0 0.000324685825034976
and O 0 0.00018013599037658423
7883del5 O 0 0.012528510764241219
in O 0 0.00020518874225672334
exon O 0 0.0021670081187039614
55 O 0 0.001342401490546763
. O 0 0.0009471419034525752

The O 0 0.001645278069190681
mutations O 0 0.004398765508085489
4612del165 O 1 0.9202195405960083
and O 0 0.00036052303039468825
7883del5 O 0 0.4699186384677887
were O 0 8.025956776691601e-05
found O 0 4.6023302274988964e-05
in O 0 2.4785653295111842e-05
more O 0 1.3190291610953864e-05
than O 0 1.7083299098885618e-05
two O 0 1.3369504813454114e-05
unrelated O 0 4.978089782525785e-05
families O 0 2.8757451218552887e-05
; O 0 1.4634663784818258e-05
44 O 0 3.5426721296971664e-05
% O 0 2.0094226783839986e-05
( O 0 2.6589908884488977e-05
7 O 0 3.61968413926661e-05
of O 0 2.0833789676544257e-05
16 O 0 4.50435618404299e-05
) O 0 2.093482544296421e-05
of O 0 3.069075319217518e-05
the O 0 5.657664223690517e-05
mutant O 0 0.0004182911361567676
alleles O 0 9.022857557283714e-05
had O 0 4.9765672883950174e-05
one O 0 3.09803981508594e-05
of O 0 4.7618214011890814e-05
the O 0 9.930280066328123e-05
two O 0 0.00015292561147361994
mutations O 0 0.0007357686990872025
. O 0 0.0006672559538856149

The O 0 0.0022261005360633135
4612del165 O 1 0.8239842653274536
mutations O 0 0.0006068423972465098
in O 0 9.596779273124412e-05
three O 0 4.072431329404935e-05
different O 0 1.6651230907882564e-05
families O 0 3.445875699981116e-05
were O 0 2.175707049900666e-05
all O 0 1.712678567855619e-05
ascribed O 0 6.274447514442727e-05
to O 0 1.3898365978093352e-05
the O 0 2.8923319405294023e-05
same O 0 4.188824459561147e-05
T O 1 0.6666214466094971
- O 0 0.008001325652003288
- O 0 0.0017499017994850874
> O 0 0.00030026116291992366
A O 0 0.00011516024096636102
substitution O 0 0.00016190171299967915
at O 0 6.48566274321638e-05
the O 0 7.62530617066659e-05
splice O 0 0.0005203131586313248
donor O 0 0.00024134803970810026
site O 0 0.0003017263952642679
in O 0 0.00016885710647329688
intron O 0 0.00441635912284255
33 O 0 0.0015474911779165268
. O 0 0.0009312081965617836

Microsatellite O 0 0.1389646828174591
genotyping O 0 0.008957617916166782
around O 0 0.0006119488389231265
the O 0 0.0002880835672840476
ATM O 0 0.002918174024671316
locus O 0 0.0010729188797995448
also O 0 8.241539035225287e-05
indicated O 0 8.908797462936491e-05
that O 0 2.5598325009923428e-05
a O 0 4.731637818622403e-05
common O 0 4.9580597988097e-05
haplotype O 0 0.0003797726531047374
was O 0 0.00014740574988536537
shared O 0 8.272008562926203e-05
by O 0 4.640955739887431e-05
the O 0 0.00011609743523877114
mutant O 0 0.0015019321581348777
alleles O 0 0.0003341645060572773
in O 0 0.00012801050615962595
both O 0 0.00019419316959101707
mutations O 0 0.0011451385216787457
. O 0 0.0008767695399001241

This O 0 0.0006367170135490596
suggests O 0 0.0003522516635712236
that O 0 5.238053563516587e-05
these O 0 2.362969462410547e-05
two O 0 5.021042306907475e-05
founder O 0 0.01484307274222374
mutations O 0 0.0003144115908071399
may O 0 9.372095519211143e-05
be O 0 5.871330722584389e-05
predominant O 0 0.0003954428539145738
among O 0 0.00016421581676695496
Japanese O 0 0.0015974758425727487
ATM O 0 0.00736245047301054
mutant O 0 0.00530198821797967
alleles O 0 0.0020861926022917032
. O 0 0.0011499756947159767

W474C O 0 0.0818321630358696
amino O 0 0.0012326532742008567
acid O 0 0.0011804236564785242
substitution O 0 0.00050089176511392
affects O 0 0.00021109085355419666
early O 0 8.05426316219382e-05
processing O 0 5.621738819172606e-05
of O 0 3.8485199183924124e-05
the O 0 5.365819015423767e-05
alpha O 0 0.00016769605281297117
- O 0 9.49720197240822e-05
subunit O 0 9.294025949202478e-05
of O 0 7.67814926803112e-05
beta O 0 0.0005889771273359656
- O 0 0.0027114604599773884
hexosaminidase O 0 0.14331495761871338
A O 0 0.000207355129532516
and O 0 6.125304935267195e-05
is O 0 5.8065237681148574e-05
associated O 0 0.00010093464516103268
with O 0 0.00026754860300570726
subacute O 1 0.9999969005584717
G B-Disease 1 0.9971426129341125
( I-Disease 0 0.05285949632525444
M2 I-Disease 1 0.9920185208320618
) I-Disease 0 0.0007866109372116625
gangliosidosis I-Disease 0 0.09835430979728699
. O 0 0.0016172971809282899

Mutations O 0 0.0023774991277605295
in O 0 0.0004030991985928267
the O 0 0.0004694537492468953
HEXA O 1 0.9977704286575317
gene O 0 0.00021075582480989397
, O 0 6.589730764972046e-05
encoding O 0 5.332275395630859e-05
the O 0 4.44235593022313e-05
alpha O 0 0.00014253212430048734
- O 0 0.00011419336806284264
subunit O 0 7.505964458687231e-05
of O 0 6.15597891737707e-05
beta O 0 0.0003595115558709949
- O 0 0.0018936747219413519
hexosaminidase O 0 0.33018869161605835
A O 0 0.0005414126790128648
( O 0 0.00016397079161833972
Hex O 0 0.0006691351882182062
A O 0 0.00011894643103005365
) O 0 3.788108369917609e-05
, O 0 2.4116567146847956e-05
that O 0 2.3992462956812233e-05
abolish O 0 0.00020408675482030958
Hex O 0 0.00048235911526717246
A O 0 0.00021915536490269005
enzyme O 0 0.00038985852734185755
activity O 0 0.00049212557496503
cause O 1 0.9782690405845642
Tay B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999847412109375
Sachs I-Disease 1 0.9999959468841553
disease I-Disease 1 0.9999990463256836
( O 1 0.9363198280334473
TSD B-Disease 1 0.9999903440475464
) O 0 0.0002234547137049958
, O 0 8.604798495071009e-05
the O 0 0.00021856023522559553
fatal O 1 0.9995311498641968
infantile B-Disease 1 0.9997828602790833
form I-Disease 0 0.0004953378811478615
of I-Disease 0 0.007669190410524607
G I-Disease 1 0.9569620490074158
( I-Disease 0 0.0013816237915307283
M2 I-Disease 1 0.8721994161605835
) I-Disease 0 0.00020731028052978218
gangliosidosis I-Disease 0 0.18296420574188232
, I-Disease 0 0.00022448462550528347
Type I-Disease 0 0.0006320088286884129
1 I-Disease 0 0.0006580909830518067
. O 0 0.0008986729080788791

Less O 0 0.003241651225835085
severe O 1 0.999569833278656
, O 0 0.07182062417268753
subacute O 1 0.9999985694885254
( O 1 0.9786794185638428
juvenile O 1 0.9999898672103882
- O 1 0.9999706745147705
onset O 1 0.9999984502792358
) O 0 0.10033021122217178
and O 0 0.17413346469402313
chronic O 1 0.9999997615814209
( O 1 0.5380748510360718
adult O 1 0.6031150221824646
- O 1 0.9994696974754333
onset O 1 0.9999586343765259
) O 0 0.0001795022835722193
variants O 0 8.645824709674343e-05
are O 0 1.5712039385107346e-05
characterized O 0 8.339171472471207e-05
by O 0 2.0201445295242593e-05
a O 0 6.625053356401622e-05
broad O 0 0.00017927410954143852
spectrum O 0 0.0001770710077835247
of O 0 0.00016843242337927222
clinical O 0 0.434613436460495
manifestations O 1 0.8766109347343445
and O 0 8.587183401687071e-05
are O 0 2.020036663452629e-05
associated O 0 4.119679579162039e-05
with O 0 3.1407362257596105e-05
residual O 0 0.0007514202152378857
levels O 0 8.052818884607404e-05
of O 0 9.625410893931985e-05
Hex O 0 0.0028730782214552164
A O 0 0.000665229803416878
enzyme O 0 0.0007834664429537952
activity O 0 0.0006477232091128826
. O 0 0.0008636341081000865

We O 0 0.0007203119457699358
identified O 0 0.000497890985570848
a O 0 0.0003949348465539515
1422 O 1 0.6268162727355957
G O 0 0.08191034197807312
- O 0 0.05615781247615814
- O 0 0.025537967681884766
> O 0 0.002870126161724329
C O 0 0.0004511426668614149
( O 0 7.37961963750422e-05
amino O 0 0.00010510413267184049
acid O 0 0.00023819487250875682
W474C O 0 0.003544148290529847
) O 0 5.098109977552667e-05
substitution O 0 9.530969691695645e-05
in O 0 2.5722858481458388e-05
the O 0 3.310222382424399e-05
first O 0 4.728795829578303e-05
position O 0 6.634525198023766e-05
of O 0 7.209176692413166e-05
exon O 0 0.00040123023791238666
13 O 0 0.0001126729985116981
of O 0 0.0001383162016281858
HEXA O 1 0.9007291793823242
of O 0 0.00012480061559472233
a O 0 0.00016809564840514213
non O 0 0.0006445794133469462
- O 0 0.009183712303638458
Jewish O 0 0.0014995922101661563
proband O 1 0.991521954536438
who O 0 0.0005294769653119147
manifested O 0 0.1367138773202896
a O 0 0.0007955910987220705
subacute O 1 0.9998706579208374
variant O 0 0.007842520251870155
of O 0 0.0014715684810653329
G B-Disease 1 0.9329105019569397
( I-Disease 0 0.006997209507972002
M2 I-Disease 1 0.9282451272010803
) I-Disease 0 0.0005701045738533139
gangliosidosis I-Disease 0 0.0503728948533535
. O 0 0.001302398624829948

On O 0 0.0011000854428857565
the O 0 0.0006908830255270004
second O 0 0.0013599821832031012
maternally O 0 0.4426128566265106
inherited O 1 0.8825502395629883
allele O 0 0.0007495099562220275
, O 0 9.896485425997525e-05
we O 0 5.442232213681564e-05
identified O 0 8.557582623325288e-05
the O 0 0.00014813394227530807
common O 0 0.007363531272858381
infantile O 1 0.9999979734420776
disease O 1 0.9999988079071045
- O 1 0.9988504648208618
causing O 1 0.9917359948158264
4 O 0 0.007808688096702099
- O 0 0.03923055902123451
bp O 0 0.0018656346946954727
insertion O 0 0.0015726042911410332
, O 0 0.00024119438603520393
+ O 0 0.002160304458811879
TATC O 1 0.9438081979751587
1278 O 0 0.40636104345321655
, O 0 0.00024132136604748666
in O 0 0.0002078711986541748
exon O 0 0.0020099584944546223
11 O 0 0.001265161670744419
. O 0 0.001358436536975205

Pulse O 0 0.08132869005203247
- O 0 0.0030145093332976103
chase O 0 0.0012029128847643733
analysis O 0 0.0002501466660760343
using O 0 0.00019473792053759098
proband O 0 0.41841793060302734
fibroblasts O 0 0.0022712163627147675
revealed O 0 0.00019043093197979033
that O 0 3.214533717255108e-05
the O 0 7.414747233269736e-05
W474C O 0 0.1871994584798813
- O 0 0.0005224550841376185
containing O 0 0.00016229644825216383
alpha O 0 0.00022885117505211383
- O 0 0.0002072298084385693
subunit O 0 0.00014146071043796837
precursor O 0 0.00028430778183974326
was O 0 0.00011848467693198472
normally O 0 5.8766690926859155e-05
synthesized O 0 7.367103535216302e-05
, O 0 2.7250373022980057e-05
but O 0 1.689248892944306e-05
not O 0 1.2226418220961932e-05
phosphorylated O 0 9.766222501639277e-05
or O 0 2.8979229682590812e-05
secreted O 0 0.00012305148993618786
, O 0 3.3717537007760257e-05
and O 0 2.8534535886137746e-05
the O 0 5.864766353624873e-05
mature O 0 0.00030522668384946883
lysosomal O 0 0.2101522982120514
alpha O 0 0.0005670308019034564
- O 0 0.0005619375151582062
subunit O 0 0.00021983051556162536
was O 0 0.0001859214826254174
not O 0 0.00012422667350620031
detected O 0 0.0008698243764229119
. O 0 0.0008027973817661405

When O 0 0.0016883250791579485
the O 0 0.0009629856795072556
W474C O 0 0.2687029540538788
- O 0 0.0012841074494645
containing O 0 0.00028389826184138656
alpha O 0 0.000406819861382246
- O 0 0.0005152391386218369
subunit O 0 0.0002776749315671623
was O 0 0.0003687873249873519
transiently O 0 0.0028127836994826794
co O 0 0.0005642831092700362
- O 0 0.00026257961872033775
expressed O 0 8.813710883259773e-05
with O 0 2.8546784960781224e-05
the O 0 7.017359166638926e-05
beta O 0 0.00017692707479000092
- O 0 0.00013075085007585585
subunit O 0 9.505701746093109e-05
to O 0 3.016050686710514e-05
produce O 0 6.506948557216674e-05
Hex O 0 0.00036940272548235953
A O 0 0.00015367488958872855
( O 0 9.20398670132272e-05
alphabeta O 0 0.0009786251466721296
) O 0 5.328371480572969e-05
in O 0 6.692585156997666e-05
COS O 1 0.8772118091583252
- O 0 0.001973043428733945
7 O 0 0.0001794776471797377
cells O 0 9.503924957243726e-05
, O 0 3.325476427562535e-05
the O 0 4.245767559041269e-05
mature O 0 0.00010616926738293841
alpha O 0 0.00013848960225004703
- O 0 0.00013684923760592937
subunit O 0 6.3466010033153e-05
was O 0 5.2036157285328954e-05
present O 0 2.2680225811200216e-05
, O 0 1.7183294403366745e-05
but O 0 1.1069558240706101e-05
its O 0 1.0436995580676012e-05
level O 0 1.6904479707591236e-05
was O 0 3.285183265688829e-05
much O 0 2.029937422776129e-05
lower O 0 2.2652036932413466e-05
than O 0 9.469773431192152e-06
that O 0 1.0143330655409954e-05
from O 0 1.5076247109391261e-05
normal O 0 4.66054116259329e-05
alpha O 0 0.00012887397315353155
- O 0 0.00015945512859616429
subunit O 0 0.00012453515955712646
transfections O 0 0.00757884094491601
, O 0 3.038603790628258e-05
although O 0 2.0714289348688908e-05
higher O 0 2.1414985894807614e-05
than O 0 1.629597318242304e-05
in O 0 1.7301688785664737e-05
those O 0 2.3598549887537956e-05
cells O 0 0.00010320835281163454
transfected O 0 0.0006846664473414421
with O 0 3.764592111110687e-05
an O 0 6.106735236244276e-05
alpha O 0 0.0002976699615828693
- O 0 0.0002838046057149768
subunit O 0 0.0003050823579542339
associated O 0 0.00023774901637807488
with O 0 0.0004369502130430192
infantile O 1 0.999900221824646
TSD B-Disease 1 0.9999134540557861
. O 0 0.0034495904110372066

Furthermore O 0 0.0026452105958014727
, O 0 0.00030362140387296677
the O 0 0.00014043244300410151
precursor O 0 0.0003463394532445818
level O 0 0.00010468843538546935
of O 0 9.354952635476366e-05
the O 0 0.00012388646428007632
W474C O 0 0.4402215778827667
alpha O 0 0.000566225266084075
- O 0 0.00026132608763873577
subunit O 0 8.568271732656285e-05
was O 0 5.854049595654942e-05
found O 0 2.8317936084931716e-05
to O 0 2.3193779270513915e-05
accumulate O 0 5.59315703867469e-05
in O 0 2.6179079213761725e-05
comparison O 0 4.690320565714501e-05
to O 0 2.923142528743483e-05
the O 0 6.04335727985017e-05
normal O 0 0.00018802171689458191
alpha O 0 0.0004337600839789957
- O 0 0.0004942938103340566
subunit O 0 0.0006274974439293146
precursor O 0 0.0013983685057610273
levels O 0 0.0006949786911718547
. O 0 0.0010231882333755493

We O 0 0.0005991642829030752
conclude O 0 0.0004920838982798159
that O 0 0.00010008308890974149
the O 0 0.00014791093417443335
1422 O 1 0.5323370695114136
G O 0 0.19117970764636993
- O 0 0.29264846444129944
- O 0 0.27109336853027344
> O 0 0.05689258128404617
C O 0 0.0004656476085074246
mutation O 0 9.081814641831443e-05
is O 0 2.466708974679932e-05
the O 0 3.8665602914988995e-05
cause O 0 0.00019902916392311454
of O 0 0.000147900078445673
Hex B-Disease 1 0.8294403553009033
A I-Disease 1 0.8036129474639893
enzyme I-Disease 1 0.9983793497085571
deficiency I-Disease 1 0.999992847442627
in O 0 0.0001747613277984783
the O 0 0.0010422738268971443
proband O 1 0.9981946349143982
. O 0 0.001606050063855946

The O 0 0.0015691432636231184
resulting O 0 0.0020775978919118643
W474C O 0 0.34163016080856323
substitution O 0 0.0011122201103717089
clearly O 0 0.0003240272053517401
interferes O 0 0.0005890987231396139
with O 0 7.614705100422725e-05
alpha O 0 0.000242974390857853
- O 0 0.00017473433399572968
subunit O 0 7.839421596145257e-05
processing O 0 5.629388761008158e-05
, O 0 1.997416802623775e-05
but O 0 1.3711658539250493e-05
because O 0 1.548802356410306e-05
the O 0 2.230751488241367e-05
base O 0 6.555284198839217e-05
substitution O 0 0.0001297135604545474
falls O 0 0.00022109087149146944
at O 0 4.974578769179061e-05
the O 0 3.550491601345129e-05
first O 0 3.190878851455636e-05
position O 0 3.505516724544577e-05
of O 0 3.9310292777372524e-05
exon O 0 0.0002768821141216904
13 O 0 7.59713802835904e-05
, O 0 5.1203271141275764e-05
aberrant O 0 0.0004969735164195299
splicing O 0 0.0001630779734114185
may O 0 3.389582707313821e-05
also O 0 2.825125920935534e-05
contribute O 0 5.1943490689154714e-05
to O 0 3.2928557629929855e-05
Hex B-Disease 0 0.014069168828427792
A I-Disease 0 0.04084267094731331
deficiency I-Disease 1 0.9999330043792725
in O 0 0.00013505289098247886
this O 0 0.00018820236437022686
proband O 1 0.9570615291595459
. O 0 0.0003903524193447083
. O 0 0.0008290522382594645

Two O 0 0.0023400422651320696
frequent O 0 0.003157894592732191
missense O 0 0.050789736211299896
mutations O 0 0.03998809680342674
in O 0 0.07115538418292999
Pendred B-Disease 1 0.9999984502792358
syndrome I-Disease 1 0.9999997615814209
. O 0 0.28775036334991455

Pendred B-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
is O 1 0.9924097061157227
an O 1 0.9999086856842041
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999918937683105
by O 1 0.9795680046081543
early O 1 0.9998767375946045
childhood O 1 0.9999997615814209
deafness B-Disease 1 1.0
and O 1 0.9999538660049438
goiter B-Disease 1 1.0
. O 1 0.9589371681213379

A O 0 0.0014027486322447658
century O 0 0.0007867871318012476
after O 0 0.0002269702235935256
its O 0 8.286662341561168e-05
recognition O 0 0.00019443476048763841
as O 0 0.00010092954471474513
a O 0 0.004781242460012436
syndrome O 1 0.9999979734420776
by O 0 0.0008267679368145764
Vaughan O 1 0.99100261926651
Pendred O 1 0.9998162388801575
, O 0 0.0007842238410376012
the O 0 0.013009145855903625
disease O 1 0.9999841451644897
gene O 0 0.022292062640190125
( O 0 0.002883506240323186
PDS O 1 0.9975099563598633
) O 0 7.469820411643013e-05
was O 0 0.00011949051986448467
mapped O 0 0.00020231895905453712
to O 0 0.00012893861276097596
chromosome O 0 0.0011227952782064676
7q22 O 1 0.8884571194648743
- O 0 0.31463122367858887
q31 O 1 0.9295309782028198
. O 0 0.0020561092533171177

1 O 0 0.0012797850649803877
and O 0 0.000325608387356624
, O 0 0.0001892525324365124
recently O 0 0.00020454826881177723
, O 0 7.57786983740516e-05
found O 0 6.0767593822674826e-05
to O 0 5.216533463681117e-05
encode O 0 0.0002073616487905383
a O 0 0.0003910530067514628
putative O 0 0.016102753579616547
sulfate O 1 0.9820469617843628
transporter O 1 0.8214080929756165
. O 0 0.001883467542938888

We O 0 0.0009063506149686873
performed O 0 0.0008087866008281708
mutation O 0 0.0002603961620479822
analysis O 0 8.742935460759327e-05
of O 0 7.45103825465776e-05
the O 0 0.0001944909308804199
PDS B-Disease 1 0.9995854496955872
gene O 0 0.00029968260787427425
in O 0 8.104248263407499e-05
patients O 0 0.0037596921902149916
from O 0 7.38087110221386e-05
14 O 0 0.00024254391610156745
Pendred B-Disease 1 0.6765772700309753
families O 0 8.596154657425359e-05
originating O 0 7.475050369976088e-05
from O 0 2.8785767426597886e-05
seven O 0 4.718498166766949e-05
countries O 0 2.065649096039124e-05
and O 0 3.929777449229732e-05
identified O 0 0.00011537777027115226
all O 0 0.0001118172804126516
mutations O 0 0.0007433952996507287
. O 0 0.0007313465466722846

The O 0 0.0016321928706020117
mutations O 0 0.00048494775546714664
include O 0 0.0001407702948199585
three O 0 7.4000061431434e-05
single O 0 0.00010292648948961869
base O 0 0.00017954611394088715
deletions O 0 0.00027521641459316015
, O 0 6.376915553119034e-05
one O 0 7.026940875221044e-05
splice O 0 0.00045762790250591934
site O 0 0.00024317094357684255
mutation O 0 0.0001982581161428243
and O 0 9.575937292538583e-05
10 O 0 0.00024890151689760387
missense O 0 0.0030960168223828077
mutations O 0 0.0012498891446739435
. O 0 0.0011099274270236492

One O 0 0.0024430775083601475
missense O 0 0.08287468552589417
mutation O 0 0.015741150826215744
( O 0 0.0008886944269761443
L236P O 1 0.7142410278320312
) O 0 0.0001186584631795995
was O 0 0.00012002677976852283
found O 0 3.526650834828615e-05
in O 0 2.9397420803434215e-05
a O 0 4.151926259510219e-05
homozygous O 0 7.3716786573641e-05
state O 0 3.032842869288288e-05
in O 0 2.1992886104271747e-05
two O 0 2.4850573026924394e-05
consanguineous O 0 0.0031755343079566956
families O 0 5.8194178564008325e-05
and O 0 3.223067324142903e-05
in O 0 1.9903851352864876e-05
a O 0 4.65742195956409e-05
heterozygous O 0 5.7636363635538146e-05
state O 0 2.5763538360479288e-05
in O 0 2.488453174009919e-05
five O 0 5.771590076619759e-05
additional O 0 9.117444278672338e-05
non O 0 0.0003869078936986625
- O 0 0.0033377730287611485
consanguineous O 0 0.03368419408798218
families O 0 0.0011202909518033266
. O 0 0.0014151183422654867

Another O 0 0.0060747284442186356
missense O 0 0.23509439826011658
mutation O 0 0.03600076213479042
( O 0 0.0010290425270795822
T416P O 1 0.8147138953208923
) O 0 0.00010306043259333819
was O 0 0.00014846879639662802
found O 0 3.747792652575299e-05
in O 0 3.260915036662482e-05
a O 0 5.2731618779944256e-05
homozygous O 0 9.224054520018399e-05
state O 0 2.2214127966435626e-05
in O 0 1.5548524970654398e-05
one O 0 2.5787579943425953e-05
family O 0 5.9986406995449215e-05
and O 0 3.19292739732191e-05
in O 0 3.1234900234267116e-05
a O 0 5.9850870457012206e-05
heterozygous O 0 0.000107242536614649
state O 0 5.465115827973932e-05
in O 0 7.033860310912132e-05
four O 0 0.00020832277368754148
families O 0 0.0005849818699061871
. O 0 0.000990564003586769

Pendred B-Disease 1 0.995686411857605
patients O 0 0.015112576074898243
in O 0 0.00028031415422447026
three O 0 0.00021300878142938018
non O 0 0.004655207507312298
- O 0 0.27471739053726196
consanguineous O 0 0.3690987825393677
families O 0 0.00017361994832754135
were O 0 5.3339586884249e-05
shown O 0 4.7842335334280506e-05
to O 0 3.9300659409491345e-05
be O 0 5.134889215696603e-05
compound O 0 0.0008514337823726237
heterozygotes O 0 0.0038857683539390564
for O 0 0.00020841615332756191
L236P O 1 0.6587195992469788
and O 0 0.0008129295310936868
T416P O 1 0.7525753378868103
. O 0 0.0019635623320937157

In O 0 0.0004324556211940944
total O 0 0.00024279793433379382
, O 0 8.177204290404916e-05
one O 0 4.6503260819008574e-05
or O 0 2.8530945201055147e-05
both O 0 1.6609646991128102e-05
of O 0 2.504941585357301e-05
these O 0 1.095661264116643e-05
mutations O 0 2.755775858531706e-05
were O 0 1.4688481314806268e-05
found O 0 2.015599238802679e-05
in O 0 1.4422734238905832e-05
nine O 0 3.735603968380019e-05
of O 0 5.0610142352525145e-05
the O 0 8.227294165408239e-05
14 O 0 0.00017229432705789804
families O 0 0.00023573335784021765
analyzed O 0 0.0006844096351414919
. O 0 0.0009616141323931515

The O 0 0.0010454780422151089
identification O 0 0.0006658203201368451
of O 0 0.00023343367502093315
two O 0 0.00014367178664542735
frequent O 0 0.011578530073165894
PDS B-Disease 1 0.9999428987503052
mutations O 0 0.000829608179628849
will O 0 0.00010135758202522993
facilitate O 0 0.0001736885024001822
the O 0 0.00018128044030163437
molecular O 0 0.0017735696164891124
diagnosis O 1 0.998730480670929
of O 1 0.9298120141029358
Pendred B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
. O 0 0.38793620467185974

Insertional O 1 0.9755834341049194
mutation O 0 0.0034177692141383886
by O 0 0.0005414328188635409
transposable O 0 0.05884953960776329
element O 0 0.0011483874404802918
, O 0 0.0002514978405088186
L1 O 0 0.047591738402843475
, O 0 7.105557597242296e-05
in O 0 5.039275492890738e-05
the O 0 0.00013811928511131555
DMD B-Disease 1 0.999806821346283
gene O 0 0.00014463065599557012
results O 0 8.049287862377241e-05
in O 0 0.0001146546783274971
X B-Disease 1 0.6768122911453247
- I-Disease 1 0.975459098815918
linked I-Disease 1 0.9506686329841614
dilated I-Disease 1 0.9999760389328003
cardiomyopathy I-Disease 1 0.9999988079071045
. O 0 0.11084175109863281

X B-Disease 1 0.9645570516586304
- I-Disease 1 0.9954603314399719
linked I-Disease 1 0.9976775050163269
dilated I-Disease 1 0.9999992847442627
cardiomyopathy I-Disease 1 1.0
( O 1 0.9998688697814941
XLDCM B-Disease 1 0.9999985694885254
) O 0 0.0007726004696451128
is O 0 0.00017907560686580837
a O 0 0.00032144790748134255
clinical O 0 0.045911118388175964
phenotype O 0 0.04386880248785019
of O 0 0.000755965884309262
dystrophinopathy B-Disease 1 0.9995360374450684
which O 0 0.00010527395352255553
is O 0 8.59095889609307e-05
characterized O 0 0.0018897582776844501
by O 0 0.0001273807283723727
preferential O 0 0.3178451657295227
myocardial B-Disease 1 0.9999984502792358
involvement I-Disease 0 0.3436499834060669
without O 0 0.00026504401466809213
any O 0 0.0001492153387516737
overt O 0 0.05927182734012604
clinical O 1 0.7114177346229553
signs O 1 0.9003555178642273
of O 1 0.8886173367500305
skeletal B-Disease 1 0.9999996423721313
myopathy I-Disease 1 0.9999996423721313
. O 0 0.1546417474746704

To O 0 0.00044184955186210573
date O 0 0.00029261221061460674
, O 0 0.00011650333908619359
several O 0 8.919899846659973e-05
mutations O 0 0.0001482298830524087
in O 0 0.00012969264935236424
the O 0 0.2714252471923828
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.999671459197998
, O 1 0.9436556696891785
DMD O 1 0.999998927116394
, O 0 0.00016162655083462596
have O 0 3.0862182029522955e-05
been O 0 3.1874998967396095e-05
identified O 0 4.110222289455123e-05
in O 0 4.2179421143373474e-05
patients O 0 0.022313518449664116
with O 0 0.0001833945425460115
XLDCM B-Disease 1 0.9998986721038818
, O 0 8.791197615209967e-05
but O 0 4.050115603604354e-05
a O 0 5.5740150855854154e-05
pathogenic O 0 0.00011838856880785897
correlation O 0 6.408957415260375e-05
of O 0 5.440073800855316e-05
these O 0 3.977505548391491e-05
cardiospecific O 1 0.5536019802093506
mutations O 0 0.00020954356295987964
in O 0 0.0001655417581787333
DMD O 1 0.9996740818023682
with O 0 0.0001716211118036881
the O 0 0.0013540707295760512
XLDCM B-Disease 1 0.9999527931213379
phenotype O 0 0.10627143830060959
has O 0 0.00012354199134279042
remained O 0 0.0002438628434902057
to O 0 0.00012823299039155245
be O 0 0.00022846963838674128
elucidated O 0 0.004363349173218012
. O 0 0.001419978914782405

We O 0 0.0007130824378691614
report O 0 0.0003031441301573068
here O 0 0.0001057362460414879
the O 0 7.105530676199123e-05
identification O 0 9.808106551645324e-05
of O 0 7.841306069167331e-05
a O 0 0.00011541991261765361
unique O 0 0.0001428815594408661
de O 0 0.0007071704603731632
novo O 0 0.0033499361015856266
L1 O 0 0.010094096884131432
insertion O 0 0.0004345047927927226
in O 0 7.079369970597327e-05
the O 0 0.00011599950812524185
muscle O 0 0.06900244206190109
exon O 0 0.0011627376079559326
1 O 0 0.00011154782987432554
in O 0 8.305229857796803e-05
DMD O 1 0.9983696341514587
in O 0 9.167504322249442e-05
three O 0 0.00018403795547783375
XLDCM B-Disease 1 0.9997634291648865
patients O 0 0.006771267391741276
from O 0 8.205731865018606e-05
two O 0 9.384132863488048e-05
unrelated O 0 0.0005234946729615331
Japanese O 0 0.0014445686247199774
families O 0 0.0009508400107733905
. O 0 0.0010861988412216306

The O 0 0.0011739542242139578
insertion O 0 0.0022787535563111305
was O 0 0.0004797906440217048
a O 0 0.00023469817824661732
5 O 0 0.00023478813818655908
- O 0 0.0005059528048150241
truncated O 0 0.000385715946322307
form O 0 6.010642755427398e-05
of O 0 7.276699761860073e-05
human O 0 0.00010385223140474409
L1 O 0 0.005404336377978325
inversely O 0 0.00015270324365701526
integrated O 0 0.00011365669342922047
in O 0 2.2392345272237435e-05
the O 0 2.6093734049936756e-05
5 O 0 5.198070721235126e-05
- O 0 0.0001286014448851347
untranslated O 0 0.0002955879899673164
region O 0 5.748201874666847e-05
in O 0 3.455059413681738e-05
the O 0 0.000127153325593099
muscle O 1 0.862436830997467
exon O 0 0.00671216519549489
1 O 0 7.172409823397174e-05
, O 0 3.594247391447425e-05
which O 0 1.78777063410962e-05
affected O 0 3.631325307651423e-05
the O 0 2.4019112970563583e-05
transcription O 0 8.206139318645e-05
or O 0 2.2852042093290947e-05
the O 0 3.614258821471594e-05
stability O 0 0.0001621366827748716
of O 0 6.726354331476614e-05
the O 0 0.00040905902278609574
muscle O 1 0.9187589287757874
form O 0 9.42254628171213e-05
of O 0 0.000320313818519935
dystrophin O 1 0.9765790700912476
transcripts O 0 0.0001363628398394212
but O 0 1.7594837117940187e-05
not O 0 9.085888450499624e-06
that O 0 9.382718417327851e-06
of O 0 2.3035050617181696e-05
the O 0 9.816658712225035e-05
brain O 1 0.9440756440162659
or O 0 0.009097416885197163
Purkinje O 1 0.9999861717224121
cell O 0 0.08142408728599548
form O 0 0.00016700448759365827
, O 0 6.115721771493554e-05
probably O 0 6.230949657037854e-05
due O 0 3.3708405680954456e-05
to O 0 1.7455353372497484e-05
its O 0 2.4580300305387937e-05
unique O 0 6.656687037320808e-05
site O 0 0.0001713232195470482
of O 0 0.00021201063646003604
integration O 0 0.0012166120577603579
. O 0 0.0008025449933484197

We O 0 0.0007778806611895561
speculate O 0 0.0005212503601796925
that O 0 0.00011604862083913758
this O 0 5.1631228416226804e-05
insertion O 0 0.00019069730478804559
of O 0 5.016079740016721e-05
an O 0 6.875657709315419e-05
L1 O 0 0.0702771544456482
sequence O 0 0.00012797229283023626
in O 0 0.00010745321196736768
DMD O 1 0.9998846054077148
is O 0 6.631368887610734e-05
responsible O 0 6.842802395112813e-05
for O 0 1.528652137494646e-05
some O 0 1.4823417586740106e-05
of O 0 2.530507481424138e-05
the O 0 3.661306618596427e-05
population O 0 2.9769505999865942e-05
of O 0 6.953842239454389e-05
Japanese O 0 0.04449256882071495
patients O 0 0.28701332211494446
with O 0 0.000443748984253034
XLDCM B-Disease 1 0.9996218681335449
. O 0 0.000697542040143162
. O 0 0.001318897819146514

Severe O 1 0.9990506768226624
early O 1 0.7215613126754761
- O 1 0.9999657869338989
onset O 1 0.9999997615814209
obesity B-Disease 1 1.0
, O 1 0.9999713897705078
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9978101849555969
red O 1 0.999995231628418
hair O 1 0.9999902248382568
pigmentation O 1 0.9999973773956299
caused O 1 0.9998958110809326
by O 0 0.10564575344324112
POMC O 1 0.9999874830245972
mutations O 0 0.003284724662080407
in O 0 0.00039904910954646766
humans O 0 0.0008303729700855911
. O 0 0.0009957279544323683

Sequential O 0 0.0073923030868172646
cleavage O 0 0.0041287969797849655
of O 0 0.000545173475984484
the O 0 0.00025361828738823533
precursor O 0 0.0007071656873449683
protein O 0 0.0002191574458265677
pre O 0 0.001372246420942247
- O 0 0.004470620304346085
pro O 0 0.013286296278238297
- O 0 0.20217262208461761
opiomelanocortin O 1 0.9826812148094177
( O 0 0.0008094866061583161
POMC O 1 0.91068035364151
) O 0 0.00024623190984129906
generates O 0 0.0003749326860997826
the O 0 0.00019405897182878107
melanocortin O 0 0.444730281829834
peptides O 0 0.001280837575905025
adrenocorticotrophin O 1 0.9290802478790283
( O 0 0.0012106570648029447
ACTH O 1 0.8463795185089111
) O 0 0.00017853650206234306
, O 0 0.0002865190035663545
melanocyte O 1 0.9989181756973267
- O 1 0.8142825961112976
stimulating O 1 0.944544792175293
hormones O 1 0.7544344067573547
( O 0 0.0009565325453877449
MSH O 1 0.9974969029426575
) O 0 0.00010168072185479105
alpha O 0 0.0001818742894101888
, O 0 4.835822983295657e-05
beta O 0 9.367539314553142e-05
and O 0 2.7101565137854777e-05
gamma O 0 9.184758528135717e-05
as O 0 2.8585902327904478e-05
well O 0 2.165844853152521e-05
as O 0 3.327233935124241e-05
the O 0 7.816922152414918e-05
opioid O 0 0.012838932685554028
- O 0 0.0041003478690981865
receptor O 0 0.0008178158896043897
ligand O 0 0.0036700358614325523
beta O 0 0.004166572820395231
- O 0 0.027693120762705803
endorphin O 1 0.7490319609642029
. O 0 0.001520116813480854

While O 0 0.0007722459849901497
a O 0 0.00032451783772557974
few O 0 0.0002051365445367992
cases O 0 0.0001812683476600796
of O 0 0.0014436444034799933
isolated O 1 0.999599277973175
ACTH B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999979734420776
have O 0 0.0001022647411446087
been O 0 0.0001390567485941574
reported O 0 0.0004790558014065027
( O 0 0.0011339773191139102
OMIM O 1 0.999639630317688
201400 O 1 0.952104926109314
) O 0 0.00013970467261970043
, O 0 0.0001329153892584145
an O 0 0.00028772346558980644
inherited O 1 0.9999399185180664
POMC O 1 0.999998927116394
defect O 1 0.9998968839645386
has O 0 0.00022138406347949058
not O 0 5.073539796285331e-05
been O 0 6.716317147947848e-05
described O 0 0.00021579008898697793
so O 0 0.00011999427078990266
far O 0 0.0003136430459562689
. O 0 0.000705486279912293

Recent O 0 0.0016049632104113698
studies O 0 0.0003868186322506517
in O 0 0.0001613404310774058
animal O 0 0.00022255592921283096
models O 0 0.00011622615420492366
elucidated O 0 0.00032695182017050683
a O 0 5.690205216524191e-05
central O 0 6.102141924202442e-05
role O 0 9.39751262194477e-05
of O 0 9.942521865013987e-05
alpha O 0 0.0014785074163228273
- O 0 0.04694311320781708
MSH O 1 0.8956612348556519
in O 0 4.5934735680930316e-05
the O 0 4.073681702720933e-05
regulation O 0 5.194393816054799e-05
of O 0 4.761912350659259e-05
food O 0 9.010940266307443e-05
intake O 0 0.0001633026695344597
by O 0 2.7353165933163837e-05
activation O 0 7.80418558861129e-05
of O 0 4.657759563997388e-05
the O 0 0.0001314570545218885
brain O 0 0.047401025891304016
melanocortin O 1 0.7065516710281372
- O 0 0.0007735681138001382
4 O 0 0.0002157555427402258
- O 0 0.0005656079738400877
receptor O 0 0.00023639239952899516
( O 0 0.00015461837756447494
MC4 O 1 0.907982587814331
- O 0 0.000774661370087415
R O 0 0.00046825865865685046
; O 0 5.616203634417616e-05
refs O 0 0.0002641086757648736
3 O 0 5.687823795597069e-05
- O 0 9.894927643472329e-05
5 O 0 3.9046703022904694e-05
) O 0 2.4632861823192798e-05
and O 0 2.0956218577339314e-05
the O 0 2.825713272613939e-05
linkage O 0 0.00020553925423882902
of O 0 8.484241698170081e-05
human O 0 0.0005081223789602518
obesity B-Disease 1 0.9471945762634277
to O 0 4.1433031583437696e-05
chromosome O 0 0.00013466992822941393
2 O 0 4.0082035411614925e-05
in O 0 2.2065150915295817e-05
close O 0 5.4528663895325735e-05
proximity O 0 0.00010085094982059672
to O 0 3.68333057849668e-05
the O 0 0.00011816323240054771
POMC O 1 0.9985610842704773
locus O 0 0.0012437989935278893
, O 0 5.8122077462030575e-05
led O 0 8.37790867080912e-05
to O 0 1.553380752739031e-05
the O 0 2.208439400419593e-05
proposal O 0 4.2580373701639473e-05
of O 0 3.341246338095516e-05
an O 0 5.342984513845295e-05
association O 0 0.00034436595160514116
of O 0 0.0006541688926517963
POMC O 1 0.9999632835388184
with O 0 0.0008207732462324202
human O 0 0.035929709672927856
obesity B-Disease 1 0.9997673630714417
. O 0 0.0016910607228055596

The O 0 0.0020691286772489548
dual O 0 0.00163977628108114
role O 0 0.000896698678843677
of O 0 0.0004988111322745681
alpha O 0 0.014262238517403603
- O 0 0.31778842210769653
MSH O 1 0.9881353378295898
in O 0 0.00019688124302774668
regulating O 0 0.0004843887872993946
food O 0 0.00033029564656317234
intake O 0 0.0006020252476446331
and O 0 7.776157872285694e-05
influencing O 0 0.0012978455051779747
hair O 1 0.9398453235626221
pigmentation O 1 0.9982995390892029
predicts O 0 0.005410814192146063
that O 0 4.835559957427904e-05
the O 0 9.517801663605496e-05
phenotype O 0 0.0021428046748042107
associated O 0 5.620334923150949e-05
with O 0 4.5345339458435774e-05
a O 0 0.00026896013878285885
defect O 1 0.9774875044822693
in O 0 0.00024385028518736362
POMC O 1 0.9997351765632629
function O 0 0.00014506626757793128
would O 0 9.026050247484818e-05
include O 0 0.00017450189625378698
obesity B-Disease 1 0.950895369052887
, O 0 0.0001900047209346667
alteration O 0 0.2613638639450073
in O 0 0.002296348800882697
pigmentation O 1 0.9999895095825195
and O 1 0.982448160648346
ACTH B-Disease 1 0.9999979734420776
deficiency I-Disease 1 0.9999980926513672
. O 0 0.008469315245747566

The O 0 0.0011978140100836754
observation O 0 0.0014761495403945446
of O 0 0.0003596800670493394
these O 0 0.00011698313755914569
symptoms O 0 0.2593475878238678
in O 0 6.359305552905425e-05
two O 0 7.315466064028442e-05
probands O 1 0.7667120695114136
prompted O 0 0.0004542494425550103
us O 0 9.184776718029752e-05
to O 0 3.320982068544254e-05
search O 0 8.635657286504284e-05
for O 0 5.491476258612238e-05
mutations O 0 0.00014628615463152528
within O 0 0.00012140149192418903
their O 0 0.00018140961765311658
POMC O 1 0.9862599968910217
genes O 0 0.0011585397878661752
. O 0 0.0011631841771304607

Patient O 0 0.3542896807193756
1 O 0 0.00047572251060046256
was O 0 0.0003295693313702941
found O 0 6.72408496029675e-05
to O 0 3.419321365072392e-05
be O 0 2.83968765870668e-05
a O 0 6.562909402418882e-05
compound O 0 0.00039108211058191955
heterozygote O 0 0.0010632742196321487
for O 0 3.7004243495175615e-05
two O 0 2.8292188289924525e-05
mutations O 0 6.46703556412831e-05
in O 0 3.975473009631969e-05
exon O 0 0.00046357736573554575
3 O 0 0.00011585093307076022
( O 0 0.00016357589629478753
G7013T O 0 0.29013338685035706
, O 0 0.0001317223213845864
C7133delta O 0 0.33475345373153687
) O 0 6.634708552155644e-05
which O 0 4.513308158493601e-05
interfere O 0 0.0001062940718838945
with O 0 4.184975477983244e-05
appropriate O 0 9.274160402128473e-05
synthesis O 0 0.00024983042385429144
of O 0 0.00026622775476425886
ACTH O 1 0.9287324547767639
and O 0 0.0005333320586942136
alpha O 0 0.00564375426620245
- O 0 0.225262850522995
MSH O 1 0.9959050416946411
. O 0 0.002483619377017021

Patient O 0 0.2139890491962433
2 O 0 0.0009359357645735145
was O 0 0.0009111514664255083
homozygous O 0 0.0005373004241846502
for O 0 7.5396521424409e-05
a O 0 0.00013392527762334794
mutation O 0 0.00016781459271442145
in O 0 8.14160011941567e-05
exon O 0 0.000844277034047991
2 O 0 0.00023684676853008568
( O 0 0.00031712910276837647
C3804A O 0 0.06301423162221909
) O 0 0.0002964417217299342
which O 0 0.00041437699110247195
abolishes O 0 0.026855647563934326
POMC O 1 0.9383664131164551
translation O 0 0.003516291966661811
. O 0 0.002008734503760934

These O 0 0.00057236134307459
findings O 0 0.0004251374048180878
represent O 0 0.00015545982751064003
the O 0 8.370666182599962e-05
first O 0 7.32058979338035e-05
examples O 0 8.37624684209004e-05
of O 0 8.062078268267214e-05
a O 0 0.0004229461192153394
genetic B-Disease 0 0.34198787808418274
defect I-Disease 1 0.9994514584541321
within O 0 0.0002578062703832984
the O 0 0.003396772313863039
POMC O 1 0.9998936653137207
gene O 0 0.00014053987979423255
and O 0 5.185920963413082e-05
define O 0 0.00011067068408010527
a O 0 0.00015192215505521744
new O 0 0.0007184555288404226
monogenic B-Disease 1 0.9999969005584717
endocrine I-Disease 1 0.9999964237213135
disorder I-Disease 1 0.9999836683273315
resulting O 0 0.01175739150494337
in O 0 0.0002779482747428119
early O 0 0.3573135435581207
- O 1 0.9999608993530273
onset O 1 0.9999996423721313
obesity B-Disease 1 0.9999998807907104
, O 1 0.9998944997787476
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9901638627052307
red O 1 0.999976634979248
hair O 1 0.9999432563781738
pigmentation O 1 0.9998806715011597
. O 0 0.001348549616523087
. O 0 0.0015873353695496917

A O 0 0.0028546710964292288
European O 0 0.0009891196386888623
multicenter O 0 0.04151749983429909
study O 0 0.0005569869535975158
of O 0 0.004034410696476698
phenylalanine B-Disease 1 0.9999464750289917
hydroxylase I-Disease 1 0.9999938011169434
deficiency I-Disease 1 0.9999995231628418
: O 0 0.0003318213566672057
classification O 0 0.00028413653490133584
of O 0 0.00013666639279108495
105 O 0 0.0010223258286714554
mutations O 0 0.00010699105769162998
and O 0 2.3672457245993428e-05
a O 0 4.1831557609839365e-05
general O 0 6.415953248506412e-05
system O 0 4.181181429885328e-05
for O 0 3.790392293012701e-05
genotype O 0 0.00035953777842223644
- O 0 0.0003988585667684674
based O 0 0.00011274296412011608
prediction O 0 0.0007929886924102902
of O 0 0.0008792077424004674
metabolic O 1 0.9961035251617432
phenotype O 0 0.3882443606853485
. O 0 0.0013091075234115124

Phenylketonuria B-Disease 1 0.9999498128890991
( O 0 0.4097026288509369
PKU B-Disease 1 0.9999369382858276
) O 0 0.000721121032256633
and O 0 0.000789444602560252
mild B-Disease 1 0.9995453953742981
hyperphenylalaninemia I-Disease 1 0.9999980926513672
( O 1 0.9759011268615723
MHP B-Disease 1 0.9999990463256836
) O 0 0.00046638457570225
are O 0 0.00012524612247943878
allelic B-Disease 1 0.9990944862365723
disorders I-Disease 1 0.9999562501907349
caused O 0 0.39157548546791077
by O 0 8.688629168318585e-05
mutations O 0 0.00010234619549009949
in O 0 5.421802052296698e-05
the O 0 9.580320329405367e-05
gene O 0 0.00023193839297164232
encoding O 0 0.0004115254560019821
phenylalanine O 0 0.14398770034313202
hydroxylase O 1 0.9849470853805542
( O 0 0.060639169067144394
PAH O 1 0.9999756813049316
) O 0 0.0008710862603038549
. O 0 0.0009849821217358112

Previous O 0 0.001172134536318481
studies O 0 0.0003789920301642269
have O 0 7.55630899220705e-05
suggested O 0 9.133909770753235e-05
that O 0 3.512363036861643e-05
the O 0 7.346254278672859e-05
highly O 0 0.00021906389156356454
variable O 0 0.0003212184237781912
metabolic O 1 0.9654233455657959
phenotypes O 1 0.9749071598052979
of O 1 0.9994909763336182
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
correlate O 1 0.9958871006965637
with O 1 0.9894038438796997
PAH O 1 0.9999995231628418
genotypes O 1 0.9980541467666626
. O 0 0.004723055753856897

We O 0 0.0008397959172725677
identified O 0 0.0004634821380022913
both O 0 0.0001411864795954898
causative O 0 0.004069287329912186
mutations O 0 0.0002448443847242743
in O 0 0.00010487557301530614
686 O 1 0.9740355014801025
patients O 0 0.03839625418186188
from O 0 0.00011247021029703319
seven O 0 0.00026271131355315447
European O 0 0.00028832373209297657
centers O 0 0.000868640374392271
. O 0 0.0007958743372000754

On O 0 0.0006205737008713186
the O 0 0.0002225147618446499
basis O 0 8.87983333086595e-05
of O 0 7.004068174865097e-05
the O 0 7.622195698786527e-05
phenotypic O 0 0.0002427669387543574
characteristics O 0 0.00017146719619631767
of O 0 0.0001764773769536987
297 O 1 0.8170449733734131
functionally O 1 0.9402057528495789
hemizygous O 1 0.9989238381385803
patients O 0 0.013876846991479397
, O 0 4.731092121801339e-05
105 O 0 9.556979784974828e-05
of O 0 4.7059562348295e-05
the O 0 4.7848177928244695e-05
mutations O 0 4.512744635576382e-05
were O 0 1.3805183698423207e-05
assigned O 0 4.213053762214258e-05
to O 0 1.8635548258316703e-05
one O 0 3.2845160603756085e-05
of O 0 5.841780875925906e-05
four O 0 0.00013223881251178682
arbitrary O 0 0.000341093516908586
phenotype O 0 0.0022544360253959894
categories O 0 0.0005855268100276589
. O 0 0.0007409467361867428

We O 0 0.0012803685385733843
proposed O 0 0.0006686607957817614
and O 0 0.0002444417623337358
tested O 0 0.0002960491110570729
a O 0 0.0001295922847930342
simple O 0 0.000102427919046022
model O 0 0.0001235492673004046
for O 0 5.128879638505168e-05
correlation O 0 0.00020411417062859982
between O 0 0.00016590456652920693
genotype O 0 0.0007638201932422817
and O 0 0.00023713867994956672
phenotypic O 0 0.0016784245381131768
outcome O 0 0.0014259651070460677
. O 0 0.0011988921323791146

The O 0 0.0018944225739687681
observed O 0 0.0012728414731100202
phenotype O 0 0.002963493810966611
matched O 0 0.0003944376076105982
the O 0 0.00012050706573063508
predicted O 0 0.00026762846391648054
phenotype O 0 0.0002202106115873903
in O 0 2.1996575014782138e-05
79 O 0 8.962103311205283e-05
% O 0 2.4268279958050698e-05
of O 0 2.6916472052107565e-05
the O 0 2.6358144168625586e-05
cases O 0 2.683003003767226e-05
, O 0 1.693006561254151e-05
and O 0 1.0394174751127139e-05
in O 0 8.019050255825277e-06
only O 0 9.399789632880129e-06
5 O 0 2.2702079149894416e-05
of O 0 3.534270217642188e-05
184 O 0 0.001370675745420158
patients O 0 0.007190348580479622
was O 0 0.00013862119521945715
the O 0 5.9710746427299455e-05
observed O 0 7.079464558046311e-05
phenotype O 0 0.00014259424642659724
more O 0 1.6199892343138345e-05
than O 0 1.4753859431948513e-05
one O 0 2.7589128876570612e-05
category O 0 6.219587521627545e-05
away O 0 7.253987860167399e-05
from O 0 5.759867781307548e-05
that O 0 9.641532233217731e-05
expected O 0 0.000397621130105108
. O 0 0.0007033937145024538

Among O 0 0.0007965610129758716
the O 0 0.0002752369036898017
seven O 0 0.000177008580067195
contributing O 0 0.0003296893846709281
centers O 0 0.0002205554483225569
, O 0 5.69056355743669e-05
the O 0 4.956395423505455e-05
proportion O 0 9.61433834163472e-05
of O 0 0.00019766183686442673
patients O 0 0.044320981949567795
for O 0 5.103630610392429e-05
whom O 0 0.0001331909588770941
the O 0 5.285294901113957e-05
observed O 0 0.00010356523853261024
phenotype O 0 0.00037272454937919974
did O 0 3.792811548919417e-05
not O 0 1.427018560207216e-05
match O 0 3.153012949042022e-05
the O 0 2.432379733363632e-05
predicted O 0 7.473638834198937e-05
phenotype O 0 0.00011618580901995301
was O 0 5.042332850280218e-05
4 O 0 4.1490129660815e-05
% O 0 3.426257899263874e-05
- O 0 8.27524418127723e-05
23 O 0 5.4911626648390666e-05
% O 0 4.703901140601374e-05
( O 0 9.038350253831595e-05
P O 0 0.001658732071518898
< O 0 0.0008310572593472898
. O 0 7.373674452537671e-05
0001 O 0 0.0011754182633012533
) O 0 4.1122297261608765e-05
, O 0 3.41756094712764e-05
suggesting O 0 6.240785296540707e-05
that O 0 1.5453615560545586e-05
differences O 0 2.7941072403336875e-05
in O 0 1.5320831153076142e-05
methods O 0 2.5257288143620826e-05
used O 0 2.11078513530083e-05
for O 0 2.4869514163583517e-05
mutation O 0 0.0002323620137758553
detection O 0 0.001447862945497036
or O 0 0.00013545399997383356
phenotype O 0 0.010311564430594444
classification O 0 0.0002976189134642482
may O 0 4.876478124060668e-05
account O 0 3.394709710846655e-05
for O 0 2.3773678549332544e-05
a O 0 7.215946243377402e-05
considerable O 0 0.0001660828129388392
proportion O 0 0.00018660631030797958
of O 0 0.0003336185764055699
genotype O 0 0.2957380414009094
- O 0 0.47126153111457825
phenotype O 0 0.06255234777927399
inconsistencies O 0 0.00449411990121007
. O 0 0.0015097332652658224

Our O 0 0.0014057516818866134
data O 0 0.0002911851042881608
indicate O 0 0.0002685921499505639
that O 0 0.00013699063856620342
the O 0 0.0014228480868041515
PAH O 1 0.9999994039535522
- O 1 0.9213408827781677
mutation O 0 0.004707619547843933
genotype O 0 0.0006769406609237194
is O 0 7.097688649082556e-05
the O 0 5.3559015213977545e-05
main O 0 0.00016913555737119168
determinant O 0 0.002860420849174261
of O 0 0.0007326998747885227
metabolic O 1 0.9959008097648621
phenotype O 0 0.15337757766246796
in O 0 0.00013750795915257186
most O 0 0.0010929540731012821
patients O 1 0.9997442364692688
with O 1 0.9995966553688049
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
. O 0 0.28788548707962036

In O 0 0.000697199022397399
the O 0 0.0002832355967257172
present O 0 0.00021836279483977705
study O 0 0.00012174128642072901
, O 0 5.029409658163786e-05
the O 0 5.637974027195014e-05
classification O 0 0.00022819270088803023
of O 0 0.0004310914082452655
105 O 1 0.9806445240974426
PAH O 1 0.9999997615814209
mutations O 0 0.0005884076235815883
may O 0 4.920687933918089e-05
allow O 0 2.6362869903095998e-05
the O 0 3.316014044685289e-05
prediction O 0 0.00010488006955711171
of O 0 4.6449495130218565e-05
the O 0 7.245256711030379e-05
biochemical O 0 0.0005826189881190658
phenotype O 0 0.0003706596326082945
in O 0 4.592378536472097e-05
> O 0 0.00017716290312819183
10 O 0 4.272880687494762e-05
, O 0 3.930553430109285e-05
000 O 0 0.00017631020455155522
genotypes O 0 0.001131165074184537
, O 0 4.3678850488504395e-05
which O 0 2.4103690520860255e-05
may O 0 1.8383521819487214e-05
be O 0 1.602995143912267e-05
useful O 0 2.2565793187823147e-05
for O 0 1.6411695469287224e-05
the O 0 3.9421334804501384e-05
management O 0 0.00015539950982201844
of O 0 0.00028473042766563594
hyperphenylalaninemia B-Disease 1 0.9996410608291626
in O 0 0.0010878981556743383
newborns O 1 0.9008042216300964
. O 0 0.001421390101313591

Somatic O 0 0.06757429987192154
instability O 0 0.007209190633147955
of O 0 0.0007002534694038332
the O 0 0.0008389033610001206
CTG O 1 0.9907325506210327
repeat O 0 0.0011710989056155086
in O 0 0.0001572676410432905
mice O 0 0.0004968962748534977
transgenic O 0 0.0006481214659288526
for O 0 8.109305053949356e-05
the O 0 0.00816455390304327
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
region O 1 0.6071314811706543
is O 0 0.005332417786121368
age O 0 0.00464380020275712
dependent O 0 0.00013655958173330873
but O 0 2.7526237317943014e-05
not O 0 1.9759889255510643e-05
correlated O 0 4.2539093556115404e-05
to O 0 1.9914428776246496e-05
the O 0 6.431445217458531e-05
relative O 0 0.00020684271294157952
intertissue O 1 0.5257095694541931
transcription O 0 0.0009215455502271652
levels O 0 0.0005785506218671799
and O 0 0.000682463520206511
proliferative O 1 0.9983837604522705
capacities O 0 0.0064942315220832825
. O 0 0.0017841891385614872

A O 0 0.005081252194941044
( O 0 0.002064464846625924
CTG O 0 0.17754316329956055
) O 0 0.00033571463427506387
nexpansion O 0 0.0011142418952658772
in O 0 8.381745283259079e-05
the O 0 7.530354923801497e-05
3 O 0 0.00011984048614976928
- O 0 0.00028606673004105687
untranslated O 0 0.0007887783576734364
region O 0 0.00011642181198112667
( O 0 9.548618254484609e-05
UTR O 0 0.0008272887789644301
) O 0 4.242323120706715e-05
of O 0 4.819810783374123e-05
the O 0 0.0001359971793135628
DM O 1 0.9998911619186401
protein O 0 0.00018338370136916637
kinase O 0 0.00040902316686697304
gene O 0 0.0001592398330103606
( O 0 0.00014125893358141184
DMPK O 1 0.5214162468910217
) O 0 8.511356281815097e-05
is O 0 7.17186921974644e-05
responsible O 0 0.00021911150543019176
for O 0 0.0004342358442954719
causing O 1 0.9999681711196899
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9998904466629028
DM B-Disease 1 0.9999995231628418
) O 0 0.0033464066218584776
. O 0 0.0018091946840286255

Major O 0 0.023035889491438866
instability O 1 0.5429577231407166
, O 0 0.000320069317240268
with O 0 0.00010766223567770794
very O 0 7.673376239836216e-05
large O 0 7.244337029987946e-05
expansions O 0 0.0002545708848629147
between O 0 6.273328472161666e-05
generations O 0 0.00013626976578962058
and O 0 5.423125548986718e-05
high O 0 0.00010845626820810139
levels O 0 8.871285535860807e-05
of O 0 0.00014827032282482833
somatic O 1 0.6326048970222473
mosaicism O 1 0.9959838390350342
, O 0 0.0001866038073785603
is O 0 0.00010820689931279048
observed O 0 0.000191792132682167
in O 0 0.0002233903796877712
patients O 0 0.007838076911866665
. O 0 0.0011361317010596395

There O 0 0.0010595335625112057
is O 0 0.0002512847713660449
a O 0 0.0002197747671743855
good O 0 0.0001900210336316377
correlation O 0 0.00011598657147260383
between O 0 6.41670631011948e-05
repeat O 0 0.00022419179731514305
size O 0 6.972852861508727e-05
( O 0 4.823971903533675e-05
at O 0 4.326029011281207e-05
least O 0 3.290334643679671e-05
in O 0 3.488381844363175e-05
leucocytes O 0 0.0902947261929512
) O 0 4.843272108701058e-05
, O 0 6.453655078075826e-05
clinical O 0 0.0006948631489649415
severity O 0 0.02104518935084343
and O 0 8.034762868192047e-05
age O 0 0.0004812945262528956
of O 0 0.002280405256897211
onset O 1 0.9999053478240967
. O 0 0.003634335706010461

The O 0 0.0034695379436016083
trinucleotide O 1 0.9926992058753967
repeat O 0 0.13526973128318787
instability O 1 0.576503574848175
mechanisms O 0 0.0009116047294810414
involved O 0 0.00048192846588790417
in O 0 0.002603529253974557
DM B-Disease 1 0.9999994039535522
and O 0 0.000961899000685662
other O 0 0.00015631498536095023
human O 0 0.3797420859336853
genetic B-Disease 1 0.9989359974861145
diseases I-Disease 1 0.9999849796295166
are O 0 0.0001992672769119963
unknown O 0 0.0037696913350373507
. O 0 0.0008107742760330439

We O 0 0.0011274231364950538
studied O 0 0.0013257443206384778
somatic O 0 0.0034638114739209414
instability O 0 0.0016687973402440548
by O 0 0.00013297419354785234
measuring O 0 0.000550751225091517
the O 0 0.00025231781182810664
CTG O 1 0.9192798733711243
repeat O 0 0.00036407425068318844
length O 0 7.535700569860637e-05
at O 0 4.855915904045105e-05
several O 0 2.6819030608749017e-05
ages O 0 6.520178430946544e-05
in O 0 3.1098177714738995e-05
various O 0 3.545518120517954e-05
tissues O 0 0.00020865077385678887
of O 0 7.77116947574541e-05
transgenic O 0 0.0031839346047490835
mice O 0 0.00022971295402385294
carrying O 0 0.00015167002857197076
a O 0 0.00015001623251009732
( O 0 0.00020214235701132566
CTG O 0 0.26668834686279297
) O 0 0.00011364142847014591
55expansion O 0 0.0017090165056288242
surrounded O 0 0.0004892145516350865
by O 0 5.4206957429414615e-05
45 O 0 8.850330050336197e-05
kb O 0 0.0002593612007331103
of O 0 7.18159499228932e-05
the O 0 0.00010706373723223805
human O 0 0.000785496027674526
DM B-Disease 1 0.9999744892120361
region O 0 0.00025441995239816606
, O 0 0.00010196492803515866
using O 0 0.00010200605174759403
small O 0 0.00025568201090209186
- O 0 0.0014411286683753133
pool O 0 0.002401045523583889
PCR O 0 0.004006244242191315
. O 0 0.0011245902860537171

These O 0 0.0006972951232455671
mice O 0 0.000979833654128015
have O 0 7.758595165796578e-05
been O 0 6.720679812133312e-05
shown O 0 7.476134487660602e-05
to O 0 3.270520028308965e-05
reproduce O 0 8.800769137451425e-05
the O 0 7.11591201252304e-05
intergenerational O 0 0.005898658186197281
and O 0 0.00013346275954972953
somatic O 0 0.0011138779809698462
instability O 0 0.0005332524888217449
of O 0 0.00011612202069954947
the O 0 0.00012384734873194247
55 O 0 0.0004295125254429877
CTG O 1 0.867605984210968
repeat O 0 0.0004577121580950916
suggesting O 0 0.00015469579375348985
that O 0 4.185798024991527e-05
surrounding O 0 0.00012506102211773396
sequences O 0 5.9799636801471934e-05
and O 0 4.1596937080612406e-05
the O 0 6.698662764392793e-05
chromatin O 0 0.00045115945977158844
environment O 0 0.0001351112441625446
are O 0 3.6863391869701445e-05
involved O 0 0.00013492739526554942
in O 0 0.00018113582336809486
instability O 0 0.07193348556756973
mechanisms O 0 0.0021118714939802885
. O 0 0.001430174452252686

As O 0 0.0007618185481987894
observed O 0 0.0002170560765080154
in O 0 5.3866337111685425e-05
some O 0 2.5274830477428623e-05
of O 0 4.735456968774088e-05
the O 0 0.0001208263638545759
tissues O 1 0.7149063348770142
of O 1 0.9437857866287231
DM B-Disease 1 1.0
patients O 1 0.9996339082717896
, O 0 0.0002102492144331336
there O 0 4.312210148782469e-05
is O 0 4.826843360206112e-05
a O 0 6.784855941077694e-05
tendency O 0 0.00011986298341071233
for O 0 3.774467040784657e-05
repeat O 0 0.00018995290156453848
length O 0 7.465120870620012e-05
and O 0 6.167824903968722e-05
somatic O 0 0.0007776623824611306
mosaicism O 0 0.0164673812687397
to O 0 2.348981251998339e-05
increase O 0 3.069344529649243e-05
with O 0 1.9642389815999195e-05
the O 0 3.518008452374488e-05
age O 0 9.538043377688155e-05
of O 0 0.000133123408886604
the O 0 0.00043978355824947357
mouse O 0 0.0025711834896355867
. O 0 0.0010273674270138144

Furthermore O 0 0.003288892563432455
, O 0 0.0004152047331444919
we O 0 0.00017285184003412724
observed O 0 0.00016459143080282956
no O 0 7.333179382840171e-05
correlation O 0 9.203557419823483e-05
between O 0 5.483825589180924e-05
the O 0 9.032490197569132e-05
somatic O 0 0.00931114237755537
mutation O 0 0.0007396473083645105
rate O 0 0.00021649037080351263
and O 0 0.00025571734295226634
tissue O 1 0.5762420892715454
proliferation O 0 0.10040505230426788
capacity O 0 0.0018949006916955113
. O 0 0.0012517737923189998

The O 0 0.0017252374673262239
somatic O 0 0.14092963933944702
mutation O 0 0.0011067610466852784
rates O 0 0.00013010499242227525
in O 0 5.517912723007612e-05
different O 0 2.758447044470813e-05
tissues O 0 0.00016835455608088523
were O 0 1.7662792743067257e-05
also O 0 1.750903538777493e-05
not O 0 8.605410585005302e-06
correlated O 0 2.5052928322111256e-05
to O 0 9.850438800640404e-06
the O 0 1.9625105778686702e-05
relative O 0 7.66594530432485e-05
inter O 0 0.04312508553266525
- O 0 0.38925230503082275
tissue O 0 0.017171218991279602
difference O 0 4.396175791043788e-05
in O 0 1.8883467419072986e-05
transcriptional O 0 7.209699833765626e-05
levels O 0 2.1758585717179812e-05
of O 0 1.577606235514395e-05
the O 0 2.1153275156393647e-05
three O 0 2.4680266506038606e-05
genes O 0 5.508480899152346e-05
( O 0 0.00015344881103374064
DMAHP O 1 0.9698829650878906
, O 0 0.00012401149433571845
DMPK O 0 0.46018508076667786
and O 0 7.152179023250937e-05
59 O 0 0.0002005384158110246
) O 0 7.12819819455035e-05
surrounding O 0 0.00026914794580079615
the O 0 0.00022532607545144856
repeat O 0 0.0010428344830870628
. O 0 0.00033692969009280205
. O 0 0.000945142179261893

A O 0 0.004498905502259731
novel O 0 0.0031416844576597214
missense O 0 0.026535753160715103
mutation O 0 0.0010019938927143812
in O 0 0.00012588058598339558
patients O 0 0.021695364266633987
from O 0 0.00011926078877877444
a O 0 0.0029449625872075558
retinoblastoma B-Disease 1 0.99947589635849
pedigree O 0 0.33161020278930664
showing O 0 0.0011935048969462514
only O 0 7.884435035521165e-05
mild O 0 0.09410735219717026
expression O 0 0.00020342347852420062
of O 0 0.0003073771367780864
the O 0 0.10452805459499359
tumor B-Disease 1 0.9999914169311523
phenotype O 1 0.9142217636108398
. O 0 0.0016268425388261676

We O 0 0.0007378654554486275
have O 0 0.00015505433839280158
used O 0 0.00013687246246263385
single O 0 0.0001643485011300072
strand O 0 0.000316816964186728
conformation O 0 0.00026819348568096757
polymorphism O 0 0.00018266748520545661
analysis O 0 4.7538356739096344e-05
to O 0 2.4788630980765447e-05
study O 0 4.1994560888269916e-05
the O 0 3.5921577364206314e-05
27 O 0 8.472640183754265e-05
exons O 0 0.00017425348050892353
of O 0 5.901559052290395e-05
the O 0 0.00014080654364079237
RB1 O 1 0.9919043183326721
gene O 0 7.397775334538892e-05
in O 0 2.4145192583091557e-05
individuals O 0 1.85993303603027e-05
from O 0 2.4774804842309095e-05
a O 0 5.868548760190606e-05
family O 0 0.00015433512453455478
showing O 0 0.0005149489734321833
mild O 0 0.0778261199593544
expression O 0 0.000149175786646083
of O 0 0.0002073826181003824
the O 0 0.005629263818264008
retinoblastoma B-Disease 1 0.9998553991317749
phenotype O 1 0.9528188109397888
. O 0 0.0012524626217782497

In O 0 0.0006943214102648199
this O 0 0.00029922209796495736
family O 0 0.000391702022170648
affected O 0 0.00042508248589001596
individuals O 0 0.00011302036728011444
developed O 0 0.017458509653806686
unilateral B-Disease 1 0.8675370812416077
tumors I-Disease 1 0.9999537467956543
and O 0 0.0001467944821342826
, O 0 7.12549954187125e-05
as O 0 3.1347219191957265e-05
a O 0 4.568960139295086e-05
result O 0 3.248202847316861e-05
of O 0 4.730166983790696e-05
linkage O 0 0.0033647457603365183
analysis O 0 6.534045678563416e-05
, O 0 0.00013013900024816394
unaffected O 0 0.006606067530810833
mutation O 0 0.00039838621160015464
carriers O 0 0.00013008242240175605
were O 0 3.508784357109107e-05
also O 0 5.009855885873549e-05
identified O 0 9.096775465877727e-05
within O 0 0.00011478857777547091
the O 0 0.00032738977461121976
pedigree O 0 0.004463715944439173
. O 0 0.0011168725322932005

A O 0 0.0023610463831573725
single O 0 0.00068711768835783
band O 0 0.0006026773480698466
shift O 0 0.0003962998744100332
using O 0 0.0001303004246437922
SSCP O 0 0.47382378578186035
was O 0 0.00022896031441632658
identified O 0 7.410195394186303e-05
in O 0 4.7328652726719156e-05
exon O 0 0.0003156255406793207
21 O 0 0.00011613863898674026
which O 0 3.805016240221448e-05
resulted O 0 0.00011103705037385225
in O 0 3.017173003172502e-05
a O 0 5.726972813135944e-05
missense O 0 0.00024087747442536056
mutation O 0 8.31116340123117e-05
converting O 0 9.56000731093809e-05
a O 0 0.00012805066944565624
cys O 1 0.730093240737915
- O 0 0.0242003221064806
- O 0 0.008031223900616169
> O 0 0.0008172776433639228
arg O 0 0.0010469610569998622
at O 0 8.645132766105235e-05
nucleotide O 0 9.57374504650943e-05
position O 0 6.665579712716863e-05
28 O 0 9.513281838735566e-05
in O 0 8.28116390039213e-05
the O 0 0.0003003968740813434
exon O 0 0.004038065671920776
. O 0 0.0011929274769499898

The O 0 0.0022239836398512125
mutation O 0 0.003464312292635441
destroyed O 0 0.004711246583610773
an O 0 0.0006951860268600285
NdeI O 1 0.9391513466835022
restriction O 0 0.002204085001721978
enzyme O 0 0.0015402386197820306
site O 0 0.002195164328441024
. O 0 0.0012897680280730128

Analysis O 0 0.0008433829061686993
of O 0 0.0002984869934152812
all O 0 9.833298099692911e-05
family O 0 0.00012708446593023837
members O 0 5.3175488574197516e-05
demonstrated O 0 0.00013091976870782673
that O 0 3.1699299142928794e-05
the O 0 6.365948502207175e-05
missense O 0 0.0035218566190451384
mutation O 0 0.003824367420747876
co O 0 0.11164217442274094
- O 0 0.46593353152275085
segregated O 0 0.19220462441444397
with O 0 0.0014459063531830907
patients O 1 0.9936009049415588
with O 0 0.200775608420372
tumors B-Disease 1 0.9999951124191284
or O 0 0.0017669734079390764
who O 0 0.0005664477357640862
, O 0 4.298464409657754e-05
as O 0 3.028992796316743e-05
a O 0 5.1196100685046986e-05
result O 0 4.7087894927244633e-05
of O 0 4.229913611197844e-05
linkage O 0 0.0006526904762722552
analysis O 0 5.03285918966867e-05
had O 0 5.9280861023580655e-05
been O 0 3.932570689357817e-05
predicted O 0 8.166730549419299e-05
to O 0 3.6226781958248466e-05
carry O 0 9.310081804869696e-05
the O 0 0.0002706602681428194
predisposing O 0 0.08163851499557495
mutation O 0 0.00186854915227741
. O 0 0.0007886769599281251

These O 0 0.0004176066431682557
observations O 0 0.00048177142161875963
point O 0 0.00022223000996746123
to O 0 8.451780740870163e-05
another O 0 0.0001119157241191715
region O 0 0.00011418660869821906
of O 0 9.090825915336609e-05
the O 0 0.0003530351386871189
RB1 O 1 0.9998313188552856
gene O 0 0.0002475879155099392
where O 0 8.534958760719746e-05
mutations O 0 5.8881461882265285e-05
only O 0 2.350796239625197e-05
modify O 0 4.654411895899102e-05
the O 0 2.2163829271448776e-05
function O 0 2.811646663758438e-05
of O 0 3.1062252674018964e-05
the O 0 3.377447137609124e-05
gene O 0 5.9739453718066216e-05
and O 0 2.5308405383839272e-05
raise O 0 4.260633068042807e-05
important O 0 3.085806019953452e-05
questions O 0 4.4336888095131144e-05
for O 0 2.9408920454443432e-05
genetic O 0 0.00017304642824456096
counseling O 0 0.002499206457287073
in O 0 4.1307768697151914e-05
families O 0 8.663138578413054e-05
with O 0 5.216563295107335e-05
these O 0 6.276361818891019e-05
distinctive O 0 0.0014651198871433735
phenotypes O 0 0.009169921278953552
. O 0 0.0003543770289979875
. O 0 0.0008930251933634281

Maternal B-Disease 1 0.9459757208824158
disomy I-Disease 1 0.9993247985839844
and O 1 0.9531275629997253
Prader B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9960512518882751
with O 0 0.37062761187553406
gamete O 1 0.9998749494552612
complementation O 1 0.999835729598999
in O 0 0.0001526082050986588
a O 0 0.00013901485363021493
case O 0 9.076690184883773e-05
of O 0 9.043090540217236e-05
familial O 1 0.9510864019393921
translocation O 0 0.3184616267681122
( O 0 8.768525731284171e-05
3 O 0 4.455563612282276e-05
; O 0 3.0267636248026974e-05
15 O 0 4.785630153492093e-05
) O 0 3.985137300333008e-05
( O 0 6.735532952006906e-05
p25 O 0 0.002610541181638837
; O 0 8.102416177280247e-05
q11 O 0 0.0013889280380681157
. O 0 9.081364987650886e-05
2 O 0 0.00017776632739696652
) O 0 0.0002997463452629745
. O 0 0.0006363054853864014

Maternal B-Disease 1 0.995236873626709
uniparental I-Disease 1 0.9999637603759766
disomy I-Disease 1 0.9999620914459229
( I-Disease 1 0.8017704486846924
UPD I-Disease 1 0.9999607801437378
) I-Disease 0 0.00027737647178582847
for I-Disease 0 9.517020953353494e-05
chromosome I-Disease 0 0.0002088599867420271
15 I-Disease 0 9.240827057510614e-05
is O 0 3.486981586320326e-05
responsible O 0 4.9199086788576096e-05
for O 0 1.3895224583393428e-05
an O 0 2.7092002710560337e-05
estimated O 0 3.984726936323568e-05
30 O 0 3.842751539195888e-05
% O 0 2.2145848561194725e-05
of O 0 4.3441203160909936e-05
cases O 0 9.720120579004288e-05
of O 0 0.08076894283294678
Prader B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999499320983887
PWS B-Disease 1 0.9999996423721313
) O 0 0.009681565687060356
. O 0 0.002183701377362013

We O 0 0.0007726339972577989
report O 0 0.00027329480508342385
on O 0 8.58894272823818e-05
an O 0 6.63461978547275e-05
unusual O 0 8.788533887127414e-05
case O 0 0.00010876594751607627
of O 0 0.00010967264825012535
maternal B-Disease 0 0.4399895668029785
disomy I-Disease 1 0.9977374076843262
15 I-Disease 0 0.0005618004943244159
in O 0 0.0002394171169726178
PWS B-Disease 1 0.9999828338623047
that O 0 3.9837010262999684e-05
is O 0 2.3496488211094402e-05
most O 0 1.7089490938815288e-05
consistent O 0 3.249950168537907e-05
with O 0 1.6591473467997275e-05
adjacent O 0 7.22152108210139e-05
- O 0 0.0001815736759454012
1 O 0 6.824945739936084e-05
segregation O 0 0.0003227157285436988
of O 0 3.684374314616434e-05
a O 0 6.821231363574043e-05
paternal O 0 0.003546237014234066
t O 0 0.0012157264864072204
( O 0 3.726111026480794e-05
3 O 0 3.4003896871581674e-05
; O 0 1.8083541363012046e-05
15 O 0 4.088498462806456e-05
) O 0 3.936307621188462e-05
( O 0 8.134196832543239e-05
p25 O 0 0.002835931023582816
; O 0 7.346492930082604e-05
q11 O 0 0.0009160549379885197
. O 0 4.7828561946516857e-05
2 O 0 5.789764691144228e-05
) O 0 4.956754492013715e-05
with O 0 4.8894231440499425e-05
simultaneous O 0 0.00021011695207562298
maternal O 0 0.001979227876290679
meiotic O 1 0.907778263092041
nondisjunction O 1 0.7086048722267151
for O 0 0.00031285316799767315
chromosome O 0 0.0009493057150393724
15 O 0 0.0007375188870355487
. O 0 0.0012491048546507955

The O 0 0.002497321693226695
patient O 1 0.9221184849739075
( O 0 0.006453052628785372
J O 1 0.87981116771698
. O 0 7.405942596960813e-05
B O 0 0.00017701870820019394
. O 0 1.527426684333477e-05
) O 0 1.5909410649328493e-05
, O 0 1.2299205991439521e-05
a O 0 1.9082091966993175e-05
17 O 0 7.175659266067669e-05
- O 0 0.00035471064620651305
year O 0 8.609378710389137e-05
- O 0 0.001282232697121799
old O 0 0.0020854342728853226
white O 0 0.003397198161110282
male O 0 0.0015260149957612157
with O 0 0.00040950655238702893
PWS B-Disease 1 0.9999932050704956
, O 0 0.00018460510182194412
was O 0 0.00013833411503583193
found O 0 3.45120279234834e-05
to O 0 1.800747668312397e-05
have O 0 1.7273066987399943e-05
47 O 0 6.770165055058897e-05
chromosomes O 0 5.851961759617552e-05
with O 0 2.940488229796756e-05
a O 0 0.00011314155563013628
supernumerary O 1 0.7953783273696899
, O 0 0.00019631700706668198
paternal O 0 0.029068704694509506
der O 0 0.12171504646539688
( O 0 0.00010229361214442179
15 O 0 6.328595918603241e-05
) O 0 2.7720014259102754e-05
consisting O 0 4.010191696579568e-05
of O 0 5.018237425247207e-05
the O 0 7.381251634797081e-05
short O 0 0.00010370359814260155
arm O 0 0.0008433611947111785
and O 0 5.055390647612512e-05
the O 0 0.00011141814320581034
proximal O 1 0.8011341691017151
long O 0 0.0002852096513379365
arm O 0 0.002277083694934845
of O 0 0.00010248390026390553
chromosome O 0 0.0005428062286227942
15 O 0 0.00015818125393707305
, O 0 0.00014472198381554335
and O 0 0.00022822970640845597
distal O 1 0.9618579149246216
chromosome O 0 0.2658275365829468
arm O 1 0.9193592667579651
3p O 1 0.982016384601593
. O 0 0.002732837339863181

The O 0 0.002016015350818634
t O 0 0.036288611590862274
( O 0 0.00019964952662121505
3 O 0 0.00012856515240855515
; O 0 4.041006832267158e-05
15 O 0 5.306348975864239e-05
) O 0 2.9756591175100766e-05
was O 0 5.298556789057329e-05
present O 0 2.8252068659639917e-05
in O 0 1.643484392843675e-05
the O 0 2.4543947802158073e-05
balanced O 0 4.907239053864032e-05
state O 0 2.352666706428863e-05
in O 0 2.054580363619607e-05
the O 0 9.66936640907079e-05
patients O 0 0.05573444068431854
father O 0 0.010572228580713272
and O 0 0.00018692186858970672
a O 0 0.0009233446326106787
sister O 0 0.07303496450185776
. O 0 0.0012205155799165368

Fluorescent O 0 0.008457946591079235
in O 0 0.0006787885213270783
situ O 0 0.002577003790065646
hybridization O 0 0.0006567316595464945
analysis O 0 0.0001634653308428824
demonstrated O 0 0.00024229056725744158
that O 0 7.696357351960614e-05
the O 0 0.00014239843585528433
PWS B-Disease 1 0.9997852444648743
critical O 0 0.00033909932244569063
region O 0 0.0001230066700372845
resided O 0 0.00017469767772126943
on O 0 3.060648305108771e-05
the O 0 4.18327545048669e-05
derivative O 0 0.00013511884026229382
chromosome O 0 0.00011889632150996476
3 O 0 2.5601497327443212e-05
and O 0 1.6280222553177737e-05
that O 0 9.86740087682847e-06
there O 0 1.3414574823400471e-05
was O 0 4.5023720304016024e-05
no O 0 3.490711605991237e-05
deletion O 0 0.0001190272014355287
of O 0 6.20105056441389e-05
the O 0 0.00017160949937533587
PWS B-Disease 1 0.9999332427978516
region O 0 0.00020922055409755558
on O 0 6.476219277828932e-05
the O 0 7.58360984036699e-05
normal O 0 0.00012436202086973935
pair O 0 0.00018905596516560763
of O 0 0.00014210613153409213
15s O 0 0.03165702894330025
present O 0 0.0003088605881202966
in O 0 0.0004018580657429993
J O 0 0.258167564868927
. O 0 0.000993396039120853

B O 0 0.06603053957223892
. O 0 0.014615250751376152

Methylation O 0 0.002177676884457469
analysis O 0 0.00045778282219544053
at O 0 0.00033878395333886147
exon O 0 0.0009795196820050478
alpha O 0 0.00030683985096402466
of O 0 9.716635395307094e-05
the O 0 8.548105688532814e-05
small O 0 0.00012600042100530118
nuclear O 0 0.0004934440949000418
ribonucleoprotein O 1 0.8369316458702087
- O 0 0.0013959270436316729
associated O 0 0.00015080103185027838
polypeptide O 0 0.002424010308459401
N O 0 0.001290242886170745
( O 0 0.00029916278435848653
SNRPN O 1 0.9300289154052734
) O 0 0.00011552462819963694
gene O 0 0.0001317486894549802
showed O 0 9.134004358202219e-05
a O 0 5.999728091410361e-05
pattern O 0 0.00011816446931334212
characteristic O 0 9.622511424822733e-05
of O 0 5.377846900955774e-05
only O 0 4.102367165614851e-05
the O 0 7.227984315250069e-05
maternal O 0 0.01587183214724064
chromosome O 0 0.0005615692352876067
15 O 0 0.00021772991749458015
in O 0 0.0003752360644284636
J O 0 0.18766318261623383
. O 0 0.0009525556233711541

B O 0 0.06977932155132294
. O 0 0.012573500163853168

Maternal B-Disease 1 0.9512315988540649
disomy I-Disease 1 0.9800453782081604
was O 0 0.001936121378093958
confirmed O 0 0.00044479587813839316
by O 0 0.0001922260271385312
polymerase O 0 0.0007641692645847797
chain O 0 0.00024909808416850865
reaction O 0 0.00011604054452618584
analysis O 0 4.3184743844904006e-05
of O 0 6.957661389606073e-05
microsatellite O 0 0.0006821942515671253
repeats O 0 0.00014685468340758234
at O 0 7.38198432372883e-05
the O 0 7.62859417591244e-05
gamma O 0 0.0004279625427443534
- O 0 0.0008836881024762988
aminobutyric O 0 0.15455180406570435
acid O 0 0.0011258325539529324
receptor O 0 0.000636732263956219
beta3 O 0 0.02984030358493328
subunit O 0 0.0008789150160737336
( O 0 0.0006632717559114099
GABRB3 O 1 0.8709242343902588
) O 0 0.0009384235600009561
locus O 0 0.0042856615036726
. O 0 0.002018058905377984

A O 0 0.006538019515573978
niece O 1 0.9522330164909363
( O 0 0.000987747684121132
B O 0 0.004122449085116386
. O 0 7.79942492954433e-05
B O 0 0.0002640366437844932
. O 0 2.4662480427650735e-05
) O 0 1.5460425856872462e-05
with O 0 1.2790584150934592e-05
45 O 0 2.4828119421727024e-05
chromosomes O 0 3.490318704280071e-05
and O 0 1.6616824723314494e-05
the O 0 1.665318268351257e-05
derivative O 0 5.5570952099515125e-05
3 O 0 3.9840884710429236e-05
but O 0 1.9590643205447122e-05
without O 0 2.203445001214277e-05
the O 0 3.6774941690964624e-05
der O 0 0.0005670848186127841
( O 0 5.511854396900162e-05
15 O 0 4.595698555931449e-05
) O 0 3.305355494376272e-05
demonstrated O 0 8.273933781310916e-05
a O 0 7.475206803064793e-05
phenotype O 0 0.00028689077589660883
consistent O 0 6.794852379243821e-05
with O 0 2.6364983568782918e-05
that O 0 3.622222357080318e-05
reported O 0 9.212231816491112e-05
for O 0 6.913257675478235e-05
haploinsufficiency O 0 0.020179299637675285
of O 0 0.0003754770732484758
distal O 1 0.9035930037498474
3 O 0 0.001411590725183487
p O 0 0.004821178037673235
. O 0 0.0012414975790306926

Uniparental B-Disease 1 0.9998990297317505
disomy I-Disease 1 0.9970723390579224
associated O 0 0.0014119604602456093
with O 0 0.0004122846876271069
unbalanced O 0 0.31196072697639465
segregation O 1 0.8640508055686951
of O 0 0.005666250362992287
non O 1 0.9682522416114807
- O 1 0.9992905855178833
Robertsonian O 1 0.9999375343322754
translocations O 1 0.5692106485366821
has O 0 0.00012735063501168042
been O 0 6.747748557245359e-05
reported O 0 6.105733336880803e-05
previously O 0 4.421376434038393e-05
but O 0 3.0418572350754403e-05
has O 0 2.0473726181080565e-05
not O 0 1.0871473023144063e-05
, O 0 1.529833571112249e-05
to O 0 1.0888603355851956e-05
our O 0 3.2578882382949814e-05
knowledge O 0 7.00449527357705e-05
, O 0 3.7455916753970087e-05
been O 0 3.416782055865042e-05
observed O 0 7.048102270346135e-05
in O 0 4.368251757114194e-05
a O 0 0.00012618364416994154
case O 0 0.0003432595985941589
of O 0 0.001085834694094956
PWS B-Disease 1 0.9999760389328003
. O 0 0.0038693908136337996

Furthermore O 0 0.002847510389983654
, O 0 0.0003558741300366819
our O 0 0.00019933265866711736
findings O 0 0.00014723536150995642
are O 0 3.478787766653113e-05
best O 0 9.437509288545698e-05
interpreted O 0 0.00012080263695679605
as O 0 0.00010428331006551161
true O 0 0.0004559154622256756
gamete O 1 0.5658273100852966
complementation O 1 0.9970454573631287
resulting O 0 0.004906509071588516
in O 0 0.0006208748091012239
maternal B-Disease 1 0.96894371509552
UPD I-Disease 1 0.9998929500579834
15 I-Disease 0 0.004604789894074202
and O 0 0.003502977779135108
PWS B-Disease 1 0.9996496438980103

Schwartz B-Disease 1 0.9559292197227478
- I-Disease 1 0.998259961605072
Jampel I-Disease 1 0.9999861717224121
syndrome I-Disease 1 0.9999988079071045
type I-Disease 0 0.2857932150363922
2 I-Disease 0 0.0031837441492825747
and O 0 0.008684742264449596
Stuve B-Disease 1 0.9999961853027344
- I-Disease 1 0.9999891519546509
Wiedemann I-Disease 1 0.9999988079071045
syndrome I-Disease 1 0.9999997615814209
: O 0 0.0004788197693414986
a O 0 0.0002352537849219516
case O 0 0.0002818319480866194
for O 0 0.00010901077621383592
" O 0 0.0004931566072627902
lumping O 0 0.0048766047693789005
" O 0 0.0012432518415153027
. O 0 0.000988390645943582

Recent O 0 0.0016719683771952987
studies O 0 0.0003282911784481257
demonstrated O 0 0.0004593091434799135
the O 0 0.00012350428733043373
existence O 0 0.000171754028997384
of O 0 8.605602488387376e-05
a O 0 0.00016242277342826128
genetically O 0 0.00011968128819717094
distinct O 0 5.683990093530156e-05
, O 0 4.540089867077768e-05
usually O 0 2.9690885639865883e-05
lethal O 0 8.337510371347889e-05
form O 0 3.8103684346424416e-05
of O 0 5.12521255586762e-05
the O 0 0.00015215380699373782
Schwartz B-Disease 1 0.9588984847068787
- I-Disease 1 0.9997387528419495
Jampel I-Disease 1 0.9999986886978149
syndrome I-Disease 1 0.9999998807907104
( O 1 0.6313160061836243
SJS B-Disease 1 0.9999552965164185
) O 0 0.0004446496022865176
of O 0 0.018495803698897362
myotonia B-Disease 1 0.9999982118606567
and O 1 0.592228353023529
skeletal B-Disease 1 0.9999978542327881
dysplasia I-Disease 1 0.9999988079071045
, O 0 0.00047168260789476335
which O 0 7.495936733903363e-05
we O 0 9.042142482940108e-05
called O 0 0.0004449788830243051
SJS B-Disease 1 0.976079523563385
type I-Disease 0 0.001228579320013523
2 I-Disease 0 0.0007380250026471913
. O 0 0.000808489159680903

This O 0 0.005728013813495636
disorder O 1 0.9997531771659851
is O 0 0.0003068196529056877
reminiscent O 0 0.012285355478525162
of O 0 0.0002761850191745907
another O 0 0.001235836185514927
rare O 0 0.0037430799566209316
condition O 0 0.035025663673877716
, O 0 9.90879925666377e-05
the O 0 0.0006630239658989012
Stuve B-Disease 1 0.9999963045120239
- I-Disease 1 0.9999871253967285
Wiedemann I-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
( O 1 0.9209082126617432
SWS B-Disease 1 0.9996067881584167
) O 0 9.76796291070059e-05
, O 0 5.739618427469395e-05
which O 0 3.0841467378195375e-05
comprises O 0 0.00012654151942115277
campomelia B-Disease 0 0.10937807708978653
at O 0 0.00024012212816160172
birth O 0 0.12126652896404266
with O 0 0.011073476634919643
skeletal B-Disease 1 0.999997615814209
dysplasia I-Disease 1 0.9999998807907104
, O 0 0.330722838640213
contractures B-Disease 1 0.9999788999557495
, O 0 0.0003299884556327015
and O 0 0.00012659005005843937
early B-Disease 0 0.00045732877333648503
death I-Disease 0 0.010706638917326927
. O 0 0.0010320324217900634

To O 0 0.0004779392620548606
test O 0 0.0003983927017543465
for O 0 9.341927216155455e-05
possible O 0 0.00015845616871956736
nosologic O 0 0.3134711682796478
identity O 0 0.00029808771796524525
between O 0 0.00019463284115772694
these O 0 0.00011667743819998577
disorders O 1 0.9998202919960022
, O 0 7.344852929236367e-05
we O 0 2.8475275030359626e-05
reviewed O 0 3.964796269428916e-05
the O 0 2.6884456019615754e-05
literature O 0 3.654901229310781e-05
and O 0 1.3828348528477363e-05
obtained O 0 2.5021625333465636e-05
a O 0 2.960999154311139e-05
follow O 0 4.309279393055476e-05
- O 0 7.218601240310818e-05
up O 0 2.7510335712577216e-05
of O 0 2.5695324438856915e-05
the O 0 1.968736069102306e-05
only O 0 1.7003136235871352e-05
two O 0 2.401411984465085e-05
surviving O 0 0.0009052226669155061
patients O 0 0.0014984343433752656
, O 0 3.3420048566767946e-05
one O 0 3.0965420592110604e-05
with O 0 3.703431866597384e-05
SJS B-Disease 1 0.9579099416732788
type I-Disease 0 0.00022505469678435475
2 I-Disease 0 5.98977530898992e-05
at O 0 3.682343594846316e-05
age O 0 3.8510639569722116e-05
10 O 0 3.298918454675004e-05
years O 0 2.8221451429999433e-05
and O 0 1.8188437024946325e-05
another O 0 5.459489693748765e-05
with O 0 4.226381133776158e-05
SWS B-Disease 0 0.4625793993473053
at O 0 0.00014282489428296685
age O 0 0.00019256173982284963
7 O 0 0.00032567139714956284
years O 0 0.0004902801010757685
. O 0 0.0006822534487582743

Patients O 0 0.362928181886673
reported O 0 0.0007379603339359164
as O 0 0.00026291125686839223
having O 0 0.000477485271403566
either O 0 0.000905065331608057
neonatal O 1 0.9999938011169434
SJS B-Disease 1 0.9999741315841675
or O 0 0.00461531663313508
SWS B-Disease 1 0.977605938911438
presented O 0 0.00022495687881018966
a O 0 9.527662768959999e-05
combination O 0 8.922102279029787e-05
of O 0 5.4334061132976785e-05
a O 0 0.000719189178198576
severe O 1 0.9998809099197388
, O 1 0.5640472173690796
prenatal O 1 0.9999980926513672
- O 1 0.9999995231628418
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999808073043823
with O 1 0.9999402761459351
congenital B-Disease 1 1.0
joint I-Disease 1 0.9999998807907104
contractures I-Disease 1 1.0
, O 1 0.9999933242797852
respiratory O 1 1.0
and O 1 0.9948256015777588
feeding O 1 0.999772846698761
difficulties O 1 0.9995723366737366
, O 0 0.0030916635878384113
tendency O 0 0.015386955812573433
to O 0 0.0001230374036822468
hyperthermia B-Disease 1 0.9999529123306274
, O 0 8.885254646884277e-05
and O 0 4.8467598389834166e-05
frequent O 0 0.00010766140621853992
death O 0 0.0004282704903744161
in O 0 7.794867269694805e-05
infancy O 0 0.015323806554079056
) O 0 5.6539651268394664e-05
with O 0 5.613291068584658e-05
a O 0 0.00017932061746250838
distinct O 0 0.0005082647548988461
campomelic B-Disease 1 0.9998987913131714
- I-Disease 1 0.9998890161514282
metaphyseal I-Disease 1 0.9999934434890747
skeletal I-Disease 1 0.9999964237213135
dysplasia I-Disease 1 0.9999978542327881
. O 0 0.0371675081551075

The O 0 0.0008831155719235539
similarity O 0 0.0004995226627215743
of O 0 0.00018554707639850676
the O 0 0.00023423675156664103
clinical O 0 0.04950912669301033
and O 0 0.000309458322590217
radiographic O 1 0.9659323692321777
findings O 0 0.00019584287656471133
is O 0 6.501948519144207e-05
so O 0 3.701941386680119e-05
extensive O 0 0.00012354867067188025
that O 0 4.4384858483681455e-05
these O 0 4.731384615297429e-05
disorders O 1 0.9828657507896423
appear O 0 6.433561793528497e-05
to O 0 2.7561911338125356e-05
be O 0 2.3883319954620674e-05
a O 0 0.00012329014134593308
single O 0 0.00026239585713483393
entity O 0 0.0009671439765952528
. O 0 0.0007695965468883514

The O 0 0.0007715777610428631
follow O 0 0.0005333537119440734
- O 0 0.0007725495961494744
up O 0 0.00013140792725607753
observation O 0 0.0002603797765914351
of O 0 8.91910822247155e-05
an O 0 5.5328138842014596e-05
identical O 0 7.909962732810527e-05
and O 0 4.153561530984007e-05
unique O 0 6.337914965115488e-05
pattern O 0 0.0010389350354671478
of O 0 0.2374211847782135
progressive O 1 0.9999990463256836
bone B-Disease 1 0.9999998807907104
dysplasia I-Disease 1 0.9999994039535522
in O 0 0.0002314726880285889
the O 0 0.0002441143151372671
two O 0 5.476603837450966e-05
patients O 0 0.06196640431880951
( O 0 3.9331931475317106e-05
one O 0 2.9652572266058996e-05
with O 0 4.865886512561701e-05
SJS B-Disease 1 0.9909390211105347
type I-Disease 0 0.00024153818958438933
2 I-Disease 0 5.469578172778711e-05
, O 0 3.054391345358454e-05
one O 0 3.54589028574992e-05
with O 0 5.650698585668579e-05
SWS B-Disease 1 0.6551229953765869
) O 0 0.00010170903988182545
surviving O 0 0.00029917535721324384
beyond O 0 0.0002045474830083549
infancy O 0 0.0007537757628597319
adds O 0 0.00015042017912492156
to O 0 2.7376963771530427e-05
the O 0 4.538444773061201e-05
evidence O 0 6.73905378789641e-05
in O 0 5.690509715350345e-05
favor O 0 0.00010049296543002129
of O 0 0.00018777647346723825
identity O 0 0.0009185365634039044
. O 0 0.0009755298378877342

The O 0 0.0015524979680776596
hypothesis O 0 0.001960850553587079
that O 0 0.0003776199009735137
SWS B-Disease 1 0.98415607213974
and O 0 0.0005458033410832286
SJS B-Disease 1 0.9980161190032959
type I-Disease 0 0.0006046139751560986
2 I-Disease 0 9.997997403843328e-05
are O 0 1.978070395125542e-05
the O 0 4.1051382140722126e-05
same O 0 0.00011272855772404
disorder O 1 0.9957263469696045
should O 0 5.187231727177277e-05
be O 0 3.906093479599804e-05
testable O 0 0.00021079799626022577
by O 0 6.314019992714748e-05
molecular O 0 0.00014640142035204917
methods O 0 0.00015250912110786885
. O 0 0.00021683496015612036
. O 0 0.0007357596186921

A O 0 0.002858876483514905
mouse O 0 0.0029274318367242813
model O 0 0.0009977068984881043
of O 0 0.029107825830578804
severe O 1 0.9999996423721313
von B-Disease 1 0.9999998807907104
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999222755432129
defects O 1 0.9999994039535522
in O 1 0.9783923625946045
hemostasis O 1 0.9999992847442627
and O 1 0.9853867292404175
thrombosis B-Disease 1 0.999998927116394
. O 0 0.10363584011793137

von B-Disease 1 0.9963380098342896
Willebrand I-Disease 1 0.9999651908874512
factor I-Disease 1 0.9960921406745911
( I-Disease 1 0.9594787955284119
vWf I-Disease 1 0.9999691247940063
) I-Disease 1 0.9990988969802856
deficiency I-Disease 1 1.0
causes O 1 0.9999990463256836
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.8291919231414795
humans O 1 0.5766342878341675
. O 0 0.0025747751351445913

We O 0 0.0008757225004956126
generated O 0 0.0006557953311130404
a O 0 0.0003264264378231019
mouse O 0 0.0005851430469192564
model O 0 0.0002083209838019684
for O 0 8.550650090910494e-05
this O 0 8.399523358093575e-05
disease O 0 0.49311766028404236
by O 0 8.175208495231345e-05
using O 0 0.00013039387704338878
gene O 0 0.0003195171884726733
targeting O 0 0.000700327567756176
. O 0 0.0008452647016383708

vWf B-Disease 1 0.9975455403327942
- I-Disease 1 0.9930362105369568
deficient I-Disease 1 0.9777916073799133
mice O 0 0.0019831350073218346
appeared O 0 0.00028942039352841675
normal O 0 0.0001698077830951661
at O 0 0.000168312166351825
birth O 0 0.0008477038354612887
; O 0 4.179168536211364e-05
they O 0 3.759580431506038e-05
were O 0 7.200863910838962e-05
viable O 0 0.0004659948463086039
and O 0 0.00033200232428498566
fertile O 0 0.004477387294173241
. O 0 0.0013602833496406674

Neither O 0 0.01447232998907566
vWf O 1 0.670303463935852
nor O 0 0.008203379809856415
vWf O 1 0.931454062461853
propolypeptide O 1 0.9970430731773376
( O 0 0.024648524820804596
von B-Disease 1 0.9981569647789001
Willebrand I-Disease 1 0.9999969005584717
antigen O 1 0.9991939663887024
II O 1 0.9913682341575623
) O 0 0.000119121337775141
were O 0 8.645890193292871e-05
detectable O 0 0.00023298496671486646
in O 0 7.940246723592281e-05
plasma O 0 0.0006482650060206652
, O 0 0.00015488266944885254
platelets O 1 0.6288066506385803
, O 0 0.00012823213182855397
or O 0 0.00020161799329798669
endothelial O 1 0.7451643347740173
cells O 0 0.00018809112953022122
of O 0 0.00011415176413720474
the O 0 0.00026859165518544614
homozygous O 0 0.007797561585903168
mutant O 0 0.04726557433605194
mice O 0 0.0020964443683624268
. O 0 0.0011863315012305975

The O 0 0.00557114789262414
mutant O 1 0.9882468581199646
mice O 1 0.9158828854560852
exhibited O 1 0.8463702201843262
defects O 1 0.9997465014457703
in O 0 0.001376582309603691
hemostasis O 1 0.9999209642410278
with O 0 0.00041797664016485214
a O 0 0.014805036596953869
highly O 1 0.6362394094467163
prolonged O 1 0.9999915361404419
bleeding O 1 0.9999980926513672
time O 0 0.002904654247686267
and O 0 0.0023619607090950012
spontaneous O 1 0.8565047383308411
bleeding O 1 0.9972007274627686
events O 0 9.714782936498523e-05
in O 0 4.189040191704407e-05
approximately O 0 6.656425830442458e-05
10 O 0 7.313261448871344e-05
% O 0 9.188683179672807e-05
of O 0 0.00027961478917859495
neonates O 0 0.03436217084527016
. O 0 0.0011397808557376266

As O 0 0.0006406352622434497
in O 0 0.00020812226284760982
the O 0 0.0003158723411615938
human O 0 0.009649238549172878
disease O 1 0.9995850920677185
, O 0 0.00015778282249812037
the O 0 0.00034034106647595763
factor O 0 0.2550203204154968
VIII O 1 0.9969465136528015
level O 0 0.00011274704593233764
in O 0 3.4449753002263606e-05
these O 0 2.6523579435888678e-05
mice O 0 0.00015893903037067503
was O 0 6.850055797258392e-05
reduced O 0 4.9786500312620774e-05
strongly O 0 2.9610640922328457e-05
as O 0 2.1137504518264905e-05
a O 0 3.476572237559594e-05
result O 0 3.7886577047174796e-05
of O 0 2.3202428565127775e-05
the O 0 4.6567467506974936e-05
lack O 0 0.00013318282435648143
of O 0 0.0001346202625427395
protection O 0 0.013106065802276134
provided O 0 0.0003947176446672529
by O 0 0.000297467689961195
vWf O 0 0.01635756716132164
. O 0 0.0010913225123658776

Defective O 1 0.9999403953552246
thrombosis B-Disease 1 0.9999829530715942
in O 0 0.019687166437506676
mutant O 1 0.9950883984565735
mice O 0 0.06336433440446854
was O 0 0.0005267785163596272
also O 0 0.00010738702985690907
evident O 0 0.00016026162484195083
in O 0 3.357795867486857e-05
an O 0 3.9333208405878395e-05
in O 0 8.428344881394878e-05
vivo O 0 0.002355195116251707
model O 0 0.0011473627528175712
of O 0 0.15274973213672638
vascular B-Disease 1 0.9999996423721313
injury I-Disease 1 0.9999786615371704
. O 0 0.012776064686477184

In O 0 0.0007622234406881034
this O 0 0.00026716626598499715
model O 0 0.0004116157360840589
, O 0 0.00014720293984282762
the O 0 0.00018219956837128848
exteriorized O 1 0.9136347770690918
mesentery O 1 0.9604693651199341
was O 0 0.02954898402094841
superfused O 1 0.9971674084663391
with O 0 0.0010948828421533108
ferric O 1 0.9999523162841797
chloride O 0 0.1396644115447998
and O 0 8.729364344617352e-05
the O 0 8.728665125090629e-05
accumulation O 0 0.012705662287771702
of O 0 0.0007437833119183779
fluorescently O 1 0.9995924830436707
labeled O 1 0.6451317667961121
platelets O 1 0.7740700244903564
was O 0 0.000580188469029963
observed O 0 0.00032793486025184393
by O 0 0.00028845597989857197
intravital O 0 0.08486577868461609
microscopy O 0 0.003937817644327879
. O 0 0.0013833196135237813

We O 0 0.0009529387461952865
conclude O 0 0.000913565861992538
that O 0 0.00015941090532578528
these O 0 6.866930198157206e-05
mice O 0 0.0002209939411841333
very O 0 6.802224379498512e-05
closely O 0 0.00013606459833681583
mimic O 1 0.9008349180221558
severe O 1 0.9999916553497314
human O 1 0.9999160766601562
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.42691570520401
will O 0 0.00013646767183672637
be O 0 3.0100221920292825e-05
very O 0 2.349447095184587e-05
useful O 0 2.852751458704006e-05
for O 0 1.5022326806501951e-05
investigating O 0 4.1694795072544366e-05
the O 0 4.1720490116858855e-05
role O 0 7.514902972616255e-05
of O 0 7.200671825557947e-05
vWf O 0 0.015144354663789272
in O 0 7.1729977207724e-05
normal O 0 0.00022483679640572518
physiology O 0 0.09684272855520248
and O 0 0.00010794605623232201
in O 0 0.00027633857098408043
disease O 1 0.9997915625572205
models O 0 0.0010535110486671329
. O 0 0.0002313063305336982
. O 0 0.0005613658577203751

Oral O 0 0.3729226887226105
contraceptives O 0 0.4285099506378174
and O 0 0.0005357756745070219
the O 0 0.000622463645413518
risk O 1 0.739056408405304
of O 1 0.9883005619049072
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9952422380447388

Hereditary B-Disease 1 0.999997615814209
Ovarian I-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.999998927116394
Clinical O 1 0.9997766613960266
Study O 0 0.35013601183891296
Group O 0 0.07634752243757248
. O 0 0.0026247305795550346

BACKGROUND O 0 0.005837649572640657
Women O 0 0.0008965504821389914
with O 0 0.00013068292173556983
mutations O 0 0.00010007049422711134
in O 0 3.731907781912014e-05
either O 0 5.27304109709803e-05
the O 0 9.722037793835625e-05
BRCA1 O 1 0.6082522869110107
or O 0 6.516311987070367e-05
the O 0 0.00011039758828701451
BRCA2 O 0 0.46987321972846985
gene O 0 8.219679875764996e-05
have O 0 2.373177085246425e-05
a O 0 6.808539183111861e-05
high O 0 0.000506252923514694
lifetime O 0 0.27355557680130005
risk O 1 0.7386904954910278
of O 1 0.9913080334663391
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
. O 0 0.1636311411857605

Oral O 1 0.909337043762207
contraceptives O 1 0.9988295435905457
protect O 1 0.9736059308052063
against O 1 0.9992868304252625
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
in O 0 0.02520790509879589
general O 0 0.17007896304130554
, O 0 0.00022090251150075346
but O 0 2.9201833967817947e-05
it O 0 1.730848816805519e-05
is O 0 1.9710580090759322e-05
not O 0 9.68601307249628e-06
known O 0 1.8509477740735747e-05
whether O 0 1.5016668839962222e-05
they O 0 1.2432346011337359e-05
also O 0 3.202102743671276e-05
protect O 0 0.00011194391117896885
against O 0 0.00011588849883992225
hereditary B-Disease 1 0.7532173991203308
forms I-Disease 0 0.10008328408002853
of I-Disease 1 0.9993984699249268
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.43651968240737915

METHODS O 0 0.0014399361098185182
We O 0 0.00041405530646443367
enrolled O 0 0.0008405163534916937
207 O 0 0.0020208556670695543
women O 0 0.0013616799842566252
with O 0 0.022735636681318283
hereditary B-Disease 1 0.9999994039535522
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
and O 0 0.010577184148132801
161 O 0 0.06239096820354462
of O 0 0.0007512204465456307
their O 0 7.823977648513392e-05
sisters O 0 0.00802703108638525
as O 0 5.102662544231862e-05
controls O 0 5.310848791850731e-05
in O 0 3.2105941500049084e-05
a O 0 8.697051089257002e-05
case O 0 0.00029033684404566884
- O 0 0.002074955962598324
control O 0 0.0004233650106471032
study O 0 0.0005141299916431308
. O 0 0.0007255544769577682

All O 0 0.0006248819991014898
the O 0 0.0005085647571831942
patients O 0 0.0048095290549099445
carried O 0 0.0001810867979656905
a O 0 0.0001989521406358108
pathogenic O 0 0.0015398735413327813
mutation O 0 0.00016520338249392807
in O 0 3.9447328163078055e-05
either O 0 8.320329652633518e-05
BRCA1 O 0 0.12673768401145935
( O 0 0.00012363579298835248
179 O 0 0.0005152873345650733
women O 0 0.00025178526993840933
) O 0 9.989696991397068e-05
or O 0 0.00011473811900941655
BRCA2 O 0 0.14186668395996094
( O 0 0.00013660048716701567
28 O 0 0.00032720129820518196
women O 0 0.00044892108417116106
) O 0 0.00043884236947633326
. O 0 0.0008051596814766526

The O 0 0.0008604504400864244
control O 0 0.0008039546082727611
women O 0 0.00030163206974975765
were O 0 7.527856359956786e-05
enrolled O 0 0.00024113139079418033
regardless O 0 9.400253475178033e-05
of O 0 5.960163616691716e-05
whether O 0 4.526333577814512e-05
or O 0 3.138395186397247e-05
not O 0 1.9334696844452992e-05
they O 0 3.131366247544065e-05
had O 0 0.00010476791794644669
either O 0 0.00019858067389577627
mutation O 0 0.0006477133138105273
. O 0 0.00072511873440817

Lifetime O 0 0.0062608616426587105
histories O 0 0.0016456788871437311
of O 0 0.0006774066132493317
oral O 1 0.867309033870697
- O 1 0.8945024013519287
contraceptive O 0 0.4314628541469574
use O 0 4.253179213264957e-05
were O 0 2.410948400211055e-05
obtained O 0 3.1227245926856995e-05
by O 0 2.2955531676416285e-05
interview O 0 5.049194078310393e-05
or O 0 1.9769011487369426e-05
by O 0 1.4818839190411381e-05
written O 0 2.217708606622182e-05
questionnaire O 0 5.963040530332364e-05
and O 0 1.9163333490723744e-05
were O 0 1.675083694863133e-05
compared O 0 4.0226437704404816e-05
between O 0 4.730870932689868e-05
patients O 0 0.014773625880479813
and O 0 5.375878026825376e-05
control O 0 0.0002254479331895709
women O 0 0.00021960465528536588
, O 0 5.113003135193139e-05
after O 0 9.09096488612704e-05
adjustment O 0 0.00028860257589258254
for O 0 3.404653034522198e-05
year O 0 7.639236719114706e-05
of O 0 0.0001259319542441517
birth O 0 0.0031009686645120382
and O 0 0.0002878095838241279
parity O 0 0.017396869137883186
. O 0 0.0010924922535195947

RESULTS O 0 0.0015289197908714414
The O 0 0.00044274525134824216
adjusted O 0 0.001116289640776813
odds O 0 0.002113064518198371
ratio O 0 0.03420984372496605
for O 0 0.10193438082933426
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999947547912598
associated O 0 0.0003634796885307878
with O 0 4.673020157497376e-05
any O 0 3.8265076000243425e-05
past O 0 6.056776692275889e-05
use O 0 4.797958172275685e-05
of O 0 0.00011403448297642171
oral O 0 0.018523653969168663
contraceptives O 0 0.25271138548851013
was O 0 0.0010620913235470653
0 O 0 0.0007418589084409177
. O 0 0.0008825949626043439

5 O 0 0.0011315677547827363
( O 0 0.0003656597400549799
95 O 0 0.000382795202312991
percent O 0 0.00016087466792669147
confidence O 0 0.00025624086265452206
interval O 0 0.0001549565204186365
, O 0 4.634635479305871e-05
0 O 0 4.028759212815203e-05
. O 0 1.898576010717079e-05
3 O 0 3.5043132811551914e-05
to O 0 2.8997863410040736e-05
0 O 0 8.316031016875058e-05
. O 0 6.998753815423697e-05
8 O 0 0.00024908571504056454
) O 0 0.0003249057335779071
. O 0 0.001021752366796136

The O 0 0.0024818656966090202
risk O 0 0.007483388762921095
decreased O 0 0.0009152613929472864
with O 0 8.031391917029396e-05
increasing O 0 0.00010090010619023815
duration O 0 0.00013243882858660072
of O 0 5.590432192548178e-05
use O 0 2.514841253287159e-05
( O 0 3.773081334657036e-05
P O 0 0.00012164008512627333
for O 0 1.9685183360707015e-05
trend O 0 5.5799078836571425e-05
, O 0 3.3982665627263486e-05
< O 0 0.00013963659876026213
0 O 0 5.205402339925058e-05
. O 0 2.727109495026525e-05
001 O 0 0.00037485387292690575
) O 0 3.207863846910186e-05
; O 0 1.921444527397398e-05
use O 0 1.4575692148355301e-05
for O 0 1.1594906936807092e-05
six O 0 2.1092499082442373e-05
or O 0 1.1815151083283126e-05
more O 0 1.076184071280295e-05
years O 0 1.599219103809446e-05
was O 0 3.961478068958968e-05
associated O 0 2.0758487153216265e-05
with O 0 1.2503734978963621e-05
a O 0 3.503694824757986e-05
60 O 0 8.561966387787834e-05
percent O 0 9.546523506287485e-05
reduction O 0 0.0003016326518263668
in O 0 0.00021974749688524753
risk O 0 0.0017946161096915603
. O 0 0.0012753157643601298

Oral O 0 0.34669458866119385
- O 1 0.7041866183280945
contraceptive O 1 0.9434486031532288
use O 0 0.00033476014505140483
protected O 0 0.13258183002471924
against O 1 0.9475222826004028
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999867677688599
both O 0 0.00016860997129697353
for O 0 0.0001098528882721439
carriers O 0 0.00016325378965120763
of O 0 8.000983507372439e-05
the O 0 0.0004491460567805916
BRCA1 O 1 0.9781855344772339
mutation O 0 0.00047499078209511936
( O 0 6.414338713511825e-05
odds O 0 0.00013278794358484447
ratio O 0 6.030702934367582e-05
, O 0 2.6322875783080235e-05
0 O 0 2.37715012190165e-05
. O 0 1.37456736410968e-05
5 O 0 2.5343377274111845e-05
; O 0 1.3506808500096668e-05
95 O 0 3.981657573604025e-05
percent O 0 2.9964499844936654e-05
confidence O 0 6.0962622228544205e-05
interval O 0 5.210895687923767e-05
, O 0 1.7605629182071425e-05
0 O 0 2.696714182093274e-05
. O 0 1.5446572433575056e-05
3 O 0 1.892330874397885e-05
to O 0 1.1587810149649158e-05
0 O 0 2.5879446184262633e-05
. O 0 1.911017534439452e-05
9 O 0 3.773930802708492e-05
) O 0 2.9531453037634492e-05
and O 0 2.3793316358933225e-05
for O 0 2.0599127310561016e-05
carriers O 0 4.6577773900935426e-05
of O 0 3.1574334570905194e-05
the O 0 0.00010333046520827338
BRCA2 O 1 0.7381829023361206
mutation O 0 0.00035459044738672674
( O 0 6.972999108256772e-05
odds O 0 0.00017321416817139834
ratio O 0 8.208000508602709e-05
, O 0 2.5828927391557954e-05
0 O 0 2.3635780962649733e-05
. O 0 1.1860590348078404e-05
4 O 0 2.449098974466324e-05
; O 0 1.2138934835093096e-05
95 O 0 3.849169661407359e-05
percent O 0 2.627497451612726e-05
confidence O 0 6.0080637922510505e-05
interval O 0 4.707595144282095e-05
, O 0 2.2755140889785253e-05
0 O 0 3.358686080900952e-05
. O 0 1.4217805073712952e-05
2 O 0 2.2966853066463955e-05
to O 0 1.7946271327673458e-05
1 O 0 6.794515502406284e-05
. O 0 5.7016881328308955e-05
1 O 0 0.00015496389823965728
) O 0 0.00022022449411451817
. O 0 0.0005823014071211219

CONCLUSIONS O 0 0.005254159215837717
Oral O 0 0.1751360297203064
- O 0 0.4981914758682251
contraceptive O 1 0.53057461977005
use O 0 0.00010805171768879518
may O 0 9.077260619960725e-05
reduce O 0 0.0001022944925352931
the O 0 9.414229862159118e-05
risk O 0 0.38647717237472534
of O 1 0.9906070232391357
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 0.04747503250837326
women O 0 0.10471303015947342
with O 0 0.0002808207646012306
pathogenic O 0 0.06164732947945595
mutations O 0 0.00019723748846445233
in O 0 8.676449215272442e-05
the O 0 0.0013350790832191706
BRCA1 O 1 0.9994786381721497
or O 0 0.010388627648353577
BRCA2 O 1 0.9903063774108887
gene O 0 0.007085081655532122

A O 0 0.003327533369883895
Japanese O 0 0.0026970109902322292
family O 0 0.000879292783793062
with O 0 0.0004526253032963723
adrenoleukodystrophy B-Disease 1 0.9999721050262451
with O 0 0.00017770596605259925
a O 0 0.00022542774968314916
codon O 0 0.00048457944649271667
291 O 0 0.0007560840458609164
deletion O 0 0.0005359731148928404
: O 0 7.207390444818884e-05
a O 0 8.475234062643722e-05
clinical O 0 0.004034474026411772
, O 0 9.939715528162196e-05
biochemical O 0 0.0029460759833455086
, O 0 0.0001359209418296814
pathological O 0 0.4385385811328888
, O 0 0.00016841781325638294
and O 0 0.00014428654685616493
genetic O 0 0.0005778402555733919
report O 0 0.0005388477584347129
. O 0 0.0010052137076854706

We O 0 0.0009001742582768202
report O 0 0.0003725275455508381
a O 0 0.00018554195412434638
Japanese O 0 0.0004864069924224168
family O 0 0.0006216845358721912
with O 0 0.010172078385949135
adrenoleukodystrophy B-Disease 1 0.9999998807907104
( O 1 0.9885433912277222
ALD B-Disease 1 0.9999984502792358
) O 0 0.00012308714212849736
with O 0 3.685583214974031e-05
a O 0 4.312127930461429e-05
three O 0 3.0074228561716154e-05
base O 0 0.00010606049181660637
pair O 0 0.00010163748811464757
deletion O 0 0.0003404327144380659
( O 0 9.207647235598415e-05
delGAG O 0 0.009945739060640335
291 O 0 0.00031436901190318167
) O 0 7.778494182275608e-05
in O 0 7.100620132405311e-05
the O 0 0.00033171154791489244
ALD B-Disease 1 0.9999641180038452
gene O 0 0.0017850989243015647
. O 0 0.0010341317392885685

A O 0 0.00223179766908288
variety O 0 0.0005505434237420559
of O 0 0.0003494910488370806
phenotypes O 0 0.0009275599732063711
were O 0 8.02142676548101e-05
observed O 0 0.00012505576887633651
within O 0 0.00014811869186814874
this O 0 0.00012621494533959776
family O 0 0.0006622358923777938
. O 0 0.0007773952675051987

While O 0 0.000903836393263191
the O 0 0.0004701527941506356
proband O 1 0.9962735176086426
( O 0 0.002322289627045393
patient O 0 0.19273944199085236
1 O 0 0.00020346869132481515
) O 0 6.0787009715568274e-05
was O 0 0.00010288311023032293
classified O 0 5.6707682233536616e-05
as O 0 3.046269375772681e-05
having O 0 4.6651079173898324e-05
a O 0 4.965459811501205e-05
rare O 0 0.00011380766227375716
intermediate O 0 0.00024092868261504918
type O 0 0.00016113473975565284
of O 0 0.00010882486822083592
adult O 0 0.008031823672354221
cerebral O 1 0.9998636245727539
and O 0 0.06288420408964157
cerebello O 1 0.9999959468841553
- O 1 0.9998284578323364
brain O 1 0.9957350492477417
stem O 0 0.008916842751204967
forms O 0 9.698751091491431e-05
, O 0 6.265508272917941e-05
his O 0 0.00027584107010625303
younger O 0 0.018170658499002457
brother O 0 0.11994287371635437
( O 0 0.00038336505531333387
patient O 0 0.026876162737607956
2 O 0 9.043676982400939e-05
) O 0 4.725145117845386e-05
and O 0 5.900106771150604e-05
nephew O 0 0.03498769551515579
( O 0 0.00017443468095734715
patient O 0 0.0034613963216543198
3 O 0 0.00013341543672140688
) O 0 6.620222848141566e-05
had O 0 0.00016172765754163265
a O 0 0.0006500044255517423
childhood O 1 0.998862624168396
ALD B-Disease 1 0.9999971389770508
type O 1 0.7405124306678772
. O 0 0.0027411021292209625

Another O 0 0.005612947046756744
nephew O 1 0.9583572149276733
( O 0 0.001528053660877049
patient O 0 0.0329737663269043
4 O 0 0.00018947607895825058
) O 0 6.478227442130446e-05
of O 0 7.968903810251504e-05
patient O 0 0.01922476850450039
1 O 0 0.00011968916078330949
was O 0 0.00014430703595280647
classified O 0 0.00010284632298862562
as O 0 5.522366700461134e-05
having O 0 0.0001452554715797305
an O 0 0.0002341204381082207
adolescent O 0 0.14277228713035583
form O 0 0.001036031055264175
. O 0 0.001200029975734651

The O 0 0.001788981957361102
tau O 0 0.002369931200519204
level O 0 0.0003043299657292664
in O 0 0.00011739323963411152
the O 0 0.0002780829381663352
cerebrospinal O 1 0.9998306035995483
fluid O 1 0.9983951449394226
( O 0 0.28659695386886597
CSF O 1 0.9961256384849548
) O 0 5.8964509662473574e-05
in O 0 4.1338076698593795e-05
patient O 0 0.0011128209298476577
1 O 0 6.40843209112063e-05
was O 0 6.477263377746567e-05
as O 0 2.926528213720303e-05
high O 0 4.6162200305843726e-05
as O 0 2.3845970645197667e-05
that O 0 2.7408208552515134e-05
of O 0 0.00012209902342874557
patients O 1 0.9724995493888855
with O 1 0.8763676881790161
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999994039535522
( O 1 0.6515818238258362
AD B-Disease 0 0.21118029952049255
) O 0 0.0004895331221632659
. O 0 0.0006709040026180446

His O 0 0.007653203327208757
brain O 1 0.8222687244415283
magnetic O 0 0.004458528012037277
resonance O 0 0.015152565203607082
image O 0 0.33953776955604553
( O 0 0.01383473351597786
MRI O 1 0.9651413559913635
) O 0 0.00018314062617719173
showed O 0 0.00047323410399258137
abnormalities B-Disease 0 0.010587569326162338
in I-Disease 0 5.6175806093961e-05
the I-Disease 0 0.0001956853229785338
bilateral I-Disease 1 0.654348611831665
cerebellar I-Disease 1 0.9999983310699463
hemispheres I-Disease 1 0.9988058805465698
and O 0 0.49606871604919434
brain O 1 0.9998279809951782
stem O 1 0.6720072031021118
, O 0 0.00010577759530860931
but O 0 2.6329253159929067e-05
not O 0 1.7261407265323214e-05
in O 0 3.0274331948021427e-05
the O 0 0.00020378222689032555
cerebral O 1 0.9983441829681396
white O 0 0.023480435833334923
matter O 0 0.00011857770005008206
, O 0 5.040428732172586e-05
where O 0 5.854652408743277e-05
marked O 0 0.0001988967414945364
reductions O 0 0.000163653094205074
of O 0 0.00011110823106719181
the O 0 0.0015425399178639054
cerebral O 1 0.9999493360519409
blood O 1 0.9392033219337463
flow O 0 0.0009870496578514576
and O 0 0.00017563399160280824
oxygen O 0 0.013550161384046078
metabolism O 0 0.00025559618370607495
were O 0 4.596886719809845e-05
clearly O 0 0.00010077894694404677
demonstrated O 0 0.0001602940319571644
by O 0 8.39997228467837e-05
positron O 0 0.0014082822017371655
emission O 0 0.0006188958650454879
tomography O 0 0.0012801873963326216
( O 0 0.0004449460539035499
PET O 0 0.0025888285599648952
) O 0 0.0005283489590510726
. O 0 0.001019614632241428

In O 0 0.0008929592440836132
patients O 0 0.0063969530165195465
2 O 0 0.00020674135885201395
and O 0 8.415085903834552e-05
3 O 0 8.52797893458046e-05
, O 0 5.739651169278659e-05
the O 0 8.030396566027775e-05
autopsy O 0 0.0010307078482583165
findings O 0 0.00023573472572024912
showed O 0 0.0006636853213422
massive O 0 0.38700005412101746
demyelination B-Disease 1 0.999806821346283
of I-Disease 0 0.0009722988470457494
the I-Disease 0 0.014430195093154907
cerebral I-Disease 1 0.999924898147583
white I-Disease 0 0.069514200091362
matter I-Disease 0 0.00011127490142825991
with O 0 4.6943565394030884e-05
sparing O 0 0.0010909057455137372
of O 0 0.00014264904893934727
the O 0 0.0014094238867983222
U O 1 0.9996564388275146
- O 1 0.9500730037689209
fibers O 1 0.5650970339775085
, O 0 8.289761171909049e-05
compatible O 0 0.00011316077143419534
with O 0 4.7973182518035173e-05
the O 0 0.0001032797372317873
findings O 0 0.00026201739092357457
of O 0 0.0008073451463133097
childhood O 1 0.9993847608566284
ALD B-Disease 1 0.9999961853027344
. O 0 0.008210361003875732

Oleic O 0 0.0948832556605339
and O 0 0.0023608990013599396
erucic O 1 0.8788650035858154
acids O 0 0.0008568745688535273
( O 0 0.0005679758032783866
Lorenzos O 0 0.11478401720523834
Oil O 0 0.000304893939755857
) O 0 7.428818207699805e-05
were O 0 3.999505497631617e-05
administered O 0 8.180933218682185e-05
to O 0 2.9861148505005985e-05
patients O 0 0.00017046398716047406
1 O 0 4.592737604980357e-05
and O 0 4.118925426155329e-05
4 O 0 7.806984649505466e-05
, O 0 3.719571395777166e-05
but O 0 3.823283259407617e-05
sufficient O 0 0.00012563234486151487
effectiveness O 0 0.00020035073976032436
was O 0 0.00022511478164233267
not O 0 0.00013521680375561118
obtained O 0 0.0005173878744244576
. O 0 0.0007769258227199316

The O 0 0.0008340961067005992
findings O 0 0.00037414944381453097
in O 0 9.702154784463346e-05
this O 0 5.5138778407126665e-05
family O 0 9.607501124264672e-05
suggest O 0 9.473413956584409e-05
that O 0 4.676532989833504e-05
delGAG291 O 0 0.0939374640583992
is O 0 5.393568426370621e-05
part O 0 8.271409024018794e-05
of O 0 6.276691419770941e-05
the O 0 0.00018068542703986168
cause O 0 0.007057624403387308
of O 0 0.0005478010862134397
Japanese O 0 0.45569556951522827
ALD B-Disease 1 0.9999791383743286
with O 0 0.0006103365449234843
phenotypic O 0 0.0026839477941393852
variations O 0 0.0012729105073958635
. O 0 0.0012206643586978316

Moreover O 0 0.0029055175837129354
, O 0 0.0003628020058386028
although O 0 0.00014427445421461016
the O 0 6.986363587202504e-05
scale O 0 0.00015138741582632065
of O 0 5.499589315149933e-05
the O 0 5.891094770049676e-05
study O 0 5.664650598191656e-05
is O 0 3.96255127270706e-05
limited O 0 2.901396328525152e-05
, O 0 2.2040945623302832e-05
there O 0 1.730865187710151e-05
is O 0 1.961105408554431e-05
a O 0 5.0730752263916656e-05
possibility O 0 9.677759953774512e-05
that O 0 4.2592680983943865e-05
PET O 0 0.0007671092753298581
can O 0 3.4536591556388885e-05
detect O 0 0.00011734524014173076
an O 0 0.00010667271999409422
insidious B-Disease 1 0.9634679555892944
lesion I-Disease 1 0.9979105591773987
which O 0 7.042900688247755e-05
is O 0 7.639965770067647e-05
undetectable O 0 0.0023432839661836624
by O 0 5.6309032515855506e-05
computed O 0 0.0001933827152242884
tomogram O 1 0.9314428567886353
( O 0 0.0004513493331614882
CT O 0 0.18028007447719574
) O 0 6.418902921723202e-05
or O 0 5.235017306404188e-05
MRI O 0 0.0014278622111305594
analysis O 0 3.8006426620995626e-05
, O 0 2.3478836737922393e-05
and O 0 2.0748115275637247e-05
that O 0 1.5075442206580192e-05
the O 0 2.8524931622087024e-05
higher O 0 3.963352719438262e-05
level O 0 4.2017229134216905e-05
of O 0 6.856199615867808e-05
tau O 0 0.00038269118522293866
reflects O 0 0.00015559613530058414
the O 0 7.313052628887817e-05
process O 0 0.00012790314212907106
of O 0 0.0003874554531648755
neuronal B-Disease 1 0.9834222793579102
degeneration I-Disease 1 0.9999967813491821
in O 0 0.09500493854284286
ALD B-Disease 1 0.999995231628418
. O 0 0.007005420513451099

Lorenzos O 1 0.8043550848960876
Oil O 0 0.002689884277060628
should O 0 0.0003083706833422184
be O 0 6.145865336293355e-05
given O 0 6.205984391272068e-05
in O 0 5.6159839004976675e-05
the O 0 0.00011461706890258938
early O 0 0.00029089042800478637
stage O 0 0.0011837193742394447
. O 0 0.00038943137042224407
. O 0 0.0008358783670701087

Nonsense O 0 0.014062442816793919
mutation O 0 0.0010065094102174044
in O 0 0.00022644840646535158
exon O 0 0.0010110456496477127
4 O 0 0.00020169242634437978
of O 0 0.00019760265422519296
human O 0 0.0003410035860724747
complement O 0 0.015928372740745544
C9 O 1 0.999535322189331
gene O 0 0.00017066224245354533
is O 0 3.896004272974096e-05
the O 0 5.765483729192056e-05
major O 0 0.00017475849017500877
cause O 0 0.000820548739284277
of O 0 0.00040052307303994894
Japanese O 1 0.506757915019989
complement B-Disease 1 0.9944954514503479
C9 I-Disease 1 0.9999969005584717
deficiency I-Disease 1 0.9999971389770508
. O 0 0.00492888642475009

Deficiency B-Disease 1 0.999678373336792
of I-Disease 0 0.0008238911395892501
the I-Disease 0 0.0007191367330960929
ninth I-Disease 1 0.9216657280921936
component I-Disease 0 0.004330975469201803
of I-Disease 0 0.000248408381594345
human I-Disease 0 0.0023528768215328455
complement I-Disease 0 0.037847358733415604
( O 0 0.009377761743962765
C9 O 1 0.9993020296096802
) O 0 5.120415153214708e-05
is O 0 2.800672154990025e-05
the O 0 2.7532225431059487e-05
most O 0 3.731622564373538e-05
common O 0 0.00026914666523225605
complement B-Disease 1 0.9682697653770447
deficiency I-Disease 1 0.9999988079071045
in O 0 0.0001786841603461653
Japan O 0 0.0012690010480582714
but O 0 4.6878656576154754e-05
is O 0 4.451728818821721e-05
rare O 0 9.605897503206506e-05
in O 0 4.1360555769642815e-05
other O 0 6.749884778400883e-05
countries O 0 0.000135155045427382
. O 0 0.0004389473469927907

We O 0 0.000688093074131757
studied O 0 0.0004725867765955627
the O 0 0.0001633874053368345
molecular O 0 0.00020354046137072146
basis O 0 0.00010672674397937953
of O 0 0.0007284483872354031
C9 B-Disease 1 0.9999918937683105
deficiency I-Disease 1 0.9999681711196899
in O 0 0.00016673908976372331
four O 0 0.0003380577254574746
Japanese O 1 0.8784369230270386
C9 B-Disease 1 0.9999985694885254
- I-Disease 1 0.9999175071716309
deficient I-Disease 1 0.9999210834503174
patients O 1 0.9574688673019409
who O 0 0.005663140676915646
had O 0 0.42380842566490173
suffered O 1 0.9999966621398926
from O 1 0.9964401125907898
meningococcal B-Disease 1 0.9999998807907104
meningitis I-Disease 1 0.9999995231628418
. O 1 0.6671876907348633

Direct O 0 0.0021547728683799505
sequencing O 0 0.0014138008700683713
of O 0 0.000735627138055861
amplified O 0 0.0028991177678108215
C9 O 1 0.8382201194763184
cDNA O 0 0.0015923475148156285
and O 0 0.00013333657989278436
DNA O 0 0.00015381565026473254
revealed O 0 0.00013750350626651198
a O 0 0.00010373465192969888
nonsense O 0 0.0004340361338108778
substitution O 0 0.00032843236112967134
( O 0 0.00014113426732365042
CGA O 0 0.002925386419519782
- O 0 0.0022307327017188072
- O 0 0.0019291330827400088
> O 0 0.0011213949183002114
TGA O 0 0.01180580910295248
) O 0 6.120155740063637e-05
at O 0 6.663939711870626e-05
codon O 0 0.00016767909983173013
95 O 0 8.059103129198775e-05
in O 0 3.1456522265216336e-05
exon O 0 0.0001852681307354942
4 O 0 7.505621033487841e-05
in O 0 4.544335024547763e-05
the O 0 9.639518975745887e-05
four O 0 0.00031880062306299806
C9 B-Disease 1 0.999803364276886
- I-Disease 1 0.8703959584236145
deficient I-Disease 1 0.5338538885116577
individuals O 0 0.0005366299883462489
. O 0 0.000867865514010191

An O 0 0.0015237093903124332
allele O 0 0.0017398908967152238
- O 0 0.00108443817589432
specific O 0 0.00019663883722387254
polymerase O 0 0.0008078253595158458
chain O 0 0.00037342729046940804
reaction O 0 0.0002641519531607628
system O 0 9.281537495553493e-05
designed O 0 8.651069947518408e-05
to O 0 2.492802195774857e-05
detect O 0 6.33169911452569e-05
exclusively O 0 3.6489949707174674e-05
only O 0 1.4601695511373691e-05
one O 0 2.22577691602055e-05
of O 0 2.6045903723570518e-05
the O 0 5.268492168397643e-05
normal O 0 8.467124280286953e-05
and O 0 4.693268783739768e-05
mutant O 0 0.000601008185185492
alleles O 0 0.00010369400115450844
indicated O 0 5.0744976761052385e-05
that O 0 1.59447081387043e-05
all O 0 1.0770845619845204e-05
the O 0 2.263497663079761e-05
four O 0 3.700950037455186e-05
patients O 0 0.00022384409385267645
were O 0 3.18106212944258e-05
homozygous O 0 7.167035801103339e-05
for O 0 1.8550330423749983e-05
the O 0 3.250861482229084e-05
mutation O 0 6.426479376386851e-05
in O 0 2.8069292966392823e-05
exon O 0 0.0003494031261652708
4 O 0 5.725586015614681e-05
and O 0 2.5179657313856296e-05
that O 0 1.531132511445321e-05
the O 0 2.686779771465808e-05
parents O 0 6.223159289220348e-05
of O 0 8.614100079284981e-05
patient O 0 0.0897790938615799
2 O 0 0.0003033806278835982
were O 0 0.00035387519164942205
heterozygous O 0 0.0014793876325711608
. O 0 0.0009561927290633321

The O 0 0.0012123769847676158
common O 0 0.0004700672288890928
mutation O 0 0.0003738586965482682
at O 0 0.00017495905922260135
codon O 0 0.00028011511312797666
95 O 0 0.00015135998546611518
in O 0 5.593055902863853e-05
exon O 0 0.00040306904702447355
4 O 0 8.593301754444838e-05
might O 0 6.601889617741108e-05
be O 0 3.236342308809981e-05
responsible O 0 0.00011224769696127623
for O 0 7.706933683948591e-05
most O 0 0.00029276622808538377
Japanese O 1 0.6031292676925659
C9 B-Disease 1 0.999995231628418
deficiency I-Disease 1 0.999997615814209
. O 0 0.0020101501140743494
. O 0 0.00180584448389709

BRCA1 O 0 0.027442844584584236
required O 0 0.0007242557476274669
for O 0 0.00030555890407413244
transcription O 0 0.0017605217872187495
- O 0 0.17701372504234314
coupled O 0 0.16472142934799194
repair O 1 0.9860092997550964
of O 0 0.01887352392077446
oxidative O 1 0.9984007477760315
DNA O 0 0.04132414981722832
damage O 1 0.7445191144943237
. O 0 0.00195904728025198

The O 0 0.17273718118667603
breast B-Disease 1 0.9999959468841553
and I-Disease 1 0.9993370175361633
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.999994158744812
gene O 1 0.9586221575737
BRCA1 O 1 0.9979464411735535
encodes O 0 0.0016364884795621037
a O 0 0.0029109406750649214
zinc O 1 0.9815535545349121
finger O 0 0.06369645148515701
protein O 0 0.0003095816937275231
of O 0 0.0003808040637522936
unknown O 0 0.0011577344266697764
function O 0 0.0009830868802964687
. O 0 0.001136808772571385

Association O 0 0.002986965235322714
of O 0 0.0006325719878077507
the O 0 0.0004577544459607452
BRCA1 O 0 0.4589090347290039
protein O 0 0.0001321237359661609
with O 0 6.213648157427087e-05
the O 0 0.0001485932880314067
DNA O 0 0.0006634228047914803
repair O 1 0.8528502583503723
protein O 0 0.0003396817483007908
Rad51 O 0 0.2057262808084488
and O 0 6.860260327812284e-05
changes O 0 6.272491009440273e-05
in O 0 2.9172551876399666e-05
the O 0 4.2649822717066854e-05
phosphorylation O 0 0.00010069959535030648
and O 0 3.643320451374166e-05
cellular O 0 0.00010946254769805819
localization O 0 0.00014616777480114251
of O 0 3.5332926927367225e-05
the O 0 3.937490328098647e-05
protein O 0 4.7896839532768354e-05
after O 0 6.706819112878293e-05
exposure O 0 0.0001225121959578246
to O 0 2.7105623303214088e-05
DNA O 0 0.0001433616562280804
- O 0 0.000525788520462811
damaging O 0 0.0009179587941616774
agents O 0 6.718571967212483e-05
are O 0 1.543208782095462e-05
consistent O 0 4.7456556785618886e-05
with O 0 2.5602766982046887e-05
a O 0 6.652485171798617e-05
role O 0 0.00016645948926452547
for O 0 9.275044430978596e-05
BRCA1 O 1 0.5968194007873535
in O 0 0.00028489824035204947
DNA O 0 0.0031016231514513493
repair O 1 0.9049113392829895
. O 0 0.001793679897673428

Here O 0 0.001177537371404469
, O 0 0.0003546212101355195
it O 0 9.762719855643809e-05
is O 0 0.00010920440399786457
shown O 0 0.00011178902059327811
that O 0 7.11631219019182e-05
mouse O 0 0.0011125592282041907
embryonic O 0 0.023849301040172577
stem O 0 0.07456310838460922
cells O 0 0.008213172666728497
deficient B-Disease 0 0.31216809153556824
in I-Disease 0 0.000144590376294218
BRCA1 I-Disease 1 0.6293505430221558
are O 0 3.868596104439348e-05
defective O 0 0.0019878544844686985
in O 0 3.495248529361561e-05
the O 0 4.2946459871018305e-05
ability O 0 4.874325532000512e-05
to O 0 2.1235371605143882e-05
carry O 0 4.2655763536458835e-05
out O 0 5.2218001656001434e-05
transcription O 0 0.00041052341111935675
- O 0 0.04459403082728386
coupled O 0 0.06579972058534622
repair O 1 0.9656648635864258
of O 0 0.0074274553917348385
oxidative O 1 0.9960475564002991
DNA O 0 0.015120435506105423
damage O 1 0.5305233001708984
, O 0 7.631068001501262e-05
and O 0 6.357855454552919e-05
are O 0 3.77637188648805e-05
hypersensitive O 0 0.0032172228675335646
to O 0 0.00012284371769055724
ionizing O 0 0.2813812792301178
radiation O 0 0.051233403384685516
and O 0 0.00028796770493499935
hydrogen O 0 0.002818969776853919
peroxide O 0 0.014733167365193367
. O 0 0.001500329584814608

These O 0 0.000581644126214087
results O 0 0.0003512237162794918
suggest O 0 0.0003262705577071756
that O 0 0.00015197577886283398
BRCA1 O 1 0.5691864490509033
participates O 0 0.00028257074882276356
, O 0 6.598830077564344e-05
directly O 0 4.072893352713436e-05
or O 0 2.9581173293991014e-05
indirectly O 0 5.728349060518667e-05
, O 0 3.218582787667401e-05
in O 0 4.267887197784148e-05
transcription O 0 0.00047750616795383394
- O 0 0.057000257074832916
coupled O 0 0.10553877800703049
repair O 1 0.9774335026741028
of O 0 0.017865044996142387
oxidative O 1 0.9993687272071838
DNA O 0 0.025566261261701584
damage O 1 0.5845820307731628
. O 0 0.0003142935165669769
. O 0 0.0006760921678505838

Truncation O 0 0.03168847784399986
mutations O 0 0.0014016818022355437
in O 0 0.0003131461562588811
the O 0 0.0003853873931802809
transactivation O 0 0.007915248163044453
region O 0 0.0004399615863803774
of O 0 0.0004418655880726874
PAX6 O 1 0.9984548091888428
result O 0 0.0002951914502773434
in O 0 0.0001610821927897632
dominant O 0 0.00963575392961502
- O 0 0.09130711108446121
negative O 0 0.0011102046119049191
mutants O 0 0.015029487200081348
. O 0 0.0014649054501205683

PAX6 O 1 0.9932001233100891
is O 0 0.0004388226952869445
a O 0 0.0002595640253275633
transcription O 0 0.0003486750356387347
factor O 0 0.00013261914136819541
with O 0 2.783752825052943e-05
two O 0 3.3505475585116073e-05
DNA O 0 0.00012692315794993192
- O 0 0.00024463949375785887
binding O 0 7.517820631619543e-05
domains O 0 0.0001235240779351443
( O 0 8.220550080295652e-05
paired O 0 0.0002492372877895832
box O 0 0.0002596932463347912
and O 0 7.636774535058066e-05
homeobox O 0 0.0036376952193677425
) O 0 4.851893390878104e-05
and O 0 4.6622884838143364e-05
a O 0 7.345217454712838e-05
proline O 0 0.00058992940466851
- O 0 0.00048498454270884395
serine O 0 0.0008064105059020221
- O 0 0.0007871965644881129
threonine O 0 0.0012727874564006925
( O 0 0.0003129100950900465
PST O 0 0.04960041493177414
) O 0 0.0002417527139186859
- O 0 0.000785485899541527
rich O 0 0.0007108149584382772
transactivation O 0 0.004689446184784174
domain O 0 0.0014693589182570577
. O 0 0.0012552805710583925

PAX6 O 1 0.9997022747993469
regulates O 0 0.19345593452453613
eye O 1 0.5491727590560913
development O 0 0.0006129052489995956
in O 0 0.00014938361709937453
animals O 0 0.00012842645810451359
ranging O 0 0.00017330271657556295
from O 0 9.502258035354316e-05
jellyfish O 0 0.0003162616631016135
to O 0 9.1706526291091e-05
Drosophila O 0 0.0004876687889918685
to O 0 0.00015495976549573243
humans O 0 0.0004950704169459641
. O 0 0.000747917452827096

Heterozygous O 0 0.0035970842000097036
mutations O 0 0.0006102097686380148
in O 0 0.00023341187625192106
the O 0 0.0003361233975738287
human O 0 0.0016369075747206807
PAX6 O 1 0.9997362494468689
gene O 0 0.00028176960768178105
result O 0 8.368000999325886e-05
in O 0 4.334573168307543e-05
various O 0 3.934607593691908e-05
phenotypes O 0 0.0002766754769254476
, O 0 4.9789352488005534e-05
including O 0 0.0001056900728144683
aniridia B-Disease 1 0.999716579914093
, O 0 0.0011385091347619891
Peters B-Disease 1 0.9985528588294983
anomaly I-Disease 1 0.9996824264526367
, O 0 0.003876694245263934
autosomal B-Disease 1 0.9925429821014404
dominant I-Disease 1 0.9835061430931091
keratitis I-Disease 1 0.9999974966049194
, O 0 0.11327489465475082
and O 0 0.14029331505298615
familial B-Disease 1 0.9999934434890747
foveal I-Disease 1 0.9999992847442627
dysplasia I-Disease 1 0.9999995231628418
. O 0 0.45996004343032837

It O 0 0.0007150917081162333
is O 0 0.00026028993306681514
believed O 0 0.0002355334145249799
that O 0 6.5537155023776e-05
the O 0 0.00011326029925839975
mutated O 0 0.0004526904958765954
allele O 0 0.00022767549671698362
of O 0 0.00015716267807874829
PAX6 O 1 0.9969332218170166
produces O 0 0.00016655302897561342
an O 0 6.358237442327663e-05
inactive O 0 0.0002137819246854633
protein O 0 7.597420335514471e-05
and O 0 9.416222746949643e-05
aniridia B-Disease 1 0.9985632300376892
is O 0 0.00017809511336963624
caused O 0 0.006249622907489538
due O 0 0.00022437056759372354
to O 0 0.00019880611216649413
genetic O 0 0.0018125406932085752
haploinsufficiency O 1 0.9085319638252258
. O 0 0.0014409002615138888

However O 0 0.0008736015297472477
, O 0 0.0003296083596069366
several O 0 0.00015695721958763897
truncation O 0 0.0041239880956709385
mutations O 0 0.00018822173296939582
have O 0 2.684986793610733e-05
been O 0 2.174732435378246e-05
found O 0 1.7357679098495282e-05
to O 0 1.4069181816012133e-05
occur O 0 1.533032991574146e-05
in O 0 1.6024418073357083e-05
the O 0 4.739811993204057e-05
C O 0 0.0002854901540558785
- O 0 0.00038082091487012804
terminal O 0 0.00031425367342308164
half O 0 4.816258660866879e-05
of O 0 9.754047641763464e-05
PAX6 O 1 0.9989182949066162
in O 0 0.00014511746121570468
patients O 0 0.06596806645393372
with O 0 0.0001881406205939129
Aniridia B-Disease 1 0.9998515844345093
resulting O 0 0.002210457343608141
in O 0 8.691140101291239e-05
mutant O 0 0.0013217541854828596
proteins O 0 3.8463880628114566e-05
that O 0 2.0015280824736692e-05
retain O 0 5.769157723989338e-05
the O 0 4.6825753088342026e-05
DNA O 0 9.679606591816992e-05
- O 0 0.00012286551645956933
binding O 0 3.634512904682197e-05
domains O 0 4.089360299985856e-05
but O 0 2.690543442440685e-05
have O 0 2.3677199351368472e-05
lost O 0 0.00011262444604653865
most O 0 5.979461639071815e-05
of O 0 0.00011519242980284616
the O 0 0.0002828505530487746
transactivation O 0 0.04035276547074318
domain O 0 0.001447022776119411
. O 0 0.0013143226969987154

It O 0 0.0005190476076677442
is O 0 0.00019530487770680338
not O 0 4.637080564862117e-05
clear O 0 7.333585381275043e-05
whether O 0 6.997285527177155e-05
such O 0 5.0654860388021916e-05
mutants O 0 0.0009086281643249094
really O 0 0.000161717165610753
behave O 0 0.00012836178939323872
as O 0 5.877038711332716e-05
loss O 0 0.000763121759518981
- O 0 0.000628696521744132
of O 0 0.00020918803056702018
- O 0 0.04748525470495224
function O 0 0.00017487634613644332
mutants O 0 0.0017392367590218782
as O 0 0.0001869844418251887
predicted O 0 0.00036411869223229587
by O 0 0.00026877454365603626
haploinsufficiency O 0 0.18708354234695435
. O 0 0.0010566547280177474

Contrary O 0 0.0014323798241093755
to O 0 0.00015677772171329707
this O 0 7.73888168623671e-05
theory O 0 0.00014773222210351378
, O 0 6.654135358985513e-05
our O 0 7.264330633915961e-05
data O 0 3.563731661415659e-05
showed O 0 7.53097192500718e-05
that O 0 2.262060297653079e-05
these O 0 2.2226675355341285e-05
mutants O 0 0.00018003469449467957
are O 0 2.3634518584003672e-05
dominant O 0 0.0001479890925111249
- O 0 0.0002095935051329434
negative O 0 9.59235112532042e-05
in O 0 8.99981168913655e-05
transient O 0 0.04448384419083595
transfection O 0 0.4903005361557007
assays O 0 0.00016742380103096366
when O 0 5.7475223002256826e-05
they O 0 2.0629027858376503e-05
are O 0 2.1610667317872867e-05
coexpressed O 0 0.0011264730710536242
with O 0 0.00013376410061027855
wild O 0 0.0007292516529560089
- O 0 0.22635866701602936
type O 0 0.06434540450572968
PAX6 O 1 0.9971655011177063
. O 0 0.0017596478573977947

We O 0 0.0004993505426682532
found O 0 0.00016153964679688215
that O 0 7.557361095678061e-05
the O 0 8.757995965424925e-05
dominant O 0 0.001769540598616004
- O 0 0.027872156351804733
negative O 0 0.00021578885207418352
effects O 0 0.0003142650530207902
result O 0 4.428849933901802e-05
from O 0 3.154959267703816e-05
the O 0 6.424365710699931e-05
enhanced O 0 0.00019502241048030555
DNA O 0 9.213611338054761e-05
binding O 0 6.978294550208375e-05
ability O 0 7.254389493027702e-05
of O 0 9.800562111195177e-05
these O 0 0.00013930439308751374
mutants O 0 0.002680801786482334
. O 0 0.0007454782025888562

Kinetic O 0 0.004878421314060688
studies O 0 0.0006032969104126096
of O 0 0.00036978573189117014
binding O 0 0.000292726035695523
and O 0 0.0001410941476933658
dissociation O 0 0.001910827006213367
revealed O 0 0.00027732306625694036
that O 0 3.9312431908911094e-05
various O 0 3.601583739509806e-05
truncation O 0 0.000546219409443438
mutants O 0 0.000261644454440102
have O 0 2.478288661222905e-05
3 O 0 6.835661042714491e-05
- O 0 0.0001961097150342539
5 O 0 8.140218415064737e-05
- O 0 0.00019404286285862327
fold O 0 0.00010195122013101354
higher O 0 4.100200385437347e-05
affinity O 0 4.424582584761083e-05
to O 0 1.2166900887677912e-05
various O 0 1.877873182820622e-05
DNA O 0 5.2342038543429226e-05
- O 0 8.718101162230596e-05
binding O 0 2.4501663574483246e-05
sites O 0 2.3821063223294914e-05
when O 0 2.5582852686056867e-05
compared O 0 2.3858847271185368e-05
with O 0 1.9084276573266834e-05
the O 0 6.156742165330797e-05
wild O 0 0.000425909151090309
- O 0 0.05713088437914848
type O 0 0.028297508135437965
PAX6 O 1 0.9981258511543274
. O 0 0.0017877937061712146

These O 0 0.0005220717284828424
results O 0 0.00028608334832824767
provide O 0 0.00011412129970267415
a O 0 8.880306995706633e-05
new O 0 7.285989704541862e-05
insight O 0 0.00020968506578356028
into O 0 4.89927115268074e-05
the O 0 6.957894220249727e-05
role O 0 0.00015509383229073137
of O 0 0.00021226874378044158
mutant O 1 0.8217052221298218
PAX6 O 1 0.9998476505279541
in O 0 0.001062272465787828
causing O 1 0.9733662009239197
aniridia B-Disease 1 0.9995535016059875
. O 0 0.0007403831696137786
. O 0 0.000950004206970334

Reversal O 1 0.8721175193786621
of O 1 0.930990993976593
severe O 1 0.9999997615814209
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.963556170463562
excellent O 1 0.9922278523445129
neuropsychologic O 1 0.999701201915741
outcome O 0 0.0006912274984642863
in O 0 9.280865197069943e-05
very B-Disease 0 0.000113905050966423
- I-Disease 0 0.010397534817457199
long I-Disease 0 0.001333327847532928
- I-Disease 0 0.30944597721099854
chain I-Disease 0 0.11975159496068954
acyl I-Disease 1 0.9123251438140869
- I-Disease 1 0.9576881527900696
coenzyme I-Disease 1 0.9607429504394531
A I-Disease 1 0.9870267510414124
dehydrogenase I-Disease 1 0.9998314380645752
deficiency I-Disease 1 0.9999867677688599
. O 0 0.00424655806273222

Very B-Disease 0 0.0017037545330822468
- I-Disease 0 0.00859820656478405
long I-Disease 0 0.0013621748657897115
- I-Disease 0 0.05518956109881401
chain I-Disease 0 0.0053665428422391415
acyl I-Disease 0 0.10309553891420364
- I-Disease 0 0.13215456902980804
coenzyme I-Disease 0 0.0421118289232254
A I-Disease 0 0.053267620503902435
dehydrogenase I-Disease 1 0.9934321045875549
( I-Disease 0 0.15376491844654083
VLCAD I-Disease 1 0.9999914169311523
) I-Disease 0 0.20459553599357605
deficiency I-Disease 1 0.9999957084655762
is O 0 0.0005940027185715735
a O 0 0.1178274154663086
disorder O 1 0.999994158744812
of O 0 0.2739228308200836
fatty O 1 0.9932031631469727
acid O 1 0.8931707739830017
beta O 0 0.012168153189122677
oxidation O 0 0.00039270793786272407
that O 0 4.084605097887106e-05
reportedly O 0 0.00018996612925548106
has O 0 8.599827560828999e-05
high O 0 0.0001847769890446216
rates O 0 0.00013620767276734114
of O 0 0.0002516763051971793
morbidity O 1 0.8775198459625244
and O 0 0.0006560187903232872
mortality O 0 0.1647592931985855
. O 0 0.0013054164592176676

We O 0 0.0005203684559091926
describe O 0 0.0003598986950237304
the O 0 0.00010135189222637564
outcome O 0 0.00010535198089201003
of O 0 5.1512753998395056e-05
a O 0 6.0538430261658505e-05
5 O 0 9.128788224188611e-05
- O 0 0.0005859600496478379
year O 0 0.0001578318770043552
- O 0 0.0054443045519292355
old O 0 0.040572911500930786
girl O 1 0.9808802008628845
with O 1 0.6068356037139893
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
who O 0 0.0030167545191943645
was O 0 0.0006009294302202761
first O 0 4.827469092560932e-05
seen O 0 5.086901364848018e-05
at O 0 3.5617707908386365e-05
5 O 0 3.26585432048887e-05
months O 0 3.604050289141014e-05
of O 0 5.1919771067332476e-05
age O 0 0.0014710905961692333
with O 0 0.09939446300268173
severe O 1 0.9999998807907104
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9999977350234985
hepatomegaly B-Disease 1 1.0
, O 1 0.9999735355377197
encephalopathy B-Disease 1 1.0
, O 1 0.7261942625045776
and O 0 0.1874637007713318
hypotonia B-Disease 1 0.9996988773345947
. O 0 0.004263223614543676

Biochemical O 0 0.030116572976112366
studies O 0 0.003307522274553776
indicated O 1 0.9953345656394958
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
caused O 1 0.9994921684265137
by O 0 0.0007164361886680126
a O 0 0.006117742974311113
stable O 0 0.4509730041027069
yet O 0 0.0011065086582675576
inactive O 0 0.01630009151995182
enzyme O 0 0.0030595646239817142
. O 0 0.0010962777305394411

Molecular O 0 0.003680620575323701
genetic O 0 0.0009637319017201662
analysis O 0 0.0002808378776535392
of O 0 0.00023038148356135935
her O 0 0.00402611680328846
VLCAD O 1 0.9997891783714294
gene O 0 0.0008185101323761046
revealed O 0 0.0007943321252241731
a O 0 0.00048500829143449664
T1372C O 1 0.9922599196434021
( O 0 0.0009202570654451847
F458L O 1 0.8906823992729187
) O 0 0.0002873769262805581
missense O 0 0.0015505199553444982
mutation O 0 0.0004306913469918072
and O 0 0.00015056338452268392
a O 0 0.0005727233947254717
1668 O 1 0.8302406668663025
ACAG O 1 0.9984443783760071
1669 O 1 0.8110460042953491
splice O 0 0.014917794615030289
site O 0 0.0024704106617718935
mutation O 0 0.002713271416723728
. O 0 0.0012511208187788725

After O 0 0.0033525193575769663
initial O 0 0.003639818402007222
treatment O 1 0.8506487607955933
with O 0 0.0018273862078785896
intravenous O 1 0.9997976422309875
glucose O 1 0.6984464526176453
and O 0 0.0016364534385502338
carnitine O 1 0.999670147895813
, O 0 0.00013633890193887055
the O 0 0.0001405192306265235
patient O 0 0.008499817922711372
has O 0 7.096957415342331e-05
thrived O 0 0.0003639290516730398
on O 0 4.3961590563412756e-05
a O 0 7.486050890292972e-05
low O 0 0.000161910051247105
- O 0 0.0004891694406978786
fat O 0 0.0002308331022504717
diet O 0 0.0002529243065509945
supplemented O 0 0.0001864099904196337
with O 0 6.3104453147389e-05
medium O 0 0.00017470767488703132
- O 0 0.0005087921745143831
chain O 0 0.0003582602075766772
triglyceride O 0 0.0012253876775503159
oil O 0 0.0003506010107230395
and O 0 0.00021213642321527004
carnitine O 1 0.8220138549804688
and O 0 0.0003540896577760577
avoidance O 0 0.27541661262512207
of O 0 0.0012921938905492425
fasting O 0 0.28584176301956177
. O 0 0.0015016940888017416

Her O 1 0.9936674237251282
ventricular O 1 0.9999959468841553
hypertrophy O 1 0.9999291896820068
resolved O 0 0.0019649644382297993
significantly O 0 0.00022507122776005417
over O 0 8.956046076491475e-05
1 O 0 9.310738823842257e-05
year O 0 9.831291390582919e-05
, O 0 7.235431985463947e-05
and O 0 8.773560693953186e-05
cognitively O 0 0.2705673575401306
, O 0 7.195708894869313e-05
she O 0 7.210944750113413e-05
is O 0 3.986817682744004e-05
in O 0 4.213262945995666e-05
the O 0 9.059810690814629e-05
superior O 0 0.000302922009723261
range O 0 0.00014005212869960815
for O 0 0.00014388606359716505
age O 0 0.000594908487983048
. O 0 0.0009754321654327214

Clinical O 0 0.09274216741323471
recognition O 0 0.14279720187187195
of O 1 0.9966062307357788
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.14129550755023956
important O 0 0.00036560394801199436
because O 0 6.73146205372177e-05
it O 0 2.268944081151858e-05
is O 0 1.7624261090531945e-05
one O 0 1.3894627954869065e-05
of O 0 2.066366323560942e-05
the O 0 3.006935367011465e-05
few O 0 5.7150140492012724e-05
directly O 0 0.0002870794851332903
treatable O 1 0.9999831914901733
causes O 1 0.9890323281288147
of O 1 0.9172989130020142
cardiomyopathy B-Disease 1 1.0
in O 0 0.23203729093074799
children O 1 0.6080575585365295
. O 0 0.0008890530443750322
. O 0 0.0011346525279805064

Cloning O 0 0.00435712281614542
of O 0 0.0005508531467057765
a O 0 0.00038284261245280504
novel O 0 0.0003648351412266493
member O 0 0.0001369745732517913
of O 0 0.00012345530558377504
the O 0 0.00018097131396643817
low O 0 0.0024926483165472746
- O 0 0.31345218420028687
density O 0 0.007931358180940151
lipoprotein O 1 0.9489029049873352
receptor O 0 0.001775727141648531
family O 0 0.0011080881813541055
. O 0 0.0011560427956283092

A O 0 0.002624025335535407
gene O 0 0.0008007254800759256
encoding O 0 0.0002704312209971249
a O 0 0.00015423685545101762
novel O 0 0.0002657641307450831
transmembrane O 0 0.00047513499157503247
protein O 0 9.054981637746096e-05
was O 0 6.885328912176192e-05
identified O 0 4.6390978241106495e-05
by O 0 1.8811839254340157e-05
DNA O 0 4.3922787881456316e-05
sequence O 0 3.3836786315077916e-05
analysis O 0 2.7091951778857037e-05
within O 0 3.6405210266821086e-05
the O 0 9.492947719991207e-05
insulin B-Disease 1 0.907061755657196
- I-Disease 1 0.9701088666915894
dependent I-Disease 1 0.9551303386688232
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999990463256836
( O 1 0.658898115158081
IDDM B-Disease 1 0.9999440908432007
) O 0 0.0004672376380767673
locus O 0 0.011784303933382034
IDDM4 O 1 0.8939292430877686
on O 0 0.00041191105265170336
chromosome O 0 0.004251259379088879
11q13 O 0 0.3813619911670685
. O 0 0.0013650058535858989

Based O 0 0.0008306546369567513
on O 0 0.00024229336122516543
its O 0 0.00011337310570525005
chromosomal O 0 0.0009179928456433117
position O 0 0.00015490759687963873
, O 0 5.364550088415854e-05
this O 0 2.9200746212154627e-05
gene O 0 5.9972622693749145e-05
is O 0 3.202600419172086e-05
a O 0 4.2061008571181446e-05
candidate O 0 0.00011288443056400865
for O 0 9.438256529392675e-05
conferring O 0 0.011162019334733486
susceptibility O 1 0.8965964317321777
to O 0 0.0006672355812042952
diabetes B-Disease 1 0.9999276399612427
. O 0 0.0018943090690299869

The O 0 0.0011868388392031193
gene O 0 0.0006021417211741209
, O 0 0.00021093753457535058
termed O 0 0.0006935151759535074
low O 0 0.00046129070688039064
- O 0 0.0028102092910557985
density O 0 0.00042017389205284417
lipoprotein O 0 0.23354138433933258
receptor O 0 0.00022747325419913977
related O 0 6.542674964293838e-05
protein O 0 5.08280390931759e-05
5 O 0 0.0001144622074207291
( O 0 0.00014699478924740106
LRP5 O 0 0.1934765875339508
) O 0 5.50879594811704e-05
, O 0 3.332711276016198e-05
encodes O 0 6.406268948921934e-05
a O 0 4.316604827181436e-05
protein O 0 4.663030995288864e-05
of O 0 5.731933924835175e-05
1615 O 0 0.0004885759553872049
amino O 0 7.186321454355493e-05
acids O 0 5.549236448132433e-05
that O 0 3.7319929106161e-05
contains O 0 4.303444075048901e-05
conserved O 0 7.043276855256408e-05
modules O 0 9.752875484991819e-05
which O 0 2.609261719044298e-05
are O 0 9.16119370231172e-06
characteristic O 0 4.050076677231118e-05
of O 0 3.2585900044068694e-05
the O 0 6.435930845327675e-05
low O 0 0.001139680971391499
- O 0 0.38890936970710754
density O 0 0.03815966472029686
lipoprotein O 1 0.9996240139007568
( O 0 0.009302745573222637
LDL O 1 0.9581682682037354
) O 0 0.0003117104643024504
receptor O 0 0.0008358242339454591
family O 0 0.0006657650228589773
. O 0 0.0008419529185630381

These O 0 0.0007882069912739098
modules O 0 0.0014685909263789654
include O 0 0.00029100413667038083
a O 0 0.00025380938313901424
putative O 0 0.0008986116154119372
signal O 0 0.00040521592018194497
peptide O 0 0.0002355327596887946
for O 0 3.9110134821385145e-05
protein O 0 4.5137774577597156e-05
export O 0 6.139076867839321e-05
, O 0 5.1626062486320734e-05
four O 0 9.24223568290472e-05
epidermal O 1 0.873466968536377
growth O 0 0.00472967280074954
factor O 0 0.005684553645551205
( O 0 0.0003982560010626912
EGF O 1 0.5555171370506287
) O 0 8.790638094069436e-05
repeats O 0 0.000167306192452088
with O 0 3.404195376788266e-05
associated O 0 6.567823584191501e-05
spacer O 0 0.00031181276426650584
domains O 0 9.424037853023037e-05
, O 0 6.209495040820912e-05
three O 0 0.00010200196993537247
LDL O 1 0.9847593903541565
- O 0 0.24592524766921997
receptor O 0 0.0016967123374342918
( O 0 0.00036738303606398404
LDLR O 1 0.9431800246238708
) O 0 8.345567766809836e-05
repeats O 0 0.00015047584020067006
, O 0 5.617473289021291e-05
a O 0 7.657559035578743e-05
single O 0 9.609472181182355e-05
transmembrane O 0 0.0003508587833493948
spanning O 0 0.00025675445795059204
domain O 0 0.00013612068141810596
, O 0 8.656202408019453e-05
and O 0 0.00011807334522018209
a O 0 0.00033350122976116836
cytoplasmic O 0 0.001305534504354
domain O 0 0.0012245033867657185
. O 0 0.0010698222322389483

The O 0 0.0009594231960363686
encoded O 0 0.00042267225217074156
protein O 0 0.00019243580754846334
has O 0 6.000597568345256e-05
a O 0 8.089007314993069e-05
unique O 0 7.721145811956376e-05
organization O 0 0.00010464162187417969
of O 0 0.0002267093805130571
EGF O 1 0.9984362721443176
and O 0 0.0004744368779938668
LDLR O 1 0.9996944665908813
repeats O 0 0.0009938853327184916
; O 0 7.394884596578777e-05
therefore O 0 6.943287007743493e-05
, O 0 7.556712080258876e-05
LRP5 O 0 0.49891161918640137
likely O 0 8.229978993767872e-05
represents O 0 8.072471246123314e-05
a O 0 5.0381604523863643e-05
new O 0 4.5855293137719855e-05
category O 0 0.00011154974345117807
of O 0 0.00010014572035288438
the O 0 0.00027718613273464143
LDLR O 1 0.998788058757782
family O 0 0.0022341497242450714
. O 0 0.0010280228452757

Both O 0 0.0011024897685274482
human O 0 0.0010856024455279112
and O 0 0.000808298063930124
mouse O 1 0.9006179571151733
LRP5 O 1 0.9999467134475708
cDNAs O 1 0.9957306981086731
have O 0 8.383439853787422e-05
been O 0 5.5248157877940685e-05
isolated O 0 9.844575833994895e-05
and O 0 2.7628224415821023e-05
the O 0 4.168898885836825e-05
encoded O 0 4.699798591900617e-05
mature O 0 5.696970401913859e-05
proteins O 0 2.550577664806042e-05
are O 0 1.0863615898415446e-05
95 O 0 3.708626900333911e-05
% O 0 2.008867340919096e-05
identical O 0 3.536454460117966e-05
, O 0 3.27030174958054e-05
indicating O 0 7.267080945894122e-05
a O 0 5.447112926049158e-05
high O 0 7.554348121630028e-05
degree O 0 0.00011225452908547595
of O 0 9.856861288426444e-05
evolutionary O 0 0.00041923686512745917
conservation O 0 0.000523377675563097
. O 0 0.00025330172502435744
. O 0 0.0005669689271599054

The O 0 0.002559611340984702
APC B-Disease 1 0.721358060836792
variants O 0 0.0015967695508152246
I1307K O 1 0.8748288750648499
and O 0 0.0003974651626776904
E1317Q O 1 0.8384618759155273
are O 0 6.589334952877834e-05
associated O 0 0.0007758854189887643
with O 1 0.7578347325325012
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999997615814209
, O 0 0.00896427035331726
but O 0 7.371503306785598e-05
not O 0 3.237724376958795e-05
always O 0 7.700344576733187e-05
with O 0 4.7464614908676594e-05
a O 0 0.00014991298667155206
family O 0 0.0003334074863232672
history O 0 0.00108632305637002
. O 0 0.0010957485064864159

Classical O 0 0.44618746638298035
familial B-Disease 1 0.999992847442627
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
( O 1 0.9991022348403931
FAP B-Disease 1 0.9999853372573853
) O 0 0.00025755123351700604
is O 0 0.0001286588521907106
a O 0 0.00031026717624627054
high O 0 0.36201798915863037
- O 1 0.9987366795539856
penetrance O 1 0.9999781847000122
autosomal B-Disease 1 0.9999616146087646
dominant I-Disease 1 0.999575674533844
disease I-Disease 1 0.9999886751174927
that O 0 0.0003092099796049297
predisposes O 1 0.9554584622383118
to O 0 5.326958489604294e-05
hundreds O 0 9.936786955222487e-05
or O 0 5.501980922417715e-05
thousands O 0 0.0005244433414191008
of O 1 0.6628378033638
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
and I-Disease 1 0.9474161267280579
carcinoma I-Disease 1 0.9999997615814209
and O 0 0.0004958279896527529
that O 0 5.728982432628982e-05
results O 0 7.038376497803256e-05
from O 0 6.025553011568263e-05
truncating O 0 0.004743234254419804
mutations O 0 0.00020294322166591883
in O 0 0.00010252818174194545
the O 0 0.00024276229669339955
APC B-Disease 1 0.7914576530456543
gene O 0 0.000918072066269815
. O 0 0.0007997409556992352

A O 0 0.005206717178225517
variant O 0 0.006401543039828539
of O 0 0.0028977065812796354
FAP B-Disease 1 0.9999827146530151
is O 1 0.7817190289497375
attenuated B-Disease 1 0.9999949932098389
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999911785125732
, O 0 0.0006062862812541425
which O 0 4.249344419804402e-05
results O 0 5.6151970056816936e-05
from O 0 8.391021401621401e-05
germ O 1 0.9964017868041992
- O 0 0.033827487379312515
line O 0 0.00015565221838187426
mutations O 0 3.7040568713564426e-05
in O 0 1.796757715055719e-05
the O 0 2.1364439817261882e-05
5 O 0 3.505616768961772e-05
and O 0 2.615899393276777e-05
3 O 0 3.2497824577149004e-05
regions O 0 3.2993055356200784e-05
of O 0 5.7313271099701524e-05
the O 0 0.00022303283913061023
APC B-Disease 1 0.7424824237823486
gene O 0 0.0009923288598656654
. O 0 0.0006958356243558228

Attenuated B-Disease 1 0.9999544620513916
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 0.9999994039535522
patients O 1 0.9999089241027832
have O 0 0.002687386004254222
" O 1 0.5611088275909424
multiple O 1 0.9004969596862793
" O 1 0.9998443126678467
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999974966049194
( O 0 0.0009018892305903137
typically O 0 7.087623816914856e-05
fewer O 0 5.151329605723731e-05
than O 0 2.110603963956237e-05
100 O 0 4.333589458838105e-05
) O 0 3.384004594408907e-05
without O 0 4.4259581045480445e-05
the O 0 0.00011558422556845471
florid O 0 0.053984809666872025
phenotype O 0 0.002246291609480977
of O 0 0.00039630327955819666
classical O 0 0.004690404981374741
FAP B-Disease 1 0.9996726512908936
. O 0 0.0026586547028273344

Another O 0 0.0023251639213413
group O 0 0.0007890531560406089
of O 0 0.0006309583550319076
patients O 0 0.49453258514404297
with O 0 0.0004217211971990764
multiple O 0 0.09220733493566513
adenomas B-Disease 1 0.999915361404419
has O 0 0.0001813865965232253
no O 0 8.710288966540247e-05
mutations O 0 7.518329221056774e-05
in O 0 3.570320404833183e-05
the O 0 0.00010298705456079915
APC B-Disease 1 0.9259999990463257
gene O 0 0.00012453693489078432
, O 0 3.6940422432962805e-05
and O 0 2.284964284626767e-05
their O 0 2.372118251514621e-05
phenotype O 0 0.0007380468887276947
probably O 0 5.883476114831865e-05
results O 0 1.8140333850169554e-05
from O 0 1.399436587234959e-05
variation O 0 2.9201582947280258e-05
at O 0 2.7885222152690403e-05
a O 0 6.108669185778126e-05
locus O 0 0.0004209018952678889
, O 0 4.2022758862003684e-05
or O 0 4.7516965423710644e-05
loci O 0 0.00020890637824777514
, O 0 5.923796561546624e-05
elsewhere O 0 7.982282113516703e-05
in O 0 6.225842662388459e-05
the O 0 0.00019798778521362692
genome O 0 0.0009485065820626915
. O 0 0.0010715137468650937

Recently O 0 0.0027813217602670193
, O 0 0.0004397326847538352
however O 0 0.0001247625332325697
, O 0 0.00010634061618475243
a O 0 0.00012642114597838372
missense O 0 0.0009667041013017297
variant O 0 0.0006863240851089358
of O 0 0.0002873172052204609
APC B-Disease 1 0.9996126294136047
( O 0 0.0045259324833750725
I1307K O 1 0.9769176244735718
) O 0 9.414965461473912e-05
was O 0 0.00011693216947605833
described O 0 8.58773200889118e-05
that O 0 2.9821392672602087e-05
confers O 0 0.00018833429203368723
an O 0 7.271468348335475e-05
increased O 0 0.00033056276151910424
risk O 0 0.09553267061710358
of O 1 0.9860143661499023
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999998807907104
, O 0 0.018620900809764862
including O 0 0.0006560087786056101
multiple O 0 0.049076370894908905
adenomas B-Disease 1 0.9998637437820435
, O 0 0.0004908045521005988
in O 0 0.0004738147836178541
Ashkenazim O 0 0.3071865141391754
. O 0 0.001595754874870181

We O 0 0.0004881008935626596
have O 0 0.0001125648632296361
studied O 0 0.00014571896463166922
a O 0 7.115769403753802e-05
set O 0 4.969941437593661e-05
of O 0 6.249504804145545e-05
164 O 0 0.0013583137188106775
patients O 0 0.1598641574382782
with O 0 0.0007523788372054696
multiple O 1 0.9731940031051636
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999996423721313
and I-Disease 1 0.887819230556488
/ I-Disease 1 0.999854564666748
or I-Disease 0 0.22939375042915344
carcinoma I-Disease 1 0.9999839067459106
and O 0 0.0002373323222855106
analyzed O 0 0.00028101468342356384
codons O 0 0.0005818619974888861
1263 O 0 0.07891611009836197
- O 0 0.003555268282070756
1377 O 0 0.17206346988677979
( O 0 0.00030838861130177975
exon O 0 0.0014145957538858056
15G O 0 0.0016228541499003768
) O 0 6.622319051530212e-05
of O 0 8.777310722507536e-05
the O 0 0.0001350738893961534
APC B-Disease 0 0.025997502729296684
gene O 0 0.000246745184995234
for O 0 0.00017203137394972146
germ O 1 0.9833863377571106
- O 0 0.032306864857673645
line O 0 0.0017018577782437205
variants O 0 0.0013505559181794524
. O 0 0.0013164762640371919

Three O 0 0.0015257325721904635
patients O 0 0.005512762814760208
with O 0 0.00019536727631930262
the O 0 0.0004002476925961673
I1307K O 1 0.9948186278343201
allele O 0 0.0006322149420157075
were O 0 0.00010840737377293408
detected O 0 0.00021294946782290936
, O 0 0.00010104799730470404
each O 0 6.210673745954409e-05
of O 0 0.00024519875296391547
Ashkenazi O 0 0.002611831296235323
descent O 0 0.0028858049772679806
. O 0 0.0013403394259512424

Four O 0 0.002014374826103449
patients O 0 0.006700729485601187
had O 0 0.0005008903099223971
a O 0 0.0007937282789498568
germ O 1 0.9997580647468567
- O 1 0.824567973613739
line O 0 0.019804583862423897
E1317Q O 1 0.9816400408744812
missense O 0 0.025785990059375763
variant O 0 0.0007208846509456635
of O 0 0.00015555207210127264
APC O 1 0.8976202011108398
that O 0 2.8073947760276496e-05
was O 0 5.2140570915071294e-05
not O 0 1.1289582289464306e-05
present O 0 1.8199179976363666e-05
in O 0 1.2079796761099715e-05
controls O 0 2.5279001420130953e-05
; O 0 1.2282139323360752e-05
one O 0 1.148393585026497e-05
of O 0 1.7945125364349224e-05
these O 0 9.56067924562376e-06
individuals O 0 1.2441953003872186e-05
had O 0 2.5641840693424456e-05
an O 0 2.7343152396497317e-05
unusually O 0 0.00011494587670313194
large O 0 5.07338518218603e-05
number O 0 4.314480975153856e-05
of O 0 0.00015970392269082367
metaplastic B-Disease 1 0.996027946472168
polyps I-Disease 1 0.6066767573356628
of I-Disease 0 0.00033216254087165
the I-Disease 0 0.0011523893335834146
colorectum I-Disease 1 0.9808099865913391
. O 0 0.0017542853020131588

There O 0 0.0007858573226258159
is O 0 0.00024465512251481414
increasing O 0 0.00014543261204380542
evidence O 0 8.062085544224828e-05
that O 0 2.5177594579872675e-05
there O 0 3.665226176963188e-05
exist O 0 8.875210187397897e-05
germ O 1 0.8490059971809387
- O 0 0.0008783951052464545
line O 0 0.00017993617802858353
variants O 0 7.376748544629663e-05
of O 0 6.221188959898427e-05
the O 0 9.76452647591941e-05
APC B-Disease 1 0.6372262239456177
gene O 0 7.794852717779577e-05
that O 0 2.6364279619883746e-05
predispose O 0 0.00016576272901147604
to O 0 2.2139682187116705e-05
the O 0 4.083035673829727e-05
development O 0 0.00014912131882738322
of O 0 0.0019664426799863577
multiple O 1 0.9977472424507141
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9985575079917908
carcinoma I-Disease 1 1.0
, O 0 0.008416597731411457
but O 0 7.19027011655271e-05
without O 0 4.741923476103693e-05
the O 0 0.0001042998192133382
florid O 0 0.36921706795692444
phenotype O 0 0.0021321887616068125
of O 0 0.0001316548732575029
classical O 0 0.003192578675225377
FAP B-Disease 1 0.9998815059661865
, O 0 0.00011067784362239763
and O 0 6.356552330544218e-05
possibly O 0 9.450784273212776e-05
with O 0 5.6971224694279954e-05
importance O 0 0.0008631486562080681
for O 0 0.29379138350486755
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
risk O 0 0.3087800145149231
in O 0 0.00012518951552920043
the O 0 0.00022284193255472928
general O 0 0.0005716659361496568
population O 0 0.00019065257220063359
. O 0 0.0002684738428797573
. O 0 0.0006269379518926144

Genomic O 0 0.004155464470386505
structure O 0 0.0016082441434264183
of O 0 0.0007090434082783759
the O 0 0.06330879777669907
human O 1 0.9999570846557617
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999891519546509
CLD B-Disease 1 0.9999996423721313
) O 0 0.037434257566928864
gene O 0 0.0025981005746871233
. O 0 0.0010458581382408738

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999996423721313
diarrhea I-Disease 1 1.0
( O 1 0.9999879598617554
CLD B-Disease 1 0.9999998807907104
) O 0 0.03740330785512924
is O 0 0.00038552997284568846
caused O 0 0.031765975058078766
by O 0 4.0675251511856914e-05
mutations O 0 5.980123387416825e-05
in O 0 3.471238960628398e-05
a O 0 8.438750228378922e-05
gene O 0 0.00012921112647745758
which O 0 7.557461503893137e-05
encodes O 0 0.0004945672117173672
an O 0 0.0007484190282411873
intestinal O 1 0.999937891960144
anion O 1 0.9849263429641724
transporter O 1 0.9636828899383545
. O 0 0.002373214578256011

We O 0 0.0009157192544080317
report O 0 0.00026227484340779483
here O 0 0.00016167431022040546
the O 0 0.00010453072172822431
complete O 0 0.00018238973279949278
genomic O 0 0.0001785538624972105
organization O 0 7.686881872359663e-05
of O 0 6.151494744699448e-05
the O 0 0.00016288511687889695
human O 0 0.0006298489170148969
CLD B-Disease 1 0.9997537732124329
gene O 0 0.00016799310105852783
which O 0 6.332303019007668e-05
spans O 0 0.00024828006280586123
approximately O 0 0.00012018792767776176
39kb O 0 0.023305421695113182
, O 0 9.195644088322297e-05
and O 0 0.00010277192632202059
comprises O 0 0.0004012587305624038
21 O 0 0.0005439114756882191
exons O 0 0.0019537247717380524
. O 0 0.0009895081166177988

All O 0 0.00156008533667773
exon O 0 0.008277885615825653
/ O 0 0.003110485151410103
intron O 0 0.003323781071230769
boundaries O 0 0.0003806222230195999
conform O 0 0.0002900474355556071
to O 0 8.681994950165972e-05
the O 0 0.0002425455313641578
GT O 1 0.9194768667221069
/ O 0 0.3570369780063629
AG O 1 0.818192183971405
rule O 0 0.0019025907386094332
. O 0 0.0016147177666425705

An O 0 0.0010692476062104106
analysis O 0 0.0004989813314750791
of O 0 0.00034226474235765636
the O 0 0.00027759710792452097
putative O 0 0.0024475594982504845
promoter O 0 0.004366490989923477
region O 0 0.00023438954667653888
sequence O 0 0.00014274660497903824
shows O 0 0.0001570281747262925
a O 0 0.0002602249151095748
putative O 0 0.10973786562681198
TATA O 1 0.9994639754295349
box O 0 0.0012870803475379944
and O 0 0.00020576379029080272
predicts O 0 0.0005673299892805517
multiple O 0 0.0002245696377940476
transcription O 0 0.00043659735820256174
factor O 0 0.00044319944572634995
binding O 0 0.0003301092947367579
sites O 0 0.0005698804743587971
. O 0 0.0009569040848873556

The O 0 0.0008543679723516107
genomic O 0 0.0007737207342870533
structure O 0 0.0003110292018391192
was O 0 0.0001839616452343762
determined O 0 9.213532030116767e-05
using O 0 4.2868752643698826e-05
DNA O 0 7.282884325832129e-05
from O 0 2.043237691395916e-05
several O 0 2.1462503354996443e-05
sources O 0 2.4149752789526246e-05
including O 0 3.5374530853005126e-05
multiple O 0 6.359171675285324e-05
large O 0 9.79307951638475e-05
- O 0 0.0031958201434463263
insert O 0 0.002301213564351201
libaries O 0 0.06181473284959793
and O 0 9.645422687754035e-05
genomic O 0 0.0002244030765723437
DNA O 0 0.0001626875309739262
from O 0 0.00012739069643430412
Finnish O 1 0.9034871459007263
CLD B-Disease 1 0.9999934434890747
patients O 1 0.8514959812164307
and O 0 0.0005994635284878314
controls O 0 0.0015060409205034375
. O 0 0.001436000457033515

Exon O 0 0.19078493118286133
- O 0 0.003456922248005867
specific O 0 0.00029263366013765335
primers O 0 0.0010405172361060977
developed O 0 0.00015619101759511977
in O 0 4.8744412197265774e-05
this O 0 3.2288997317664325e-05
study O 0 4.571683530230075e-05
will O 0 3.772570926230401e-05
facilitate O 0 8.359921048395336e-05
mutation O 0 0.00010051031858893111
screening O 0 0.00010634994396241382
studies O 0 5.633367982227355e-05
of O 0 0.00015178765170276165
patients O 0 0.08802604675292969
with O 0 0.00024451425997540355
the O 0 0.04550454020500183
disease O 1 0.9999721050262451
. O 0 0.00751140620559454

Genomic O 0 0.003403511829674244
sequencing O 0 0.0011107397731393576
of O 0 0.0003703721158672124
a O 0 0.0007271725917235017
BAC O 1 0.998606264591217
clone O 1 0.9974333643913269
H O 1 0.9952176809310913
_ O 0 0.0008074420038610697
RG364P16 O 0 0.20529988408088684
revealed O 0 0.0002140568831237033
the O 0 4.504949174588546e-05
presence O 0 4.841928239329718e-05
of O 0 3.5815675801131874e-05
another O 0 8.150781650329009e-05
, O 0 3.665072290459648e-05
highly O 0 4.072314914083108e-05
homologous O 0 7.792852557031438e-05
gene O 0 3.1481104088015854e-05
3 O 0 3.428260606597178e-05
of O 0 3.117389132967219e-05
the O 0 0.00011528484174050391
CLD B-Disease 1 0.9999384880065918
gene O 0 0.00016218940436374396
, O 0 4.031464777654037e-05
with O 0 3.1530489650322124e-05
a O 0 5.6074539315886796e-05
similar O 0 5.1558996347012e-05
genomic O 0 0.0001187145899166353
structure O 0 0.00010437842138344422
, O 0 3.8703929021721706e-05
recently O 0 9.916851558955386e-05
identified O 0 6.148057582322508e-05
as O 0 6.425989704439417e-05
the O 0 0.002501782262697816
Pendred B-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
gene O 1 0.9598986506462097
( O 0 0.4177780747413635
PDS B-Disease 1 0.9999297857284546
) O 0 0.000648943183477968
. O 0 0.00047445722157135606
. O 0 0.0010740540456026793

The O 0 0.004727563820779324
APCI1307K O 1 0.9998643398284912
allele O 0 0.2617745101451874
and O 0 0.010577064007520676
cancer B-Disease 1 0.9997777342796326
risk O 0 0.0055880774743855
in O 0 8.539355621905997e-05
a O 0 0.00024279608624055982
community O 0 0.000246339914156124
- O 0 0.0009842521976679564
based O 0 7.084097887855023e-05
study O 0 0.00012175265874247998
of O 0 0.00021518806170206517
Ashkenazi O 0 0.011236495338380337
Jews O 0 0.0028797329869121313
. O 0 0.001459796796552837

Mutations O 0 0.0047826156951487064
in O 0 0.000818475557025522
APC O 1 0.5907888412475586
are O 0 0.00015284250548575073
classically O 0 0.04155450686812401
associated O 0 0.0004640661063604057
with O 0 0.007198969833552837
familial B-Disease 1 0.9999992847442627
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999772310256958
FAP B-Disease 1 0.9999990463256836
) O 0 0.0008715096628293395
, O 0 0.0002322570508113131
a O 0 0.0005873610498383641
highly O 0 0.18627040088176727
penetrant O 1 0.999992847442627
autosomal B-Disease 1 0.9999946355819702
dominant I-Disease 1 0.9999892711639404
disorder I-Disease 1 1.0
characterized O 1 0.9999432563781738
by O 1 0.9668973684310913
multiple O 1 0.9999710321426392
intestinal O 1 1.0
polyps B-Disease 1 0.9999988079071045
and O 0 0.04296810179948807
, O 0 0.0019648626912385225
without O 0 0.0004742592282127589
surgical O 1 0.9981891512870789
intervention O 0 0.0022866507060825825
, O 0 6.599711923627183e-05
the O 0 8.364090899704024e-05
development O 0 0.003900991752743721
of O 1 0.9670394659042358
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 1 0.9915140271186829
CRC B-Disease 1 0.9998416900634766
) O 0 0.0009927913779392838
. O 0 0.0011431467719376087

APC B-Disease 1 0.5237568616867065
is O 0 0.0012454433599486947
a O 0 0.013571567833423615
tumour O 1 0.999996542930603
- O 1 0.992794930934906
suppressor O 1 0.9907251000404358
gene O 0 0.0004713015223387629
, O 0 0.00010918034968199208
and O 0 0.00010585004201857373
somatic O 0 0.15939247608184814
loss O 0 0.21411263942718506
occurs O 0 0.0010776001727208495
in O 0 0.0005473370547406375
tumours B-Disease 1 0.9997147917747498
. O 0 0.0014903274131938815

The O 0 0.0035162714775651693
germline O 1 0.995707631111145
T O 1 0.9751974940299988
- O 0 0.0026052140165120363
to O 0 0.0001373708655592054
- O 0 0.0009317975491285324
A O 0 0.0003831383946817368
transversion O 0 0.11968167871236801
responsible O 0 0.00017787756223697215
for O 0 5.0725673645501956e-05
the O 0 0.000176363653736189
APC O 1 0.830207109451294
I1307K O 1 0.6471914052963257
allele O 0 0.00024137107538990676
converts O 0 0.00011836779594887048
the O 0 6.098156882217154e-05
wild O 0 9.112681436818093e-05
- O 0 0.00017109353211708367
type O 0 7.31875334167853e-05
sequence O 0 4.4270687794778496e-05
to O 0 3.743606066564098e-05
a O 0 0.00024774891790002584
homopolymer O 1 0.999871015548706
tract O 1 0.9999825954437256
( O 0 0.3625178337097168
A8 O 1 0.999735414981842
) O 0 0.00011646935308817774
that O 0 5.5596294259885326e-05
is O 0 0.0001021085336105898
genetically O 0 0.00031339615816250443
unstable O 0 0.030656857416033745
and O 0 0.00019830784003715962
prone O 0 0.12848277390003204
to O 0 0.0003016004047822207
somatic O 0 0.21538902819156647
mutation O 0 0.0046662939712405205
. O 0 0.0013770130462944508

The O 0 0.003040904179215431
I1307K O 1 0.771020770072937
allele O 0 0.002028354909271002
was O 0 0.0004867535026278347
found O 0 0.00018903179443441331
in O 0 0.00022190436720848083
6 O 0 0.0009217755869030952
. O 0 0.0009387052268721163

1 O 0 0.0011517582461237907
% O 0 0.00035869283601641655
of O 0 0.0002921784471254796
unselected O 0 0.10489584505558014
Ashkenazi O 0 0.002961090998724103
Jews O 0 0.0003151510318275541
and O 0 8.943364809965715e-05
higher O 0 8.488377352477983e-05
proportions O 0 0.0003795578668359667
of O 0 0.00010433304851176217
Ashkenazim O 0 0.1117931678891182
with O 0 6.111850234447047e-05
family O 0 0.000163674631039612
or O 0 7.171103061409667e-05
personal O 0 0.00016462785424664617
histories O 0 0.0002660658210515976
of O 0 0.001505838823504746
CRC B-Disease 1 0.999824583530426
( O 0 0.005896896589547396
ref O 1 0.5530762076377869
. O 0 0.00017310387920588255
2 O 0 0.0002467752783559263
) O 0 0.0003291445318609476
. O 0 0.0007499808561988175

To O 0 0.000694220419973135
evaluate O 0 0.0008139596902765334
the O 0 0.00021151857799850404
role O 0 0.00032452461891807616
of O 0 0.00029639198328368366
I1307K O 1 0.996795117855072
in O 0 0.0005983903538435698
cancer B-Disease 1 0.996802568435669
, O 0 0.00016177023644559085
we O 0 8.11088175396435e-05
genotyped O 0 0.07971660792827606
5 O 0 0.00017969647888094187
, O 0 0.0001750648661982268
081 O 0 0.044041913002729416
Ashkenazi O 0 0.0008935324149206281
volunteers O 0 0.0003866186598315835
in O 0 0.00012949432129971683
a O 0 0.0002487250021658838
community O 0 0.0005066482699476182
survey O 0 0.0009587898966856301
. O 0 0.001319726463407278

Risk O 0 0.02222995087504387
of O 0 0.019305981695652008
developing O 1 0.9993292093276978
colorectal B-Disease 1 0.9999998807907104
, I-Disease 1 0.9330964684486389
breast I-Disease 1 0.9999831914901733
and I-Disease 0 0.00050112244207412
other I-Disease 0 7.215698133222759e-05
cancers I-Disease 0 0.12861992418766022
were O 0 4.400857142172754e-05
compared O 0 6.502574251499027e-05
between O 0 9.451568621443585e-05
genotyped O 1 0.988207995891571
I1307K O 1 0.9968704581260681
carriers O 0 0.0011917855590581894
and O 0 5.973170846118592e-05
non O 0 0.0006068302318453789
- O 0 0.007653290405869484
carriers O 0 9.795881487661973e-05
and O 0 2.5438224838580936e-05
their O 0 2.1565434508374892e-05
first O 0 0.00010120248043676838
- O 0 0.0006105821230448782
degree O 0 0.0004959763027727604
relatives O 0 0.0010996577329933643
. O 0 0.0007308539352379739

Sperm O 0 0.0029755132272839546
DNA O 0 0.0012617342872545123
analysis O 0 0.000371516594896093
in O 0 0.00026438882923685014
a O 0 0.0015143025666475296
Friedreich B-Disease 1 0.9999192953109741
ataxia I-Disease 1 0.9999889135360718
premutation O 1 0.999886155128479
carrier O 1 0.5003753900527954
suggests O 0 0.0010279003763571382
both O 0 0.00019529202836565673
meiotic O 1 0.75736403465271
and O 0 0.00027283295639790595
mitotic O 0 0.01734289340674877
expansion O 0 0.0006734401104040444
in O 0 0.00019530915596988052
the O 0 0.00044197464012540877
FRDA B-Disease 1 0.9983606934547424
gene O 0 0.0020635328255593777
. O 0 0.0014797693584114313

Friedreich B-Disease 1 0.9999535083770752
ataxia I-Disease 1 0.9999316930770874
is O 0 0.003396859159693122
usually O 0 0.00046312680933624506
caused O 0 0.0028591742739081383
by O 0 6.179062620503828e-05
an O 0 6.392099749064073e-05
expansion O 0 0.00018551101675257087
of O 0 8.386837725993246e-05
a O 0 0.0002627068024594337
GAA O 0 0.0018849686020985246
trinucleotide O 0 0.056614670902490616
repeat O 0 0.00039003996062092483
in O 0 0.0001023550721583888
intron O 0 0.0014846248086541891
1 O 0 0.00016231101471930742
of O 0 0.00018681034271139652
the O 0 0.00042928452603518963
FRDA B-Disease 1 0.9965303540229797
gene O 0 0.0018394452054053545
. O 0 0.0013949276180937886

Occasionally O 0 0.0018371276091784239
, O 0 0.0004721000441350043
a O 0 0.0002570363285485655
fully O 0 0.0003405448514968157
expanded O 0 0.00023082912957761437
allele O 0 0.00018766048015095294
has O 0 3.678020220831968e-05
been O 0 2.8909616958117113e-05
found O 0 2.5909699616022408e-05
to O 0 2.4396322260145098e-05
arise O 0 5.2313342166598886e-05
from O 0 2.5370751245645806e-05
a O 0 7.336537237279117e-05
premutation O 0 0.0046676271595060825
of O 0 9.196047176374123e-05
100 O 0 0.00017933669732883573
or O 0 0.00013430611579678953
less O 0 0.00022545889078173786
triplet O 0 0.011203072965145111
repeats O 0 0.001935513224452734
. O 0 0.0009427018230780959

We O 0 0.0008772842702455819
have O 0 0.00019575440092012286
examined O 0 0.00033621976035647094
the O 0 0.00010777892748592421
sperm O 0 0.00021782128897029907
DNA O 0 0.00020901835523545742
of O 0 0.00019988039275631309
a O 0 0.001056393957696855
premutation O 1 0.9933952689170837
carrier O 0 0.09972065687179565
. O 0 0.0015682261437177658

This O 0 0.0012074956903234124
mans O 0 0.023710964247584343
leucocyte O 0 0.4089360535144806
DNA O 0 0.0007081563817337155
showed O 0 0.00027279002824798226
one O 0 8.996361430035904e-05
normal O 0 0.00012986824731342494
allele O 0 0.00013399591261986643
and O 0 2.981601755891461e-05
one O 0 3.768047827179544e-05
allele O 0 0.00011780299246311188
of O 0 7.100843504304066e-05
approximately O 0 0.00015239513595588505
100 O 0 0.000409553584177047
repeats O 0 0.0013849164824932814
. O 0 0.001074385130777955

His O 0 0.0025211472529917955
sperm O 0 0.001085433061234653
showed O 0 0.0005555562092922628
an O 0 0.0001307055790675804
expanded O 0 0.00024887631298042834
allele O 0 0.00020269877859391272
in O 0 5.151452569407411e-05
a O 0 9.675915498519316e-05
tight O 0 0.00017342949286103249
range O 0 6.838007539045066e-05
centering O 0 0.00022179311781655997
on O 0 3.853657835861668e-05
a O 0 5.119121487950906e-05
size O 0 7.067929254844785e-05
of O 0 9.396723180543631e-05
approximately O 0 0.0003569347318261862
320 O 0 0.0016770332586020231
trinucleotide O 0 0.25011685490608215
repeats O 0 0.002354837954044342
. O 0 0.0015583453932777047

His O 0 0.0065909577533602715
affected O 0 0.01546706072986126
son O 0 0.4900881052017212
has O 0 0.0005806708941236138
repeat O 0 0.0010254580993205309
sizes O 0 0.000248002732405439
of O 0 0.00024781274260021746
1040 O 0 0.1180775836110115
and O 0 0.0005478606326505542
540 O 0 0.005468812771141529
. O 0 0.0013981048250570893

These O 0 0.0004313184763304889
data O 0 0.00015542114851996303
suggest O 0 0.00019479217007756233
that O 0 4.736080518341623e-05
expansion O 0 0.0001035432142089121
occurs O 0 5.276023148326203e-05
in O 0 2.0556348317768425e-05
two O 0 1.7812903024605475e-05
stages O 0 8.324997907038778e-05
, O 0 2.9548300517490134e-05
the O 0 2.677211341506336e-05
first O 0 5.139513814356178e-05
during O 0 0.00013145868433639407
meiosis O 0 0.001438446925021708
followed O 0 0.00010792857210617512
by O 0 5.512885036296211e-05
a O 0 0.00014994818775448948
second O 0 0.0006537127774208784
mitotic O 0 0.016882875934243202
expansion O 0 0.0022483435459434986
. O 0 0.0011234317207708955

We O 0 0.0006458036950789392
also O 0 0.00020440183288883418
show O 0 0.00020437299099285156
that O 0 3.926634963136166e-05
in O 0 4.700300996773876e-05
all O 0 4.112983151571825e-05
informative O 0 0.0001844449870986864
carrier O 0 0.00040358619298785925
father O 0 0.0001982125686481595
to O 0 4.156696013524197e-05
affected O 0 0.00017785889212973416
child O 0 0.00283596059307456
transmissions O 0 0.0001597127557033673
, O 0 2.8582793675013818e-05
with O 0 1.5316174540203065e-05
the O 0 3.18699239869602e-05
notable O 0 4.0155799069907516e-05
exception O 0 5.500586121343076e-05
of O 0 5.475841317093e-05
the O 0 0.00013556538033299148
premutation O 1 0.9581024050712585
carrier O 0 0.0013174396008253098
, O 0 5.78357903577853e-05
the O 0 6.350189505610615e-05
expansion O 0 0.00027965049957856536
size O 0 0.00023384534870274365
decreases O 0 0.0004796559805981815
. O 0 0.00022875388094689697
. O 0 0.0006425268366001546

The O 0 0.0023956503719091415
R496H O 1 0.6972519755363464
mutation O 0 0.001720538712106645
of O 0 0.0006679972284473479
arylsulfatase O 1 0.9978551268577576
A O 0 0.017338579520583153
does O 0 0.0003185098757967353
not O 0 0.0003155695740133524
cause O 1 0.9508523941040039
metachromatic B-Disease 1 0.9999517202377319
leukodystrophy I-Disease 1 0.9999740123748779
. O 0 0.004002258647233248

Deficiency B-Disease 1 0.9999116659164429
of I-Disease 0 0.004582778550684452
arylsulfatase I-Disease 1 0.9996129870414734
A I-Disease 1 0.8846191167831421
( O 0 0.21356013417243958
ARSA O 1 0.9996985197067261
) O 0 0.0006113204872235656
enzyme O 0 0.0013165164273232222
activity O 0 0.0008233730914071202
causes O 1 0.9248194098472595
metachromatic B-Disease 1 0.9999805688858032
leukodystrophy I-Disease 1 0.9999979734420776
( O 1 0.8024260997772217
MLD B-Disease 1 0.9999634027481079
) O 0 0.0015922405291348696
. O 0 0.0012592959683388472

A O 0 0.002136895200237632
number O 0 0.0005679855821654201
of O 0 0.0009514980483800173
ARSA O 1 0.9994027614593506
gene O 0 0.0012677200138568878
mutations O 0 0.0006317441584542394
responsible O 0 0.0005821232916787267
for O 0 0.0003126116353087127
MLD B-Disease 1 0.9998492002487183
have O 0 0.00019630765018519014
been O 0 0.000263545720372349
identified O 0 0.0005837361677549779
. O 0 0.0009710457525216043

Recently O 0 0.002116408431902528
, O 0 0.0004681689606513828
the O 0 0.00035903873504139483
R496H O 1 0.6681342720985413
mutation O 0 0.0007515333127230406
of O 0 0.00031808565836399794
ARSA O 1 0.9993426203727722
was O 0 0.00038272730307653546
proposed O 0 7.253787043737248e-05
to O 0 2.686974585230928e-05
be O 0 2.6847563276533037e-05
a O 0 7.449460827047005e-05
cause O 0 0.000386476400308311
of O 0 0.00047473094309680164
MLD B-Disease 1 0.9999740123748779
( O 0 0.0013848302187398076
Draghia O 1 0.9702953696250916
et O 0 0.004048965871334076
al O 0 0.0012187294196337461
. O 0 0.0001378667657263577
, O 0 0.0001650138437980786
1997 O 0 0.0005891934270039201
) O 0 0.00046562787611037493
. O 0 0.0009308019652962685

We O 0 0.0005289617110975087
have O 0 0.0001129397569457069
investigated O 0 0.0002630197850521654
the O 0 0.0001845813385443762
R496H O 1 0.9849564433097839
mutation O 0 0.0007711101789027452
and O 0 6.18417325313203e-05
found O 0 3.22689265885856e-05
this O 0 2.1912868760409765e-05
mutation O 0 4.701511352322996e-05
at O 0 2.5617910068831407e-05
a O 0 3.61144047928974e-05
relatively O 0 2.1937938072369434e-05
high O 0 3.254298280808143e-05
frequency O 0 1.9855280697811395e-05
in O 0 1.0098448910866864e-05
an O 0 1.4498305063170847e-05
African O 0 3.854915121337399e-05
American O 0 4.17397495766636e-05
population O 0 2.457310438330751e-05
( O 0 3.27054804074578e-05
f O 0 6.887476047268137e-05
= O 0 9.118296293308958e-05
0 O 0 4.593044286593795e-05
. O 0 3.0251590942498296e-05
09 O 0 0.0002664324129000306
, O 0 6.935749115655199e-05
n O 0 0.00016713989316485822
= O 0 0.0002729924162849784
61 O 0 0.00040583364898338914
subjects O 0 0.0004697409167420119
) O 0 0.00032832592842169106
. O 0 0.0006382293067872524

The O 0 0.003594101406633854
ARSA O 1 0.9928930401802063
enzyme O 0 0.0013513150624930859
activity O 0 0.00026612039073370397
in O 0 7.854800060158595e-05
subjects O 0 9.729875455377623e-05
with O 0 3.7104204238858074e-05
and O 0 4.320620064390823e-05
without O 0 5.384907854022458e-05
the O 0 0.00011538227408891544
R496H O 1 0.9645823240280151
mutation O 0 0.0006199573981575668
was O 0 0.00018960837041959167
determined O 0 0.00013172834587749094
and O 0 5.4574284149566665e-05
found O 0 7.071792788337916e-05
to O 0 7.013091089902446e-05
be O 0 0.00010624645074130967
normal O 0 0.00035625885357148945
. O 0 0.0006454449612647295

It O 0 0.0005992003134451807
is O 0 0.0003488672082312405
therefore O 0 0.00017160753486678004
concluded O 0 0.00023642348241992295
that O 0 8.206178608816117e-05
the O 0 0.0001599816168891266
R496H O 1 0.8796294331550598
mutation O 0 0.0008876619394868612
of O 0 0.00047562687541358173
ARSA O 1 0.9982093572616577
does O 0 9.0389272372704e-05
not O 0 2.5489291147096083e-05
negatively O 0 6.222079537110403e-05
influence O 0 4.6220517106121406e-05
the O 0 4.2556217522360384e-05
activity O 0 8.431704191025347e-05
of O 0 0.0001540904340799898
ARSA O 1 0.995729386806488
and O 0 0.00011543598520802334
is O 0 7.057382026687264e-05
not O 0 5.343443262972869e-05
a O 0 0.0002707978419493884
cause O 0 0.007946358062326908
of O 0 0.005843358114361763
MLD B-Disease 1 0.9999356269836426

Down O 0 0.0032503539696335793
- O 0 0.001921156537719071
regulation O 0 0.0004713252710644156
of O 0 0.00041213553049601614
transmembrane O 0 0.17731843888759613
carbonic O 1 0.9974111914634705
anhydrases O 1 0.9998862743377686
in O 1 0.6579831838607788
renal B-Disease 1 1.0
cell I-Disease 1 0.999964714050293
carcinoma I-Disease 1 0.9999997615814209
cell O 0 0.15557213127613068
lines O 0 0.00031989908893592656
by O 0 9.578620665706694e-05
wild O 0 0.0004943296662531793
- O 0 0.03089592233300209
type O 0 0.00762787414714694
von B-Disease 1 0.8637700080871582
Hippel I-Disease 1 0.9992508292198181
- I-Disease 1 0.9641752243041992
Lindau I-Disease 1 0.9965860843658447
transgenes O 1 0.8015336394309998
. O 0 0.00333008193410933

To O 0 0.0006467565544880927
discover O 0 0.0009613356087356806
genes O 0 0.00027572826365940273
involved O 0 0.00019455660367384553
in O 0 0.00013276413665153086
von B-Disease 0 0.031709324568510056
Hippel I-Disease 1 0.9989480376243591
- I-Disease 1 0.9631074666976929
Lindau I-Disease 1 0.9998536109924316
( O 0 0.059177007526159286
VHL B-Disease 1 0.9997503161430359
) O 0 0.00026629731291905046
- O 0 0.0095356535166502
mediated O 0 0.008163033053278923
carcinogenesis O 1 0.9510109424591064
, O 0 0.00017031890456564724
we O 0 0.00012835935922339559
used O 0 0.0005228351801633835
renal B-Disease 1 0.9999980926513672
cell I-Disease 1 0.998320996761322
carcinoma I-Disease 1 0.9999992847442627
cell O 0 0.10145465284585953
lines O 0 0.0006210337160155177
stably O 0 0.008670705370604992
transfected O 0 0.01439669355750084
with O 0 0.00010142352402908728
wild O 0 0.0006084144697524607
- O 0 0.14107409119606018
type O 0 0.09492243081331253
VHL O 1 0.9996836185455322
- O 0 0.274687260389328
expressing O 0 0.005559887271374464
transgenes O 0 0.27758386731147766
. O 0 0.0018359787063673139

Large O 0 0.002006695605814457
- O 0 0.002579796826466918
scale O 0 0.0008341970387846231
RNA O 0 0.0004062391526531428
differential O 0 0.0003198377962689847
display O 0 0.00017283916531596333
technology O 0 0.00011270361574133858
applied O 0 4.0798677218845114e-05
to O 0 2.312495962542016e-05
these O 0 2.1066325643914752e-05
cell O 0 8.495228394167498e-05
lines O 0 5.3668631153414026e-05
identified O 0 4.58483409602195e-05
several O 0 2.9791175620630383e-05
differentially O 0 0.0001646262826398015
expressed O 0 6.750155444024131e-05
genes O 0 4.655352677218616e-05
, O 0 3.6711520806420594e-05
including O 0 5.472698467201553e-05
an O 0 0.00012014861567877233
alpha O 0 0.0008497863309457898
carbonic O 0 0.21427088975906372
anhydrase O 1 0.9395654797554016
gene O 0 0.0008336559403687716
, O 0 0.0005207994254305959
termed O 0 0.006858334876596928
CA12 O 1 0.9804518818855286
. O 0 0.002961341757327318

The O 0 0.0011235077399760485
deduced O 0 0.0014465785352513194
protein O 0 0.00020531518384814262
sequence O 0 0.00011630862718448043
was O 0 9.126630175160244e-05
classified O 0 7.336369890253991e-05
as O 0 3.6414658097783104e-05
a O 0 5.7138695410685614e-05
one O 0 8.992356742965057e-05
- O 0 0.0008798409253358841
pass O 0 0.00024113254039548337
transmembrane O 0 0.007828152738511562
CA O 0 0.000723726290743798
possessing O 0 0.0002161727170459926
an O 0 0.00011438255023676902
apparently O 0 0.00034494558349251747
intact O 0 0.0004317354178056121
catalytic O 0 0.0004141400277148932
domain O 0 0.00014061681577004492
in O 0 0.00010531521547818556
the O 0 0.00029589561745524406
extracellular O 0 0.0019157148199155927
CA O 0 0.00578308617696166
module O 0 0.018563508987426758
. O 0 0.00173175148665905

Reintroduced O 0 0.013872228562831879
wild O 0 0.00486072339117527
- O 0 0.29322031140327454
type O 0 0.04287482053041458
VHL B-Disease 1 0.9934961795806885
strongly O 0 0.00031487413798458874
inhibited O 0 0.000531564699485898
the O 0 8.45737595227547e-05
overexpression O 0 0.000342910730978474
of O 0 6.673389725619927e-05
the O 0 0.0001263457234017551
CA12 O 1 0.9655421376228333
gene O 0 0.0001259944256162271
in O 0 7.113190804375336e-05
the O 0 0.000321983068715781
parental O 1 0.9820281267166138
renal B-Disease 1 1.0
cell I-Disease 1 0.9999938011169434
carcinoma I-Disease 1 1.0
cell O 1 0.9923931360244751
lines O 0 0.019795607775449753
. O 0 0.0013602250255644321

Similar O 0 0.001270597567781806
results O 0 0.00037281904951669276
were O 0 0.0001256745308637619
obtained O 0 0.0001877254544524476
with O 0 0.0001053379091899842
CA9 O 1 0.77745521068573
, O 0 0.00018892802472691983
encoding O 0 0.00014594703679904342
another O 0 0.00022238220844883472
transmembrane O 0 0.002220775466412306
CA O 0 0.0004988866858184338
with O 0 0.00011087687744293362
an O 0 0.00012791118933819234
intact O 0 0.0008898587548173964
catalytic O 0 0.0015198411419987679
domain O 0 0.0012313383631408215
. O 0 0.0009854278760030866

Although O 0 0.0007234220975078642
both O 0 0.0001834687136579305
domains O 0 0.00035494944313541055
of O 0 0.00016290205530822277
the O 0 0.00031870490056462586
VHL B-Disease 1 0.9945942759513855
protein O 0 0.00018497476412449032
contribute O 0 0.0001359625457553193
to O 0 3.2331216061720625e-05
regulation O 0 7.336935959756374e-05
of O 0 9.60371908149682e-05
CA12 O 1 0.9924824833869934
expression O 0 0.0002431751199765131
, O 0 7.594117050757632e-05
the O 0 9.505521302344278e-05
elongin O 0 0.008961512707173824
binding O 0 0.00014849839499220252
domain O 0 0.00017487000150140375
alone O 0 0.00021687877597287297
could O 0 0.00015073418035171926
effectively O 0 0.0004893563454970717
regulate O 0 0.0009029597858898342
CA9 O 1 0.9038229584693909
expression O 0 0.002625548280775547
. O 0 0.0015038606943562627

We O 0 0.00168585404753685
mapped O 0 0.003428323194384575
CA12 O 1 0.9567030668258667
and O 0 0.001025831326842308
CA9 O 1 0.9663788080215454
loci O 0 0.0020595481619238853
to O 0 0.00034317205427214503
chromosome O 0 0.001016989815980196
bands O 0 0.0010478541953489184
15q22 O 0 0.4322105050086975
and O 0 0.0008478790987282991
17q21 O 1 0.8241886496543884
. O 0 0.0018980614840984344

2 O 0 0.001323328586295247
respectively O 0 0.0007766037015244365
, O 0 0.00020153399964328855
regions O 0 0.00014430718147195876
prone O 0 0.0010155616328120232
to O 0 9.033842798089609e-05
amplification O 0 0.0006456442642956972
in O 0 0.00011429750156821683
some O 0 0.0001594808418303728
human O 0 0.0011144991731271148
cancers B-Disease 1 0.9027672410011292
. O 0 0.0014297141460701823

Additional O 0 0.0011858399957418442
experiments O 0 0.0006031364900991321
are O 0 5.042938937549479e-05
needed O 0 9.887513442663476e-05
to O 0 2.8329226552159525e-05
define O 0 4.971970338374376e-05
the O 0 3.96183313569054e-05
role O 0 0.00010495530295884237
of O 0 0.00020450554438866675
CA O 1 0.8641344904899597
IX O 1 0.9999034404754639
and O 0 0.0005407715798355639
CA O 0 0.19304592907428741
XII O 1 0.9423930644989014
enzymes O 0 7.934773020679131e-05
in O 0 1.9590419469750486e-05
the O 0 2.3141350538935512e-05
regulation O 0 5.217946454649791e-05
of O 0 4.831706974073313e-05
pH O 0 0.0002096278767567128
in O 0 3.913397449650802e-05
the O 0 6.661791849182919e-05
extracellular O 0 0.0003248403372708708
microenvironment O 0 0.0016135803889483213
and O 0 3.65254636562895e-05
its O 0 2.6827447072719224e-05
potential O 0 9.118991874856874e-05
impact O 0 0.00019335767137818038
on O 0 0.0002309563715243712
cancer B-Disease 1 0.9989896416664124
cell O 0 0.03824346512556076
growth O 0 0.0018757007783278823
. O 0 0.0010030865669250488

A O 0 0.0021370660979300737
gene O 0 0.0006722672842442989
encoding O 0 0.00025752425426617265
a O 0 0.00015591098053846508
transmembrane O 0 0.0007494471501559019
protein O 0 0.00011407428974052891
is O 0 7.296989497262985e-05
mutated O 0 0.0003933385305572301
in O 0 0.0001330642553512007
patients O 1 0.9907240271568298
with O 1 0.9645923376083374
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.999992847442627
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.999995231628418
Wolfram B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
) O 0 0.15653938055038452
. O 0 0.0024129312951117754

Wolfram B-Disease 1 0.9999895095825195
syndrome I-Disease 1 0.9999998807907104
( O 1 0.9720712304115295
WFS B-Disease 1 0.9999812841415405
; O 0 0.12321695685386658
OMIM O 1 0.9999871253967285
222300 O 1 0.9997623562812805
) O 0 0.00044390748371370137
is O 0 0.0003222293744329363
an O 0 0.034632354974746704
autosomal B-Disease 1 0.999996542930603
recessive I-Disease 1 0.9999997615814209
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
defined O 0 0.16760753095149994
by O 0 0.005136856809258461
young O 1 0.9930827617645264
- O 1 0.9998725652694702
onset O 1 0.9999984502792358
non O 1 0.9999513626098633
- O 1 0.9999980926513672
immune O 1 0.9999995231628418
insulin B-Disease 1 0.9999977350234985
- I-Disease 1 0.9999943971633911
dependent I-Disease 1 0.9999659061431885
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.999797523021698
progressive O 1 0.9999996423721313
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999991655349731
. O 1 0.5448604822158813

Linkage O 0 0.0067080785520374775
to O 0 0.0006163957878015935
markers O 0 0.0010497050825506449
on O 0 0.000314428994897753
chromosome O 0 0.002424146980047226
4p O 1 0.8476444482803345
was O 0 0.0004363811749499291
confirmed O 0 0.00023639126447960734
in O 0 0.00016671681078150868
five O 0 0.00021738538634963334
families O 0 0.0008245265344157815
. O 0 0.0009669832070358098

On O 0 0.0007182399276643991
the O 0 0.00028409212245605886
basis O 0 0.0002091890200972557
of O 0 0.0004171347536612302
meiotic O 1 0.9997448325157166
recombinants O 1 0.9999696016311646
and O 1 0.6147153973579407
disease O 1 0.9999964237213135
- O 1 0.9836134910583496
associated O 0 0.002631408628076315
haplotypes O 0 0.037094030529260635
, O 0 0.00014067716256249696
the O 0 0.00027263243100605905
WFS B-Disease 1 0.9982719421386719
gene O 0 0.00015367429296020418
was O 0 0.00012630151468329132
localized O 0 0.0001730999065330252
to O 0 4.434746006154455e-05
a O 0 0.00014649720105808228
BAC O 1 0.8632466793060303
/ O 0 0.1502416431903839
P1 O 0 0.24977050721645355
contig O 0 0.006310069002211094
of O 0 0.00011407472629798576
less O 0 9.12603791221045e-05
than O 0 0.00010175909119425341
250 O 0 0.0005217543803155422
kb O 0 0.0027118714060634375
. O 0 0.0007227503228932619

Mutations O 0 0.002233104081824422
in O 0 0.0003484147018752992
a O 0 0.0004463380901142955
novel O 0 0.0010009869001805782
gene O 0 0.0004912454169243574
( O 0 0.00032348211971111596
WFS1 O 1 0.8251623511314392
) O 0 9.018005948746577e-05
encoding O 0 7.66518569434993e-05
a O 0 7.411552360281348e-05
putative O 0 0.0004409825196489692
transmembrane O 0 0.0003519173769745976
protein O 0 5.854786650161259e-05
were O 0 1.9628270820248872e-05
found O 0 1.9120310753351077e-05
in O 0 1.613121094123926e-05
all O 0 1.8509690562495962e-05
affected O 0 4.664662992581725e-05
individuals O 0 2.3619648345629685e-05
in O 0 2.7587708245846443e-05
six O 0 0.00020715713617391884
WFS B-Disease 1 0.9995672106742859
families O 0 0.00019983999663963914
, O 0 6.929402297828346e-05
and O 0 3.417619882384315e-05
these O 0 2.732044958975166e-05
mutations O 0 8.357689512195066e-05
were O 0 3.741193359019235e-05
associated O 0 7.726538024144247e-05
with O 0 0.000124034660984762
the O 0 0.029004443436861038
disease O 1 0.999995231628418
phenotype O 1 0.9984884262084961
. O 0 0.003176076104864478

WFS1 O 1 0.9884454011917114
appears O 0 0.0016485409578308463
to O 0 0.0002080671110888943
function O 0 0.00016153950127772987
in O 0 8.285429794341326e-05
survival O 0 0.0013799045700579882
of O 0 0.0003446678165346384
islet O 1 0.9791716933250427
beta O 1 0.8563461899757385
- O 1 0.9186671376228333
cells O 0 0.0046775625087320805
and O 0 0.00020104096620343626
neurons O 0 0.001170737436041236
. O 0 0.0003267558349762112
. O 0 0.0008145036990754306

Stable O 0 0.004686330910772085
interaction O 0 0.0006250886362977326
between O 0 0.00016913328727241606
the O 0 9.867075277725235e-05
products O 0 0.00013677772949449718
of O 0 0.0001154494020738639
the O 0 0.0004198203678242862
BRCA1 O 1 0.9950388073921204
and O 0 0.0025713862851262093
BRCA2 O 1 0.9997997879981995
tumor B-Disease 1 0.9999493360519409
suppressor O 1 0.9610483050346375
genes O 0 0.0003652134328149259
in O 0 0.00028650532476603985
mitotic O 1 0.5308390259742737
and O 0 0.0008204886107705534
meiotic O 1 0.9980053305625916
cells O 0 0.006110441405326128
. O 0 0.0014778240583837032

BRCA1 O 1 0.9983307719230652
and O 0 0.0017175455577671528
BRCA2 O 0 0.3675367832183838
account O 0 0.00022007901861798018
for O 0 6.347357702907175e-05
most O 0 4.122065001865849e-05
cases O 0 6.022048546583392e-05
of O 0 9.688970749266446e-05
familial O 1 0.9598619341850281
, O 0 0.0011930911568924785
early O 0 0.14222979545593262
onset O 1 0.9999978542327881
breast B-Disease 1 0.9999982118606567
and I-Disease 1 0.9050717949867249
/ I-Disease 1 0.9999948740005493
or I-Disease 1 0.9997472167015076
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999983310699463
and O 0 0.0010850044200196862
encode O 0 0.00017381143698003143
products O 0 0.00011686985817505047
that O 0 3.49091824318748e-05
each O 0 5.0983624532818794e-05
interact O 0 0.00017473667685408145
with O 0 0.00026743460330180824
hRAD51 O 0 0.25600185990333557
. O 0 0.0015117134898900986

Results O 0 0.0012481878511607647
presented O 0 0.0006040743319317698
here O 0 0.00024134598788805306
show O 0 0.00021179123723413795
that O 0 0.00010489187116036192
BRCA1 O 1 0.5803912281990051
and O 0 0.00021882860164623708
BRCA2 O 1 0.6856845021247864
coexist O 0 0.00024958470021374524
in O 0 5.688951932825148e-05
a O 0 8.626142516732216e-05
biochemical O 0 0.0003670396108645946
complex O 0 0.000127397506730631
and O 0 6.483213655883446e-05
colocalize O 0 0.37014445662498474
in O 0 0.00013583955296780914
subnuclear O 1 0.8467115163803101
foci O 0 0.010990244336426258
in O 0 8.92543830559589e-05
somatic O 0 0.027859503403306007
cells O 0 0.00015117565635591745
and O 0 4.0444032492814586e-05
on O 0 4.596172220772132e-05
the O 0 8.450056338915601e-05
axial O 0 0.0004444369114935398
elements O 0 0.00020068150479346514
of O 0 0.0002679756726138294
developing O 0 0.0036063380539417267
synaptonemal O 1 0.9900949001312256
complexes O 0 0.03972012549638748
. O 0 0.0014592333463951945

Like O 0 0.009859156794846058
BRCA1 O 1 0.9902753829956055
and O 0 0.0017173313535749912
RAD51 O 1 0.9996354579925537
, O 0 0.001582522178068757
BRCA2 O 1 0.8907501101493835
relocates O 0 0.01758643612265587
to O 0 0.00026991963386535645
PCNA O 1 0.8455051183700562
+ O 0 0.0006931603420525789
replication O 0 0.00028251524781808257
sites O 0 8.135096868500113e-05
following O 0 8.38545456645079e-05
exposure O 0 0.00013707097969017923
of O 0 0.00010089702846016735
S O 0 0.07291761040687561
phase O 0 0.010345694608986378
cells O 0 0.00043281872058287263
to O 0 0.00012362375855445862
hydroxyurea O 0 0.2807992994785309
or O 0 0.0007054836023598909
UV O 1 0.968723714351654
irradiation O 0 0.00893566943705082
. O 0 0.00199725735001266

Thus O 0 0.003727382980287075
, O 0 0.002129410393536091
BRCA1 O 1 0.941752016544342
and O 0 0.000627877947408706
BRCA2 O 0 0.3100661635398865
participate O 0 0.00018988228111993521
, O 0 6.898604624439031e-05
together O 0 4.4014028389938176e-05
, O 0 3.502652907627635e-05
in O 0 2.0531582777039148e-05
a O 0 0.00010737884440459311
pathway O 0 0.043076470494270325
( O 0 0.00012927765783388168
s O 0 0.000558086670935154
) O 0 2.9230561267468147e-05
associated O 0 2.289984331582673e-05
with O 0 1.37685528898146e-05
the O 0 3.640083741629496e-05
activation O 0 9.222092921845615e-05
of O 0 7.781150634400547e-05
double O 0 0.0018292955355718732
- O 0 0.010295042768120766
strand O 0 0.0007808736409060657
break O 0 0.0008104676380753517
repair O 0 0.31215834617614746
and O 0 0.0002313027944182977
/ O 0 0.0028189080767333508
or O 0 0.0004641174746211618
homologous O 0 0.0020559406839311123
recombination O 0 0.003587859682738781
. O 0 0.0015607955865561962

Dysfunction O 1 0.9992604851722717
of O 0 0.0016460809856653214
this O 0 0.00038735830457881093
pathway O 0 0.46525838971138
may O 0 0.00012418544793035835
be O 0 2.338815465918742e-05
a O 0 5.2936880820197985e-05
general O 0 9.962450712919235e-05
phenomenon O 0 9.624035010347143e-05
in O 0 2.336313991690986e-05
the O 0 2.627863250381779e-05
majority O 0 1.9533912563929334e-05
of O 0 2.640735692693852e-05
cases O 0 5.066857920610346e-05
of O 0 0.0004672122304327786
hereditary B-Disease 1 0.9999864101409912
breast I-Disease 1 0.9999994039535522
and I-Disease 1 0.9977300763130188
/ I-Disease 1 0.9999988079071045
or I-Disease 1 0.9999693632125854
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.012173754163086414
. O 0 0.0019506262615323067

A O 0 0.005350762512534857
novel O 0 0.003523457096889615
Arg362Ser O 0 0.3496498763561249
mutation O 0 0.0006683887913823128
in O 0 0.00015573312703054398
the O 0 0.00020896994101349264
sterol O 0 0.003972409293055534
27 O 0 0.0006858187261968851
- O 0 0.04882422089576721
hydroxylase O 0 0.2469986081123352
gene O 0 0.00033138252911157906
( O 0 0.0002690063265617937
CYP27 O 1 0.9079048037528992
) O 0 8.829407306620851e-05
: O 0 5.034458081354387e-05
its O 0 3.493102849461138e-05
effects O 0 0.00011078851821366698
on O 0 6.747928273398429e-05
pre O 0 0.0004962918465025723
- O 0 0.0004920859937556088
mRNA O 0 0.0003354340442456305
splicing O 0 0.000505736272316426
and O 0 0.00019906712986994535
enzyme O 0 0.0005951806087978184
activity O 0 0.0006699429941363633
. O 0 0.0008514474611729383

A O 0 0.00384879088960588
novel O 0 0.0017874875338748097
C O 0 0.0006739557138644159
to O 0 7.387674122583121e-05
A O 0 0.00015513566904701293
mutation O 0 9.843787120189518e-05
in O 0 4.020998312626034e-05
the O 0 6.0017653595423326e-05
sterol O 0 0.0017397673800587654
27 O 0 0.0004426194936968386
- O 0 0.012380373664200306
hydroxylase O 0 0.05564877763390541
gene O 0 0.00024954165564849973
( O 0 0.00016268536273855716
CYP27 O 1 0.5215953588485718
) O 0 6.400114216376096e-05
was O 0 0.00010425894288346171
identified O 0 7.95098312664777e-05
by O 0 5.418648652266711e-05
sequencing O 0 0.00028111031861044466
amplified O 0 0.0008026888244785368
CYP27 O 0 0.4782519042491913
gene O 0 0.00015651006833650172
products O 0 0.00010226502490695566
from O 0 6.108232628321275e-05
a O 0 0.00018697035557124764
patient O 0 0.08853232860565186
with O 0 0.0016678665997460485
cerebrotendinous B-Disease 1 0.9999929666519165
xanthomatosis I-Disease 1 0.9999923706054688
( O 1 0.6157222390174866
CTX B-Disease 1 0.9998370409011841
) O 0 0.0014009104343131185
. O 0 0.001709680538624525

The O 0 0.0017294611316174269
mutation O 0 0.0011290299007669091
changed O 0 0.0004422637866809964
the O 0 0.0002573553938418627
adrenodoxin O 0 0.05822848156094551
cofactor O 0 0.0030840085819363594
binding O 0 0.00019150084699504077
residue O 0 0.0007389498641714454
362Arg O 0 0.004425910767167807
to O 0 0.00018312913016416132
362Ser O 0 0.21409572660923004
( O 0 0.0005623431643471122
CGT O 1 0.7473132014274597
362Arg O 0 0.1735004335641861
to O 0 0.00020035819034092128
AGT O 1 0.9999657869338989
362Ser O 1 0.9936462640762329
) O 0 0.00010342855239287019
, O 0 4.760990850627422e-05
and O 0 3.703721449710429e-05
was O 0 0.00014274890418164432
responsible O 0 0.00022979092318564653
for O 0 0.0001285498437937349
deficiency O 1 0.997952938079834
in O 0 5.303970829118043e-05
the O 0 0.00013004076026845723
sterol O 0 0.33792364597320557
27 O 0 0.0011279195314273238
- O 0 0.06684842705726624
hydroxylase O 0 0.009677709080278873
activity O 0 0.00011042106052627787
, O 0 3.5787266824627295e-05
as O 0 3.26060107909143e-05
confirmed O 0 3.670521982712671e-05
by O 0 2.2751839424017817e-05
expression O 0 5.9683075960492715e-05
of O 0 6.327799201244488e-05
mutant O 0 0.0004458206531126052
cDNA O 0 0.0005805901600979269
into O 0 0.00024025817401707172
COS O 1 0.9894847273826599
- O 0 0.021004723384976387
1 O 0 0.0009608080727048218
cells O 0 0.0015441610012203455
. O 0 0.0009931462118402123

Quantitative O 0 0.0019820439629256725
analysis O 0 0.00040780301787890494
showed O 0 0.000346380373230204
that O 0 5.874528505955823e-05
the O 0 7.0644797233399e-05
expression O 0 0.00011220328451599926
of O 0 0.0001583377452334389
CYP27 O 1 0.9947535991668701
gene O 0 0.00019001014879904687
mRNA O 0 0.00012281352246645838
in O 0 5.228715599514544e-05
the O 0 0.0001013463843264617
patient O 0 0.0006464739562943578
represented O 0 0.0003127660893369466
52 O 0 0.0012543781194835901
. O 0 0.0009066754137165844

5 O 0 0.0015152523992583156
% O 0 0.00046663853572681546
of O 0 0.0003605989913921803
the O 0 0.0004456383176147938
normal O 0 0.0009086229838430882
level O 0 0.0008514220244251192
. O 0 0.001018911600112915

As O 0 0.0008585135219618678
the O 0 0.000370798516087234
mutation O 0 0.0003109560057055205
occurred O 0 0.00021554867271333933
at O 0 9.38688826863654e-05
the O 0 6.444362225010991e-05
penultimate O 0 0.0007050472195260227
nucleotide O 0 0.00011339797492837533
of O 0 6.139714969322085e-05
exon O 0 0.00029583610012196004
6 O 0 9.199721534969285e-05
( O 0 5.497754318639636e-05
- O 0 8.744560182094574e-05
2 O 0 2.952452632598579e-05
position O 0 3.604276935220696e-05
of O 0 4.70377090096008e-05
exon O 0 0.0003554408031050116
6 O 0 0.000173410473507829
- O 0 0.00032942264806479216
intron O 0 0.0014468416338786483
6 O 0 0.00017029761511366814
splice O 0 0.00039653718704357743
site O 0 0.00011578876001294702
) O 0 3.220535290893167e-05
of O 0 2.7707383196684532e-05
the O 0 4.5282678911462426e-05
gene O 0 7.133257167879492e-05
, O 0 3.2487288990523666e-05
we O 0 3.3933145459741354e-05
hypothesized O 0 0.00011013251059921458
that O 0 2.4415874577243812e-05
the O 0 6.075368946767412e-05
mutation O 0 0.0002950969210360199
may O 0 7.599514356115833e-05
partially O 0 0.00014955362712498754
affect O 0 7.005056977504864e-05
the O 0 3.639222995843738e-05
normal O 0 6.239447247935459e-05
splicing O 0 0.0001365444768453017
efficiency O 0 0.0001436769962310791
in O 0 4.85408709209878e-05
exon O 0 0.0004486390098463744
6 O 0 0.00012180629710201174
and O 0 6.824229785706848e-05
cause O 0 0.00016044481890276074
alternative O 0 7.656551315449178e-05
splicing O 0 0.00015157619782257825
elsewhere O 0 5.2173094445606694e-05
, O 0 2.992235022247769e-05
which O 0 1.8818029275280423e-05
resulted O 0 5.97747894062195e-05
in O 0 4.174126297584735e-05
decreased O 0 0.0002195293054683134
transcript O 0 0.00020709805539809167
in O 0 9.738935477798805e-05
the O 0 0.0002864373382180929
patient O 0 0.03396270424127579
. O 0 0.0011239508166909218

Transfection O 0 0.2163253128528595
of O 0 0.0011385350953787565
constructed O 0 0.009235563687980175
minigenes O 1 0.7526172399520874
, O 0 0.00012665656686294824
with O 0 4.96671927976422e-05
or O 0 3.994748476543464e-05
without O 0 3.5801025660475716e-05
the O 0 3.621431460487656e-05
mutation O 0 6.397892138920724e-05
, O 0 4.488952981773764e-05
into O 0 0.00010453081631567329
COS O 1 0.9986764788627625
- O 0 0.031333934515714645
1 O 0 0.00013688970648217946
cells O 0 8.100910054054111e-05
confirmed O 0 3.259363802499138e-05
that O 0 1.5783132766955532e-05
the O 0 4.909729250357486e-05
mutant O 0 0.009885119274258614
minigene O 1 0.7290030121803284
was O 0 0.00022656393412034959
responsible O 0 0.0001307081984123215
for O 0 4.079124846612103e-05
a O 0 7.895570888649672e-05
mRNA O 0 0.00011246967915212736
species O 0 2.6753614292829297e-05
alternatively O 0 7.849549729144201e-05
spliced O 0 0.0001383283088216558
at O 0 7.577096403110772e-05
an O 0 6.448241038015112e-05
activated O 0 0.0004191347979940474
cryptic O 0 0.00025989115238189697
5 O 0 0.00010266064782626927
splice O 0 0.00028172231395728886
site O 0 0.00014902252587489784
88 O 0 0.00019004131900146604
bp O 0 0.00025731511414051056
upstream O 0 0.00011702976917149499
from O 0 2.5520181225147098e-05
the O 0 3.886563717969693e-05
3 O 0 5.9105135733261704e-05
end O 0 9.627210238249972e-05
of O 0 0.00012724501721095294
exon O 0 0.00151516729965806
6 O 0 0.0008640065207146108
. O 0 0.0009035308030433953

Our O 0 0.0014427126152440906
data O 0 0.00025280710542574525
suggest O 0 0.00013882476196158677
that O 0 4.250811252859421e-05
the O 0 6.174309237394482e-05
C O 0 0.00014684518100693822
to O 0 3.775594086619094e-05
A O 0 8.814836473902687e-05
mutation O 0 9.19062877073884e-05
at O 0 6.958132871659473e-05
the O 0 6.416932592401281e-05
penultimate O 0 0.0006736358627676964
nucleotide O 0 0.00010159001249121502
of O 0 5.815700569655746e-05
exon O 0 0.00023724565107841045
6 O 0 7.034262671368197e-05
of O 0 5.24562674399931e-05
the O 0 9.133054845733568e-05
CYP27 O 1 0.9960278272628784
gene O 0 0.00010409037349745631
not O 0 2.3449367290595546e-05
only O 0 3.622720032581128e-05
causes O 0 0.0005065111326985061
the O 0 0.00010389243834652007
deficiency B-Disease 1 0.9987010955810547
in I-Disease 0 3.928866863134317e-05
the I-Disease 0 9.051123197423294e-05
sterol I-Disease 0 0.30493947863578796
27 I-Disease 0 0.0036882103886455297
- I-Disease 0 0.34976330399513245
hydroxylase I-Disease 0 0.1947942078113556
activity I-Disease 0 0.00011690707469824702
, O 0 4.478101618587971e-05
but O 0 2.76121045317268e-05
also O 0 4.464852827368304e-05
partially O 0 0.00013430432591121644
leads O 0 9.437815606361255e-05
to O 0 4.239872214384377e-05
alternative O 0 0.00012361032713670284
pre O 0 0.00031966008828021586
- O 0 0.00027414478245191276
mRNA O 0 0.00017091268091462553
splicing O 0 0.00025084023945964873
of O 0 0.00010617230145726353
the O 0 0.000298714468954131
gene O 0 0.0005742184002883732
. O 0 0.0007201129337772727

To O 0 0.0008468964952044189
our O 0 0.0005220702732913196
knowledge O 0 0.00036556244594976306
, O 0 0.00011905161227332428
this O 0 3.494695192785002e-05
is O 0 3.1914965802570805e-05
the O 0 4.2356572521384805e-05
first O 0 6.383729487424716e-05
report O 0 3.941983595723286e-05
regarding O 0 5.331186912371777e-05
effects O 0 6.605416274396703e-05
on O 0 3.315919093438424e-05
pre O 0 0.00018004377488978207
- O 0 0.00015822003479115665
mRNA O 0 8.913232886698097e-05
splicing O 0 7.186780567280948e-05
of O 0 2.8614376788027585e-05
a O 0 4.782245014212094e-05
mutation O 0 5.8053556131199e-05
at O 0 3.641204966697842e-05
the O 0 4.881884524365887e-05
- O 0 0.00013033795403316617
2 O 0 6.001387373544276e-05
position O 0 6.310072058113292e-05
of O 0 8.923684799810871e-05
a O 0 0.0001577791990712285
5 O 0 0.0003488296642899513
splice O 0 0.0022712810896337032
site O 0 0.0013760895235463977
. O 0 0.0011197819840162992

ATM O 0 0.06292574852705002
germline O 0 0.2782989740371704
mutations O 0 0.001883635763078928
in O 0 0.0006358292885124683
classical O 0 0.24369555711746216
ataxia B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999749660491943
telangiectasia I-Disease 1 0.9999970197677612
patients O 1 0.9690601229667664
in O 0 0.00033342750975862145
the O 0 0.0006568302633240819
Dutch O 0 0.007488008588552475
population O 0 0.000623139610979706
. O 0 0.0009117988520301878

Germline O 0 0.48713362216949463
mutations O 0 0.0012625963427126408
in O 0 0.00022135495964903384
the O 0 0.00014677799481432885
ATM O 0 0.0006129681132733822
gene O 0 7.652346539543942e-05
are O 0 1.524578510725405e-05
responsible O 0 8.984650048660114e-05
for O 0 5.2007435442646965e-05
the O 0 0.10623832046985626
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 1 0.9999521970748901
A B-Disease 1 0.9999940395355225
- I-Disease 1 0.999990701675415
T I-Disease 1 0.9999188184738159
) O 0 0.0008264379575848579
. O 0 0.00117012532427907

In O 0 0.0005793077289126813
our O 0 0.0002962699218187481
study O 0 0.00010222242417512462
, O 0 5.248578600003384e-05
we O 0 3.803797153523192e-05
have O 0 1.5983714547473937e-05
determined O 0 4.438553878571838e-05
the O 0 5.331502325134352e-05
ATM O 0 0.00022260792320594192
mutation O 0 8.84749460965395e-05
spectrum O 0 5.8601261116564274e-05
in O 0 2.150712680304423e-05
19 O 0 7.14474226697348e-05
classical O 0 0.00018347991863265634
A B-Disease 1 0.974492073059082
- I-Disease 1 0.999945878982544
T I-Disease 1 0.9999849796295166
patients O 0 0.060202982276678085
, O 0 3.19491300615482e-05
including O 0 1.8906639525084756e-05
some O 0 1.7040487364283763e-05
immigrant O 0 0.00010682489664759487
populations O 0 3.588890831451863e-05
, O 0 2.5944087610696442e-05
as O 0 2.3783697542967275e-05
well O 0 2.416103961877525e-05
as O 0 3.7375059037003666e-05
12 O 0 7.328482024604455e-05
of O 0 0.00012562971096485853
Dutch O 0 0.00038427760591730475
ethnic O 0 0.0003431808727327734
origin O 0 0.00046777506940998137
. O 0 0.0008564121089875698

Both O 0 0.0007085945107974112
the O 0 0.00036703294608742
protein O 0 0.00034607472480274737
truncation O 0 0.0020156078971922398
test O 0 0.0002499733818694949
( O 0 0.00012987518857698888
PTT O 0 0.0006566769443452358
) O 0 4.905891546513885e-05
and O 0 3.154604200972244e-05
the O 0 5.3121613746043295e-05
restriction O 0 0.00013090042921248823
endonuclease O 0 0.0022882770281285048
fingerprinting O 0 0.0013100584037601948
( O 0 0.0002909936010837555
REF O 0 0.20404697954654694
) O 0 4.774926492245868e-05
method O 0 3.769898466998711e-05
were O 0 2.00317008420825e-05
used O 0 1.3077899893687572e-05
and O 0 1.388739747198997e-05
compared O 0 1.7161743016913533e-05
for O 0 1.2754967428918462e-05
their O 0 1.568039442645386e-05
detection O 0 8.321663335664198e-05
efficiency O 0 9.247771959053352e-05
, O 0 2.895199395425152e-05
identifying O 0 5.9971996961394325e-05
76 O 0 7.370814273599535e-05
% O 0 2.4078923161141574e-05
and O 0 2.2238416931941174e-05
60 O 0 3.944657510146499e-05
% O 0 3.033462053281255e-05
of O 0 4.5643653720617294e-05
the O 0 8.742477075429633e-05
mutations O 0 0.00018896909023169428
, O 0 0.00014010768791195005
respectively O 0 0.0004070675349794328
. O 0 0.000755318149458617

Most O 0 0.001469475100748241
patients O 0 0.00714977877214551
were O 0 0.0002163566678063944
found O 0 0.00020071689505130053
to O 0 0.00014961625856813043
be O 0 0.00023929617600515485
compound O 0 0.005722590256482363
heterozygote O 0 0.22294563055038452
. O 0 0.002010570839047432

Seventeen O 0 0.005389516241848469
mutations O 0 0.001045769895426929
were O 0 0.00019046560919377953
distinct O 0 0.0001269179629161954
, O 0 7.707007171120495e-05
of O 0 5.625782432616688e-05
which O 0 2.8724531148327515e-05
10 O 0 3.991305857198313e-05
were O 0 3.819820994976908e-05
not O 0 5.3490715799853206e-05
reported O 0 0.00020540175319183618
previously O 0 0.0004994414630346
. O 0 0.0005914357607252896

Mutations O 0 0.0022465332876890898
are O 0 0.00021529071091208607
small O 0 0.00020427480922080576
deletions O 0 0.0007381242467090487
or O 0 0.0001637406530790031
point O 0 0.00026765477377921343
mutations O 0 0.000364111881935969
frequently O 0 0.00033361633541062474
affecting O 0 0.0008057265658862889
splice O 0 0.003015191527083516
sites O 0 0.0011303148930892348
. O 0 0.0012445533648133278

Moreover O 0 0.0053850398398935795
, O 0 0.0009511482203379273
a O 0 0.001421594526618719
16 O 0 0.0016473437426611781
. O 0 0.0019381551537662745

7 O 0 0.003856044728308916
- O 0 0.0026461519300937653
kb O 0 0.002102624624967575
genomic O 0 0.0006393952062353492
deletion O 0 0.0004310309886932373
of O 0 8.372726733796299e-05
the O 0 8.640071609988809e-05
3 O 0 7.244876906042919e-05
end O 0 6.76306735840626e-05
of O 0 3.7827587220817804e-05
the O 0 5.234892887528986e-05
gene O 0 4.604639616445638e-05
, O 0 2.0842177036684006e-05
most O 0 1.1374461792001966e-05
likely O 0 2.0299356037867256e-05
a O 0 3.374031075509265e-05
result O 0 2.3998825781745836e-05
of O 0 3.0214372600312345e-05
recombination O 0 0.00012352655176073313
between O 0 3.8017158658476546e-05
two O 0 3.604473022278398e-05
LINE O 0 0.00024062748707365245
elements O 0 0.00010647668386809528
, O 0 8.580266148783267e-05
was O 0 0.0003905193880200386
identified O 0 0.0006217565387487411
. O 0 0.0007094459724612534

The O 0 0.0008652040269225836
most O 0 0.00023622070148121566
frequently O 0 0.0001951401645783335
found O 0 0.00011878320947289467
mutation O 0 0.00019648928719107062
, O 0 4.027737304568291e-05
identified O 0 3.637165355030447e-05
in O 0 2.5101162464125082e-05
three O 0 3.089722304139286e-05
unrelated O 0 0.00015368603635579348
Turkish O 0 0.0010910596465691924
A B-Disease 1 0.9957407712936401
- I-Disease 1 0.9999052286148071
T I-Disease 1 0.9998219609260559
individuals O 0 5.6586144637549296e-05
, O 0 5.5865628382889554e-05
was O 0 0.00010891143756452948
previously O 0 5.778297418146394e-05
described O 0 5.4115742386784405e-05
to O 0 1.999957748921588e-05
be O 0 1.927249104483053e-05
a O 0 7.297149568330497e-05
Turkish O 0 0.0002351156435906887
A B-Disease 0 0.2164878100156784
- I-Disease 1 0.9917437434196472
T I-Disease 1 0.9992610812187195
founder O 1 0.7151337265968323
mutation O 0 0.004729044158011675
. O 0 0.0013492036378011107

The O 0 0.0007165727438405156
presence O 0 0.0004828764358535409
of O 0 0.000193026804481633
a O 0 0.00028538971673697233
founder O 1 0.53885418176651
mutation O 0 0.0009198301704600453
among O 0 6.118603778304532e-05
relatively O 0 4.7861500206636265e-05
small O 0 2.3797447283868678e-05
ethnic O 0 2.636696990521159e-05
population O 0 1.5415305824717507e-05
groups O 0 1.1398937203921378e-05
in O 0 1.8076574633596465e-05
Western O 0 5.287386375130154e-05
Europe O 0 4.9484329792903736e-05
could O 0 3.716699211508967e-05
indicate O 0 6.521136674564332e-05
a O 0 8.205560152418911e-05
high O 0 0.00013923122605774552
carrier O 0 0.0002767984406091273
frequency O 0 7.293441740330309e-05
in O 0 6.670233415206894e-05
such O 0 0.00012105665518902242
communities O 0 0.00032453142921440303
. O 0 0.0007176439394243062

In O 0 0.00113257288467139
patients O 0 0.003127165138721466
of O 0 0.0002369289577472955
Dutch O 0 0.000589506234973669
ethnic O 0 0.00015094404807314277
origin O 0 0.00010194072092417628
, O 0 8.092494681477547e-05
however O 0 4.13870693591889e-05
, O 0 3.0046938263694756e-05
no O 0 4.1594237700337544e-05
significant O 0 6.894487887620926e-05
founder O 0 0.003125533228740096
effect O 0 0.0001378800516249612
could O 0 7.584998820675537e-05
be O 0 9.40784957492724e-05
identified O 0 0.00043777943938039243
. O 0 0.0005955494707450271

The O 0 0.0015167318051680923
observed O 0 0.0007717468542978168
genetic O 0 0.0005305350641719997
heterogeneity O 0 0.0006537500885315239
including O 0 0.00011727284436346963
the O 0 7.626862498000264e-05
relative O 0 0.00012768441229127347
high O 0 9.835456148721278e-05
percentage O 0 8.298017928609625e-05
of O 0 7.725624163867906e-05
splice O 0 0.013517020270228386
- O 0 0.004473784472793341
site O 0 0.00018469365022610873
mutations O 0 0.00011555988021427765
had O 0 7.85366864874959e-05
no O 0 8.363572123926133e-05
reflection O 0 0.0003964837233070284
on O 0 0.00019339047139510512
the O 0 0.0004157911171205342
phenotype O 0 0.008846761658787727
. O 0 0.001425349386408925

All O 0 0.0017491074977442622
patients O 0 0.1953357756137848
manifested O 0 0.09897346794605255
classical O 0 0.002416306873783469
A B-Disease 1 0.9985430240631104
- I-Disease 1 0.9998666048049927
T I-Disease 1 0.9995978474617004
and O 0 0.0002817707136273384
increased O 0 0.00035107461735606194
cellular O 0 0.001527685672044754
radioresistant O 0 0.2669314444065094
DNA O 0 0.0009974412387236953
synthesis O 0 0.0016384308692067862
. O 0 0.0011330745182931423

Determination O 0 0.003690562676638365
of O 0 0.0006254179170355201
the O 0 0.0003710385935846716
genomic O 0 0.0004616320366039872
structure O 0 0.00022399824229069054
of O 0 0.00015484189498238266
the O 0 0.00026057547074742615
COL4A4 O 1 0.9986394047737122
gene O 0 0.00019036993035115302
and O 0 6.184532685438171e-05
of O 0 0.00016545498510822654
novel O 1 0.6255698204040527
mutations O 1 0.9945966005325317
causing O 1 0.9999765157699585
autosomal B-Disease 1 0.9999991655349731
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9944120049476624

Autosomal B-Disease 1 0.9999972581863403
recessive I-Disease 1 0.9999997615814209
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9680702090263367
a O 1 0.9965285658836365
progressive O 1 0.9999988079071045
hematuric B-Disease 1 0.9999997615814209
glomerulonephritis I-Disease 1 0.9999998807907104
characterized O 1 0.9998385906219482
by O 1 0.5673168301582336
glomerular B-Disease 1 0.9999990463256836
basement I-Disease 1 0.9999936819076538
membrane I-Disease 1 0.9997488856315613
abnormalities I-Disease 1 0.9998785257339478
and O 0 0.00021041047875769436
associated O 0 8.274659921880811e-05
with O 0 3.239819125155918e-05
mutations O 0 4.4563326810020953e-05
in O 0 1.783652805897873e-05
either O 0 2.7473317459225655e-05
the O 0 4.9255704652750865e-05
COL4A3 O 1 0.9770166277885437
or O 0 5.8798475947696716e-05
the O 0 9.280493395635858e-05
COL4A4 O 1 0.9967347979545593
gene O 0 9.690042497823015e-05
, O 0 3.168950934195891e-05
which O 0 1.5067134881974198e-05
encode O 0 4.2530737118795514e-05
the O 0 3.791773269767873e-05
alpha3 O 0 0.030809791758656502
and O 0 0.0001812647096812725
alpha4 O 1 0.9978062510490417
type O 1 0.967560350894928
IV O 1 0.9999910593032837
collagen O 1 0.9999154806137085
chains O 0 0.01538962870836258
, O 0 0.0003754344070330262
respectively O 0 0.000705511134583503
. O 0 0.0005913531640544534

To O 0 0.0006717234500683844
date O 0 0.00042233997373841703
, O 0 0.00017097040836233646
mutation O 0 0.00024280026264023036
screening O 0 0.00010588012810330838
in O 0 2.635326745803468e-05
the O 0 3.6476449167821556e-05
two O 0 2.596257945697289e-05
genes O 0 4.9694768676999956e-05
has O 0 4.311207158025354e-05
been O 0 5.16523105034139e-05
hampered O 0 0.0031373384408652782
by O 0 5.0256701797479764e-05
the O 0 7.577494397992268e-05
lack O 0 0.00020279658201616257
of O 0 0.00019107406842522323
genomic O 0 0.0007785588386468589
structure O 0 0.0008158273412846029
information O 0 0.0005078662652522326
. O 0 0.0011510706972330809

We O 0 0.0009623858495615423
report O 0 0.0003495853452477604
here O 0 0.00016952402074821293
the O 0 0.00011019155499525368
complete O 0 0.0001586269645486027
characterization O 0 0.0001811501570045948
of O 0 5.931302803219296e-05
the O 0 6.561745976796374e-05
48 O 0 0.00011673242261167616
exons O 0 0.00022888784587848932
of O 0 6.756968650734052e-05
the O 0 0.00012567310477606952
COL4A4 O 1 0.9956896901130676
gene O 0 0.00016122771194204688
, O 0 4.740661825053394e-05
a O 0 8.193378016585484e-05
comprehensive O 0 0.000285404414171353
gene O 0 0.00011368683044565842
screen O 0 9.383614087710157e-05
, O 0 3.1971256248652935e-05
and O 0 1.956581400008872e-05
the O 0 2.4447190298815258e-05
subsequent O 0 5.4576623369939625e-05
detection O 0 0.00010388420923845842
of O 0 5.824036998092197e-05
10 O 0 6.481828313553706e-05
novel O 0 0.00016013912681955844
mutations O 0 9.853891970124096e-05
in O 0 7.24042984074913e-05
eight O 0 0.0057474421337246895
patients O 1 0.9999396800994873
diagnosed O 1 0.9999996423721313
with O 1 0.9994010925292969
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9978011250495911

Furthermore O 0 0.0027918291743844748
, O 0 0.00039303983794525266
we O 0 0.00011298446770524606
identified O 0 0.00011154665844514966
a O 0 0.00013068717089481652
glycine O 0 0.0002446334110572934
to O 0 6.464964098995551e-05
alanine O 0 0.000361436337698251
substitution O 0 0.00016186048742383718
in O 0 4.594717393047176e-05
the O 0 0.00010905382077908143
collagenous O 1 0.7186590433120728
domain O 0 7.795268902555108e-05
that O 0 3.156891398248263e-05
is O 0 4.062725929543376e-05
apparently O 0 9.455616236664355e-05
silent O 0 0.00016614868945907801
in O 0 2.8905677027069032e-05
the O 0 7.124419062165543e-05
heterozygous O 0 0.00017966704035643488
carriers O 0 0.00013953026791568846
, O 0 6.220963405212387e-05
in O 0 0.00010773698886623606
11 O 0 0.00047270054346881807
. O 0 0.0007889831904321909

5 O 0 0.0006562896305695176
% O 0 0.00015838681429158896
of O 0 9.517928265267983e-05
all O 0 4.303012974560261e-05
control O 0 7.778775761835277e-05
individuals O 0 3.085258504142985e-05
, O 0 2.73673576884903e-05
and O 0 2.9875332984374836e-05
in O 0 2.1546336938627064e-05
one O 0 3.132844722131267e-05
control O 0 7.515834295190871e-05
individual O 0 6.75517730996944e-05
homozygous O 0 0.00017804042727220803
for O 0 5.855210838490166e-05
this O 0 0.0001025202582241036
glycine O 0 0.0011966548627242446
substitution O 0 0.001767397508956492
. O 0 0.0011652907123789191

There O 0 0.0006657745689153671
has O 0 0.00025281941634602845
been O 0 0.00010725808533607051
no O 0 5.146375042386353e-05
previous O 0 4.220919799990952e-05
finding O 0 5.2630384743679315e-05
of O 0 5.4779295169282705e-05
a O 0 7.176589133450761e-05
glycine O 0 0.00035143326385878026
substitution O 0 0.0001388683303957805
that O 0 2.7850965125253424e-05
is O 0 2.6676822017179802e-05
not O 0 1.761273233569227e-05
associated O 0 3.223752719350159e-05
with O 0 2.961866084660869e-05
any O 0 5.94050798099488e-05
obvious O 0 0.0006378084653988481
phenotype O 0 0.005175556521862745
in O 0 0.000189736791071482
homozygous O 0 0.002921892097219825
individuals O 0 0.0005701531772501767
. O 0 0.001233278657309711

Founder O 1 0.994720458984375
BRCA1 O 1 0.9987478256225586
and O 0 0.003310134168714285
BRCA2 O 1 0.9865559339523315
mutations O 0 0.0010034042643383145
in O 0 0.0002590254007373005
French O 0 0.14724256098270416
Canadian O 1 0.997190535068512
breast B-Disease 1 0.9999997615814209
and I-Disease 1 0.9998887777328491
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 1 0.9195787310600281
. O 0 0.04371548071503639

We O 0 0.0006035258411429822
have O 0 0.00011411477316869423
identified O 0 0.00011027953587472439
four O 0 7.608818123117089e-05
mutations O 0 6.82592872180976e-05
in O 0 2.4347793441847898e-05
each O 0 1.8939899746328592e-05
of O 0 6.753471097908914e-05
the O 0 0.04447544366121292
breast B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999997615814209
- O 1 0.9999622106552124
susceptibility O 1 0.999482274055481
genes O 0 0.0033802103716880083
, O 0 0.001516427262686193
BRCA1 O 1 0.986711323261261
and O 0 0.00017778969777282327
BRCA2 O 0 0.219207763671875
, O 0 4.936183540849015e-05
in O 0 4.5379510993370786e-05
French O 0 0.0027251136489212513
Canadian O 1 0.8254969716072083
breast B-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999995231628418
and O 1 0.9998815059661865
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
families O 0 0.41644883155822754
from O 0 0.016827376559376717
Quebec O 1 0.794281005859375
. O 0 0.0018758258083835244

To O 0 0.0007734324899502099
identify O 0 0.000905283959582448
founder O 0 0.06248888000845909
effects O 0 0.002262930618599057
, O 0 0.00012131112453062087
we O 0 8.004051051102579e-05
examined O 0 0.00018890170031227171
independently O 0 0.00010280249261995777
ascertained O 0 0.0005775423487648368
French O 0 0.0005083188298158348
Canadian O 0 0.001886079553514719
cancer B-Disease 1 0.7414385676383972
families O 0 0.0001070369835360907
for O 0 4.597321094479412e-05
the O 0 4.984123006579466e-05
distribution O 0 4.9528000090504065e-05
of O 0 7.709389319643378e-05
these O 0 6.87067731632851e-05
eight O 0 0.00027837257948704064
mutations O 0 0.0008504863362759352
. O 0 0.0009848431218415499

Mutations O 0 0.0013896728632971644
were O 0 0.00019221246475353837
found O 0 9.996767767006531e-05
in O 0 7.278621342265978e-05
41 O 0 0.00019476634042803198
of O 0 0.00022910794359631836
97 O 0 0.0015214895829558372
families O 0 0.000973937101662159
. O 0 0.000971543719060719

Six O 0 0.001052842359058559
of O 0 0.0004440458142198622
eight O 0 0.0003189569106325507
mutations O 0 0.00018816556257661432
were O 0 8.208658255171031e-05
observed O 0 0.0001319058210356161
at O 0 0.00013440630573313683
least O 0 0.00016049100668169558
twice O 0 0.0005266213556751609
. O 0 0.0008505616569891572

The O 0 0.005219274200499058
BRCA1 O 1 0.9991351962089539
C4446T O 1 0.9971714615821838
mutation O 0 0.0020915900822728872
was O 0 0.00033540220465511084
the O 0 7.060311327222735e-05
most O 0 3.781099439947866e-05
common O 0 6.520452006952837e-05
mutation O 0 9.817089448915794e-05
found O 0 3.054956687265076e-05
, O 0 3.954254134441726e-05
followed O 0 0.00010471817222423851
by O 0 7.354125409619883e-05
the O 0 0.0002786596305668354
BRCA2 O 1 0.994183361530304
8765delAG O 1 0.9888595342636108
mutation O 0 0.008163311518728733
. O 0 0.0015130534302443266

Together O 0 0.0013315335381776094
, O 0 0.0002504526637494564
these O 0 5.690813486580737e-05
mutations O 0 7.598689262522385e-05
were O 0 2.8968566766707227e-05
found O 0 2.4248061890830286e-05
in O 0 1.7929340174305253e-05
28 O 0 5.1097715186188e-05
of O 0 3.983267743024044e-05
41 O 0 9.58730379352346e-05
families O 0 4.751474261865951e-05
identified O 0 4.520519360085018e-05
to O 0 3.145951995975338e-05
have O 0 6.002371446811594e-05
a O 0 0.00025362844462506473
mutation O 0 0.0009139498579315841
. O 0 0.0009395418455824256

The O 0 0.001170314266346395
odds O 0 0.0011131677310913801
of O 0 0.0002627724315971136
detection O 0 0.0003214221214875579
of O 0 6.589423719560727e-05
any O 0 3.781143095693551e-05
of O 0 5.1306993555044755e-05
the O 0 8.3896768046543e-05
four O 0 0.00018290485604666173
BRCA1 O 1 0.9202247858047485
mutations O 0 0.0003793184005189687
was O 0 0.0005032290937379003
18 O 0 0.0006428101332858205
. O 0 0.0007323570898734033

7x O 1 0.9577873349189758
greater O 0 0.0007669985061511397
if O 0 0.00012903872993774712
one O 0 6.044221663614735e-05
or O 0 3.863585880026221e-05
more O 0 2.6247949790558778e-05
cases O 0 0.00013868809037376195
of O 1 0.9016004800796509
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999984502792358
were O 0 0.0005286966334097087
also O 0 7.863658538553864e-05
present O 0 9.677704656496644e-05
in O 0 8.023798727663234e-05
the O 0 0.00018140771135222167
family O 0 0.0007400005124509335
. O 0 0.0007177218794822693

The O 0 0.0010170616442337632
odds O 0 0.0011238683946430683
of O 0 0.00026438754866831005
detection O 0 0.00041312346002086997
of O 0 8.947219612309709e-05
any O 0 5.668660014634952e-05
of O 0 6.599415792152286e-05
the O 0 0.00010575701162451878
four O 0 0.0002886802249122411
BRCA2 O 1 0.7458664774894714
mutations O 0 0.00040345671004615724
was O 0 0.0005173198296688497
5 O 0 0.0006887737545184791
. O 0 0.0009163817740045488

3x O 0 0.1966395080089569
greater O 0 0.0007635428919456899
if O 0 0.0001400694891344756
there O 0 4.1186191083397716e-05
were O 0 2.6698762667365372e-05
at O 0 4.1723429603734985e-05
least O 0 2.96429298032308e-05
five O 0 3.2934050977928564e-05
cases O 0 5.1424114644760266e-05
of O 0 0.0009465713519603014
breast B-Disease 1 0.9999938011169434
cancer I-Disease 1 0.9998549222946167
in O 0 0.0002782704250421375
the O 0 0.0006508028600364923
family O 0 0.005637603346258402
. O 0 0.0011540035484358668

Interestingly O 0 0.0036098200362175703
, O 0 0.0005331051652319729
the O 0 0.00021246637334115803
presence O 0 0.00022494079894386232
of O 0 0.00022847966465633363
a O 0 0.37210434675216675
breast B-Disease 1 0.9999980926513672
cancer I-Disease 1 0.9999532699584961
case O 0 0.05819164961576462
< O 0 0.05601979419589043
36 O 0 9.877788397716358e-05
years O 0 3.9386432035826147e-05
of O 0 5.039938696427271e-05
age O 0 0.00011560495477169752
was O 0 0.0001055185857694596
strongly O 0 3.719731466844678e-05
predictive O 0 6.360287079587579e-05
of O 0 2.6281139071215875e-05
the O 0 3.320966425235383e-05
presence O 0 4.451423228601925e-05
of O 0 3.452661258052103e-05
any O 0 3.0080625947448425e-05
of O 0 5.024739948567003e-05
the O 0 0.00012675818288698792
eight O 0 0.0002543433220125735
mutations O 0 0.0006732771289534867
screened O 0 0.0015576034784317017
. O 0 0.000886102847289294

Carriers O 0 0.0023462946992367506
of O 0 0.0002965601743198931
the O 0 0.00015011914365459234
same O 0 8.371951116714627e-05
mutation O 0 0.0001299793948419392
, O 0 3.197601472493261e-05
from O 0 1.8578233721200377e-05
different O 0 1.0292576007486787e-05
families O 0 2.4642427888466045e-05
, O 0 2.2593956600758247e-05
shared O 0 4.272175647201948e-05
similar O 0 4.2058520193677396e-05
haplotypes O 0 0.00025869710952974856
, O 0 4.5404016418615356e-05
indicating O 0 9.393882646691054e-05
that O 0 2.681742080312688e-05
the O 0 5.012464680476114e-05
mutant O 0 0.001179701997898519
alleles O 0 0.0001206411252496764
were O 0 3.133460631943308e-05
likely O 0 3.625153112807311e-05
to O 0 1.5654459275538102e-05
be O 0 1.4156651559460443e-05
identical O 0 3.0481060093734413e-05
by O 0 1.926879667735193e-05
descent O 0 7.868421380408108e-05
for O 0 2.532994403736666e-05
a O 0 6.425836181733757e-05
mutation O 0 0.00012793582573067397
in O 0 5.060184048488736e-05
the O 0 0.00015142351912800223
founder O 0 0.01070914976298809
population O 0 0.00036869029281660914
. O 0 0.0008035011123865843

The O 0 0.001117543550208211
identification O 0 0.000762785435654223
of O 0 0.0005580348079092801
common O 0 0.005470043048262596
BRCA1 O 1 0.9988774657249451
and O 0 0.0011090406915172935
BRCA2 O 1 0.9717075228691101
mutations O 0 0.0002885563881136477
will O 0 5.358863927540369e-05
facilitate O 0 0.00012339647219050676
carrier O 0 0.0003361596609465778
detection O 0 0.00011600891593843699
in O 0 4.7158529923763126e-05
French O 0 0.0012292390456423163
Canadian O 1 0.7985331416130066
breast B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999997615814209
and O 1 0.9999300241470337
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 1 0.9593348503112793
. O 0 0.027225714176893234

Are O 0 0.0017039994709193707
Dp71 O 1 0.9701205492019653
and O 0 0.0030738189816474915
Dp140 O 1 0.9995458722114563
brain O 1 0.996563732624054
dystrophin O 1 0.9624510407447815
isoforms O 0 0.0007283827289938927
related O 0 0.0004312923410907388
to O 0 0.0003181438660249114
cognitive B-Disease 1 0.999049723148346
impairment I-Disease 1 0.9999942779541016
in O 1 0.9973840117454529
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9998431205749512

Molecular O 0 0.002890353323891759
study O 0 0.0006219918141141534
and O 0 0.0002628095098771155
neuropsychological O 0 0.0011395951732993126
analysis O 0 7.917314360383898e-05
were O 0 4.7293553507188335e-05
performed O 0 8.869001612765715e-05
concurrently O 0 0.00012460774451028556
on O 0 8.206812344724312e-05
49 O 0 0.0013165290001779795
patients O 1 0.972481369972229
with O 1 0.9399144649505615
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999932050704956
DMD B-Disease 1 1.0
) O 0 0.0006699685472995043
in O 0 7.786583591951057e-05
order O 0 4.228574471198954e-05
to O 0 1.902811709442176e-05
find O 0 4.1938645154004917e-05
a O 0 6.27063782303594e-05
molecular O 0 7.845884101698175e-05
explanation O 0 8.728348620934412e-05
for O 0 4.689846537075937e-05
the O 0 0.00015007689944468439
cognitive B-Disease 0 0.31863775849342346
impairment I-Disease 1 0.9788122773170471
observed O 0 0.000259709864621982
in O 0 0.00025190290762111545
most O 0 0.0015797046944499016
DMD B-Disease 1 0.9999940395355225
patients O 1 0.9635211825370789
. O 0 0.0019576894119381905

Complete O 0 0.0014902991242706776
analysis O 0 0.00027158617740496993
of O 0 0.00018833877402357757
the O 0 0.0002321410138392821
dystrophin O 1 0.984886109828949
gene O 0 0.00024279378703795373
was O 0 0.0001405095827067271
performed O 0 7.473482401110232e-05
to O 0 2.1122552425367758e-05
define O 0 5.117418186273426e-05
the O 0 4.838475433643907e-05
localization O 0 0.00023348220565821975
of O 0 7.169455784605816e-05
deletions O 0 0.0003251635062042624
and O 0 4.4501241063699126e-05
duplications O 0 0.0002811545564327389
in O 0 4.038244514958933e-05
relation O 0 9.607418905943632e-05
to O 0 4.115187766728923e-05
the O 0 0.00013577585923485458
different O 0 0.0002762914227787405
DMD B-Disease 1 0.9997336268424988
promoters O 0 0.1223805770277977
. O 0 0.002127304207533598

Qualitative O 0 0.001845850725658238
analysis O 0 0.0003350190818309784
of O 0 0.0001778585574356839
the O 0 0.0002537085092626512
Dp71 O 1 0.8776496648788452
transcript O 0 0.0004837159940507263
and O 0 7.953288150019944e-05
testing O 0 9.017069533001631e-05
for O 0 2.2528636691276915e-05
the O 0 3.387643664609641e-05
specific O 0 2.8640642995014787e-05
first O 0 7.630718755535781e-05
exon O 0 0.00045523230801336467
of O 0 0.00018864522280637175
Dp140 O 0 0.01802772656083107
were O 0 0.00011416091001592577
also O 0 0.00013358982687350363
carried O 0 0.000265308452071622
out O 0 0.0003994637809228152
. O 0 0.0010386052308604121

Neuropsychological O 0 0.0569634884595871
analysis O 0 0.000931643124204129
assessed O 0 0.0010717010591179132
verbal O 0 0.001389249344356358
and O 0 0.0003659285430330783
visuospatial O 1 0.7555176615715027
intelligence O 0 0.0005797128542326391
, O 0 0.00020424011745490134
verbal O 0 0.0036390647292137146
memory O 0 0.05072103813290596
, O 0 0.00015695721958763897
and O 0 0.00017972390924114734
reading O 0 0.0009623555233702064
skills O 0 0.001996865961700678
. O 0 0.000907695444766432

Comparison O 0 0.0018004064913839102
of O 0 0.0005868495791219175
molecular O 0 0.0006219512433744967
and O 0 0.000202790237381123
psychometric O 0 0.0019138731295242906
findings O 0 0.00020733951532747597
demonstrated O 0 0.0002816916676238179
that O 0 3.5756696888711303e-05
deletions O 0 0.0002427386789349839
and O 0 5.2204952226020396e-05
duplications O 0 0.00037694373168051243
that O 0 2.9955013815197162e-05
were O 0 2.809194484143518e-05
localized O 0 0.00011926556908292696
in O 0 2.4022659999900497e-05
the O 0 4.8664529458619654e-05
distal O 0 0.005437701940536499
part O 0 6.3316932937596e-05
of O 0 3.9154616388259456e-05
the O 0 6.592315185116604e-05
gene O 0 9.304534614784643e-05
seemed O 0 0.00011195811384823173
to O 0 2.6729947421699762e-05
be O 0 3.856907642330043e-05
preferentially O 0 0.0002003199770115316
associated O 0 0.00020782639330718666
with O 0 0.0003222785599064082
cognitive B-Disease 1 0.8074168562889099
impairment I-Disease 1 0.9985248446464539
. O 0 0.0018287260318174958

Two O 0 0.0011402908712625504
altered O 0 0.0012200523633509874
Dp71 O 0 0.013403029181063175
transcripts O 0 0.0005092336796224117
and O 0 8.880323730409145e-05
two O 0 8.65919137140736e-05
deleted O 0 0.0003493809490464628
Dp140 O 0 0.0021673147566616535
DNA O 0 0.00010712070798035711
sequences O 0 4.317996354075149e-05
were O 0 2.2207499569049105e-05
found O 0 2.8490539989434183e-05
in O 0 5.46339615539182e-05
four O 0 0.00021936943812761456
patients O 1 0.9814413785934448
with O 1 0.8707433938980103
severe O 1 0.9999998807907104
cerebral B-Disease 1 0.9999998807907104
dysfunction I-Disease 1 0.9999997615814209
. O 1 0.9671828746795654

These O 0 0.00034958633477799594
findings O 0 0.00027988097281195223
suggest O 0 0.00010824776836670935
that O 0 2.54789374594111e-05
some O 0 1.9504517695168033e-05
sequences O 0 2.1221767383394763e-05
located O 0 3.64767292921897e-05
in O 0 2.5083434593398124e-05
the O 0 5.321657954482362e-05
distal O 0 0.003650410333648324
part O 0 6.111884431447834e-05
of O 0 4.6276360080810264e-05
the O 0 4.707581319962628e-05
gene O 0 4.8051660996861756e-05
and O 0 2.608721661090385e-05
, O 0 2.271511584694963e-05
in O 0 2.205766213592142e-05
particular O 0 3.339357499498874e-05
, O 0 3.995038059656508e-05
some O 0 3.9292041037697345e-05
DMD B-Disease 1 0.9957708716392517
isoforms O 0 7.75551816332154e-05
expressed O 0 4.8914334911387414e-05
in O 0 3.8593800127273425e-05
the O 0 0.00012024557508993894
brain O 0 0.4233068823814392
may O 0 4.877342871623114e-05
be O 0 1.94994227058487e-05
related O 0 4.98165245517157e-05
to O 0 3.2617797842249274e-05
the O 0 0.00023318362946156412
cognitive B-Disease 1 0.9699174165725708
impairment I-Disease 1 0.9998440742492676
associated O 0 0.008339389227330685
with O 0 0.010781718418002129
DMD B-Disease 1 0.999993085861206
. O 0 0.0008849257719703019
. O 0 0.0012542922049760818

I1307K O 1 0.998233437538147
APC O 1 0.9890702962875366
and O 0 0.0011307045351713896
hMLH1 O 1 0.5443217754364014
mutations O 0 0.0003279398661106825
in O 0 7.697230466874316e-05
a O 0 9.829528426053002e-05
non O 0 0.00023434488684870303
- O 0 0.0003871090884786099
Jewish O 0 0.00024529368965886533
family O 0 0.000187892175745219
with O 0 0.00023558597604278475
hereditary B-Disease 1 0.9999425411224365
non I-Disease 1 0.9999918937683105
- I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 1 0.9660543203353882

We O 0 0.0009075379348360002
describe O 0 0.000772508792579174
a O 0 0.00030730152502655983
French O 0 0.0004883491201326251
Canadian O 0 0.001065799966454506
hereditary B-Disease 1 0.9996079802513123
non I-Disease 1 0.999915361404419
- I-Disease 1 0.9999996423721313
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999945163726807
HNPCC B-Disease 1 0.9999998807907104
) O 0 0.03815499320626259
kindred O 1 0.9367676377296448
which O 0 0.0001171248804894276
carries O 0 0.00025607110001146793
a O 0 0.0002445844584144652
novel O 0 0.0011033228365704417
truncating O 0 0.09520609676837921
mutation O 0 0.001236427342519164
in O 0 0.0005645539495162666
hMLH1 O 1 0.5597369074821472
. O 0 0.0015466565964743495

Interestingly O 0 0.005917449481785297
, O 0 0.0006908297073096037
the O 0 0.0005633955588564277
I1307K O 1 0.9971254467964172
APC O 1 0.9939070343971252
polymorphism O 0 0.001545102335512638
, O 0 7.288171036634594e-05
associated O 0 5.1086510211462155e-05
with O 0 2.3632084776181728e-05
an O 0 5.479701212607324e-05
increased O 0 0.0006037720595486462
risk O 1 0.5879439115524292
of O 1 0.9995306730270386
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.1372222900390625
is O 0 0.00019403731857892126
also O 0 4.637222082237713e-05
present O 0 6.817758549004793e-05
in O 0 6.029483847669326e-05
this O 0 9.748589218361303e-05
family O 0 0.0005655839340761304
. O 0 0.0006058746366761625

The O 0 0.0024497872218489647
I1307K O 1 0.9000809788703918
polymorphism O 0 0.0015528026269748807
has O 0 0.0001277406554436311
previously O 0 8.234884444391355e-05
only O 0 2.4930639483500272e-05
been O 0 2.6442536182003096e-05
identified O 0 3.478190774330869e-05
in O 0 2.3956292352522723e-05
individuals O 0 3.9385908166877925e-05
of O 0 0.00011338673357386142
self O 0 0.3543178141117096
- O 1 0.6502423286437988
reported O 0 0.001078133936971426
Ashkenazi O 0 0.004266485571861267
Jewish O 0 0.001136920414865017
origins O 0 0.002698640339076519
. O 0 0.0011558623518794775

In O 0 0.0005064478609710932
addition O 0 0.00019216483633499593
, O 0 6.872195808682591e-05
in O 0 3.519330493872985e-05
this O 0 2.715910341066774e-05
family O 0 5.567438711295836e-05
, O 0 2.5557690605637617e-05
there O 0 1.7716640286380425e-05
appears O 0 3.433152232901193e-05
to O 0 1.1120833733002655e-05
be O 0 1.1869777154061012e-05
no O 0 1.8439708583173342e-05
relationship O 0 3.788050526054576e-05
between O 0 2.8255677534616552e-05
the O 0 6.79841177770868e-05
I1307K O 1 0.8286345601081848
polymorphism O 0 0.00028865542844869196
and O 0 4.0470651583746076e-05
the O 0 5.8009558415506035e-05
presence O 0 0.00011570222704904154
or O 0 8.049610914895311e-05
absence O 0 0.001287910621613264
of O 0 0.002724084537476301
cancer B-Disease 1 0.9998440742492676
. O 0 0.0007961565861478448
. O 0 0.001189672970212996

Identification O 0 0.0016344018513336778
of O 0 0.0004328869981691241
a O 0 0.00041528529254719615
novel O 0 0.00046353007201105356
mutation O 0 0.0001833207643358037
of O 0 8.376286859856918e-05
the O 0 0.00016419842722825706
CPO O 0 0.028539882972836494
gene O 0 8.725453517399728e-05
in O 0 6.644421227974817e-05
a O 0 0.0001846674276748672
Japanese O 0 0.002323165535926819
hereditary B-Disease 1 0.994511604309082
coproporphyria I-Disease 1 0.9995681643486023
family O 0 0.01252798456698656
. O 0 0.0016501476056873798

Hereditary B-Disease 1 0.9997351765632629
coproporphyria I-Disease 1 0.9999712705612183
( O 1 0.8708688020706177
HCP B-Disease 1 0.9997627139091492
) O 0 0.00042534148087725043
is O 0 0.0002055859222309664
an O 0 0.0005903361015953124
autosomal B-Disease 1 0.9986147880554199
dominant I-Disease 1 0.9994121789932251
disease I-Disease 1 0.9999971389770508
characterized O 1 0.987834095954895
by O 0 0.0039730495773255825
a O 1 0.9307866096496582
deficiency B-Disease 1 0.9999995231628418
of I-Disease 1 0.9450624585151672
coproporphyrinogen I-Disease 1 0.9999990463256836
oxidase I-Disease 1 0.9999399185180664
( O 0 0.07368871569633484
CPO O 1 0.6199254989624023
) O 0 9.161613706965e-05
caused O 0 0.00018787926819641143
by O 0 2.9427097615553066e-05
a O 0 7.982685201568529e-05
mutation O 0 0.00012145093933213502
in O 0 7.835326687199995e-05
the O 0 0.00025322975125163794
CPO O 0 0.020842308178544044
gene O 0 0.0009069172665476799
. O 0 0.0007926131947897375

Only O 0 0.00048202177276834846
11 O 0 0.0004094554460607469
mutations O 0 0.00020173587836325169
of O 0 8.412493480136618e-05
the O 0 8.740759221836925e-05
gene O 0 0.00011366926628397778
have O 0 3.848288906738162e-05
been O 0 8.233746484620497e-05
reported O 0 0.00021486374316737056
in O 0 0.00035060298978351057
HCP B-Disease 1 0.9989013671875
patients O 1 0.5350514650344849
. O 0 0.0013968205312266946

We O 0 0.0010589251760393381
report O 0 0.0003860614087898284
another O 0 0.0002942863793577999
mutation O 0 0.0002652472467161715
in O 0 9.552151459502056e-05
a O 0 0.0002970879140775651
Japanese O 0 0.001269059139303863
family O 0 0.001283993711695075
. O 0 0.001175094861537218

Polymerase O 0 0.010392245836555958
chain O 0 0.0038634976372122765
reaction O 0 0.0017735138535499573
- O 0 0.0016093518352136016
single O 0 0.0003511087561491877
strand O 0 0.0005634570261463523
conformational O 0 0.0004838395689148456
polymorphism O 0 0.00022646848810836673
and O 0 3.953484701924026e-05
direct O 0 4.138351505389437e-05
sequence O 0 4.123759572394192e-05
analyses O 0 5.1138322305632755e-05
demonstrated O 0 7.022875070106238e-05
a O 0 4.959785655955784e-05
C O 0 0.00010121714876731858
to O 0 4.10139728046488e-05
T O 0 0.00033162589534185827
substitution O 0 8.808459097053856e-05
in O 0 3.0208437237888575e-05
exon O 0 0.00016349212091881782
1 O 0 4.828901364817284e-05
of O 0 4.618967795977369e-05
the O 0 5.186484850128181e-05
CPO O 0 0.0004560506495181471
gene O 0 6.552891136379912e-05
at O 0 4.8821264499565586e-05
nucleotide O 0 6.903066241648048e-05
position O 0 4.619363971869461e-05
85 O 0 7.736453699180856e-05
, O 0 3.2272437238134444e-05
which O 0 2.391684756730683e-05
lies O 0 8.723473001737148e-05
in O 0 2.9939621526864357e-05
the O 0 6.364958971971646e-05
putative O 0 0.0009231705334968865
presequence O 0 0.046033456921577454
for O 0 0.00011459227243904024
targeting O 0 0.00027534240507520735
to O 0 0.00018517134594731033
mitochondria O 0 0.0017395869363099337
. O 0 0.0007319796131923795

This O 0 0.0010069658746942878
mutation O 0 0.0008134479867294431
changes O 0 0.00023071383475326002
the O 0 0.00012908797361887991
codon O 0 0.00030278947087936103
for O 0 6.938797741895542e-05
glutamine O 0 0.0002308868133695796
to O 0 4.857384192291647e-05
a O 0 0.00011910918692592531
termination O 0 0.0006761109107173979
codon O 0 0.0004883250221610069
at O 0 0.00017328585090581328
amino O 0 0.0001764767075655982
acid O 0 0.0003759360406547785
position O 0 0.00034148572012782097
29 O 0 0.0012648976407945156
. O 0 0.0011245126370340586

MaeI O 1 0.6357074975967407
restriction O 0 0.0014522402780130506
analysis O 0 0.000351300579495728
showed O 0 0.0002694447466637939
two O 0 7.857863965909928e-05
other O 0 6.460396980401129e-05
carriers O 0 0.00017042222316376865
in O 0 5.952086576144211e-05
the O 0 0.000172251311596483
family O 0 0.0009460201254114509
. O 0 0.0011805557878687978

The O 0 0.003844568505883217
C O 1 0.8167997002601624
- O 1 0.9936222434043884
T O 1 0.9768174290657043
mutation O 0 0.0004229597980156541
is O 0 6.89664448145777e-05
located O 0 0.00011399188224459067
within O 0 6.794237560825422e-05
a O 0 8.571401122026145e-05
recently O 0 0.000126550454297103
proposed O 0 0.00011867859575431794
putative O 0 0.00033924708259291947
alternative O 0 0.00014134650700725615
translation O 0 0.0001632787025300786
initiation O 0 0.0002754069573711604
codon O 0 0.00037739911931566894
( O 0 0.00017439045768696815
TIC O 0 0.07572904229164124
- O 0 0.00025852350518107414
1 O 0 8.974666707217693e-05
) O 0 4.459784759092145e-05
, O 0 4.147707295487635e-05
supporting O 0 5.840505036758259e-05
that O 0 5.648769729305059e-05
TIC O 1 0.6849116683006287
- O 0 0.0006473831017501652
1 O 0 7.175556675065309e-05
is O 0 3.407745680306107e-05
the O 0 5.808196510770358e-05
real O 0 0.0002239348104922101
TIC O 0 0.10841605812311172
rather O 0 9.910736844176427e-05
than O 0 0.00010722433944465593
TIC O 1 0.7059481739997864
- O 0 0.0013568778522312641
2 O 0 0.00030010606860741973
. O 0 0.00024248006229754537
. O 0 0.0007350041996687651

Human B-Disease 0 0.0063218604773283005
complement I-Disease 0 0.15465056896209717
factor I-Disease 1 0.9991499185562134
H I-Disease 1 0.9999972581863403
deficiency I-Disease 1 0.9999998807907104
associated O 1 0.9980376362800598
with O 1 0.9999790191650391
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9996905326843262

This O 0 0.0005710026598535478
study O 0 0.0002023473207373172
reports O 0 0.00012846245954278857
on O 0 4.831748447031714e-05
six O 0 8.337852341355756e-05
cases O 0 9.030423098010942e-05
of O 0 0.00196977611631155
deficiency B-Disease 1 0.9999943971633911
in I-Disease 0 0.00011074373469455168
the I-Disease 0 0.00013361734454520047
human I-Disease 0 0.00011822250962723047
complement I-Disease 0 0.00011955661466345191
regulatory I-Disease 0 0.00011386802361812443
protein I-Disease 0 8.774883463047445e-05
Factor I-Disease 0 0.005087527446448803
H I-Disease 1 0.9079789519309998
( O 0 0.00018498816643841565
FH O 0 0.4139411449432373
) O 0 2.6177856852882542e-05
in O 0 2.0574292648234405e-05
the O 0 2.7287223929306492e-05
context O 0 6.302494875853881e-05
of O 0 0.0003042136668227613
an O 1 0.9289331436157227
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.997374415397644

Five O 0 0.0008081155829131603
of O 0 0.00037006783531978726
the O 0 0.0001686372997937724
cases O 0 9.392063657287508e-05
were O 0 5.303106445353478e-05
observed O 0 0.00012126994988648221
in O 0 6.853885133750737e-05
children O 0 0.00037777546094730496
presenting O 0 0.23217441141605377
with O 1 0.9943916201591492
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999995231628418
HUS B-Disease 1 1.0
) O 1 0.9400333762168884
. O 0 0.013515202328562737

Two O 0 0.0005961373099125922
of O 0 0.0003817524993792176
the O 0 0.00030565241468138993
children O 0 0.0020982411224395037
exhibited O 0 0.49253278970718384
a O 1 0.9130083322525024
homozygous O 1 0.9998631477355957
deficiency O 1 0.9999990463256836
characterized O 0 0.11676337569952011
by O 0 7.547350105596706e-05
the O 0 8.175917901098728e-05
absence O 0 0.00017597933765500784
of O 0 5.175067053642124e-05
the O 0 6.379475962603465e-05
150 O 0 0.00016259323456324637
- O 0 0.0018910833168774843
kD O 0 0.006655107252299786
form O 0 4.9556107114767656e-05
of O 0 6.068328002584167e-05
Factor O 0 0.0039948043413460255
H O 0 0.10236477106809616
and O 0 2.878626219171565e-05
the O 0 3.0224888178054243e-05
presence O 0 6.216741167008877e-05
, O 0 3.3246898965444416e-05
upon O 0 5.384415271691978e-05
immunoblotting O 0 0.0005990437348373234
, O 0 2.4109116566251032e-05
of O 0 2.424172816972714e-05
the O 0 3.6666173400590196e-05
42 O 0 0.0001366107608191669
- O 0 0.0005608540377579629
kD O 0 0.08169848471879959
Factor O 0 0.0010641077533364296
H O 0 0.02796137146651745
- O 0 0.0001548135478515178
like O 0 5.3259173000697047e-05
protein O 0 4.360011371318251e-05
1 O 0 4.829117824556306e-05
( O 0 7.961726078065112e-05
FHL O 0 0.10608676075935364
- O 0 0.0002032218617387116
1 O 0 5.7662971812533215e-05
) O 0 2.822882561304141e-05
and O 0 2.6316249204683118e-05
other O 0 4.130403613089584e-05
FH O 1 0.8030216097831726
- O 0 0.000902546860743314
related O 0 0.00015485784388147295
protein O 0 0.0002060633705696091
( O 0 0.0004908751579932868
FHR O 1 0.978188157081604
) O 0 0.0003724661364685744
bands O 0 0.0011965635931119323
. O 0 0.0011144080199301243

Southern O 0 0.004254781175404787
blot O 0 0.009528175927698612
and O 0 0.0004390620451886207
PCR O 0 0.0005086144083179533
analysis O 0 8.557076216675341e-05
of O 0 4.909101699013263e-05
DNA O 0 0.00010054703307105228
of O 0 7.665572775295004e-05
one O 0 0.00012935203267261386
patient O 1 0.6079562306404114
with O 0 0.0016716913087293506
homozygous O 1 0.9667269587516785
deficiency O 1 0.9999901056289673
ruled O 0 0.0010557138593867421
out O 0 5.191501622903161e-05
the O 0 4.872833233093843e-05
presence O 0 6.094396303524263e-05
of O 0 3.876177652273327e-05
a O 0 4.958683712175116e-05
large O 0 4.195880683255382e-05
deletion O 0 9.378433605888858e-05
of O 0 3.643823947641067e-05
the O 0 0.00010112376912729815
FH O 1 0.9986853003501892
gene O 0 0.00011355464812368155
as O 0 4.533790342975408e-05
the O 0 7.782196189509705e-05
underlying O 0 0.377349853515625
defect O 1 0.9995150566101074
for O 0 0.000741198193281889
the O 0 0.29311150312423706
deficiency O 1 0.999996542930603
. O 0 0.006392383947968483

The O 0 0.0007881813799031079
other O 0 0.00018379438552074134
four O 0 0.00021205896337050945
children O 0 0.00031153103918768466
presented O 0 0.00041755492566153407
with O 0 0.0010806131176650524
heterozygous O 1 0.9376718401908875
deficiency O 1 0.9999966621398926
and O 0 0.0003332892374601215
exhibited O 0 0.022040052339434624
a O 0 0.0006312584737315774
normal O 0 0.0009419197449460626
immunoblotting O 1 0.8362724781036377
pattern O 0 0.0003811808710452169
of O 0 0.00012142314517404884
proteins O 0 0.00010648135503288358
of O 0 0.00018136757717002183
the O 0 0.0006959371385164559
FH O 1 0.9990730285644531
family O 0 0.002621936146169901
. O 0 0.001618088106624782

Factor B-Disease 1 0.9983768463134766
H I-Disease 1 0.9999719858169556
deficiency I-Disease 1 0.9999828338623047
is O 0 0.00036323443055152893
the O 0 0.000406062783440575
only O 0 0.0011660829186439514
complement B-Disease 1 0.9979898929595947
deficiency I-Disease 1 0.9999995231628418
associated O 0 0.09863516688346863
with O 0 0.07536336779594421
HUS B-Disease 1 0.9999977350234985
. O 0 0.014983023516833782

These O 0 0.0005014027119614184
observations O 0 0.0004364339984022081
suggest O 0 0.00021581292094197124
a O 0 0.00017163797747343779
role O 0 0.0001796067226678133
for O 0 0.00012048453936586156
FH O 1 0.9982049465179443
and O 0 0.00041867472464218736
/ O 1 0.6225146651268005
or O 0 0.0004822997725568712
FH O 1 0.9694762825965881
receptors O 0 0.00022894065477885306
in O 0 9.861319267656654e-05
the O 0 0.00021579215535894036
pathogenesis O 1 0.9885474443435669
of O 1 0.5034911036491394
idiopathic O 1 0.9999997615814209
HUS B-Disease 1 0.9999996423721313
. O 0 0.03711431846022606
. O 0 0.0026280544698238373

Further O 0 0.001130622811615467
evidence O 0 0.00047713951789774
for O 0 0.0001347712823189795
a O 0 0.0001942198141478002
major O 0 0.00028939807089045644
ancient O 0 0.0030271990690380335
mutation O 1 0.9086600542068481
underlying O 1 0.9998651742935181
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
from O 0 0.10846159607172012
linkage O 1 0.9983609318733215
disequilibrium O 1 0.998221218585968
studies O 0 0.00020449890871532261
in O 0 0.00011532969074323773
the O 0 0.00021858775289729238
Japanese O 0 0.0009584665531292558
population O 0 0.0004442826902959496
. O 0 0.000836071209050715

The O 1 0.930925190448761
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
( O 1 0.9998359680175781
DM B-Disease 1 0.9999997615814209
) O 0 0.0015621561324223876
mutation O 0 0.00039846712024882436
is O 0 5.454192069009878e-05
an O 0 6.695750926155597e-05
unstable O 1 0.8139125108718872
( O 0 0.0008614955586381257
CTG O 1 0.9587047696113586
) O 0 6.405181920854375e-05
n O 0 0.00010135102638741955
repeat O 0 8.990075730253011e-05
, O 0 2.004374073294457e-05
present O 0 1.890198836917989e-05
at O 0 2.137071714969352e-05
a O 0 2.383606079092715e-05
copy O 0 3.566468512872234e-05
number O 0 9.795040568860713e-06
of O 0 1.9965333194704726e-05
5 O 0 5.2352821512613446e-05
- O 0 0.00013255138765089214
37 O 0 9.58827295107767e-05
repeats O 0 0.00011348581028869376
on O 0 5.2070106903556734e-05
normal O 0 9.261415834771469e-05
chromosomes O 0 9.461821900913492e-05
but O 0 3.0732953746337444e-05
amplified O 0 0.00012046202755300328
to O 0 3.823436054517515e-05
50 O 0 0.00013086697435937822
- O 0 0.00028624868718907237
3000 O 0 0.0005906068254262209
copies O 0 0.0002938901598099619
on O 0 0.0003125514485873282
DM B-Disease 1 0.9967520236968994
chromosomes O 0 0.0023626843467354774
. O 0 0.0012702401727437973

Previous O 0 0.0013868991518393159
findings O 0 0.0004909715498797596
in O 0 0.00017251365352422
Caucasian O 0 0.0013679268304258585
populations O 0 0.00013433916319627315
of O 0 0.0001834452705224976
a O 0 0.23576229810714722
DM B-Disease 1 0.9999995231628418
founder O 1 0.9947403073310852
chromosome O 0 0.0017083585262298584
raise O 0 0.000137611452373676
a O 0 6.560844485647976e-05
question O 0 6.034137913957238e-05
about O 0 3.9387035940308124e-05
the O 0 4.581587199936621e-05
molecular O 0 7.76456217863597e-05
events O 0 6.557216693181545e-05
involved O 0 5.769438575953245e-05
in O 0 5.9647238231264055e-05
the O 0 0.0001389411772834137
expansion O 0 0.001325800083577633
mutation O 0 0.0014113965444266796
. O 0 0.0009546971996314824

To O 0 0.0005125971511006355
investigate O 0 0.0005461035761982203
whether O 0 0.00023883685935288668
a O 0 0.0001791685208445415
founder O 0 0.0025844441261142492
chromosome O 0 0.0003400426940061152
for O 0 5.7144799939123914e-05
the O 0 0.0007046221289783716
DM B-Disease 1 0.9999973773956299
mutation O 0 0.0005790018476545811
exists O 0 7.544529944425449e-05
in O 0 2.5105615350184962e-05
the O 0 3.7010733649367467e-05
Japanese O 0 0.00012879876885563135
population O 0 3.0071303626755252e-05
, O 0 2.774545646389015e-05
we O 0 4.304654794395901e-05
genotyped O 0 0.0008530851337127388
families O 0 6.919100997038186e-05
using O 0 3.9410628232872114e-05
polymorphic O 0 0.00021798169473186135
markers O 0 0.00016999732179101557
near O 0 0.00017703406047075987
the O 0 0.00010879478213610128
( O 0 0.0002306126698385924
CTG O 0 0.06264298409223557
) O 0 0.00016601155220996588
n O 0 0.000374583643861115
repeat O 0 0.00042518627014942467
region O 0 0.0003462793247308582
and O 0 0.0002884177374653518
constructed O 0 0.0020007151179015636
haplotypes O 0 0.005920682102441788
. O 0 0.0016470975242555141

Six O 0 0.001422715256921947
different O 0 0.00028674662462435663
haplotypes O 0 0.0010302670998498797
were O 0 0.0001371507387375459
found O 0 0.00020148829207755625
and O 0 0.000405419385060668
DM B-Disease 1 0.9998922348022461
alleles O 0 0.0008404544205404818
were O 0 0.0002588727802503854
always O 0 0.0006065712659619749
haplotype O 0 0.0023017192725092173
A O 0 0.001850919215939939
. O 0 0.0012143586063757539

To O 0 0.00040981860365718603
find O 0 0.00020489668531809002
an O 0 8.706569497007877e-05
origin O 0 6.226192635949701e-05
of O 0 5.480992331285961e-05
the O 0 0.00010914807353401557
( O 0 0.0004142136313021183
CTG O 1 0.9403733611106873
) O 0 6.7008615587838e-05
n O 0 0.00015014660311862826
repeat O 0 0.00017584481975063682
mutation O 0 6.87320571159944e-05
and O 0 1.765592060110066e-05
to O 0 1.3983347344037611e-05
investigate O 0 4.914863166050054e-05
the O 0 3.0189312383299693e-05
mechanism O 0 4.936941695632413e-05
of O 0 4.092610106454231e-05
the O 0 4.286233524908312e-05
expansion O 0 0.00019519317720551044
mutation O 0 7.364588236669078e-05
in O 0 2.0742159904330038e-05
the O 0 3.649308200692758e-05
Japanese O 0 0.0001194581636809744
population O 0 2.4296437914017588e-05
we O 0 2.2563597667613067e-05
have O 0 1.5143164091568906e-05
studied O 0 4.888537296210416e-05
90 O 0 8.122647705022246e-05
Japanese O 0 0.0004470888525247574
DM B-Disease 1 0.9979923963546753
families O 0 0.00015426214667968452
comprising O 0 0.00013266276801005006
190 O 0 0.00027271462022326887
affected O 0 0.00019583653192967176
and O 0 8.788315608398989e-05
130 O 0 0.00035579167888499796
unaffected O 0 0.0013731857761740685
members O 0 0.0004929669084958732
. O 0 0.0008573568193241954

The O 0 0.0008478871313855052
results O 0 0.00030101099400781095
suggest O 0 0.00014081930567044765
that O 0 3.562151687219739e-05
a O 0 4.819981040782295e-05
few O 0 4.406618609209545e-05
common O 0 6.642495281994343e-05
ancestral O 0 0.001777391298674047
mutations O 0 0.00010168556764256209
in O 0 2.5664468921604566e-05
both O 0 3.0179469831637107e-05
Caucasian O 0 0.011088921688497066
and O 0 4.506697951001115e-05
Japanese O 0 0.00019984932441730052
populations O 0 3.294247289886698e-05
have O 0 1.1904398888873402e-05
originated O 0 3.9068530895747244e-05
by O 0 1.4957640814827755e-05
expansion O 0 4.053933298564516e-05
of O 0 2.4897515686461702e-05
an O 0 2.829515688063111e-05
ancestral O 0 0.00014148594345897436
n O 0 8.808325219433755e-05
= O 0 0.00010923867375822738
5 O 0 6.08559676038567e-05
repeat O 0 0.00010466047388035804
to O 0 2.694770591915585e-05
n O 0 0.00010189999738940969
= O 0 0.0001412454730598256
19 O 0 0.00019111233996227384
- O 0 0.00034733055508695543
37 O 0 0.00042999719153158367
copies O 0 0.0005194197874516249
. O 0 0.0007591958274133503

These O 0 0.00041864480590447783
data O 0 0.0002565437462180853
support O 0 0.0003209588467143476
multistep O 0 0.001142146997153759
models O 0 0.00026308404630981386
of O 0 0.0002331485302420333
triplet O 0 0.32963207364082336
repeat O 0 0.001369921606965363
expansion O 0 0.00031384045723825693
that O 0 3.435959297348745e-05
have O 0 2.2716307285008952e-05
been O 0 3.5243476304458454e-05
proposed O 0 5.49519645574037e-05
for O 0 4.878073013969697e-05
both O 0 0.00017166596080642194
DM B-Disease 1 0.9999805688858032
and O 0 0.0031132453586906195
Friedreichs B-Disease 1 0.9998916387557983
ataxia I-Disease 1 0.9998918771743774
. O 0 0.001092444988898933
. O 0 0.0014953783247619867

The O 0 0.001237482880242169
molecular O 0 0.0008013719343580306
basis O 0 0.00043882941827178
of O 0 0.024212639778852463
C6 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999963045120239
in O 0 0.00019867991795763373
the O 0 0.0001974941696971655
western O 0 0.0005609593936242163
Cape O 0 0.02589002251625061
, O 0 0.0002506279561202973
South O 0 0.0005426810821518302
Africa O 0 0.001126698451116681
. O 0 0.0009597284952178597

Deficiency B-Disease 1 0.9997039437294006
of I-Disease 0 0.0010662346612662077
the I-Disease 0 0.0007843287312425673
sixth I-Disease 1 0.7915990948677063
component I-Disease 0 0.009118284098803997
of I-Disease 0 0.00026145888841710985
human I-Disease 0 0.0008664989727549255
complement I-Disease 0 0.08858577907085419
( O 0 0.03436597064137459
C6 O 1 0.999713122844696
) O 0 6.18141348240897e-05
has O 0 2.3498752852901816e-05
been O 0 1.6377534848288633e-05
reported O 0 1.800613790692296e-05
in O 0 1.2183458238723688e-05
a O 0 2.0407975171110593e-05
number O 0 1.259243072126992e-05
of O 0 2.4525415938114747e-05
families O 0 3.7312027416191995e-05
from O 0 2.8901127734570764e-05
the O 0 5.534344381885603e-05
western O 0 0.0001553555193822831
Cape O 0 0.0013984018005430698
, O 0 0.0001804234052542597
South O 0 0.0005634812405332923
Africa O 0 0.0010143887484446168
. O 0 0.0010040566558018327

Meningococcal B-Disease 1 0.9999945163726807
disease I-Disease 1 0.9999808073043823
is O 0 0.0024024585727602243
endemic O 0 0.11079265177249908
in O 0 0.00014230070519261062
the O 0 0.00018249462300445884
Cape O 0 0.003818369470536709
and O 0 5.51581870240625e-05
almost O 0 5.770170537289232e-05
all O 0 2.9413631636998616e-05
pedigrees O 0 0.00015339029778260738
of O 0 0.00016708794282749295
total O 1 0.7192391753196716
C6 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
( O 1 0.576790988445282
C6Q0 O 1 0.9998025298118591
) O 0 0.00010420975013403222
have O 0 5.3208565077511594e-05
been O 0 7.881082274252549e-05
ascertained O 0 0.0005145234172232449
because O 0 0.000172343134181574
of O 0 0.0009386113961227238
recurrent O 1 0.9999696016311646
disease O 1 0.9999914169311523
. O 0 0.0665784478187561

We O 0 0.0007981702801771462
have O 0 0.0001896926260087639
sequenced O 0 0.0003559684846550226
the O 0 0.00012086312926840037
expressed O 0 0.00014159944839775562
exons O 0 0.0002877382794395089
of O 0 0.00010806130012497306
the O 0 0.000239847824559547
C6 O 1 0.9989245533943176
gene O 0 0.0001339523441856727
from O 0 3.447200288064778e-05
selected O 0 4.9920621677301824e-05
cases O 0 3.358634785399772e-05
and O 0 2.5253193598473445e-05
have O 0 1.194105607282836e-05
found O 0 2.225004391220864e-05
three O 0 2.934051190095488e-05
molecular O 0 0.0001675060484558344
defects O 0 0.36941638588905334
leading O 0 0.0003391067439224571
to O 0 7.443766662618145e-05
total O 0 0.10849827527999878
deficiency O 1 0.9999995231628418
879delG O 1 0.999821126461029
, O 0 0.00019531736325006932
which O 0 3.508553345454857e-05
is O 0 3.329493847559206e-05
the O 0 4.57741625723429e-05
common O 0 0.00010171834583161399
defect O 1 0.6498280763626099
in O 0 5.19466120749712e-05
the O 0 0.00010872778511838987
Cape O 0 0.0018032677471637726
and O 0 6.61499725538306e-05
hitherto O 0 0.00040085194632411003
unreported O 0 0.0002686700318008661
, O 0 6.737473449902609e-05
and O 0 6.905463669681922e-05
1195delC O 1 0.6383535861968994
and O 0 0.00014357507461681962
1936delG O 1 0.5358594059944153
, O 0 6.842443690402433e-05
which O 0 1.920363683893811e-05
have O 0 1.2112014701415319e-05
been O 0 2.320875682926271e-05
previously O 0 4.1043866076506674e-05
reported O 0 6.687276618322358e-05
in O 0 6.096762081142515e-05
African O 0 0.0006136099109426141
- O 0 0.011618725024163723
Americans O 0 0.0010764714097604156
. O 0 0.0011468769516795874

We O 0 0.0008428129367530346
also O 0 0.000278404972050339
show O 0 0.00017772462160792202
that O 0 7.303741585928947e-05
the O 0 0.0001274278765777126
879delG O 1 0.9301585555076599
and O 0 0.0008777170442044735
1195delC O 1 0.9997168183326721
defects O 1 0.9947380423545837
are O 0 5.146487455931492e-05
associated O 0 0.00010554926848271862
with O 0 0.00010662075510481372
characteristic O 1 0.6181981563568115
C6 O 1 0.9999945163726807
/ O 1 0.9937983155250549
C7 O 1 0.9997372031211853
region O 0 0.0004260999849066138
DNA O 0 0.00046398385893553495
marker O 0 0.006218640133738518
haplotypes O 0 0.0007224207511171699
, O 0 0.00010479769844096154
although O 0 0.00010644581925589591
small O 0 0.00011182815069332719
variations O 0 0.00020508274610619992
were O 0 0.00014603625459130853
observed O 0 0.0006137169548310339
. O 0 0.0008190723019652069

The O 0 0.00299444398842752
1936delG O 1 0.9985594153404236
defect O 1 0.9977768063545227
was O 0 0.0010385083733126521
observed O 0 0.0001362019538646564
only O 0 3.854749593301676e-05
once O 0 5.6177414080593735e-05
in O 0 2.3361157218459994e-05
the O 0 3.695994382724166e-05
Cape O 0 0.0006135303410701454
, O 0 4.974369949195534e-05
but O 0 2.420412056380883e-05
its O 0 3.710806049639359e-05
associated O 0 0.00010462295904289931
haplotype O 0 0.000534649530891329
could O 0 0.00012240430805832148
be O 0 0.0001598823582753539
deduced O 0 0.0016458795871585608
. O 0 0.0010724742896854877

The O 0 0.0006042493041604757
data O 0 0.0001324303593719378
from O 0 6.39396530459635e-05
the O 0 8.376110781682655e-05
haplotypes O 0 0.00035306272911839187
indicate O 0 7.887232641223818e-05
that O 0 2.3015352780930698e-05
these O 0 1.2200201126688626e-05
three O 0 3.1970343115972355e-05
molecular O 0 0.0001481686922488734
defects O 0 0.1265936642885208
account O 0 4.8718480684328824e-05
for O 0 3.7849888030905277e-05
the O 0 7.81343478593044e-05
defects O 0 0.22687354683876038
in O 0 3.267003921791911e-05
all O 0 2.3752194465487264e-05
the O 0 4.5599972509080544e-05
38 O 0 0.0001446972746634856
unrelated O 0 0.004585263319313526
C6Q0 O 1 0.9950615763664246
individuals O 0 4.716968396678567e-05
we O 0 3.182084401487373e-05
have O 0 2.575751750555355e-05
studied O 0 8.020340465009212e-05
from O 0 8.503341814503074e-05
the O 0 0.00026564509607851505
Cape O 0 0.0036020197439938784
. O 0 0.0012765895808115602

We O 0 0.0007434339495375752
have O 0 0.00019676338706631213
also O 0 0.0001294502435484901
observed O 0 0.00011094836372649297
the O 0 0.00015367109153885394
879delG O 0 0.23466598987579346
defect O 0 0.107744961977005
in O 0 8.22807996883057e-05
two O 0 0.00011705879296641797
Dutch O 1 0.5201337933540344
C6 B-Disease 1 0.9999986886978149
- I-Disease 1 0.9970141649246216
deficient I-Disease 1 0.9974454641342163
kindreds O 0 0.48101159930229187
, O 0 0.00010547008423600346
but O 0 4.59542716271244e-05
the O 0 0.00011441418610047549
879delG O 1 0.9864481687545776
defect O 1 0.9429393410682678
in O 0 8.318029722431675e-05
the O 0 0.00016572244931012392
Cape O 0 0.01208021305501461
probably O 0 0.00012747164873871952
did O 0 4.1184543078998104e-05
not O 0 2.1530768208322115e-05
come O 0 3.804276275332086e-05
from O 0 3.9142894820543006e-05
The O 0 0.0001187397210742347
Netherlands O 0 0.00037391213118098676
. O 0 0.00028817972633987665
. O 0 0.0006937935249879956

Complement B-Disease 1 0.9991245865821838
C7 I-Disease 1 0.9999985694885254
deficiency I-Disease 1 0.9999977350234985
: O 0 0.0012356002116575837
seven O 0 0.0004343006294220686
further O 0 0.00033736921614035964
molecular O 0 0.003894238267093897
defects O 1 0.9746934175491333
and O 0 0.00020360162307042629
their O 0 0.00013447347737383097
associated O 0 0.00047698579146526754
marker O 0 0.10477177798748016
haplotypes O 0 0.01779436133801937
. O 0 0.0021543384063988924

Seven O 0 0.0013431860134005547
further O 0 0.0004338893049862236
molecular O 0 0.00048718886682763696
bases O 0 0.0006840112037025392
of O 1 0.5023868680000305
C7 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999997615814209
are O 0 0.000402510748244822
described O 0 0.004815076012164354
. O 0 0.0011486002476885915

All O 0 0.0004945364780724049
these O 0 0.000136132090119645
new O 0 0.00019650989270303398
molecular O 0 0.0004895126912742853
defects O 0 0.15859538316726685
involve O 0 0.00012514834816101938
single O 0 0.00014940780238248408
- O 0 0.0006562458584085107
nucleotide O 0 0.00010622962872730568
events O 0 5.84670779062435e-05
, O 0 3.8554811908397824e-05
deletions O 0 0.00012688418792095035
and O 0 3.1940970075083897e-05
substitutions O 0 8.703664207132533e-05
, O 0 2.753941953415051e-05
some O 0 1.6196754586417228e-05
of O 0 4.317559796618298e-05
which O 0 4.0002953028306365e-05
alter O 0 0.00017627455235924572
splice O 0 0.00046570401173084974
sites O 0 8.602188609074801e-05
, O 0 8.885711577022448e-05
and O 0 0.0001320419687544927
others O 0 0.00031948796822689474
codons O 0 0.0017618638230487704
. O 0 0.0009615903254598379

They O 0 0.0005963430157862604
are O 0 0.00011723482748493552
distributed O 0 0.00013641253462992609
along O 0 0.00013334484538063407
the O 0 0.00021987117361277342
C7 O 1 0.9947598576545715
gene O 0 0.0001768864312907681
, O 0 6.12012081546709e-05
but O 0 4.233028812450357e-05
predominantly O 0 7.447628013323992e-05
towards O 0 0.00011175555118825287
the O 0 0.00012872401566710323
3 O 0 0.0002725196536630392
end O 0 0.0009232413140125573
. O 0 0.0008912732009775937

All O 0 0.0007637135568074882
were O 0 0.00024171281256712973
found O 0 0.00018369907047599554
in O 0 0.00016461404447909445
compound O 0 0.0024267949629575014
heterozygous O 0 0.0012927564093843102
individuals O 0 0.0006552652921527624
. O 0 0.0011690558167174459

The O 0 0.015847614035010338
C6 O 1 0.9999140501022339
/ O 1 0.9975559711456299
C7 O 1 0.999685525894165
marker O 0 0.26037493348121643
haplotypes O 0 0.007088873535394669
associated O 0 0.00036391898174770176
with O 0 0.0002441932447254658
most O 0 0.0009095662389881909
C7 B-Disease 1 0.9999842643737793
defects I-Disease 1 0.9991475343704224
are O 0 0.00012599995534401387
tabulated O 0 0.0006536429282277822
. O 0 0.00030871047056280077
. O 0 0.0006564398063346744

A O 0 0.002847987227141857
genome O 0 0.0014056802028790116
- O 0 0.0008680637110956013
wide O 0 0.00018557682051323354
search O 0 0.0001898696064017713
for O 0 0.00012327838339842856
chromosomal O 0 0.028282906860113144
loci O 0 0.002962175291031599
linked O 0 0.00185747432988137
to O 0 0.00021195648878347129
mental O 1 0.9998904466629028
health O 1 0.9204181432723999
wellness O 1 0.9871655702590942
in O 0 0.0001361367612844333
relatives O 0 0.0004912552540190518
at O 0 0.0003644342068582773
high O 0 0.07463619112968445
risk O 1 0.8080701231956482
for O 1 0.8850813508033752
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 0.9999997615814209
among O 0 0.1841071993112564
the O 0 0.037752408534288406
Old O 1 0.9644352793693542
Order O 0 0.0026573757641017437
Amish O 0 0.17967718839645386
. O 0 0.0016439673490822315

Bipolar B-Disease 1 0.9999998807907104
affective I-Disease 1 0.999998927116394
disorder I-Disease 1 0.9999998807907104
( O 1 0.9999215602874756
BPAD B-Disease 1 1.0
; O 1 0.9999628067016602
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.3531683683395386
is O 0 0.0014109777985140681
characterized O 0 0.017514100298285484
by O 0 6.682585080852732e-05
episodes O 0 0.00023513045744039118
of O 0 0.0017222678288817406
mania B-Disease 1 0.9999877214431763
and O 0 0.0035421245265752077
/ O 1 0.8901214003562927
or O 0 0.0005964211886748672
hypomania B-Disease 1 0.9994719624519348
interspersed O 0 0.0009542996995151043
with O 0 0.00015652916044928133
periods O 0 0.000632513256277889
of O 0 0.0018331558676436543
depression B-Disease 1 0.9999353885650635
. O 0 0.004991284105926752

Compelling O 0 0.003200340550392866
evidence O 0 0.0006519383168779314
supports O 0 0.00044608753523789346
a O 0 0.00020258304721210152
significant O 0 0.00014383434609044343
genetic O 0 0.00018609939434099942
component O 0 0.00039467797614634037
in O 0 7.202141568996012e-05
the O 0 0.00015144082135520875
susceptibility O 0 0.018472399562597275
to O 0 0.0001564524573041126
develop O 0 0.007075740955770016
BPAD B-Disease 1 0.9997989535331726
. O 0 0.0020087920129299164

To O 0 0.0006565173389390111
date O 0 0.0003833361843135208
, O 0 0.0001723042078083381
however O 0 0.00011855484626721591
, O 0 9.410263737663627e-05
linkage O 0 0.0002787228731904179
studies O 0 6.251894956221804e-05
have O 0 2.2406678908737376e-05
attempted O 0 0.00010352830577176064
only O 0 3.1616124033462256e-05
to O 0 3.500288585200906e-05
identify O 0 0.0001361352187814191
chromosomal O 0 0.009422669187188148
loci O 0 0.0008617784478701651
that O 0 7.8039854997769e-05
cause O 0 0.002454731147736311
or O 0 6.629326526308432e-05
increase O 0 7.921150245238096e-05
the O 0 0.00014238485891837627
risk O 0 0.0004520135116763413
of O 0 0.0007008376996964216
developing O 0 0.22494131326675415
BPAD B-Disease 1 0.9999549388885498
. O 0 0.0028615461196750402

To O 0 0.0004657954559661448
determine O 0 0.0002004044217756018
whether O 0 0.00012224754027556628
there O 0 7.824828935554251e-05
could O 0 7.889443077147007e-05
be O 0 4.5128781493986025e-05
protective O 0 0.07113265246152878
alleles O 0 0.00014070079487282783
that O 0 2.8977630790905096e-05
prevent O 0 0.00010262971045449376
or O 0 2.9940589229227044e-05
reduce O 0 5.575849354499951e-05
the O 0 5.9196176152909175e-05
risk O 0 0.0001838813186623156
of O 0 0.0001517595665063709
developing O 0 0.0623677559196949
BPAD B-Disease 1 0.9999700784683228
, O 0 7.133591134333983e-05
similar O 0 2.6997657187166624e-05
to O 0 1.799915116862394e-05
what O 0 2.2180089217727073e-05
is O 0 2.443455559841823e-05
observed O 0 3.819424091489054e-05
in O 0 2.8111990104662254e-05
other O 0 4.6824679884593934e-05
genetic B-Disease 1 0.944162905216217
disorders I-Disease 1 0.9999958276748657
, O 0 0.001268833875656128
we O 0 0.00011637898569460958
used O 0 0.0006670016446150839
mental O 1 0.9999833106994629
health O 1 0.9995248317718506
wellness O 1 0.9999758005142212
( O 0 0.00570080429315567
absence O 0 0.010478559881448746
of O 0 0.0011933969799429178
any O 0 0.2704452574253082
psychiatric B-Disease 1 0.9999997615814209
disorder I-Disease 1 0.9999997615814209
) O 0 0.0005109792109578848
as O 0 6.474755355156958e-05
the O 0 0.00010781550372485071
phenotype O 0 0.0006309902528300881
in O 0 3.630417995736934e-05
our O 0 9.102155308937654e-05
genome O 0 0.00019054407312069088
- O 0 0.0002533587394282222
wide O 0 0.00010846702934941277
linkage O 0 0.00038828185643069446
scan O 0 0.0001334080589003861
of O 0 4.895590973319486e-05
several O 0 4.348559014033526e-05
large O 0 9.641339420340955e-05
multigeneration O 0 0.041820038110017776
Old O 0 0.0006787626771256328
Order O 0 0.0002548549964558333
Amish O 0 0.0016933968290686607
pedigrees O 0 0.0006004430470056832
exhibiting O 0 0.0005094332154840231
an O 0 0.00013119907816872
extremely O 0 0.00033076893305405974
high O 0 0.0009106702636927366
incidence O 0 0.20083850622177124
of O 0 0.004348699003458023
BPAD B-Disease 1 0.9999743700027466
. O 0 0.003178122453391552

We O 0 0.0007479331688955426
have O 0 0.00019396148854866624
found O 0 0.00010497051698621362
strong O 0 0.00010700698476284742
evidence O 0 9.203662193613127e-05
for O 0 5.278117168927565e-05
a O 0 9.934940317180008e-05
locus O 0 0.00025187412393279374
on O 0 8.035337668843567e-05
chromosome O 0 0.00035545756691135466
4p O 1 0.6981958746910095
at O 0 0.0002984053280670196
D4S2949 O 0 0.06764565408229828
( O 0 0.0001754661207087338
maximum O 0 0.0002856467035599053
GENEHUNTER O 1 0.7503923177719116
- O 0 0.0008711186237633228
PLUS O 0 0.0003907407517544925
nonparametric O 0 0.0007776023703627288
linkage O 0 0.000405199738452211
score O 0 9.449703065911308e-05
= O 0 0.000136740185553208
4 O 0 9.139379835687578e-05
. O 0 4.040417115902528e-05
05 O 0 0.0003551766276359558
, O 0 6.220999057404697e-05
P O 0 0.00020600113202817738
= O 0 0.00010581249080132693
5 O 0 3.6697310861200094e-05
. O 0 1.693755984888412e-05
22 O 0 4.279878339730203e-05
x O 0 6.602847133763134e-05
10 O 0 4.02257101086434e-05
( O 0 5.4393578466260806e-05
- O 0 0.0001379523891955614
4 O 0 8.890347089618444e-05
) O 0 6.268389552133158e-05
; O 0 5.848592263646424e-05
SIBPAL O 0 0.0026170487981289625
Pempirical O 0 0.0008407687419094145
value O 0 7.07920771674253e-05
< O 0 0.000179494425537996
3 O 0 4.169121530139819e-05
x O 0 8.986159082269296e-05
10 O 0 4.03510348405689e-05
( O 0 6.119595491327345e-05
- O 0 0.00010868258686969057
5 O 0 6.167795800138265e-05
) O 0 3.375734013388865e-05
) O 0 2.893706005124841e-05
and O 0 2.7596783183980733e-05
suggestive O 0 9.94462679955177e-05
evidence O 0 3.4448177757440135e-05
for O 0 2.3585478629684076e-05
a O 0 6.566051160916686e-05
locus O 0 0.00021594199643004686
on O 0 9.203855006489903e-05
chromosome O 0 0.00048689174582250416
4q O 0 0.044635992497205734
at O 0 0.00015281917876563966
D4S397 O 0 0.021474938839673996
( O 0 0.00019377845455892384
maximum O 0 0.00024111391394399107
GENEHUNTER O 1 0.5418639779090881
- O 0 0.00057799625210464
PLUS O 0 0.0004613625933416188
nonparametric O 0 0.0007816729485057294
linkage O 0 0.000312979071168229
score O 0 7.085251854732633e-05
= O 0 0.00011203275789739564
3 O 0 4.8267280362779275e-05
. O 0 2.377186501689721e-05
29 O 0 5.5019390856614336e-05
, O 0 4.74511252832599e-05
P O 0 0.00015527894720435143
= O 0 8.478442759951577e-05
2 O 0 3.641236253315583e-05
. O 0 2.1670619389624335e-05
57 O 0 6.933189433766529e-05
x O 0 6.888284406159073e-05
10 O 0 4.0866350900614634e-05
( O 0 4.939126665703952e-05
- O 0 0.00010702881263568997
3 O 0 6.285892595769837e-05
) O 0 4.43528697360307e-05
; O 0 5.143005182617344e-05
SIBPAL O 0 0.0019413696136325598
Pempirical O 0 0.0010618555825203657
value O 0 9.5563598733861e-05
< O 0 0.0002414117770968005
1 O 0 5.873285044799559e-05
x O 0 6.941154424566776e-05
10 O 0 4.5348802814260125e-05
( O 0 4.710837310994975e-05
- O 0 8.33237572805956e-05
3 O 0 4.77414287161082e-05
) O 0 3.5173037758795545e-05
) O 0 2.5374089091201313e-05
that O 0 2.0846948245889507e-05
are O 0 2.1312142052920535e-05
linked O 0 0.00014910752361174673
to O 0 0.00016738518024794757
mental O 1 0.9996297359466553
health O 1 0.9862207174301147
wellness O 1 0.9995644688606262
. O 0 0.002988371765241027

These O 0 0.0004373173287604004
findings O 0 0.00024721803492866457
are O 0 4.52958993264474e-05
consistent O 0 8.625994087196887e-05
with O 0 3.308502709842287e-05
the O 0 7.44764183764346e-05
hypothesis O 0 0.00015304637781810015
that O 0 2.367724482610356e-05
certain O 0 3.724132329807617e-05
alleles O 0 0.00010682653373805806
could O 0 4.7174544306471944e-05
prevent O 0 8.481766417389736e-05
or O 0 3.155578815494664e-05
modify O 0 9.549856622470543e-05
the O 0 6.38102792436257e-05
clinical O 0 0.001601631403900683
manifestations O 0 0.0716014951467514
of O 0 0.004463373217731714
BPAD B-Disease 1 0.9999961853027344
and O 0 0.00068420305615291
perhaps O 0 0.0011857361532747746
other O 0 0.0001980986271519214
related O 1 0.7224427461624146
affective B-Disease 1 0.9999961853027344
disorders I-Disease 1 0.9999971389770508
. O 0 0.2202945351600647

Segregation O 1 0.9963992834091187
distortion O 1 0.9985653758049011
in O 1 0.7553475499153137
myotonic B-Disease 1 0.9999979734420776
dystrophy I-Disease 1 0.9999984502792358
. O 0 0.2863274812698364

Myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 1.0
( O 1 0.9998098015785217
DM B-Disease 1 0.9999998807907104
) O 0 0.004532795399427414
is O 0 0.00040334369987249374
an O 0 0.0021779462695121765
autosomal B-Disease 1 0.9998633861541748
dominant I-Disease 1 0.9997463822364807
disease I-Disease 1 0.9999940395355225
which O 0 0.00018844279111362994
, O 0 5.713400969398208e-05
in O 0 3.225062391720712e-05
the O 0 5.867675645276904e-05
typical O 0 0.00020520752877928317
pedigree O 0 0.0006066585774533451
, O 0 4.6016721171326935e-05
shows O 0 7.615017239004374e-05
a O 0 0.00012911137309856713
three O 0 0.000168802376720123
generation O 0 0.002602839842438698
anticipation O 0 0.004296441096812487
cascade O 0 0.06530395150184631
. O 0 0.0014219621662050486

This O 0 0.000984483864158392
results O 0 0.0010925396345555782
in O 0 0.0025285028386861086
infertility B-Disease 1 0.9999979734420776
and O 1 0.9999176263809204
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999397993087769
CDM B-Disease 1 0.9999852180480957
) O 0 0.00027034434606321156
with O 0 6.490130181191489e-05
the O 0 0.00010102534724865109
disappearance O 0 0.0016283767763525248
of O 0 0.0011100193951278925
DM B-Disease 1 0.9999802112579346
in O 0 0.0002935846569016576
that O 0 0.00031494020367972553
pedigree O 0 0.007029863074421883
. O 0 0.0009193192818202078

The O 0 0.0010042613139376044
concept O 0 0.0008404403342865407
of O 0 0.0003828814660664648
segregation O 1 0.8526183366775513
distortion O 0 0.4857480227947235
, O 0 9.673405293142423e-05
where O 0 4.34844296250958e-05
there O 0 2.348004636587575e-05
is O 0 2.3838902052375488e-05
preferential O 0 6.846072210464627e-05
transmission O 0 5.85479756409768e-05
of O 0 2.3374304873868823e-05
the O 0 2.879076055251062e-05
larger O 0 4.201233969070017e-05
allele O 0 7.703451410634443e-05
at O 0 6.688578287139535e-05
the O 0 0.00023801758652552962
DM B-Disease 1 0.9999958276748657
locus O 0 0.01279637310653925
, O 0 5.1615577831398696e-05
has O 0 2.9712869945797138e-05
been O 0 3.668086355901323e-05
put O 0 4.5115873945178464e-05
forward O 0 5.5284308473346755e-05
to O 0 2.7436084565124474e-05
explain O 0 7.769079093122855e-05
partially O 0 0.00015668146079406142
the O 0 7.98986729932949e-05
maintenance O 0 0.0017263422487303615
of O 0 0.00043091760016977787
DM B-Disease 1 0.9999572038650513
in O 0 0.000190678023500368
the O 0 0.00038405199302360415
population O 0 0.000407315616030246
. O 0 0.0008200688171200454

In O 0 0.0005613032262772322
a O 0 0.0003732502809725702
survey O 0 0.00035996802034787834
of O 0 0.000280343258054927
DM B-Disease 1 0.9999086856842041
in O 0 0.00011722836643457413
Northern O 0 0.00023441907251253724
Ireland O 0 0.0002374667819822207
, O 0 0.0001164913410320878
59 O 0 0.0004308549396228045
pedigrees O 0 0.0010384708875790238
were O 0 0.00025870202807709575
ascertained O 0 0.002673011040315032
. O 0 0.0011711646802723408

Sibships O 1 0.7286127805709839
where O 0 0.0008471084292978048
the O 0 0.00022737566905561835
status O 0 0.00018981366883963346
of O 0 8.733843424124643e-05
all O 0 3.530635513016023e-05
the O 0 3.9244259824045e-05
members O 0 3.4733584470814094e-05
had O 0 4.423932477948256e-05
been O 0 3.377292523509823e-05
identified O 0 3.998796455562115e-05
were O 0 1.754403638187796e-05
examined O 0 5.3935324103804305e-05
to O 0 1.9519964553182945e-05
determine O 0 2.9872597224311903e-05
the O 0 3.409549390198663e-05
transmission O 0 0.0001340319577138871
of O 0 7.447699317708611e-05
the O 0 0.0003950221580453217
DM B-Disease 1 0.99998939037323
expansion O 0 0.0009838987607508898
from O 0 0.00010774828842841089
affected O 0 0.0001856023009167984
parents O 0 0.00012396136298775673
to O 0 5.520670674741268e-05
their O 0 0.00014782859943807125
offspring O 0 0.0014565304154530168
. O 0 0.0009032049565576017

Where O 0 0.001714121550321579
the O 0 0.0006477867136709392
transmitting O 0 0.0022744862362742424
parent O 0 0.0010722760343924165
was O 0 0.000517407082952559
male O 0 0.0005666736396960914
, O 0 0.0003001172444783151
58 O 0 0.0011941997800022364
. O 0 0.0011976194800809026

3 O 0 0.0009204078814946115
% O 0 0.00024148295051418245
of O 0 0.00011965104204136878
the O 0 0.0001202925996039994
offspring O 0 0.00047984003322198987
were O 0 5.072084240964614e-05
affected O 0 0.00010158991790376604
, O 0 2.486633457010612e-05
and O 0 1.5324820196838118e-05
in O 0 1.7671503883320838e-05
the O 0 3.19594910251908e-05
case O 0 4.581499888445251e-05
of O 0 4.974872717866674e-05
a O 0 0.00011109912156825885
female O 0 0.0009021581499837339
transmitting O 0 0.006155712530016899
parent O 0 0.0008308675605803728
, O 0 0.0001909502170747146
68 O 0 0.0014563617296516895
. O 0 0.001090875593945384

7 O 0 0.003195675788447261
% O 0 0.0011404146207496524
were O 0 0.000822142290417105
affected O 0 0.001724738860502839
. O 0 0.0012562911724671721

Studies O 0 0.0018381025874987245
on O 0 0.0008100591949187219
meiotic O 1 0.9079792499542236
drive O 0 0.0038415309973061085
in O 0 0.00037155914469622076
DM B-Disease 1 0.9999762773513794
have O 0 0.0001179601313197054
shown O 0 7.919307972770184e-05
increased O 0 7.462814392056316e-05
transmission O 0 9.032773959916085e-05
of O 0 3.222557279514149e-05
the O 0 4.733109017251991e-05
larger O 0 5.374934698920697e-05
allele O 0 8.529709884896874e-05
at O 0 5.744404552388005e-05
the O 0 0.00014351854042615741
DM B-Disease 1 0.9995155334472656
locus O 0 0.0011111039202660322
in O 0 0.00020802485232707113
non O 0 0.013334072194993496
- O 1 0.9732301235198975
DM O 1 0.9999871253967285
heterozygotes O 1 0.6562979817390442
for O 0 0.0008377059129998088
CTGn O 1 0.9539617300033569
. O 0 0.0024712616577744484

This O 0 0.0005048370803706348
study O 0 0.00023512863845098764
provides O 0 0.00016109571151901037
further O 0 8.804738899925724e-05
evidence O 0 7.907611143309623e-05
that O 0 4.863687718170695e-05
the O 0 0.0001775945129338652
DM B-Disease 1 0.9999520778656006
expansion O 0 0.0009078691946342587
tends O 0 0.0002419034717604518
to O 0 7.343830657191575e-05
be O 0 0.0001073313396773301
transmitted O 0 0.000523048045579344
preferentially O 0 0.0014318996109068394
. O 0 0.0007386470097117126

Diagnosis O 1 0.9982635378837585
of O 1 0.6158717274665833
hemochromatosis B-Disease 1 0.9999955892562866
. O 0 0.1696915179491043

If O 0 0.022132884711027145
untreated O 1 0.9999847412109375
, O 1 0.9757322072982788
hemochromatosis B-Disease 1 1.0
can O 0 0.26570892333984375
cause O 1 0.9999042749404907
serious O 1 0.9999889135360718
illness O 1 0.9999990463256836
and O 0 0.12112834304571152
early B-Disease 0 0.2868122458457947
death I-Disease 1 0.9814087748527527
, O 0 0.000241888701566495
but O 0 4.838839959120378e-05
the O 0 0.0002593651588540524
disease O 1 0.9983168840408325
is O 0 0.0001348489458905533
still O 0 0.00020877296628896147
substantially O 0 0.0008360161446034908
under O 0 0.006827869452536106
- O 1 0.9978491067886353
diagnosed O 1 0.9999382495880127
. O 0 0.0020267062354832888

The O 0 0.0016039044130593538
cornerstone O 0 0.28287267684936523
of O 0 0.0007150116143748164
screening O 0 0.0008246804936788976
and O 0 0.00013941229553893209
case O 0 0.00021850191114936024
detection O 0 0.00035344919888302684
is O 0 6.63813843857497e-05
the O 0 8.176393748726696e-05
measurement O 0 0.00017925018619280308
of O 0 0.0001732161472318694
serum O 1 0.8205490112304688
transferrin O 1 0.7760850191116333
saturation O 0 0.0013729935744777322
and O 0 0.00013708510959986597
the O 0 0.00031995397876016796
serum O 0 0.11043141782283783
ferritin O 0 0.22228357195854187
level O 0 0.0012777713127434254
. O 0 0.0010884838411584496

Once O 0 0.0036128638312220573
the O 0 0.0012400172417983413
diagnosis O 1 0.6848248243331909
is O 0 0.00021236063912510872
suspected O 0 0.0013214267091825604
, O 0 0.0001752158277668059
physicians O 0 0.00046470225788652897
must O 0 7.597928197355941e-05
use O 0 9.659551869845018e-05
serum O 0 0.19728335738182068
ferritin O 1 0.9192734956741333
levels O 0 0.00039846578147262335
and O 0 0.0002526230236981064
hepatic O 1 0.998874843120575
iron O 1 0.9968505501747131
stores O 0 0.00038992881309241056
on O 0 0.0002171071682823822
liver O 1 0.9900879263877869
biopsy O 1 0.6003955006599426
specimens O 0 0.00015768266166560352
to O 0 5.863916885573417e-05
assess O 0 0.0002841706736944616
patients O 0 0.0002935253141913563
for O 0 4.8806930863065645e-05
the O 0 0.00010380727326264605
presence O 0 0.00032444632961414754
of O 0 0.00110021629370749
iron B-Disease 1 0.9999425411224365
overload I-Disease 1 0.9998075366020203
. O 0 0.002040258375927806

Liver O 1 0.9999536275863647
biopsy O 1 0.9964877367019653
is O 0 0.00036827230360358953
also O 0 7.348391227424145e-05
used O 0 3.114513310720213e-05
to O 0 1.77623860508902e-05
establish O 0 4.419370088726282e-05
the O 0 3.301297692814842e-05
presence O 0 6.399015546776354e-05
or O 0 3.994550570496358e-05
absence O 0 0.00035200390266254544
of O 0 0.0012059406144544482
cirrhosis B-Disease 1 0.999994158744812
, O 0 0.0005195583798922598
which O 0 5.881659308215603e-05
can O 0 6.392990326276049e-05
affect O 0 0.00047771609388291836
prognosis O 1 0.9957308173179626
and O 0 0.00039384918636642396
management O 0 0.004135506227612495
. O 0 0.001108079683035612

A O 0 0.001958768581971526
DNA O 0 0.0010689006885513663
- O 0 0.0007532752933911979
based O 0 8.900721877580509e-05
test O 0 8.843969408189878e-05
for O 0 3.2989628380164504e-05
the O 0 0.00010467365791555494
HFE O 1 0.9966936111450195
gene O 0 0.00011552913929335773
is O 0 3.633656888268888e-05
commercially O 0 4.2107320041395724e-05
available O 0 1.5310448361560702e-05
, O 0 1.3926041901868302e-05
but O 0 8.696722943568602e-06
its O 0 1.0465390005265363e-05
place O 0 2.7630016120383516e-05
in O 0 1.899668131954968e-05
the O 0 7.357849972322583e-05
diagnosis O 1 0.9479921460151672
of O 0 0.06765718758106232
hemochromatosis B-Disease 1 0.9999996423721313
is O 0 0.0021720591466873884
still O 0 0.0002711797133088112
being O 0 0.0003575297014322132
evaluated O 0 0.0011038086377084255
. O 0 0.0008177489507943392

Currently O 0 0.0009599023032933474
, O 0 0.00026876202900893986
the O 0 0.00017328652029391378
most O 0 5.821871309308335e-05
useful O 0 5.387939017964527e-05
role O 0 6.608276453334838e-05
for O 0 2.5277144231949933e-05
this O 0 1.753139258653391e-05
test O 0 3.096400178037584e-05
is O 0 1.2515115486166906e-05
in O 0 1.3011395822104532e-05
the O 0 3.035545341845136e-05
detection O 0 0.0002510019694454968
of O 0 0.00021810643374919891
hemochromatosis B-Disease 1 0.9999967813491821
in O 0 5.210394010646269e-05
the O 0 5.757325197919272e-05
family O 0 6.0497688536997885e-05
members O 0 2.6823148800758645e-05
of O 0 9.10831950022839e-05
patients O 0 0.011757614091038704
with O 0 3.6374876799527556e-05
a O 0 0.00015772281039971858
proven O 0 0.006638854276388884
case O 0 0.00023974626674316823
of O 0 0.0003489372320473194
the O 0 0.02050424925982952
disease O 1 0.9998985528945923
. O 0 0.002856305567547679

It O 0 0.0005956182139925659
is O 0 0.0003062433679588139
crucial O 0 0.0006065168417990208
to O 0 0.00035496571217663586
diagnose O 1 0.9999592304229736
hemochromatosis B-Disease 1 0.9999998807907104
before O 1 0.9996353387832642
hepatic B-Disease 1 0.9999998807907104
cirrhosis I-Disease 1 1.0
develops O 1 0.9999971389770508
because O 1 0.9990599751472473
phlebotomy O 1 0.9999997615814209
therapy O 1 0.9999974966049194
can O 0 0.31401729583740234
avert O 1 0.9999955892562866
serious O 1 0.9999997615814209
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9207866191864014
can O 0 0.0003223381645511836
even O 0 8.487219747621566e-05
lead O 0 0.00020878609211649746
to O 0 5.0024082156596705e-05
normal O 0 0.00016391796816606075
life O 0 0.0004584142880048603
expectancy O 0 0.0036648644600063562
. O 0 0.00029940358945168555
. O 0 0.0005639093578793108

Prevalence O 0 0.013822156004607677
of O 0 0.0009249423164874315
the O 0 0.0021234690211713314
I1307K O 1 0.9999446868896484
APC B-Disease 1 0.9998008608818054
gene O 0 0.0006190569838508964
variant O 0 0.0002388295833952725
in O 0 6.0629194194916636e-05
Israeli O 0 0.00017668481450527906
Jews O 0 0.00012722404790110886
of O 0 5.6873952416935936e-05
differing O 0 5.396732012741268e-05
ethnic O 0 6.367678724927828e-05
origin O 0 7.790154631948099e-05
and O 0 0.00026044182595796883
risk O 0 0.38730913400650024
for O 0 0.3580332398414612
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999986886978149
. O 0 0.15665380656719208

BACKGROUND O 0 0.011854030191898346
& O 0 0.01347648911178112
AIMS O 0 0.002001593355089426
Israeli O 0 0.0005649250815622509
Jews O 0 0.0002730377309489995
of O 0 8.961880666902289e-05
European O 0 0.00010373247641837224
birth O 0 0.0020933044143021107
, O 0 5.567735934164375e-05
i O 0 0.00010652115452103317
. O 0 3.637914778664708e-05
e O 0 6.581837078556418e-05
. O 0 2.6459840228199027e-05
, O 0 2.677231896086596e-05
Ashkenazim O 0 0.0002526827738620341
, O 0 3.5423581721261144e-05
have O 0 2.2364238247973844e-05
the O 0 9.214243618771434e-05
highest O 1 0.979487955570221
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
incidence O 1 0.9921233057975769
of O 0 0.0012312234612181783
any O 0 0.0001511456648586318
Israeli O 0 0.0005410907906480134
ethnic O 0 0.000378286320483312
group O 0 0.0007034527370706201
. O 0 0.0009595209849067032

The O 0 0.0042742411606013775
I1307K O 1 0.9990555644035339
APC B-Disease 1 0.9956874251365662
gene O 0 0.0015948001528158784
variant O 0 0.0014693181728944182
was O 0 0.0004021989298053086
found O 0 0.00017021727398969233
in O 0 0.00023310139658860862
6 O 0 0.0007379903108812869
. O 0 0.0009911110391840339

1 O 0 0.0006153956055641174
% O 0 0.00023227650672197342
of O 0 0.00013186884461902082
American O 0 0.0001446402893634513
Jews O 0 0.00015325901040341705
, O 0 4.657990575651638e-05
28 O 0 6.556879088748246e-05
% O 0 3.633688174886629e-05
of O 0 7.594754424644634e-05
their O 0 0.00045819193474017084
familial O 1 0.9999994039535522
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cases O 0 0.3863357901573181
, O 0 0.0004292037629056722
but O 0 4.4438223994802684e-05
not O 0 3.667841519927606e-05
in O 0 7.056723552523181e-05
non O 0 0.00048626051284372807
- O 0 0.0058069187216460705
Jews O 0 0.0010117355268448591
. O 0 0.0007715501706115901

We O 0 0.0008191762026399374
assessed O 0 0.0009519159211777151
the O 0 0.0004802283365279436
I1307K O 1 0.8311272263526917
prevalence O 0 0.006740815471857786
in O 0 9.316964133176953e-05
Israeli O 0 0.0002608628128655255
Jews O 0 0.00016949977725744247
of O 0 7.044660742394626e-05
differing O 0 6.007112824590877e-05
ethnic O 0 8.021197572816163e-05
origin O 0 0.00012563905329443514
and O 0 0.00037030939711257815
risk O 1 0.8489956855773926
for O 1 0.8125017881393433
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
. O 1 0.5037665367126465

METHODS O 0 0.001404826296493411
DNA O 0 0.0005378965870477259
samples O 0 0.00021110998932272196
from O 0 8.535561937605962e-05
500 O 0 0.00022354759857989848
unrelated O 0 0.00024856426171027124
Jews O 0 0.0001308070932282135
of O 0 4.959393118042499e-05
European O 0 5.6425567890983075e-05
or O 0 5.912317647016607e-05
non O 0 0.00015934828843455762
- O 0 0.00020121759735047817
European O 0 3.4849243093049154e-05
origin O 0 3.284823105786927e-05
, O 0 2.2401680325856432e-05
with O 0 1.8492521121515892e-05
or O 0 1.9949080524384044e-05
without O 0 1.9680564946611412e-05
a O 0 3.8497204513987526e-05
personal O 0 0.00013369100634008646
and O 0 7.406719669234008e-05
/ O 0 0.004286513663828373
or O 0 5.117335240356624e-05
family O 0 8.174272807082161e-05
history O 0 0.00011076369264628738
of O 0 0.0004666020395234227
neoplasia B-Disease 1 0.9997792840003967
, O 0 9.220299398293719e-05
were O 0 4.564178016153164e-05
examined O 0 0.00012387368769850582
for O 0 4.235980668454431e-05
the O 0 0.00010736624244600534
I1307K O 0 0.12245822697877884
variant O 0 0.00023568035976495594
by O 0 5.762713772128336e-05
the O 0 8.204323967220262e-05
allele O 0 0.00019513419829308987
- O 0 0.0002743680961430073
specific O 0 0.00011700789036694914
oligonucleotide O 0 0.001449751784093678
( O 0 0.0003952926490455866
ASO O 1 0.5265721678733826
) O 0 0.000392279151128605
method O 0 0.000521205656696111
. O 0 0.0005622965400107205

RESULTS O 0 0.0008931357297115028
In O 0 0.00020399392815306783
persons O 0 0.00021052605006843805
at O 0 0.00019876364967785776
average O 0 0.0003516131837386638
risk O 0 0.11020409315824509
for O 0 0.08605288714170456
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
, O 0 0.18539419770240784
I1307K O 1 0.9990321397781372
was O 0 0.001763243111781776
found O 0 0.00011514311336213723
in O 0 0.00015294295735657215
5 O 0 0.00048019556561484933
. O 0 0.0007266945904120803

0 O 0 0.0010811301181092858
% O 0 0.00037474522832781076
of O 0 0.0002323901717318222
120 O 0 0.00037304748548194766
European O 0 0.00022784224711358547
and O 0 0.00024778436636552215
1 O 0 0.0006602665525861084
. O 0 0.0008461156976409256

6 O 0 0.0015280332881957293
% O 0 0.0002908117021434009
of O 0 0.00026702950708568096
188 O 0 0.00060435471823439
non O 0 0.00038557659718208015
- O 0 0.0003385560121387243
European O 0 9.873061935650185e-05
Jews O 0 0.0002390225272392854
( O 0 0.00016484053048770875
P O 0 0.0009853738592937589
= O 0 0.00033605226781219244
0 O 0 0.00018882482254412025
. O 0 0.00015887916379142553
08 O 0 0.001324585871770978
) O 0 0.0004961995873600245
. O 0 0.0010687831090763211

It O 0 0.0011559586273506284
occurred O 0 0.0017565949819982052
in O 0 0.0005125158349983394
15 O 0 0.0015346944564953446
. O 0 0.0018641807837411761

4 O 0 0.0007539919461123645
% O 0 0.00024569628294557333
of O 0 0.00017032280447892845
52 O 0 0.0003525395877659321
Ashkenazi O 0 0.0018422085558995605
Israelis O 0 0.0005605387268587947
with O 0 0.0003072968393098563
familial O 1 0.9998983144760132
cancer B-Disease 1 0.9999758005142212
( O 0 0.062101732939481735
P O 1 0.7129719257354736
= O 0 0.00043351019849069417
0 O 0 6.471922097261995e-05
. O 0 4.390486719785258e-05
02 O 0 0.0009677315829321742
) O 0 3.12709053105209e-05
and O 0 2.224836680397857e-05
was O 0 3.0000381229911e-05
not O 0 8.88845170265995e-06
detected O 0 2.6492336473893374e-05
in O 0 1.669293487793766e-05
51 O 0 6.812754145357758e-05
non O 0 9.396202949574217e-05
- O 0 0.00018864611047320068
European O 0 6.879173452034593e-05
Jews O 0 0.00022276163508649915
at O 0 0.0004300812433939427
increased O 0 0.00820118747651577
cancer B-Disease 1 0.999357283115387
risk O 0 0.027287160977721214
. O 0 0.0012152078561484814

Colorectal B-Disease 1 0.9999914169311523
neoplasia I-Disease 1 0.9999613761901855
occurred O 0 0.22022928297519684
personally O 0 0.00781332328915596
or O 0 8.948516187956557e-05
in O 0 3.235632539144717e-05
the O 0 4.5590149966301396e-05
families O 0 3.559584365575574e-05
of O 0 3.3172633266076446e-05
13 O 0 5.331715874490328e-05
of O 0 6.140834011603147e-05
20 O 0 0.0001530249137431383
Ashkenazi O 0 0.045319270342588425
I1307K O 1 0.950625479221344
carriers O 0 0.00026091805193573236
, O 0 4.670587441069074e-05
8 O 0 6.640962237725034e-05
of O 0 5.9950780268991366e-05
whom O 0 0.00012425331806298345
also O 0 4.017686296720058e-05
had O 0 6.07602960371878e-05
a O 0 8.07404940132983e-05
personal O 0 0.00018156450823880732
or O 0 8.264723874162883e-05
family O 0 0.0002270479017170146
history O 0 0.0006750414613634348
of O 0 0.036170583218336105
noncolonic O 1 0.9999691247940063
neoplasia B-Disease 1 0.9999459981918335
. O 0 0.004125264938920736

CONCLUSIONS O 0 0.0037699169479310513
The O 0 0.0020021970849484205
I1307K O 1 0.9991418123245239
APC O 1 0.9981855750083923
variant O 0 0.002718429546803236
may O 0 0.0001226927270181477
represent O 0 9.071757813217118e-05
a O 0 0.00015133155102375895
susceptibility O 0 0.09019903838634491
gene O 0 0.00024931810912676156
for O 0 0.00021748551807831973
colorectal B-Disease 1 0.9999912977218628
, I-Disease 0 0.00017189559002872556
or I-Disease 0 5.643778422381729e-05
other I-Disease 0 2.7585785574046895e-05
, I-Disease 0 0.0001745871122693643
cancers I-Disease 0 0.44003236293792725
in O 0 6.689828296657652e-05
Ashkenazi O 0 0.031123628839850426
Jews O 0 0.00045953731751069427
, O 0 7.196291699074209e-05
and O 0 5.7036897487705573e-05
partially O 0 0.00038683266029693186
explains O 0 0.00017459577065892518
the O 0 8.047706796787679e-05
higher O 0 0.00027495570247992873
incidence O 1 0.9448521137237549
of O 1 0.9141259789466858
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.999993085861206
in O 0 0.0013942597433924675
European O 0 0.0008229589438997209
Israelis O 0 0.006701009348034859
. O 0 0.0012676812475547194

Systematic O 0 0.00344165600836277
analysis O 0 0.0009082481847144663
of O 0 0.0009025777690112591
coproporphyrinogen O 1 0.9998359680175781
oxidase O 1 0.9990932941436768
gene O 0 0.02086709253489971
defects O 1 0.9932034015655518
in O 0 0.00042485506855882704
hereditary B-Disease 1 0.9998906850814819
coproporphyria I-Disease 1 0.9999762773513794
and O 0 0.05356776714324951
mutation O 0 0.22069673240184784
update O 0 0.005463151726871729
. O 0 0.001086335047148168

Hereditary B-Disease 1 0.9997034668922424
coproporphyria I-Disease 1 0.9999662637710571
( O 1 0.8228904008865356
HC B-Disease 1 0.9999524354934692
) O 0 0.0012805125443264842
is O 0 0.0010485613020136952
an O 0 0.23474837839603424
acute O 1 0.9999998807907104
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9970718622207642
autosomal O 1 0.9999899864196777
dominant O 1 0.9999092817306519
inheritance O 1 0.999864935874939
caused O 1 0.9996694326400757
by O 0 0.002187940524891019
deficient B-Disease 1 0.9376078844070435
activity I-Disease 0 0.00036098866257816553
of I-Disease 0 0.0027175312861800194
coproporphyrinogen I-Disease 1 0.9999884366989136
III I-Disease 1 0.9999901056289673
oxidase I-Disease 1 0.9966239929199219
( O 0 0.0014113736106082797
CPO O 0 0.025908175855875015
) O 0 0.0004820986941922456
. O 0 0.0008670923416502774

Clinical O 1 0.7616503238677979
manifestations O 1 0.8394644856452942
of O 0 0.017645694315433502
the O 1 0.8275703191757202
disease O 1 0.9999910593032837
are O 0 0.00013336556730791926
characterized O 1 0.649427056312561
by O 0 0.004495878703892231
acute O 1 0.9999982118606567
attacks O 1 0.956121563911438
of O 1 0.9999215602874756
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.7065297961235046
precipitated O 1 0.9999843835830688
by O 0 0.004687353502959013
drugs O 0 0.3212870657444
, O 0 0.0006960634491406381
fasting O 0 0.4840628206729889
, O 0 0.0005810157745145261
cyclical O 1 0.998836100101471
hormonal O 1 0.9990146160125732
changes O 0 0.0007887592073529959
, O 0 0.0045239306055009365
or O 0 0.08933081477880478
infectious B-Disease 1 0.9999889135360718
diseases I-Disease 1 0.9999799728393555
. O 0 0.026345273479819298

Skin O 1 0.9999895095825195
photosensitivity O 1 0.9999399185180664
may O 0 0.0021469879429787397
also O 0 0.00045670627150684595
be O 0 0.0002391576999798417
present O 0 0.0007865757797844708
. O 0 0.001116459839977324

The O 0 0.001180920284241438
seven O 0 0.0006342182168737054
exons O 0 0.0011431783204898238
, O 0 0.00026994565268978477
the O 0 0.0002112293877871707
exon O 0 0.0032932625617831945
/ O 0 0.0014740342739969492
intron O 0 0.0015749286394566298
boundaries O 0 0.000126932849525474
and O 0 4.6834058593958616e-05
part O 0 6.18361882516183e-05
of O 0 5.283158316160552e-05
3 O 0 8.244226046372205e-05
noncoding O 0 0.0002291778364451602
sequence O 0 6.152175774332136e-05
of O 0 4.305648326408118e-05
the O 0 7.12478649802506e-05
CPO O 0 0.0009494631085544825
gene O 0 6.92341782269068e-05
were O 0 2.8654108973569237e-05
systematically O 0 9.419689740752801e-05
analyzed O 0 4.5724336814600974e-05
by O 0 2.991107976413332e-05
an O 0 4.349562732386403e-05
exon O 0 0.00047325665946118534
- O 0 0.000332221738062799
by O 0 8.534031076123938e-05
- O 0 0.0006992592243477702
exon O 0 0.001782566192559898
denaturing O 0 0.12418849021196365
gradient O 0 0.10056357085704803
gel O 1 0.8777788877487183
electrophoresis O 0 0.07193513959646225
( O 0 0.0003649172722361982
DGGE O 1 0.6219268441200256
) O 0 0.00010450390254845843
strategy O 0 0.0001329759688815102
followed O 0 8.557933324482292e-05
by O 0 2.8283744541113265e-05
direct O 0 3.1004248739918694e-05
sequencing O 0 7.68229438108392e-05
in O 0 3.139179170830175e-05
seven O 0 7.557988283224404e-05
unrelated O 0 0.0003530612157192081
heterozygous O 0 0.0014302806230261922
HC B-Disease 1 0.9997312426567078
patients O 0 0.21158204972743988
from O 0 0.00012919979053549469
France O 0 0.001957364147529006
, O 0 0.0001821971236495301
Holland O 0 0.002453187946230173
, O 0 0.00011866433487739414
and O 0 0.00013567905989475548
Czech O 0 0.0012469900539144874
Republic O 0 0.0018156473524868488
. O 0 0.0012944098562002182

Seven O 0 0.0024557774886488914
novel O 0 0.0024046972393989563
mutations O 0 0.0005413465551100671
and O 0 0.00014710304094478488
two O 0 8.398610225412995e-05
new O 0 0.0001688093034317717
polymorphisms O 0 0.0006637934711761773
were O 0 0.0003576994640752673
detected O 0 0.0015452831285074353
. O 0 0.0012161261402070522

Among O 0 0.0009859040146693587
these O 0 0.0001394976716255769
mutations O 0 0.00014654664846602827
two O 0 4.6507961087627336e-05
are O 0 3.0845996661810204e-05
missense O 0 0.0006578809698112309
( O 0 0.00017780394409783185
G197W O 1 0.7574363946914673
, O 0 0.0001493083982495591
W427R O 0 0.1861465573310852
) O 0 3.678812936414033e-05
, O 0 3.080872556893155e-05
two O 0 1.879492810985539e-05
are O 0 2.085295091092121e-05
nonsense O 0 0.000337758450768888
( O 0 0.00010821143223438412
Q306X O 0 0.2350233495235443
, O 0 0.0001064902899088338
Q385X O 0 0.09506179392337799
) O 0 4.746298145619221e-05
, O 0 3.015001129824668e-05
two O 0 1.5691734006395563e-05
are O 0 1.5345354768214747e-05
small O 0 4.5874057832406834e-05
deletions O 0 0.00028868846129626036
( O 0 0.00011822814121842384
662de14bp O 0 0.025936905294656754
; O 0 0.00010981885134242475
1168del3bp O 0 0.0013234892394393682
removing O 0 0.0001691136130830273
a O 0 6.966006912989542e-05
glycine O 0 0.00013603322440758348
at O 0 4.4231648644199595e-05
position O 0 5.186039561522193e-05
390 O 0 0.00018152952543459833
) O 0 2.4601455152151175e-05
, O 0 2.55273134825984e-05
and O 0 1.6206658983719535e-05
one O 0 1.930562029883731e-05
is O 0 2.646165739861317e-05
a O 0 5.110970960231498e-05
splicing O 0 0.00016726857575122267
mutation O 0 0.00014503418060485274
( O 0 0.00010843454947462305
IVS1 O 1 0.8157633543014526
- O 0 0.015764113515615463
15c O 1 0.7138121724128723
- O 0 0.3057698607444763
- O 0 0.23684406280517578
> O 0 0.016105685383081436
g O 0 0.0003741344844456762
) O 0 7.135720079531893e-05
which O 0 5.013870031689294e-05
creates O 0 0.00016480186604894698
a O 0 0.0001365793723380193
new O 0 0.00025845548952929676
acceptor O 0 0.001116243889555335
splice O 0 0.0028376628179103136
site O 0 0.0016817381838336587
. O 0 0.0014807836851105094

The O 0 0.0014343623770400882
pathological O 0 0.0025060258340090513
significance O 0 0.0004081697843503207
of O 0 0.00013216945808380842
the O 0 0.00011848659050883725
point O 0 0.00019797569257207215
mutations O 0 0.000491723301820457
G197W O 1 0.7902255654335022
, O 0 0.00014244503108784556
W427R O 0 0.17020824551582336
, O 0 6.322684930637479e-05
and O 0 3.424954411457293e-05
the O 0 3.9409951568813995e-05
in O 0 6.423544982681051e-05
- O 0 0.005426461808383465
frame O 0 0.004931202158331871
deletion O 0 0.007039972580969334
390delGly O 0 0.08972419798374176
were O 0 6.229428254300728e-05
assessed O 0 9.943393524736166e-05
by O 0 2.8786069378838874e-05
their O 0 2.2277283278526738e-05
respective O 0 4.494680615607649e-05
expression O 0 8.060593972913921e-05
in O 0 3.4287349990336224e-05
a O 0 8.585405885241926e-05
prokaryotic O 0 0.00024929954088293016
system O 0 9.583391511114314e-05
using O 0 7.123848627088591e-05
site O 0 0.00028739607660099864
- O 0 0.0007205914589576423
directed O 0 0.0007757162093184888
mutagenesis O 0 0.004490415565669537
. O 0 0.0008301229099743068

These O 0 0.0007328283390961587
mutations O 0 0.0006759451935067773
resulted O 0 0.00044218834955245256
in O 0 0.0001179542814497836
the O 0 0.0001709733478492126
absence O 0 0.0008504327270202339
or O 0 0.00010072782606584951
a O 0 0.0001967558782780543
dramatic O 0 0.0008663379121571779
decrease O 0 0.0004580888489726931
of O 0 0.00048611959209665656
CPO O 0 0.07057639211416245
activity O 0 0.0012320587411522865
. O 0 0.0013191733742132783

The O 0 0.000716798473149538
two O 0 0.00020836450858041644
polymorphisms O 0 0.0004926954279653728
were O 0 0.00011010982416337356
localized O 0 0.00019290135242044926
in O 0 5.4671065299771726e-05
noncoding O 0 0.00026851793518289924
part O 0 6.58338176435791e-05
of O 0 4.126474232180044e-05
the O 0 3.83642764063552e-05
gene O 0 4.75612141599413e-05
1 O 0 3.671725789899938e-05
) O 0 3.28743044519797e-05
a O 0 6.227575795492157e-05
C O 0 0.0002577713457867503
/ O 0 0.0003974216233473271
G O 0 0.0002900629478972405
polymorphism O 0 0.00012202043581055477
in O 0 3.3294811146333814e-05
the O 0 6.523972115246579e-05
promotor O 0 0.007503305096179247
region O 0 0.0001452667056582868
, O 0 6.895152182551101e-05
142 O 0 0.0001919578789966181
bp O 0 0.0003498197183944285
upstream O 0 0.00017378242046106607
from O 0 5.2935465646442026e-05
the O 0 5.625965059152804e-05
transcriptional O 0 0.00021410179033409804
initiation O 0 0.0002700346813071519
site O 0 0.0001532315363874659
( O 0 0.00018195720622316003
- O 0 0.0027678562328219414
142C O 1 0.8572157621383667
/ O 0 0.07779917865991592
G O 0 0.0011468338780105114
) O 0 4.1113515180768445e-05
, O 0 3.168853800161742e-05
and O 0 1.8882439690059982e-05
2 O 0 3.513776391628198e-05
) O 0 2.6862930099014193e-05
a O 0 4.8787016567075625e-05
6 O 0 0.00010529172868700698
bp O 0 0.00040367370820604265
deletion O 0 0.0002490294282324612
polymorphism O 0 0.00014335701416712254
in O 0 3.298421506769955e-05
the O 0 4.07556290156208e-05
3 O 0 5.7474182540318e-05
noncoding O 0 0.00015072755923029035
part O 0 5.4815671319374815e-05
of O 0 3.819675475824624e-05
the O 0 8.452893234789371e-05
CPO O 0 0.00522927101701498
gene O 0 0.00014141366409603506
, O 0 7.07653452991508e-05
574 O 0 0.0006711379974149168
bp O 0 0.00030741255613975227
downstream O 0 0.00016195527859963477
of O 0 4.7716584958834574e-05
the O 0 4.7889530833344907e-05
last O 0 6.152738933451474e-05
base O 0 8.042382978601381e-05
of O 0 5.192343451199122e-05
the O 0 6.936436693649739e-05
normal O 0 0.00016582407988607883
termination O 0 0.001876075635664165
codon O 0 0.000667442858684808
( O 0 0.00027165430947206914
+ O 0 0.0012925657210871577
574 O 0 0.008737104013562202
delATTCTT O 0 0.10765776038169861
) O 0 0.0009797291131690145
. O 0 0.0014894548803567886

Five O 0 0.0038340731989592314
intragenic O 1 0.9977363348007202
dimorphisms O 1 0.9746012091636658
are O 0 0.0001370064273942262
now O 0 0.00013813574332743883
well O 0 7.834452844690531e-05
characterized O 0 0.00018488202476873994
and O 0 3.878244388033636e-05
the O 0 3.920109156752005e-05
high O 0 8.941300620790571e-05
degree O 0 0.00011612146772677079
of O 0 0.00018676863692235202
allelic O 1 0.5449044108390808
heterogeneity O 0 0.04062262177467346
in O 0 0.00018720832304097712
HC B-Disease 1 0.9995546936988831
is O 0 9.326209692517295e-05
demonstrated O 0 8.601319859735668e-05
with O 0 1.6597645299043506e-05
seven O 0 2.850130113074556e-05
new O 0 1.9927252651541494e-05
different O 0 1.0516155271034222e-05
mutations O 0 2.4886596293072216e-05
making O 0 2.4989692974486388e-05
a O 0 3.0961491574998945e-05
total O 0 4.354950215201825e-05
of O 0 9.309318556915969e-05
nineteen O 0 0.032284513115882874
CPO O 1 0.9875184893608093
gene B-Disease 0 0.002099833684042096
defects I-Disease 1 0.8958029747009277
reported O 0 0.0001708509516902268
so O 0 7.093973545124754e-05
far O 0 0.00014832220040261745
. O 0 0.0002339613129151985
. O 0 0.000534979859367013

Coincidence O 0 0.005132959224283695
of O 0 0.0005523583968169987
two O 0 0.0002114304807037115
novel O 0 0.0008488475577905774
arylsulfatase O 1 0.6364574432373047
A O 0 0.000634952390100807
alleles O 0 0.0003913280670531094
and O 0 0.00014302850468084216
mutation O 0 0.000870538700837642
459 O 1 0.7101315259933472
+ O 0 0.09550418704748154
1G O 1 0.5693148374557495
> O 0 0.0005301462952047586
A O 0 0.00013068616681266576
within O 0 6.008310447214171e-05
a O 0 0.00010329588258173317
family O 0 0.0002014151104958728
with O 0 0.0003274331393186003
metachromatic B-Disease 1 0.9998742341995239
leukodystrophy I-Disease 1 0.9999481439590454
: O 0 0.00033780254307202995
molecular O 0 0.0002941102138720453
basis O 0 0.00016316914116032422
of O 0 0.00035535069764591753
phenotypic O 0 0.0029271687380969524
heterogeneity O 0 0.006880670785903931
. O 0 0.0016250892076641321

In O 0 0.0004552926402539015
a O 0 0.0003614103188738227
family O 0 0.00018576730508357286
with O 0 8.002593676792458e-05
three O 0 5.276828596834093e-05
siblings O 0 0.00046154664596542716
, O 0 4.980369340046309e-05
one O 0 4.5514298108173534e-05
developed O 0 0.00011078598618041724
classical O 0 0.00025598934735171497
late O 0 0.05163070559501648
infantile O 1 0.999997615814209
metachromatic B-Disease 1 0.9999992847442627
leukodystrophy I-Disease 1 0.9999998807907104
( O 1 0.9710744023323059
MLD B-Disease 1 0.9999974966049194
) O 0 0.00018281910161022097
, O 0 6.841517460998148e-05
fatal O 0 0.012248022481799126
at O 0 6.402714643627405e-05
age O 0 6.532513361889869e-05
5 O 0 4.2110495996894315e-05
years O 0 3.8759408198529854e-05
, O 0 3.251773159718141e-05
with O 0 5.9513491578400135e-05
deficient O 1 0.7959123253822327
arylsulfatase O 1 0.988628625869751
A O 0 0.01575891301035881
( O 0 0.0005741527420468628
ARSA O 1 0.8270957469940186
) O 0 0.00010387501970399171
activity O 0 0.00010816440044436604
and O 0 8.885372517397627e-05
increased O 0 0.000262485264101997
galactosylsulfatide O 1 0.971807599067688
( O 0 0.006493760738521814
GS O 1 0.9997612833976746
) O 0 0.0007323969039134681
excretion O 0 0.0051409839652478695
. O 0 0.001422039233148098

The O 0 0.0006811502971686423
two O 0 0.0001422705827280879
other O 0 6.401005521183833e-05
siblings O 0 0.0005526169552467763
, O 0 9.473413956584409e-05
apparently O 0 0.00018452451331540942
healthy O 0 0.00014252423716243356
at O 0 4.023736619274132e-05
12 O 0 4.954051837557927e-05
( O 0 3.445389666012488e-05
1 O 0 4.944206739310175e-05
/ O 0 0.00010940223000943661
2 O 0 3.26200679410249e-05
) O 0 1.4873147847538348e-05
and O 0 1.465880086470861e-05
15 O 0 2.5907575036399066e-05
years O 0 2.3866767151048407e-05
, O 0 1.821645491872914e-05
respectively O 0 3.107991142314859e-05
, O 0 2.065105400106404e-05
and O 0 1.5978197552612983e-05
their O 0 2.0441011656657793e-05
father O 0 0.00040750918560661376
, O 0 8.143432933138683e-05
apparently O 0 0.0002712748828344047
healthy O 0 0.0006509784143418074
as O 0 4.975608317181468e-05
well O 0 4.946956323692575e-05
, O 0 8.04084847914055e-05
presented O 0 0.0003296124341432005
ARSA O 1 0.9788792133331299
and O 0 0.0002633507829159498
GS O 1 0.924091100692749
values O 0 0.0001433191791875288
within O 0 9.366029553348199e-05
the O 0 0.00010448457760503516
range O 0 0.00020194202079437673
of O 0 0.0008751694695092738
MLD B-Disease 1 0.9999810457229614
patients O 1 0.9246224761009216
. O 0 0.0017155158566311002

Mutation O 0 0.005610887426882982
screening O 0 0.000997797236777842
and O 0 0.00014688089140690863
sequence O 0 0.00011341008939780295
analysis O 0 8.059594983933493e-05
disclosed O 0 0.00015441050345543772
the O 0 5.3794523410033435e-05
involvement O 0 0.0001702445442788303
of O 0 6.478159048128873e-05
three O 0 5.5077507568057626e-05
different O 0 5.42059242434334e-05
ARSA O 1 0.9657385945320129
mutations O 0 0.00014403446402866393
being O 0 5.609009895124473e-05
the O 0 6.609625415876508e-05
molecular O 0 0.00012092134420527145
basis O 0 8.855310443323106e-05
of O 0 0.00020993973885197192
intrafamilial O 1 0.6875272989273071
phenotypic O 0 0.003526789601892233
heterogeneity O 0 0.014106071554124355
. O 0 0.0016356410924345255

The O 0 0.0036850173491984606
late O 0 0.21352766454219818
infantile O 1 0.9999915361404419
patient O 1 0.999211311340332
inherited O 1 0.9981057643890381
from O 0 0.0003917081921827048
his O 0 0.0019136045593768358
mother O 0 0.04806485399603844
the O 0 0.00015070242807269096
frequent O 0 0.00030066422186791897
0 O 0 0.0001592595799593255
- O 0 0.0013562568929046392
type O 0 0.0003922245523426682
mutation O 0 0.0003964797651860863
459 O 0 0.15383510291576385
+ O 0 0.010716289281845093
1G O 1 0.6003206968307495
> O 0 0.00039009572356007993
A O 0 9.461099398322403e-05
, O 0 2.6402070943731815e-05
and O 0 1.7453588952776045e-05
from O 0 1.6363623217330314e-05
his O 0 5.7193534303223714e-05
father O 0 0.00032193431979976594
a O 0 0.00012848328333348036
novel O 0 0.000280426669633016
, O 0 6.35211545159109e-05
single O 0 0.00014855944027658552
basepair O 0 0.09108306467533112
microdeletion O 0 0.009373287670314312
of O 0 8.660511230118573e-05
guanine O 0 0.0003351813356857747
at O 0 7.574244227726012e-05
nucleotide O 0 0.00010637904779287055
7 O 0 8.621685265097767e-05
in O 0 7.510461000492796e-05
exon O 0 0.0006061401218175888
1 O 0 0.00035745950299315155
( O 0 0.0005201093736104667
7delG O 0 0.009009488858282566
) O 0 0.0008239798480644822
. O 0 0.0010563115356490016

The O 0 0.0011037413496524096
two O 0 0.0004660308186430484
clinically O 0 0.11538324505090714
unaffected O 0 0.0036965440958738327
siblings O 0 0.0008299180772155523
carried O 0 0.00019972225709352642
the O 0 0.00013856250734534115
maternal O 0 0.20924942195415497
mutation O 0 0.028206972405314445
459 O 1 0.9688856601715088
+ O 0 0.3938736021518707
1G O 1 0.9493122100830078
> O 0 0.0010478217154741287
A O 0 0.0001724179310258478
and O 0 3.603339064284228e-05
, O 0 3.926923454855569e-05
on O 0 2.8273145289858803e-05
their O 0 3.2273237593472004e-05
paternal O 0 0.00036864582216367126
allele O 0 0.00012625649105757475
, O 0 4.807907316717319e-05
a O 0 6.224643584573641e-05
novel O 0 0.0001841588964452967
cytosine O 0 0.00021554416161961854
to O 0 5.676796718034893e-05
thymidine O 0 0.00037046000943519175
transition O 0 0.00023036038328427821
at O 0 0.00013865873916074634
nucleotide O 0 0.00026016487390734255
2435 O 0 0.0030596910510212183
in O 0 8.622548921266571e-05
exon O 0 0.0005135270184837282
8 O 0 0.0001319478324148804
, O 0 6.04219276283402e-05
resulting O 0 9.995852451538667e-05
in O 0 4.575002458295785e-05
substitution O 0 0.00015984682249836624
of O 0 0.00010504612873774022
alanine O 0 0.0006848187767900527
464 O 0 0.013956825248897076
by O 0 0.0002074557705782354
valine O 1 0.7459365725517273
( O 0 0.001563172321766615
A464V O 1 0.7903300523757935
) O 0 0.0006390236085280776
. O 0 0.0010670454939827323

The O 0 0.0025359313003718853
fathers O 0 0.005101492628455162
genotype O 0 0.004988599568605423
thus O 0 0.0006932660471647978
was O 0 0.003466426394879818
7delG O 1 0.9957140684127808
/ O 1 0.9181461930274963
A464V O 1 0.9778006076812744
. O 0 0.003069667611271143

Mutation O 0 0.0761728286743164
A464V O 1 0.6004102826118469
was O 0 0.0008545869495719671
not O 0 9.631452121539041e-05
found O 0 0.00010835869034053758
in O 0 0.00010136821947526187
18 O 0 0.0004559562948998064
unrelated O 0 0.4495028555393219
MLD B-Disease 1 0.9999971389770508
patients O 1 0.8028135895729065
and O 0 0.00033956021070480347
50 O 0 0.0006478627328760922
controls O 0 0.0012990995310246944
. O 0 0.0012411364587023854

A464V O 1 0.8488689064979553
, O 0 0.001030708895996213
although O 0 0.0003948184894397855
clearly O 0 0.0004266519390512258
modifying O 0 0.002083430765196681
ARSA O 1 0.999042809009552
and O 0 0.0009928656509146094
GS O 1 0.9999352693557739
levels O 0 0.00025622767861932516
, O 0 9.30198875721544e-05
apparently O 0 0.0001975073537323624
bears O 0 0.00018522820028010756
little O 0 0.00010858126915991306
significance O 0 0.00018291498417966068
for O 0 9.253736061509699e-05
clinical O 0 0.002834948245435953
manifestation O 1 0.9860730171203613
of O 0 0.16663578152656555
MLD B-Disease 1 0.999994158744812
, O 0 0.0010821254691109061
mimicking O 0 0.013027905486524105
the O 0 0.0007101845694705844
frequent O 0 0.00601603789255023
ARSA O 1 0.9991976618766785
pseudodeficiency O 1 0.9905173182487488
allele O 0 0.005826656706631184
. O 0 0.0019654263742268085

Our O 0 0.0013447405071929097
results O 0 0.00035142083652317524
demonstrate O 0 0.0002793206076603383
that O 0 4.34447247243952e-05
in O 0 4.460333730094135e-05
certain O 0 5.6731001677690074e-05
genetic O 0 0.00034251902252435684
conditions O 0 0.18469403684139252
MLD B-Disease 1 0.9999983310699463
- O 1 0.9807580709457397
like O 0 0.023964766412973404
ARSA O 1 0.9999426603317261
and O 0 0.0006512514082714915
GS O 1 0.9997745156288147
values O 0 8.0978061305359e-05
need O 0 4.9523045163368806e-05
not O 0 1.7944561477634124e-05
be O 0 2.4329317966476083e-05
paralleled O 0 0.0003422937588766217
by O 0 0.00013893375580664724
clinical O 1 0.9425035715103149
disease O 1 0.999913215637207
, O 0 0.00019037157471757382
a O 0 0.00024446650058962405
finding O 0 0.0003460933512542397
with O 0 0.00020816948381252587
serious O 1 0.735393762588501
diagnostic O 1 0.8742814660072327
and O 0 0.00137402955442667
prognostic O 1 0.9978235960006714
implications O 0 0.03799651935696602
. O 0 0.0016579007497057319

Moreover O 0 0.004606897477060556
, O 0 0.0009487089118920267
further O 0 0.0008982469444163144
ARSA O 1 0.989251434803009
alleles O 0 0.0010430420516058803
functionally O 0 0.0007663489668630064
similar O 0 8.598974818596616e-05
to O 0 6.526659853989258e-05
A464V O 0 0.09905441105365753
might O 0 7.822082261554897e-05
exist O 0 2.558822052378673e-05
which O 0 1.2634399354283232e-05
, O 0 1.2411306670401245e-05
together O 0 1.244128816324519e-05
with O 0 1.849218642746564e-05
0 O 0 8.158371929312125e-05
- O 0 0.010305940173566341
type O 0 0.0012506257044151425
mutations O 0 0.00017786872922442853
, O 0 6.553221464855596e-05
may O 0 0.00010091973672388121
cause O 0 0.10794969648122787
pathological O 1 0.9985039234161377
ARSA O 1 0.9999905824661255
and O 0 0.06330612301826477
GS O 1 0.9999914169311523
levels O 0 0.0001858821342466399
, O 0 4.224064832669683e-05
but O 0 2.396257514192257e-05
not O 0 2.5433444534428418e-05
clinical O 0 0.0003380103735253215
outbreak O 1 0.5015558004379272
of O 0 0.0010435663862153888
the O 0 0.2622630298137665
disease O 1 0.9999804496765137
. O 0 0.0008045898866839707
. O 0 0.0009322432451881468

Human O 1 0.9915002584457397
MLH1 O 1 0.9999934434890747
deficiency O 1 0.9999991655349731
predisposes O 1 0.9998836517333984
to O 0 0.06823378056287766
hematological B-Disease 1 0.9999948740005493
malignancy I-Disease 1 0.9999991655349731
and O 1 0.9646307826042175
neurofibromatosis B-Disease 1 0.9999988079071045
type I-Disease 1 0.9462355375289917
1 I-Disease 0 0.003027725499123335
. O 0 0.00156586489174515

Heterozygous O 0 0.021245697513222694
germ O 1 0.99561607837677
- O 0 0.04711773991584778
line O 0 0.0009202692890539765
mutations O 0 0.00019572993915062398
in O 0 7.058674964355305e-05
the O 0 0.00016951335419435054
DNA O 0 0.0008397671044804156
mismatch O 1 0.9937310814857483
repair O 1 0.9214258790016174
genes O 0 0.00025629071751609445
lead O 0 0.0006176343886181712
to O 0 0.0004126985732000321
hereditary B-Disease 1 0.9999706745147705
nonpolyposis I-Disease 1 0.9999996423721313
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 0.4793035387992859

The O 0 0.4477357864379883
disease O 1 0.9999827146530151
susceptibility O 1 0.9847322106361389
of O 0 0.005483116488903761
individuals O 0 0.0008084248402155936
who O 0 0.002856598934158683
constitutionally O 0 0.016225410625338554
lack O 0 0.0012145702494308352
both O 0 6.549055251525715e-05
wild O 0 0.0015320866368710995
- O 0 0.14613109827041626
type O 0 0.0026325001381337643
alleles O 0 0.0004692930669989437
is O 0 0.00023269548546522856
unknown O 0 0.0006478423019871116
. O 0 0.0008416801574639976

We O 0 0.0006875198450870812
have O 0 0.00015593715943396091
identified O 0 0.00015123187040444463
three O 0 8.395768236368895e-05
offspring O 0 0.00023294362472370267
in O 0 0.00010596536594675854
a O 0 0.03650530055165291
hereditary B-Disease 1 0.999998927116394
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9970781803131104
who O 1 0.905335009098053
developed O 1 0.9956029653549194
hematological B-Disease 1 0.999996542930603
malignancy I-Disease 1 0.9999980926513672
at O 0 0.008750655688345432
a O 0 0.0002927910827565938
very O 0 5.147793490323238e-05
early O 0 7.375291897915304e-05
age O 0 6.72500827931799e-05
, O 0 2.3550483092549257e-05
and O 0 1.913683627208229e-05
at O 0 2.137936098733917e-05
least O 0 1.6289757695631124e-05
two O 0 1.5160273505898658e-05
of O 0 2.61466975643998e-05
them O 0 3.480672967270948e-05
displayed O 0 0.0001797684672055766
signs O 0 0.0003433657984714955
of O 0 0.0003366915916558355
neurofibromatosis B-Disease 1 0.9999717473983765
type I-Disease 0 0.14898304641246796
1 I-Disease 0 0.000939789810217917
( O 0 0.001065291347913444
NF1 B-Disease 1 0.8575156927108765
) O 0 0.0007941664080135524
. O 0 0.0012634370941668749

DNA O 0 0.0014846036210656166
sequence O 0 0.0004113103204872459
analysis O 0 0.00017617577395867556
and O 0 0.00013380451127886772
allele O 0 0.00034568278351798654
- O 0 0.00023164002050179988
specific O 0 6.601832865271717e-05
amplification O 0 0.00031700608087703586
in O 0 4.7573368647135794e-05
two O 0 5.0173428462585434e-05
siblings O 0 0.00029764726059511304
revealed O 0 0.0002997351693920791
a O 0 0.0002079308615066111
homozygous O 0 0.0037580260541290045
MLH1 O 1 0.9984564781188965
mutation O 0 0.002187376143410802
( O 0 0.0004202235140837729
C676T O 1 0.9930154085159302
- O 1 0.891952395439148
- O 1 0.8906930088996887
> O 0 0.49160119891166687
Arg226Stop O 1 0.9762009382247925
) O 0 0.0008090751944109797
. O 0 0.0010210418840870261

Thus O 0 0.0014479801757261157
, O 0 0.0006459483993239701
a O 0 0.0006332391640171409
homozygous O 0 0.0032812387216836214
germ O 1 0.995688259601593
- O 0 0.4648555517196655
line O 0 0.033566124737262726
MLH1 O 1 0.9998306035995483
mutation O 0 0.03948233649134636
and O 0 0.0019293497316539288
consequent O 1 0.9999780654907227
mismatch O 1 0.9999994039535522
repair O 1 0.9999990463256836
deficiency O 1 0.9999988079071045
results O 0 0.0004076619225088507
in O 0 0.00011780220665968955
a O 0 0.012213758192956448
mutator O 1 0.9999696016311646
phenotype O 1 0.9516414403915405
characterized O 0 0.38228750228881836
by O 0 0.0031453364063054323
leukemia B-Disease 1 0.9999996423721313
and O 1 0.8807114362716675
/ O 1 0.9999916553497314
or O 1 0.9964821338653564
lymphoma B-Disease 1 1.0
associated O 0 0.11096018552780151
with O 0 0.05644318461418152
neurofibromatosis B-Disease 1 0.9999982118606567
type I-Disease 1 0.7347065806388855
1 I-Disease 0 0.0010079857893288136
. O 0 0.00033446596353314817
. O 0 0.0006682302337139845

Missense O 0 0.04364226758480072
mutations O 0 0.0006823269068263471
in O 0 0.00015907622582744807
the O 0 9.82383280643262e-05
most O 0 4.5941567805130035e-05
ancient O 0 0.00012339717068243772
residues O 0 9.10534945433028e-05
of O 0 9.532715193927288e-05
the O 0 0.00020452564058359712
PAX6 O 1 0.9974911212921143
paired O 0 0.0006844602175988257
domain O 0 0.00023453666653949767
underlie O 0 0.001441938104107976
a O 0 0.0002640572492964566
spectrum O 0 0.0017898072255775332
of O 0 0.18744023144245148
human O 1 0.9999191761016846
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999997615814209
malformations I-Disease 1 0.9999995231628418
. O 1 0.9193108677864075

Mutations O 0 0.0013471979182213545
of O 0 0.00043034489499405026
the O 0 0.00037529831752181053
human O 0 0.00937442947179079
PAX6 O 1 0.9999711513519287
gene O 1 0.7939651608467102
underlie O 1 0.9999536275863647
aniridia B-Disease 1 0.9999996423721313
( O 1 0.9977116584777832
congenital B-Disease 1 0.9999998807907104
absence I-Disease 1 0.701758086681366
of I-Disease 0 0.010490951128304005
the I-Disease 0 0.3470020294189453
iris I-Disease 1 0.9995228052139282
) O 0 7.070168067002669e-05
, O 0 4.8085174057632685e-05
a O 0 9.399034752277657e-05
rare O 0 0.00119447847828269
dominant O 0 0.1273202747106552
malformation B-Disease 1 0.9999004602432251
of I-Disease 0 0.005291827488690615
the I-Disease 0 0.08629617094993591
eye I-Disease 1 0.9981446266174316
. O 0 0.002949861343950033

The O 0 0.0010118845384567976
spectrum O 0 0.0011305689113214612
of O 0 0.0007397014414891601
PAX6 O 1 0.9999731779098511
mutations O 0 0.10483662039041519
in O 0 0.005886058323085308
aniridia B-Disease 1 0.9999980926513672
patients O 1 0.9757432341575623
is O 0 0.00020264893828425556
highly O 0 0.0001096681589842774
biased O 0 8.026431169128045e-05
, O 0 3.170135823893361e-05
with O 0 2.1629221009789035e-05
92 O 0 6.570035475306213e-05
% O 0 2.0982775822631083e-05
of O 0 2.699706601561047e-05
all O 0 2.025236790359486e-05
reported O 0 6.734788621542975e-05
mutations O 0 5.8038553106598556e-05
leading O 0 5.441837492980994e-05
to O 0 3.125724833807908e-05
premature O 0 0.0004475254681892693
truncation O 0 0.00032140465918928385
of O 0 5.761334614362568e-05
the O 0 6.793266220483929e-05
protein O 0 6.60720543237403e-05
( O 0 5.18829510838259e-05
nonsense O 0 0.0003635907487478107
, O 0 5.052845517639071e-05
splicing O 0 0.00016237881209235638
, O 0 6.136741285445169e-05
insertions O 0 0.00030447306926362216
and O 0 5.2581774070858955e-05
deletions O 0 0.0001313608227064833
) O 0 2.2684940631734207e-05
and O 0 1.5987678125384264e-05
just O 0 2.8162115995655768e-05
2 O 0 2.208127625635825e-05
% O 0 1.682592846918851e-05
leading O 0 4.463972072699107e-05
to O 0 1.9855357095366344e-05
substitution O 0 5.282532947603613e-05
of O 0 2.9468099455698393e-05
one O 0 3.8815262087155133e-05
amino O 0 6.018052954459563e-05
acid O 0 0.00010594233026495203
by O 0 4.127336069359444e-05
another O 0 0.00014189776265993714
( O 0 0.0002007115399464965
missense O 0 0.002101578051224351
) O 0 0.0003323228156659752
. O 0 0.0007052799337543547

The O 0 0.0009467215859331191
extraordinary O 0 0.001177474157884717
conservation O 0 0.0004567558644339442
of O 0 0.00016174247139133513
the O 0 0.00023157069517765194
PAX6 O 1 0.9375134706497192
protein O 0 0.0001114576734835282
at O 0 6.135008879937232e-05
the O 0 4.156953582423739e-05
amino O 0 5.106231037643738e-05
acid O 0 0.0001409286487614736
level O 0 8.75985060702078e-05
amongst O 0 0.00022923860524315387
vertebrates O 0 0.00034950568806380033
predicts O 0 0.0003990627883467823
that O 0 7.04073827364482e-05
pathological O 0 0.0669441819190979
missense O 0 0.02509618178009987
mutations O 0 0.00021333601034712046
should O 0 3.861029472318478e-05
in O 0 2.1490764993359335e-05
fact O 0 4.0733364585321397e-05
be O 0 1.612096639291849e-05
common O 0 2.7854577638208866e-05
even O 0 2.5192892280756496e-05
though O 0 2.679543467820622e-05
they O 0 1.5945772247505374e-05
are O 0 1.8182490748586133e-05
hardly O 0 0.00014239682059269398
ever O 0 0.00017370539717376232
seen O 0 0.00026353265275247395
in O 0 0.0003742460976354778
aniridia B-Disease 1 0.9997804760932922
patients O 1 0.692583441734314
. O 0 0.0016786339692771435

This O 0 0.000525673502124846
indicates O 0 0.0004222759453114122
that O 0 6.061687963665463e-05
there O 0 4.5686247176490724e-05
is O 0 3.700745219248347e-05
a O 0 9.998483437811956e-05
heavy O 0 0.017000993713736534
ascertainment O 1 0.97355055809021
bias O 0 0.0005773954908363521
in O 0 5.1141199946869165e-05
the O 0 5.8490604715188965e-05
selection O 0 0.00010459143959451467
of O 0 0.00017005081463139504
patients O 0 0.4304448962211609
for O 0 0.0002496677916496992
PAX6 O 1 0.9999052286148071
mutation O 0 0.00039692054269835353
analysis O 0 4.940426879329607e-05
and O 0 3.35206241288688e-05
that O 0 2.8419934096746147e-05
the O 0 8.117861580103636e-05
missing O 0 0.003699982538819313
PAX6 O 1 0.9997726082801819
missense O 0 0.2747390568256378
mutations O 0 0.0006828659097664058
frequently O 0 0.00019807671196758747
may O 0 0.0002825424598995596
underlie O 0 0.009746850468218327
phenotypes O 0 0.0016362547175958753
distinct O 0 0.000308066577417776
from O 0 0.0005999762797728181
textbook O 1 0.753619909286499
aniridia B-Disease 1 0.9995840191841125
. O 0 0.00285773235373199

Here O 0 0.0010012795682996511
we O 0 0.0002754799497779459
present O 0 0.00027598682208918035
four O 0 0.00021896509861107916
novel O 0 0.0009590585250407457
PAX6 O 1 0.9992759823799133
missense O 0 0.025772811844944954
mutations O 0 0.00014856172492727637
, O 0 3.369831756572239e-05
two O 0 2.2573196474695578e-05
in O 0 3.099810055573471e-05
association O 0 0.00015613889263477176
with O 0 9.6771793323569e-05
atypical O 1 0.9985114932060242
phenotypes O 1 0.9941291809082031
ectopia B-Disease 1 0.9999749660491943
pupillae I-Disease 1 0.9999510049819946
( O 0 0.005368503276258707
displaced B-Disease 0 0.19828175008296967
pupils I-Disease 0 0.03483371064066887
) O 0 0.0005100383423268795
and O 0 0.04192394018173218
congenital B-Disease 1 0.9999998807907104
nystagmus I-Disease 1 0.9999841451644897
( O 0 0.0008910172618925571
searching B-Disease 0 0.0007749447831884027
gaze I-Disease 0 0.09959739446640015
) O 0 5.5411037465091795e-05
, O 0 4.003744834335521e-05
and O 0 2.3207629055832513e-05
two O 0 2.002675500989426e-05
in O 0 3.7873931432841346e-05
association O 0 0.00015265315596479923
with O 0 8.429116132901981e-05
more O 0 0.00013727633631788194
recognizable O 0 0.10543029755353928
aniridia B-Disease 1 0.999657392501831
phenotypes O 1 0.540236234664917
. O 0 0.002112743677571416

Strikingly O 0 0.0052198083139956
, O 0 0.00036742715747095644
all O 0 9.623888036003336e-05
four O 0 7.217961683636531e-05
mutations O 0 7.342051685554907e-05
are O 0 2.1248763005132787e-05
located O 0 8.01505011622794e-05
within O 0 6.228241545613855e-05
the O 0 0.00012285086268093437
PAX6 O 1 0.871251106262207
paired O 0 0.00034373984090052545
domain O 0 0.00010070420830743387
and O 0 5.352245716494508e-05
affect O 0 5.6044391385512426e-05
amino O 0 4.30706531915348e-05
acids O 0 3.6730321880895644e-05
which O 0 1.512440121587133e-05
are O 0 7.810827810317278e-06
highly O 0 3.2292511605191976e-05
conserved O 0 4.869229087489657e-05
in O 0 2.7638239771476947e-05
all O 0 4.869702024734579e-05
known O 0 0.00015590562543366104
paired O 0 0.0004559825756587088
domain O 0 0.00042429222958162427
proteins O 0 0.000596125319134444
. O 0 0.0007935548201203346

Our O 0 0.0008977018878795207
results O 0 0.00026927291764877737
support O 0 0.0001481079525547102
the O 0 7.275977986864746e-05
hypothesis O 0 0.00011895822535734624
that O 0 3.4983499062946066e-05
the O 0 3.6791916500078514e-05
under O 0 6.010642755427398e-05
- O 0 0.00014305143849924207
representation O 0 5.739339758292772e-05
of O 0 0.00010305728210369125
missense O 0 0.032613299787044525
mutations O 0 0.0004160891112405807
is O 0 0.00010459264012752101
caused O 0 0.007921803742647171
by O 0 0.0001120671586249955
ascertainment O 1 0.9914208650588989
bias O 0 0.001124585047364235
and O 0 5.718709871871397e-05
suggest O 0 6.112100527388975e-05
that O 0 2.5789375285967253e-05
a O 0 4.3415358959464356e-05
substantial O 0 0.00012433688971213996
burden O 0 0.024532552808523178
of O 0 0.027825815603137016
PAX6 B-Disease 1 0.9999990463256836
- I-Disease 1 0.999874472618103
related I-Disease 1 0.8809153437614441
disease I-Disease 1 0.9999656677246094
remains O 0 0.030262911692261696
to O 0 6.64154504192993e-05
be O 0 0.00010051491699414328
uncovered O 0 0.0013180439127609134
. O 0 0.00034774522646330297
. O 0 0.0008051040931604803

The O 0 0.001835716888308525
chromosomal O 0 0.003433682257309556
order O 0 0.0003421012661419809
of O 0 0.00021815615764353424
genes O 0 0.00015292532043531537
controlling O 0 0.00032856076722964644
the O 0 0.00018429241026751697
major O 0 0.005496409256011248
histocompatibility O 1 0.9999121427536011
complex O 0 0.0025695892982184887
, O 0 0.00027971985400654376
properdin O 1 0.9904198050498962
factor O 0 0.08277206867933273
B O 0 0.0244457870721817
, O 0 9.209939162246883e-05
and O 0 0.00010237342939944938
deficiency B-Disease 1 0.9872562885284424
of I-Disease 0 6.520713213831186e-05
the I-Disease 0 0.00010191310866503045
second I-Disease 0 0.0004875933227594942
component I-Disease 0 0.0008106321329250932
of I-Disease 0 0.00032912695314735174
complement I-Disease 0 0.0018100490560755134
. O 0 0.0006559425382874906

The O 0 0.0011249020462855697
relationship O 0 0.0006042853347025812
of O 0 0.00022890658874530345
the O 0 0.0001917782356031239
genes O 0 0.00018843649013433605
coding O 0 0.000398957054130733
for O 0 0.00010511756408959627
HLA O 0 0.4569888114929199
to O 0 4.371689647086896e-05
those O 0 3.513076444505714e-05
coding O 0 0.00012586712546180934
for O 0 7.182142144301906e-05
properdin O 1 0.846811830997467
Factor O 0 0.007996584288775921
B O 0 0.03356365114450455
allotypes O 1 0.8281161785125732
and O 0 0.00010047706018667668
for O 0 7.132413884392008e-05
deficiency B-Disease 1 0.9966629147529602
of I-Disease 0 7.381920295301825e-05
the I-Disease 0 8.890966273611411e-05
second I-Disease 0 0.0002664329076651484
component I-Disease 0 0.0003447170602157712
of I-Disease 0 0.00010397312144050375
complement I-Disease 0 0.0012883406598120928
( O 0 0.0002885822032112628
C2 O 1 0.6735203862190247
) O 0 4.845955845667049e-05
was O 0 5.875884380657226e-05
studied O 0 5.0931048463098705e-05
in O 0 3.2502601243322715e-05
families O 0 7.495450699934736e-05
of O 0 0.00039757811464369297
patients O 1 0.9987862706184387
with O 1 0.9848533868789673
connective O 1 0.9999998807907104
tissue O 1 0.9999995231628418
disorders O 1 0.9999991655349731
. O 1 0.5474251508712769

Patients O 0 0.04725128412246704
were O 0 0.0004235927190165967
selected O 0 0.00028638733783736825
because O 0 9.716033673612401e-05
they O 0 6.498093716800213e-05
were O 0 0.00010177617514273152
heterozygous O 0 0.0003663741808850318
or O 0 0.0002132542576873675
homozygous O 0 0.02318337932229042
for O 0 0.014892646111547947
C2 B-Disease 1 0.9999984502792358
deficiency I-Disease 1 0.9999990463256836
. O 0 0.015641063451766968

12 O 0 0.001538872835226357
families O 0 0.0004430925182532519
with O 0 0.0002363216335652396
15 O 0 0.0004957380588166416
matings O 0 0.004589029587805271
informative O 0 0.0023119542747735977
for O 0 0.009318667463958263
C2 B-Disease 1 0.9999969005584717
deficiency I-Disease 1 0.9999978542327881
were O 0 0.0006280090310610831
found O 0 0.000988717540167272
. O 0 0.0014874323969706893

Of O 0 0.0014305436052381992
57 O 0 0.0016858202870935202
informative O 0 0.001562513061799109
meioses O 0 0.04800719767808914
, O 0 0.0001879514747997746
two O 0 7.162334804888815e-05
crossovers O 0 0.0002713630674406886
were O 0 6.981143087614328e-05
noted O 0 0.00011313551658531651
between O 0 7.815915887476876e-05
the O 0 0.004372701980173588
C2 B-Disease 1 0.9999991655349731
deficiency I-Disease 1 0.9999994039535522
gene O 0 0.0005179553409107029
and O 0 0.00012232894368935376
the O 0 0.018318410962820053
HLA O 1 0.9999986886978149
- O 1 0.9891813397407532
B O 0 0.06766096502542496
gene O 0 8.411610906478018e-05
, O 0 3.434864993323572e-05
with O 0 2.635625787661411e-05
a O 0 7.639528485015035e-05
recombinant O 0 0.0004056521283928305
fraction O 0 0.0002433332847431302
of O 0 0.0001976403727894649
0 O 0 0.0006689289584755898
. O 0 0.0008710190886631608

035 O 1 0.9178293943405151
. O 0 0.017719415947794914

A O 0 0.0022811139933764935
lod O 0 0.005293967202305794
score O 0 0.00033285896643064916
of O 0 0.00015872108633629978
13 O 0 0.0001770068920450285
was O 0 0.00018935362459160388
calculated O 0 9.071256499737501e-05
for O 0 6.981209298828617e-05
linkage O 0 0.004466115031391382
between O 0 0.0274108424782753
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
and O 1 0.9492804408073425
HLA O 1 0.9999996423721313
- O 1 0.9818821549415588
B O 0 0.004428346641361713
at O 0 7.854754221625626e-05
a O 0 5.956276800134219e-05
maximum O 0 6.032336750649847e-05
likelihood O 0 5.752177457907237e-05
value O 0 2.5938770704669878e-05
of O 0 3.749722964130342e-05
the O 0 6.675426266156137e-05
recombinant O 0 0.0003242385573685169
fraction O 0 0.0002630458911880851
of O 0 0.00019686752057168633
0 O 0 0.0004507377161644399
. O 0 0.0007047306280583143

04 O 0 0.3552648723125458
. O 0 0.02235516533255577

18 O 0 0.001999748172238469
families O 0 0.0006037329440005124
with O 0 0.00019352308299858123
21 O 0 0.00034304644213989377
informative O 0 0.00047369979438371956
matings O 0 0.0005978916306048632
for O 0 8.970952330855653e-05
both O 0 0.00011424738477217034
properdin O 1 0.8450102210044861
Factor O 0 0.016057224944233894
B O 0 0.18147458136081696
allotype O 1 0.9940657615661621
and O 0 0.0023912680335342884
HLA O 1 0.9999574422836304
- O 0 0.46561935544013977
B O 0 0.0025358640123158693
were O 0 0.00025619688676670194
found O 0 0.0006284593255259097
. O 0 0.0010824349010363221

Of O 0 0.0017772329738363624
72 O 0 0.0017130326014012098
informative O 0 0.001371725695207715
meioses O 0 0.09755277633666992
, O 0 0.00011995881504844874
three O 0 6.022577144904062e-05
recombinants O 0 0.029024766758084297
were O 0 4.6206419938243926e-05
found O 0 3.462114545982331e-05
, O 0 3.9266422390937805e-05
giving O 0 7.133890176191926e-05
a O 0 0.00012542144395411015
recombinant O 0 0.0005295462906360626
fraction O 0 0.000276537291938439
of O 0 0.00022804831678513438
0 O 0 0.0005460109678097069
. O 0 0.0005926368176005781

042 O 1 0.9203663468360901
. O 0 0.02543051727116108

A O 0 0.0017358862096443772
lod O 0 0.0034646219573915005
score O 0 0.00025892682606354356
of O 0 0.00010921451030299067
16 O 0 0.00018666502728592604
between O 0 0.00029041519155725837
HLA O 1 0.9999301433563232
- O 0 0.29371437430381775
B O 0 0.0033721127547323704
and O 0 8.712133421795443e-05
Factor O 0 0.0012858466943725944
B O 0 0.0013952782610431314
allotypes O 0 0.01428316906094551
was O 0 8.482317207381129e-05
calculated O 0 4.20535470766481e-05
at O 0 3.0062245059525594e-05
a O 0 3.557609670679085e-05
maximum O 0 6.323047273326665e-05
likelihood O 0 7.123087561922148e-05
value O 0 3.305040081613697e-05
of O 0 4.9111524276668206e-05
the O 0 0.00010011334961745888
recombinant O 0 0.0006216798210516572
fraction O 0 0.0002936036908067763
of O 0 0.00030131591483950615
0 O 0 0.0006569097749888897
. O 0 0.0008875748608261347

04 O 1 0.586472749710083
. O 0 0.0178386177867651

A O 0 0.0032766542863100767
crossover O 0 0.002516495529562235
was O 0 0.00045999186113476753
shown O 0 0.0001136481441790238
to O 0 3.342397030792199e-05
have O 0 2.360478538321331e-05
occurred O 0 9.08879010239616e-05
between O 0 3.154567821184173e-05
genes O 0 3.556551018846221e-05
for O 0 3.013888454006519e-05
Factor O 0 0.00016525411047041416
B O 0 0.0003803037980105728
and O 0 9.070849046111107e-05
HLA O 1 0.9993336796760559
- O 0 0.014503661543130875
D O 0 0.0007263123989105225
, O 0 3.889923027600162e-05
in O 0 3.620378265623003e-05
which O 0 5.9799524024128914e-05
HLA O 1 0.9969304203987122
- O 0 0.0779024064540863
D O 0 0.2793383002281189
segregared O 1 0.9378851652145386
with O 0 0.0005958756664767861
HLA O 1 0.9999592304229736
- O 0 0.14389078319072723
A O 0 0.0016103872330859303
and O 0 0.00028821927844546735
B O 0 0.003693628590553999
. O 0 0.0009392768843099475

These O 0 0.0004745210171677172
studies O 0 0.00032991988700814545
suggest O 0 0.0002051257761195302
that O 0 4.1628685721661896e-05
the O 0 6.064457556931302e-05
genes O 0 8.123637962853536e-05
for O 0 6.325989670585841e-05
Factor O 0 0.004376390483230352
B O 1 0.7636955976486206
and O 0 0.24905817210674286
C2 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999945163726807
are O 0 2.5735937015269883e-05
located O 0 6.503274926217273e-05
outside O 0 5.44639588042628e-05
those O 0 3.973956700065173e-05
for O 0 7.241533603519201e-05
HLA O 1 0.9591872692108154
, O 0 3.6858149542240426e-05
that O 0 1.3190881873015314e-05
the O 0 2.1602754713967443e-05
order O 0 3.1391762604471296e-05
of O 0 4.931294824928045e-05
genese O 1 0.6444303393363953
is O 0 0.00025412419927306473
HLA O 1 0.9980485439300537
- O 0 0.0007179781678132713
A O 0 0.00019618752412497997
, O 0 7.586734864162281e-05
- O 0 0.0006490974919870496
B O 0 0.00036088560591451824
, O 0 9.452713857172057e-05
- O 0 0.0011058493983000517
D O 0 0.0033111947122961283
, O 0 8.826032717479393e-05
Factor O 0 0.001030938234180212
B O 0 0.11221855133771896
allotype O 1 0.9998031258583069
, O 1 0.75235915184021
C2 B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999984502792358
, O 0 9.887588385026902e-05
that O 0 2.993550879182294e-05
the O 0 4.8623336624586955e-05
genes O 0 0.00010942465451080352
coding O 0 0.0009330493630841374
for O 0 0.0010767955100163817
C2 B-Disease 1 0.9999980926513672
deficiency I-Disease 1 0.9999983310699463
and O 0 0.0003859784046653658
Factor O 0 0.009529566392302513
B O 0 0.0010978375794366002
allotypes O 0 0.0009760690154507756
are O 0 1.550756314827595e-05
approximately O 0 4.080938015249558e-05
3 O 0 4.323113171267323e-05
- O 0 0.00011232199176447466
- O 0 0.0001229977497132495
5 O 0 8.563223673263565e-05
centimorgans O 0 0.00037142791552469134
from O 0 5.9872738347621635e-05
the O 0 0.00012216200411785394
HLA O 1 0.9895406365394592
- O 0 0.0012404379667714238
A O 0 0.0008195621194317937
and O 0 0.001013707253150642
HLA O 1 0.9999816417694092
- O 1 0.7954053282737732
B O 0 0.07145972549915314
loci O 0 0.000585486413910985
, O 0 6.459035648731515e-05
and O 0 2.731641143327579e-05
that O 0 2.1055217075627297e-05
the O 0 4.085742693860084e-05
apparent O 0 0.0002764830132946372
lack O 0 0.00014986870519351214
of O 0 0.00013065077655483037
recombinants O 1 0.5689793229103088
between O 0 9.337875962955877e-05
the O 0 0.00016726394824218005
Factor O 0 0.1670656055212021
B O 1 0.6559287309646606
gene O 0 0.01858694851398468
and O 0 0.14421603083610535
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
gene O 0 0.0006293391925282776
suggests O 0 9.871894144453108e-05
that O 0 1.8993601770489477e-05
these O 0 1.123909623856889e-05
two O 0 1.3377592040342279e-05
genes O 0 3.075189306400716e-05
lie O 0 6.960555037949234e-05
in O 0 2.7903712179977447e-05
close O 0 5.463833804242313e-05
proximity O 0 0.00012794387293979526
to O 0 5.65114023629576e-05
one O 0 0.00010218763054581359
another O 0 0.00048243312630802393
. O 0 0.0007792903343215585

Distribution O 0 0.0015680649084970355
of O 0 0.0007852539420127869
emerin O 1 0.9425285458564758
and O 0 0.0003760140389204025
lamins O 0 0.2545607388019562
in O 0 0.000139859679620713
the O 0 0.00020870011940132827
heart O 1 0.759135365486145
and O 0 0.00017602094158064574
implications O 0 0.0019150784937664866
for O 0 0.0005127424956299365
Emery B-Disease 1 0.9995160102844238
- I-Disease 1 0.9999793767929077
Dreifuss I-Disease 1 0.999998927116394
muscular I-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999995231628418
. O 0 0.4804602265357971

Emerin O 1 0.6719257831573486
is O 0 0.0005138943088240921
a O 0 0.00033459070255048573
nuclear O 0 0.0005419509252533317
membrane O 0 0.00039712240686640143
protein O 0 9.199116902891546e-05
which O 0 3.6060577258467674e-05
is O 0 4.315674232202582e-05
missing O 0 0.00013258817489258945
or O 0 0.0001066854310920462
defective O 0 0.044999830424785614
in O 0 0.0002723347570281476
Emery B-Disease 1 0.9989944100379944
- I-Disease 1 0.9999833106994629
Dreifuss I-Disease 1 0.9999998807907104
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999033212661743
EDMD B-Disease 1 0.9999988079071045
) O 0 0.01535495650023222
. O 0 0.002381558297201991

It O 0 0.0005374512984417379
is O 0 0.00020272331312298775
one O 0 9.159238106803969e-05
member O 0 9.439831774216145e-05
of O 0 5.5447089835070074e-05
a O 0 9.361083357362077e-05
family O 0 0.0001388275413773954
of O 0 0.0008757826290093362
lamina O 1 0.9999662637710571
- O 1 0.5687879920005798
associated O 0 0.0001518265635240823
proteins O 0 6.428029882954434e-05
which O 0 4.469202394830063e-05
includes O 0 9.607656829757616e-05
LAP1 O 1 0.8991744518280029
, O 0 0.00018439505947753787
LAP2 O 1 0.938279926776886
and O 0 0.00028994239983148873
lamin O 1 0.8632798790931702
B O 0 0.1793181598186493
receptor O 0 0.0026153638027608395
( O 0 0.001191174378618598
LBR O 1 0.9961573481559753
) O 0 0.0011461032554507256
. O 0 0.0018432408105581999

A O 0 0.0016525986138731241
panel O 0 0.0009220641804859042
of O 0 0.00031654915073886514
16 O 0 0.0008203423349186778
monoclonal O 0 0.4587792754173279
antibodies O 0 0.038162052631378174
( O 0 0.0006929704686626792
mAbs O 0 0.05903506278991699
) O 0 8.14497034298256e-05
has O 0 3.944123091059737e-05
been O 0 3.021627344423905e-05
mapped O 0 6.517722795251757e-05
to O 0 1.7848475181381218e-05
six O 0 2.7061247237725183e-05
specific O 0 1.966709351108875e-05
sites O 0 2.873968333005905e-05
throughout O 0 4.077047560713254e-05
the O 0 6.443784513976425e-05
emerin O 0 0.040066540241241455
molecule O 0 0.00020446031703613698
using O 0 8.50114447530359e-05
phage O 0 0.15728382766246796
- O 0 0.0005595746333710849
displayed O 0 0.00017014618788380176
peptide O 0 0.00012679082283284515
libraries O 0 4.427283784025349e-05
and O 0 2.0064971977262758e-05
has O 0 2.1045561879873276e-05
been O 0 2.4883842343115248e-05
used O 0 2.9642167646670714e-05
to O 0 4.2170249798800796e-05
localize O 0 0.0007637121016159654
emerin O 0 0.03196180611848831
in O 0 0.0001042228759615682
human O 0 0.0002820389054249972
and O 0 0.00037608874845318496
rabbit O 1 0.9116873741149902
heart O 1 0.9971900582313538
. O 0 0.002560290042310953

Several O 0 0.0020261730533093214
mAbs O 0 0.010634439066052437
against O 0 0.000549777876585722
different O 0 0.00017155584646388888
emerin O 1 0.7194679975509644
epitopes O 0 0.0040210760198533535
did O 0 0.00012848364713136107
not O 0 4.823824929189868e-05
recognize O 0 0.00020410462457221001
intercalated O 0 0.031857576221227646
discs O 0 0.0003009050851687789
in O 0 5.6692384532652795e-05
the O 0 0.00013480625057127327
heart O 1 0.9712665677070618
, O 0 7.236935925902799e-05
though O 0 3.8556099752895534e-05
they O 0 2.290206975885667e-05
recognized O 0 8.804679964669049e-05
cardiomyocyte O 0 0.15689624845981598
nuclei O 0 0.00034712813794612885
strongly O 0 6.103678606450558e-05
, O 0 3.1354426027974114e-05
both O 0 2.3570863049826585e-05
at O 0 3.519592064549215e-05
the O 0 7.063718658173457e-05
rim O 0 0.0005605155020020902
and O 0 6.996978481765836e-05
in O 0 9.09180598682724e-05
intranuclear O 0 0.3108087182044983
spots O 0 0.0005488513270393014
or O 0 0.00027790822787210345
channels O 0 0.0004198407696094364
. O 0 0.0008416897035203874

A O 0 0.01034572347998619
polyclonal O 1 0.7473524212837219
rabbit O 0 0.2442171722650528
antiserum O 0 0.27783203125
against O 0 0.0018041793955489993
emerin O 1 0.9047676920890808
did O 0 0.00023027892166282982
recognize O 0 0.0001917442277772352
both O 0 6.967726949369535e-05
nuclear O 0 0.00025626481510698795
membrane O 0 0.00025876445579342544
and O 0 9.223781671607867e-05
intercalated O 0 0.0664987564086914
discs O 0 0.0002387462736805901
but O 0 3.941153045161627e-05
, O 0 3.107517113676295e-05
after O 0 7.348873623413965e-05
affinity O 0 9.330692410003394e-05
purification O 0 0.0018248134292662144
against O 0 6.932852556928992e-05
a O 0 0.00010146589193027467
pure O 0 0.003032709937542677
- O 0 0.08596156537532806
emerin O 0 0.49302613735198975
band O 0 0.00011673932749545202
on O 0 3.202844527550042e-05
a O 0 5.108845653012395e-05
western O 0 8.085707668215036e-05
blot O 0 0.0023533424828201532
, O 0 7.790028757881373e-05
it O 0 5.0342998292762786e-05
stained O 0 0.00393660319969058
only O 0 6.940359889995307e-05
the O 0 0.00019584437541197985
nuclear O 0 0.0007125400588847697
membrane O 0 0.0013225877191871405
. O 0 0.0007098102942109108

These O 0 0.00047379740863107145
results O 0 0.00019642952247522771
would O 0 6.475342524936423e-05
not O 0 3.4059587051160634e-05
be O 0 3.336658119224012e-05
expected O 0 5.111516293254681e-05
if O 0 4.816010914510116e-05
immunostaining O 0 0.01214178092777729
at O 0 0.00019440379401203245
intercalated O 0 0.03239363804459572
discs O 0 0.0002207660727435723
were O 0 4.495062239584513e-05
due O 0 3.882040618918836e-05
to O 0 1.832914858823642e-05
a O 0 3.436090628383681e-05
product O 0 4.769401493831538e-05
of O 0 3.596887836465612e-05
the O 0 7.950641156639904e-05
emerin O 1 0.9831798076629639
gene O 0 0.00014167168410494924
and O 0 3.711259341798723e-05
, O 0 2.8967628168174997e-05
therefore O 0 3.38871031999588e-05
, O 0 2.1678657503798604e-05
cast O 0 4.223295400151983e-05
some O 0 1.6243871868937276e-05
doubt O 0 5.7234676205553114e-05
upon O 0 4.447001629159786e-05
the O 0 4.37704220530577e-05
hypothesis O 0 0.00032166187884286046
that O 0 0.00019118067575618625
cardiac B-Disease 1 0.999996542930603
defects I-Disease 1 0.9999852180480957
in O 0 0.021548084914684296
EDMD B-Disease 1 0.999997615814209
are O 0 7.663460564799607e-05
caused O 0 0.022274618968367577
by O 0 9.617758769309148e-05
absence O 0 0.0006006045150570571
of O 0 0.0004097928467672318
emerin O 1 0.9948863387107849
from O 0 0.0008719965117052197
intercalated O 1 0.9566054344177246
discs O 0 0.0075097172521054745
. O 0 0.0012642521178349853

Although O 0 0.0017753619467839599
emerin O 0 0.40981030464172363
was O 0 0.0006247685523703694
abundant O 0 0.00029470358276739717
in O 0 9.11087408894673e-05
the O 0 8.959377009887248e-05
membranes O 0 0.0003342113341204822
of O 0 0.00021100696176290512
cardiomyocyte O 1 0.9758711457252502
nuclei O 0 0.0015581910265609622
, O 0 4.752798122353852e-05
it O 0 2.1259933419059962e-05
was O 0 6.878819112898782e-05
absent O 0 9.661983494879678e-05
from O 0 2.546819996496197e-05
many O 0 3.6332861782284454e-05
non O 0 0.0005314855952747166
- O 1 0.614102303981781
myocyte O 1 0.9996987581253052
cells O 0 0.0007015386363491416
in O 0 0.0001563394325785339
the O 0 0.0004584413836710155
heart O 1 0.956247866153717
. O 0 0.0014207601780071855

This O 0 0.0007734412793070078
distribution O 0 0.00034853428951464593
of O 0 0.0002850889868568629
emerin O 1 0.867694616317749
was O 0 0.00033651554258540273
similar O 0 5.762291038990952e-05
to O 0 2.2817941498942673e-05
that O 0 2.3968312234501354e-05
of O 0 5.100609268993139e-05
lamin O 0 0.19975097477436066
A O 0 0.00033857973176054657
, O 0 5.336629692465067e-05
a O 0 6.111045513534918e-05
candidate O 0 0.00014732172712683678
gene O 0 0.0001180107647087425
for O 0 4.158551018917933e-05
an O 0 0.00012487989442888647
autosomal O 0 0.01277259923517704
form O 0 0.000376272713765502
of O 0 0.005274865310639143
EDMD B-Disease 1 0.9999796152114868
. O 0 0.003833652241155505

In O 0 0.0011965191224589944
contrast O 0 0.001659733010455966
, O 0 0.0008300189510919154
lamin O 1 0.9894183278083801
B1 O 1 0.99925297498703
was O 0 0.0012653361773118377
absent O 0 0.0010877955937758088
from O 0 0.0002315139427082613
cardiomyocyte O 1 0.9064087271690369
nuclei O 0 0.0017763121286407113
, O 0 0.00016572244931012392
showing O 0 0.00040644072578288615
that O 0 0.0001626689190743491
lamin O 1 0.9946054816246033
B1 O 1 0.9988219141960144
is O 0 0.00010478230979060754
not O 0 4.539899236988276e-05
essential O 0 0.00012508225336205214
for O 0 4.532951788860373e-05
localization O 0 0.00030148719088174403
of O 0 0.00011147032637381926
emerin O 0 0.005486422684043646
to O 0 8.795240137260407e-05
the O 0 0.00021418958203867078
nuclear O 0 0.0015751153696328402
lamina O 1 0.8635199666023254
. O 0 0.0011662095785140991

Lamin O 1 0.9994257688522339
B1 O 1 0.9995385408401489
is O 0 0.0005885378341190517
also O 0 0.00015770761820022017
almost O 0 0.00019019901810679585
completely O 0 0.0005786851979792118
absent O 0 0.006198924034833908
from O 0 0.0009739156812429428
skeletal O 1 0.999924898147583
muscle O 1 0.999679446220398
nuclei O 1 0.657795786857605
. O 0 0.0018182314233854413

In O 0 0.002015889622271061
EDMD B-Disease 1 0.9968493580818176
, O 0 0.0003653161402326077
the O 0 0.00015154022548813373
additional O 0 0.00020537040836643428
absence O 0 0.0004489832208491862
of O 0 0.00044863129733130336
lamin O 1 0.9997517466545105
B1 O 1 0.9999821186065674
from O 0 0.014061881229281425
heart O 1 0.9999539852142334
and O 0 0.32115787267684937
skeletal O 1 0.9999972581863403
muscle O 1 0.9999465942382812
nuclei O 1 0.6237572431564331
which O 0 0.00016836995200719684
already O 0 0.0002809522848110646
lack O 0 0.0044830571860075
emerin O 1 0.9746249914169312
may O 0 6.443459278671071e-05
offer O 0 3.459774234215729e-05
an O 0 3.587590254028328e-05
alternative O 0 6.312021287158132e-05
explanation O 0 6.367752212099731e-05
of O 0 4.115144838578999e-05
why O 0 9.189858246827498e-05
these O 0 3.671729427878745e-05
tissues O 0 0.00031914058490656316
are O 0 2.9103777706041e-05
particularly O 0 0.00018224440282210708
affected O 0 0.0004014798905700445
. O 0 0.0002605958143249154
. O 0 0.0007993409526534379

Genetic O 0 0.0018590929685160518
mapping O 0 0.0011336002498865128
of O 0 0.000390431348932907
the O 0 0.0005840917583554983
copper B-Disease 1 0.986777126789093
toxicosis I-Disease 1 0.9992916584014893
locus O 0 0.0032570967450737953
in O 0 0.0002264082431793213
Bedlington O 0 0.44962194561958313
terriers O 0 0.002942598657682538
to O 0 9.182202484225854e-05
dog O 0 0.00047516959602944553
chromosome O 0 0.0001215257725561969
10 O 0 4.0927156078396365e-05
, O 0 3.5697688872460276e-05
in O 0 2.6317253286833875e-05
a O 0 6.844518793513998e-05
region O 0 0.00013544844114221632
syntenic O 0 0.020832309499382973
to O 0 8.219279698096216e-05
human O 0 0.00021673183073289692
chromosome O 0 0.0007254816009663045
region O 0 0.001004282385110855
2p13 O 1 0.9963682889938354
- O 1 0.7992638349533081
p16 O 1 0.791039764881134
. O 0 0.0028008895460516214

Abnormal O 1 0.9997496008872986
hepatic B-Disease 1 0.9999899864196777
copper I-Disease 1 0.9998014569282532
accumulation I-Disease 1 0.9903567433357239
is O 0 0.00033189536770805717
recognized O 0 0.00023123710707295686
as O 0 0.00022005889331921935
an O 0 0.028907861560583115
inherited B-Disease 1 0.9999990463256836
disorder I-Disease 1 0.9999996423721313
in O 0 0.013995674438774586
man O 1 0.9905753135681152
, O 0 0.005891302600502968
mouse O 0 0.022150743752717972
, O 0 0.00029110684408806264
rat O 0 0.13465522229671478
and O 0 0.0003046086640097201
dog O 0 0.0033778096549212933
. O 0 0.001012987457215786

The O 0 0.0017364580417051911
major O 0 0.0028536885511130095
cause O 0 0.41486188769340515
of O 0 0.0592794194817543
hepatic B-Disease 1 0.9999972581863403
copper I-Disease 1 0.9998990297317505
accumulation I-Disease 1 0.9873234629631042
in O 0 0.00020647542260121554
man O 0 0.01252401527017355
is O 0 6.479122384916991e-05
a O 0 0.00029089543386362493
dysfunctional O 1 0.9960112571716309
ATP7B O 1 0.9999852180480957
gene O 0 0.01556435413658619
, O 0 0.001153617282398045
causing O 1 0.9951862692832947
Wilson B-Disease 1 0.99968421459198
disease I-Disease 1 0.999996542930603
( O 1 0.64949631690979
WD B-Disease 1 0.9998472929000854
) O 0 0.0013460274785757065
. O 0 0.0013074426678940654

Mutations O 0 0.003091647522523999
in O 0 0.00043879676377400756
the O 0 0.0005089961923658848
ATP7B O 1 0.9984708428382874
genes O 0 0.0002295119484188035
have O 0 5.278570097289048e-05
also O 0 4.4079301005695015e-05
been O 0 6.494450644822791e-05
demonstrated O 0 0.00019579357467591763
in O 0 0.0001421596680302173
mouse O 0 0.0013459424953907728
and O 0 0.0005672846455127001
rat O 0 0.16261085867881775
. O 0 0.001512026647105813

The O 0 0.0031525178346782923
ATP7B O 1 0.9985997080802917
gene O 0 0.0007725426112301648
has O 0 0.00013726468023378402
been O 0 7.248180190799758e-05
excluded O 0 0.00016717893595341593
in O 0 4.955572876497172e-05
the O 0 7.44177887099795e-05
much O 0 0.0001263257145183161
rarer O 0 0.07181167602539062
human O 0 0.045272789895534515
copper B-Disease 1 0.9999756813049316
overload I-Disease 1 0.9999979734420776
disease O 1 0.9999916553497314
non B-Disease 1 0.8475534915924072
- I-Disease 1 0.9751107692718506
Indian I-Disease 0 0.2350001335144043
childhood I-Disease 1 0.9999549388885498
cirrhosis I-Disease 1 0.9999986886978149
, O 0 0.013977432623505592
indicating O 0 0.036251578480005264
genetic O 0 0.007439163513481617
heterogeneity O 0 0.17380887269973755
. O 0 0.0015404879814013839

By O 0 0.0012378141982480884
investigating O 0 0.0015751429600641131
the O 0 0.0005854280316270888
common O 0 0.004191309213638306
autosomal O 1 0.9997398257255554
recessive O 1 0.9999767541885376
copper B-Disease 1 0.9999914169311523
toxicosis I-Disease 1 0.9999994039535522
( O 1 0.7570478320121765
CT B-Disease 1 0.9794529676437378
) O 0 0.00011477018415462226
in O 0 9.965986100723967e-05
Bedlington O 1 0.6981929540634155
terriers O 0 0.009263578802347183
, O 0 6.871418008813635e-05
we O 0 3.6057350371265784e-05
have O 0 1.549948865431361e-05
identified O 0 4.064694803673774e-05
a O 0 4.692261791205965e-05
new O 0 7.197266677394509e-05
locus O 0 0.00046983070205897093
involved O 0 0.0002689504181034863
in O 0 0.0031790754292160273
progressive O 1 0.9999972581863403
liver B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999996423721313
. O 1 0.6558716893196106

We O 0 0.0006136236479505897
examined O 0 0.0007338584400713444
whether O 0 0.0002093666116707027
the O 0 0.00030167264048941433
WD B-Disease 1 0.9990687966346741
gene O 0 0.0022867911029607058
ATP7B O 1 0.9975392818450928
was O 0 0.0008489037863910198
also O 0 0.00011865778651554137
causative O 0 0.002886194968596101
for O 0 9.779566607903689e-05
CT B-Disease 0 0.0031134868040680885
by O 0 6.394757656380534e-05
investigating O 0 0.00012927470379509032
the O 0 0.00011020983220078051
chromosomal O 0 0.057948868721723557
co O 0 0.02982662431895733
- O 0 0.02435252070426941
localization O 0 0.005912609864026308
of O 0 0.0004678377299569547
ATP7B O 1 0.9992996454238892
and O 0 0.00021648335678037256
C04107 O 0 0.12877805531024933
, O 0 7.61962219257839e-05
using O 0 4.698082557297312e-05
fluorescence O 0 0.000204084615688771
in O 0 6.807882891735062e-05
situ O 0 0.0007499848143197596
hybridization O 0 0.0003146659000776708
( O 0 0.0002566702023614198
FISH O 0 0.0004129917360842228
) O 0 0.00033712180447764695
. O 0 0.0007857707678340375

C04107 O 0 0.4992949366569519
is O 0 0.0009834278607740998
an O 0 0.00042219687020406127
anonymous O 0 0.0010458615142852068
microsatellite O 0 0.046704962849617004
marker O 0 0.002813079860061407
closely O 0 0.0003489695372991264
linked O 0 0.0007535433978773654
to O 0 0.0004933994496241212
CT B-Disease 0 0.3173370063304901
. O 0 0.0016911542043089867

However O 0 0.0026733872946351767
, O 0 0.002022281987592578
BAC O 1 0.9199933409690857
clones O 0 0.049970269203186035
containing O 0 0.0010921795619651675
ATP7B O 1 0.9281882643699646
and O 0 0.00017694408597890288
C04107 O 0 0.01354101300239563
mapped O 0 0.0002558048872742802
to O 0 7.335935515584424e-05
the O 0 0.00011569009075174108
canine O 0 0.029683314263820648
chromosome O 0 0.0005322745419107378
regions O 0 0.0001313125976594165
CFA22q11 O 1 0.9747903347015381
and O 0 0.0002164065808756277
CFA10q26 O 1 0.9854533076286316
, O 0 0.00011487047595437616
respectively O 0 9.55121431616135e-05
, O 0 7.397260924335569e-05
demonstrating O 0 0.0003032097592949867
that O 0 7.843601633794606e-05
WD B-Disease 1 0.8186869621276855
cannot O 0 0.00019180933304596692
be O 0 0.00012243397941347212
homologous O 0 0.000607712019700557
to O 0 0.00034125562524423003
CT B-Disease 0 0.03704646974802017
. O 0 0.0017446919810026884

The O 0 0.0034684729762375355
copper O 0 0.21898241341114044
transport O 0 0.003118805820122361
genes O 0 0.001198336249217391
CTR1 O 1 0.9988849759101868
and O 0 0.00043303827987983823
CTR2 O 1 0.9905417561531067
were O 0 0.00010175268835155293
also O 0 6.167030369397253e-05
excluded O 0 0.00013146456331014633
as O 0 4.4427626562537625e-05
candidate O 0 0.00012026885815430433
genes O 0 6.742550613125786e-05
for O 0 5.811000301036984e-05
CT B-Disease 0 0.003938041627407074
since O 0 6.0434031183831394e-05
they O 0 2.48480628215475e-05
both O 0 3.328668753965758e-05
mapped O 0 0.00015625447849743068
to O 0 9.760597458807752e-05
canine O 0 0.007625102531164885
chromosome O 0 0.0018039578571915627
region O 0 0.0017734260763972998
CFA11q22 O 1 0.9902350902557373
. O 0 0.0022191659081727266

2 O 0 0.005217601079493761
- O 0 0.007691860664635897
22 O 0 0.004774714820086956
. O 0 0.003491723444312811

5 O 0 0.01487208716571331
. O 0 0.011715955100953579

A O 0 0.0019959374330937862
transcribed O 0 0.0007378358277492225
sequence O 0 0.00027575637795962393
identified O 0 0.000166820187587291
from O 0 9.088070510188118e-05
the O 0 0.0001441177009837702
C04107 O 1 0.9227186441421509
- O 0 0.03025558590888977
containing O 0 0.00036317575722932816
BAC O 1 0.5003193020820618
was O 0 0.00019390119996387511
found O 0 3.245651532779448e-05
to O 0 2.180800584028475e-05
be O 0 1.858078576333355e-05
homologous O 0 6.486343045253307e-05
to O 0 1.6553731256863102e-05
a O 0 4.513751628110185e-05
gene O 0 4.27037084591575e-05
expressed O 0 4.686747706728056e-05
from O 0 4.5798089558957145e-05
human O 0 0.00016955117462202907
chromosome O 0 0.035221923142671585
2p13 O 1 0.998832643032074
- O 1 0.6648784875869751
p16 O 1 0.5839123129844666
, O 0 0.00010842213669093326
a O 0 0.00012210379645694047
region O 0 0.00016974173195194453
devoid O 0 0.0005724237416870892
of O 0 0.00013268770999275148
any O 0 0.00019440767937339842
positional O 0 0.0016137479105964303
candidate O 0 0.000831729790661484
genes O 0 0.0008372024167329073
. O 0 0.0009815172525122762

Molecular O 0 0.001293256296776235
analysis O 0 0.00028316135285422206
of O 0 0.00017839542124420404
the O 0 0.00020513164054136723
APC B-Disease 0 0.08438865095376968
gene O 0 0.00011829243157990277
in O 0 5.8882247685687616e-05
205 O 0 0.0003102405462414026
families O 0 0.0001039559647324495
: O 0 0.00011271340190432966
extended O 0 0.0002816970518324524
genotype O 0 0.003729854244738817
- O 0 0.012395674362778664
phenotype O 0 0.006118279416114092
correlations O 0 0.0003234438772778958
in O 0 0.00013234680227469653
FAP B-Disease 1 0.9962728023529053
and O 0 7.580862438771874e-05
evidence O 0 5.923739809077233e-05
for O 0 2.548598604334984e-05
the O 0 5.061516640125774e-05
role O 0 0.00010592636681394652
of O 0 0.00013391964603215456
APC B-Disease 0 0.4297228157520294
amino O 0 0.00019782493473030627
acid O 0 0.0016757979756221175
changes O 0 0.0002831962192431092
in O 0 0.11467543244361877
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
predisposition O 1 0.9999821186065674
. O 0 0.18403096497058868

BACKGROUND O 0 0.012436885386705399
/ O 0 0.0266670323908329
AIMS O 0 0.0014757377794012427
The O 0 0.00029106135480105877
development O 0 0.0044017028994858265
of O 1 0.9400951266288757
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999958276748657
and O 0 0.0002778926573228091
a O 0 0.0001712647353997454
variable O 0 7.981840462889522e-05
range O 0 5.595766197075136e-05
of O 0 0.00011976061796303838
extracolonic O 1 0.9871944785118103
manifestations O 1 0.9072766304016113
in O 0 0.008440038189291954
familial B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999617338180542
FAP B-Disease 1 0.9999988079071045
) O 0 0.00025535799795761704
is O 0 5.879656600882299e-05
the O 0 3.737591396202333e-05
result O 0 3.5713252145797014e-05
of O 0 3.951088001485914e-05
the O 0 7.147610449464992e-05
dominant O 0 0.0010600838577374816
inheritance O 0 0.050505269318819046
of O 1 0.7769867777824402
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999997615814209
( O 1 0.9972295165061951
APC B-Disease 1 0.9999480247497559
) O 0 0.000962853548116982
gene O 0 0.0010021415073424578
mutations O 0 0.0012085024500265718
. O 0 0.0010153024923056364

In O 0 0.0004930228460580111
this O 0 0.00012059338769176975
study O 0 9.880765719572082e-05
, O 0 5.406688796938397e-05
direct O 0 3.947167351725511e-05
mutation O 0 6.294098420767114e-05
analysis O 0 2.4331638996955007e-05
of O 0 3.568448300939053e-05
the O 0 8.735260053072125e-05
APC B-Disease 1 0.8991621136665344
gene O 0 0.0001272109366254881
was O 0 9.097174915950745e-05
performed O 0 7.477874169126153e-05
to O 0 2.991091059811879e-05
determine O 0 6.157780444482341e-05
genotype O 0 0.000598951883148402
- O 0 0.0008335245074704289
phenotype O 0 0.00043557805474847555
correlations O 0 0.00014390733849722892
for O 0 4.557975989882834e-05
nine O 0 0.00018399917462375015
extracolonic O 1 0.9410414099693298
manifestations O 0 0.010918664745986462
and O 0 4.479759081732482e-05
to O 0 3.083146657445468e-05
investigate O 0 9.879144636215642e-05
the O 0 6.222756201168522e-05
incidence O 0 0.003248605877161026
of O 0 0.00021437325631268322
APC B-Disease 1 0.9714512825012207
mutations O 0 0.0002742812503129244
in O 0 0.00024187052622437477
non O 1 0.9728919267654419
- O 1 0.9999903440475464
FAP O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
. O 0 0.2470923662185669

METHODS O 0 0.0027402027044445276
The O 0 0.0010272738290950656
APC B-Disease 0 0.49656805396080017
gene O 0 0.00043961236951872706
was O 0 0.0003258922079112381
analysed O 0 0.0002320109197171405
in O 0 8.63736859173514e-05
190 O 0 0.0002726319362409413
unrelated O 0 0.00043107286910526454
FAP B-Disease 1 0.6926058530807495
and O 0 0.00011250637180637568
15 O 0 0.0004982318496331573
non O 1 0.9012769460678101
- O 1 0.999991774559021
FAP O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
patients O 1 0.9839134812355042
using O 0 0.0003887790662702173
denaturing O 1 0.9974932670593262
gradient O 1 0.9510431885719299
gel O 1 0.9578123688697815
electrophoresis O 0 0.002262968337163329
, O 0 8.339378837263212e-05
the O 0 5.984368181088939e-05
protein O 0 0.00011251173418713734
truncation O 0 0.0008185566402971745
test O 0 0.00015272099699359387
, O 0 8.321805944433436e-05
and O 0 9.001493890536949e-05
direct O 0 0.00026888426509685814
sequencing O 0 0.000754693930502981
. O 0 0.0008077921229414642

RESULTS O 0 0.004565810319036245
Chain O 0 0.0023108061868697405
terminating O 0 0.0018478682031854987
signals O 0 0.0003154384030494839
were O 0 6.625565583817661e-05
only O 0 3.40443839377258e-05
identified O 0 5.896372385905124e-05
in O 0 4.061462823301554e-05
patients O 0 0.0002031439944403246
belonging O 0 0.00010495271271793172
to O 0 3.9457259845221415e-05
the O 0 0.00013555114855989814
FAP B-Disease 1 0.997525155544281
group O 0 0.00017891789320856333
( O 0 0.00027296668849885464
105 O 0 0.0014881349634379148
patients O 0 0.013915124349296093
) O 0 0.00037653016624972224
. O 0 0.0009253359748981893

Amino O 0 0.0013847878435626626
acid O 0 0.0010095147881656885
changes O 0 0.00016846695507410914
were O 0 5.448531010188162e-05
identified O 0 7.817951700417325e-05
in O 0 2.969734305224847e-05
four O 0 5.755491656600498e-05
patients O 0 0.0005305082304403186
, O 0 3.018942879862152e-05
three O 0 2.9180730052758008e-05
of O 0 5.63848479941953e-05
whom O 0 0.00011368715058779344
belonged O 0 0.00016406837676186115
to O 0 3.522734550642781e-05
the O 0 8.136833639582619e-05
non O 0 0.002656862372532487
- O 1 0.8642641305923462
FAP O 1 0.9999527931213379
group O 0 0.008816215209662914
of O 1 0.9974138140678406
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
patients O 1 0.9999464750289917
. O 0 0.12047496438026428

Genotype O 1 0.9453333020210266
- O 1 0.8171796202659607
phenotype O 0 0.10455337166786194
correlations O 0 0.0007437028689309955
identified O 0 0.00020094821229577065
significant O 0 0.00010951577860396355
differences O 0 7.304918835870922e-05
in O 0 3.157969331368804e-05
the O 0 3.553899659891613e-05
nature O 0 7.992861355887726e-05
of O 0 8.17030668258667e-05
certain O 0 0.00013488030526787043
extracolonic O 1 0.999154806137085
manifestations O 1 0.9892479777336121
in O 0 0.00981176272034645
FAP B-Disease 1 0.9999933242797852
patients O 0 0.3991268575191498
belonging O 0 0.000629810499958694
to O 0 0.00010314775136066601
three O 0 0.0002698905300348997
mutation O 0 0.0017556136008352041
subgroups O 0 0.002846021903678775
. O 0 0.0013215715298429132

CONCLUSIONS O 0 0.003218449419364333
Extended O 0 0.0034320165868848562
genotype O 0 0.47765666246414185
- O 0 0.29990658164024353
phenotype O 0 0.016581371426582336
correlations O 0 0.00031514864531345665
made O 0 8.010067540453747e-05
in O 0 4.5136439439374954e-05
this O 0 3.315426147310063e-05
study O 0 4.8110530769918114e-05
may O 0 3.204344830010086e-05
have O 0 1.5771518519613892e-05
the O 0 2.2971342332311906e-05
potential O 0 3.7447487557074055e-05
to O 0 1.554591472086031e-05
determine O 0 2.1166790247661993e-05
the O 0 2.7260823117103428e-05
most O 0 2.554331331339199e-05
appropriate O 0 5.0676891987677664e-05
surveillance O 0 0.0001271213113795966
and O 0 0.00011588232155190781
prophylactic O 1 0.9914155602455139
treatment O 1 0.9974058270454407
regimens O 1 0.9803413152694702
for O 0 0.00017093877249863
those O 0 0.00011535202793311328
patients O 1 0.7504756450653076
with O 0 0.00045300688361749053
mutations O 0 0.005860825069248676
associated O 0 0.0002918326645158231
with O 0 0.00021881420980207622
life O 0 0.1535450667142868
threatening O 1 0.9429128170013428
conditions O 0 0.27048856019973755
. O 0 0.0020208940841257572

This O 0 0.0006355984369292855
study O 0 0.0002667028165888041
also O 0 0.00011564234591787681
provided O 0 0.0001494728057878092
evidence O 0 0.0001000720149022527
for O 0 4.0025232010520995e-05
the O 0 8.015371713554487e-05
pathological O 0 0.0038848973345011473
nature O 0 0.00019966209947597235
of O 0 8.825855911709368e-05
amino O 0 6.037930506863631e-05
acid O 0 0.00013835351273883134
changes O 0 4.3350275518605486e-05
in O 0 3.801701313932426e-05
APC O 0 0.01358299981802702
associated O 0 4.5140313886804506e-05
with O 0 2.9372258723014966e-05
both O 0 5.0536840717541054e-05
FAP B-Disease 1 0.9991517066955566
and O 0 0.001367855118587613
non O 1 0.9967881441116333
- O 1 0.9999986886978149
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999638795852661
. O 0 0.01901123858988285
. O 0 0.0016197360819205642

Inherited B-Disease 1 0.9999966621398926
colorectal I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999998807907104
and O 1 0.9998268485069275
cancer B-Disease 1 0.9999992847442627
risk O 1 0.9937639832496643
of O 0 0.3715502619743347
the O 1 0.928134560585022
APC O 1 0.9999759197235107
I1307K O 1 0.9998188614845276
polymorphism O 0 0.21769769489765167
. O 0 0.0021256671752780676

Germ O 1 0.9978210926055908
- O 0 0.0822976604104042
line O 0 0.0014673173427581787
and O 0 0.0003817636170424521
somatic O 0 0.002385619794949889
truncating O 0 0.004997203592211008
mutations O 0 0.00023009478172753006
of O 0 0.0001008625840768218
the O 0 0.0001758243452059105
APC B-Disease 1 0.838820219039917
gene O 0 9.334563947049901e-05
are O 0 1.9064993466599844e-05
thought O 0 6.0220427258173004e-05
to O 0 5.671666076523252e-05
initiate O 0 0.016401879489421844
colorectal B-Disease 1 0.9999933242797852
tumor I-Disease 1 0.9999710321426392
formation O 1 0.993177056312561
in O 1 0.8040595054626465
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999768733978271
sporadic O 1 0.9999994039535522
colorectal O 1 1.0
carcinogenesis O 1 0.9999990463256836
, O 1 0.5555105209350586
respectively O 0 0.014201908372342587
. O 0 0.0017542269779369235

Recently O 0 0.002363120671361685
, O 0 0.0004864802467636764
an O 0 0.0003128129174001515
isoleucine O 1 0.5644864439964294
- O 0 0.1160602793097496
- O 0 0.013967958278954029
> O 0 0.001165776397101581
lysine O 0 0.000563669775146991
polymorphism O 0 0.0002986162144225091
at O 0 0.0001517145719844848
codon O 0 0.0004841343907173723
1307 O 0 0.009313149377703667
( O 0 0.0001560769887873903
I1307K O 0 0.0024180642794817686
) O 0 5.3525614930549636e-05
of O 0 5.479743049363606e-05
the O 0 0.00010222963464912027
APC B-Disease 0 0.19104111194610596
gene O 0 6.588870019186288e-05
has O 0 2.2541660655406304e-05
been O 0 2.0110179320909083e-05
identified O 0 2.123128251696471e-05
in O 0 1.888838414743077e-05
6 O 0 4.394239658722654e-05
% O 0 2.4216173187596723e-05
- O 0 7.843908679205924e-05
7 O 0 5.094800508231856e-05
% O 0 2.27459822781384e-05
of O 0 4.321414962760173e-05
the O 0 7.161051325965673e-05
Ashkenazi O 0 0.0006736192153766751
Jewish O 0 0.00041700873407535255
population O 0 0.00031963663059286773
. O 0 0.00061464385362342

To O 0 0.0005826417473144829
assess O 0 0.0007133964099921286
the O 0 0.0003084918425884098
risk O 0 0.00031869151280261576
of O 0 0.00014819498755969107
this O 0 9.866304026218131e-05
common O 0 0.00034088233951479197
APC B-Disease 1 0.9981098175048828
allelic O 1 0.9804419279098511
variant O 0 0.4769226312637329
in O 0 0.008423174731433392
colorectal O 1 0.9999996423721313
carcinogenesis O 1 0.9999748468399048
, O 0 0.00025325294700451195
we O 0 4.85760610899888e-05
have O 0 3.1869833037490025e-05
analyzed O 0 5.6999917433131486e-05
a O 0 4.945752880303189e-05
large O 0 5.828414941788651e-05
cohort O 0 0.00045669273822568357
of O 0 9.669016435509548e-05
unselected O 0 0.08086216449737549
Ashkenazi O 0 0.0015912380767986178
Jewish O 0 0.00034024534397758543
subjects O 0 0.0003591367567423731
with O 0 0.0005069482140243053
adenomatous B-Disease 1 0.9999958276748657
polyps I-Disease 1 0.9998395442962646
and O 0 0.000873786339070648
. O 0 0.0014972876524552703
or O 1 0.8500332236289978
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999934434890747
, I-Disease 0 0.0003661091614048928
for O 0 0.0001338502042926848
the O 0 0.0010843492345884442
APC O 1 0.998853325843811
I1307K O 1 0.9970421195030212
polymorphism O 0 0.011102022603154182
. O 0 0.0016020743642002344

The O 0 0.004525348544120789
APC O 1 0.9772879481315613
I1307K O 1 0.8148068189620972
allele O 0 0.0011310073314234614
was O 0 0.00027442825376056135
identified O 0 8.350065036211163e-05
in O 0 4.2143430619034916e-05
48 O 0 9.770608448889107e-05
( O 0 5.525674350792542e-05
10 O 0 4.0914510464062914e-05
. O 0 2.582959132269025e-05
1 O 0 4.05971659347415e-05
% O 0 3.770585681195371e-05
) O 0 6.958670564927161e-05
of O 0 0.00018852564971894026
476 O 0 0.07803957909345627
patients O 0 0.04580795392394066
. O 0 0.001158705330453813

Compared O 0 0.0009888295317068696
with O 0 0.0001503364328527823
the O 0 9.432256047148257e-05
frequency O 0 4.220541086397134e-05
in O 0 2.2150579752633348e-05
two O 0 1.6100013453979045e-05
separate O 0 1.8463180822436698e-05
population O 0 1.514281757408753e-05
control O 0 3.1515253795078024e-05
groups O 0 2.103282167809084e-05
, O 0 4.148438893025741e-05
the O 0 0.00012753922783304006
APC O 1 0.9969456791877747
I1307K O 1 0.9949730634689331
allele O 0 0.00040891830576583743
is O 0 6.104010390117764e-05
associated O 0 5.1860592066077515e-05
with O 0 2.808757926686667e-05
an O 0 4.623683344107121e-05
estimated O 0 0.00010875059524551034
relative O 0 0.00016558091738261282
risk O 0 0.00026997135137207806
of O 0 0.00023025411064736545
1 O 0 0.0005715512670576572
. O 0 0.0008178174612112343

5 O 0 0.004739175550639629
- O 0 0.009203140623867512
1 O 0 0.002148296916857362
. O 0 0.0029609021730720997

7 O 0 0.004119585733860731
for O 0 0.002253967570140958
colorectal B-Disease 1 0.9999833106994629
neoplasia I-Disease 1 0.9996511936187744
( O 0 0.0005669532110914588
both O 0 0.00020796674652956426
P O 0 0.04046207666397095
= O 0 0.0009792257333174348
. O 0 0.00025678769452497363
01 O 0 0.013452962972223759
) O 0 0.0006028532516211271
. O 0 0.0010219597024843097

Furthermore O 0 0.0023615786340087652
, O 0 0.0005439933156594634
compared O 0 0.00029276314307935536
with O 0 0.00018768086738418788
noncarriers O 1 0.9470536112785339
, O 0 0.0005288255633786321
APC O 1 0.9873110055923462
I1307K O 1 0.978272020816803
carriers O 0 0.0004405745421536267
had O 0 9.98422983684577e-05
increased O 0 6.036848935764283e-05
numbers O 0 6.101996041252278e-05
of O 0 0.00020993591169826686
adenomas B-Disease 1 0.9998406171798706
and O 0 0.031547434628009796
colorectal B-Disease 1 0.9999978542327881
cancers I-Disease 1 0.9976381063461304
per O 0 0.0004058917402289808
patient O 1 0.8728162050247192
( O 0 0.0010651991469785571
P O 0 0.15331849455833435
= O 0 0.00037280330434441566
. O 0 4.329896910348907e-05
03 O 0 0.0008196805138140917
) O 0 3.0381139367818832e-05
, O 0 2.8592661692528054e-05
as O 0 1.804416206141468e-05
well O 0 2.06518034246983e-05
as O 0 2.956185744551476e-05
a O 0 8.090426854323596e-05
younger O 0 0.0003843083686660975
age O 0 0.0005268342792987823
at O 0 0.0010958366328850389
diagnosis O 1 0.9728171229362488
. O 0 0.001369985518977046

We O 0 0.0010011271806433797
conclude O 0 0.0008245300850830972
that O 0 0.00016769382636994123
the O 0 0.0002924454165622592
APC O 1 0.893503725528717
I1307K O 1 0.9563988447189331
variant O 0 0.002964615123346448
leads O 0 0.0006617901381105185
to O 0 0.00010306573676643893
increased O 0 0.0026898509822785854
adenoma B-Disease 1 0.9999865293502808
formation O 0 0.013806702569127083
and O 0 5.698839231627062e-05
directly O 0 2.691280133149121e-05
contributes O 0 5.723817230318673e-05
to O 0 1.3497807231033221e-05
3 O 0 2.665225838427432e-05
% O 0 2.160246549465228e-05
- O 0 6.588041287614033e-05
4 O 0 3.834558083326556e-05
% O 0 3.2678013667464256e-05
of O 0 5.3979569202056155e-05
all O 0 9.647906699683517e-05
Ashkenazi O 0 0.42099273204803467
Jewish O 1 0.9766704440116882
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.999992847442627
. O 0 0.01645064540207386

The O 0 0.0014798243064433336
estimated O 0 0.0007740230648778379
relative O 0 0.0005283413920551538
risk O 0 0.0006205651443451643
for O 0 0.00014123361324891448
carriers O 0 0.0005517455865629017
may O 0 7.519748760387301e-05
justify O 0 0.0001919414207804948
specific O 0 5.6890439736889675e-05
clinical O 0 0.00023856853658799082
screening O 0 0.00012708544090855867
for O 0 3.761061452678405e-05
the O 0 4.798095687874593e-05
360 O 0 0.0001497963967267424
, O 0 5.976361717330292e-05
000 O 0 0.00011444386473158374
Americans O 0 6.668274727417156e-05
expected O 0 4.83149487990886e-05
to O 0 2.8045957151334733e-05
harbor O 0 0.00027522954042069614
this O 0 3.883347744704224e-05
allele O 0 0.00010751521767815575
, O 0 3.1143710657488555e-05
and O 0 2.4939674403867684e-05
genetic O 0 3.8504174881381914e-05
testing O 0 3.720643144333735e-05
in O 0 1.2485978913900908e-05
the O 0 1.707245064608287e-05
setting O 0 4.3007854401366785e-05
of O 0 3.7422425521072e-05
long O 0 0.00030046849860809743
- O 0 0.004740607459098101
term O 0 0.0001469050912419334
- O 0 0.00046241728705354035
outcome O 0 8.105191955110058e-05
studies O 0 4.422776692081243e-05
may O 0 4.993790571461432e-05
impact O 0 0.00012935091217514127
significantly O 0 0.0002899064274970442
on O 0 0.0045095402747392654
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999984502792358
prevention O 1 0.9998205304145813
in O 0 0.0005647732177749276
this O 0 0.00025288230972364545
population O 0 0.0003624894598033279
. O 0 0.0008782502845861018

Localization O 0 0.010716056451201439
of O 0 0.001031385618261993
human O 0 0.001263194135390222
BRCA1 O 0 0.26828938722610474
and O 0 7.208249007817358e-05
its O 0 4.710899884230457e-05
loss O 0 0.00021403114078566432
in O 0 5.4630523663945496e-05
high O 0 0.0003713790501933545
- O 0 0.021394148468971252
grade O 0 0.024101562798023224
, O 0 0.0004061965155415237
non B-Disease 0 0.2767762839794159
- I-Disease 1 0.9995380640029907
inherited I-Disease 1 0.9999914169311523
breast I-Disease 1 0.9999977350234985
carcinomas I-Disease 1 0.9999879598617554
. O 0 0.015957122668623924

Although O 0 0.0010875043226405978
the O 0 0.0004593503545038402
link O 0 0.0005678163142874837
between O 0 0.00020197895355522633
the O 0 0.0005306589882820845
BRCA1 O 1 0.9999481439590454
tumour B-Disease 1 0.9999983310699463
- O 1 0.9975551962852478
suppressor O 1 0.9990605711936951
gene O 0 0.0042425356805324554
and O 0 0.009510817006230354
hereditary B-Disease 1 0.9999980926513672
breast I-Disease 1 1.0
and I-Disease 1 0.9999969005584717
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.28057241439819336
established O 0 0.002694573951885104
, O 0 5.264338687993586e-05
the O 0 4.1851872083498165e-05
role O 0 7.110208389349282e-05
, O 0 2.3351534764515236e-05
if O 0 1.2008846169919707e-05
any O 0 1.1062169505748898e-05
, O 0 1.4506326806440484e-05
of O 0 4.2672036215662956e-05
BRCA1 O 1 0.5565865635871887
in O 0 0.00012168753164587542
non B-Disease 1 0.7646009922027588
- I-Disease 1 0.9996342658996582
familial I-Disease 1 0.9999858140945435
cancers I-Disease 1 0.9999676942825317
is O 0 0.01001765951514244
unclear O 0 0.0023989675100892782
. O 0 0.0013760344590991735

BRCA1 O 1 0.985111653804779
mutations O 0 0.001039840397424996
are O 0 6.918428698554635e-05
rare O 0 0.00016877548478078097
in O 0 8.043011621339247e-05
sporadic B-Disease 1 0.5244206786155701
cancers I-Disease 1 0.9937043786048889
, O 0 0.00011689146776916459
but O 0 5.057208181824535e-05
loss O 0 0.007231709081679583
of O 0 0.0003736420476343483
BRCA1 O 1 0.9933370351791382
resulting O 0 0.002426981693133712
from O 0 9.253709140466526e-05
reduced O 0 0.00016145770496223122
expression O 0 0.00012167071690782905
or O 0 5.2112336561549455e-05
incorrect O 0 0.00013575708726420999
subcellular O 0 0.00048636223073117435
localization O 0 0.00040645082481205463
is O 0 4.254688246874139e-05
postulated O 0 0.00010991618182742968
to O 0 1.640950358705595e-05
be O 0 1.4718727470608428e-05
important O 0 2.89330037048785e-05
in O 0 4.337612699600868e-05
non B-Disease 0 0.002890258328989148
- I-Disease 1 0.9965813755989075
familial I-Disease 1 0.9999943971633911
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.999950647354126
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999983310699463
. O 0 0.3644098937511444

Epigenetic O 1 0.5492666363716125
loss O 1 0.6955921649932861
, O 0 0.00039333966560661793
however O 0 0.00014097447274252772
, O 0 7.205404835985973e-05
has O 0 4.596373764798045e-05
not O 0 2.187766403949354e-05
received O 0 6.631672295043245e-05
general O 0 0.00011646201892290264
acceptance O 0 0.00017864274559542537
due O 0 6.863564340164885e-05
to O 0 4.356877980171703e-05
controversy O 0 0.00020358724577818066
regarding O 0 7.14017151040025e-05
the O 0 6.837772525614128e-05
subcellular O 0 0.00043982741772197187
localization O 0 0.0005506225861608982
of O 0 0.00010882403148571029
BRCA1 O 0 0.14531482756137848
proteins O 0 5.121586946188472e-05
, O 0 3.539126555551775e-05
reports O 0 3.23803978972137e-05
of O 0 2.247584779979661e-05
which O 0 1.4213793292583432e-05
have O 0 1.2267168131074868e-05
ranged O 0 5.418721048044972e-05
from O 0 1.9661241822177544e-05
exclusively O 0 3.206077599315904e-05
nuclear O 0 7.408344390569255e-05
, O 0 2.6140713089262135e-05
to O 0 2.0590328858816065e-05
conditionally O 0 0.00015191287093330175
nuclear O 0 8.733743015909567e-05
, O 0 3.6956807889509946e-05
to O 0 2.4510496587026864e-05
the O 0 0.000108389176602941
ER O 1 0.9487691521644592
/ O 0 0.00981459766626358
golgi O 0 0.013922024518251419
, O 0 8.501063712174073e-05
to O 0 6.469798245234415e-05
cytoplasmic O 0 0.00038054969627410173
invaginations O 0 0.0022335334215313196
into O 0 0.00021350610768422484
the O 0 0.0003968338714912534
nucleus O 0 0.0032686807680875063
. O 0 0.0011451516766101122

In O 0 0.00048729617265053093
an O 0 0.00016493753355462104
attempt O 0 0.00023637346748728305
to O 0 4.562972753774375e-05
resolve O 0 0.000123895428259857
this O 0 4.069085116498172e-05
issue O 0 6.642368680331856e-05
, O 0 4.075784090673551e-05
we O 0 2.972874244733248e-05
have O 0 2.666227737790905e-05
comprehensively O 0 0.0004081102379132062
characterized O 0 0.0003493055119179189
19 O 0 0.0006229258724488318
anti O 1 0.5597890615463257
- O 1 0.9745294451713562
BRCA1 O 1 0.9969505071640015
antibodies O 0 0.01681884191930294
. O 0 0.001488184672780335

These O 0 0.0008284540963359177
reagents O 0 0.001358845504000783
detect O 0 0.00047419092152267694
a O 0 0.00022478747996501625
220 O 0 0.0004950862494297326
- O 0 0.0012490071821957827
kD O 0 0.006798484828323126
protein O 0 0.0001294469111599028
localized O 0 0.00017217807180713862
in O 0 4.392111441120505e-05
discrete O 0 0.00010343288158765063
nuclear O 0 0.00015626595995854586
foci O 0 0.0002767514670267701
in O 0 3.9805487176636234e-05
all O 0 6.031634984537959e-05
epithelial O 1 0.6254884600639343
cell O 0 0.00043865881161764264
lines O 0 9.451487130718306e-05
, O 0 3.808559995377436e-05
including O 0 3.0422168492805213e-05
those O 0 3.28408095811028e-05
derived O 0 0.0001424677175236866
from O 0 0.0003176365571562201
breast B-Disease 1 0.9992628693580627
malignancies I-Disease 1 0.9940600991249084
. O 0 0.001794151496142149

Immunohistochemical O 1 0.9877017140388489
staining O 1 0.503479540348053
of O 0 0.003392974380403757
human O 0 0.16746360063552856
breast O 1 0.9998682737350464
specimens O 0 0.002412297995761037
also O 0 0.0003066103090532124
revealed O 0 0.0018514953553676605
BRCA1 O 1 0.5623129606246948
nuclear O 0 0.0009280549711547792
foci O 0 0.06517248600721359
in O 0 0.0006927099311724305
benign O 1 0.9999479055404663
breast O 1 0.9999918937683105
, O 0 0.47541022300720215
invasive B-Disease 1 0.999987006187439
lobular I-Disease 1 0.9999996423721313
cancers I-Disease 1 0.9999028444290161
and O 0 0.004746762569993734
low B-Disease 1 0.7328468561172485
- I-Disease 1 0.9989193677902222
grade I-Disease 1 0.9998165965080261
ductal I-Disease 1 0.9999978542327881
carcinomas I-Disease 1 0.9999607801437378
. O 0 0.0041809375397861

Conversely O 0 0.13093972206115723
, O 0 0.002147146500647068
BRCA1 O 1 0.6995040774345398
expression O 0 0.0005269136163406074
was O 0 0.0004496139008551836
reduced O 0 0.00015103617624845356
or O 0 5.393393075792119e-05
undetectable O 0 0.0003838197735603899
in O 0 2.589962059573736e-05
the O 0 3.079474117839709e-05
majority O 0 2.9021768568782136e-05
of O 0 4.9697897338774055e-05
high O 0 0.0006762348348274827
- O 0 0.41378965973854065
grade O 1 0.8742328882217407
, O 0 0.04452043026685715
ductal B-Disease 1 0.9999982118606567
carcinomas I-Disease 1 0.9999692440032959
, O 0 0.00023168374900706112
suggesting O 0 0.00024089608632493764
that O 0 4.942179293720983e-05
absence O 0 0.0004207321908324957
of O 0 0.0003205239772796631
BRCA1 O 1 0.9969421029090881
may O 0 0.000127051753224805
contribute O 0 7.712653314229101e-05
to O 0 3.3415872167097405e-05
the O 0 6.754886999260634e-05
pathogenesis O 0 0.0144053278490901
of O 0 4.6133067371556535e-05
a O 0 6.131301779532805e-05
significant O 0 4.84483789477963e-05
percentage O 0 8.275922300526872e-05
of O 0 0.0004521180235315114
sporadic B-Disease 1 0.9993833303451538
breast I-Disease 1 0.9999985694885254
cancers I-Disease 1 0.9998376369476318
. O 0 0.0012076498242095113
. O 0 0.0013640058459714055

